data_2naf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2naf _Structure_validation_residue.Date_analyzed 2017-01-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 1.1 pm0 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.902 0.382 . . . . 74.409999999999997 110.315 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' CD ' ' HD2' ' A' ' 86' ' ' PRO . 93.9 Cg_endo -96.23 162.01 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.026 2.484 . . . . 71.5 113.495 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.676 HD11 HG22 ' A' ' 91' ' ' VAL . 58.0 tp -89.45 122.78 32.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.168 -0.924 . . . . 75.219999999999999 108.797 172.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.73 105.37 17.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.484 -0.561 . . . . 73.450000000000003 109.484 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.511 ' HB ' HD22 ' A' ' 62' ' ' LEU . 38.2 t -107.07 113.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 74.340000000000003 110.525 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HB ' HG22 ' A' ' 92' ' ' VAL . 58.3 t -109.86 118.1 56.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.669 -0.696 . . . . 74.340000000000003 109.716 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.27 122.72 7.45 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.201 -0.999 . . . . 74.319999999999993 111.779 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.437 HD12 ' HA3' ' A' ' 117' ' ' GLY . 46.5 tp -77.77 82.04 4.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.329 0.585 . . . . 75.010000000000005 109.79 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -164.2 101.73 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.271 -0.877 . . . . 55.5 111.104 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 65' ' ' PRO . 50.8 m-80 -88.38 146.94 38.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.494 -0.188 . . . . 72.040000000000006 110.494 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.446 ' CG ' ' HZ2' ' A' ' 64' ' ' LYS . 25.5 Cg_exo -62.96 96.43 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 123.06 2.507 . . . . 73.430000000000007 112.697 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . -122.33 119.1 3.86 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.38 -0.827 . . . . 73.019999999999996 111.3 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.45 -54.12 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 124.359 3.373 . . . . 75.310000000000002 114.58 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -105.09 -30.08 9.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.439 0.533 . . . . 71.519999999999996 112.439 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CZ ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 p90 -89.13 2.68 53.79 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.17 -0.612 . . . . 75.299999999999997 112.059 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 -1.51 52.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.893 0.377 . . . . 74.299999999999997 110.679 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.6 10.76 16.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.292 -0.413 . . . . 74.25 110.868 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.568 HG23 ' H ' ' A' ' 22' ' ' HIS . 6.2 t -105.1 -174.58 2.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.757 -0.377 . . . . 70.109999999999999 110.898 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 54.5 mtt180 -57.24 -20.94 30.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.61 0.596 . . . . 65.120000000000005 112.61 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.568 ' H ' HG23 ' A' ' 20' ' ' THR . 5.5 t-160 -91.65 14.05 16.27 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 72.150000000000006 111.609 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.17 1.06 57.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.837 -0.345 . . . . 74.319999999999993 110.379 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 88.0 mt -51.41 -48.11 62.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.822 -0.626 . . . . 71.349999999999994 111.745 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.76 93.34 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.958 -0.639 . . . . 71.310000000000002 112.846 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.679 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 77.9 t80 -80.35 -26.97 38.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.627 0.251 . . . . 75.299999999999997 110.824 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.902 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 7.2 mmt -55.18 -53.45 55.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 111.931 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.634 HG22 HG12 ' A' ' 93' ' ' ILE . 90.2 t -56.12 -45.57 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.76 0.314 . . . . 74.319999999999993 111.048 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -48.85 74.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 70.040000000000006 111.186 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.33 -40.02 96.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 55.350000000000001 110.814 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 166' ' ' VAL . 45.0 t -67.4 -45.63 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 74.329999999999998 111.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.36 -45.14 94.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 75.109999999999999 110.482 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.53 -31.72 73.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 74.349999999999994 110.549 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -45.47 49.53 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.598 -0.728 . . . . 70.209999999999994 113.081 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.468 ' HG3' HD12 ' A' ' 36' ' ' ILE . 13.1 ptp180 -70.36 -34.95 73.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.094 0.447 . . . . 74.129999999999995 110.933 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -71.65 -37.02 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.071 0.463 . . . . 74.120000000000005 110.117 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.17 53.44 2.66 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.74 -0.743 . . . . 75.049999999999997 112.202 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.6 m -147.6 144.82 28.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.651 0.263 . . . . 75.299999999999997 110.487 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.06 147.81 25.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.302 -0.408 . . . . 73.329999999999998 110.423 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 p90 -78.25 132.64 37.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 72.430000000000007 110.894 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -99.59 150.26 22.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.782 -0.645 . . . . 74.549999999999997 110.893 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.427 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 24.6 t -73.16 124.08 29.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 73.140000000000001 111.427 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -88.08 99.96 12.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 74.439999999999998 109.064 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -69.23 86.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 74.049999999999997 110.553 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -173.13 -62.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.07 -0.968 . . . . 72.549999999999997 109.189 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -99.48 -14.63 19.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.643 -0.708 . . . . 74.409999999999997 110.846 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.54 67.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.836 -0.697 . . . . 63.409999999999997 112.467 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB3' HD13 ' A' ' 79' ' ' LEU . . . -93.7 163.05 13.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.705 0.288 . . . . 75.129999999999995 110.767 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.921 ' HB2' ' HE3' ' A' ' 64' ' ' LYS . 29.8 mt-10 -124.04 131.48 53.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 61.420000000000002 110.274 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -133.33 139.14 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.521 . . . . 74.439999999999998 110.718 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 8.5 p -119.18 142.67 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.435 -0.348 . . . . 74.219999999999999 110.079 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.412 HG23 HG12 ' A' ' 61' ' ' VAL . 14.1 p -108.29 143.43 37.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.953 0.353 . . . . 74.450000000000003 111.953 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.18 -164.43 21.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.202 -0.523 . . . . 72.409999999999997 111.887 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -134.12 122.83 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.75 0.275 . . . . 64.209999999999994 110.622 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.048 HD21 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -111.16 119.1 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 62.32 109.486 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.02 -67.6 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.412 0.685 . . . . 75.140000000000001 111.656 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.43 12.79 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.982 -0.847 . . . . 61.329999999999998 110.982 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.516 ' O ' HD23 ' A' ' 55' ' ' LEU . 47.0 m -126.31 146.0 50.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 71.409999999999997 109.414 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 18.0 m -67.62 131.71 46.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.701 -0.481 . . . . 70.019999999999996 109.701 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.048 ' HB ' HD21 ' A' ' 55' ' ' LEU . 9.9 p -111.65 127.98 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.904 0.383 . . . . 75.049999999999997 110.132 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 52' ' ' THR . 11.5 m -117.13 109.26 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.308 0.575 . . . . 73.030000000000001 109.846 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.511 HD22 ' HB ' ' A' ' 7' ' ' VAL . 78.3 mt -92.57 106.36 18.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.561 -0.745 . . . . 75.409999999999997 109.748 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 127.88 55.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.814 -0.63 . . . . 74.0 110.922 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.921 ' HE3' ' HB2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -123.63 143.6 42.14 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.11 -0.7 . . . . 71.340000000000003 109.11 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.812 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 14.6 Cg_exo -69.65 175.59 7.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.179 2.586 . . . . 71.530000000000001 113.598 -173.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.653 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 7.1 ptm180 -77.38 -61.81 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 72.329999999999998 110.949 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.653 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 24.6 p -169.49 166.79 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.55 -0.537 . . . . 72.230000000000004 109.55 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.0 t80 70.27 144.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.657 0.741 . . . . 73.0 112.595 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.5 -56.17 20.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 75.530000000000001 111.721 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -58.04 -43.7 86.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.165 -0.471 . . . . 71.140000000000001 111.573 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 8.6 mm-40 -56.66 -41.57 77.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.530000000000001 111.132 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.5 m -57.5 -32.44 67.02 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.515 0.51 . . . . 72.430000000000007 111.306 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -65.16 -47.11 84.74 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.654 -0.784 . . . . 74.450000000000003 112.349 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 25.6 ptt180 -89.22 3.06 53.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.981 -0.288 . . . . 73.349999999999994 111.111 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.812 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 23.2 mm-40 -66.92 -38.24 85.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 71.209999999999994 110.783 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.11 -34.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.977 -0.556 . . . . 73.129999999999995 111.696 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.526 ' O ' ' HD3' ' A' ' 81' ' ' LYS . . . -54.18 -73.3 0.43 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.975 -0.557 . . . . 64.319999999999993 113.642 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 18.5 Cg_endo -59.79 -23.21 71.22 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.081 2.521 . . . . 72.140000000000001 113.407 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.565 HD13 ' HB3' ' A' ' 48' ' ' ALA . 34.8 mt -75.41 -43.03 52.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.071 -0.252 . . . . 75.030000000000001 111.386 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.77 80.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 71.5 110.825 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 77' ' ' GLY . 2.2 mptp? -80.79 -26.34 37.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.771 -0.649 . . . . 72.310000000000002 110.037 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -56.6 -52.45 64.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.602 -0.726 . . . . 75.219999999999999 110.857 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -94.92 -1.2 53.06 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.849 -0.34 . . . . 73.030000000000001 110.709 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 63.12 90.95 0.07 Allowed 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.787 0.679 . . . . 64.540000000000006 110.731 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.27 123.7 76.83 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.472 -0.786 . . . . 65.430000000000007 112.414 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.585 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 5.9 Cg_exo -79.81 113.35 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.804 2.336 . . . . 74.030000000000001 109.452 162.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 24.9 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.853 2.368 . . . . 74.420000000000002 113.778 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -92.6 -57.74 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 74.430000000000007 109.721 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -173.64 148.99 1.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.942 -0.572 . . . . 74.120000000000005 109.861 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 tt -124.18 122.1 63.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.335 0.588 . . . . 71.540000000000006 110.935 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.676 HG22 HD11 ' A' ' 5' ' ' LEU . 98.9 t -113.19 126.68 70.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 75.439999999999998 109.977 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 t -129.48 107.02 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 71.019999999999996 110.239 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.634 HG12 HG22 ' A' ' 28' ' ' VAL . 4.2 mp -84.5 133.74 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.702 -0.681 . . . . 73.420000000000002 109.329 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CE1' ' HG3' ' A' ' 132' ' ' ARG . 57.0 p-80 -151.8 179.58 8.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.895 0.379 . . . . 63.039999999999999 111.116 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.23 148.57 26.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.228 -0.897 . . . . 71.420000000000002 111.092 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.836 ' HG3' ' HB3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -140.95 115.04 9.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 73.299999999999997 110.374 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 137' ' ' VAL . 95.5 mt -82.75 -14.16 55.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.632 -0.713 . . . . 75.530000000000001 112.458 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -94.39 -12.13 28.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.902 0.382 . . . . 70.120000000000005 110.984 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.576 HD12 ' HD2' ' A' ' 105' ' ' ARG . 46.3 mm -106.63 139.45 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 72.340000000000003 111.895 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.83 142.21 30.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.958 -1.019 . . . . 72.230000000000004 111.617 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.3 t80 -68.43 115.12 7.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 64.239999999999995 111.241 -173.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.07 -16.78 6.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.329 -0.938 . . . . 71.099999999999994 113.635 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -114.21 159.97 19.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.402 0.601 . . . . 75.200000000000003 111.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.23 129.32 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 73.150000000000006 111.444 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.716 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 75.2 ttt180 -109.3 125.39 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.052 -0.722 . . . . 65.140000000000001 109.052 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.23 118.26 35.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 71.010000000000005 111.35 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.79 161.43 26.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.161 -0.681 . . . . 73.299999999999997 109.161 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.78 -72.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.232 0.456 . . . . 73.349999999999994 112.232 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.48 -126.19 3.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.364 -0.922 . . . . 73.319999999999993 113.56 -173.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.96 152.56 26.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.007 -0.616 . . . . 73.510000000000005 112.454 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.5 163.54 32.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.81 -0.71 . . . . 73.450000000000003 112.048 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.14 164.34 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.219 -0.289 . . . . 71.340000000000003 110.219 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -30.27 5.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.831 -0.7 . . . . 73.129999999999995 111.954 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.16 -170.58 24.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.952 -0.642 . . . . 72.120000000000005 111.649 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -103.14 -86.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.432 0.53 . . . . 72.0 112.432 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -118.24 -64.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.765 0.654 . . . . 73.439999999999998 112.765 -170.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.437 ' HA3' HD12 ' A' ' 10' ' ' LEU . . . -48.11 -49.43 24.29 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.495 0.497 . . . . 72.150000000000006 114.314 -168.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.567 ' H ' HD21 ' A' ' 118' ' ' LEU . 1.7 pt? -57.77 -35.06 70.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 73.420000000000002 111.883 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.473 ' HG3' ' HG ' ' A' ' 118' ' ' LEU . 78.8 mtp180 -80.18 -40.05 28.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.065 -0.516 . . . . 75.010000000000005 110.484 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.43 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 45.0 m -69.6 -42.5 74.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.624 -0.716 . . . . 71.439999999999998 112.154 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.47 -27.93 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.88 0.326 . . . . 72.540000000000006 111.88 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.37 91.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 73.219999999999999 110.731 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 m -79.23 -22.62 44.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.03 -0.532 . . . . 71.420000000000002 111.163 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.43 77.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 72.450000000000003 111.176 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.86 -41.59 6.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.338 -0.392 . . . . 73.219999999999999 111.025 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.28 -5.83 63.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.792 -0.718 . . . . 73.420000000000002 111.835 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 52.7 m -125.38 126.8 45.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.936 0.398 . . . . 74.409999999999997 110.171 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.58 -160.91 1.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.031 -0.531 . . . . 74.439999999999998 109.825 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 69.85 72.63 0.23 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.5 0.667 . . . . 75.400000000000006 111.204 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -140.86 -82.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.222 -0.899 . . . . 71.420000000000002 109.411 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -152.29 103.69 2.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 74.019999999999996 110.327 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.49 ' HG3' ' CE1' ' A' ' 94' ' ' HIS . 2.6 tpp180 -102.56 108.79 20.21 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 73.109999999999999 108.865 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 84.0 t -82.66 116.36 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.227 0.537 . . . . 73.239999999999995 111.211 -171.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.836 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 54.1 mtt180 -105.11 111.18 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.207 -0.906 . . . . 74.219999999999999 109.984 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 24' ' ' LEU . 58.4 mt -95.65 118.57 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.108 -0.701 . . . . 74.120000000000005 109.108 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -60.64 128.25 44.94 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.773 -0.727 . . . . 64.349999999999994 111.993 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 97' ' ' LEU . 8.9 p -98.51 -5.86 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 75.319999999999993 110.744 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.23 -108.5 0.93 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.643 -0.789 . . . . 73.510000000000005 112.402 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -153.98 157.13 32.49 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.418 -0.215 . . . . 75.349999999999994 110.418 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.93 135.01 56.67 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.718 2.279 . . . . 73.099999999999994 111.73 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.517 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 59.0 Cg_endo -73.29 164.76 34.38 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.77 2.313 . . . . 74.040000000000006 112.627 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -26.03 6.92 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.879 -0.677 . . . . 72.109999999999999 112.24 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -105.53 -66.96 0.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.731 0.301 . . . . 73.450000000000003 111.782 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -77.57 161.13 28.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.916 0.389 . . . . 75.010000000000005 111.621 -174.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.36 137.4 68.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.446 -0.797 . . . . 72.430000000000007 111.02 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.81 -44.7 30.81 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 63.140000000000001 113.417 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.26 -34.95 66.11 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.001 -0.28 . . . . 71.519999999999996 110.68 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.09 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 63.340000000000003 110.778 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.517 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 32.8 t80 -68.16 -26.56 65.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 72.519999999999996 110.318 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 25.3 t -81.66 -16.99 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.779 -0.646 . . . . 74.230000000000004 109.735 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.36 -11.25 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.716 -0.675 . . . . 75.129999999999995 110.858 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -113.64 104.66 12.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.17 0.509 . . . . 73.150000000000006 110.412 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.568 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 51.1 t30 -90.84 79.7 5.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 72.0 111.336 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.475 ' C ' ' HG1' ' A' ' 155' ' ' THR . 93.4 m-85 -146.56 135.67 22.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 72.450000000000003 109.585 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.602 HG23 ' H ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -154.29 -171.62 3.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.915 -0.772 . . . . 75.340000000000003 108.915 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.602 ' H ' HG23 ' A' ' 155' ' ' THR . . . -92.46 -71.62 0.64 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.855 0.316 . . . . 73.299999999999997 111.855 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.01 -51.66 4.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 73.120000000000005 111.689 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 1.1 pm0 -69.26 -17.03 63.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.784 . . . . 74.299999999999997 111.468 -172.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -64.48 -27.07 68.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.736 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.59 -20.2 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 111.032 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.7 6.92 39.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 75.400000000000006 111.791 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.669 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 84.2 t -53.66 -55.09 38.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.087 0.403 . . . . 75.319999999999993 112.087 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.6 Cg_exo -53.62 -39.81 81.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.027 1.818 . . . . 75.510000000000005 112.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 m -65.62 -50.96 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.36 -0.382 . . . . 63.539999999999999 111.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.12 -32.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 65.230000000000004 111.401 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.517 HG12 HG22 ' A' ' 31' ' ' VAL . 75.7 t -69.05 -45.87 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.636 -0.256 . . . . 74.530000000000001 111.109 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -60.13 -41.35 92.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.282 . . . . 71.230000000000004 110.635 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.25 -37.61 78.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 71.140000000000001 111.261 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.12 74.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 74.230000000000004 110.884 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.621 ' HA ' HG11 ' A' ' 28' ' ' VAL . . . -65.21 -34.33 78.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 73.239999999999995 110.838 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.28 -42.98 64.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.753 -0.658 . . . . 63.149999999999999 110.633 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -65.99 -25.86 67.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 75.129999999999995 111.087 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.8 m -61.27 -37.96 85.03 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 74.010000000000005 110.404 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 55' ' ' LEU . 34.0 tt0 -73.1 -30.76 63.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 74.540000000000006 110.078 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.19 -28.44 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 73.230000000000004 110.366 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.7 mt -64.94 -25.39 67.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 75.0 110.822 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.557 HD11 HD12 ' A' ' 5' ' ' LEU . 26.7 mm -80.72 -51.21 16.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 74.030000000000001 110.733 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -73.3 -42.5 62.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.651 . . . . 62.109999999999999 112.313 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.44 ' HA ' ' OE1' ' A' ' 179' ' ' GLN . 6.9 tp60 -93.46 -62.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.766 0.317 . . . . 70.230000000000004 111.325 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.38 -129.8 3.24 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.65 -0.786 . . . . 70.439999999999998 112.21 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 182' ' ' GLU . 3.0 pp -124.01 -46.77 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 74.310000000000002 111.923 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 44.8 tt0 -74.19 -57.56 2.22 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.671 0.249 . . . . 75.129999999999995 111.671 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.3 Cg_exo -63.97 -25.34 66.8 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.515 1.477 . . . . 73.030000000000001 111.475 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 188' ' ' VAL . . . -70.28 -50.18 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 65.510000000000005 110.89 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -65.56 -30.57 71.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.907 0.384 . . . . 73.400000000000006 110.141 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.56 -45.01 95.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 55.329999999999998 109.837 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 91.2 m -59.74 -42.45 93.2 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.989 -0.55 . . . . 72.040000000000006 110.685 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 184' ' ' ALA . 58.7 t -66.43 -34.28 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.949 -0.568 . . . . 74.439999999999998 111.892 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.35 5.94 46.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.196 -0.315 . . . . 73.040000000000006 111.844 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.04 -17.91 38.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 70.439999999999998 111.066 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.361 -0.828 . . . . 72.129999999999995 109.986 178.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.661 ' HG3' HG21 ' A' ' 58' ' ' THR . 10.3 pt-20 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.341 0.591 . . . . 75.019999999999996 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -96.57 113.39 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.56 2.84 . . . . 72.200000000000003 112.207 175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.619 HD13 HD11 ' A' ' 177' ' ' ILE . 45.7 tp -88.66 119.67 29.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.509 -0.314 . . . . 73.420000000000002 110.383 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.593 ' HA ' HG23 ' A' ' 61' ' ' VAL . 61.2 tp -92.67 107.12 18.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 74.5 109.861 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.641 ' HB ' HD21 ' A' ' 62' ' ' LEU . 42.7 t -98.05 117.36 42.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.025 -0.534 . . . . 71.340000000000003 109.756 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.24 114.84 41.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 74.439999999999998 110.002 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.83 122.75 7.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 71.120000000000005 111.732 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.67 100.06 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.864 0.364 . . . . 74.040000000000006 110.778 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.95 135.45 11.43 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.818 -0.628 . . . . 71.239999999999995 111.85 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 34.5 m-80 -139.32 129.04 14.25 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 110.225 -0.287 . . . . 74.540000000000006 110.225 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 31.8 Cg_exo -59.19 165.6 8.64 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.408 2.739 . . . . 74.329999999999998 113.483 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.63 111.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.748 -0.941 . . . . 75.409999999999997 110.748 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -45.22 -50.28 9.15 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.326 2.684 . . . . 70.239999999999995 113.155 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -100.98 -10.93 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.216 -0.447 . . . . 63.119999999999997 111.367 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.403 ' CD1' HD23 ' A' ' 151' ' ' LEU . 39.7 m-85 -101.18 1.81 39.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 74.5 112.258 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.573 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -87.71 -15.06 38.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.04 0.448 . . . . 73.540000000000006 110.625 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -105.5 9.78 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 75.030000000000001 110.412 -175.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 153' ' ' ASN . 75.6 p -111.74 -169.5 1.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.125 -0.489 . . . . 72.010000000000005 111.389 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 62.9 mtt180 -67.08 -4.94 11.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.042 0.449 . . . . 75.25 111.013 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -76.0 -8.76 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 75.140000000000001 111.142 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 24.4 m-80 -134.38 32.34 3.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.756 -0.202 . . . . 71.230000000000004 111.509 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.63 HD12 HG12 ' A' ' 137' ' ' VAL . 64.6 mt -58.29 -38.21 76.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.718 0.294 . . . . 65.329999999999998 111.437 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.36 87.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.837 -0.697 . . . . 65.010000000000005 112.303 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.428 ' HE1' ' HD2' ' A' ' 64' ' ' LYS . 87.3 t80 -73.61 -32.72 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.611 0.244 . . . . 75.230000000000004 110.867 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.4 mmt -53.44 -47.43 69.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.043 -0.526 . . . . 73.430000000000007 111.263 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.09 -42.93 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.056 -0.52 . . . . 71.129999999999995 110.77 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.413 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -61.96 -40.47 95.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 72.239999999999995 110.909 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.69 -46.82 88.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 71.450000000000003 110.242 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -33.22 59.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 75.519999999999996 111.173 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 29' ' ' ALA . 64.9 mt -57.74 -50.06 74.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.128 -0.323 . . . . 73.409999999999997 110.128 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.85 68.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.52 . . . . 64.409999999999997 110.673 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.87 -48.39 66.78 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.617 -0.719 . . . . 54.409999999999997 112.894 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -73.9 -22.76 59.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.169 0.485 . . . . 74.510000000000005 111.054 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -45.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.401 . . . . 65.409999999999997 110.001 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.6 37.02 4.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.939 -0.648 . . . . 61.299999999999997 111.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.4 m -153.45 117.79 4.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.728 0.299 . . . . 74.150000000000006 110.486 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.04 145.3 32.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.325 -0.398 . . . . 45.240000000000002 110.887 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.041 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 5.1 p90 -68.55 145.63 53.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 75.310000000000002 111.644 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.41 145.33 48.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 72.0 110.436 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.671 HG23 ' HG3' ' A' ' 49' ' ' GLU . 51.5 t -68.68 125.88 27.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.252 -0.431 . . . . 74.319999999999993 111.082 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -80.74 143.77 32.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 70.040000000000006 110.445 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 10.0 tmtt? -62.32 -63.91 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 74.510000000000005 111.129 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -74.0 -31.17 62.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.258 -0.428 . . . . 75.510000000000005 111.665 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 m -81.66 -28.04 33.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.859 0.361 . . . . 75.409999999999997 111.524 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.33 95.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.542 -0.837 . . . . 61.530000000000001 111.615 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.19 144.01 31.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.446 -0.205 . . . . 72.549999999999997 110.446 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HG3' HG23 ' A' ' 42' ' ' VAL . 2.6 mp0 -73.78 123.29 23.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.161 -0.472 . . . . 72.239999999999995 111.213 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.3 t -138.74 140.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.633 . . . . 73.540000000000006 109.662 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.041 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 14.5 p -136.84 148.43 26.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.301 . . . . 73.030000000000001 110.933 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.628 HG23 HG12 ' A' ' 61' ' ' VAL . 24.0 p -103.36 161.27 13.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.175 -0.466 . . . . 71.109999999999999 110.902 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.95 -161.28 30.66 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.133 -0.556 . . . . 74.340000000000003 111.799 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.587 ' HD2' ' HA ' ' A' ' 59' ' ' SER . 11.0 mmm180 -131.75 127.32 36.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.803 0.301 . . . . 75.409999999999997 110.201 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.112 HD22 ' HB ' ' A' ' 60' ' ' VAL . 1.6 pt? -121.78 119.03 30.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.578 . . . . 75.420000000000002 109.441 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . . . 58.45 10.16 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.767 -0.651 . . . . 71.239999999999995 112.667 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.07 -16.87 17.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.54 -0.838 . . . . 74.200000000000003 112.45 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.661 HG21 ' HG3' ' A' ' 3' ' ' GLU . 98.0 m -89.88 139.73 30.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.246 -0.279 . . . . 72.120000000000005 110.246 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.587 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 20.8 m -68.45 109.74 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.688 -0.486 . . . . 74.219999999999999 109.688 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.112 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -98.93 136.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.115 0.483 . . . . 71.230000000000004 111.058 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.628 HG12 HG23 ' A' ' 52' ' ' THR . 6.4 m -120.43 112.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.741 -0.663 . . . . 75.120000000000005 109.318 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' A' ' 7' ' ' VAL . 91.9 mt -91.91 109.58 20.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 74.230000000000004 109.629 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.7 129.3 51.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.02 -0.536 . . . . 74.409999999999997 110.964 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 3.4 ptmt -121.28 132.32 24.24 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.769 -0.65 . . . . 75.530000000000001 110.175 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 24.0 Cg_exo -64.34 155.88 63.17 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.46 2.107 . . . . 75.209999999999994 110.959 174.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 18.1 ptp180 -65.17 -59.74 3.77 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.927 -0.309 . . . . 72.299999999999997 110.958 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 5.0 p -169.44 152.31 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.896 -0.409 . . . . 55.420000000000002 109.896 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.2 t80 75.48 126.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.874 0.733 . . . . 74.409999999999997 111.393 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -60.81 -40.21 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.393 -0.821 . . . . 75.319999999999993 112.209 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.76 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 73.420000000000002 110.851 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 4.9 tm-20 -68.64 -38.15 80.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.872 -0.788 . . . . 72.420000000000002 108.872 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -64.66 -23.7 67.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.811 . . . . 61.399999999999999 111.237 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.09 -29.99 76.49 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.982 -0.554 . . . . 71.140000000000001 112.993 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 36.0 ptt180 -93.26 -1.9 55.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 73.319999999999993 110.585 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -93.93 -47.97 6.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.977 -0.556 . . . . 75.239999999999995 111.333 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.2 -33.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 61.049999999999997 112.051 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 -70.78 0.88 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.027 -0.606 . . . . 73.450000000000003 112.765 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.37 -29.19 88.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.885 2.39 . . . . 75.430000000000007 112.634 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.65 -49.0 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 73.239999999999995 111.467 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -62.98 -37.19 86.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 73.109999999999999 111.18 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -2.77 57.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.103 -0.498 . . . . 75.519999999999996 111.502 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.51 -33.12 70.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 75.230000000000004 110.265 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 6' ' ' LEU . 42.6 p90 -109.05 18.69 20.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.714 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.5 m 57.84 69.72 0.71 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.382 -0.827 . . . . 70.010000000000005 112.692 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 80' ' ' ALA . 3.9 p -130.08 145.91 59.23 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.077 -0.249 . . . . 75.209999999999994 110.517 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.75 145.92 87.45 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.984 1.789 . . . . 74.340000000000003 109.406 163.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.27 83.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.811 2.341 . . . . 63.439999999999998 113.691 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -159.66 -173.7 4.26 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.198 0.999 . . . . 72.349999999999994 108.762 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.475 ' NE2' ' HB2' ' A' ' 3' ' ' GLU . 14.5 mm100 57.53 31.52 20.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.201 0.445 . . . . 72.120000000000005 112.201 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.5 tt -111.33 135.46 50.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.979 0.419 . . . . 73.420000000000002 110.636 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.18 122.9 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.629 . . . . 73.310000000000002 109.757 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.8 114.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 74.540000000000006 111.038 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.546 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 63.7 mt -100.1 121.76 51.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.078 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.608 ' CE1' ' HG2' ' A' ' 134' ' ' ARG . 6.1 p-80 -159.59 -176.25 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 75.319999999999993 111.1 -176.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.18 154.93 22.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.209 -0.905 . . . . 74.540000000000006 111.791 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 8.9 tp10 -133.88 126.4 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.366 -0.605 . . . . 73.519999999999996 109.366 167.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.713 ' HA ' HG23 ' A' ' 137' ' ' VAL . 7.5 tt -82.97 -24.8 32.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 72.150000000000006 111.111 -172.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.93 4.38 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 73.409999999999997 111.342 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mm -111.15 140.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.506 -0.316 . . . . 74.140000000000001 110.689 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.1 136.35 35.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.801 -0.636 . . . . 75.329999999999998 112.179 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.601 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 72.5 t80 -63.08 128.91 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.744 . . . . 75.450000000000003 111.523 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 108.66 -14.21 35.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.626 -0.797 . . . . 53.420000000000002 113.415 172.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 69.7 mmt-85 -124.32 168.77 12.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.446 0.623 . . . . 72.319999999999993 110.83 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.46 133.38 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 75.120000000000005 111.373 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 10.6 tpp180 -113.56 127.73 56.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.79 -0.641 . . . . 74.219999999999999 109.388 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.48 153.3 18.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 74.310000000000002 111.026 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 112' ' ' GLU . 38.3 tptt -153.71 148.17 26.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.263 -0.643 . . . . 75.200000000000003 109.263 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.8 mp -123.59 -90.62 0.57 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.099 0.476 . . . . 73.450000000000003 111.141 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.51 106.08 2.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.177 -0.535 . . . . 62.219999999999999 112.413 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.44 151.25 5.4 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.91 -0.662 . . . . 73.400000000000006 111.734 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.63 78.33 1.61 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.963 -0.637 . . . . 71.129999999999995 111.675 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 107' ' ' LYS . 32.0 tt0 -120.79 122.39 40.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.093 -0.336 . . . . 75.430000000000007 110.093 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.569 ' HA2' ' OE1' ' A' ' 96' ' ' GLU . . . 152.03 134.89 2.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.383 -0.687 . . . . 74.510000000000005 111.383 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.84 2.69 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.555 -0.831 . . . . 71.219999999999999 114.258 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -152.82 140.85 20.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.444 0.622 . . . . 74.310000000000002 110.857 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -45.7 -55.29 6.64 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.624 0.972 . . . . 64.540000000000006 113.624 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.8 -41.18 19.76 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 114.793 0.677 . . . . 71.5 114.793 -166.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 132' ' ' ARG . 3.3 pp -67.0 -25.76 66.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.102 0.451 . . . . 75.040000000000006 111.8 -173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -39.57 26.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 74.400000000000006 110.238 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.8 m -67.1 -38.02 84.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 73.420000000000002 111.703 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.1 -33.34 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 75.5 111.058 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.78 -33.44 72.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 64.329999999999998 110.318 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -70.05 -21.86 63.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.613 -0.721 . . . . 74.340000000000003 110.775 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.39 -27.84 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 61.310000000000002 111.248 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -103.64 -41.43 5.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.083 -0.508 . . . . 74.329999999999998 110.695 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.02 -0.79 79.51 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.478 -0.649 . . . . 65.150000000000006 111.478 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.7 m -115.97 143.68 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.84 -0.43 . . . . 74.409999999999997 109.84 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -120.68 -161.93 0.92 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.297 -0.41 . . . . 73.430000000000007 109.9 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.52 18.86 2.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.658 0.742 . . . . 72.439999999999998 110.416 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 45.4 p90 -86.43 156.99 19.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.598 -0.728 . . . . 74.109999999999999 110.058 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.532 ' HD1' HD11 ' A' ' 176' ' ' LEU . 13.3 m-70 -78.29 110.8 13.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 73.420000000000002 110.577 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.491 ' HD2' ' HB2' ' A' ' 118' ' ' LEU . 32.0 ttp-105 -108.98 109.38 20.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.915 -0.584 . . . . 74.519999999999996 110.111 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 61.2 t -85.6 133.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.531 -0.758 . . . . 73.030000000000001 109.979 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.792 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 84.7 mtm180 -131.23 109.33 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.248 -0.433 . . . . 75.319999999999993 111.226 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.01 123.54 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 72.310000000000002 109.586 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.45 125.2 28.59 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.758 -0.734 . . . . 63.340000000000003 112.151 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' ' 97' ' ' LEU . 24.4 m -88.73 -12.45 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.785 0.326 . . . . 73.319999999999993 111.089 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 138.14 -142.18 12.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.761 -0.733 . . . . 63.509999999999998 111.929 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 138' ' ' GLY . 12.0 mmm180 -131.8 149.55 73.73 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.166 -0.679 . . . . 75.439999999999998 109.166 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 52.1 Cg_exo -55.26 114.5 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.678 2.252 . . . . 74.209999999999994 112.157 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.2 Cg_endo -82.72 160.34 16.46 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.205 2.604 . . . . 71.099999999999994 112.508 -176.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -18.71 9.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.928 -0.653 . . . . 55.219999999999999 112.245 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -87.14 -45.27 10.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.065 0.46 . . . . 75.049999999999997 110.52 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 32.7 pttt -119.65 144.02 47.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.648 -0.705 . . . . 73.420000000000002 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.62 139.64 89.44 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.751 -0.659 . . . . 71.129999999999995 110.868 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.09 -34.04 45.77 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.361 2.708 . . . . 74.530000000000001 113.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.6 61.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.099 0.476 . . . . 73.120000000000005 111.171 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.36 -18.78 29.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 54.329999999999998 110.454 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.426 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 63.9 t80 -69.32 -27.44 65.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 75.400000000000006 110.687 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.9 m -86.09 1.44 5.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.504 -0.316 . . . . 65.299999999999997 111.239 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.403 HD23 ' CD1' ' A' ' 17' ' ' TYR . 79.5 mt -95.53 1.33 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.632 0.234 . . . . 74.430000000000007 111.632 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.18 150.44 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 74.430000000000007 110.312 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.771 ' HB3' HG22 ' A' ' 20' ' ' THR . 27.1 p-10 -129.44 30.01 5.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.508 . . . . 71.200000000000003 111.223 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -146.84 143.76 28.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.138 -0.319 . . . . 71.319999999999993 110.138 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.64 177.18 11.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.808 -1.182 . . . . 73.140000000000001 107.808 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.6 -72.41 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.416 0.553 . . . . 40.020000000000003 112.252 -173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.17 -46.91 5.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.334 0.588 . . . . 53.119999999999997 111.885 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 1.2 pm0 -67.91 -17.21 64.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 73.439999999999998 112.064 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -65.31 -25.24 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.677 0.275 . . . . 74.319999999999993 110.387 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.61 -17.12 54.55 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.273 -0.421 . . . . 75.230000000000004 111.592 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' O ' HG21 ' A' ' 165' ' ' ILE . 60.6 mt-10 -85.84 -20.38 29.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.102 -0.239 . . . . 75.310000000000002 110.912 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.712 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 58.8 t -52.17 -55.79 27.99 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.399 . . . . 72.310000000000002 112.079 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 34.9 Cg_exo -61.94 -23.91 76.37 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.103 1.869 . . . . 63.240000000000002 112.525 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 11.5 m -81.8 -46.05 14.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.44 . . . . 63.450000000000003 111.021 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.528 HG22 ' CZ3' ' A' ' 191' ' ' TRP . 40.2 pt -65.94 -30.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.377 -0.374 . . . . 74.120000000000005 111.936 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 162' ' ' VAL . 56.2 t -61.25 -48.26 89.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 63.030000000000001 110.623 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.73 -39.73 95.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 110.744 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 164' ' ' THR . 71.9 mm-40 -65.68 -41.85 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 75.129999999999995 110.5 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.9 80.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 72.150000000000006 110.686 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.73 88.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 71.319999999999993 110.474 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.55 -37.05 76.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 74.319999999999993 110.362 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.84 -30.33 70.77 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 111.091 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 63.0 m -62.48 -43.34 99.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 61.310000000000002 110.143 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 41.3 mt-10 -71.72 -28.95 64.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 71.530000000000001 109.996 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.8 tp -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 71.540000000000006 110.545 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.532 HD11 ' HD1' ' A' ' 131' ' ' HIS . 85.1 mt -65.42 -22.0 66.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.819 -0.628 . . . . 73.439999999999998 110.69 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 5' ' ' LEU . 3.3 mm -80.49 -49.68 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.841 -0.618 . . . . 73.120000000000005 111.421 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.36 -28.53 12.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.511 0.93 . . . . 64.439999999999998 113.511 -167.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -100.59 -77.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.462 -0.495 . . . . 74.030000000000001 111.964 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -131.65 134.56 7.73 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.923 -1.132 . . . . 62.119999999999997 113.338 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.1 -34.39 38.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.933 0.397 . . . . 73.540000000000006 109.953 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.627 ' HG2' ' HD3' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -120.92 -36.28 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.702 1.001 . . . . 74.239999999999995 113.702 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.627 ' HD3' ' HG2' ' A' ' 182' ' ' GLU . 84.5 Cg_endo -81.55 -5.03 12.47 Favored 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 121.177 1.456 . . . . 74.150000000000006 113.635 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 187' ' ' THR . . . -69.47 -31.72 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 72.340000000000003 111.33 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.2 pt20 -67.97 -19.43 64.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 111.682 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -56.11 -43.09 77.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.329 . . . . 74.219999999999999 111.121 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 184' ' ' ALA . 15.4 t -76.44 -19.38 58.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.685 0.279 . . . . 62.43 111.132 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.89 -40.44 52.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 74.209999999999994 110.917 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -84.19 1.39 44.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.927 -0.309 . . . . 72.219999999999999 111.255 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.35 -4.02 57.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.917 0.389 . . . . 75.329999999999998 110.873 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.528 ' CZ3' HG22 ' A' ' 165' ' ' ILE . 17.7 t90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.318 -0.849 . . . . 71.019999999999996 110.364 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.433 ' HG3' HG21 ' A' ' 58' ' ' THR . 7.4 pt-20 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 121.051 0.453 . . . . 74.239999999999995 110.816 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HG2' HG11 ' A' ' 85' ' ' VAL . 14.0 Cg_endo -92.31 113.56 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.623 2.882 . . . . 65.099999999999994 112.615 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.647 HD11 HG13 ' A' ' 177' ' ' ILE . 95.7 mt -72.21 114.9 10.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.543 -0.753 . . . . 74.340000000000003 110.689 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 85' ' ' VAL . 42.9 tp -93.68 104.66 16.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.008 -0.738 . . . . 70.430000000000007 109.008 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.608 ' HB ' HD23 ' A' ' 62' ' ' LEU . 47.9 t -109.94 123.79 66.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.334 -0.394 . . . . 74.239999999999995 110.175 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 57.8 t -110.13 114.82 48.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.668 . . . . 72.109999999999999 110.292 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.29 122.37 7.42 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.244 -0.742 . . . . 65.439999999999998 111.244 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.771 ' HG ' ' HE1' ' A' ' 22' ' ' HIS . 30.3 tp -85.92 82.73 8.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.363 0.601 . . . . 75.439999999999998 110.998 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -150.49 118.26 0.91 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.342 -0.845 . . . . 75.239999999999995 111.115 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.64 151.56 37.61 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.497 -0.186 . . . . 75.420000000000002 110.497 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.27 161.62 45.33 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.465 2.11 . . . . 74.310000000000002 112.464 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' HA3' ' HD1' ' A' ' 17' ' ' TYR . . . 148.75 142.74 3.67 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.852 -0.613 . . . . 74.140000000000001 111.782 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.33 -42.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.826 2.35 . . . . 64.019999999999996 112.216 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 20' ' ' THR . 8.0 p -90.76 -37.93 13.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.937 -0.574 . . . . 64.310000000000002 110.856 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HD1' ' HA3' ' A' ' 14' ' ' GLY . 84.9 m-85 -62.04 -35.09 77.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.896 -0.593 . . . . 73.219999999999999 112.281 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 -13.25 60.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 75.200000000000003 111.104 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -112.06 28.26 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 74.409999999999997 110.334 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.797 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 79.2 p -102.12 -176.39 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.841 -0.618 . . . . 72.329999999999998 110.906 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -86.41 -15.42 40.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.476 0.655 . . . . 74.530000000000001 109.503 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.771 ' HE1' ' HG ' ' A' ' 10' ' ' LEU . 14.8 t-80 -76.75 -22.25 54.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.145 -0.934 . . . . 74.540000000000006 110.405 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' HG2' ' A' ' 27' ' ' MET . 65.7 t30 -73.78 -0.08 14.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.006 0.432 . . . . 73.510000000000005 111.266 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.39 -29.5 68.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.562 -0.29 . . . . 73.400000000000006 111.254 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.32 -30.71 78.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.926 -0.654 . . . . 72.510000000000005 112.49 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 67.2 t80 -90.36 -22.38 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.784 -0.244 . . . . 74.25 110.833 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.446 ' O ' HG21 ' A' ' 31' ' ' VAL . 26.2 mmt -50.49 -48.3 56.9 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 111.766 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.88 -46.86 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 73.010000000000005 110.803 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.31 82.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 73.150000000000006 111.388 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.4 -37.27 84.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.398 . . . . 74.329999999999998 111.04 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 27' ' ' MET . 62.6 t -65.51 -39.04 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.181 0.515 . . . . 73.439999999999998 109.852 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.85 -43.27 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.624 . . . . 75.340000000000003 110.698 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.22 90.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 72.239999999999995 110.906 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.49 91.26 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.982 -0.554 . . . . 72.140000000000001 112.878 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -70.13 -24.2 63.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.818 0.309 . . . . 73.140000000000001 111.206 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.613 HD12 ' HA3' ' A' ' 53' ' ' GLY . 82.7 mt -77.58 -49.77 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.409 -0.589 . . . . 73.420000000000002 109.409 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.99 62.19 1.07 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.84 -0.695 . . . . 54.310000000000002 112.425 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.4 m -156.3 144.62 19.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.919 0.39 . . . . 73.319999999999993 110.718 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.98 151.65 27.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 73.420000000000002 110.215 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.98 138.54 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 110.672 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -101.36 126.6 48.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 75.530000000000001 110.043 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 t -78.1 129.75 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 74.430000000000007 110.301 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -68.79 102.71 1.6 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.622 -0.263 . . . . 65.400000000000006 110.776 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 58.7 tttm -64.11 88.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.121 -0.696 . . . . 74.230000000000004 109.121 172.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.8 tttp 174.22 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.928 -1.033 . . . . 74.530000000000001 109.021 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 p -125.15 -19.18 5.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.538 -0.755 . . . . 73.319999999999993 111.477 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.73 18.23 45.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 53.420000000000002 112.955 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.65 123.43 35.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.579 0.228 . . . . 74.329999999999998 110.654 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 2.2 mp0 -84.98 140.34 31.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 74.109999999999999 110.928 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -139.4 137.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 110.404 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 6.9 p -118.91 145.49 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.709 -0.478 . . . . 74.439999999999998 109.709 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.533 HG22 HG11 ' A' ' 61' ' ' VAL . 1.6 m -116.71 142.59 46.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.232 -0.44 . . . . 65.219999999999999 111.637 -172.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.613 ' HA3' HD12 ' A' ' 36' ' ' ILE . . . -178.17 -161.53 26.39 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.173 -0.771 . . . . 73.230000000000004 111.173 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.954 ' HG2' ' HA ' ' A' ' 59' ' ' SER . 37.2 mtm180 -136.34 146.09 46.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.916 0.389 . . . . 72.0 110.684 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.59 103.05 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 74.019999999999996 109.698 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.19 -51.58 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.963 0.79 . . . . 75.540000000000006 111.713 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.21 -36.98 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.048 -0.821 . . . . 63.329999999999998 111.048 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 3' ' ' GLU . 4.1 m -68.58 151.56 46.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.439 0.295 . . . . 74.299999999999997 110.37 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.954 ' HA ' ' HG2' ' A' ' 54' ' ' ARG . 21.9 m -85.72 139.98 30.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.678 . . . . 70.310000000000002 109.171 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.35 132.1 52.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.368 0.604 . . . . 74.230000000000004 111.307 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.533 HG11 HG22 ' A' ' 52' ' ' THR . 8.3 m -117.68 115.5 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 71.25 109.333 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.608 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.7 mt -92.42 104.59 16.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.951 -0.568 . . . . 74.040000000000006 109.838 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -108.98 137.58 46.68 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 73.0 110.146 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 49' ' ' GLU . 12.8 ptmm? -130.71 143.01 47.61 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 71.530000000000001 110.498 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.41 166.67 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.521 2.147 . . . . 64.430000000000007 111.635 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -84.8 -54.14 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.798 -0.361 . . . . 73.239999999999995 111.395 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.9 p -167.67 163.54 14.41 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.699 0.259 . . . . 71.209999999999994 111.699 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 69.41 163.81 0.24 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.976 0.797 . . . . 72.040000000000006 112.565 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.0 mmt -73.24 -56.61 4.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.922 -0.581 . . . . 72.230000000000004 110.946 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.08 -40.65 87.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.817 -0.629 . . . . 70.329999999999998 111.783 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 67' ' ' CYS . 42.7 mt-10 -59.84 -40.31 88.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.523 -0.308 . . . . 64.439999999999998 110.861 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -36.27 83.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.863 0.363 . . . . 64.310000000000002 110.53 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.459 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.88 -39.89 97.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.46 -0.656 . . . . 73.530000000000001 111.46 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.28 -0.54 19.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 75.129999999999995 110.726 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.542 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 23.0 mm-40 -103.53 -51.05 3.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 74.430000000000007 111.038 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.81 -34.69 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 70.310000000000002 111.31 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.32 -67.19 2.34 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.989 -0.55 . . . . 72.349999999999994 113.374 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.87 -27.6 59.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.692 2.261 . . . . 63.229999999999997 113.612 -177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 47.2 mt -57.5 -40.55 78.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.848 0.314 . . . . 73.239999999999995 111.848 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.73 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.022 0.439 . . . . 74.329999999999998 111.378 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.99 -7.41 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.354 -0.385 . . . . 73.140000000000001 111.235 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -79.12 -46.65 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.83 0.348 . . . . 74.230000000000004 110.128 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -93.03 1.45 57.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 111.232 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 60.46 37.57 19.74 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.686 0.617 . . . . 72.400000000000006 110.752 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 6' ' ' LEU . 27.5 m -92.15 142.98 26.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.81 -0.632 . . . . 64.340000000000003 110.466 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.81 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 4.1 Cg_exo -77.0 133.9 14.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.68 2.253 . . . . 70.129999999999995 111.81 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.545 ' O ' HG22 ' A' ' 90' ' ' ILE . 36.2 Cg_endo -66.0 -4.56 10.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.974 2.45 . . . . 74.430000000000007 112.587 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.81 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.9 pt20 -71.62 -20.38 61.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.105 -0.498 . . . . 75.299999999999997 110.598 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.746 ' HG3' ' HG3' ' A' ' 88' ' ' GLN . 97.9 mt-30 -124.43 24.52 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.083 -0.508 . . . . 74.439999999999998 111.655 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 87' ' ' PRO . 13.1 tt -86.93 105.5 15.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.757 0.789 . . . . 74.5 110.176 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.77 113.38 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.369 -0.832 . . . . 73.109999999999999 110.631 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.62 114.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.408 -0.36 . . . . 73.400000000000006 110.157 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 58.3 mt -101.26 120.16 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.913 -0.585 . . . . 74.409999999999997 109.776 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.41 ' CE1' HD21 ' A' ' 118' ' ' LEU . 32.1 p80 -142.01 174.9 10.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.966 0.413 . . . . 72.219999999999999 111.349 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' CG ' ' HE2' ' A' ' 115' ' ' HIS . 8.9 p-10 -84.21 148.28 26.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.219 -0.901 . . . . 74.340000000000003 109.529 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.662 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -139.5 128.85 24.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.079 0.466 . . . . 74.040000000000006 110.389 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.55 -33.93 25.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.68 -0.691 . . . . 74.340000000000003 111.681 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.53 -38.49 26.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 64.140000000000001 111.392 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.604 HG12 ' OE1' ' A' ' 96' ' ' GLU . 37.9 mm -65.58 143.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 71.439999999999998 111.628 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 12.1 m-20 -57.07 139.59 51.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.602 -0.726 . . . . 73.150000000000006 111.218 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.704 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 80.3 t80 -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 74.430000000000007 111.683 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.26 -24.38 22.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.656 -0.702 . . . . 62.439999999999998 112.825 174.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -90.92 130.92 36.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.145 0.498 . . . . 65.409999999999997 110.842 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.42 114.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.947 -0.76 . . . . 74.099999999999994 108.947 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -107.48 125.19 50.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 75.319999999999993 110.254 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.3 mt -103.89 135.19 45.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.616 -0.72 . . . . 74.150000000000006 110.526 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.26 156.54 45.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.944 -0.762 . . . . 75.310000000000002 108.944 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.37 -132.4 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.463 -0.569 . . . . 73.109999999999999 109.463 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' A' ' 129' ' ' ASN . . . 49.34 -153.01 2.92 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.423 -0.418 . . . . 71.319999999999993 112.759 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.35 173.29 27.29 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.778 -0.929 . . . . 74.010000000000005 110.778 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 119' ' ' ARG . . . -83.55 85.49 1.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.146 -1.026 . . . . 64.319999999999993 111.922 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 -43.01 11.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.635 0.255 . . . . 75.040000000000006 111.268 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.84 109.23 2.87 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.146 -0.55 . . . . 75.430000000000007 112.343 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.48 -100.85 0.2 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.057 -0.592 . . . . 74.209999999999994 111.969 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.483 ' HE2' ' CG ' ' A' ' 95' ' ' ASP . 4.8 p80 -164.17 173.99 11.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.585 0.231 . . . . 74.129999999999995 111.322 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -40.21 -56.17 1.99 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.129 1.159 . . . . 74.200000000000003 114.129 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.44 -29.25 72.82 Favored Glycine 0 CA--C 1.509 -0.283 0 C-N-CA 121.233 -0.508 . . . . 73.439999999999998 112.476 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 23.5 tp -65.83 -38.67 89.53 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.426 -0.387 . . . . 73.340000000000003 110.68 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 111' ' ' GLY . 1.7 mpp_? -79.65 -23.25 42.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.76 -0.376 . . . . 70.129999999999995 110.625 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -66.95 -44.81 79.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 63.0 110.603 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.459 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.2 m -69.3 -27.77 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 74.340000000000003 110.798 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.16 -43.57 61.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.109999999999999 110.524 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -70.28 -25.52 63.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 65.129999999999995 111.589 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.68 92.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 52.549999999999997 110.643 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.52 -42.07 20.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.855 -0.611 . . . . 74.230000000000004 110.336 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.08 1.81 88.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.935 -0.65 . . . . 60.539999999999999 111.757 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.621 HG21 ' HE1' ' A' ' 130' ' ' PHE . 4.8 m -111.5 122.66 48.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.931 0.396 . . . . 72.120000000000005 110.308 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 53.7 mtmt -126.63 178.83 5.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 110.453 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.481 ' HA ' ' N ' ' A' ' 109' ' ' GLY . 22.8 m-20 75.35 67.71 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.862 0.726 . . . . 74.329999999999998 112.112 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.621 ' HE1' HG21 ' A' ' 127' ' ' THR . 60.5 m-85 -142.99 -87.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 74.109999999999999 111.337 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.478 ' C ' ' HD2' ' A' ' 132' ' ' ARG . 12.7 t60 -161.88 104.97 1.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.635 0.255 . . . . 72.329999999999998 110.644 -174.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 131' ' ' HIS . 2.6 mpt_? -114.27 141.03 48.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.529 0.204 . . . . 73.109999999999999 110.549 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 93.5 t -104.19 118.23 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 72.120000000000005 111.047 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.662 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 35.6 mtp180 -112.41 104.67 12.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.061 -0.518 . . . . 71.549999999999997 110.254 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.3 mt -85.81 115.09 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.85 -0.426 . . . . 72.209999999999994 109.85 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.31 118.77 11.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.902 -0.666 . . . . 73.049999999999997 112.651 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.52 -11.51 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 73.140000000000001 110.086 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.704 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 136.9 -77.55 0.34 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 73.519999999999996 113.326 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -170.73 165.6 5.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.983 -0.377 . . . . 72.030000000000001 109.983 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 53.1 Cg_exo -53.85 142.1 64.25 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.474 2.116 . . . . 73.340000000000003 111.279 171.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 25.3 Cg_exo -61.72 -66.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 123.027 2.485 . . . . 75.099999999999994 113.327 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.7 -69.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.589 -0.815 . . . . 65.109999999999999 112.438 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 143' ' ' ARG . 10.5 mmt180 -82.01 -70.07 0.57 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.85 0.357 . . . . 74.200000000000003 110.778 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.571 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -80.89 159.99 24.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 73.430000000000007 110.486 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.742 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 2.5 p30 -79.76 166.39 41.21 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.548 -0.296 . . . . 74.439999999999998 110.776 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 10.9 Cg_endo -53.79 -36.0 80.98 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.371 2.714 . . . . 72.019999999999996 113.986 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.15 77.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 72.439999999999998 110.603 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.91 -31.87 59.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.083 -0.508 . . . . 72.219999999999999 110.216 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.571 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 88.9 t80 -64.5 -42.81 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.567 -0.742 . . . . 71.230000000000004 111.321 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.797 ' O ' ' HB ' ' A' ' 20' ' ' THR . 34.9 m -83.28 -9.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.915 -0.314 . . . . 74.129999999999995 111.167 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.409 ' O ' HG21 ' A' ' 20' ' ' THR . 49.5 tp -83.75 -25.63 30.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.104 0.478 . . . . 74.530000000000001 111.136 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.04 176.68 8.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.962 0.41 . . . . 75.019999999999996 110.616 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -81.26 171.97 14.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 72.420000000000002 110.662 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.563 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 40.3 m-85 -65.44 145.13 56.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 73.340000000000003 110.097 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -68.92 162.2 27.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.284 -0.265 . . . . 73.400000000000006 110.284 -178.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.92 9.52 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.033 0.753 . . . . 75.530000000000001 113.033 -162.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.74 88.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.012 0.434 . . . . 62.329999999999998 112.13 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.566 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 2.2 pm0 -89.34 -16.58 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.077 -0.511 . . . . 74.5 111.655 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.735 ' HB2' ' O ' ' A' ' 155' ' ' THR . 60.2 ttt180 -61.04 -25.09 66.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 74.439999999999998 111.424 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.33 -14.4 62.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.283 -0.417 . . . . 75.010000000000005 111.919 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -111.4 5.97 20.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.742 0.306 . . . . 73.310000000000002 111.245 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.518 HG21 ' HZ ' ' A' ' 101' ' ' PHE . 94.8 t -63.82 -52.73 55.41 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.449 -0.341 . . . . 63.439999999999998 111.746 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 11.3 Cg_endo -55.53 -33.79 87.63 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.927 1.752 . . . . 70.140000000000001 111.873 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.7 m -65.95 -49.46 67.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.625 -0.716 . . . . 75.030000000000001 111.178 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 162' ' ' VAL . 35.3 pt -67.89 -30.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.431 -0.35 . . . . 75.239999999999995 111.42 -175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.4 t -63.9 -45.47 96.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.402 . . . . 73.340000000000003 110.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -67.86 -37.6 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 71.239999999999995 110.812 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -63.65 -44.31 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 74.299999999999997 110.896 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.95 98.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.219 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.24 96.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 111.253 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.84 -44.14 86.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 73.299999999999997 110.522 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.615 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -64.3 -37.96 89.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 73.109999999999999 111.664 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 87.3 m -58.32 -40.36 81.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.865 0.364 . . . . 71.310000000000002 111.045 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.13 -40.03 90.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 71.329999999999998 110.235 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.55 -37.34 87.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 74.239999999999995 110.885 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 87.1 mt -60.18 -42.86 95.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 74.5 111.868 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.647 HG13 HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.87 -27.28 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 74.319999999999993 110.382 -176.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -83.96 -58.28 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.216 -0.447 . . . . 54.439999999999998 111.841 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -24.98 35.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 72.030000000000001 111.439 -175.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 113.89 -161.13 12.81 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.641 -0.79 . . . . 75.209999999999994 112.112 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.64 -68.8 0.68 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.741 0.305 . . . . 73.450000000000003 110.847 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.64 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.6 tt0 -55.02 -55.3 40.48 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.155 0.798 . . . . 75.120000000000005 113.155 -172.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 23.1 Cg_exo -65.16 -31.06 54.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.15 1.9 . . . . 64.430000000000007 113.087 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.43 -48.71 7.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.504 0.557 . . . . 74.099999999999994 112.504 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -20.23 65.7 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 121.216 -0.193 . . . . 74.219999999999999 111.51 -174.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -53.54 -51.08 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.415 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -72.28 -21.62 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 71.319999999999993 111.266 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.8 t -70.11 -24.2 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 73.530000000000001 111.283 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -116.91 13.38 14.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.882 0.372 . . . . 72.030000000000001 110.388 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.11 27.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.092 -0.503 . . . . 71.099999999999994 111.092 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.428 ' HH2' HG22 ' A' ' 165' ' ' ILE . 15.1 p-90 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.301 -0.857 . . . . 75.510000000000005 110.912 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 14.3 pt-20 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.252 0.548 . . . . 72.329999999999998 110.414 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 1.3 Cg_endo -83.71 110.19 1.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.805 2.337 . . . . 73.420000000000002 112.113 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 89' ' ' GLN . 36.7 tp -74.32 118.35 17.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 75.040000000000006 109.846 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.457 ' HA ' HG23 ' A' ' 61' ' ' VAL . 69.8 tp -92.8 104.96 17.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.18 -0.464 . . . . 75.040000000000006 110.128 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.488 ' HB ' HD23 ' A' ' 62' ' ' LEU . 44.9 t -105.58 121.27 57.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.246 -0.434 . . . . 72.329999999999998 110.408 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.95 114.87 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.754 -0.657 . . . . 74.430000000000007 109.902 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.85 123.15 6.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.846 -0.692 . . . . 73.329999999999998 111.846 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 96.16 1.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.846 0.355 . . . . 74.129999999999995 110.199 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -111.93 85.68 0.4 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.783 -0.723 . . . . 61.200000000000003 112.993 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 28.0 m-80 -100.89 117.75 61.91 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.995 -0.372 . . . . 73.25 109.995 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 3.0 Cg_exo -75.49 177.79 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.155 2.57 . . . . 74.129999999999995 112.369 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 17' ' ' TYR . . . 155.5 179.05 30.32 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.04 -0.6 . . . . 72.310000000000002 111.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.09 -71.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.885 2.39 . . . . 74.340000000000003 111.559 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.593 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 15.1 t -117.33 6.26 12.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.815 -0.809 . . . . 71.420000000000002 108.815 172.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.2 t80 -69.19 -26.09 64.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.778 -1.101 . . . . 75.219999999999999 110.313 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . . . -87.48 1.6 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 74.409999999999997 110.983 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.593 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -120.72 3.18 10.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.445 . . . . 75.030000000000001 110.435 -178.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.821 ' HA ' ' HB3' ' A' ' 153' ' ' ASN . 14.9 t -103.7 -177.66 3.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.918 0.39 . . . . 73.129999999999995 111.875 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' HD3' HG11 ' A' ' 137' ' ' VAL . 61.6 mtt180 -64.92 -20.72 66.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.0 -0.546 . . . . 74.400000000000006 111.63 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.506 ' H ' HG21 ' A' ' 20' ' ' THR . 5.9 t60 -78.78 -7.99 58.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.972 0.415 . . . . 71.040000000000006 110.576 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.26 8.22 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 72.120000000000005 110.43 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 75.0 mt -55.74 -29.8 60.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.511 -0.313 . . . . 75.120000000000005 111.67 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.56 -33.05 86.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 72.030000000000001 112.462 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.617 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 87.5 t80 -88.36 -30.7 19.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.544 0.212 . . . . 72.439999999999998 110.718 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mmm -50.19 -42.89 52.12 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 64.010000000000005 111.993 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 t -69.53 -47.15 73.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.345 . . . . 75.430000000000007 110.789 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.57 74.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.29 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.3 -45.43 91.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 74.420000000000002 110.9 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.8 t -72.85 -36.82 53.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.592 . . . . 74.030000000000001 110.503 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.03 -44.99 96.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.876 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.83 80.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 64.409999999999997 110.554 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.59 95.21 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.866 -0.606 . . . . 74.420000000000002 112.832 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -21.57 54.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 117.044 0.422 . . . . 75.549999999999997 111.314 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.507 HD12 ' HA3' ' A' ' 53' ' ' GLY . 80.6 mt -77.84 -43.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.585 -0.524 . . . . 73.310000000000002 109.585 173.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.04 33.81 5.89 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.868 -0.682 . . . . 75.319999999999993 111.942 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -145.66 135.32 23.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.746 0.308 . . . . 73.109999999999999 110.253 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 148.44 24.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.287 -0.415 . . . . 74.299999999999997 110.693 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.771 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 11.1 p90 -66.31 124.72 23.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.61 . . . . 75.129999999999995 110.638 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -101.1 143.88 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 110.608 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 ' HG2' ' A' ' 49' ' ' GLU . 19.7 t -81.69 135.55 24.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 73.120000000000005 111.584 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.36 104.51 16.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.932 -0.577 . . . . 74.319999999999993 109.97 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.48 90.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.9 -0.408 . . . . 75.109999999999999 109.9 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.5 tptt 174.34 -58.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.251 -0.886 . . . . 74.219999999999999 108.695 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -106.76 -14.33 15.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.345 -0.843 . . . . 74.120000000000005 110.519 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 83.76 3.9 89.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.943 -0.646 . . . . 62.200000000000003 112.348 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.38 144.29 28.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.821 0.344 . . . . 75.409999999999997 110.746 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.615 ' HG2' HG21 ' A' ' 42' ' ' VAL . 36.2 mt-10 -108.56 122.16 46.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.944 -0.571 . . . . 72.109999999999999 109.637 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -129.15 137.56 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.441 -0.345 . . . . 72.200000000000003 110.476 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.771 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 5.0 p -121.47 135.63 61.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.934 0.397 . . . . 75.400000000000006 110.2 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.762 HG23 HG13 ' A' ' 61' ' ' VAL . 11.9 p -106.71 136.58 46.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.132 -0.485 . . . . 70.310000000000002 110.982 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' A' ' 36' ' ' ILE . . . -160.7 -161.14 11.22 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.473 -0.87 . . . . 45.219999999999999 112.576 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 13.2 mmt180 -121.59 142.41 50.13 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 73.5 110.088 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.122 HD23 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -126.9 115.77 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.726 -0.842 . . . . 74.219999999999999 108.726 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.6 -36.83 0.31 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.706 -0.679 . . . . 65.230000000000004 111.305 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 165.88 -33.15 0.23 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.852 -0.899 . . . . 72.239999999999995 110.852 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 59' ' ' SER . 1.7 m -75.37 169.24 18.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.372 -0.414 . . . . 73.439999999999998 110.759 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.465 ' H ' HG21 ' A' ' 58' ' ' THR . 2.9 m -79.78 131.46 35.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.753 0.311 . . . . 74.040000000000006 111.383 -175.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.122 ' HB ' HD23 ' A' ' 55' ' ' LEU . 12.1 p -127.06 137.42 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.94 -0.392 . . . . 74.230000000000004 109.94 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.762 HG13 HG23 ' A' ' 52' ' ' THR . 12.4 m -120.25 115.4 47.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.209 0.528 . . . . 74.400000000000006 110.532 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 61.9 mt -96.79 105.0 17.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 74.230000000000004 109.586 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.2 127.58 55.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.979 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 6.4 ptmt -119.15 126.69 26.91 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.393 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.759 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 39.6 Cg_exo -61.53 149.74 88.4 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.398 2.065 . . . . 65.099999999999994 110.619 173.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 25.7 ptt180 -64.55 -53.42 48.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 75.109999999999999 111.13 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 29.1 p -168.57 174.69 6.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.422 -0.214 . . . . 64.329999999999998 110.422 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.534 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 9.9 t80 75.27 138.27 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.047 0.842 . . . . 74.099999999999994 112.316 167.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.97 -52.69 62.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 64.230000000000004 111.322 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.56 -36.65 76.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 111.17 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 6.4 mt-10 -60.31 -43.55 96.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.705 -0.225 . . . . 64.150000000000006 110.821 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -54.87 -32.42 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.372 0.42 . . . . 70.409999999999997 111.341 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.793 ' HA2' HG11 ' A' ' 121' ' ' VAL . . . -67.47 -39.21 91.27 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.895 -0.669 . . . . 64.109999999999999 112.118 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.416 ' NH2' ' HG2' ' A' ' 71' ' ' GLU . 20.1 ptt180 -91.09 2.75 56.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 73.219999999999999 110.681 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.759 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 24.6 mm-40 -81.23 -51.89 7.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 74.230000000000004 110.22 174.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.17 -44.77 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.757 -0.656 . . . . 63.310000000000002 112.29 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.79 -66.23 2.7 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.135 -0.484 . . . . 75.420000000000002 113.674 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 -41.43 78.87 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.867 2.378 . . . . 75.200000000000003 113.0 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.03 -39.54 95.05 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.768 0.284 . . . . 74.299999999999997 111.768 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.38 91.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.0 0.428 . . . . 73.140000000000001 111.163 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.9 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.172 -0.467 . . . . 71.299999999999997 111.068 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.88 -42.12 97.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 72.209999999999994 109.696 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -82.16 -15.28 53.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.723 -0.671 . . . . 73.230000000000004 110.621 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m 62.37 34.68 15.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.762 -0.653 . . . . 62.409999999999997 110.515 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.4 m -100.29 143.99 27.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.757 -0.656 . . . . 71.319999999999993 110.635 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 10.5 Cg_exo -71.2 115.62 4.35 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.733 2.289 . . . . 64.099999999999994 111.574 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.39 33.28 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.185 2.59 . . . . 73.140000000000001 113.4 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -78.65 -48.75 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.339 -0.615 . . . . 74.430000000000007 109.339 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.519 ' HB3' HD11 ' A' ' 5' ' ' LEU . 1.8 mp0 -88.86 68.59 8.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.751 -0.659 . . . . 71.230000000000004 109.812 175.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.17 138.03 31.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.54 -0.755 . . . . 75.230000000000004 110.388 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.1 t -127.75 109.88 20.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 73.329999999999998 110.067 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 58.5 t -105.78 113.43 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.702 -0.481 . . . . 73.5 109.702 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 58.2 mt -93.46 122.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.062 -0.517 . . . . 75.010000000000005 110.396 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.424 ' HE1' ' CB ' ' A' ' 115' ' ' HIS . 16.7 t-80 -149.02 162.89 39.01 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.643 -0.423 . . . . 74.239999999999995 112.129 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.56 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 8.8 p-10 -90.34 139.28 30.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.465 -0.789 . . . . 71.530000000000001 110.314 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.795 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 75.8 mm-40 -137.23 140.38 41.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.911 0.386 . . . . 71.549999999999997 111.734 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.454 HD23 ' HB ' ' A' ' 137' ' ' VAL . 95.1 mt -84.22 -25.6 29.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.819 -0.628 . . . . 74.400000000000006 112.039 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.2 -34.47 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.468 0.651 . . . . 61.549999999999997 110.542 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.666 ' HB ' ' HA2' ' A' ' 136' ' ' GLY . 9.2 mt -84.64 139.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.473 -0.785 . . . . 74.140000000000001 109.999 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -67.08 144.77 55.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.883 -0.414 . . . . 72.329999999999998 109.883 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 65.7 t80 -63.37 124.4 21.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 75.140000000000001 110.773 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.88 -21.11 8.0 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.059 -1.067 . . . . 61.219999999999999 113.469 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -123.69 169.11 11.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.541 0.671 . . . . 75.109999999999999 111.234 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.61 HG12 HG13 ' A' ' 135' ' ' ILE . 65.9 mt -118.65 139.38 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.918 -0.583 . . . . 70.019999999999996 110.745 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.427 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 25.6 tpt180 -111.98 124.15 51.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 73.219999999999999 110.049 176.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.2 mt -108.21 127.25 53.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 74.040000000000006 110.181 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -154.8 151.03 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.49 -0.559 . . . . 75.430000000000007 109.49 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 1.3 pt? -67.3 -71.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 74.140000000000001 111.668 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.862 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -153.75 155.31 26.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.724 -0.55 . . . . 64.319999999999993 111.724 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.41 176.56 18.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.947 -0.644 . . . . 72.200000000000003 111.691 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.0 77.45 2.11 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.73 -0.748 . . . . 73.5 111.899 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -129.83 21.31 5.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.709 0.766 . . . . 73.549999999999997 109.341 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -145.78 95.42 0.17 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.457 -0.792 . . . . 62.43 112.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.99 67.5 3.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 62.5 112.112 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.575 ' CE1' ' HA ' ' A' ' 96' ' ' GLU . 33.0 m80 -139.19 146.04 40.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 73.349999999999994 111.008 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.66 -55.15 38.77 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.642 -0.708 . . . . 75.439999999999998 111.95 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.72 -28.84 70.22 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.853 -0.612 . . . . 64.209999999999994 112.081 -168.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 74.430000000000007 110.127 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.98 -27.24 60.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.794 -0.639 . . . . 74.430000000000007 110.139 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.2 m -66.69 -52.17 47.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 73.5 110.766 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.793 HG11 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -66.33 -30.65 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.737 0.303 . . . . 70.340000000000003 110.84 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.02 71.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 111.138 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.4 m -84.62 -35.58 22.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 62.5 111.101 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.5 . . . . 64.219999999999999 111.269 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 -42.43 12.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.205 0.526 . . . . 74.230000000000004 110.076 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.13 -13.38 32.69 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.732 -0.667 . . . . 64.439999999999998 112.879 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 p -114.01 122.93 48.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.408 0.623 . . . . 72.129999999999995 111.624 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 4.5 mptt -99.75 -91.7 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.79 -1.189 . . . . 75.209999999999994 107.79 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 55.07 7.97 0.21 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.854 1.798 . . . . 73.349999999999994 115.854 162.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.31 -90.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.955 0.798 . . . . 72.439999999999998 111.923 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -175.92 135.38 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 63.310000000000002 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.562 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 10.5 mpt_? -121.49 124.53 44.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.083 -0.508 . . . . 71.409999999999997 110.056 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 59.1 t -83.9 104.07 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.688 -0.486 . . . . 71.0 109.688 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.795 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 49.1 mtm-85 -122.64 127.6 49.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.883 0.373 . . . . 75.219999999999999 110.53 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 104' ' ' ILE . 3.8 mp -94.28 139.9 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.567 -0.742 . . . . 73.319999999999993 109.859 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.666 ' HA2' ' HB ' ' A' ' 99' ' ' ILE . . . -72.61 129.66 14.13 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.868 -0.682 . . . . 72.530000000000001 112.646 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.607 HG11 ' HD3' ' A' ' 21' ' ' ARG . 27.3 t -95.92 -11.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.316 0.579 . . . . 73.310000000000002 109.972 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.14 166.52 26.83 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.676 -0.773 . . . . 71.530000000000001 111.849 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.42 146.56 50.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.172 -0.307 . . . . 73.099999999999994 110.172 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.63 120.59 7.74 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.012 2.475 . . . . 64.439999999999998 113.122 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.91 158.94 40.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.239 2.626 . . . . 73.040000000000006 112.558 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.25 -24.66 6.73 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.855 -0.688 . . . . 55.409999999999997 112.805 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -83.82 -70.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.711 0.255 . . . . 73.450000000000003 110.738 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.573 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -89.29 157.11 18.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.465 -0.494 . . . . 75.200000000000003 110.594 178.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.28 133.0 92.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 73.540000000000006 111.738 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.56 -29.04 88.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.252 2.635 . . . . 72.230000000000004 113.06 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.463 . . . . 63.409999999999997 109.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 152' ' ' GLU . . . -69.36 -28.65 66.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.61 -0.723 . . . . 64.430000000000007 109.975 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.573 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 87.0 t80 -65.13 -29.59 70.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 74.310000000000002 110.809 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.3 -23.22 10.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 75.129999999999995 110.343 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.35 -26.01 30.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 75.140000000000001 111.081 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.539 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 8.9 pt-20 -87.31 153.28 21.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 74.150000000000006 110.501 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.821 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 34.9 p-10 -132.77 14.18 4.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 72.439999999999998 110.908 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.513 ' C ' ' HG1' ' A' ' 155' ' ' THR . 72.3 m-85 -107.03 156.08 19.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 75.200000000000003 110.304 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -169.83 178.37 4.06 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.716 -1.216 . . . . 74.239999999999995 107.716 175.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.93 -72.95 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.234 -0.586 . . . . 72.030000000000001 111.074 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.57 -24.02 16.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.465 0.65 . . . . 73.420000000000002 110.194 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 22.3 mp0 -68.6 -36.83 79.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.316 -0.856 . . . . 75.319999999999993 110.556 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.55 ' HA ' HG22 ' A' ' 162' ' ' VAL . 7.7 tpt180 -68.1 -17.61 64.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 73.420000000000002 110.501 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.07 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 73.409999999999997 110.919 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 165' ' ' ILE . 34.8 mt-10 -89.7 -5.42 57.06 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.179 -0.208 . . . . 72.420000000000002 111.534 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.653 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 85.2 t -56.32 -51.8 78.08 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.667 0.247 . . . . 73.219999999999999 111.667 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 23.9 Cg_exo -64.97 -29.52 57.44 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.761 1.64 . . . . 64.219999999999999 111.984 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.1 m -73.59 -40.25 64.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.761 -0.654 . . . . 75.400000000000006 111.83 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.481 HD12 HG22 ' A' ' 135' ' ' ILE . 34.8 pt -64.93 -30.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 121.031 -0.268 . . . . 65.310000000000002 110.969 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.01 -39.34 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.418 . . . . 74.129999999999995 109.98 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 163' ' ' PRO . 8.8 mm-40 -58.59 -50.62 73.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.697 -0.683 . . . . 71.209999999999994 110.413 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.99 -32.88 72.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.745 -0.661 . . . . 74.439999999999998 111.232 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.39 78.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 74.219999999999999 110.606 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.86 95.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.497 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.99 -50.06 75.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 65.400000000000006 110.961 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.673 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.85 -44.97 96.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 74.400000000000006 111.702 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.5 m -56.32 -42.78 78.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 75.450000000000003 111.359 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.84 -29.45 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 74.340000000000003 110.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.11 -28.62 66.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 74.530000000000001 110.472 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.2 mt -60.04 -47.34 86.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.862 -0.608 . . . . 75.420000000000002 111.084 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -37.37 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.545 . . . . 74.319999999999993 110.832 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -77.79 -54.51 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.83 0.307 . . . . 64.209999999999994 111.83 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -94.34 -57.28 2.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.404 -0.362 . . . . 75.430000000000007 110.632 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 159.77 151.74 6.26 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.744 -0.741 . . . . 64.310000000000002 111.848 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.5 ' HA ' ' CD2' ' A' ' 176' ' ' LEU . 4.0 pp -71.92 -24.55 61.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.841 0.353 . . . . 75.430000000000007 111.546 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.463 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 30.0 tt0 -82.9 -51.96 0.67 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.387 -0.369 . . . . 73.450000000000003 111.612 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 17.2 Cg_endo -59.9 -35.9 92.21 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.058 1.839 . . . . 73.540000000000006 112.168 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.14 -45.32 89.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.349 . . . . 73.049999999999997 110.331 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -54.72 -49.78 69.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.738 -0.664 . . . . 63.140000000000001 110.783 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 189' ' ' HIS . 57.8 t30 -57.69 -35.93 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 74.5 110.861 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.2 m -70.69 -54.24 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 64.299999999999997 110.992 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.3 t -67.83 -43.32 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.61 0.596 . . . . 74.239999999999995 112.61 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 186' ' ' ASN . 1.3 p80 -76.09 -3.81 38.03 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.667 -0.413 . . . . 74.549999999999997 111.39 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.98 22.08 8.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.096 0.474 . . . . 62.229999999999997 110.429 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.8 t90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.404 -0.808 . . . . 74.219999999999999 110.354 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.519 -0.549 . . . . 74.140000000000001 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.876 ' HB2' HG13 ' A' ' 85' ' ' VAL . 5.6 Cg_endo -87.8 118.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.77 2.314 . . . . 75.129999999999995 112.617 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.6 tp -88.0 121.14 30.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 72.040000000000006 109.651 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.663 HD22 HD12 ' A' ' 90' ' ' ILE . 61.1 tp -92.87 117.5 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.969 -0.382 . . . . 64.519999999999996 109.969 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.744 ' HB ' HD22 ' A' ' 62' ' ' LEU . 46.4 t -113.53 118.06 57.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.655 -0.498 . . . . 73.430000000000007 109.655 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.53 114.96 45.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.886 -0.597 . . . . 71.019999999999996 109.97 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.502 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -105.9 122.17 7.02 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.568 -0.825 . . . . 72.019999999999996 111.674 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.79 89.59 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 75.200000000000003 110.711 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.814 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -142.75 110.55 0.62 Allowed Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.488 -0.778 . . . . 75.349999999999994 111.4 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.39 149.96 47.98 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.531 0.205 . . . . 74.319999999999993 110.664 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.671 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 73.7 Cg_endo -74.39 175.91 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.454 2.102 . . . . 60.119999999999997 111.791 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 17' ' ' TYR . . . 121.34 136.79 5.11 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.423 -0.894 . . . . 71.310000000000002 112.1 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.68 -28.7 82.73 Favored 'Trans proline' 0 C--O 1.225 -0.147 0 C-N-CA 123.159 2.573 . . . . 74.129999999999995 112.988 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 t -113.08 16.35 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 74.510000000000005 111.062 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CD1' ' HA3' ' A' ' 14' ' ' GLY . 75.5 m-85 -106.28 -34.87 7.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 70.510000000000005 111.611 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.14 -4.5 25.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.247 0.832 . . . . 74.439999999999998 113.247 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.619 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -124.42 27.78 6.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.127 0.489 . . . . 72.510000000000005 110.753 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 69.5 p -102.5 -170.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.738 -0.665 . . . . 75.319999999999993 110.087 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 55.0 mtt180 -84.52 -0.73 54.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.986 0.422 . . . . 62.409999999999997 110.459 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -105.21 19.49 20.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 72.140000000000001 110.683 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -99.08 3.31 46.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.377 -0.374 . . . . 74.409999999999997 110.596 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.424 HD13 HG13 ' A' ' 137' ' ' VAL . 91.1 mt -55.67 -42.76 75.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.781 -0.645 . . . . 74.340000000000003 112.064 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -64.38 -37.75 94.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.65 -0.786 . . . . 53.530000000000001 112.004 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.814 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 75.4 t80 -73.21 -32.77 64.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.263 -0.273 . . . . 73.129999999999995 110.263 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.865 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 9.0 mmt -54.21 -54.02 45.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 74.319999999999993 111.692 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.95 -45.04 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 73.319999999999993 110.919 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.64 95.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 73.019999999999996 111.117 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.93 -42.27 97.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 71.120000000000005 110.978 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 27' ' ' MET . 90.4 t -61.88 -44.18 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.310000000000002 110.585 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.38 -40.9 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 73.340000000000003 110.8 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.24 86.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.942 0.401 . . . . 74.5 110.532 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.9 -42.51 85.74 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.769 -0.65 . . . . 71.040000000000006 113.01 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.554 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.3 ptm180 -68.05 -31.32 70.89 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.984 0.392 . . . . 71.530000000000001 111.371 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.554 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 71.040000000000006 109.945 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.31 43.29 4.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.95 -0.643 . . . . 73.120000000000005 112.265 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -129.56 158.62 38.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.671 0.272 . . . . 73.040000000000006 110.595 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.91 165.33 11.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 73.439999999999998 109.496 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.421 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 35.4 p90 -80.38 143.84 33.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.204 0.526 . . . . 74.420000000000002 111.339 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -106.44 133.46 51.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 73.230000000000004 109.336 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.57 124.23 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.348 . . . . 75.409999999999997 110.661 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -71.53 104.86 3.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.94 -0.573 . . . . 73.150000000000006 110.302 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 1.3 tmmt? -73.79 83.79 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.583 . . . . 71.099999999999994 109.734 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 170.84 -48.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.673 -1.148 . . . . 74.329999999999998 109.151 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -104.45 -28.43 11.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.465 -0.789 . . . . 74.129999999999995 110.702 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.2 9.49 73.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.852 -0.69 . . . . 75.400000000000006 111.475 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.29 134.23 34.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 43.450000000000003 111.131 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 8.8 mt-10 -91.67 131.95 36.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.793 -0.64 . . . . 71.030000000000001 110.291 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.31 137.15 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 73.510000000000005 110.494 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 62' ' ' LEU . 3.8 p -126.99 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.746 -0.464 . . . . 71.120000000000005 109.746 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.766 HG21 HG13 ' A' ' 61' ' ' VAL . 24.4 p -108.8 151.32 26.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 73.200000000000003 111.944 -173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.31 -161.81 20.37 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.752 -0.658 . . . . 65.099999999999994 111.612 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.644 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 20.3 mmt180 -133.15 139.17 46.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.751 -0.462 . . . . 70.310000000000002 109.751 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.062 HD21 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -130.18 116.7 18.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.659 0.266 . . . . 72.319999999999993 110.295 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 68.5 -27.96 0.15 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.672 0.789 . . . . 74.129999999999995 112.594 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 156.69 -30.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.537 -1.025 . . . . 72.400000000000006 110.537 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -79.36 157.22 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.674 -0.763 . . . . 73.319999999999993 109.785 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.644 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 14.0 t -83.21 136.09 34.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.332 -0.618 . . . . 74.340000000000003 109.332 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.062 ' HB ' HD21 ' A' ' 55' ' ' LEU . 10.9 p -117.43 124.23 72.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.211 0.529 . . . . 74.209999999999994 110.672 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 52' ' ' THR . 8.9 m -113.04 111.78 37.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.322 0.582 . . . . 72.040000000000006 109.71 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 7' ' ' VAL . 54.7 mt -92.79 115.81 28.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.585 -0.734 . . . . 71.530000000000001 110.47 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.5 147.62 41.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 74.239999999999995 110.218 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 17.0 ptmt -132.96 131.78 22.1 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.336 -0.393 . . . . 64.439999999999998 111.081 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 12.4 Cg_endo -57.37 136.11 74.14 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.915 2.41 . . . . 63.229999999999997 111.187 172.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.671 ' HD2' ' HG3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -92.61 -59.96 1.94 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.82 -0.352 . . . . 74.349999999999994 111.512 -172.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.4 p -156.92 145.12 19.49 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.12 -0.232 . . . . 75.230000000000004 110.981 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.627 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 35.7 t80 66.43 115.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 124.177 0.923 . . . . 75.230000000000004 111.09 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.543 ' HG2' ' HB3' ' A' ' 116' ' ' ASN . 1.9 mpt? -51.71 -56.27 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.312 -0.858 . . . . 73.209999999999994 111.94 -174.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.627 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 47.9 t30 -55.26 -49.71 71.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.246 -0.434 . . . . 72.150000000000006 111.136 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 mm-40 -59.52 -49.9 76.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 63.25 111.127 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.488 ' O ' HG21 ' A' ' 76' ' ' VAL . 50.7 m -60.48 -40.78 92.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.322 -0.399 . . . . 75.239999999999995 111.142 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.53 -43.33 97.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.902 -0.665 . . . . 61.039999999999999 112.048 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 70' ' ' ASN . 34.5 mtp-105 -69.82 -32.95 71.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.752 0.31 . . . . 74.340000000000003 110.521 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 81.2 mm-40 -65.15 -28.28 69.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.919 -0.582 . . . . 74.129999999999995 111.858 -177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 72' ' ' SER . 55.6 t -65.66 -31.12 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 72.510000000000005 110.847 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.31 -69.62 1.21 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.962 -0.563 . . . . 75.319999999999993 112.993 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.91 -36.32 95.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.916 2.411 . . . . 73.349999999999994 112.77 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.52 -39.01 89.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 110.262 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.21 90.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 60.009999999999998 111.258 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -18.99 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.399 -0.364 . . . . 74.439999999999998 111.101 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.43 -37.32 80.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.357 -0.383 . . . . 71.400000000000006 110.548 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -101.53 4.17 40.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 74.420000000000002 111.321 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 m 63.44 31.93 14.71 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.888 -0.596 . . . . 71.530000000000001 111.546 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.876 HG13 ' HB2' ' A' ' 4' ' ' PRO . 16.7 m -81.78 143.35 50.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.383 . . . . 72.420000000000002 110.584 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 7.9 Cg_exo -73.64 137.85 25.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.679 2.253 . . . . 53.439999999999998 111.498 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.99 -10.76 24.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.812 2.342 . . . . 75.420000000000002 113.121 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.11 -26.96 18.04 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.034 -0.266 . . . . 74.200000000000003 110.486 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -95.09 62.68 2.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.258 0.551 . . . . 74.140000000000001 110.422 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.663 HD12 HD22 ' A' ' 6' ' ' LEU . 8.1 tt -140.41 117.34 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 72.099999999999994 110.57 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.17 114.38 35.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 74.239999999999995 110.182 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.558 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 48.4 t -96.99 108.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 72.120000000000005 110.824 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.512 HD12 ' HB ' ' A' ' 133' ' ' VAL . 44.0 mm -89.62 119.32 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.778 -0.646 . . . . 74.420000000000002 109.699 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -138.47 165.22 27.39 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.411 -0.516 . . . . 72.319999999999993 111.183 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.75 142.33 29.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 72.519999999999996 109.358 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.847 ' HG2' HG12 ' A' ' 99' ' ' ILE . 18.4 tp10 -127.34 123.23 35.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.838 0.351 . . . . 71.239999999999995 111.357 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.9 mt -84.21 -14.76 49.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 72.120000000000005 111.254 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.88 -31.99 17.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 71.140000000000001 111.646 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.847 HG12 ' HG2' ' A' ' 96' ' ' GLU . 29.0 mm -85.52 146.21 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 74.109999999999999 111.408 -173.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' CG ' ' A' ' 103' ' ' ARG . 14.2 m-20 -64.31 153.28 38.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.631 -0.713 . . . . 72.430000000000007 111.04 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.1 111.29 4.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.131 -0.692 . . . . 75.310000000000002 109.131 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.815 ' HA2' HD11 ' A' ' 165' ' ' ILE . . . 101.65 6.08 50.45 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.483 -0.865 . . . . 43.409999999999997 112.104 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 27.1 mmt180 -103.33 141.83 35.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.756 0.313 . . . . 74.530000000000001 110.778 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 mt -107.93 136.86 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.682 -0.859 . . . . 75.519999999999996 108.682 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.54 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -144.04 162.27 36.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 72.099999999999994 110.562 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.81 133.06 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.868 0.366 . . . . 73.040000000000006 110.359 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 57.1 tptt -106.52 105.06 14.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 75.120000000000005 109.869 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.828 ' H ' HD21 ' A' ' 108' ' ' LEU . 1.2 pt? -78.59 -133.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.979 -0.555 . . . . 70.109999999999999 110.672 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.7 132.78 11.32 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.538 -0.839 . . . . 74.099999999999994 111.117 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 150.01 5.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.961 -1.114 . . . . 65.349999999999994 113.083 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.0 -153.34 29.44 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.176 -0.769 . . . . 55.299999999999997 111.176 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 78.85 -61.21 0.36 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.497 0.719 . . . . 75.049999999999997 111.92 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.25 115.82 5.01 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.116 -0.564 . . . . 74.140000000000001 112.068 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.09 -114.31 0.58 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.03 -0.828 . . . . 74.019999999999996 111.03 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -174.89 -82.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.495 0.188 . . . . 72.409999999999997 111.182 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.543 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 14.6 m120 -130.78 -70.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.531 0.567 . . . . 75.219999999999999 112.531 -172.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.3 -17.8 80.12 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 121.063 -0.589 . . . . 55.439999999999998 112.055 -167.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.11 -30.62 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.981 -0.61 . . . . 65.409999999999997 110.649 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -79.82 -29.15 40.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 74.310000000000002 111.12 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.9 m -75.31 -47.03 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 75.140000000000001 111.687 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.89 -21.98 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.53 -0.305 . . . . 73.319999999999993 111.585 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.82 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 53.100000000000001 111.599 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -70.6 -39.81 73.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.269 -0.423 . . . . 72.219999999999999 111.675 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.48 58.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 53.5 111.339 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.41 -41.83 62.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.319 -0.401 . . . . 72.200000000000003 110.996 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.96 2.42 52.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.878 -0.677 . . . . 73.329999999999998 112.039 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 m -131.19 121.02 24.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.792 0.33 . . . . 74.430000000000007 110.396 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.588 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -99.25 -64.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.714 -0.847 . . . . 75.310000000000002 108.714 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.7 t30 31.74 61.55 0.29 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.861 1.265 . . . . 73.030000000000001 114.099 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.755 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 84.2 m-85 70.57 -23.45 0.17 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.893 1.442 . . . . 74.209999999999994 114.893 166.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -79.98 53.64 1.73 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.607 0.966 . . . . 73.540000000000006 113.607 -169.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.558 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 1.3 mpp_? -137.35 111.26 8.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.8 -0.445 . . . . 75.129999999999995 109.8 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 93' ' ' ILE . 57.6 t -85.24 131.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.081 0.467 . . . . 74.239999999999995 110.583 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 105' ' ' ARG . 49.0 mtp180 -106.18 117.28 33.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.679 -0.691 . . . . 75.129999999999995 110.027 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.58 118.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.938 -0.764 . . . . 64.230000000000004 108.938 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.31 12.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.668 . . . . 45.509999999999998 113.451 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.424 HG13 HD13 ' A' ' 24' ' ' LEU . 35.6 m -94.11 2.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 65.150000000000006 110.669 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.13 179.84 17.15 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.044 -0.598 . . . . 74.140000000000001 112.007 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.433 ' H ' ' HG3' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -70.69 149.95 95.33 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.469 0.135 . . . . 74.5 110.921 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 47.2 Cg_exo -37.74 128.55 0.82 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.253 3.302 . . . . 75.040000000000006 113.935 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.9 Cg_exo -73.69 135.07 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.477 2.784 . . . . 73.0 112.625 -177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -112.68 162.23 12.44 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.063 -0.815 . . . . 71.530000000000001 111.063 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 143' ' ' ARG . 2.0 tpm_? 71.63 -75.21 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.132 0.573 . . . . 63.32 110.132 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.486 ' HD2' ' HD1' ' A' ' 149' ' ' PHE . 6.8 ptpp? -78.82 144.44 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.075 -0.342 . . . . 74.299999999999997 110.075 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.33 139.93 94.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.108 -0.497 . . . . 73.010000000000005 110.246 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.0 -28.89 19.99 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.254 2.636 . . . . 74.129999999999995 113.437 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -68.42 -36.19 78.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.377 . . . . 73.319999999999993 110.802 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.57 -25.64 30.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.466 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' HD1' ' HD2' ' A' ' 144' ' ' LYS . 90.3 t80 -62.28 -38.08 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.679 -0.692 . . . . 72.099999999999994 110.987 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.612 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.5 m -84.94 -0.61 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.395 . . . . 73.109999999999999 111.369 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 147' ' ' ALA . 73.1 mt -98.42 12.47 34.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 72.230000000000004 111.22 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 11.1 pt-20 -129.24 177.06 7.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.489 -0.323 . . . . 70.219999999999999 110.414 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -77.74 177.97 7.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.931 -0.577 . . . . 64.010000000000005 111.377 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.498 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 68.1 m-85 -80.06 165.05 22.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 74.430000000000007 110.81 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.637 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -75.95 -153.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.84 0.311 . . . . 74.200000000000003 111.84 -175.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.39 -70.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.059 0.392 . . . . 74.219999999999999 112.059 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.33 -44.66 35.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 72.549999999999997 111.386 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.93 -21.6 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.907 -0.588 . . . . 72.340000000000003 111.246 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' A' ' 155' ' ' THR . 25.9 ttt180 -63.41 -24.1 67.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.025 0.44 . . . . 73.0 110.788 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.17 -19.54 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 111.032 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.86 -11.12 45.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 72.219999999999999 111.09 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 166' ' ' VAL . 47.9 t -60.98 -61.22 8.45 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.018 -0.537 . . . . 62.43 112.207 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.447 ' CD ' ' HB ' ' A' ' 162' ' ' VAL . 18.4 Cg_endo -59.05 -34.15 98.87 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.027 1.818 . . . . 74.409999999999997 112.601 -175.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.6 m -66.15 -39.3 89.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 75.109999999999999 111.763 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.815 HD11 ' HA2' ' A' ' 102' ' ' GLY . 43.6 pt -78.97 -30.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.762 -0.375 . . . . 73.040000000000006 110.848 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.1 t -62.68 -42.66 96.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.741 0.305 . . . . 64.329999999999998 110.64 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 46.6 mt-10 -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 74.319999999999993 110.834 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -73.5 -33.92 65.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 75.219999999999999 111.309 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.27 96.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 72.540000000000006 111.131 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.89 91.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 72.319999999999993 110.851 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.27 -35.74 76.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 65.439999999999998 111.422 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -62.21 -38.64 89.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.716 0.294 . . . . 71.239999999999995 110.759 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 54.8 m -60.48 -36.78 79.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 62.340000000000003 110.593 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.83 -33.95 57.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 64.409999999999997 110.576 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.29 -27.78 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 74.200000000000003 110.555 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.9 mt -63.13 -33.38 75.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.939 -0.573 . . . . 75.120000000000005 110.371 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.8 mm -80.47 -55.63 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 74.150000000000006 110.877 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.29 -54.67 37.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.689 -0.687 . . . . 74.530000000000001 112.1 -173.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' A' ' 183' ' ' PRO . 36.4 tt0 -93.33 -50.14 5.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.367 -0.379 . . . . 71.340000000000003 110.352 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.55 147.98 5.93 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.775 -0.726 . . . . 74.120000000000005 111.453 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.421 HD13 ' N ' ' A' ' 182' ' ' GLU . 4.2 pp -64.92 -27.28 68.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.895 0.348 . . . . 74.450000000000003 111.89 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.704 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 40.6 tt0 -76.95 -52.55 1.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.837 -0.165 . . . . 64.230000000000004 111.283 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.9 Cg_exo -65.17 -34.98 43.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.548 1.499 . . . . 73.25 112.56 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.463 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -73.52 -31.48 63.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.119 0.414 . . . . 75.299999999999997 112.119 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 12.2 pt20 -61.75 -21.25 64.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.874 -0.331 . . . . 72.239999999999995 110.825 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -55.06 -52.56 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.354 -0.61 . . . . 75.340000000000003 109.354 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -46.29 76.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 75.340000000000003 110.87 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 184' ' ' ALA . 10.7 t -67.58 -13.08 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 111.964 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -102.42 -22.67 14.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.344 0.498 . . . . 73.019999999999996 112.344 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.42 -25.88 6.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.704 0.631 . . . . 75.409999999999997 112.704 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.1 t90 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.233 -0.889 . . . . 73.540000000000006 110.374 -174.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.243 0.544 . . . . 73.219999999999999 110.95 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 Cg_endo -94.09 143.62 1.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.18 2.586 . . . . 75.140000000000001 112.587 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.24 120.69 39.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.418 -0.586 . . . . 73.420000000000002 109.418 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.496 ' HB2' HE22 ' A' ' 88' ' ' GLN . 46.9 tp -92.13 105.23 17.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.26 -0.427 . . . . 71.329999999999998 109.989 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.692 ' HB ' HD22 ' A' ' 62' ' ' LEU . 43.3 t -118.9 127.25 75.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 63.399999999999999 110.377 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.06 121.8 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.557 . . . . 70.030000000000001 110.115 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.98 122.04 6.53 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.317 -0.944 . . . . 62.030000000000001 111.65 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.3 tp -108.75 86.77 2.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.296 0.57 . . . . 74.340000000000003 110.243 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 147.42 18.61 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.344 -0.843 . . . . 74.540000000000006 111.416 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.855 HD22 ' HB3' ' A' ' 17' ' ' TYR . 1.1 p-10 -93.33 109.61 41.39 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.958 0.409 . . . . 73.329999999999998 110.893 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 2.0 Cg_endo -82.05 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.861 2.374 . . . . 74.349999999999994 112.731 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.67 -151.68 28.52 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.719 -0.753 . . . . 63.340000000000003 112.083 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.24 -49.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.94 2.427 . . . . 73.010000000000005 112.795 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -107.26 -26.24 11.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 74.230000000000004 111.923 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.855 ' HB3' HD22 ' A' ' 12' ' ' ASN . 88.4 m-85 -71.44 -17.41 62.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.902 0.704 . . . . 73.329999999999998 112.902 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.493 ' C ' ' HD2' ' A' ' 19' ' ' LYS . . . -71.44 -7.0 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.927 0.343 . . . . 72.409999999999997 111.927 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HD2' ' C ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -123.12 20.09 9.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.643 -0.253 . . . . 75.150000000000006 111.021 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.572 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 75.6 p -101.34 178.02 4.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.602 0.239 . . . . 71.010000000000005 111.532 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.736 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 67.5 mtt180 -59.21 -23.54 62.37 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.077 0.465 . . . . 72.420000000000002 110.709 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.705 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 1.7 t-80 -98.23 17.23 19.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 75.400000000000006 111.492 -173.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.61 3.13 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.117 0.484 . . . . 74.040000000000006 110.405 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -52.76 -35.27 56.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 64.329999999999998 112.303 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA2' HG21 ' A' ' 93' ' ' ILE . . . -63.63 -25.65 69.07 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.136 -0.554 . . . . 41.119999999999997 112.984 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -90.32 -29.89 17.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.633 0.254 . . . . 74.230000000000004 110.864 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.902 ' HA ' ' HE1' ' A' ' 27' ' ' MET . 7.2 mmt -54.74 -48.08 73.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.528 0.566 . . . . 73.400000000000006 112.528 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.813 ' HB ' HD13 ' A' ' 93' ' ' ILE . 44.7 t -62.03 -45.24 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.726 0.298 . . . . 72.450000000000003 111.139 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.07 89.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 74.329999999999998 111.112 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.24 -48.91 77.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 62.140000000000001 110.968 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.0 -38.56 83.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.225 -0.443 . . . . 64.439999999999998 111.031 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.0 mt -63.77 -47.1 82.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.602 -0.272 . . . . 55.310000000000002 110.922 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.94 85.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.969 0.414 . . . . 74.400000000000006 110.543 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.51 -39.73 86.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.719 -0.673 . . . . 72.329999999999998 113.601 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.906 ' HG3' HD12 ' A' ' 36' ' ' ILE . 15.2 ptp180 -68.79 -36.41 78.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.378 0.589 . . . . 64.319999999999993 111.825 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.906 HD12 ' HG3' ' A' ' 35' ' ' ARG . 3.0 mp -77.89 -36.69 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 74.439999999999998 109.623 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.9 48.15 3.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.896 -0.669 . . . . 74.200000000000003 111.976 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.31 162.33 17.66 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.786 0.327 . . . . 73.430000000000007 110.352 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.82 130.63 56.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 71.510000000000005 110.691 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.496 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 19.1 p90 -70.18 133.59 47.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 73.040000000000006 110.286 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.28 134.83 54.66 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.937 -0.574 . . . . 75.219999999999999 110.7 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.786 HG22 ' HG2' ' A' ' 49' ' ' GLU . 43.5 t -72.83 118.07 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 71.25 110.202 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.49 93.38 3.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.195 -1.039 . . . . 72.450000000000003 108.195 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.46 79.73 2.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.978 0.894 . . . . 74.540000000000006 110.2 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -169.25 -53.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.763 -1.562 . . . . 71.540000000000006 106.915 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -93.71 -28.55 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.944 -1.025 . . . . 63.109999999999999 110.241 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 29.59 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.945 -0.645 . . . . 61.350000000000001 112.153 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.14 146.22 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.319 -0.252 . . . . 53.340000000000003 110.319 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.786 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.1 mt-10 -98.85 138.75 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.304 -0.407 . . . . 74.439999999999998 110.397 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 137.96 51.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 74.219999999999999 110.468 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 62' ' ' LEU . 7.5 p -128.86 139.13 52.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.477 -0.329 . . . . 75.349999999999994 110.377 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.521 HG23 HG11 ' A' ' 61' ' ' VAL . 17.4 p -101.49 177.74 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.728 0.299 . . . . 72.25 111.449 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.53 40.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.161 -0.543 . . . . 72.450000000000003 111.966 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.77 ' H ' HG12 ' A' ' 36' ' ' ILE . 18.0 mmt180 -133.54 130.1 37.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.721 0.296 . . . . 74.329999999999998 110.737 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.026 HD23 ' HB ' ' A' ' 60' ' ' VAL . 2.4 pt? -130.84 115.76 17.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.323 -0.621 . . . . 74.510000000000005 109.323 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.72 23.51 13.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.816 -0.629 . . . . 75.230000000000004 111.264 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.71 -30.88 8.87 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.073 -0.584 . . . . 74.530000000000001 111.665 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.454 ' O ' HD22 ' A' ' 55' ' ' LEU . 75.0 m -70.49 142.96 51.84 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.795 0.438 . . . . 75.439999999999998 110.453 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.523 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 5.1 p -79.85 122.17 26.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.686 0.279 . . . . 74.349999999999994 110.73 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.026 ' HB ' HD23 ' A' ' 55' ' ' LEU . 12.1 p -97.37 138.5 22.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.113 -0.328 . . . . 72.230000000000004 110.113 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.521 HG11 HG23 ' A' ' 52' ' ' THR . 7.2 m -124.21 108.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.329 0.585 . . . . 73.219999999999999 110.193 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 7' ' ' VAL . 79.9 mt -95.22 119.55 33.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.562 -0.744 . . . . 75.319999999999993 110.333 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.74 147.74 39.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.484 . . . . 72.129999999999995 110.637 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 16.0 ptmt -132.85 143.27 47.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 72.209999999999994 110.31 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 17.8 Cg_exo -67.45 160.21 48.88 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.74 2.293 . . . . 74.219999999999999 111.683 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.481 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 39.6 ttt-85 -70.67 -63.17 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 73.420000000000002 110.173 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 47.8 m -165.89 147.73 7.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.776 -0.647 . . . . 74.340000000000003 110.102 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 t80 70.62 162.05 0.24 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.68 0.752 . . . . 75.340000000000003 112.269 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 69' ' ' MET . 1.9 mpt? -79.6 -16.08 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 73.040000000000006 111.365 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -73.62 -50.05 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.269 -0.423 . . . . 64.430000000000007 110.125 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 18.7 mt-10 -68.9 -41.06 78.76 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.978 0.362 . . . . 74.420000000000002 111.978 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 p -52.36 -44.43 65.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.94 0.348 . . . . 72.549999999999997 111.94 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -68.8 -25.46 75.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 63.520000000000003 112.545 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -94.21 -7.12 43.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.551 0.215 . . . . 75.239999999999995 111.338 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 19.4 mm-40 -102.33 -52.72 3.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.64 -0.254 . . . . 75.299999999999997 111.477 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.26 -40.52 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 75.310000000000002 111.601 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.653 ' HA2' HD23 ' A' ' 125' ' ' LEU . . . -55.83 -66.22 2.99 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.074 -0.512 . . . . 52.25 112.919 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.29 -39.05 93.06 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.741 2.294 . . . . 65.439999999999998 113.025 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.19 -45.91 83.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.753 0.279 . . . . 71.0 111.753 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -44.2 71.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.217 0.532 . . . . 73.439999999999998 111.162 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -86.25 -7.83 58.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.949 -0.568 . . . . 74.319999999999993 111.658 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -77.23 -53.99 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 74.040000000000006 110.163 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -89.07 5.25 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 73.129999999999995 110.397 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.6 m 60.32 84.13 0.13 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 63.130000000000003 113.241 171.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.49 142.26 27.29 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.852 -0.613 . . . . 75.25 109.498 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.77 172.14 16.86 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.51 2.14 . . . . 75.349999999999994 111.69 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 96.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.215 1.944 . . . . 73.099999999999994 111.463 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' A' ' 6' ' ' LEU . 12.8 pt20 -133.25 177.61 7.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.662 -0.699 . . . . 73.120000000000005 110.038 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -66.2 104.75 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 74.200000000000003 111.136 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.1 tt -93.65 112.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.788 -0.642 . . . . 74.519999999999996 109.696 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.1 t -100.17 111.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.664 -0.698 . . . . 73.129999999999995 110.855 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.515 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 57.9 t -99.38 116.54 42.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.496 -0.557 . . . . 73.030000000000001 109.496 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.813 HD13 ' HB ' ' A' ' 28' ' ' VAL . 35.3 mt -87.05 122.86 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 74.420000000000002 110.622 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 41.4 t-80 -151.68 170.89 18.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.813 0.34 . . . . 75.129999999999995 110.465 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.06 153.71 22.54 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.91 0.484 . . . . 73.349999999999994 111.108 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.924 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 9.1 tp10 -118.2 121.56 40.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.579 . . . . 70.340000000000003 110.907 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.5 mt -83.5 -21.17 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 74.120000000000005 110.877 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.65 -19.83 34.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 72.120000000000005 111.808 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.719 HG13 ' HB2' ' A' ' 105' ' ' ARG . 29.0 mm -107.64 139.52 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.532 -0.304 . . . . 72.019999999999996 111.443 -175.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.679 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 3.8 m-20 -55.78 152.17 10.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.501 -0.772 . . . . 74.319999999999993 111.405 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.4 t80 -67.55 109.2 3.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.649 -0.705 . . . . 75.120000000000005 110.421 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.746 ' HA2' HG22 ' A' ' 165' ' ' ILE . . . 137.46 -23.85 3.1 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.405 -0.902 . . . . 75.430000000000007 113.165 176.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -108.28 151.59 25.76 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.515 -0.403 . . . . 73.400000000000006 110.33 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.795 ' HB ' HG22 ' A' ' 188' ' ' VAL . 3.6 mp -105.29 136.87 37.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.156 0.503 . . . . 71.519999999999996 110.149 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.719 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.1 tpt180 -108.89 140.31 42.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.639 -0.71 . . . . 73.239999999999995 109.785 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' A' ' 185' ' ' GLN . 98.3 mt -122.66 121.08 35.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.431 -0.35 . . . . 73.340000000000003 110.238 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -116.65 138.89 51.11 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.926 -0.398 . . . . 74.040000000000006 109.926 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.9 mp -79.5 -71.4 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.75 -0.659 . . . . 74.239999999999995 110.379 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.33 -144.53 6.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.004 -0.544 . . . . 73.209999999999994 112.913 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.01 156.26 35.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.959 -0.638 . . . . 65.120000000000005 112.665 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.12 152.76 13.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.94 -0.647 . . . . 62.5 111.747 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -67.74 139.9 56.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.285 -0.265 . . . . 71.230000000000004 110.285 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 143.62 60.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.032 -0.604 . . . . 71.420000000000002 112.16 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.22 2.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.298 -0.953 . . . . 75.409999999999997 113.254 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.7 m80 55.75 -101.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.677 0.621 . . . . 73.340000000000003 112.677 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.02 -69.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.099 0.777 . . . . 74.140000000000001 113.099 -166.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -47.09 92.51 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.178 -0.534 . . . . 65.150000000000006 112.708 -165.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.0 -47.5 82.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.313 -0.443 . . . . 65.430000000000007 111.737 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -79.93 -22.16 43.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.944 0.35 . . . . 74.109999999999999 111.944 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.535 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 73.5 m -61.87 -52.43 64.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 72.329999999999998 110.486 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.39 -28.85 36.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.009 0.433 . . . . 73.209999999999994 110.722 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.95 74.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 65.230000000000004 111.004 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -84.55 -38.06 20.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.397 -0.365 . . . . 71.319999999999993 111.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.32 -52.9 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 74.409999999999997 111.032 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.653 HD23 ' HA2' ' A' ' 77' ' ' GLY . 95.9 mt -78.7 -32.36 46.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 73.530000000000001 110.361 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.05 -5.53 66.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.004 -0.617 . . . . 73.450000000000003 112.447 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.3 m -114.23 121.89 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.358 0.599 . . . . 64.540000000000006 111.7 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.2 -93.99 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.392 -1.336 . . . . 74.340000000000003 107.392 168.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.24 -8.2 0.2 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.151 1.537 . . . . 72.209999999999994 115.151 159.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 75.0 m-85 -119.27 -107.96 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.428 0.558 . . . . 65.409999999999997 111.865 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -146.97 118.33 7.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 72.430000000000007 111.321 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.515 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 11.9 mpt_? -106.33 123.95 48.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 73.510000000000005 109.642 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.405 ' HA ' HD21 ' A' ' 106' ' ' LEU . 94.1 t -83.57 117.32 29.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 110.479 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.924 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.7 mtt180 -120.01 117.88 29.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.75 -0.659 . . . . 72.450000000000003 110.642 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 135' ' ' ILE . 4.3 mp -91.09 117.61 34.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.631 -0.507 . . . . 74.230000000000004 109.631 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.37 130.53 41.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.206 -0.521 . . . . 70.439999999999998 113.156 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.83 -0.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.049 0.452 . . . . 71.209999999999994 111.074 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.679 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 111.8 -83.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.5 -0.857 . . . . 72.430000000000007 112.882 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -164.1 168.45 9.38 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.445 -0.206 . . . . 72.519999999999996 110.445 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.0 Cg_exo -59.38 135.56 65.99 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.243 1.962 . . . . 74.140000000000001 110.385 166.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.651 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 26.1 Cg_exo -61.76 -38.48 59.83 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.769 2.312 . . . . 73.219999999999999 112.603 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.1 -71.7 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.027 -0.606 . . . . 75.030000000000001 113.308 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 143' ' ' ARG . 13.7 ttp180 -78.88 -31.11 45.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 71.129999999999995 111.274 -175.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 8.0 ptmm? -116.36 152.8 33.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 74.230000000000004 109.836 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.84 134.18 95.97 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.446 -0.343 . . . . 73.409999999999997 111.194 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.651 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 81.2 Cg_exo -47.66 -44.4 26.2 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.63 2.887 . . . . 55.340000000000003 113.626 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.09 87.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.041 0.448 . . . . 65.400000000000006 110.729 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.46 -18.8 60.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.812 -0.631 . . . . 71.420000000000002 110.68 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.528 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 89.3 t80 -84.18 -34.82 23.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.156 -0.474 . . . . 73.519999999999996 111.048 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.705 ' HB ' ' HB2' ' A' ' 22' ' ' HIS . 34.1 m -84.66 -17.03 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.666 0.617 . . . . 61.43 112.666 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.18 -7.44 59.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.059 0.457 . . . . 74.319999999999993 111.473 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 4.1 pt-20 -111.06 172.84 6.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.985 -0.552 . . . . 73.310000000000002 109.555 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.736 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 33.1 p30 -142.27 -20.54 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.815 0.341 . . . . 74.420000000000002 111.349 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -62.63 114.06 3.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 74.420000000000002 111.245 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.41 179.85 7.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 74.010000000000005 108.757 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.07 -71.86 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 73.019999999999996 111.864 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.58 -43.65 7.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 73.420000000000002 111.582 -174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.532 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 1.6 pm0 -72.15 -19.83 61.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.463 -0.789 . . . . 73.519999999999996 112.229 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -69.75 -38.0 76.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 64.030000000000001 110.139 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.23 60.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 110.911 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.78 1.25 57.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 73.239999999999995 112.046 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 166' ' ' VAL . 89.1 t -57.01 -57.06 27.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.061 -0.256 . . . . 62.210000000000001 110.648 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.3 Cg_endo -60.23 -30.33 90.95 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.967 1.778 . . . . 74.439999999999998 112.055 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.1 m -67.0 -48.12 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 70.219999999999999 111.175 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.746 HG22 ' HA2' ' A' ' 102' ' ' GLY . 42.3 pt -74.24 -20.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.578 -0.283 . . . . 73.430000000000007 111.319 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 162' ' ' VAL . 70.0 t -62.8 -45.11 99.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.966 -0.383 . . . . 74.319999999999993 109.966 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -58.73 -46.93 86.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.09 -0.505 . . . . 74.310000000000002 110.037 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.65 -54.22 48.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.313 -0.858 . . . . 75.439999999999998 111.144 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.63 -40.91 89.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 71.299999999999997 111.566 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.695 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.37 -49.45 69.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 72.219999999999999 111.216 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.35 -31.41 60.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 73.209999999999994 111.907 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -59.74 -46.57 88.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.094 -0.335 . . . . 64.329999999999998 110.094 173.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.8 m -58.88 -40.21 83.73 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.257 -0.429 . . . . 73.329999999999998 110.903 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.688 ' HG3' ' HB2' ' A' ' 55' ' ' LEU . 33.5 tt0 -65.94 -42.95 89.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 64.510000000000005 110.028 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.15 -25.79 65.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 75.310000000000002 111.195 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 86.9 mt -62.03 -32.28 72.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.498 -0.319 . . . . 73.319999999999993 111.271 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.434 HG21 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -80.14 -25.39 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.17 0.509 . . . . 71.140000000000001 110.047 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -86.32 -47.34 9.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 74.200000000000003 111.59 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 184' ' ' ALA . 24.2 tp60 -86.04 -59.5 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.476 -0.329 . . . . 74.510000000000005 110.207 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.66 -75.0 0.89 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.032 0.773 . . . . 75.439999999999998 115.032 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.6 tp -42.47 -69.81 0.12 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.209 1.188 . . . . 70.530000000000001 114.209 -163.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.568 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 tt0 -139.91 -59.45 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.481 0.549 . . . . 64.329999999999998 112.481 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.568 ' HD2' ' H ' ' A' ' 182' ' ' GLU . 18.4 Cg_endo -59.12 -17.2 37.28 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.079 1.853 . . . . 71.109999999999999 112.853 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . . . -60.3 -58.79 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.474 -0.33 . . . . 71.239999999999995 111.243 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.521 ' O ' ' HD2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -77.15 -28.42 54.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.802 -0.359 . . . . 72.040000000000006 111.181 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 183' ' ' PRO . 24.5 t-20 -57.75 -39.56 77.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.875 0.369 . . . . 74.0 110.61 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 84.8 m -65.1 -57.43 8.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.817 -0.629 . . . . 70.140000000000001 112.368 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.795 HG22 ' HB ' ' A' ' 104' ' ' ILE . 2.0 p -64.13 -18.87 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 113.499 0.926 . . . . 74.049999999999997 113.499 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.521 ' HD2' ' O ' ' A' ' 185' ' ' GLN . 9.0 p80 -106.95 -6.93 17.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.152 -0.619 . . . . 70.200000000000003 111.723 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.42 4.29 3.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.431 0.53 . . . . 63.210000000000001 112.431 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.471 -0.776 . . . . 73.340000000000003 109.849 -179.149 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 108.685 -0.857 . . . . 74.349999999999994 108.685 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.783 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 62.0 Cg_endo -90.88 171.61 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.981 2.454 . . . . 72.019999999999996 113.277 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.736 ' HB2' HD11 ' A' ' 177' ' ' ILE . 49.2 tp -119.63 110.05 16.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.554 -0.748 . . . . 74.010000000000005 109.801 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.681 ' HA ' HG23 ' A' ' 61' ' ' VAL . 51.0 tp -92.53 107.95 19.61 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.874 -0.787 . . . . 73.140000000000001 108.874 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.667 ' HB ' HD22 ' A' ' 62' ' ' LEU . 49.4 t -100.83 116.72 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.795 -0.639 . . . . 74.340000000000003 110.731 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.71 114.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.465 -0.789 . . . . 73.310000000000002 109.302 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.41 122.26 7.29 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.211 -0.995 . . . . 73.120000000000005 111.985 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -79.01 91.38 4.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 74.329999999999998 109.689 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 23' ' ' ASN . . . -152.66 122.24 1.28 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.561 -0.828 . . . . 70.540000000000006 112.376 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 12.8 m120 -112.34 98.05 41.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.792 -0.818 . . . . 71.549999999999997 108.792 172.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 6.7 Cg_exo -73.75 58.65 4.03 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.581 2.854 . . . . 73.319999999999993 112.997 -172.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.08 175.0 39.7 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.521 -0.632 . . . . 73.319999999999993 111.521 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.26 -57.61 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.62 2.88 . . . . 71.299999999999997 113.515 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -107.38 7.35 29.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.537 0.684 . . . . 74.140000000000001 110.431 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HA ' ' OG1' ' A' ' 20' ' ' THR . 97.9 m-85 -94.13 -15.61 24.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 72.219999999999999 111.959 -172.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.81 -34.46 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.721 0.638 . . . . 63.43 112.721 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.6 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -115.76 14.95 16.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.135 0.493 . . . . 73.239999999999995 111.459 -176.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.578 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.7 p -109.37 -172.97 2.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.279 -0.418 . . . . 73.109999999999999 110.273 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 64.7 mtt85 -68.04 1.44 2.74 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.208 0.447 . . . . 73.319999999999993 112.208 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.53 -5.26 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.332 -0.23 . . . . 75.129999999999995 111.117 -176.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.795 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 t30 -143.23 9.37 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.315 0.579 . . . . 72.109999999999999 111.247 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 20' ' ' THR . 51.1 mt -68.57 -28.06 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.92 -0.488 . . . . 72.409999999999997 111.784 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.85 -21.85 71.61 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.45 -0.881 . . . . 74.209999999999994 112.188 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 81.0 t80 -80.38 -21.75 42.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.558 0.218 . . . . 74.219999999999999 111.108 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.88 ' HA ' ' HE1' ' A' ' 27' ' ' MET . 11.0 mmt -51.13 -51.51 52.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.351 -0.386 . . . . 72.200000000000003 111.682 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.596 HG13 ' HA ' ' A' ' 170' ' ' ALA . 57.4 t -61.17 -43.5 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 72.439999999999998 111.044 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.28 -40.68 97.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.0 -0.546 . . . . 50.299999999999997 110.858 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.29 -41.2 98.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 74.430000000000007 110.61 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 27' ' ' MET . 66.5 t -62.97 -34.46 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.653 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.3 mt -64.34 -33.87 76.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.367 -0.378 . . . . 74.129999999999995 110.672 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -39.07 46.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.336 -0.393 . . . . 75.019999999999996 110.474 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.39 -40.12 96.2 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.629 . . . . 65.430000000000007 113.039 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' LEU . 11.0 ptm180 -66.24 -21.78 66.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.842 0.353 . . . . 75.150000000000006 110.812 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.16 -48.89 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.458 . . . . 73.409999999999997 110.317 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.24 38.12 2.53 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.96 -0.638 . . . . 64.219999999999999 112.161 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 m -126.12 146.09 50.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.303 . . . . 74.510000000000005 110.58 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.34 142.86 33.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 73.0 111.018 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.796 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 16.8 p90 -74.4 147.0 42.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 72.129999999999995 110.757 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.711 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -128.7 145.21 51.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.034 -0.358 . . . . 73.219999999999999 110.034 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.848 HG22 ' HG3' ' A' ' 49' ' ' GLU . 32.7 t -76.52 134.33 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.277 -0.42 . . . . 75.530000000000001 111.398 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -94.99 125.55 39.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.427 -0.583 . . . . 75.150000000000006 109.427 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.32 -36.55 84.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.379 . . . . 64.120000000000005 110.889 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -83.38 4.14 28.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 72.420000000000002 110.924 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m -125.59 -29.02 3.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.812 0.339 . . . . 70.540000000000006 111.308 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.37 29.23 73.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.961 -0.638 . . . . 72.200000000000003 111.812 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.52 37.19 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.614 0.245 . . . . 73.319999999999993 110.587 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.848 ' HG3' HG22 ' A' ' 42' ' ' VAL . 4.5 mp0 -85.68 131.22 34.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.54 . . . . 73.219999999999999 110.795 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.25 149.46 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 74.030000000000001 109.429 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.796 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.4 p -144.42 138.81 23.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 74.140000000000001 110.544 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.689 HG23 HG13 ' A' ' 61' ' ' VAL . 41.5 p -107.61 136.97 46.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 62.149999999999999 110.896 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.6 -166.02 13.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.929 -0.653 . . . . 74.420000000000002 111.914 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -131.21 105.82 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.486 -0.191 . . . . 73.530000000000001 110.486 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.112 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.2 pt? -96.68 115.91 28.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.835 -0.802 . . . . 73.540000000000006 108.835 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.58 -49.43 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.619 -0.719 . . . . 60.130000000000003 111.474 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.16 -33.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.261 -0.736 . . . . 73.239999999999995 111.261 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.8 148.06 50.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.968 -0.616 . . . . 63.509999999999998 111.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 m -70.83 114.8 9.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.992 -0.373 . . . . 74.239999999999995 109.992 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.112 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.5 p -97.02 127.14 49.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.568 -0.531 . . . . 73.340000000000003 109.568 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.689 HG13 HG23 ' A' ' 52' ' ' THR . 2.8 m -116.51 109.13 26.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.375 0.607 . . . . 73.420000000000002 110.27 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 7' ' ' VAL . 50.7 mt -96.14 120.52 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.376 -0.829 . . . . 75.430000000000007 110.022 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.85 129.85 51.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.364 -0.38 . . . . 64.310000000000002 110.659 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 8.2 ptmm? -115.91 121.45 34.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.281 -0.418 . . . . 74.409999999999997 110.541 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 27.3 Cg_exo -62.0 156.72 47.8 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.715 2.276 . . . . 73.140000000000001 111.362 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HG3' ' N ' ' A' ' 67' ' ' CYS . 9.1 ptt180 -77.49 -55.9 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.442 -0.503 . . . . 73.25 110.345 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.585 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 21.1 p -167.5 173.63 8.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.748 -0.206 . . . . 73.519999999999996 110.469 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 t80 67.62 162.77 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.96 0.788 . . . . 75.430000000000007 112.188 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -21.15 25.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.861 -0.609 . . . . 73.150000000000006 112.272 -175.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -94.86 -38.64 10.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.724 0.297 . . . . 74.219999999999999 111.263 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.76 -26.45 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 72.319999999999993 111.121 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -45.0 95.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 72.349999999999994 110.478 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.09 -33.86 84.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.877 -0.678 . . . . 64.519999999999996 111.722 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -74.26 -8.42 56.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 74.430000000000007 111.244 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 65' ' ' PRO . 82.8 mt-30 -103.96 -49.87 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 75.129999999999995 111.534 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.02 -29.95 42.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.814 0.302 . . . . 72.409999999999997 111.814 -176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.29 7.08 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.143 -0.551 . . . . 74.219999999999999 112.67 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.38 -37.69 94.49 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.908 2.406 . . . . 73.239999999999995 113.032 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 64.8 mt -58.08 -39.15 77.82 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.924 0.342 . . . . 74.400000000000006 111.924 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.85 -41.97 88.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 72.120000000000005 110.874 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -23.8 27.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.173 -0.467 . . . . 74.040000000000006 111.207 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -60.87 -46.65 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.212 0.529 . . . . 75.040000000000006 109.854 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.12 -14.99 48.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.713 -0.676 . . . . 74.0 110.281 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 60.67 47.71 7.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.606 0.717 . . . . 74.040000000000006 110.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.783 ' HB ' ' HG3' ' A' ' 4' ' ' PRO . 27.4 m -102.13 137.23 19.41 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.327 -0.852 . . . . 72.219999999999999 110.215 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.62 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 23.4 Cg_exo -64.58 137.7 55.88 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.623 2.216 . . . . 74.219999999999999 111.713 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -87.11 53.11 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.991 2.46 . . . . 74.239999999999995 113.574 -172.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.62 ' OE1' ' HB2' ' A' ' 86' ' ' PRO . 10.7 mp0 -59.28 -57.1 14.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 73.420000000000002 110.68 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.539 HE22 HD13 ' A' ' 5' ' ' LEU . 9.7 pt20 -144.03 102.45 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.541 0.686 . . . . 74.25 112.394 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.598 HD13 HD11 ' A' ' 125' ' ' LEU . 5.8 tt -98.18 115.58 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.36 -0.836 . . . . 72.319999999999993 109.129 170.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.44 117.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.947 -0.57 . . . . 75.319999999999993 110.801 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.556 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 44.7 t -97.24 103.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 72.430000000000007 109.23 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 28' ' ' VAL . 58.0 mt -86.12 119.24 34.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.947 -0.57 . . . . 72.540000000000006 109.84 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.437 ' CE1' HD21 ' A' ' 118' ' ' LEU . 28.3 p80 -151.67 170.65 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.89 -0.596 . . . . 75.239999999999995 110.522 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.63 150.23 24.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.319 -0.623 . . . . 72.230000000000004 109.319 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.671 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 7.8 tp10 -124.99 119.81 29.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.94 0.4 . . . . 74.340000000000003 110.045 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.489 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 92.7 mt -82.39 -0.51 46.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 73.439999999999998 110.06 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 27.9 t70 -83.05 -11.01 58.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.358 -0.837 . . . . 71.010000000000005 110.459 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' A' ' 105' ' ' ARG . 12.4 tt -132.06 148.9 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.945 0.403 . . . . 74.519999999999996 111.347 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.37 145.57 21.89 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.354 -0.839 . . . . 74.409999999999997 112.43 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -62.15 126.42 27.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 72.400000000000006 110.374 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' N ' ' HD1' ' A' ' 101' ' ' PHE . . . 117.78 -19.29 11.33 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 75.349999999999994 113.404 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.452 HH12 ' CD ' ' A' ' 161' ' ' GLU . 59.3 mmt-85 -120.63 147.67 44.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.447 0.623 . . . . 73.439999999999998 111.069 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.2 mp -104.27 132.59 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.191 -0.459 . . . . 74.400000000000006 110.425 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.685 ' HB2' HD12 ' A' ' 99' ' ' ILE . 16.2 tpt180 -116.57 126.18 52.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 73.319999999999993 109.683 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.599 HD11 HG23 ' A' ' 188' ' ' VAL . 40.2 mt -97.48 111.29 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.266 0.555 . . . . 74.099999999999994 110.159 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' HB3' ' NE ' ' A' ' 134' ' ' ARG . 57.1 tptt -102.25 141.07 35.67 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.752 -1.203 . . . . 72.510000000000005 107.752 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.821 ' H ' HD22 ' A' ' 108' ' ' LEU . 1.1 pt? -75.55 -124.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.735 0.272 . . . . 73.430000000000007 111.735 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.909 ' HA3' ' HG3' ' A' ' 128' ' ' LYS . . . -82.01 142.03 22.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.431 -0.89 . . . . 62.039999999999999 112.584 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 153.4 5.86 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.716 -0.754 . . . . 75.329999999999998 112.321 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.53 77.06 0.32 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.672 -0.971 . . . . 72.329999999999998 110.672 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.99 144.1 22.04 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.382 -0.599 . . . . 72.420000000000002 109.382 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.0 -165.54 34.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.597 -0.811 . . . . 64.349999999999994 111.9 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.79 18.44 25.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.71 -0.757 . . . . 71.019999999999996 113.157 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -139.54 122.67 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.278 -0.542 . . . . 73.030000000000001 111.035 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.91 -52.5 60.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.984 -1.007 . . . . 60.210000000000001 112.107 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.35 -30.89 65.26 Favored Glycine 0 N--CA 1.46 0.29 0 CA-C-N 116.329 -0.396 . . . . 73.209999999999994 112.968 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.437 HD21 ' CE1' ' A' ' 94' ' ' HIS . 14.3 tp -60.52 -32.46 71.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.441 0.638 . . . . 74.019999999999996 110.673 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -79.23 -34.52 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 74.319999999999993 110.213 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.9 m -73.16 -44.39 60.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 63.329999999999998 111.406 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.03 -34.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 120.801 0.334 . . . . 73.299999999999997 111.14 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.46 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.978 0.418 . . . . 73.420000000000002 110.57 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 m -71.51 -23.59 61.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 62.509999999999998 110.884 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.4 -34.01 54.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 61.530000000000001 110.507 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.598 HD11 HD13 ' A' ' 90' ' ' ILE . 88.0 mt -80.59 -42.82 21.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.914 -0.584 . . . . 72.209999999999994 110.653 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.44 89.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.024 -0.608 . . . . 75.310000000000002 112.365 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.1 p -112.37 163.09 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 75.25 111.185 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.909 ' HG3' ' HA3' ' A' ' 109' ' ' GLY . 12.5 tppt? -83.47 -56.86 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.869 -0.605 . . . . 74.120000000000005 110.755 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.94 81.92 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.741 0.65 . . . . 71.299999999999997 110.964 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.762 ' HD1' HD11 ' A' ' 108' ' ' LEU . 67.7 m-85 -71.07 68.17 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.258 1.207 . . . . 74.409999999999997 114.258 -168.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 37.8 p-80 163.57 115.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.908 0.883 . . . . 74.019999999999996 111.843 162.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 92' ' ' VAL . 5.0 mpt_? -128.93 147.24 50.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 74.420000000000002 110.216 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.414 ' HB ' HG12 ' A' ' 93' ' ' ILE . 88.1 t -86.31 127.81 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.847 0.356 . . . . 64.400000000000006 111.032 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.671 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.0 mtt180 -131.37 109.75 10.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 71.209999999999994 110.563 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 54.4 mt -88.99 125.87 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 110.279 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.533 ' CA ' HG23 ' A' ' 99' ' ' ILE . . . -72.5 114.98 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.67 -0.776 . . . . 74.299999999999997 111.965 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 24' ' ' LEU . 22.8 t -119.81 10.43 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.764 0.792 . . . . 63.450000000000003 110.27 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 97' ' ' LEU . . . 138.19 172.22 12.47 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.214 -0.993 . . . . 62.409999999999997 112.97 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -101.48 162.31 20.88 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.784 -0.45 . . . . 75.439999999999998 109.784 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 36.1 Cg_exo -60.72 133.01 45.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.672 2.248 . . . . 64.219999999999999 112.243 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.606 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 55.2 Cg_endo -70.56 127.31 13.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.71 2.273 . . . . 73.109999999999999 112.156 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.08 43.11 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.886 -0.673 . . . . 74.120000000000005 112.555 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -163.35 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.007 0.432 . . . . 74.310000000000002 110.219 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -89.38 159.57 17.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.622 . . . . 75.430000000000007 110.82 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.8 140.98 97.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 71.439999999999998 110.994 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.13 -38.68 60.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.225 2.616 . . . . 72.120000000000005 113.082 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.412 ' HA ' HG22 ' A' ' 150' ' ' VAL . . . -70.19 -30.36 67.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.194 0.521 . . . . 62.219999999999999 110.655 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 151' ' ' LEU . . . -76.72 -18.52 58.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.65 -0.705 . . . . 74.150000000000006 110.226 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.606 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 59.7 t80 -84.54 -31.64 24.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 75.319999999999993 110.829 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 34.6 m -85.18 -6.02 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 72.409999999999997 112.245 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 4.4 pp -87.39 -8.35 56.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 74.129999999999995 110.182 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.64 171.11 8.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.228 -0.896 . . . . 74.219999999999999 109.669 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -170.7 87.44 0.12 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.9 0.381 . . . . 55.130000000000003 110.932 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -154.97 135.99 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.325 -0.398 . . . . 74.140000000000001 110.447 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -160.88 -164.84 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 71.120000000000005 108.243 175.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.404 ' H ' HG21 ' A' ' 155' ' ' THR . . . -96.42 -73.41 0.6 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.773 0.657 . . . . 62.210000000000001 112.773 -175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.49 -43.2 8.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.261 0.553 . . . . 64.299999999999997 111.118 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -68.96 -21.6 64.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.493 -0.776 . . . . 72.409999999999997 110.515 -178.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -83.6 -15.26 49.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.622 -0.717 . . . . 73.549999999999997 110.361 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.46 -42.63 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 73.409999999999997 111.778 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.452 ' CD ' HH12 ' A' ' 103' ' ' ARG . 15.4 pt-20 -83.43 11.04 7.46 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.923 0.342 . . . . 64.400000000000006 111.923 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.624 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 87.0 t -54.03 -53.35 59.37 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.388 -0.369 . . . . 75.129999999999995 111.962 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 71.3 Cg_exo -52.03 -38.35 69.62 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.03 1.82 . . . . 72.340000000000003 112.511 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.0 m -68.6 -46.26 69.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 75.25 111.405 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.01 -24.83 24.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 121.098 -0.241 . . . . 70.439999999999998 111.452 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 162' ' ' VAL . 90.3 t -64.15 -43.74 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 73.239999999999995 110.047 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.82 -36.71 81.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 75.299999999999997 110.559 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.08 -51.54 53.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 72.219999999999999 110.657 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 73.340000000000003 111.535 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.52 -57.02 14.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 71.439999999999998 111.279 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.95 -26.7 62.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.485 -0.325 . . . . 74.209999999999994 111.181 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.505 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.87 -38.6 86.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.34 . . . . 74.5 110.539 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 m -66.96 -34.74 78.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.235 -0.439 . . . . 74.099999999999994 110.765 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.488 ' HA ' HD11 ' A' ' 55' ' ' LEU . 44.1 tt0 -71.91 -34.93 69.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.532 . . . . 74.510000000000005 109.853 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.29 -26.64 68.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 74.420000000000002 110.772 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 91.7 mt -64.74 -21.7 66.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 72.239999999999995 110.955 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.736 HD11 ' HB2' ' A' ' 5' ' ' LEU . 28.0 mm -80.75 -50.71 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 74.450000000000003 110.74 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.86 -38.83 61.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.801 -0.636 . . . . 63.049999999999997 112.403 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -99.02 -56.64 2.37 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.924 -0.311 . . . . 72.340000000000003 111.536 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 141.77 -124.99 2.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.44 -0.886 . . . . 62.409999999999997 112.117 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.83 -46.97 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.032 0.382 . . . . 71.340000000000003 112.032 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.817 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 30.2 tt0 -73.44 -61.33 1.44 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.095 0.406 . . . . 72.230000000000004 112.095 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 17.7 Cg_exo -67.18 -14.9 44.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.741 1.628 . . . . 75.140000000000001 111.884 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.57 14.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 60.450000000000003 111.144 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.553 ' HA ' HD13 ' A' ' 106' ' ' LEU . 10.0 pt20 -65.25 -27.94 69.01 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 121.112 -0.235 . . . . 73.439999999999998 110.876 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.501 ' HA ' ' NE2' ' A' ' 189' ' ' HIS . 65.7 t30 -59.53 -45.53 91.48 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.389 -0.369 . . . . 75.129999999999995 110.31 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.2 m -63.69 -38.26 90.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 75.329999999999998 110.882 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.599 HG23 HD11 ' A' ' 106' ' ' LEU . 59.2 t -61.71 -44.48 98.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 111.533 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.501 ' NE2' ' HA ' ' A' ' 186' ' ' ASN . 33.5 p80 -89.53 12.86 15.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.512 -0.475 . . . . 74.400000000000006 111.238 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.36 4.13 38.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.53 -0.305 . . . . 64.129999999999995 110.785 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 12.8 m0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.063 -0.97 . . . . 74.310000000000002 111.027 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.725 -0.472 . . . . 64.140000000000001 109.725 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.23 89.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.778 1.652 . . . . 71.239999999999995 110.64 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.97 118.15 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.669 -0.696 . . . . 71.129999999999995 111.475 -172.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HA ' HG22 ' A' ' 61' ' ' VAL . 34.0 tp -91.86 105.13 17.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.743 -0.662 . . . . 72.010000000000005 109.542 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.642 ' HB ' HD21 ' A' ' 62' ' ' LEU . 40.5 t -114.89 112.9 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.199 0.523 . . . . 74.200000000000003 110.422 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.78 114.77 45.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.541 -0.754 . . . . 73.209999999999994 110.005 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.42 120.76 6.09 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.337 -1.105 . . . . 73.420000000000002 110.337 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.4 tp -94.66 81.4 3.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 72.430000000000007 110.477 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.49 107.36 0.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.636 -1.165 . . . . 60.310000000000002 110.75 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -87.49 144.38 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.859 0.361 . . . . 71.120000000000005 110.777 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.66 81.74 1.01 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.813 2.342 . . . . 75.510000000000005 111.685 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 18' ' ' ALA . . . -90.64 163.88 30.01 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.893 -0.67 . . . . 72.239999999999995 111.878 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.65 -14.85 33.63 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.715 2.277 . . . . 74.430000000000007 112.717 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -141.39 -45.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.2 0.445 . . . . 75.400000000000006 112.2 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' HA ' HG23 ' A' ' 20' ' ' THR . 54.4 p90 -76.25 -2.61 32.27 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.312 0.486 . . . . 75.329999999999998 112.312 -173.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB2' ' H ' ' A' ' 14' ' ' GLY . . . -88.85 -3.31 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 74.200000000000003 110.851 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.95 19.61 10.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.496 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 17' ' ' TYR . 12.8 t -138.35 -169.11 2.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 71.439999999999998 110.104 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.48 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 70.8 mtt180 -48.12 -26.49 1.89 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.198 0.814 . . . . 75.209999999999994 113.198 -174.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -81.94 12.41 4.12 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.224 -0.298 . . . . 72.510000000000005 111.785 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' MET . 27.4 p-10 -95.8 -5.04 42.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.236 . . . . 75.239999999999995 110.745 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 96.1 mt -52.73 -38.09 60.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.791 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -62.56 -30.06 75.45 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.131 -0.556 . . . . 75.230000000000004 112.657 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -91.5 -32.89 15.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.963 -0.139 . . . . 75.010000000000005 111.346 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.418 ' HE3' HG21 ' A' ' 166' ' ' VAL . 76.3 mtp -54.58 -40.15 68.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.145 0.794 . . . . 74.25 113.145 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.837 ' HB ' HD11 ' A' ' 93' ' ' ILE . 45.5 t -63.62 -46.3 95.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 71.109999999999999 110.41 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.08 79.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 110.324 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.87 -49.0 72.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.442 -0.799 . . . . 52.299999999999997 110.564 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.66 -43.38 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.836 -0.62 . . . . 72.239999999999995 110.934 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.7 mt -59.44 -40.79 87.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 111.221 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.63 64.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 70.299999999999997 110.976 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.11 -33.39 40.78 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.99 -0.624 . . . . 43.32 113.311 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.635 ' HG3' HD12 ' A' ' 36' ' ' ILE . 14.7 ptm180 -69.78 -25.97 64.06 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.256 0.528 . . . . 72.349999999999994 111.196 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 ' HG3' ' A' ' 35' ' ' ARG . 2.0 mp -88.31 -42.21 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.542 . . . . 72.340000000000003 109.686 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.51 58.53 2.27 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.81 -0.709 . . . . 73.230000000000004 112.219 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.8 m -134.7 145.69 48.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.666 0.27 . . . . 74.099999999999994 110.562 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.52 150.82 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 65.200000000000003 110.513 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 1.1 p90 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.834 -0.621 . . . . 70.239999999999995 111.086 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -113.85 134.14 54.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 73.109999999999999 110.188 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 49' ' ' GLU . 43.6 t -74.68 129.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 74.420000000000002 111.685 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.96 149.64 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 74.239999999999995 110.378 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -70.64 -72.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.146 -0.479 . . . . 73.519999999999996 111.419 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -68.16 -27.38 66.37 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 111.374 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -83.51 -28.2 28.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.474 -0.33 . . . . 65.450000000000003 111.024 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.25 11.83 53.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.093 -0.575 . . . . 75.5 112.452 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 64' ' ' LYS . . . -120.25 151.34 39.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.67 0.271 . . . . 74.140000000000001 110.947 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 45.7 mp0 -78.92 138.8 38.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.859 -0.61 . . . . 74.040000000000006 111.602 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.36 136.81 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 75.099999999999994 109.404 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 9.4 p -121.99 144.69 30.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.734 0.302 . . . . 75.129999999999995 110.442 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.792 HG22 HG11 ' A' ' 61' ' ' VAL . 7.2 p -118.14 144.52 45.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.335 -0.393 . . . . 73.219999999999999 111.319 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.53 -174.87 38.26 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.028 -0.606 . . . . 62.32 111.87 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 -109.92 126.05 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.808 -0.231 . . . . 74.530000000000001 110.524 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.124 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -105.48 108.8 20.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.838 -0.801 . . . . 72.209999999999994 108.838 174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.91 -51.93 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.618 -0.719 . . . . 72.450000000000003 111.526 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.37 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.008 -0.837 . . . . 73.209999999999994 111.008 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.474 ' O ' HD21 ' A' ' 55' ' ' LEU . 27.1 m -78.07 153.12 32.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.403 -0.399 . . . . 75.430000000000007 110.385 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.6 m -80.8 129.13 34.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.953 -0.388 . . . . 71.409999999999997 109.953 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.124 ' HB ' HD22 ' A' ' 55' ' ' LEU . 13.9 p -118.0 135.56 58.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.926 0.393 . . . . 63.509999999999998 110.508 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.792 HG11 HG22 ' A' ' 52' ' ' THR . 17.4 m -116.14 112.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.251 0.548 . . . . 74.329999999999998 109.965 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.642 HD21 ' HB ' ' A' ' 7' ' ' VAL . 84.3 mt -98.08 113.12 24.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 73.310000000000002 110.206 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.141 -0.481 . . . . 63.450000000000003 110.72 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 3.1 ptmm? -123.81 119.3 26.89 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.182 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.45 160.9 40.55 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.703 2.268 . . . . 74.239999999999995 112.894 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 7.83 10.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.628 -0.715 . . . . 74.349999999999994 110.141 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.6 t -146.32 -179.36 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 61.420000000000002 109.613 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.7 170.72 11.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.077 0.465 . . . . 74.420000000000002 111.626 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.99 -23.41 66.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.352 -0.84 . . . . 72.400000000000006 111.455 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.05 -43.39 63.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.142 0.496 . . . . 73.230000000000004 110.21 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -75.67 -56.89 4.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.659 -0.7 . . . . 72.239999999999995 110.228 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 m -47.33 -44.62 23.87 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.745 0.653 . . . . 74.109999999999999 112.662 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.75 94.1 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.902 -0.666 . . . . 71.030000000000001 113.053 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.37 3.07 40.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.79 0.293 . . . . 74.200000000000003 111.79 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.47 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 12.7 mm-40 -91.9 -43.78 9.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.571 -0.286 . . . . 75.030000000000001 111.274 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.43 -39.96 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.368 -0.378 . . . . 71.519999999999996 111.629 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.24 -63.51 5.21 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 116.176 -0.465 . . . . 60.149999999999999 112.965 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.01 -26.02 47.58 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.131 2.554 . . . . 61.350000000000001 113.164 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 28.8 mt -72.82 -40.44 65.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.529 0.204 . . . . 73.299999999999997 111.428 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.89 -39.24 88.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.422 0.63 . . . . 63.020000000000003 109.877 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -9.34 57.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.629 -0.714 . . . . 74.310000000000002 111.388 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -66.37 -43.98 84.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 72.549999999999997 109.204 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.81 3.81 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 72.140000000000001 109.707 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.7 p 45.41 54.47 7.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.923 -1.035 . . . . 74.340000000000003 112.553 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 80' ' ' ALA . 26.8 m -81.98 150.45 65.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 73.430000000000007 110.73 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 161.33 46.39 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.673 2.249 . . . . 74.109999999999999 111.72 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -48.1 111.85 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.269 2.646 . . . . 72.310000000000002 112.175 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -128.14 -173.97 3.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 71.150000000000006 111.44 -172.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -91.24 95.45 10.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 74.140000000000001 110.988 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 tt -76.02 110.85 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.462 0.648 . . . . 64.430000000000007 110.446 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 132.63 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 72.400000000000006 110.693 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 121' ' ' VAL . 67.5 t -129.35 129.44 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.676 -0.49 . . . . 63.049999999999997 109.676 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.837 HD11 ' HB ' ' A' ' 28' ' ' VAL . 36.4 mt -106.17 126.59 61.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.46 . . . . 64.219999999999999 110.111 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.425 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 67.3 t60 -159.03 174.22 15.26 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.589 -0.445 . . . . 75.340000000000003 111.825 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 2.1 p30 -83.7 152.69 24.6 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.436 -0.802 . . . . 72.010000000000005 111.332 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG3' ' H ' ' A' ' 98' ' ' ASP . 9.0 tp10 -145.37 136.67 24.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 65.310000000000002 110.767 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.89 -15.39 48.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.931 -0.577 . . . . 75.010000000000005 111.549 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.491 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.5 t70 -75.76 -22.61 56.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 75.319999999999993 112.267 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.67 HG13 ' HB2' ' A' ' 105' ' ' ARG . 46.6 mm -113.83 144.42 21.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.865 0.364 . . . . 74.319999999999993 111.876 -172.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 146.39 17.6 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.12 -0.945 . . . . 63.229999999999997 110.479 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.641 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 63.0 t80 -66.99 108.52 2.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 110.272 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 -16.27 6.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.617 -0.801 . . . . 64.439999999999998 112.668 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -107.41 151.24 25.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.796 -0.446 . . . . 74.5 109.796 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.68 135.77 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.811 0.339 . . . . 75.200000000000003 110.776 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.67 ' HB2' HG13 ' A' ' 99' ' ' ILE . 8.6 tpp180 -108.89 125.92 52.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.477 -0.564 . . . . 74.430000000000007 109.477 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.474 HD13 HG23 ' A' ' 188' ' ' VAL . 67.8 mt -97.67 134.0 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.908 0.385 . . . . 74.040000000000006 110.183 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.702 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -120.83 119.81 33.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.804 -0.634 . . . . 74.310000000000002 110.239 -177.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.723 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.5 pt? -103.5 -138.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.758 -0.46 . . . . 73.219999999999999 109.758 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 36.04 -145.82 0.07 OUTLIER Glycine 0 C--N 1.344 0.976 0 O-C-N 123.678 0.612 . . . . 73.409999999999997 113.411 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.86 127.99 8.35 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.486 -1.045 . . . . 73.319999999999993 110.486 162.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.04 107.93 3.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 71.230000000000004 113.756 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.91 101.51 12.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 73.239999999999995 110.108 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.88 -161.47 29.59 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.332 -1.107 . . . . 64.030000000000001 110.332 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.502 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . 64.47 15.62 59.56 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.823 -0.703 . . . . 75.25 112.157 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 m80 72.91 -76.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.442 0.697 . . . . 71.420000000000002 111.742 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -134.69 -59.48 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.381 0.511 . . . . 73.310000000000002 112.381 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -57.11 -30.2 60.49 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.581 -0.343 . . . . 60.009999999999998 113.5 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.502 HD13 ' HA3' ' A' ' 114' ' ' GLY . 0.9 OUTLIER -63.87 -41.13 97.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.174 0.512 . . . . 73.430000000000007 110.101 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -76.73 -37.86 55.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.198 -0.91 . . . . 73.109999999999999 110.614 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.5 m -61.95 -49.37 76.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 74.109999999999999 111.327 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.726 HG21 HG22 ' A' ' 92' ' ' VAL . 27.3 m -72.64 -21.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 75.109999999999999 111.412 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.24 -59.74 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 111.057 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.4 m -63.27 -40.65 97.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 63.020000000000003 111.697 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.95 68.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 55.25 111.669 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.4 tp -85.02 -27.94 26.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 75.409999999999997 110.258 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.23 22.98 75.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.77 . . . . 63.030000000000001 112.249 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.8 m -124.91 121.49 34.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 74.219999999999999 110.369 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.414 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 44.9 mtmt -115.65 -173.6 2.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.047 -0.723 . . . . 74.120000000000005 109.047 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 t30 63.03 79.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.147 0.975 . . . . 74.319999999999993 109.629 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.414 ' CE2' ' HA ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -145.88 -155.51 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.443 -1.253 . . . . 73.140000000000001 109.122 -176.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -149.0 110.04 4.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 75.329999999999998 110.409 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.49 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 2.3 mpt_? -104.55 146.85 28.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.774 -0.648 . . . . 71.239999999999995 109.88 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.18 102.44 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.986 -0.552 . . . . 74.340000000000003 110.292 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -96.64 97.26 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.786 -0.643 . . . . 75.219999999999999 109.386 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.08 128.53 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.86 -0.422 . . . . 74.120000000000005 109.86 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -64.11 123.31 27.75 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.627 -0.797 . . . . 73.5 111.816 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.437 ' HA ' ' HD1' ' A' ' 101' ' ' PHE . 9.8 p -96.84 0.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.216 0.532 . . . . 64.540000000000006 110.571 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 135.82 -87.32 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.5 -0.857 . . . . 54.140000000000001 112.84 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 2.0 ptp180 -172.57 165.36 3.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 122.169 0.188 . . . . 75.519999999999996 110.536 -175.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 139' ' ' ARG . 27.9 Cg_endo -64.67 120.2 7.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.344 2.03 . . . . 74.519999999999996 111.198 171.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.15 167.09 20.12 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.727 2.285 . . . . 73.109999999999999 112.904 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.87 -59.13 0.17 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.702 -0.761 . . . . 55.109999999999999 112.59 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -79.6 -29.49 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.764 0.283 . . . . 71.329999999999998 111.764 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 134.22 51.15 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.588 -0.445 . . . . 74.450000000000003 110.402 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.5 141.55 78.42 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.389 -0.823 . . . . 75.049999999999997 110.427 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.95 -38.05 12.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.759 2.973 . . . . 75.120000000000005 113.984 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -25.83 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.943 0.402 . . . . 72.400000000000006 110.95 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.96 -21.89 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.481 . . . . 73.310000000000002 110.2 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -72.73 -38.34 67.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.801 -0.636 . . . . 62.329999999999998 110.367 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.437 HG11 HG22 ' A' ' 137' ' ' VAL . 34.2 m -82.9 2.12 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.266 -0.425 . . . . 74.340000000000003 110.486 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.95 -24.14 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.551 . . . . 75.239999999999995 110.713 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -93.07 97.88 10.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.239 0.543 . . . . 61.439999999999998 110.92 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 20' ' ' THR . 32.9 p-10 -104.5 -7.43 19.79 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.009 -0.432 . . . . 65.310000000000002 110.897 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.1 52.87 2.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.222 -0.445 . . . . 73.140000000000001 110.092 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -75.16 -173.59 2.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.703 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.462 ' H ' HG23 ' A' ' 155' ' ' THR . . . -75.67 -71.32 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.807 0.336 . . . . 74.409999999999997 111.48 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.96 -37.49 11.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.355 0.597 . . . . 73.099999999999994 110.459 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.569 ' HB3' ' CD2' ' A' ' 101' ' ' PHE . 3.6 mp0 -58.9 -34.6 71.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.962 -1.017 . . . . 72.129999999999995 111.712 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -65.93 -26.48 67.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.083 0.468 . . . . 74.450000000000003 111.123 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.89 -15.39 36.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.367 -0.379 . . . . 75.239999999999995 111.641 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -116.1 15.49 16.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.768 0.285 . . . . 75.409999999999997 111.768 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.699 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 57.9 t -56.33 -56.05 35.7 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.253 0.464 . . . . 72.219999999999999 112.253 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -66.49 -31.38 42.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.738 1.625 . . . . 72.430000000000007 112.074 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.1 m -63.97 -45.56 88.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 74.319999999999993 111.794 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.3 pt -68.75 -32.05 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 75.230000000000004 111.156 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.418 HG21 ' HE3' ' A' ' 27' ' ' MET . 57.5 t -72.58 -37.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.34 -0.391 . . . . 74.5 110.43 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.48 -51.29 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 74.239999999999995 110.887 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.04 -36.36 77.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 71.430000000000007 111.068 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.46 97.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 75.430000000000007 111.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.58 95.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 110.952 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.25 -39.8 89.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 70.239999999999995 110.615 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.484 ' HB1' HG22 ' A' ' 188' ' ' VAL . . . -63.3 -35.76 81.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 110.73 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 60.8 m -65.85 -38.5 89.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 72.420000000000002 110.543 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -65.04 -39.03 92.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 75.219999999999999 110.045 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.65 -33.8 75.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.897 -0.592 . . . . 72.510000000000005 110.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.471 HD23 ' HB2' ' A' ' 184' ' ' ALA . 96.1 mt -61.41 -34.43 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 75.230000000000004 110.817 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 mm -80.7 -40.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 73.010000000000005 111.108 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.13 -43.87 64.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.333 0.494 . . . . 53.130000000000003 112.333 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -100.25 -49.86 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.946 0.403 . . . . 75.150000000000006 110.87 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 143.71 -168.63 26.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.503 -0.639 . . . . 52.340000000000003 111.503 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 182' ' ' GLU . 4.3 pp -104.13 -24.02 13.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.769 0.285 . . . . 75.329999999999998 110.83 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.706 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 34.4 tt0 -67.11 -57.23 11.43 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 111.845 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 83.4 Cg_endo -87.47 -29.63 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.833 1.688 . . . . 73.239999999999995 113.093 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.506 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -73.93 -31.43 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.508 -0.314 . . . . 75.010000000000005 111.823 -172.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -61.81 -29.57 70.25 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.123 0.487 . . . . 75.0 110.023 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.61 -48.38 64.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.635 -0.711 . . . . 64.200000000000003 109.846 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 36.0 m -56.26 -38.46 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.631 -0.713 . . . . 61.119999999999997 111.446 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 184' ' ' ALA . 82.7 t -57.24 -37.41 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.186 0.439 . . . . 71.510000000000005 112.186 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -104.14 -28.24 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.311 -0.555 . . . . 74.409999999999997 111.996 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -94.36 12.3 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.128 0.418 . . . . 60.119999999999997 112.128 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.466 ' HB2' ' O ' ' A' ' 187' ' ' THR . 3.8 t90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.479 -0.772 . . . . 75.129999999999995 110.17 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.793 0.33 . . . . 75.319999999999993 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.58 141.91 17.9 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.172 2.581 . . . . 71.430000000000007 113.577 -173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 55' ' ' LEU . 97.0 mt -86.14 126.75 34.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.259 -0.882 . . . . 74.049999999999997 109.577 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.632 HD21 HG21 ' A' ' 85' ' ' VAL . 37.1 tp -93.28 114.77 27.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.303 . . . . 75.140000000000001 110.499 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' HD23 ' A' ' 62' ' ' LEU . 41.2 t -120.69 121.69 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.34 -0.391 . . . . 73.129999999999995 110.12 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 60.2 t -104.02 116.19 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 73.530000000000001 110.56 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.96 122.92 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.963 -0.562 . . . . 75.010000000000005 111.703 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.684 ' HG ' ' HE2' ' A' ' 22' ' ' HIS . 58.3 tp -107.74 105.07 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.931 0.396 . . . . 75.510000000000005 111.12 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -97.3 -142.94 13.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 61.420000000000002 112.098 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.757 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . 15.9 m120 -134.58 129.37 19.46 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.619 0.21 . . . . 75.340000000000003 111.155 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -96.8 173.17 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.37 2.713 . . . . 74.150000000000006 111.716 170.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.78 -176.35 19.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.408 -0.901 . . . . 74.140000000000001 112.389 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 -67.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.054 2.502 . . . . 74.409999999999997 112.859 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -127.52 11.15 6.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 72.140000000000001 111.301 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -65.55 -18.47 65.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.796 0.331 . . . . 70.219999999999999 111.102 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.757 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -75.71 -1.4 24.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 65.319999999999993 111.386 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 153' ' ' ASN . 68.3 mmtt -107.16 26.75 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 75.540000000000006 109.878 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 151' ' ' LEU . 71.2 p -102.19 172.72 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.448 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -66.0 -19.38 65.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.294 . . . . 74.530000000000001 111.249 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.684 ' HE2' ' HG ' ' A' ' 10' ' ' LEU . 82.6 t60 -76.34 -9.08 58.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 70.129999999999995 110.986 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -8.08 12.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.715 0.293 . . . . 75.349999999999994 111.466 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.404 HD13 HG21 ' A' ' 135' ' ' ILE . 94.9 mt -63.42 -31.81 73.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.375 -0.375 . . . . 74.549999999999997 110.513 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.514 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -63.83 -26.64 70.21 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.948 -0.569 . . . . 75.340000000000003 112.142 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.608 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 74.3 t80 -90.74 -36.38 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.789 0.328 . . . . 65.319999999999993 110.517 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 mmt -57.36 -42.33 81.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.547 0.573 . . . . 75.420000000000002 112.547 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 93' ' ' ILE . 48.2 t -61.74 -38.83 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 70.430000000000007 110.5 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.96 -38.64 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 71.530000000000001 110.851 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -57.36 -46.57 83.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 72.540000000000006 111.334 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.03 -45.56 95.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 71.129999999999995 110.745 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 36' ' ' ILE . 94.5 mt -61.6 -44.51 96.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.349999999999994 110.903 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.65 -35.5 72.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 71.230000000000004 111.167 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.53 -42.17 93.74 Favored Glycine 0 N--CA 1.454 -0.163 0 C-N-CA 121.288 -0.482 . . . . 61.520000000000003 112.916 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.27 -21.05 64.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.623 0.249 . . . . 74.540000000000006 111.015 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.881 HD11 ' HA3' ' A' ' 53' ' ' GLY . 70.5 mt -83.58 -45.71 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.177 0.513 . . . . 74.230000000000004 109.936 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.46 23.12 10.52 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 72.400000000000006 112.17 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -118.35 158.18 25.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.796 0.331 . . . . 64.239999999999995 110.757 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.77 146.56 43.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.726 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.593 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 38.9 p90 -80.79 151.03 28.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 71.219999999999999 110.682 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.55 164.14 32.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.855 0.359 . . . . 74.409999999999997 110.935 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 49' ' ' GLU . 46.6 t -75.2 126.1 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.694 -0.685 . . . . 75.409999999999997 112.063 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -76.45 127.13 32.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 64.349999999999994 109.125 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 38.6 ttmt -67.45 -5.93 17.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 72.540000000000006 111.964 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -80.34 -76.96 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.817 0.341 . . . . 74.340000000000003 111.402 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -90.13 -16.88 28.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.391 -0.368 . . . . 74.109999999999999 111.906 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 5.87 69.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.445 -0.883 . . . . 72.030000000000001 111.714 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.94 143.56 28.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.285 -0.265 . . . . 53.240000000000002 110.285 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HG2' HG21 ' A' ' 42' ' ' VAL . 37.3 mt-10 -94.67 132.87 38.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 74.329999999999998 110.477 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 t -136.29 142.51 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.296 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.6 p -125.26 136.75 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.905 0.384 . . . . 75.129999999999995 110.641 175.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.439 HG21 HG12 ' A' ' 61' ' ' VAL . 2.0 p -97.58 149.79 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.901 -0.59 . . . . 74.219999999999999 111.094 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.881 ' HA3' HD11 ' A' ' 36' ' ' ILE . . . -179.07 -164.89 32.49 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.434 -0.889 . . . . 74.209999999999994 112.722 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -122.35 143.04 49.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.058 -0.349 . . . . 74.439999999999998 110.058 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.114 HD21 ' HB ' ' A' ' 60' ' ' VAL . 2.6 pt? -127.84 109.04 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 75.319999999999993 109.361 174.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.05 -45.82 0.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 65.319999999999993 111.65 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.28 -27.93 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 110.72 -0.952 . . . . 74.519999999999996 110.72 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 59' ' ' SER . 2.0 m -71.79 169.38 15.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.974 -0.613 . . . . 73.400000000000006 110.436 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.47 ' H ' HG22 ' A' ' 58' ' ' THR . 14.7 m -97.35 130.56 44.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.468 -0.567 . . . . 74.049999999999997 109.468 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.114 ' HB ' HD21 ' A' ' 55' ' ' LEU . 15.0 p -120.05 137.98 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 74.310000000000002 110.688 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 52' ' ' THR . 11.9 m -122.8 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.339 0.59 . . . . 72.409999999999997 109.847 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD23 ' HB ' ' A' ' 7' ' ' VAL . 77.9 mt -92.39 110.57 21.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.686 -0.688 . . . . 75.349999999999994 110.028 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -109.64 132.23 54.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.855 -0.612 . . . . 65.540000000000006 110.674 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -120.88 127.92 26.01 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 74.430000000000007 110.369 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.591 ' HG2' HD11 ' A' ' 10' ' ' LEU . 48.4 Cg_endo -70.34 168.05 23.41 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.345 2.03 . . . . 75.049999999999997 111.262 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -89.05 -60.54 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.837 -0.345 . . . . 75.329999999999998 110.726 -176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.1 p -167.11 172.38 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 64.319999999999993 110.541 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.444 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 10.1 t80 71.2 118.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.073 0.858 . . . . 73.109999999999999 111.336 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' A' ' 69' ' ' MET . 1.9 mpt? -53.29 -56.24 18.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.589 -0.732 . . . . 62.25 111.624 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 12.5 m120 -56.62 -46.57 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 74.409999999999997 111.114 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 5.6 mm-40 -64.18 -43.99 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 73.150000000000006 111.192 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 m -57.84 -39.01 76.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 73.150000000000006 110.908 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.678 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -64.61 -34.96 91.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.519 -0.848 . . . . 74.510000000000005 111.898 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 70' ' ' ASN . 44.8 mtp180 -86.98 -2.7 58.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 74.010000000000005 110.486 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 27.5 mm-40 -79.43 -32.74 42.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 73.010000000000005 110.225 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.98 -32.18 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.681 -0.69 . . . . 72.409999999999997 110.751 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -47.17 -68.28 1.21 Allowed Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.626 -0.715 . . . . 63.439999999999998 113.871 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 -41.06 42.02 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.308 2.006 . . . . 75.239999999999995 112.844 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.57 -31.6 72.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.453 -0.339 . . . . 74.200000000000003 111.842 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.95 84.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 54.509999999999998 111.156 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -26.75 29.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.422 -0.354 . . . . 75.439999999999998 110.853 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.32 -46.04 83.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 74.510000000000005 110.376 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.58 -3.88 45.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 75.099999999999994 110.649 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m 60.71 34.69 19.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.678 -0.692 . . . . 73.400000000000006 111.313 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.632 HG21 HD21 ' A' ' 6' ' ' LEU . 26.9 m -81.25 145.97 57.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.687 -0.688 . . . . 70.239999999999995 111.063 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 2.7 Cg_exo -76.49 131.06 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.95 2.434 . . . . 71.540000000000006 111.916 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.43 47.0 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.782 2.988 . . . . 74.120000000000005 113.306 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -139.88 -37.67 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 73.129999999999995 109.926 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -84.59 -6.82 59.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 75.140000000000001 111.353 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.98 130.0 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.378 0.609 . . . . 72.349999999999994 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' A' ' 7' ' ' VAL . 45.8 t -106.16 127.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.766 . . . . 71.319999999999993 110.111 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.674 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 40.0 t -114.7 110.18 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.072 -0.344 . . . . 75.209999999999994 110.072 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 28' ' ' VAL . 39.5 mt -87.9 116.88 30.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.502 -0.317 . . . . 74.200000000000003 110.657 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -142.6 161.03 39.12 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.557 0.343 . . . . 65.430000000000007 110.197 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HB2' HG22 ' A' ' 137' ' ' VAL . 10.8 p-10 -91.65 148.27 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.509 -0.314 . . . . 61.340000000000003 110.517 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.414 ' CD ' HH22 ' A' ' 134' ' ' ARG . 73.8 tt0 -124.96 128.23 48.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.222 0.534 . . . . 74.439999999999998 111.197 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.637 HD13 ' HD3' ' A' ' 141' ' ' PRO . 47.1 tp -81.95 -13.9 56.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.666 -0.697 . . . . 65.310000000000002 111.72 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.59 5.21 51.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.259 0.552 . . . . 73.340000000000003 111.433 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.75 146.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.323 -0.399 . . . . 72.230000000000004 110.559 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.15 154.29 23.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.511 ' N ' ' HA2' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -67.68 109.76 3.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 71.430000000000007 110.071 -176.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 114.87 -8.5 21.56 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 54.030000000000001 112.623 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -98.83 132.55 44.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.882 -0.414 . . . . 75.400000000000006 109.882 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.621 ' HB ' HG13 ' A' ' 188' ' ' VAL . 3.1 mp -101.04 129.54 51.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.236 -0.438 . . . . 65.140000000000001 110.061 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -108.79 127.79 54.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.017 -0.538 . . . . 75.329999999999998 110.449 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 131' ' ' HIS . 48.1 tp -97.66 132.29 43.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.376 -0.601 . . . . 75.340000000000003 109.376 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -155.07 122.11 5.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.288 -0.415 . . . . 74.540000000000006 110.109 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.654 ' H ' HD21 ' A' ' 108' ' ' LEU . 1.4 pt? -102.3 -136.16 0.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.679 -0.408 . . . . 72.099999999999994 109.955 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.607 ' N ' ' HA ' ' A' ' 129' ' ' ASN . . . 40.3 -149.12 0.17 Allowed Glycine 0 C--N 1.334 0.472 0 O-C-N 123.625 0.578 . . . . 71.0 113.11 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.24 10.56 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.068 -1.213 . . . . 72.230000000000004 110.068 164.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.12 156.46 28.03 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.942 -1.123 . . . . 63.5 112.914 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -93.57 -178.63 4.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.792 0.33 . . . . 74.439999999999998 110.138 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.527 ' HA3' ' NH2' ' A' ' 134' ' ' ARG . . . 115.14 62.53 0.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.796 -0.716 . . . . 74.420000000000002 111.601 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.08 -102.34 0.18 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.801 -0.714 . . . . 75.310000000000002 111.593 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -154.22 168.38 26.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.254 -0.647 . . . . 74.099999999999994 109.254 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -41.86 -53.46 3.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.774 0.671 . . . . 73.319999999999993 111.617 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.497 ' HA2' ' OG ' ' A' ' 120' ' ' SER . . . -67.04 2.33 5.15 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.022 -0.535 . . . . 72.420000000000002 114.205 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.401 HD21 ' HG2' ' A' ' 132' ' ' ARG . 1.4 tt -83.83 -43.91 14.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.395 0.617 . . . . 74.420000000000002 109.366 173.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -79.68 -21.07 45.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.173 -0.921 . . . . 72.030000000000001 111.274 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.497 ' OG ' ' HA2' ' A' ' 117' ' ' GLY . 10.0 m -55.53 -43.8 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 65.120000000000005 111.726 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.678 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -68.11 -30.79 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.838 0.352 . . . . 73.409999999999997 111.343 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.403 ' HB2' ' HG3' ' A' ' 128' ' ' LYS . . . -78.16 -30.2 49.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 70.140000000000001 111.036 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.4 m -84.07 -39.71 19.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.093 -0.503 . . . . 61.130000000000003 110.967 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.51 77.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 73.519999999999996 111.861 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.643 HD21 ' HZ ' ' A' ' 130' ' ' PHE . 29.3 tp -85.45 -31.12 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.48 . . . . 73.230000000000004 109.806 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.33 -12.58 66.49 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.551 -0.75 . . . . 75.340000000000003 112.555 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.8 m -106.89 137.45 44.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.783 0.325 . . . . 73.109999999999999 110.858 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 8.0 mptt -110.58 -161.81 0.77 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.506 -0.553 . . . . 74.430000000000007 109.506 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.607 ' HA ' ' N ' ' A' ' 109' ' ' GLY . 86.3 m-20 76.6 12.97 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.199 0.6 . . . . 64.230000000000004 111.329 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.643 ' HZ ' HD21 ' A' ' 125' ' ' LEU . 16.7 m-30 -71.59 136.77 47.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.374 -0.602 . . . . 75.420000000000002 109.374 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.464 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.3 p-80 -89.88 107.77 19.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.303 0.573 . . . . 74.430000000000007 110.352 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.674 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 5.5 mpt_? -94.32 141.28 28.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.631 . . . . 75.409999999999997 110.614 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.3 t -92.9 104.18 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.555 -0.905 . . . . 73.209999999999994 108.555 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 94' ' ' HIS . 9.1 mtp180 -106.45 114.75 29.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.659 . . . . 74.140000000000001 110.529 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 135' ' ' ILE . 4.1 mp -96.71 125.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.862 -0.422 . . . . 75.409999999999997 109.862 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -61.27 132.16 48.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.134 -0.555 . . . . 71.099999999999994 112.832 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 95' ' ' ASP . 23.9 t -86.44 -9.27 11.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.327 0.584 . . . . 74.510000000000005 111.035 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 117.37 -87.31 0.43 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.127 -1.035 . . . . 74.329999999999998 113.53 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -132.18 135.45 26.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.491 0.186 . . . . 75.319999999999993 111.229 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 29.2 Cg_endo -65.28 123.13 11.06 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.455 2.103 . . . . 73.310000000000002 111.113 171.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.948 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 14.3 Cg_exo -69.45 143.47 52.45 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.183 2.589 . . . . 75.239999999999995 112.58 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.66 -50.1 0.14 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.666 -0.778 . . . . 52.130000000000003 112.494 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -83.16 -32.67 26.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 74.340000000000003 111.405 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.541 ' HD3' ' HD1' ' A' ' 149' ' ' PHE . 4.7 ptmm? -114.81 158.84 21.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.868 -0.419 . . . . 72.329999999999998 109.868 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -52.87 131.91 48.37 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 123.549 0.531 . . . . 72.239999999999995 111.824 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.948 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 53.7 Cg_exo -53.3 -41.04 75.59 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.473 2.782 . . . . 75.349999999999994 113.45 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.37 39.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 74.010000000000005 110.423 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.34 -28.14 69.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 73.530000000000001 111.123 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.541 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 71.0 t80 -73.45 -23.17 60.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 71.019999999999996 110.528 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.41 -24.2 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.493 0.663 . . . . 70.329999999999998 109.924 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.482 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 9.3 mp -87.16 12.1 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.674 -0.694 . . . . 75.510000000000005 112.043 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 149' ' ' PHE . 10.5 pt-20 -110.35 136.66 49.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.54 . . . . 63.130000000000003 111.083 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.605 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 28.9 p-10 -104.52 34.03 3.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.715 -0.675 . . . . 74.549999999999997 110.584 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.24 140.57 49.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.032 -0.531 . . . . 74.120000000000005 111.134 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.573 ' HB ' ' OE1' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -169.58 -177.71 2.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.312 -0.996 . . . . 75.420000000000002 108.312 173.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.3 -71.14 0.68 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.69 -0.404 . . . . 74.420000000000002 111.956 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.57 -42.58 8.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 74.230000000000004 111.294 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.573 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 0.6 OUTLIER -72.26 -17.42 61.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.689 -0.687 . . . . 75.329999999999998 111.175 -174.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.433 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 11.8 tpp180 -70.02 -25.56 63.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 74.430000000000007 110.149 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.53 -13.7 42.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 73.25 111.146 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -85.04 -16.83 39.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.248 -0.433 . . . . 64.319999999999993 111.098 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.765 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 47.3 t -52.23 -58.67 10.63 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 65.109999999999999 112.218 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.765 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.0 Cg_exo -59.68 -34.14 96.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.992 1.794 . . . . 61.310000000000002 112.5 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 m -71.97 -46.27 57.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.941 -0.572 . . . . 72.230000000000004 111.744 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.442 ' CD1' ' HA2' ' A' ' 102' ' ' GLY . 43.0 pt -69.2 -32.41 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 73.150000000000006 112.003 -174.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 162' ' ' VAL . 87.1 t -58.08 -42.3 82.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 64.319999999999993 111.32 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.8 -46.63 68.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.383 -0.371 . . . . 73.409999999999997 111.481 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -24.34 60.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.624 -0.262 . . . . 74.530000000000001 111.25 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.17 85.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 55.109999999999999 110.559 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.48 94.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.556 . . . . 74.010000000000005 110.377 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.01 -43.73 98.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.67 -0.696 . . . . 73.439999999999998 110.969 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.13 95.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.356 . . . . 72.5 110.944 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.408 ' HA ' HD11 ' A' ' 176' ' ' LEU . 90.8 m -61.65 -41.59 97.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 72.040000000000006 111.05 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 55' ' ' LEU . 19.4 tt0 -71.56 -31.31 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.37 . . . . 74.150000000000006 110.372 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.43 -26.93 67.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.385 . . . . 73.340000000000003 110.418 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' A' ' 173' ' ' THR . 90.8 mt -61.81 -46.47 89.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 74.0 110.911 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.565 HG13 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -81.03 -32.88 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.017 0.437 . . . . 75.430000000000007 110.386 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.13 66.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.374 -0.376 . . . . 72.010000000000005 111.699 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 179' ' ' GLN . 6.1 tp60 -117.44 -61.49 1.69 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.657 -0.247 . . . . 74.319999999999993 111.004 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.29 177.12 35.05 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.233 -0.984 . . . . 55.310000000000002 112.101 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.621 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 3.9 pp -75.76 -20.51 58.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.492 0.187 . . . . 74.549999999999997 111.397 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.62 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 54.1 mt-10 -60.87 -61.64 7.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.65 0.611 . . . . 72.319999999999993 112.65 -172.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 71.5 Cg_endo -78.23 -31.12 3.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.592 1.528 . . . . 74.219999999999999 112.51 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.77 -58.01 5.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.1 -0.5 . . . . 70.439999999999998 111.535 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 24.8 pt20 -70.36 -24.81 63.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.699 -0.401 . . . . 74.430000000000007 110.697 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 9.9 t30 -52.25 -46.83 65.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.936 -0.574 . . . . 73.439999999999998 112.041 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -83.03 -32.62 26.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.869 -0.333 . . . . 74.340000000000003 111.232 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.621 HG13 ' HB ' ' A' ' 104' ' ' ILE . 44.4 t -69.51 -28.82 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.568 -0.287 . . . . 71.150000000000006 111.724 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -99.08 10.9 40.52 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.019 -0.672 . . . . 73.530000000000001 110.91 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -141.48 31.65 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.066 0.395 . . . . 72.209999999999994 112.066 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.308 -0.853 . . . . 75.239999999999995 109.997 174.66 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.9 pm0 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.372 0.606 . . . . 75.040000000000006 110.501 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HG2' HG23 ' A' ' 85' ' ' VAL . 83.8 Cg_endo -101.86 -167.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.944 3.096 . . . . 72.409999999999997 113.014 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 177' ' ' ILE . 55.9 tp -136.5 115.79 12.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.199 -0.91 . . . . 74.150000000000006 108.77 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.56 ' HA ' HG23 ' A' ' 61' ' ' VAL . 33.7 tp -90.82 104.4 16.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.47 -0.567 . . . . 73.239999999999995 109.47 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.644 ' HB ' HD22 ' A' ' 62' ' ' LEU . 43.3 t -111.63 122.06 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.258 -0.428 . . . . 64.319999999999993 110.54 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.57 114.77 47.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.938 -0.574 . . . . 72.340000000000003 109.753 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.1 121.16 6.19 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.681 -0.968 . . . . 70.329999999999998 110.681 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.88 124.0 44.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.017 0.437 . . . . 64.040000000000006 111.431 -172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.81 -147.14 4.72 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.435 -0.666 . . . . 74.239999999999995 111.435 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -116.66 98.47 51.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.674 0.273 . . . . 75.040000000000006 111.208 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.0 118.37 5.39 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.689 2.259 . . . . 72.310000000000002 111.351 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 171.96 43.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.891 -0.671 . . . . 74.099999999999994 111.661 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.91 -72.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.843 2.362 . . . . 70.409999999999997 112.522 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -87.05 -15.01 39.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.41 0.624 . . . . 62.140000000000001 110.068 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -71.67 -23.62 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 74.129999999999995 111.546 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.36 -1.61 50.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.032 0.444 . . . . 75.439999999999998 110.98 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -108.86 15.56 23.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 73.040000000000006 110.454 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.746 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 65.6 p -101.85 -170.38 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.153 -0.476 . . . . 73.150000000000006 110.739 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -73.18 -4.94 36.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.909 0.385 . . . . 74.239999999999995 110.74 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -99.11 21.98 11.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.193 0.442 . . . . 75.25 112.193 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 27' ' ' MET . 39.2 p30 -101.37 -1.05 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.855 -0.338 . . . . 62.310000000000002 110.458 174.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.82 -37.12 70.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.969 -0.56 . . . . 74.219999999999999 111.381 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.547 ' HA2' HG21 ' A' ' 93' ' ' ILE . . . -62.54 -32.85 84.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.055 -0.593 . . . . 50.409999999999997 112.355 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -90.31 -24.61 20.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.793 -0.24 . . . . 75.340000000000003 111.239 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.83 ' HA ' ' HE1' ' A' ' 27' ' ' MET . 17.2 mmt -55.91 -51.42 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.786 0.327 . . . . 74.430000000000007 111.175 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 22.0 t -66.46 -40.71 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 72.140000000000001 110.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 74.010000000000005 111.666 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -60.33 -45.08 94.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 75.530000000000001 110.553 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.36 -43.82 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 71.329999999999998 110.77 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.5 mt -60.97 -39.32 89.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 75.239999999999995 111.156 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.77 -46.32 58.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 75.120000000000005 110.793 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.55 -34.41 89.87 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.766 -0.652 . . . . 75.109999999999999 113.42 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -20.27 62.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.033 0.416 . . . . 74.209999999999994 111.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 HD11 ' HA3' ' A' ' 53' ' ' GLY . 75.4 mt -87.05 -41.97 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.934 0.397 . . . . 74.510000000000005 110.151 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.23 60.22 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.821 -0.627 . . . . 74.120000000000005 111.914 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -100.45 140.65 34.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.801 0.334 . . . . 73.430000000000007 110.485 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.46 143.06 30.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.322 -0.399 . . . . 75.25 111.315 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.05 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 3.3 p90 -60.57 142.04 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 74.030000000000001 111.144 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 25.0 mtpp -117.81 147.47 42.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 73.430000000000007 110.852 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.648 HG21 ' HG2' ' A' ' 49' ' ' GLU . 39.5 t -75.87 128.54 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.953 -0.567 . . . . 74.0 110.169 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.427 ' CD2' ' HB ' ' A' ' 50' ' ' VAL . 27.1 m-70 -85.4 117.03 24.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.423 -0.353 . . . . 72.409999999999997 110.331 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -71.47 81.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.588 0.709 . . . . 74.430000000000007 111.175 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -175.52 -70.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.266 -0.879 . . . . 75.230000000000004 109.484 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.52 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 13.0 m -86.81 -27.95 23.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.745 -0.661 . . . . 73.209999999999994 110.662 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.429 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . 94.55 10.71 57.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 51.32 112.405 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.661 ' HB3' HD12 ' A' ' 79' ' ' LEU . . . -97.49 157.59 15.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 73.019999999999996 110.788 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.648 ' HG2' HG21 ' A' ' 42' ' ' VAL . 32.9 mt-10 -103.28 127.91 50.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.866 -0.606 . . . . 73.099999999999994 111.039 -175.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.5 t -140.53 137.97 36.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 109.817 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.05 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.2 p -116.87 135.23 57.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.886 0.374 . . . . 72.409999999999997 111.097 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.563 HG23 HG13 ' A' ' 61' ' ' VAL . 20.2 p -100.85 108.13 19.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 75.120000000000005 110.492 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.459 ' HA3' HD11 ' A' ' 36' ' ' ILE . . . -127.72 -161.7 10.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.819 -0.705 . . . . 74.519999999999996 112.178 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -129.94 143.22 50.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.652 0.226 . . . . 71.340000000000003 110.548 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 1.1 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.0 pt? -142.28 121.17 12.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.184 -0.673 . . . . 73.439999999999998 109.184 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.8 -57.24 0.46 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.41 0.684 . . . . 75.310000000000002 111.862 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.37 -12.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.343 -0.456 . . . . 75.319999999999993 112.447 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.4 p -104.05 168.82 8.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.94 0.4 . . . . 71.319999999999993 110.899 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 t -90.86 99.64 12.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 71.140000000000001 110.565 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 1.1 ' HB ' HD22 ' A' ' 55' ' ' LEU . 11.6 p -76.17 129.94 36.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.54 -0.464 . . . . 75.450000000000003 109.872 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.563 HG13 HG23 ' A' ' 52' ' ' THR . 17.6 m -118.45 111.22 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.494 0.664 . . . . 74.409999999999997 110.12 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.644 HD22 ' HB ' ' A' ' 7' ' ' VAL . 87.5 mt -92.6 117.92 30.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.759 . . . . 71.200000000000003 110.28 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.43 125.33 51.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.933 -0.576 . . . . 65.299999999999997 109.802 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -117.92 136.19 23.68 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.093 -0.503 . . . . 74.129999999999995 111.102 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.45 137.82 62.14 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.986 2.457 . . . . 71.319999999999993 111.477 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 32.5 ttt-85 -85.56 -52.78 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.741 -0.384 . . . . 74.109999999999999 110.08 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.2 p -159.44 139.17 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.467 -0.333 . . . . 71.5 110.997 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.535 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 20.5 t80 71.06 133.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.096 0.873 . . . . 60.140000000000001 111.802 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.436 ' HB3' ' CA ' ' A' ' 117' ' ' GLY . 2.0 mpt? -62.07 -56.43 19.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 75.140000000000001 112.038 -174.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.28 -41.58 97.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.394 -0.366 . . . . 74.420000000000002 111.834 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 9.0 mm-40 -63.68 -30.11 71.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.386 -0.37 . . . . 71.109999999999999 110.89 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 m -63.52 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 74.230000000000004 110.697 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.491 ' HA2' HG11 ' A' ' 121' ' ' VAL . . . -63.08 -38.16 96.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.573 -0.822 . . . . 71.109999999999999 111.098 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.58 1.41 29.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.057 0.456 . . . . 74.530000000000001 110.594 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 13.0 mm-40 -97.37 -51.8 4.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.919 -0.582 . . . . 75.349999999999994 110.07 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.65 -41.03 91.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 64.519999999999996 111.531 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.64 -65.3 3.41 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.189 -0.459 . . . . 72.430000000000007 113.083 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.63 -39.94 87.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.792 2.328 . . . . 75.5 112.873 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.661 HD12 ' HB3' ' A' ' 48' ' ' ALA . 55.1 mt -64.7 -36.99 86.05 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.816 0.302 . . . . 70.409999999999997 111.816 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.22 -41.4 83.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.403 0.62 . . . . 75.310000000000002 110.337 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 -0.82 56.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 71.439999999999998 111.666 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -80.22 -49.05 12.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 74.409999999999997 110.564 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.547 ' CE2' ' HB ' ' A' ' 85' ' ' VAL . 40.0 p90 -108.45 9.42 27.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 74.019999999999996 110.86 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m 60.67 77.95 0.3 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.397 -0.82 . . . . 71.010000000000005 112.177 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.547 ' HB ' ' CE2' ' A' ' 83' ' ' TYR . 12.9 p -107.45 130.94 22.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.15 -0.477 . . . . 75.319999999999993 109.901 175.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.64 118.64 5.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.7 2.267 . . . . 70.299999999999997 112.4 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.18 67.6 6.85 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.295 2.664 . . . . 64.439999999999998 112.097 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -146.04 -53.66 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 74.549999999999997 109.972 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -80.71 74.16 7.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.886 -0.597 . . . . 74.5 109.991 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -121.86 141.53 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 72.209999999999994 110.455 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.534 HG21 ' HE2' ' A' ' 131' ' ' HIS . 94.9 t -127.99 110.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.035 -0.53 . . . . 70.450000000000003 109.846 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.2 106.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.142 -0.318 . . . . 72.109999999999999 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.547 HG21 ' HA2' ' A' ' 25' ' ' GLY . 66.2 mt -94.97 117.34 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.349 -0.387 . . . . 75.349999999999994 110.259 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -154.78 161.21 41.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.923 0.392 . . . . 73.010000000000005 110.407 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.46 149.53 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 74.239999999999995 110.599 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.641 ' HB3' HG22 ' A' ' 99' ' ' ILE . 5.9 tp10 -123.41 109.09 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.399 -0.593 . . . . 74.120000000000005 109.399 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.761 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 6.1 mp -68.95 -34.19 74.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 75.230000000000004 111.793 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.96 -31.16 68.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.555 . . . . 72.400000000000006 112.186 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 96' ' ' GLU . 14.8 tt -97.74 160.39 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.944 0.402 . . . . 74.219999999999999 111.461 -172.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.655 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 22.2 t70 -58.5 148.83 27.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.607 -0.724 . . . . 74.349999999999994 112.158 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 69.8 t80 -69.68 138.95 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.75 -0.659 . . . . 72.439999999999998 111.948 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.09 9.92 86.53 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.526 -0.761 . . . . 63.439999999999998 113.026 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -100.45 116.43 32.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.719 -0.474 . . . . 72.319999999999993 109.719 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.7 mp -79.98 106.43 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.446 -0.575 . . . . 65.030000000000001 109.446 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -109.06 150.06 28.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.98 -0.554 . . . . 75.329999999999998 109.905 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.757 HD12 ' HB2' ' A' ' 131' ' ' HIS . 15.1 tp -113.14 146.67 38.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.665 -0.494 . . . . 72.349999999999994 109.665 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 131' ' ' HIS . 38.0 tttm -147.34 153.92 40.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.569 -0.53 . . . . 71.310000000000002 109.569 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.736 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -125.05 -71.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.281 0.363 . . . . 74.430000000000007 111.446 -176.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.736 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -63.69 161.04 36.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.273 -0.489 . . . . 62.119999999999997 112.828 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.52 143.59 31.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.935 -0.65 . . . . 71.5 112.329 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.42 -176.64 42.06 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.298 -0.721 . . . . 71.209999999999994 111.298 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -81.07 150.13 28.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 73.219999999999999 110.723 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.79 -59.56 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.743 -1.343 . . . . 73.400000000000006 109.743 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.81 ' HA3' HD21 ' A' ' 118' ' ' LEU . . . -91.48 163.97 29.01 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.67 -0.972 . . . . 53.149999999999999 110.67 170.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.568 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 4.7 t-80 -119.09 -63.33 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.268 -0.573 . . . . 72.329999999999998 111.631 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -107.82 -71.16 0.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.809 -0.357 . . . . 64.129999999999995 111.882 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 69' ' ' MET . . . -51.62 -48.24 50.15 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.812 -0.631 . . . . 72.239999999999995 114.659 -167.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.81 HD21 ' HA3' ' A' ' 114' ' ' GLY . 3.5 pp -78.28 -19.36 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.293 -0.563 . . . . 72.439999999999998 111.827 -174.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 115' ' ' HIS . 18.1 mtp180 -81.11 -26.45 36.18 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.0 -0.28 . . . . 74.230000000000004 110.29 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -67.57 -50.17 59.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.458 -0.337 . . . . 75.019999999999996 110.705 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.491 HG11 ' HA2' ' A' ' 73' ' ' GLY . 29.4 m -65.87 -33.8 66.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 70.120000000000005 111.089 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.17 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.419 . . . . 73.120000000000005 111.118 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.1 m -82.07 -28.91 32.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 75.040000000000006 110.545 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.45 -43.46 81.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 74.209999999999994 110.711 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.89 -41.5 59.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 75.040000000000006 109.743 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.7 62.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.617 -0.72 . . . . 60.549999999999997 112.25 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.474 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 6.6 m -108.54 148.01 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.843 -0.429 . . . . 75.310000000000002 109.843 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 11.6 mptt -117.2 -155.83 0.6 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.349999999999994 109.11 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.427 ' H ' ' HB3' ' A' ' 128' ' ' LYS . 66.4 t30 73.88 9.96 4.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.797 0.808 . . . . 73.140000000000001 109.654 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -87.83 127.58 35.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.331 -0.849 . . . . 65.129999999999995 109.791 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.757 ' HB2' HD12 ' A' ' 106' ' ' LEU . 35.2 p-80 -73.05 120.41 18.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.359 0.599 . . . . 74.530000000000001 111.694 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.417 ' O ' HD11 ' A' ' 106' ' ' LEU . 43.0 mtm105 -95.21 139.77 31.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 110.451 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.85 104.16 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.449 -0.945 . . . . 64.530000000000001 108.449 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 53.5 mtp180 -100.92 107.86 19.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.456 -0.793 . . . . 75.150000000000006 110.377 -172.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 135' ' ' ILE . 4.3 mp -93.81 113.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.609 . . . . 75.349999999999994 109.357 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 100' ' ' ASP . . . -57.46 138.5 48.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.136 -0.554 . . . . 73.310000000000002 113.904 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.761 ' HB ' ' HA ' ' A' ' 97' ' ' LEU . 89.6 t -88.98 -20.35 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 74.129999999999995 110.588 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.453 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 130.33 -78.43 0.38 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.282 -0.961 . . . . 75.310000000000002 113.312 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.571 ' HD3' ' O ' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -163.7 158.78 17.17 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 110.048 -0.353 . . . . 75.230000000000004 110.048 -174.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.571 ' O ' ' HD3' ' A' ' 139' ' ' ARG . 51.4 Cg_exo -55.43 159.65 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.018 2.479 . . . . 73.109999999999999 112.616 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.465 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 49.2 Cg_endo -67.12 161.45 42.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.707 2.272 . . . . 74.519999999999996 112.877 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -86.87 1.97 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.73 . . . . 74.349999999999994 112.345 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -103.21 8.28 38.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 72.329999999999998 111.412 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -131.48 161.86 31.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.407 -0.361 . . . . 75.109999999999999 110.605 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.67 150.64 25.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.454 0.471 . . . . 70.439999999999998 111.445 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.88 -43.07 59.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.776 2.317 . . . . 70.439999999999998 112.075 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.25 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 61.530000000000001 111.072 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' A' ' 151' ' ' LEU . . . -83.54 -27.8 29.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.416 -0.356 . . . . 60.409999999999997 110.949 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 86.3 t80 -67.65 -35.36 78.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.150000000000006 110.223 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.746 ' O ' ' HB ' ' A' ' 20' ' ' THR . 35.5 m -84.86 -6.22 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 111.021 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.663 HD21 HG21 ' A' ' 20' ' ' THR . 11.1 mt -90.78 6.12 45.54 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.174 0.435 . . . . 64.319999999999993 112.174 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -93.27 167.44 11.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.487 -0.485 . . . . 71.019999999999996 110.054 175.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -149.5 148.9 29.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.544 -0.298 . . . . 71.109999999999999 111.301 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.764 ' HA ' ' HG2' ' A' ' 159' ' ' ARG . 84.4 m-85 66.89 96.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.477 1.11 . . . . 75.129999999999995 112.313 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.575 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 13.3 p -114.68 -166.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 75.209999999999994 109.572 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.2 -72.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.846 0.684 . . . . 73.319999999999993 112.846 -171.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.67 -56.46 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.157 0.429 . . . . 73.439999999999998 112.157 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -65.81 -23.73 66.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.756 -0.656 . . . . 75.549999999999997 111.878 -171.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.764 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 3.3 tpp180 -71.97 -28.05 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 75.209999999999994 110.396 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 163' ' ' PRO . . . -87.6 -11.11 49.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.957 -0.565 . . . . 71.129999999999995 110.183 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.6 -3.6 59.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.731 . . . . 75.109999999999999 111.058 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.68 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 95.8 t -57.87 -52.91 70.97 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.616 -0.265 . . . . 75.25 110.731 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 51.1 Cg_exo -55.84 -35.92 94.59 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.968 1.779 . . . . 73.439999999999998 111.977 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -64.35 -48.92 73.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 75.109999999999999 111.198 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 36.0 pt -79.93 -26.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 74.129999999999995 111.944 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.48 -31.91 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.882 -0.327 . . . . 71.349999999999994 110.698 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 44.8 mt-10 -64.68 -43.32 93.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.181 0.515 . . . . 73.439999999999998 109.621 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.63 -47.23 82.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.345 -0.843 . . . . 72.5 110.851 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.38 99.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.511 . . . . 73.439999999999998 111.547 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.12 96.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 73.409999999999997 110.783 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.42 -39.04 81.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 73.430000000000007 110.687 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.88 -42.03 98.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 52.240000000000002 111.062 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.6 m -61.62 -38.13 86.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 62.399999999999999 110.516 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -73.11 -34.01 65.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 72.25 110.252 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.2 tp -66.55 -27.3 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 73.519999999999996 110.832 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 92.0 mt -61.29 -33.73 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.340000000000003 110.5 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.463 HD13 HD13 ' A' ' 5' ' ' LEU . 38.0 mm -81.28 -46.62 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 71.299999999999997 110.938 176.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.79 -61.27 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 64.430000000000007 111.773 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 179' ' ' GLN . 6.5 tp60 -93.14 -44.62 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 72.439999999999998 110.576 -175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' A' ' 183' ' ' PRO . . . 130.26 156.64 8.75 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.064 -0.814 . . . . 65.209999999999994 111.064 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.68 -27.73 66.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.164 0.482 . . . . 73.150000000000006 110.959 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.712 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 35.1 tt0 -72.5 -52.46 6.58 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.812 -0.631 . . . . 73.040000000000006 111.664 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.712 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 9.9 Cg_exo -73.89 -32.23 7.43 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.891 1.727 . . . . 63.030000000000001 112.895 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.531 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -64.3 -40.03 95.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 111.76 0.281 . . . . 74.219999999999999 111.76 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 9.9 pt20 -58.22 -30.75 66.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.645 0.259 . . . . 74.409999999999997 110.904 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.41 -47.86 74.81 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.617 -0.512 . . . . 72.319999999999993 109.617 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -59.03 -38.84 80.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.671 -0.695 . . . . 64.150000000000006 111.237 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 184' ' ' ALA . 99.5 t -58.47 -35.91 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.992 -0.549 . . . . 75.329999999999998 112.237 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.459 ' HD2' ' O ' ' A' ' 185' ' ' GLN . 9.4 p80 -106.8 15.22 25.79 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.116 -0.634 . . . . 73.109999999999999 110.675 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.86 6.52 47.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.103 -0.499 . . . . 72.439999999999998 111.496 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.489 -0.767 . . . . 74.430000000000007 110.105 176.303 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.537 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 22.3 ptt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 111.218 0.081 . . . . 73.349999999999994 111.218 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.537 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -166.73 22.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.974 0.416 . . . . 70.120000000000005 111.145 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 1.1 pm0 -87.05 130.51 47.9 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 110.315 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' CD ' ' HD2' ' A' ' 86' ' ' PRO . 93.9 Cg_endo -96.23 162.01 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.026 2.484 . . . . 71.5 113.495 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.676 HD11 HG22 ' A' ' 91' ' ' VAL . 58.0 tp -89.45 122.78 32.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.168 -0.924 . . . . 75.219999999999999 108.797 172.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.73 105.37 17.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.484 -0.561 . . . . 73.450000000000003 109.484 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.511 ' HB ' HD22 ' A' ' 62' ' ' LEU . 38.2 t -107.07 113.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 74.340000000000003 110.525 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HB ' HG22 ' A' ' 92' ' ' VAL . 58.3 t -109.86 118.1 56.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.669 -0.696 . . . . 74.340000000000003 109.716 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.27 122.72 7.45 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.201 -0.999 . . . . 74.319999999999993 111.779 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.437 HD12 ' HA3' ' A' ' 117' ' ' GLY . 46.5 tp -77.77 82.04 4.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.329 0.585 . . . . 75.010000000000005 109.79 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -164.2 101.73 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.271 -0.877 . . . . 55.5 111.104 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 65' ' ' PRO . 50.8 m-80 -88.38 146.94 38.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.494 -0.188 . . . . 72.040000000000006 110.494 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.446 ' CG ' ' HZ2' ' A' ' 64' ' ' LYS . 25.5 Cg_exo -62.96 96.43 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 123.06 2.507 . . . . 73.430000000000007 112.697 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.559 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . -122.33 119.1 3.86 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.38 -0.827 . . . . 73.019999999999996 111.3 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.45 -54.12 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 124.359 3.373 . . . . 75.310000000000002 114.58 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -105.09 -30.08 9.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.439 0.533 . . . . 71.519999999999996 112.439 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CZ ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 p90 -89.13 2.68 53.79 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.17 -0.612 . . . . 75.299999999999997 112.059 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 -1.51 52.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.893 0.377 . . . . 74.299999999999997 110.679 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.6 10.76 16.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.292 -0.413 . . . . 74.25 110.868 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.568 HG23 ' H ' ' A' ' 22' ' ' HIS . 6.2 t -105.1 -174.58 2.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.757 -0.377 . . . . 70.109999999999999 110.898 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 54.5 mtt180 -57.24 -20.94 30.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.61 0.596 . . . . 65.120000000000005 112.61 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.568 ' H ' HG23 ' A' ' 20' ' ' THR . 5.5 t-160 -91.65 14.05 16.27 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 72.150000000000006 111.609 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.17 1.06 57.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.837 -0.345 . . . . 74.319999999999993 110.379 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 88.0 mt -51.41 -48.11 62.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.822 -0.626 . . . . 71.349999999999994 111.745 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.76 93.34 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.958 -0.639 . . . . 71.310000000000002 112.846 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.679 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 77.9 t80 -80.35 -26.97 38.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.627 0.251 . . . . 75.299999999999997 110.824 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.902 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 7.2 mmt -55.18 -53.45 55.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 111.931 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.634 HG22 HG12 ' A' ' 93' ' ' ILE . 90.2 t -56.12 -45.57 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.76 0.314 . . . . 74.319999999999993 111.048 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -48.85 74.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 70.040000000000006 111.186 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.33 -40.02 96.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 55.350000000000001 110.814 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 166' ' ' VAL . 45.0 t -67.4 -45.63 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 74.329999999999998 111.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.36 -45.14 94.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 75.109999999999999 110.482 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.53 -31.72 73.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 74.349999999999994 110.549 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -45.47 49.53 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.598 -0.728 . . . . 70.209999999999994 113.081 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.468 ' HG3' HD12 ' A' ' 36' ' ' ILE . 13.1 ptp180 -70.36 -34.95 73.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.094 0.447 . . . . 74.129999999999995 110.933 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -71.65 -37.02 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.071 0.463 . . . . 74.120000000000005 110.117 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.17 53.44 2.66 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.74 -0.743 . . . . 75.049999999999997 112.202 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.6 m -147.6 144.82 28.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.651 0.263 . . . . 75.299999999999997 110.487 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.06 147.81 25.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.302 -0.408 . . . . 73.329999999999998 110.423 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 p90 -78.25 132.64 37.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 72.430000000000007 110.894 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -99.59 150.26 22.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.782 -0.645 . . . . 74.549999999999997 110.893 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.427 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 24.6 t -73.16 124.08 29.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 73.140000000000001 111.427 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -88.08 99.96 12.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 74.439999999999998 109.064 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -69.23 86.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 74.049999999999997 110.553 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -173.13 -62.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.07 -0.968 . . . . 72.549999999999997 109.189 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -99.48 -14.63 19.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.643 -0.708 . . . . 74.409999999999997 110.846 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.54 67.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.836 -0.697 . . . . 63.409999999999997 112.467 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB3' HD13 ' A' ' 79' ' ' LEU . . . -93.7 163.05 13.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.705 0.288 . . . . 75.129999999999995 110.767 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.921 ' HB2' ' HE3' ' A' ' 64' ' ' LYS . 29.8 mt-10 -124.04 131.48 53.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 61.420000000000002 110.274 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -133.33 139.14 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.521 . . . . 74.439999999999998 110.718 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 8.5 p -119.18 142.67 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.435 -0.348 . . . . 74.219999999999999 110.079 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 HG23 HG12 ' A' ' 61' ' ' VAL . 14.1 p -108.29 143.43 37.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.953 0.353 . . . . 74.450000000000003 111.953 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.18 -164.43 21.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.202 -0.523 . . . . 72.409999999999997 111.887 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -134.12 122.83 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.75 0.275 . . . . 64.209999999999994 110.622 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.048 HD21 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -111.16 119.1 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 62.32 109.486 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.02 -67.6 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.412 0.685 . . . . 75.140000000000001 111.656 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.43 12.79 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.982 -0.847 . . . . 61.329999999999998 110.982 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.516 ' O ' HD23 ' A' ' 55' ' ' LEU . 47.0 m -126.31 146.0 50.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 71.409999999999997 109.414 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 18.0 m -67.62 131.71 46.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.701 -0.481 . . . . 70.019999999999996 109.701 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.048 ' HB ' HD21 ' A' ' 55' ' ' LEU . 9.9 p -111.65 127.98 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.904 0.383 . . . . 75.049999999999997 110.132 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.412 HG12 HG23 ' A' ' 52' ' ' THR . 11.5 m -117.13 109.26 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.308 0.575 . . . . 73.030000000000001 109.846 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.511 HD22 ' HB ' ' A' ' 7' ' ' VAL . 78.3 mt -92.57 106.36 18.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.561 -0.745 . . . . 75.409999999999997 109.748 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 127.88 55.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.814 -0.63 . . . . 74.0 110.922 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.921 ' HE3' ' HB2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -123.63 143.6 42.14 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.11 -0.7 . . . . 71.340000000000003 109.11 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.812 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 14.6 Cg_exo -69.65 175.59 7.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.179 2.586 . . . . 71.530000000000001 113.598 -173.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.653 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 7.1 ptm180 -77.38 -61.81 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 72.329999999999998 110.949 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.653 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 24.6 p -169.49 166.79 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.55 -0.537 . . . . 72.230000000000004 109.55 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.0 t80 70.27 144.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.657 0.741 . . . . 73.0 112.595 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.5 -56.17 20.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 75.530000000000001 111.721 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -58.04 -43.7 86.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.165 -0.471 . . . . 71.140000000000001 111.573 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 8.6 mm-40 -56.66 -41.57 77.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.530000000000001 111.132 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.5 m -57.5 -32.44 67.02 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.515 0.51 . . . . 72.430000000000007 111.306 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -65.16 -47.11 84.74 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.654 -0.784 . . . . 74.450000000000003 112.349 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 25.6 ptt180 -89.22 3.06 53.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.981 -0.288 . . . . 73.349999999999994 111.111 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.812 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 23.2 mm-40 -66.92 -38.24 85.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 71.209999999999994 110.783 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.11 -34.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.977 -0.556 . . . . 73.129999999999995 111.696 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.526 ' O ' ' HD3' ' A' ' 81' ' ' LYS . . . -54.18 -73.3 0.43 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.975 -0.557 . . . . 64.319999999999993 113.642 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 18.5 Cg_endo -59.79 -23.21 71.22 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.081 2.521 . . . . 72.140000000000001 113.407 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.565 HD13 ' HB3' ' A' ' 48' ' ' ALA . 34.8 mt -75.41 -43.03 52.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.071 -0.252 . . . . 75.030000000000001 111.386 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.77 80.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 71.5 110.825 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 77' ' ' GLY . 2.2 mptp? -80.79 -26.34 37.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.771 -0.649 . . . . 72.310000000000002 110.037 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -56.6 -52.45 64.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.602 -0.726 . . . . 75.219999999999999 110.857 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -94.92 -1.2 53.06 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.849 -0.34 . . . . 73.030000000000001 110.709 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 63.12 90.95 0.07 Allowed 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.787 0.679 . . . . 64.540000000000006 110.731 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.27 123.7 76.83 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.472 -0.786 . . . . 65.430000000000007 112.414 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.585 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 5.9 Cg_exo -79.81 113.35 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.804 2.336 . . . . 74.030000000000001 109.452 162.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 24.9 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.853 2.368 . . . . 74.420000000000002 113.778 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -92.6 -57.74 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 74.430000000000007 109.721 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -173.64 148.99 1.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.942 -0.572 . . . . 74.120000000000005 109.861 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 tt -124.18 122.1 63.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.335 0.588 . . . . 71.540000000000006 110.935 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.676 HG22 HD11 ' A' ' 5' ' ' LEU . 98.9 t -113.19 126.68 70.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 75.439999999999998 109.977 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.528 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 t -129.48 107.02 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 71.019999999999996 110.239 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.634 HG12 HG22 ' A' ' 28' ' ' VAL . 4.2 mp -84.5 133.74 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.702 -0.681 . . . . 73.420000000000002 109.329 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CE1' ' HG3' ' A' ' 132' ' ' ARG . 57.0 p-80 -151.8 179.58 8.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.895 0.379 . . . . 63.039999999999999 111.116 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.23 148.57 26.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.228 -0.897 . . . . 71.420000000000002 111.092 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.836 ' HG3' ' HB3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -140.95 115.04 9.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 73.299999999999997 110.374 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 137' ' ' VAL . 95.5 mt -82.75 -14.16 55.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.632 -0.713 . . . . 75.530000000000001 112.458 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -94.39 -12.13 28.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.902 0.382 . . . . 70.120000000000005 110.984 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.576 HD12 ' HD2' ' A' ' 105' ' ' ARG . 46.3 mm -106.63 139.45 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 72.340000000000003 111.895 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.83 142.21 30.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.958 -1.019 . . . . 72.230000000000004 111.617 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.3 t80 -68.43 115.12 7.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 64.239999999999995 111.241 -173.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.07 -16.78 6.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.329 -0.938 . . . . 71.099999999999994 113.635 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -114.21 159.97 19.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.402 0.601 . . . . 75.200000000000003 111.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.23 129.32 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 73.150000000000006 111.444 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.716 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 75.2 ttt180 -109.3 125.39 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.052 -0.722 . . . . 65.140000000000001 109.052 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.23 118.26 35.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 71.010000000000005 111.35 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.79 161.43 26.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.161 -0.681 . . . . 73.299999999999997 109.161 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.78 -72.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.232 0.456 . . . . 73.349999999999994 112.232 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.48 -126.19 3.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.364 -0.922 . . . . 73.319999999999993 113.56 -173.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.96 152.56 26.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.007 -0.616 . . . . 73.510000000000005 112.454 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.5 163.54 32.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.81 -0.71 . . . . 73.450000000000003 112.048 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.14 164.34 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.219 -0.289 . . . . 71.340000000000003 110.219 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -30.27 5.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.831 -0.7 . . . . 73.129999999999995 111.954 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.16 -170.58 24.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.952 -0.642 . . . . 72.120000000000005 111.649 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -103.14 -86.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.432 0.53 . . . . 72.0 112.432 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -118.24 -64.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.765 0.654 . . . . 73.439999999999998 112.765 -170.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.437 ' HA3' HD12 ' A' ' 10' ' ' LEU . . . -48.11 -49.43 24.29 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.495 0.497 . . . . 72.150000000000006 114.314 -168.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.567 ' H ' HD21 ' A' ' 118' ' ' LEU . 1.7 pt? -57.77 -35.06 70.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 73.420000000000002 111.883 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.473 ' HG3' ' HG ' ' A' ' 118' ' ' LEU . 78.8 mtp180 -80.18 -40.05 28.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.065 -0.516 . . . . 75.010000000000005 110.484 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.43 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 45.0 m -69.6 -42.5 74.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.624 -0.716 . . . . 71.439999999999998 112.154 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.47 -27.93 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.88 0.326 . . . . 72.540000000000006 111.88 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.37 91.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 73.219999999999999 110.731 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 m -79.23 -22.62 44.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.03 -0.532 . . . . 71.420000000000002 111.163 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.43 77.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 72.450000000000003 111.176 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.86 -41.59 6.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.338 -0.392 . . . . 73.219999999999999 111.025 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.28 -5.83 63.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.792 -0.718 . . . . 73.420000000000002 111.835 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 52.7 m -125.38 126.8 45.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.936 0.398 . . . . 74.409999999999997 110.171 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.58 -160.91 1.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.031 -0.531 . . . . 74.439999999999998 109.825 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 69.85 72.63 0.23 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.5 0.667 . . . . 75.400000000000006 111.204 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -140.86 -82.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.222 -0.899 . . . . 71.420000000000002 109.411 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -152.29 103.69 2.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 74.019999999999996 110.327 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.49 ' HG3' ' CE1' ' A' ' 94' ' ' HIS . 2.6 tpp180 -102.56 108.79 20.21 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 73.109999999999999 108.865 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 84.0 t -82.66 116.36 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.227 0.537 . . . . 73.239999999999995 111.211 -171.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.836 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 54.1 mtt180 -105.11 111.18 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.207 -0.906 . . . . 74.219999999999999 109.984 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 24' ' ' LEU . 58.4 mt -95.65 118.57 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.108 -0.701 . . . . 74.120000000000005 109.108 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -60.64 128.25 44.94 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.773 -0.727 . . . . 64.349999999999994 111.993 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 97' ' ' LEU . 8.9 p -98.51 -5.86 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 75.319999999999993 110.744 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.23 -108.5 0.93 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.643 -0.789 . . . . 73.510000000000005 112.402 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -153.98 157.13 32.49 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.418 -0.215 . . . . 75.349999999999994 110.418 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.93 135.01 56.67 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.718 2.279 . . . . 73.099999999999994 111.73 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.517 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 59.0 Cg_endo -73.29 164.76 34.38 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.77 2.313 . . . . 74.040000000000006 112.627 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -26.03 6.92 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.879 -0.677 . . . . 72.109999999999999 112.24 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -105.53 -66.96 0.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.731 0.301 . . . . 73.450000000000003 111.782 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -77.57 161.13 28.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.916 0.389 . . . . 75.010000000000005 111.621 -174.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.36 137.4 68.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.446 -0.797 . . . . 72.430000000000007 111.02 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.81 -44.7 30.81 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 63.140000000000001 113.417 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.26 -34.95 66.11 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.001 -0.28 . . . . 71.519999999999996 110.68 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.09 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 63.340000000000003 110.778 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.517 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 32.8 t80 -68.16 -26.56 65.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 72.519999999999996 110.318 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 25.3 t -81.66 -16.99 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.779 -0.646 . . . . 74.230000000000004 109.735 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.36 -11.25 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.716 -0.675 . . . . 75.129999999999995 110.858 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -113.64 104.66 12.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.17 0.509 . . . . 73.150000000000006 110.412 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.568 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 51.1 t30 -90.84 79.7 5.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 72.0 111.336 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.475 ' C ' ' HG1' ' A' ' 155' ' ' THR . 93.4 m-85 -146.56 135.67 22.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 72.450000000000003 109.585 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.602 HG23 ' H ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -154.29 -171.62 3.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.915 -0.772 . . . . 75.340000000000003 108.915 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.602 ' H ' HG23 ' A' ' 155' ' ' THR . . . -92.46 -71.62 0.64 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.855 0.316 . . . . 73.299999999999997 111.855 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.01 -51.66 4.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 73.120000000000005 111.689 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 1.1 pm0 -69.26 -17.03 63.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.784 . . . . 74.299999999999997 111.468 -172.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -64.48 -27.07 68.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.736 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.59 -20.2 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 111.032 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.7 6.92 39.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 75.400000000000006 111.791 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.669 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 84.2 t -53.66 -55.09 38.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.087 0.403 . . . . 75.319999999999993 112.087 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.6 Cg_exo -53.62 -39.81 81.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.027 1.818 . . . . 75.510000000000005 112.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 m -65.62 -50.96 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.36 -0.382 . . . . 63.539999999999999 111.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.12 -32.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 65.230000000000004 111.401 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.517 HG12 HG22 ' A' ' 31' ' ' VAL . 75.7 t -69.05 -45.87 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.636 -0.256 . . . . 74.530000000000001 111.109 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -60.13 -41.35 92.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.282 . . . . 71.230000000000004 110.635 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.25 -37.61 78.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 71.140000000000001 111.261 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.12 74.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 74.230000000000004 110.884 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.621 ' HA ' HG11 ' A' ' 28' ' ' VAL . . . -65.21 -34.33 78.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 73.239999999999995 110.838 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.28 -42.98 64.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.753 -0.658 . . . . 63.149999999999999 110.633 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -65.99 -25.86 67.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 75.129999999999995 111.087 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.8 m -61.27 -37.96 85.03 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 74.010000000000005 110.404 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.474 ' HA ' HD12 ' A' ' 55' ' ' LEU . 34.0 tt0 -73.1 -30.76 63.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 74.540000000000006 110.078 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.19 -28.44 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 73.230000000000004 110.366 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.7 mt -64.94 -25.39 67.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 75.0 110.822 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.557 HD11 HD12 ' A' ' 5' ' ' LEU . 26.7 mm -80.72 -51.21 16.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 74.030000000000001 110.733 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -73.3 -42.5 62.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.651 . . . . 62.109999999999999 112.313 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.44 ' HA ' ' OE1' ' A' ' 179' ' ' GLN . 6.9 tp60 -93.46 -62.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.766 0.317 . . . . 70.230000000000004 111.325 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.38 -129.8 3.24 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.65 -0.786 . . . . 70.439999999999998 112.21 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 182' ' ' GLU . 3.0 pp -124.01 -46.77 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 74.310000000000002 111.923 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.785 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 44.8 tt0 -74.19 -57.56 2.22 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.671 0.249 . . . . 75.129999999999995 111.671 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.3 Cg_exo -63.97 -25.34 66.8 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.515 1.477 . . . . 73.030000000000001 111.475 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 188' ' ' VAL . . . -70.28 -50.18 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 65.510000000000005 110.89 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -65.56 -30.57 71.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.907 0.384 . . . . 73.400000000000006 110.141 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.56 -45.01 95.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 55.329999999999998 109.837 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 91.2 m -59.74 -42.45 93.2 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.989 -0.55 . . . . 72.040000000000006 110.685 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 184' ' ' ALA . 58.7 t -66.43 -34.28 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.949 -0.568 . . . . 74.439999999999998 111.892 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.35 5.94 46.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.196 -0.315 . . . . 73.040000000000006 111.844 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.04 -17.91 38.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 70.439999999999998 111.066 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.361 -0.828 . . . . 72.129999999999995 109.986 178.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 110.303 -0.258 . . . . 73.230000000000004 110.303 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.91 145.79 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 110.179 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.661 ' HG3' HG21 ' A' ' 58' ' ' THR . 10.3 pt-20 -104.24 116.83 60.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.341 0.591 . . . . 75.019999999999996 111.199 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -96.57 113.39 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.56 2.84 . . . . 72.200000000000003 112.207 175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.619 HD13 HD11 ' A' ' 177' ' ' ILE . 45.7 tp -88.66 119.67 29.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.509 -0.314 . . . . 73.420000000000002 110.383 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.593 ' HA ' HG23 ' A' ' 61' ' ' VAL . 61.2 tp -92.67 107.12 18.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 74.5 109.861 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.641 ' HB ' HD21 ' A' ' 62' ' ' LEU . 42.7 t -98.05 117.36 42.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.025 -0.534 . . . . 71.340000000000003 109.756 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.24 114.84 41.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 74.439999999999998 110.002 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.83 122.75 7.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 71.120000000000005 111.732 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.67 100.06 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.864 0.364 . . . . 74.040000000000006 110.778 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.95 135.45 11.43 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.818 -0.628 . . . . 71.239999999999995 111.85 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 34.5 m-80 -139.32 129.04 14.25 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 110.225 -0.287 . . . . 74.540000000000006 110.225 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 31.8 Cg_exo -59.19 165.6 8.64 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.408 2.739 . . . . 74.329999999999998 113.483 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.63 111.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.748 -0.941 . . . . 75.409999999999997 110.748 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -45.22 -50.28 9.15 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.326 2.684 . . . . 70.239999999999995 113.155 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -100.98 -10.93 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.216 -0.447 . . . . 63.119999999999997 111.367 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.403 ' CD1' HD23 ' A' ' 151' ' ' LEU . 39.7 m-85 -101.18 1.81 39.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 74.5 112.258 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.573 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -87.71 -15.06 38.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.04 0.448 . . . . 73.540000000000006 110.625 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -105.5 9.78 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 75.030000000000001 110.412 -175.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.771 HG22 ' HB3' ' A' ' 153' ' ' ASN . 75.6 p -111.74 -169.5 1.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.125 -0.489 . . . . 72.010000000000005 111.389 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 62.9 mtt180 -67.08 -4.94 11.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.042 0.449 . . . . 75.25 111.013 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -76.0 -8.76 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 75.140000000000001 111.142 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 24.4 m-80 -134.38 32.34 3.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.756 -0.202 . . . . 71.230000000000004 111.509 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.63 HD12 HG12 ' A' ' 137' ' ' VAL . 64.6 mt -58.29 -38.21 76.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.718 0.294 . . . . 65.329999999999998 111.437 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.36 87.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.837 -0.697 . . . . 65.010000000000005 112.303 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.428 ' HE1' ' HD2' ' A' ' 64' ' ' LYS . 87.3 t80 -73.61 -32.72 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.611 0.244 . . . . 75.230000000000004 110.867 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.4 mmt -53.44 -47.43 69.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.043 -0.526 . . . . 73.430000000000007 111.263 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.09 -42.93 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.056 -0.52 . . . . 71.129999999999995 110.77 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.413 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -61.96 -40.47 95.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 72.239999999999995 110.909 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.69 -46.82 88.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 71.450000000000003 110.242 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -33.22 59.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 75.519999999999996 111.173 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 29' ' ' ALA . 64.9 mt -57.74 -50.06 74.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.128 -0.323 . . . . 73.409999999999997 110.128 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.85 68.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.52 . . . . 64.409999999999997 110.673 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.87 -48.39 66.78 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.617 -0.719 . . . . 54.409999999999997 112.894 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -73.9 -22.76 59.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.169 0.485 . . . . 74.510000000000005 111.054 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -45.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.401 . . . . 65.409999999999997 110.001 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.6 37.02 4.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.939 -0.648 . . . . 61.299999999999997 111.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.4 m -153.45 117.79 4.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.728 0.299 . . . . 74.150000000000006 110.486 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.04 145.3 32.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.325 -0.398 . . . . 45.240000000000002 110.887 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.041 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 5.1 p90 -68.55 145.63 53.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 75.310000000000002 111.644 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.41 145.33 48.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 72.0 110.436 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.671 HG23 ' HG3' ' A' ' 49' ' ' GLU . 51.5 t -68.68 125.88 27.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.252 -0.431 . . . . 74.319999999999993 111.082 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -80.74 143.77 32.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 70.040000000000006 110.445 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 10.0 tmtt? -62.32 -63.91 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 74.510000000000005 111.129 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -74.0 -31.17 62.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.258 -0.428 . . . . 75.510000000000005 111.665 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 m -81.66 -28.04 33.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.859 0.361 . . . . 75.409999999999997 111.524 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.33 95.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.542 -0.837 . . . . 61.530000000000001 111.615 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.19 144.01 31.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.446 -0.205 . . . . 72.549999999999997 110.446 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HG3' HG23 ' A' ' 42' ' ' VAL . 2.6 mp0 -73.78 123.29 23.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.161 -0.472 . . . . 72.239999999999995 111.213 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.3 t -138.74 140.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.633 . . . . 73.540000000000006 109.662 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.041 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 14.5 p -136.84 148.43 26.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.301 . . . . 73.030000000000001 110.933 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.628 HG23 HG12 ' A' ' 61' ' ' VAL . 24.0 p -103.36 161.27 13.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.175 -0.466 . . . . 71.109999999999999 110.902 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.95 -161.28 30.66 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.133 -0.556 . . . . 74.340000000000003 111.799 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.587 ' HD2' ' HA ' ' A' ' 59' ' ' SER . 11.0 mmm180 -131.75 127.32 36.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.803 0.301 . . . . 75.409999999999997 110.201 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.112 HD22 ' HB ' ' A' ' 60' ' ' VAL . 1.6 pt? -121.78 119.03 30.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.578 . . . . 75.420000000000002 109.441 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' A' ' 174' ' ' GLU . . . 58.45 10.16 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.767 -0.651 . . . . 71.239999999999995 112.667 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.07 -16.87 17.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.54 -0.838 . . . . 74.200000000000003 112.45 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.661 HG21 ' HG3' ' A' ' 3' ' ' GLU . 98.0 m -89.88 139.73 30.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.246 -0.279 . . . . 72.120000000000005 110.246 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.587 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 20.8 m -68.45 109.74 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.688 -0.486 . . . . 74.219999999999999 109.688 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.112 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -98.93 136.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.115 0.483 . . . . 71.230000000000004 111.058 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.628 HG12 HG23 ' A' ' 52' ' ' THR . 6.4 m -120.43 112.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.741 -0.663 . . . . 75.120000000000005 109.318 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' A' ' 7' ' ' VAL . 91.9 mt -91.91 109.58 20.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 74.230000000000004 109.629 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.7 129.3 51.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.02 -0.536 . . . . 74.409999999999997 110.964 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 3.4 ptmt -121.28 132.32 24.24 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.769 -0.65 . . . . 75.530000000000001 110.175 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 24.0 Cg_exo -64.34 155.88 63.17 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.46 2.107 . . . . 75.209999999999994 110.959 174.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 18.1 ptp180 -65.17 -59.74 3.77 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.927 -0.309 . . . . 72.299999999999997 110.958 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 5.0 p -169.44 152.31 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.896 -0.409 . . . . 55.420000000000002 109.896 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.2 t80 75.48 126.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.874 0.733 . . . . 74.409999999999997 111.393 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -60.81 -40.21 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.393 -0.821 . . . . 75.319999999999993 112.209 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.76 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 73.420000000000002 110.851 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 4.9 tm-20 -68.64 -38.15 80.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.872 -0.788 . . . . 72.420000000000002 108.872 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -64.66 -23.7 67.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.811 . . . . 61.399999999999999 111.237 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.09 -29.99 76.49 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.982 -0.554 . . . . 71.140000000000001 112.993 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 36.0 ptt180 -93.26 -1.9 55.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 73.319999999999993 110.585 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -93.93 -47.97 6.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.977 -0.556 . . . . 75.239999999999995 111.333 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.2 -33.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 61.049999999999997 112.051 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 -70.78 0.88 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.027 -0.606 . . . . 73.450000000000003 112.765 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.37 -29.19 88.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.885 2.39 . . . . 75.430000000000007 112.634 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.65 -49.0 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 73.239999999999995 111.467 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -62.98 -37.19 86.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 73.109999999999999 111.18 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -2.77 57.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.103 -0.498 . . . . 75.519999999999996 111.502 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.51 -33.12 70.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 75.230000000000004 110.265 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 6' ' ' LEU . 42.6 p90 -109.05 18.69 20.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.714 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.5 m 57.84 69.72 0.71 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.382 -0.827 . . . . 70.010000000000005 112.692 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 80' ' ' ALA . 3.9 p -130.08 145.91 59.23 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.077 -0.249 . . . . 75.209999999999994 110.517 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.75 145.92 87.45 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.984 1.789 . . . . 74.340000000000003 109.406 163.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.27 83.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.811 2.341 . . . . 63.439999999999998 113.691 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -159.66 -173.7 4.26 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.198 0.999 . . . . 72.349999999999994 108.762 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.475 ' NE2' ' HB2' ' A' ' 3' ' ' GLU . 14.5 mm100 57.53 31.52 20.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.201 0.445 . . . . 72.120000000000005 112.201 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.5 tt -111.33 135.46 50.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.979 0.419 . . . . 73.420000000000002 110.636 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.18 122.9 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.629 . . . . 73.310000000000002 109.757 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.8 114.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 74.540000000000006 111.038 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.546 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 63.7 mt -100.1 121.76 51.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.078 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.608 ' CE1' ' HG2' ' A' ' 134' ' ' ARG . 6.1 p-80 -159.59 -176.25 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 75.319999999999993 111.1 -176.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.18 154.93 22.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.209 -0.905 . . . . 74.540000000000006 111.791 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 8.9 tp10 -133.88 126.4 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.366 -0.605 . . . . 73.519999999999996 109.366 167.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.713 ' HA ' HG23 ' A' ' 137' ' ' VAL . 7.5 tt -82.97 -24.8 32.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 72.150000000000006 111.111 -172.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.93 4.38 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 73.409999999999997 111.342 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mm -111.15 140.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.506 -0.316 . . . . 74.140000000000001 110.689 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.1 136.35 35.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.801 -0.636 . . . . 75.329999999999998 112.179 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.601 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 72.5 t80 -63.08 128.91 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.744 . . . . 75.450000000000003 111.523 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 108.66 -14.21 35.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.626 -0.797 . . . . 53.420000000000002 113.415 172.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 69.7 mmt-85 -124.32 168.77 12.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.446 0.623 . . . . 72.319999999999993 110.83 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.46 133.38 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 75.120000000000005 111.373 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 10.6 tpp180 -113.56 127.73 56.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.79 -0.641 . . . . 74.219999999999999 109.388 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.48 153.3 18.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 74.310000000000002 111.026 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 112' ' ' GLU . 38.3 tptt -153.71 148.17 26.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.263 -0.643 . . . . 75.200000000000003 109.263 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.8 mp -123.59 -90.62 0.57 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.099 0.476 . . . . 73.450000000000003 111.141 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.51 106.08 2.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.177 -0.535 . . . . 62.219999999999999 112.413 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.44 151.25 5.4 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.91 -0.662 . . . . 73.400000000000006 111.734 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.63 78.33 1.61 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.963 -0.637 . . . . 71.129999999999995 111.675 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 107' ' ' LYS . 32.0 tt0 -120.79 122.39 40.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.093 -0.336 . . . . 75.430000000000007 110.093 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.569 ' HA2' ' OE1' ' A' ' 96' ' ' GLU . . . 152.03 134.89 2.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.383 -0.687 . . . . 74.510000000000005 111.383 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.84 2.69 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.555 -0.831 . . . . 71.219999999999999 114.258 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -152.82 140.85 20.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.444 0.622 . . . . 74.310000000000002 110.857 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -45.7 -55.29 6.64 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.624 0.972 . . . . 64.540000000000006 113.624 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.8 -41.18 19.76 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 114.793 0.677 . . . . 71.5 114.793 -166.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 132' ' ' ARG . 3.3 pp -67.0 -25.76 66.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.102 0.451 . . . . 75.040000000000006 111.8 -173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -39.57 26.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 74.400000000000006 110.238 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.8 m -67.1 -38.02 84.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 73.420000000000002 111.703 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.1 -33.34 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 75.5 111.058 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.78 -33.44 72.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 64.329999999999998 110.318 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -70.05 -21.86 63.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.613 -0.721 . . . . 74.340000000000003 110.775 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.39 -27.84 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 61.310000000000002 111.248 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -103.64 -41.43 5.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.083 -0.508 . . . . 74.329999999999998 110.695 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.02 -0.79 79.51 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.478 -0.649 . . . . 65.150000000000006 111.478 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.7 m -115.97 143.68 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.84 -0.43 . . . . 74.409999999999997 109.84 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -120.68 -161.93 0.92 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.297 -0.41 . . . . 73.430000000000007 109.9 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.52 18.86 2.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.658 0.742 . . . . 72.439999999999998 110.416 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 45.4 p90 -86.43 156.99 19.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.598 -0.728 . . . . 74.109999999999999 110.058 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.532 ' HD1' HD11 ' A' ' 176' ' ' LEU . 13.3 m-70 -78.29 110.8 13.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 73.420000000000002 110.577 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.491 ' HD2' ' HB2' ' A' ' 118' ' ' LEU . 32.0 ttp-105 -108.98 109.38 20.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.915 -0.584 . . . . 74.519999999999996 110.111 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 61.2 t -85.6 133.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.531 -0.758 . . . . 73.030000000000001 109.979 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.792 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 84.7 mtm180 -131.23 109.33 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.248 -0.433 . . . . 75.319999999999993 111.226 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.01 123.54 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 72.310000000000002 109.586 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.45 125.2 28.59 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.758 -0.734 . . . . 63.340000000000003 112.151 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' ' 97' ' ' LEU . 24.4 m -88.73 -12.45 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.785 0.326 . . . . 73.319999999999993 111.089 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 138.14 -142.18 12.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.761 -0.733 . . . . 63.509999999999998 111.929 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 138' ' ' GLY . 12.0 mmm180 -131.8 149.55 73.73 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.166 -0.679 . . . . 75.439999999999998 109.166 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 52.1 Cg_exo -55.26 114.5 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.678 2.252 . . . . 74.209999999999994 112.157 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.2 Cg_endo -82.72 160.34 16.46 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.205 2.604 . . . . 71.099999999999994 112.508 -176.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -18.71 9.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.928 -0.653 . . . . 55.219999999999999 112.245 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -87.14 -45.27 10.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.065 0.46 . . . . 75.049999999999997 110.52 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 32.7 pttt -119.65 144.02 47.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.648 -0.705 . . . . 73.420000000000002 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.62 139.64 89.44 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.751 -0.659 . . . . 71.129999999999995 110.868 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.09 -34.04 45.77 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.361 2.708 . . . . 74.530000000000001 113.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.6 61.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.099 0.476 . . . . 73.120000000000005 111.171 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.36 -18.78 29.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 54.329999999999998 110.454 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.426 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 63.9 t80 -69.32 -27.44 65.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 75.400000000000006 110.687 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.552 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.9 m -86.09 1.44 5.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.504 -0.316 . . . . 65.299999999999997 111.239 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.403 HD23 ' CD1' ' A' ' 17' ' ' TYR . 79.5 mt -95.53 1.33 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.632 0.234 . . . . 74.430000000000007 111.632 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.18 150.44 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 74.430000000000007 110.312 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.771 ' HB3' HG22 ' A' ' 20' ' ' THR . 27.1 p-10 -129.44 30.01 5.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.508 . . . . 71.200000000000003 111.223 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -146.84 143.76 28.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.138 -0.319 . . . . 71.319999999999993 110.138 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.64 177.18 11.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.808 -1.182 . . . . 73.140000000000001 107.808 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.6 -72.41 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.416 0.553 . . . . 40.020000000000003 112.252 -173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.17 -46.91 5.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.334 0.588 . . . . 53.119999999999997 111.885 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 1.2 pm0 -67.91 -17.21 64.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 73.439999999999998 112.064 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -65.31 -25.24 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.677 0.275 . . . . 74.319999999999993 110.387 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.61 -17.12 54.55 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.273 -0.421 . . . . 75.230000000000004 111.592 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' O ' HG21 ' A' ' 165' ' ' ILE . 60.6 mt-10 -85.84 -20.38 29.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.102 -0.239 . . . . 75.310000000000002 110.912 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.712 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 58.8 t -52.17 -55.79 27.99 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.399 . . . . 72.310000000000002 112.079 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 34.9 Cg_exo -61.94 -23.91 76.37 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.103 1.869 . . . . 63.240000000000002 112.525 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.571 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 11.5 m -81.8 -46.05 14.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.44 . . . . 63.450000000000003 111.021 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.528 HG22 ' CZ3' ' A' ' 191' ' ' TRP . 40.2 pt -65.94 -30.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.377 -0.374 . . . . 74.120000000000005 111.936 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 162' ' ' VAL . 56.2 t -61.25 -48.26 89.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 63.030000000000001 110.623 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.73 -39.73 95.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.319999999999993 110.744 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 164' ' ' THR . 71.9 mm-40 -65.68 -41.85 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 75.129999999999995 110.5 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.9 80.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 72.150000000000006 110.686 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.73 88.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 71.319999999999993 110.474 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.55 -37.05 76.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 74.319999999999993 110.362 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.84 -30.33 70.77 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 111.091 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 63.0 m -62.48 -43.34 99.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 61.310000000000002 110.143 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 41.3 mt-10 -71.72 -28.95 64.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 71.530000000000001 109.996 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.8 tp -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 71.540000000000006 110.545 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.532 HD11 ' HD1' ' A' ' 131' ' ' HIS . 85.1 mt -65.42 -22.0 66.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.819 -0.628 . . . . 73.439999999999998 110.69 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 5' ' ' LEU . 3.3 mm -80.49 -49.68 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.841 -0.618 . . . . 73.120000000000005 111.421 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.36 -28.53 12.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.511 0.93 . . . . 64.439999999999998 113.511 -167.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -100.59 -77.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.462 -0.495 . . . . 74.030000000000001 111.964 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -131.65 134.56 7.73 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.923 -1.132 . . . . 62.119999999999997 113.338 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.1 -34.39 38.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.933 0.397 . . . . 73.540000000000006 109.953 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.627 ' HG2' ' HD3' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -120.92 -36.28 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.702 1.001 . . . . 74.239999999999995 113.702 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.627 ' HD3' ' HG2' ' A' ' 182' ' ' GLU . 84.5 Cg_endo -81.55 -5.03 12.47 Favored 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 121.177 1.456 . . . . 74.150000000000006 113.635 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 187' ' ' THR . . . -69.47 -31.72 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 72.340000000000003 111.33 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.2 pt20 -67.97 -19.43 64.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 111.682 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -56.11 -43.09 77.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.329 . . . . 74.219999999999999 111.121 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 184' ' ' ALA . 15.4 t -76.44 -19.38 58.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.685 0.279 . . . . 62.43 111.132 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.89 -40.44 52.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 74.209999999999994 110.917 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -84.19 1.39 44.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.927 -0.309 . . . . 72.219999999999999 111.255 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.35 -4.02 57.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.917 0.389 . . . . 75.329999999999998 110.873 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.528 ' CZ3' HG22 ' A' ' 165' ' ' ILE . 17.7 t90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.318 -0.849 . . . . 71.019999999999996 110.364 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.166 -0.309 . . . . 55.409999999999997 110.166 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.74 111.65 3.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.327 . . . . 75.340000000000003 110.46 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' HG3' HG21 ' A' ' 58' ' ' THR . 7.4 pt-20 -89.66 116.82 67.31 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.027 -0.533 . . . . 74.239999999999995 110.816 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HG2' HG11 ' A' ' 85' ' ' VAL . 14.0 Cg_endo -92.31 113.56 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.623 2.882 . . . . 65.099999999999994 112.615 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.647 HD11 HG13 ' A' ' 177' ' ' ILE . 95.7 mt -72.21 114.9 10.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.543 -0.753 . . . . 74.340000000000003 110.689 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 85' ' ' VAL . 42.9 tp -93.68 104.66 16.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.008 -0.738 . . . . 70.430000000000007 109.008 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.608 ' HB ' HD23 ' A' ' 62' ' ' LEU . 47.9 t -109.94 123.79 66.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.334 -0.394 . . . . 74.239999999999995 110.175 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 57.8 t -110.13 114.82 48.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.668 . . . . 72.109999999999999 110.292 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.29 122.37 7.42 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.244 -0.742 . . . . 65.439999999999998 111.244 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.771 ' HG ' ' HE1' ' A' ' 22' ' ' HIS . 30.3 tp -85.92 82.73 8.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.363 0.601 . . . . 75.439999999999998 110.998 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -150.49 118.26 0.91 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.342 -0.845 . . . . 75.239999999999995 111.115 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.64 151.56 37.61 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.497 -0.186 . . . . 75.420000000000002 110.497 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.27 161.62 45.33 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.465 2.11 . . . . 74.310000000000002 112.464 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' HA3' ' HD1' ' A' ' 17' ' ' TYR . . . 148.75 142.74 3.67 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.852 -0.613 . . . . 74.140000000000001 111.782 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.33 -42.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.826 2.35 . . . . 64.019999999999996 112.216 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 20' ' ' THR . 8.0 p -90.76 -37.93 13.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.937 -0.574 . . . . 64.310000000000002 110.856 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HD1' ' HA3' ' A' ' 14' ' ' GLY . 84.9 m-85 -62.04 -35.09 77.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.896 -0.593 . . . . 73.219999999999999 112.281 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 -13.25 60.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 75.200000000000003 111.104 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -112.06 28.26 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 74.409999999999997 110.334 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.797 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 79.2 p -102.12 -176.39 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.841 -0.618 . . . . 72.329999999999998 110.906 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -86.41 -15.42 40.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.476 0.655 . . . . 74.530000000000001 109.503 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.771 ' HE1' ' HG ' ' A' ' 10' ' ' LEU . 14.8 t-80 -76.75 -22.25 54.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.145 -0.934 . . . . 74.540000000000006 110.405 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' HG2' ' A' ' 27' ' ' MET . 65.7 t30 -73.78 -0.08 14.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.006 0.432 . . . . 73.510000000000005 111.266 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.39 -29.5 68.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.562 -0.29 . . . . 73.400000000000006 111.254 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.32 -30.71 78.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.926 -0.654 . . . . 72.510000000000005 112.49 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 67.2 t80 -90.36 -22.38 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.784 -0.244 . . . . 74.25 110.833 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.446 ' O ' HG21 ' A' ' 31' ' ' VAL . 26.2 mmt -50.49 -48.3 56.9 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 111.766 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.88 -46.86 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 73.010000000000005 110.803 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.31 82.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 73.150000000000006 111.388 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.4 -37.27 84.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.398 . . . . 74.329999999999998 111.04 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 27' ' ' MET . 62.6 t -65.51 -39.04 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.181 0.515 . . . . 73.439999999999998 109.852 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.85 -43.27 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.624 . . . . 75.340000000000003 110.698 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.22 90.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 72.239999999999995 110.906 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.49 91.26 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.982 -0.554 . . . . 72.140000000000001 112.878 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -70.13 -24.2 63.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.818 0.309 . . . . 73.140000000000001 111.206 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.613 HD12 ' HA3' ' A' ' 53' ' ' GLY . 82.7 mt -77.58 -49.77 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.409 -0.589 . . . . 73.420000000000002 109.409 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.99 62.19 1.07 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.84 -0.695 . . . . 54.310000000000002 112.425 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.4 m -156.3 144.62 19.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.919 0.39 . . . . 73.319999999999993 110.718 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.98 151.65 27.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 73.420000000000002 110.215 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.98 138.54 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.892 0.377 . . . . 74.319999999999993 110.672 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -101.36 126.6 48.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 75.530000000000001 110.043 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 t -78.1 129.75 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 74.430000000000007 110.301 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -68.79 102.71 1.6 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.622 -0.263 . . . . 65.400000000000006 110.776 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 58.7 tttm -64.11 88.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.121 -0.696 . . . . 74.230000000000004 109.121 172.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.8 tttp 174.22 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.928 -1.033 . . . . 74.530000000000001 109.021 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 p -125.15 -19.18 5.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.538 -0.755 . . . . 73.319999999999993 111.477 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.73 18.23 45.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 53.420000000000002 112.955 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.65 123.43 35.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.579 0.228 . . . . 74.329999999999998 110.654 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 2.2 mp0 -84.98 140.34 31.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 74.109999999999999 110.928 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -139.4 137.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 110.404 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 6.9 p -118.91 145.49 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.709 -0.478 . . . . 74.439999999999998 109.709 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.533 HG22 HG11 ' A' ' 61' ' ' VAL . 1.6 m -116.71 142.59 46.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.232 -0.44 . . . . 65.219999999999999 111.637 -172.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.613 ' HA3' HD12 ' A' ' 36' ' ' ILE . . . -178.17 -161.53 26.39 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.173 -0.771 . . . . 73.230000000000004 111.173 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.954 ' HG2' ' HA ' ' A' ' 59' ' ' SER . 37.2 mtm180 -136.34 146.09 46.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.916 0.389 . . . . 72.0 110.684 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.59 103.05 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 74.019999999999996 109.698 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.19 -51.58 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.963 0.79 . . . . 75.540000000000006 111.713 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.21 -36.98 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.048 -0.821 . . . . 63.329999999999998 111.048 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 3' ' ' GLU . 4.1 m -68.58 151.56 46.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.439 0.295 . . . . 74.299999999999997 110.37 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.954 ' HA ' ' HG2' ' A' ' 54' ' ' ARG . 21.9 m -85.72 139.98 30.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.678 . . . . 70.310000000000002 109.171 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.35 132.1 52.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.368 0.604 . . . . 74.230000000000004 111.307 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.533 HG11 HG22 ' A' ' 52' ' ' THR . 8.3 m -117.68 115.5 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 71.25 109.333 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.608 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.7 mt -92.42 104.59 16.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.951 -0.568 . . . . 74.040000000000006 109.838 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -108.98 137.58 46.68 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 73.0 110.146 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 49' ' ' GLU . 12.8 ptmm? -130.71 143.01 47.61 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 71.530000000000001 110.498 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.41 166.67 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.521 2.147 . . . . 64.430000000000007 111.635 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -84.8 -54.14 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.798 -0.361 . . . . 73.239999999999995 111.395 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.9 p -167.67 163.54 14.41 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.699 0.259 . . . . 71.209999999999994 111.699 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 69.41 163.81 0.24 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.976 0.797 . . . . 72.040000000000006 112.565 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.0 mmt -73.24 -56.61 4.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.922 -0.581 . . . . 72.230000000000004 110.946 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.08 -40.65 87.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.817 -0.629 . . . . 70.329999999999998 111.783 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 67' ' ' CYS . 42.7 mt-10 -59.84 -40.31 88.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.523 -0.308 . . . . 64.439999999999998 110.861 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -36.27 83.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.863 0.363 . . . . 64.310000000000002 110.53 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.459 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.88 -39.89 97.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.46 -0.656 . . . . 73.530000000000001 111.46 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.28 -0.54 19.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 75.129999999999995 110.726 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.542 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 23.0 mm-40 -103.53 -51.05 3.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 74.430000000000007 111.038 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.81 -34.69 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 70.310000000000002 111.31 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.32 -67.19 2.34 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.989 -0.55 . . . . 72.349999999999994 113.374 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.87 -27.6 59.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.692 2.261 . . . . 63.229999999999997 113.612 -177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 47.2 mt -57.5 -40.55 78.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.848 0.314 . . . . 73.239999999999995 111.848 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.73 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.022 0.439 . . . . 74.329999999999998 111.378 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.99 -7.41 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.354 -0.385 . . . . 73.140000000000001 111.235 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -79.12 -46.65 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.83 0.348 . . . . 74.230000000000004 110.128 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -93.03 1.45 57.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 111.232 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 60.46 37.57 19.74 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.686 0.617 . . . . 72.400000000000006 110.752 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 6' ' ' LEU . 27.5 m -92.15 142.98 26.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.81 -0.632 . . . . 64.340000000000003 110.466 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.81 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 4.1 Cg_exo -77.0 133.9 14.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.68 2.253 . . . . 70.129999999999995 111.81 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.545 ' O ' HG22 ' A' ' 90' ' ' ILE . 36.2 Cg_endo -66.0 -4.56 10.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.974 2.45 . . . . 74.430000000000007 112.587 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.81 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.9 pt20 -71.62 -20.38 61.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.105 -0.498 . . . . 75.299999999999997 110.598 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.746 ' HG3' ' HG3' ' A' ' 88' ' ' GLN . 97.9 mt-30 -124.43 24.52 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.083 -0.508 . . . . 74.439999999999998 111.655 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 87' ' ' PRO . 13.1 tt -86.93 105.5 15.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.757 0.789 . . . . 74.5 110.176 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.77 113.38 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.369 -0.832 . . . . 73.109999999999999 110.631 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.62 114.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.408 -0.36 . . . . 73.400000000000006 110.157 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 58.3 mt -101.26 120.16 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.913 -0.585 . . . . 74.409999999999997 109.776 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.41 ' CE1' HD21 ' A' ' 118' ' ' LEU . 32.1 p80 -142.01 174.9 10.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.966 0.413 . . . . 72.219999999999999 111.349 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' CG ' ' HE2' ' A' ' 115' ' ' HIS . 8.9 p-10 -84.21 148.28 26.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.219 -0.901 . . . . 74.340000000000003 109.529 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.662 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -139.5 128.85 24.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.079 0.466 . . . . 74.040000000000006 110.389 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.55 -33.93 25.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.68 -0.691 . . . . 74.340000000000003 111.681 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.53 -38.49 26.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 64.140000000000001 111.392 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.604 HG12 ' OE1' ' A' ' 96' ' ' GLU . 37.9 mm -65.58 143.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 71.439999999999998 111.628 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 12.1 m-20 -57.07 139.59 51.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.602 -0.726 . . . . 73.150000000000006 111.218 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.704 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 80.3 t80 -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 74.430000000000007 111.683 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.26 -24.38 22.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.656 -0.702 . . . . 62.439999999999998 112.825 174.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -90.92 130.92 36.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.145 0.498 . . . . 65.409999999999997 110.842 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.42 114.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.947 -0.76 . . . . 74.099999999999994 108.947 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -107.48 125.19 50.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 75.319999999999993 110.254 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.3 mt -103.89 135.19 45.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.616 -0.72 . . . . 74.150000000000006 110.526 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.26 156.54 45.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.944 -0.762 . . . . 75.310000000000002 108.944 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.37 -132.4 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.463 -0.569 . . . . 73.109999999999999 109.463 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' A' ' 129' ' ' ASN . . . 49.34 -153.01 2.92 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.423 -0.418 . . . . 71.319999999999993 112.759 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.35 173.29 27.29 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.778 -0.929 . . . . 74.010000000000005 110.778 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 119' ' ' ARG . . . -83.55 85.49 1.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.146 -1.026 . . . . 64.319999999999993 111.922 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 -43.01 11.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.635 0.255 . . . . 75.040000000000006 111.268 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.84 109.23 2.87 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.146 -0.55 . . . . 75.430000000000007 112.343 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.48 -100.85 0.2 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.057 -0.592 . . . . 74.209999999999994 111.969 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.483 ' HE2' ' CG ' ' A' ' 95' ' ' ASP . 4.8 p80 -164.17 173.99 11.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.585 0.231 . . . . 74.129999999999995 111.322 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -40.21 -56.17 1.99 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.129 1.159 . . . . 74.200000000000003 114.129 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.44 -29.25 72.82 Favored Glycine 0 CA--C 1.509 -0.283 0 C-N-CA 121.233 -0.508 . . . . 73.439999999999998 112.476 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 23.5 tp -65.83 -38.67 89.53 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.426 -0.387 . . . . 73.340000000000003 110.68 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 111' ' ' GLY . 1.7 mpp_? -79.65 -23.25 42.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.76 -0.376 . . . . 70.129999999999995 110.625 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -66.95 -44.81 79.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 63.0 110.603 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.459 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.2 m -69.3 -27.77 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 74.340000000000003 110.798 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.16 -43.57 61.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.109999999999999 110.524 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -70.28 -25.52 63.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 65.129999999999995 111.589 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.68 92.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 52.549999999999997 110.643 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.52 -42.07 20.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.855 -0.611 . . . . 74.230000000000004 110.336 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.08 1.81 88.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.935 -0.65 . . . . 60.539999999999999 111.757 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.621 HG21 ' HE1' ' A' ' 130' ' ' PHE . 4.8 m -111.5 122.66 48.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.931 0.396 . . . . 72.120000000000005 110.308 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 53.7 mtmt -126.63 178.83 5.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 110.453 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.481 ' HA ' ' N ' ' A' ' 109' ' ' GLY . 22.8 m-20 75.35 67.71 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.862 0.726 . . . . 74.329999999999998 112.112 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.621 ' HE1' HG21 ' A' ' 127' ' ' THR . 60.5 m-85 -142.99 -87.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 74.109999999999999 111.337 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.478 ' C ' ' HD2' ' A' ' 132' ' ' ARG . 12.7 t60 -161.88 104.97 1.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.635 0.255 . . . . 72.329999999999998 110.644 -174.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 131' ' ' HIS . 2.6 mpt_? -114.27 141.03 48.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.529 0.204 . . . . 73.109999999999999 110.549 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 93.5 t -104.19 118.23 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 72.120000000000005 111.047 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.662 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 35.6 mtp180 -112.41 104.67 12.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.061 -0.518 . . . . 71.549999999999997 110.254 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.3 mt -85.81 115.09 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.85 -0.426 . . . . 72.209999999999994 109.85 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.31 118.77 11.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.902 -0.666 . . . . 73.049999999999997 112.651 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.52 -11.51 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 73.140000000000001 110.086 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.704 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 136.9 -77.55 0.34 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 73.519999999999996 113.326 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -170.73 165.6 5.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.983 -0.377 . . . . 72.030000000000001 109.983 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 53.1 Cg_exo -53.85 142.1 64.25 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.474 2.116 . . . . 73.340000000000003 111.279 171.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 25.3 Cg_exo -61.72 -66.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 123.027 2.485 . . . . 75.099999999999994 113.327 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.7 -69.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.589 -0.815 . . . . 65.109999999999999 112.438 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 143' ' ' ARG . 10.5 mmt180 -82.01 -70.07 0.57 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.85 0.357 . . . . 74.200000000000003 110.778 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.571 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -80.89 159.99 24.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 73.430000000000007 110.486 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.742 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 2.5 p30 -79.76 166.39 41.21 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.548 -0.296 . . . . 74.439999999999998 110.776 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 10.9 Cg_endo -53.79 -36.0 80.98 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.371 2.714 . . . . 72.019999999999996 113.986 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.15 77.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 72.439999999999998 110.603 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.91 -31.87 59.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.083 -0.508 . . . . 72.219999999999999 110.216 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.571 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 88.9 t80 -64.5 -42.81 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.567 -0.742 . . . . 71.230000000000004 111.321 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.797 ' O ' ' HB ' ' A' ' 20' ' ' THR . 34.9 m -83.28 -9.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.915 -0.314 . . . . 74.129999999999995 111.167 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.409 ' O ' HG21 ' A' ' 20' ' ' THR . 49.5 tp -83.75 -25.63 30.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.104 0.478 . . . . 74.530000000000001 111.136 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.04 176.68 8.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.962 0.41 . . . . 75.019999999999996 110.616 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -81.26 171.97 14.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 72.420000000000002 110.662 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.563 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 40.3 m-85 -65.44 145.13 56.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 73.340000000000003 110.097 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.735 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -68.92 162.2 27.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.284 -0.265 . . . . 73.400000000000006 110.284 -178.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.92 9.52 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.033 0.753 . . . . 75.530000000000001 113.033 -162.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.74 88.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.012 0.434 . . . . 62.329999999999998 112.13 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.566 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 2.2 pm0 -89.34 -16.58 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.077 -0.511 . . . . 74.5 111.655 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.735 ' HB2' ' O ' ' A' ' 155' ' ' THR . 60.2 ttt180 -61.04 -25.09 66.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 74.439999999999998 111.424 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.33 -14.4 62.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.283 -0.417 . . . . 75.010000000000005 111.919 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -111.4 5.97 20.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.742 0.306 . . . . 73.310000000000002 111.245 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.518 HG21 ' HZ ' ' A' ' 101' ' ' PHE . 94.8 t -63.82 -52.73 55.41 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.449 -0.341 . . . . 63.439999999999998 111.746 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 11.3 Cg_endo -55.53 -33.79 87.63 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.927 1.752 . . . . 70.140000000000001 111.873 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.7 m -65.95 -49.46 67.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.625 -0.716 . . . . 75.030000000000001 111.178 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 162' ' ' VAL . 35.3 pt -67.89 -30.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.431 -0.35 . . . . 75.239999999999995 111.42 -175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.4 t -63.9 -45.47 96.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.402 . . . . 73.340000000000003 110.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -67.86 -37.6 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 71.239999999999995 110.812 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -63.65 -44.31 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 74.299999999999997 110.896 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.95 98.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.219 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.24 96.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 111.253 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.84 -44.14 86.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 73.299999999999997 110.522 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.615 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -64.3 -37.96 89.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 73.109999999999999 111.664 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 87.3 m -58.32 -40.36 81.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.865 0.364 . . . . 71.310000000000002 111.045 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.13 -40.03 90.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 71.329999999999998 110.235 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.55 -37.34 87.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 74.239999999999995 110.885 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 87.1 mt -60.18 -42.86 95.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 74.5 111.868 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.647 HG13 HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.87 -27.28 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 74.319999999999993 110.382 -176.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -83.96 -58.28 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.216 -0.447 . . . . 54.439999999999998 111.841 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -24.98 35.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 72.030000000000001 111.439 -175.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 113.89 -161.13 12.81 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.641 -0.79 . . . . 75.209999999999994 112.112 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.64 -68.8 0.68 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.741 0.305 . . . . 73.450000000000003 110.847 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.64 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.6 tt0 -55.02 -55.3 40.48 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.155 0.798 . . . . 75.120000000000005 113.155 -172.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 23.1 Cg_exo -65.16 -31.06 54.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.15 1.9 . . . . 64.430000000000007 113.087 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.43 -48.71 7.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.504 0.557 . . . . 74.099999999999994 112.504 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -20.23 65.7 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 121.216 -0.193 . . . . 74.219999999999999 111.51 -174.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -53.54 -51.08 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.415 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -72.28 -21.62 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 71.319999999999993 111.266 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.8 t -70.11 -24.2 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 73.530000000000001 111.283 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -116.91 13.38 14.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.882 0.372 . . . . 72.030000000000001 110.388 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.11 27.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.092 -0.503 . . . . 71.099999999999994 111.092 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.428 ' HH2' HG22 ' A' ' 165' ' ' ILE . 15.1 p-90 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.301 -0.857 . . . . 75.510000000000005 110.912 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.163 -0.31 . . . . 64.120000000000005 110.163 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.06 116.73 20.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 64.049999999999997 110.092 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 14.3 pt-20 -85.24 118.22 70.35 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.252 0.548 . . . . 72.329999999999998 110.414 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 1.3 Cg_endo -83.71 110.19 1.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.805 2.337 . . . . 73.420000000000002 112.113 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 89' ' ' GLN . 36.7 tp -74.32 118.35 17.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 75.040000000000006 109.846 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.457 ' HA ' HG23 ' A' ' 61' ' ' VAL . 69.8 tp -92.8 104.96 17.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.18 -0.464 . . . . 75.040000000000006 110.128 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' HB ' HD23 ' A' ' 62' ' ' LEU . 44.9 t -105.58 121.27 57.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.246 -0.434 . . . . 72.329999999999998 110.408 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.95 114.87 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.754 -0.657 . . . . 74.430000000000007 109.902 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.85 123.15 6.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.846 -0.692 . . . . 73.329999999999998 111.846 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 96.16 1.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.846 0.355 . . . . 74.129999999999995 110.199 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -111.93 85.68 0.4 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.783 -0.723 . . . . 61.200000000000003 112.993 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 28.0 m-80 -100.89 117.75 61.91 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.995 -0.372 . . . . 73.25 109.995 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 3.0 Cg_exo -75.49 177.79 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.155 2.57 . . . . 74.129999999999995 112.369 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 17' ' ' TYR . . . 155.5 179.05 30.32 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.04 -0.6 . . . . 72.310000000000002 111.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.09 -71.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.885 2.39 . . . . 74.340000000000003 111.559 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.593 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 15.1 t -117.33 6.26 12.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.815 -0.809 . . . . 71.420000000000002 108.815 172.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.2 t80 -69.19 -26.09 64.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.778 -1.101 . . . . 75.219999999999999 110.313 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 13' ' ' PRO . . . -87.48 1.6 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 74.409999999999997 110.983 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.593 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -120.72 3.18 10.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.445 . . . . 75.030000000000001 110.435 -178.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.821 ' HA ' ' HB3' ' A' ' 153' ' ' ASN . 14.9 t -103.7 -177.66 3.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.918 0.39 . . . . 73.129999999999995 111.875 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' HD3' HG11 ' A' ' 137' ' ' VAL . 61.6 mtt180 -64.92 -20.72 66.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.0 -0.546 . . . . 74.400000000000006 111.63 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.506 ' H ' HG21 ' A' ' 20' ' ' THR . 5.9 t60 -78.78 -7.99 58.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.972 0.415 . . . . 71.040000000000006 110.576 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.26 8.22 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 72.120000000000005 110.43 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 75.0 mt -55.74 -29.8 60.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.511 -0.313 . . . . 75.120000000000005 111.67 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.56 -33.05 86.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 72.030000000000001 112.462 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.617 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 87.5 t80 -88.36 -30.7 19.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.544 0.212 . . . . 72.439999999999998 110.718 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mmm -50.19 -42.89 52.12 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 64.010000000000005 111.993 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 t -69.53 -47.15 73.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.345 . . . . 75.430000000000007 110.789 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.57 74.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.29 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.3 -45.43 91.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 74.420000000000002 110.9 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.8 t -72.85 -36.82 53.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.592 . . . . 74.030000000000001 110.503 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.03 -44.99 96.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.876 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.83 80.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 64.409999999999997 110.554 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.59 95.21 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.866 -0.606 . . . . 74.420000000000002 112.832 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -21.57 54.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 117.044 0.422 . . . . 75.549999999999997 111.314 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.507 HD12 ' HA3' ' A' ' 53' ' ' GLY . 80.6 mt -77.84 -43.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.585 -0.524 . . . . 73.310000000000002 109.585 173.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.04 33.81 5.89 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.868 -0.682 . . . . 75.319999999999993 111.942 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -145.66 135.32 23.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.746 0.308 . . . . 73.109999999999999 110.253 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 148.44 24.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.287 -0.415 . . . . 74.299999999999997 110.693 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.771 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 11.1 p90 -66.31 124.72 23.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.61 . . . . 75.129999999999995 110.638 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -101.1 143.88 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 110.608 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 ' HG2' ' A' ' 49' ' ' GLU . 19.7 t -81.69 135.55 24.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 73.120000000000005 111.584 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.36 104.51 16.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.932 -0.577 . . . . 74.319999999999993 109.97 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.48 90.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.9 -0.408 . . . . 75.109999999999999 109.9 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.5 tptt 174.34 -58.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.251 -0.886 . . . . 74.219999999999999 108.695 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -106.76 -14.33 15.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.345 -0.843 . . . . 74.120000000000005 110.519 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 83.76 3.9 89.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.943 -0.646 . . . . 62.200000000000003 112.348 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.38 144.29 28.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.821 0.344 . . . . 75.409999999999997 110.746 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.615 ' HG2' HG21 ' A' ' 42' ' ' VAL . 36.2 mt-10 -108.56 122.16 46.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.944 -0.571 . . . . 72.109999999999999 109.637 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -129.15 137.56 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.441 -0.345 . . . . 72.200000000000003 110.476 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.771 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 5.0 p -121.47 135.63 61.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.934 0.397 . . . . 75.400000000000006 110.2 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.762 HG23 HG13 ' A' ' 61' ' ' VAL . 11.9 p -106.71 136.58 46.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.132 -0.485 . . . . 70.310000000000002 110.982 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' A' ' 36' ' ' ILE . . . -160.7 -161.14 11.22 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.473 -0.87 . . . . 45.219999999999999 112.576 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 13.2 mmt180 -121.59 142.41 50.13 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 73.5 110.088 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.122 HD23 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -126.9 115.77 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.726 -0.842 . . . . 74.219999999999999 108.726 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.6 -36.83 0.31 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.706 -0.679 . . . . 65.230000000000004 111.305 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 165.88 -33.15 0.23 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.852 -0.899 . . . . 72.239999999999995 110.852 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 59' ' ' SER . 1.7 m -75.37 169.24 18.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.372 -0.414 . . . . 73.439999999999998 110.759 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.465 ' H ' HG21 ' A' ' 58' ' ' THR . 2.9 m -79.78 131.46 35.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.753 0.311 . . . . 74.040000000000006 111.383 -175.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.122 ' HB ' HD23 ' A' ' 55' ' ' LEU . 12.1 p -127.06 137.42 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.94 -0.392 . . . . 74.230000000000004 109.94 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.762 HG13 HG23 ' A' ' 52' ' ' THR . 12.4 m -120.25 115.4 47.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.209 0.528 . . . . 74.400000000000006 110.532 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 61.9 mt -96.79 105.0 17.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 74.230000000000004 109.586 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.2 127.58 55.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.979 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 6.4 ptmt -119.15 126.69 26.91 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.221 -0.445 . . . . 74.319999999999993 110.393 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.759 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 39.6 Cg_exo -61.53 149.74 88.4 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.398 2.065 . . . . 65.099999999999994 110.619 173.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 25.7 ptt180 -64.55 -53.42 48.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 75.109999999999999 111.13 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 29.1 p -168.57 174.69 6.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.422 -0.214 . . . . 64.329999999999998 110.422 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.534 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 9.9 t80 75.27 138.27 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.047 0.842 . . . . 74.099999999999994 112.316 167.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.97 -52.69 62.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 64.230000000000004 111.322 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.56 -36.65 76.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 111.17 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 6.4 mt-10 -60.31 -43.55 96.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.705 -0.225 . . . . 64.150000000000006 110.821 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -54.87 -32.42 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.372 0.42 . . . . 70.409999999999997 111.341 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.793 ' HA2' HG11 ' A' ' 121' ' ' VAL . . . -67.47 -39.21 91.27 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.895 -0.669 . . . . 64.109999999999999 112.118 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' NH2' ' HG2' ' A' ' 71' ' ' GLU . 20.1 ptt180 -91.09 2.75 56.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 73.219999999999999 110.681 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.759 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 24.6 mm-40 -81.23 -51.89 7.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 74.230000000000004 110.22 174.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.17 -44.77 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.757 -0.656 . . . . 63.310000000000002 112.29 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.79 -66.23 2.7 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.135 -0.484 . . . . 75.420000000000002 113.674 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 -41.43 78.87 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.867 2.378 . . . . 75.200000000000003 113.0 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.03 -39.54 95.05 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.768 0.284 . . . . 74.299999999999997 111.768 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.38 91.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.0 0.428 . . . . 73.140000000000001 111.163 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.9 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.172 -0.467 . . . . 71.299999999999997 111.068 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.88 -42.12 97.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 72.209999999999994 109.696 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -82.16 -15.28 53.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.723 -0.671 . . . . 73.230000000000004 110.621 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m 62.37 34.68 15.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.762 -0.653 . . . . 62.409999999999997 110.515 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.4 m -100.29 143.99 27.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.757 -0.656 . . . . 71.319999999999993 110.635 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 10.5 Cg_exo -71.2 115.62 4.35 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.733 2.289 . . . . 64.099999999999994 111.574 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.39 33.28 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.185 2.59 . . . . 73.140000000000001 113.4 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -78.65 -48.75 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.339 -0.615 . . . . 74.430000000000007 109.339 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.519 ' HB3' HD11 ' A' ' 5' ' ' LEU . 1.8 mp0 -88.86 68.59 8.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.751 -0.659 . . . . 71.230000000000004 109.812 175.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.17 138.03 31.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.54 -0.755 . . . . 75.230000000000004 110.388 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.1 t -127.75 109.88 20.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 73.329999999999998 110.067 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 58.5 t -105.78 113.43 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.702 -0.481 . . . . 73.5 109.702 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 58.2 mt -93.46 122.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.062 -0.517 . . . . 75.010000000000005 110.396 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.424 ' HE1' ' CB ' ' A' ' 115' ' ' HIS . 16.7 t-80 -149.02 162.89 39.01 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.643 -0.423 . . . . 74.239999999999995 112.129 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.56 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 8.8 p-10 -90.34 139.28 30.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.465 -0.789 . . . . 71.530000000000001 110.314 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.795 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 75.8 mm-40 -137.23 140.38 41.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.911 0.386 . . . . 71.549999999999997 111.734 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.454 HD23 ' HB ' ' A' ' 137' ' ' VAL . 95.1 mt -84.22 -25.6 29.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.819 -0.628 . . . . 74.400000000000006 112.039 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.2 -34.47 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.468 0.651 . . . . 61.549999999999997 110.542 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.666 ' HB ' ' HA2' ' A' ' 136' ' ' GLY . 9.2 mt -84.64 139.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.473 -0.785 . . . . 74.140000000000001 109.999 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -67.08 144.77 55.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.883 -0.414 . . . . 72.329999999999998 109.883 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 65.7 t80 -63.37 124.4 21.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 75.140000000000001 110.773 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.88 -21.11 8.0 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.059 -1.067 . . . . 61.219999999999999 113.469 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -123.69 169.11 11.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.541 0.671 . . . . 75.109999999999999 111.234 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.61 HG12 HG13 ' A' ' 135' ' ' ILE . 65.9 mt -118.65 139.38 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.918 -0.583 . . . . 70.019999999999996 110.745 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.427 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 25.6 tpt180 -111.98 124.15 51.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 73.219999999999999 110.049 176.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.2 mt -108.21 127.25 53.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 74.040000000000006 110.181 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -154.8 151.03 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.49 -0.559 . . . . 75.430000000000007 109.49 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.862 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 1.3 pt? -67.3 -71.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 74.140000000000001 111.668 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.862 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -153.75 155.31 26.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.724 -0.55 . . . . 64.319999999999993 111.724 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.41 176.56 18.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.947 -0.644 . . . . 72.200000000000003 111.691 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.0 77.45 2.11 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.73 -0.748 . . . . 73.5 111.899 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -129.83 21.31 5.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.709 0.766 . . . . 73.549999999999997 109.341 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -145.78 95.42 0.17 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.457 -0.792 . . . . 62.43 112.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.99 67.5 3.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 62.5 112.112 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.575 ' CE1' ' HA ' ' A' ' 96' ' ' GLU . 33.0 m80 -139.19 146.04 40.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 73.349999999999994 111.008 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.66 -55.15 38.77 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.642 -0.708 . . . . 75.439999999999998 111.95 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.72 -28.84 70.22 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.853 -0.612 . . . . 64.209999999999994 112.081 -168.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 74.430000000000007 110.127 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.98 -27.24 60.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.794 -0.639 . . . . 74.430000000000007 110.139 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.2 m -66.69 -52.17 47.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 73.5 110.766 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.793 HG11 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -66.33 -30.65 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.737 0.303 . . . . 70.340000000000003 110.84 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.02 71.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 111.138 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.4 m -84.62 -35.58 22.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 62.5 111.101 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.5 . . . . 64.219999999999999 111.269 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 -42.43 12.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.205 0.526 . . . . 74.230000000000004 110.076 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.13 -13.38 32.69 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.732 -0.667 . . . . 64.439999999999998 112.879 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 p -114.01 122.93 48.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.408 0.623 . . . . 72.129999999999995 111.624 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 4.5 mptt -99.75 -91.7 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.79 -1.189 . . . . 75.209999999999994 107.79 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 55.07 7.97 0.21 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.854 1.798 . . . . 73.349999999999994 115.854 162.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.31 -90.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.955 0.798 . . . . 72.439999999999998 111.923 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -175.92 135.38 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 63.310000000000002 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.562 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 10.5 mpt_? -121.49 124.53 44.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.083 -0.508 . . . . 71.409999999999997 110.056 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 59.1 t -83.9 104.07 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.688 -0.486 . . . . 71.0 109.688 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.795 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 49.1 mtm-85 -122.64 127.6 49.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.883 0.373 . . . . 75.219999999999999 110.53 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 104' ' ' ILE . 3.8 mp -94.28 139.9 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.567 -0.742 . . . . 73.319999999999993 109.859 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.666 ' HA2' ' HB ' ' A' ' 99' ' ' ILE . . . -72.61 129.66 14.13 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.868 -0.682 . . . . 72.530000000000001 112.646 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.607 HG11 ' HD3' ' A' ' 21' ' ' ARG . 27.3 t -95.92 -11.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.316 0.579 . . . . 73.310000000000002 109.972 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.14 166.52 26.83 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.676 -0.773 . . . . 71.530000000000001 111.849 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.42 146.56 50.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.172 -0.307 . . . . 73.099999999999994 110.172 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.63 120.59 7.74 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.012 2.475 . . . . 64.439999999999998 113.122 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.91 158.94 40.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.239 2.626 . . . . 73.040000000000006 112.558 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.25 -24.66 6.73 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.855 -0.688 . . . . 55.409999999999997 112.805 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -83.82 -70.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.711 0.255 . . . . 73.450000000000003 110.738 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.573 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -89.29 157.11 18.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.465 -0.494 . . . . 75.200000000000003 110.594 178.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.28 133.0 92.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 73.540000000000006 111.738 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.56 -29.04 88.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.252 2.635 . . . . 72.230000000000004 113.06 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.463 . . . . 63.409999999999997 109.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 152' ' ' GLU . . . -69.36 -28.65 66.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.61 -0.723 . . . . 64.430000000000007 109.975 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.573 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 87.0 t80 -65.13 -29.59 70.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 74.310000000000002 110.809 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.3 -23.22 10.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 75.129999999999995 110.343 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.35 -26.01 30.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 75.140000000000001 111.081 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.539 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 8.9 pt-20 -87.31 153.28 21.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 74.150000000000006 110.501 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.821 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 34.9 p-10 -132.77 14.18 4.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 72.439999999999998 110.908 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.513 ' C ' ' HG1' ' A' ' 155' ' ' THR . 72.3 m-85 -107.03 156.08 19.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 75.200000000000003 110.304 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -169.83 178.37 4.06 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.716 -1.216 . . . . 74.239999999999995 107.716 175.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.93 -72.95 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.234 -0.586 . . . . 72.030000000000001 111.074 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.57 -24.02 16.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.465 0.65 . . . . 73.420000000000002 110.194 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 22.3 mp0 -68.6 -36.83 79.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.316 -0.856 . . . . 75.319999999999993 110.556 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.55 ' HA ' HG22 ' A' ' 162' ' ' VAL . 7.7 tpt180 -68.1 -17.61 64.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 73.420000000000002 110.501 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.07 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 73.409999999999997 110.919 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 165' ' ' ILE . 34.8 mt-10 -89.7 -5.42 57.06 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.179 -0.208 . . . . 72.420000000000002 111.534 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.653 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 85.2 t -56.32 -51.8 78.08 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.667 0.247 . . . . 73.219999999999999 111.667 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 23.9 Cg_exo -64.97 -29.52 57.44 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.761 1.64 . . . . 64.219999999999999 111.984 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.1 m -73.59 -40.25 64.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.761 -0.654 . . . . 75.400000000000006 111.83 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.481 HD12 HG22 ' A' ' 135' ' ' ILE . 34.8 pt -64.93 -30.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 121.031 -0.268 . . . . 65.310000000000002 110.969 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.01 -39.34 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.418 . . . . 74.129999999999995 109.98 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 163' ' ' PRO . 8.8 mm-40 -58.59 -50.62 73.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.697 -0.683 . . . . 71.209999999999994 110.413 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.99 -32.88 72.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.745 -0.661 . . . . 74.439999999999998 111.232 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.39 78.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 74.219999999999999 110.606 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.86 95.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.497 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.99 -50.06 75.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 65.400000000000006 110.961 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.673 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.85 -44.97 96.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 74.400000000000006 111.702 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.5 m -56.32 -42.78 78.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 75.450000000000003 111.359 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.84 -29.45 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 74.340000000000003 110.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.11 -28.62 66.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 74.530000000000001 110.472 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.2 mt -60.04 -47.34 86.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.862 -0.608 . . . . 75.420000000000002 111.084 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -37.37 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.545 . . . . 74.319999999999993 110.832 -175.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -77.79 -54.51 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.83 0.307 . . . . 64.209999999999994 111.83 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -94.34 -57.28 2.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.404 -0.362 . . . . 75.430000000000007 110.632 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 159.77 151.74 6.26 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.744 -0.741 . . . . 64.310000000000002 111.848 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.5 ' HA ' ' CD2' ' A' ' 176' ' ' LEU . 4.0 pp -71.92 -24.55 61.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.841 0.353 . . . . 75.430000000000007 111.546 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.463 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 30.0 tt0 -82.9 -51.96 0.67 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.387 -0.369 . . . . 73.450000000000003 111.612 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 17.2 Cg_endo -59.9 -35.9 92.21 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.058 1.839 . . . . 73.540000000000006 112.168 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.14 -45.32 89.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.349 . . . . 73.049999999999997 110.331 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -54.72 -49.78 69.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.738 -0.664 . . . . 63.140000000000001 110.783 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 189' ' ' HIS . 57.8 t30 -57.69 -35.93 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 74.5 110.861 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.2 m -70.69 -54.24 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 64.299999999999997 110.992 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.3 t -67.83 -43.32 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.61 0.596 . . . . 74.239999999999995 112.61 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 186' ' ' ASN . 1.3 p80 -76.09 -3.81 38.03 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.667 -0.413 . . . . 74.549999999999997 111.39 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.98 22.08 8.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.096 0.474 . . . . 62.229999999999997 110.429 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.8 t90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.404 -0.808 . . . . 74.219999999999999 110.354 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.812 -0.44 . . . . 70.549999999999997 109.812 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.72 130.13 45.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 72.120000000000005 110.763 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.6 155.57 56.41 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.519 -0.549 . . . . 74.140000000000001 109.519 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.876 ' HB2' HG13 ' A' ' 85' ' ' VAL . 5.6 Cg_endo -87.8 118.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.77 2.314 . . . . 75.129999999999995 112.617 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.6 tp -88.0 121.14 30.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 72.040000000000006 109.651 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.663 HD22 HD12 ' A' ' 90' ' ' ILE . 61.1 tp -92.87 117.5 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.969 -0.382 . . . . 64.519999999999996 109.969 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.744 ' HB ' HD22 ' A' ' 62' ' ' LEU . 46.4 t -113.53 118.06 57.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.655 -0.498 . . . . 73.430000000000007 109.655 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.53 114.96 45.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.886 -0.597 . . . . 71.019999999999996 109.97 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.502 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -105.9 122.17 7.02 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.568 -0.825 . . . . 72.019999999999996 111.674 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.79 89.59 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 75.200000000000003 110.711 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.814 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -142.75 110.55 0.62 Allowed Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.488 -0.778 . . . . 75.349999999999994 111.4 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.39 149.96 47.98 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.531 0.205 . . . . 74.319999999999993 110.664 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.671 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 73.7 Cg_endo -74.39 175.91 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.454 2.102 . . . . 60.119999999999997 111.791 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 17' ' ' TYR . . . 121.34 136.79 5.11 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.423 -0.894 . . . . 71.310000000000002 112.1 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.68 -28.7 82.73 Favored 'Trans proline' 0 C--O 1.225 -0.147 0 C-N-CA 123.159 2.573 . . . . 74.129999999999995 112.988 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 t -113.08 16.35 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 74.510000000000005 111.062 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CD1' ' HA3' ' A' ' 14' ' ' GLY . 75.5 m-85 -106.28 -34.87 7.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 70.510000000000005 111.611 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.14 -4.5 25.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.247 0.832 . . . . 74.439999999999998 113.247 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.619 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -124.42 27.78 6.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.127 0.489 . . . . 72.510000000000005 110.753 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 69.5 p -102.5 -170.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.738 -0.665 . . . . 75.319999999999993 110.087 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 55.0 mtt180 -84.52 -0.73 54.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.986 0.422 . . . . 62.409999999999997 110.459 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -105.21 19.49 20.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 72.140000000000001 110.683 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -99.08 3.31 46.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.377 -0.374 . . . . 74.409999999999997 110.596 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.424 HD13 HG13 ' A' ' 137' ' ' VAL . 91.1 mt -55.67 -42.76 75.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.781 -0.645 . . . . 74.340000000000003 112.064 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -64.38 -37.75 94.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.65 -0.786 . . . . 53.530000000000001 112.004 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.814 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 75.4 t80 -73.21 -32.77 64.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.263 -0.273 . . . . 73.129999999999995 110.263 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.865 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 9.0 mmt -54.21 -54.02 45.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 74.319999999999993 111.692 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.95 -45.04 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 73.319999999999993 110.919 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.64 95.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 73.019999999999996 111.117 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.93 -42.27 97.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 71.120000000000005 110.978 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 27' ' ' MET . 90.4 t -61.88 -44.18 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.310000000000002 110.585 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.38 -40.9 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 73.340000000000003 110.8 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.24 86.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.942 0.401 . . . . 74.5 110.532 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.9 -42.51 85.74 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.769 -0.65 . . . . 71.040000000000006 113.01 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.554 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.3 ptm180 -68.05 -31.32 70.89 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.984 0.392 . . . . 71.530000000000001 111.371 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.554 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 71.040000000000006 109.945 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.31 43.29 4.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.95 -0.643 . . . . 73.120000000000005 112.265 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -129.56 158.62 38.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.671 0.272 . . . . 73.040000000000006 110.595 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.91 165.33 11.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 73.439999999999998 109.496 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.421 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 35.4 p90 -80.38 143.84 33.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.204 0.526 . . . . 74.420000000000002 111.339 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -106.44 133.46 51.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 73.230000000000004 109.336 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.57 124.23 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.348 . . . . 75.409999999999997 110.661 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -71.53 104.86 3.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.94 -0.573 . . . . 73.150000000000006 110.302 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 1.3 tmmt? -73.79 83.79 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.583 . . . . 71.099999999999994 109.734 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 170.84 -48.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.673 -1.148 . . . . 74.329999999999998 109.151 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -104.45 -28.43 11.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.465 -0.789 . . . . 74.129999999999995 110.702 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.2 9.49 73.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.852 -0.69 . . . . 75.400000000000006 111.475 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.29 134.23 34.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 43.450000000000003 111.131 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.487 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 8.8 mt-10 -91.67 131.95 36.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.793 -0.64 . . . . 71.030000000000001 110.291 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.31 137.15 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 73.510000000000005 110.494 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 62' ' ' LEU . 3.8 p -126.99 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.746 -0.464 . . . . 71.120000000000005 109.746 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.766 HG21 HG13 ' A' ' 61' ' ' VAL . 24.4 p -108.8 151.32 26.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 73.200000000000003 111.944 -173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.31 -161.81 20.37 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.752 -0.658 . . . . 65.099999999999994 111.612 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.644 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 20.3 mmt180 -133.15 139.17 46.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.751 -0.462 . . . . 70.310000000000002 109.751 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.062 HD21 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -130.18 116.7 18.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.659 0.266 . . . . 72.319999999999993 110.295 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 68.5 -27.96 0.15 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.672 0.789 . . . . 74.129999999999995 112.594 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 156.69 -30.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.537 -1.025 . . . . 72.400000000000006 110.537 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -79.36 157.22 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.674 -0.763 . . . . 73.319999999999993 109.785 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.644 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 14.0 t -83.21 136.09 34.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.332 -0.618 . . . . 74.340000000000003 109.332 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.062 ' HB ' HD21 ' A' ' 55' ' ' LEU . 10.9 p -117.43 124.23 72.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.211 0.529 . . . . 74.209999999999994 110.672 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 52' ' ' THR . 8.9 m -113.04 111.78 37.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.322 0.582 . . . . 72.040000000000006 109.71 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 7' ' ' VAL . 54.7 mt -92.79 115.81 28.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.585 -0.734 . . . . 71.530000000000001 110.47 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.5 147.62 41.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 74.239999999999995 110.218 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 17.0 ptmt -132.96 131.78 22.1 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.336 -0.393 . . . . 64.439999999999998 111.081 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 12.4 Cg_endo -57.37 136.11 74.14 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.915 2.41 . . . . 63.229999999999997 111.187 172.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.671 ' HD2' ' HG3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -92.61 -59.96 1.94 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.82 -0.352 . . . . 74.349999999999994 111.512 -172.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.4 p -156.92 145.12 19.49 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.12 -0.232 . . . . 75.230000000000004 110.981 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.627 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 35.7 t80 66.43 115.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 124.177 0.923 . . . . 75.230000000000004 111.09 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.543 ' HG2' ' HB3' ' A' ' 116' ' ' ASN . 1.9 mpt? -51.71 -56.27 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.312 -0.858 . . . . 73.209999999999994 111.94 -174.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.627 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 47.9 t30 -55.26 -49.71 71.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.246 -0.434 . . . . 72.150000000000006 111.136 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 mm-40 -59.52 -49.9 76.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 63.25 111.127 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.488 ' O ' HG21 ' A' ' 76' ' ' VAL . 50.7 m -60.48 -40.78 92.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.322 -0.399 . . . . 75.239999999999995 111.142 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.53 -43.33 97.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.902 -0.665 . . . . 61.039999999999999 112.048 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 70' ' ' ASN . 34.5 mtp-105 -69.82 -32.95 71.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.752 0.31 . . . . 74.340000000000003 110.521 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 81.2 mm-40 -65.15 -28.28 69.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.919 -0.582 . . . . 74.129999999999995 111.858 -177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 72' ' ' SER . 55.6 t -65.66 -31.12 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 72.510000000000005 110.847 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.31 -69.62 1.21 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.962 -0.563 . . . . 75.319999999999993 112.993 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.91 -36.32 95.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.916 2.411 . . . . 73.349999999999994 112.77 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.52 -39.01 89.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 110.262 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.21 90.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 60.009999999999998 111.258 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -18.99 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.399 -0.364 . . . . 74.439999999999998 111.101 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.43 -37.32 80.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.357 -0.383 . . . . 71.400000000000006 110.548 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -101.53 4.17 40.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 74.420000000000002 111.321 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 m 63.44 31.93 14.71 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.888 -0.596 . . . . 71.530000000000001 111.546 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.876 HG13 ' HB2' ' A' ' 4' ' ' PRO . 16.7 m -81.78 143.35 50.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.383 . . . . 72.420000000000002 110.584 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 7.9 Cg_exo -73.64 137.85 25.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.679 2.253 . . . . 53.439999999999998 111.498 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.99 -10.76 24.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.812 2.342 . . . . 75.420000000000002 113.121 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.11 -26.96 18.04 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.034 -0.266 . . . . 74.200000000000003 110.486 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -95.09 62.68 2.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.258 0.551 . . . . 74.140000000000001 110.422 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.663 HD12 HD22 ' A' ' 6' ' ' LEU . 8.1 tt -140.41 117.34 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 72.099999999999994 110.57 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.17 114.38 35.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 74.239999999999995 110.182 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.558 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 48.4 t -96.99 108.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 72.120000000000005 110.824 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.512 HD12 ' HB ' ' A' ' 133' ' ' VAL . 44.0 mm -89.62 119.32 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.778 -0.646 . . . . 74.420000000000002 109.699 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -138.47 165.22 27.39 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.411 -0.516 . . . . 72.319999999999993 111.183 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.75 142.33 29.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 72.519999999999996 109.358 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.847 ' HG2' HG12 ' A' ' 99' ' ' ILE . 18.4 tp10 -127.34 123.23 35.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.838 0.351 . . . . 71.239999999999995 111.357 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.9 mt -84.21 -14.76 49.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 72.120000000000005 111.254 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.88 -31.99 17.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 71.140000000000001 111.646 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.847 HG12 ' HG2' ' A' ' 96' ' ' GLU . 29.0 mm -85.52 146.21 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 74.109999999999999 111.408 -173.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.414 ' HB2' ' CG ' ' A' ' 103' ' ' ARG . 14.2 m-20 -64.31 153.28 38.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.631 -0.713 . . . . 72.430000000000007 111.04 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.1 111.29 4.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.131 -0.692 . . . . 75.310000000000002 109.131 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.815 ' HA2' HD11 ' A' ' 165' ' ' ILE . . . 101.65 6.08 50.45 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.483 -0.865 . . . . 43.409999999999997 112.104 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 27.1 mmt180 -103.33 141.83 35.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.756 0.313 . . . . 74.530000000000001 110.778 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 mt -107.93 136.86 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.682 -0.859 . . . . 75.519999999999996 108.682 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.54 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -144.04 162.27 36.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 72.099999999999994 110.562 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.81 133.06 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.868 0.366 . . . . 73.040000000000006 110.359 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 57.1 tptt -106.52 105.06 14.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 75.120000000000005 109.869 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.828 ' H ' HD21 ' A' ' 108' ' ' LEU . 1.2 pt? -78.59 -133.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.979 -0.555 . . . . 70.109999999999999 110.672 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.7 132.78 11.32 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.538 -0.839 . . . . 74.099999999999994 111.117 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 150.01 5.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.961 -1.114 . . . . 65.349999999999994 113.083 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.0 -153.34 29.44 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.176 -0.769 . . . . 55.299999999999997 111.176 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 78.85 -61.21 0.36 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.497 0.719 . . . . 75.049999999999997 111.92 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.25 115.82 5.01 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.116 -0.564 . . . . 74.140000000000001 112.068 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.09 -114.31 0.58 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.03 -0.828 . . . . 74.019999999999996 111.03 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -174.89 -82.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.495 0.188 . . . . 72.409999999999997 111.182 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.543 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 14.6 m120 -130.78 -70.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.531 0.567 . . . . 75.219999999999999 112.531 -172.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.3 -17.8 80.12 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 121.063 -0.589 . . . . 55.439999999999998 112.055 -167.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.11 -30.62 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.981 -0.61 . . . . 65.409999999999997 110.649 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -79.82 -29.15 40.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 74.310000000000002 111.12 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.9 m -75.31 -47.03 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 75.140000000000001 111.687 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.89 -21.98 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.53 -0.305 . . . . 73.319999999999993 111.585 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.82 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 53.100000000000001 111.599 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -70.6 -39.81 73.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.269 -0.423 . . . . 72.219999999999999 111.675 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.48 58.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 53.5 111.339 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.41 -41.83 62.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.319 -0.401 . . . . 72.200000000000003 110.996 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.96 2.42 52.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.878 -0.677 . . . . 73.329999999999998 112.039 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 m -131.19 121.02 24.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.792 0.33 . . . . 74.430000000000007 110.396 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.588 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -99.25 -64.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.714 -0.847 . . . . 75.310000000000002 108.714 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.7 t30 31.74 61.55 0.29 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.861 1.265 . . . . 73.030000000000001 114.099 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.755 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 84.2 m-85 70.57 -23.45 0.17 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.893 1.442 . . . . 74.209999999999994 114.893 166.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -79.98 53.64 1.73 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.607 0.966 . . . . 73.540000000000006 113.607 -169.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.558 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 1.3 mpp_? -137.35 111.26 8.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.8 -0.445 . . . . 75.129999999999995 109.8 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 93' ' ' ILE . 57.6 t -85.24 131.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.081 0.467 . . . . 74.239999999999995 110.583 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 105' ' ' ARG . 49.0 mtp180 -106.18 117.28 33.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.679 -0.691 . . . . 75.129999999999995 110.027 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.58 118.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.938 -0.764 . . . . 64.230000000000004 108.938 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.31 12.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.668 . . . . 45.509999999999998 113.451 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.424 HG13 HD13 ' A' ' 24' ' ' LEU . 35.6 m -94.11 2.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 65.150000000000006 110.669 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.13 179.84 17.15 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.044 -0.598 . . . . 74.140000000000001 112.007 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.433 ' H ' ' HG3' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -70.69 149.95 95.33 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.469 0.135 . . . . 74.5 110.921 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 47.2 Cg_exo -37.74 128.55 0.82 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.253 3.302 . . . . 75.040000000000006 113.935 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.9 Cg_exo -73.69 135.07 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.477 2.784 . . . . 73.0 112.625 -177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -112.68 162.23 12.44 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.063 -0.815 . . . . 71.530000000000001 111.063 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 143' ' ' ARG . 2.0 tpm_? 71.63 -75.21 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.132 0.573 . . . . 63.32 110.132 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.486 ' HD2' ' HD1' ' A' ' 149' ' ' PHE . 6.8 ptpp? -78.82 144.44 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.075 -0.342 . . . . 74.299999999999997 110.075 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.33 139.93 94.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.108 -0.497 . . . . 73.010000000000005 110.246 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.0 -28.89 19.99 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.254 2.636 . . . . 74.129999999999995 113.437 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -68.42 -36.19 78.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.377 . . . . 73.319999999999993 110.802 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.57 -25.64 30.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.466 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' HD1' ' HD2' ' A' ' 144' ' ' LYS . 90.3 t80 -62.28 -38.08 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.679 -0.692 . . . . 72.099999999999994 110.987 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.612 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.5 m -84.94 -0.61 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.395 . . . . 73.109999999999999 111.369 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 147' ' ' ALA . 73.1 mt -98.42 12.47 34.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 72.230000000000004 111.22 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 11.1 pt-20 -129.24 177.06 7.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.489 -0.323 . . . . 70.219999999999999 110.414 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -77.74 177.97 7.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.931 -0.577 . . . . 64.010000000000005 111.377 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.498 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 68.1 m-85 -80.06 165.05 22.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 74.430000000000007 110.81 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.637 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -75.95 -153.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.84 0.311 . . . . 74.200000000000003 111.84 -175.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.39 -70.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.059 0.392 . . . . 74.219999999999999 112.059 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.33 -44.66 35.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 72.549999999999997 111.386 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.93 -21.6 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.907 -0.588 . . . . 72.340000000000003 111.246 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' A' ' 155' ' ' THR . 25.9 ttt180 -63.41 -24.1 67.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.025 0.44 . . . . 73.0 110.788 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.17 -19.54 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 111.032 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.86 -11.12 45.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 72.219999999999999 111.09 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 166' ' ' VAL . 47.9 t -60.98 -61.22 8.45 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.018 -0.537 . . . . 62.43 112.207 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.447 ' CD ' ' HB ' ' A' ' 162' ' ' VAL . 18.4 Cg_endo -59.05 -34.15 98.87 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.027 1.818 . . . . 74.409999999999997 112.601 -175.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.6 m -66.15 -39.3 89.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 75.109999999999999 111.763 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.815 HD11 ' HA2' ' A' ' 102' ' ' GLY . 43.6 pt -78.97 -30.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.762 -0.375 . . . . 73.040000000000006 110.848 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.1 t -62.68 -42.66 96.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.741 0.305 . . . . 64.329999999999998 110.64 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 46.6 mt-10 -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 74.319999999999993 110.834 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -73.5 -33.92 65.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 75.219999999999999 111.309 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.27 96.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 72.540000000000006 111.131 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.89 91.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 72.319999999999993 110.851 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.27 -35.74 76.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 65.439999999999998 111.422 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -62.21 -38.64 89.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.716 0.294 . . . . 71.239999999999995 110.759 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 54.8 m -60.48 -36.78 79.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 62.340000000000003 110.593 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.83 -33.95 57.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 64.409999999999997 110.576 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.29 -27.78 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 74.200000000000003 110.555 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.9 mt -63.13 -33.38 75.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.939 -0.573 . . . . 75.120000000000005 110.371 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.8 mm -80.47 -55.63 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 74.150000000000006 110.877 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.29 -54.67 37.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.689 -0.687 . . . . 74.530000000000001 112.1 -173.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' A' ' 183' ' ' PRO . 36.4 tt0 -93.33 -50.14 5.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.367 -0.379 . . . . 71.340000000000003 110.352 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.55 147.98 5.93 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.775 -0.726 . . . . 74.120000000000005 111.453 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.421 HD13 ' N ' ' A' ' 182' ' ' GLU . 4.2 pp -64.92 -27.28 68.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.895 0.348 . . . . 74.450000000000003 111.89 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.704 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 40.6 tt0 -76.95 -52.55 1.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.837 -0.165 . . . . 64.230000000000004 111.283 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.9 Cg_exo -65.17 -34.98 43.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.548 1.499 . . . . 73.25 112.56 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.463 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -73.52 -31.48 63.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.119 0.414 . . . . 75.299999999999997 112.119 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 12.2 pt20 -61.75 -21.25 64.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.874 -0.331 . . . . 72.239999999999995 110.825 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -55.06 -52.56 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.354 -0.61 . . . . 75.340000000000003 109.354 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -46.29 76.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 75.340000000000003 110.87 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 184' ' ' ALA . 10.7 t -67.58 -13.08 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 111.964 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -102.42 -22.67 14.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.344 0.498 . . . . 73.019999999999996 112.344 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.42 -25.88 6.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.704 0.631 . . . . 75.409999999999997 112.704 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.1 t90 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.233 -0.889 . . . . 73.540000000000006 110.374 -174.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 111.391 0.145 . . . . 73.409999999999997 111.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.26 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.583 0.552 . . . . 73.340000000000003 110.761 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.0 125.02 69.73 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.243 0.544 . . . . 73.219999999999999 110.95 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 Cg_endo -94.09 143.62 1.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.18 2.586 . . . . 75.140000000000001 112.587 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.24 120.69 39.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.418 -0.586 . . . . 73.420000000000002 109.418 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.496 ' HB2' HE22 ' A' ' 88' ' ' GLN . 46.9 tp -92.13 105.23 17.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.26 -0.427 . . . . 71.329999999999998 109.989 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.692 ' HB ' HD22 ' A' ' 62' ' ' LEU . 43.3 t -118.9 127.25 75.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 63.399999999999999 110.377 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.06 121.8 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.557 . . . . 70.030000000000001 110.115 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.98 122.04 6.53 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.317 -0.944 . . . . 62.030000000000001 111.65 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.3 tp -108.75 86.77 2.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.296 0.57 . . . . 74.340000000000003 110.243 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 147.42 18.61 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.344 -0.843 . . . . 74.540000000000006 111.416 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.855 HD22 ' HB3' ' A' ' 17' ' ' TYR . 1.1 p-10 -93.33 109.61 41.39 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.958 0.409 . . . . 73.329999999999998 110.893 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 2.0 Cg_endo -82.05 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.861 2.374 . . . . 74.349999999999994 112.731 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.67 -151.68 28.52 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.719 -0.753 . . . . 63.340000000000003 112.083 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.24 -49.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.94 2.427 . . . . 73.010000000000005 112.795 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -107.26 -26.24 11.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 74.230000000000004 111.923 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.855 ' HB3' HD22 ' A' ' 12' ' ' ASN . 88.4 m-85 -71.44 -17.41 62.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.902 0.704 . . . . 73.329999999999998 112.902 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.493 ' C ' ' HD2' ' A' ' 19' ' ' LYS . . . -71.44 -7.0 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.927 0.343 . . . . 72.409999999999997 111.927 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HD2' ' C ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -123.12 20.09 9.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.643 -0.253 . . . . 75.150000000000006 111.021 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.572 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 75.6 p -101.34 178.02 4.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.602 0.239 . . . . 71.010000000000005 111.532 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.736 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 67.5 mtt180 -59.21 -23.54 62.37 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.077 0.465 . . . . 72.420000000000002 110.709 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.705 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 1.7 t-80 -98.23 17.23 19.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 75.400000000000006 111.492 -173.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.61 3.13 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.117 0.484 . . . . 74.040000000000006 110.405 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -52.76 -35.27 56.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 64.329999999999998 112.303 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA2' HG21 ' A' ' 93' ' ' ILE . . . -63.63 -25.65 69.07 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.136 -0.554 . . . . 41.119999999999997 112.984 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -90.32 -29.89 17.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.633 0.254 . . . . 74.230000000000004 110.864 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.902 ' HA ' ' HE1' ' A' ' 27' ' ' MET . 7.2 mmt -54.74 -48.08 73.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.528 0.566 . . . . 73.400000000000006 112.528 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.813 ' HB ' HD13 ' A' ' 93' ' ' ILE . 44.7 t -62.03 -45.24 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.726 0.298 . . . . 72.450000000000003 111.139 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.07 89.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 74.329999999999998 111.112 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.24 -48.91 77.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 62.140000000000001 110.968 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.0 -38.56 83.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.225 -0.443 . . . . 64.439999999999998 111.031 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.0 mt -63.77 -47.1 82.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.602 -0.272 . . . . 55.310000000000002 110.922 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.94 85.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.969 0.414 . . . . 74.400000000000006 110.543 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.51 -39.73 86.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.719 -0.673 . . . . 72.329999999999998 113.601 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.906 ' HG3' HD12 ' A' ' 36' ' ' ILE . 15.2 ptp180 -68.79 -36.41 78.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.378 0.589 . . . . 64.319999999999993 111.825 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.906 HD12 ' HG3' ' A' ' 35' ' ' ARG . 3.0 mp -77.89 -36.69 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 74.439999999999998 109.623 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.9 48.15 3.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.896 -0.669 . . . . 74.200000000000003 111.976 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.31 162.33 17.66 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.786 0.327 . . . . 73.430000000000007 110.352 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.82 130.63 56.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 71.510000000000005 110.691 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.496 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 19.1 p90 -70.18 133.59 47.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 73.040000000000006 110.286 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.28 134.83 54.66 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.937 -0.574 . . . . 75.219999999999999 110.7 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.786 HG22 ' HG2' ' A' ' 49' ' ' GLU . 43.5 t -72.83 118.07 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 71.25 110.202 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.49 93.38 3.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.195 -1.039 . . . . 72.450000000000003 108.195 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.46 79.73 2.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.978 0.894 . . . . 74.540000000000006 110.2 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -169.25 -53.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.763 -1.562 . . . . 71.540000000000006 106.915 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -93.71 -28.55 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.944 -1.025 . . . . 63.109999999999999 110.241 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 29.59 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.945 -0.645 . . . . 61.350000000000001 112.153 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.14 146.22 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.319 -0.252 . . . . 53.340000000000003 110.319 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.786 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.1 mt-10 -98.85 138.75 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.304 -0.407 . . . . 74.439999999999998 110.397 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 137.96 51.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 74.219999999999999 110.468 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 62' ' ' LEU . 7.5 p -128.86 139.13 52.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.477 -0.329 . . . . 75.349999999999994 110.377 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.521 HG23 HG11 ' A' ' 61' ' ' VAL . 17.4 p -101.49 177.74 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.728 0.299 . . . . 72.25 111.449 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.53 40.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.161 -0.543 . . . . 72.450000000000003 111.966 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.77 ' H ' HG12 ' A' ' 36' ' ' ILE . 18.0 mmt180 -133.54 130.1 37.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.721 0.296 . . . . 74.329999999999998 110.737 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.026 HD23 ' HB ' ' A' ' 60' ' ' VAL . 2.4 pt? -130.84 115.76 17.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.323 -0.621 . . . . 74.510000000000005 109.323 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.72 23.51 13.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.816 -0.629 . . . . 75.230000000000004 111.264 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.71 -30.88 8.87 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.073 -0.584 . . . . 74.530000000000001 111.665 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 ' O ' HD22 ' A' ' 55' ' ' LEU . 75.0 m -70.49 142.96 51.84 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.795 0.438 . . . . 75.439999999999998 110.453 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.523 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 5.1 p -79.85 122.17 26.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.686 0.279 . . . . 74.349999999999994 110.73 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.026 ' HB ' HD23 ' A' ' 55' ' ' LEU . 12.1 p -97.37 138.5 22.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.113 -0.328 . . . . 72.230000000000004 110.113 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.521 HG11 HG23 ' A' ' 52' ' ' THR . 7.2 m -124.21 108.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.329 0.585 . . . . 73.219999999999999 110.193 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 7' ' ' VAL . 79.9 mt -95.22 119.55 33.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.562 -0.744 . . . . 75.319999999999993 110.333 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.74 147.74 39.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.484 . . . . 72.129999999999995 110.637 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 16.0 ptmt -132.85 143.27 47.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 72.209999999999994 110.31 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 17.8 Cg_exo -67.45 160.21 48.88 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.74 2.293 . . . . 74.219999999999999 111.683 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.481 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 39.6 ttt-85 -70.67 -63.17 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 73.420000000000002 110.173 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 47.8 m -165.89 147.73 7.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.776 -0.647 . . . . 74.340000000000003 110.102 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 t80 70.62 162.05 0.24 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.68 0.752 . . . . 75.340000000000003 112.269 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 69' ' ' MET . 1.9 mpt? -79.6 -16.08 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 73.040000000000006 111.365 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -73.62 -50.05 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.269 -0.423 . . . . 64.430000000000007 110.125 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 18.7 mt-10 -68.9 -41.06 78.76 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.978 0.362 . . . . 74.420000000000002 111.978 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 p -52.36 -44.43 65.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.94 0.348 . . . . 72.549999999999997 111.94 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -68.8 -25.46 75.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 63.520000000000003 112.545 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -94.21 -7.12 43.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.551 0.215 . . . . 75.239999999999995 111.338 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 19.4 mm-40 -102.33 -52.72 3.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.64 -0.254 . . . . 75.299999999999997 111.477 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.26 -40.52 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 75.310000000000002 111.601 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.653 ' HA2' HD23 ' A' ' 125' ' ' LEU . . . -55.83 -66.22 2.99 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.074 -0.512 . . . . 52.25 112.919 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.29 -39.05 93.06 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.741 2.294 . . . . 65.439999999999998 113.025 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.19 -45.91 83.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.753 0.279 . . . . 71.0 111.753 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -44.2 71.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.217 0.532 . . . . 73.439999999999998 111.162 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -86.25 -7.83 58.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.949 -0.568 . . . . 74.319999999999993 111.658 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -77.23 -53.99 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 74.040000000000006 110.163 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -89.07 5.25 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 73.129999999999995 110.397 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.6 m 60.32 84.13 0.13 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 63.130000000000003 113.241 171.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.49 142.26 27.29 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.852 -0.613 . . . . 75.25 109.498 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.77 172.14 16.86 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.51 2.14 . . . . 75.349999999999994 111.69 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 96.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.215 1.944 . . . . 73.099999999999994 111.463 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' A' ' 6' ' ' LEU . 12.8 pt20 -133.25 177.61 7.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.662 -0.699 . . . . 73.120000000000005 110.038 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -66.2 104.75 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 74.200000000000003 111.136 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.1 tt -93.65 112.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.788 -0.642 . . . . 74.519999999999996 109.696 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.1 t -100.17 111.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.664 -0.698 . . . . 73.129999999999995 110.855 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.515 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 57.9 t -99.38 116.54 42.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.496 -0.557 . . . . 73.030000000000001 109.496 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.813 HD13 ' HB ' ' A' ' 28' ' ' VAL . 35.3 mt -87.05 122.86 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 74.420000000000002 110.622 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.627 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 41.4 t-80 -151.68 170.89 18.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.813 0.34 . . . . 75.129999999999995 110.465 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.06 153.71 22.54 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.91 0.484 . . . . 73.349999999999994 111.108 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.924 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 9.1 tp10 -118.2 121.56 40.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.579 . . . . 70.340000000000003 110.907 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.5 mt -83.5 -21.17 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 74.120000000000005 110.877 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.65 -19.83 34.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 72.120000000000005 111.808 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.719 HG13 ' HB2' ' A' ' 105' ' ' ARG . 29.0 mm -107.64 139.52 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.532 -0.304 . . . . 72.019999999999996 111.443 -175.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.679 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 3.8 m-20 -55.78 152.17 10.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.501 -0.772 . . . . 74.319999999999993 111.405 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.4 t80 -67.55 109.2 3.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.649 -0.705 . . . . 75.120000000000005 110.421 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.746 ' HA2' HG22 ' A' ' 165' ' ' ILE . . . 137.46 -23.85 3.1 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.405 -0.902 . . . . 75.430000000000007 113.165 176.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -108.28 151.59 25.76 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.515 -0.403 . . . . 73.400000000000006 110.33 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.795 ' HB ' HG22 ' A' ' 188' ' ' VAL . 3.6 mp -105.29 136.87 37.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.156 0.503 . . . . 71.519999999999996 110.149 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.719 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.1 tpt180 -108.89 140.31 42.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.639 -0.71 . . . . 73.239999999999995 109.785 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' A' ' 185' ' ' GLN . 98.3 mt -122.66 121.08 35.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.431 -0.35 . . . . 73.340000000000003 110.238 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -116.65 138.89 51.11 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.926 -0.398 . . . . 74.040000000000006 109.926 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.9 mp -79.5 -71.4 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.75 -0.659 . . . . 74.239999999999995 110.379 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.33 -144.53 6.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.004 -0.544 . . . . 73.209999999999994 112.913 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.01 156.26 35.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.959 -0.638 . . . . 65.120000000000005 112.665 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.12 152.76 13.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.94 -0.647 . . . . 62.5 111.747 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -67.74 139.9 56.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.285 -0.265 . . . . 71.230000000000004 110.285 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 143.62 60.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.032 -0.604 . . . . 71.420000000000002 112.16 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.22 2.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.298 -0.953 . . . . 75.409999999999997 113.254 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.7 m80 55.75 -101.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.677 0.621 . . . . 73.340000000000003 112.677 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.02 -69.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.099 0.777 . . . . 74.140000000000001 113.099 -166.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -47.09 92.51 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.178 -0.534 . . . . 65.150000000000006 112.708 -165.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.0 -47.5 82.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.313 -0.443 . . . . 65.430000000000007 111.737 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -79.93 -22.16 43.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.944 0.35 . . . . 74.109999999999999 111.944 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.535 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 73.5 m -61.87 -52.43 64.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 72.329999999999998 110.486 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.39 -28.85 36.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.009 0.433 . . . . 73.209999999999994 110.722 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.95 74.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 65.230000000000004 111.004 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -84.55 -38.06 20.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.397 -0.365 . . . . 71.319999999999993 111.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.32 -52.9 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 74.409999999999997 111.032 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.653 HD23 ' HA2' ' A' ' 77' ' ' GLY . 95.9 mt -78.7 -32.36 46.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 73.530000000000001 110.361 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.05 -5.53 66.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.004 -0.617 . . . . 73.450000000000003 112.447 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.3 m -114.23 121.89 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.358 0.599 . . . . 64.540000000000006 111.7 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.2 -93.99 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.392 -1.336 . . . . 74.340000000000003 107.392 168.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.24 -8.2 0.2 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.151 1.537 . . . . 72.209999999999994 115.151 159.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 75.0 m-85 -119.27 -107.96 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.428 0.558 . . . . 65.409999999999997 111.865 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -146.97 118.33 7.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 72.430000000000007 111.321 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.515 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 11.9 mpt_? -106.33 123.95 48.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 73.510000000000005 109.642 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.405 ' HA ' HD21 ' A' ' 106' ' ' LEU . 94.1 t -83.57 117.32 29.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 110.479 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.924 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.7 mtt180 -120.01 117.88 29.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.75 -0.659 . . . . 72.450000000000003 110.642 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 135' ' ' ILE . 4.3 mp -91.09 117.61 34.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.631 -0.507 . . . . 74.230000000000004 109.631 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.37 130.53 41.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.206 -0.521 . . . . 70.439999999999998 113.156 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.83 -0.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.049 0.452 . . . . 71.209999999999994 111.074 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.679 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 111.8 -83.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.5 -0.857 . . . . 72.430000000000007 112.882 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -164.1 168.45 9.38 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.445 -0.206 . . . . 72.519999999999996 110.445 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.0 Cg_exo -59.38 135.56 65.99 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.243 1.962 . . . . 74.140000000000001 110.385 166.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.651 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 26.1 Cg_exo -61.76 -38.48 59.83 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.769 2.312 . . . . 73.219999999999999 112.603 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.1 -71.7 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.027 -0.606 . . . . 75.030000000000001 113.308 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 143' ' ' ARG . 13.7 ttp180 -78.88 -31.11 45.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 71.129999999999995 111.274 -175.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 8.0 ptmm? -116.36 152.8 33.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 74.230000000000004 109.836 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.84 134.18 95.97 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.446 -0.343 . . . . 73.409999999999997 111.194 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.651 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 81.2 Cg_exo -47.66 -44.4 26.2 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.63 2.887 . . . . 55.340000000000003 113.626 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.09 87.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.041 0.448 . . . . 65.400000000000006 110.729 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.46 -18.8 60.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.812 -0.631 . . . . 71.420000000000002 110.68 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.528 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 89.3 t80 -84.18 -34.82 23.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.156 -0.474 . . . . 73.519999999999996 111.048 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.705 ' HB ' ' HB2' ' A' ' 22' ' ' HIS . 34.1 m -84.66 -17.03 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.666 0.617 . . . . 61.43 112.666 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.18 -7.44 59.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.059 0.457 . . . . 74.319999999999993 111.473 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 4.1 pt-20 -111.06 172.84 6.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.985 -0.552 . . . . 73.310000000000002 109.555 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.736 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 33.1 p30 -142.27 -20.54 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.815 0.341 . . . . 74.420000000000002 111.349 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -62.63 114.06 3.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 74.420000000000002 111.245 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.41 179.85 7.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 74.010000000000005 108.757 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.07 -71.86 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 73.019999999999996 111.864 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.58 -43.65 7.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 73.420000000000002 111.582 -174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.532 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 1.6 pm0 -72.15 -19.83 61.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.463 -0.789 . . . . 73.519999999999996 112.229 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -69.75 -38.0 76.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 64.030000000000001 110.139 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.23 60.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 110.911 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.78 1.25 57.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 73.239999999999995 112.046 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 166' ' ' VAL . 89.1 t -57.01 -57.06 27.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.061 -0.256 . . . . 62.210000000000001 110.648 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.3 Cg_endo -60.23 -30.33 90.95 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.967 1.778 . . . . 74.439999999999998 112.055 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.1 m -67.0 -48.12 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 70.219999999999999 111.175 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.746 HG22 ' HA2' ' A' ' 102' ' ' GLY . 42.3 pt -74.24 -20.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.578 -0.283 . . . . 73.430000000000007 111.319 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 162' ' ' VAL . 70.0 t -62.8 -45.11 99.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.966 -0.383 . . . . 74.319999999999993 109.966 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -58.73 -46.93 86.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.09 -0.505 . . . . 74.310000000000002 110.037 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.65 -54.22 48.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.313 -0.858 . . . . 75.439999999999998 111.144 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.63 -40.91 89.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 71.299999999999997 111.566 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.695 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.37 -49.45 69.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 72.219999999999999 111.216 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.35 -31.41 60.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 73.209999999999994 111.907 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -59.74 -46.57 88.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.094 -0.335 . . . . 64.329999999999998 110.094 173.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.8 m -58.88 -40.21 83.73 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.257 -0.429 . . . . 73.329999999999998 110.903 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.688 ' HG3' ' HB2' ' A' ' 55' ' ' LEU . 33.5 tt0 -65.94 -42.95 89.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 64.510000000000005 110.028 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.15 -25.79 65.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 75.310000000000002 111.195 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 86.9 mt -62.03 -32.28 72.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.498 -0.319 . . . . 73.319999999999993 111.271 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.434 HG21 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -80.14 -25.39 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.17 0.509 . . . . 71.140000000000001 110.047 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -86.32 -47.34 9.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 74.200000000000003 111.59 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 184' ' ' ALA . 24.2 tp60 -86.04 -59.5 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.476 -0.329 . . . . 74.510000000000005 110.207 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.66 -75.0 0.89 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.032 0.773 . . . . 75.439999999999998 115.032 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.6 tp -42.47 -69.81 0.12 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.209 1.188 . . . . 70.530000000000001 114.209 -163.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.568 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 tt0 -139.91 -59.45 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.481 0.549 . . . . 64.329999999999998 112.481 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.568 ' HD2' ' H ' ' A' ' 182' ' ' GLU . 18.4 Cg_endo -59.12 -17.2 37.28 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.079 1.853 . . . . 71.109999999999999 112.853 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . . . -60.3 -58.79 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.474 -0.33 . . . . 71.239999999999995 111.243 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.521 ' O ' ' HD2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -77.15 -28.42 54.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.802 -0.359 . . . . 72.040000000000006 111.181 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 183' ' ' PRO . 24.5 t-20 -57.75 -39.56 77.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.875 0.369 . . . . 74.0 110.61 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 84.8 m -65.1 -57.43 8.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.817 -0.629 . . . . 70.140000000000001 112.368 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.795 HG22 ' HB ' ' A' ' 104' ' ' ILE . 2.0 p -64.13 -18.87 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 113.499 0.926 . . . . 74.049999999999997 113.499 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.521 ' HD2' ' O ' ' A' ' 185' ' ' GLN . 9.0 p80 -106.95 -6.93 17.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.152 -0.619 . . . . 70.200000000000003 111.723 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.42 4.29 3.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.431 0.53 . . . . 63.210000000000001 112.431 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.471 -0.776 . . . . 73.340000000000003 109.849 -179.149 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 2' ' ' ALA . 21.1 ptt? . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.575 0.226 . . . . 74.310000000000002 111.134 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -139.31 42.53 2.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.022 0.439 . . . . 73.150000000000006 110.672 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER -106.25 81.61 0.83 Allowed Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.685 -0.857 . . . . 74.349999999999994 108.685 171.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.783 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 62.0 Cg_endo -90.88 171.61 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.981 2.454 . . . . 72.019999999999996 113.277 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.736 ' HB2' HD11 ' A' ' 177' ' ' ILE . 49.2 tp -119.63 110.05 16.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.554 -0.748 . . . . 74.010000000000005 109.801 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.681 ' HA ' HG23 ' A' ' 61' ' ' VAL . 51.0 tp -92.53 107.95 19.61 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.874 -0.787 . . . . 73.140000000000001 108.874 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.667 ' HB ' HD22 ' A' ' 62' ' ' LEU . 49.4 t -100.83 116.72 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.795 -0.639 . . . . 74.340000000000003 110.731 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.71 114.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.465 -0.789 . . . . 73.310000000000002 109.302 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.41 122.26 7.29 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.211 -0.995 . . . . 73.120000000000005 111.985 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -79.01 91.38 4.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 74.329999999999998 109.689 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 23' ' ' ASN . . . -152.66 122.24 1.28 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.561 -0.828 . . . . 70.540000000000006 112.376 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 12.8 m120 -112.34 98.05 41.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.792 -0.818 . . . . 71.549999999999997 108.792 172.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 6.7 Cg_exo -73.75 58.65 4.03 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.581 2.854 . . . . 73.319999999999993 112.997 -172.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.08 175.0 39.7 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.521 -0.632 . . . . 73.319999999999993 111.521 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.26 -57.61 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.62 2.88 . . . . 71.299999999999997 113.515 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -107.38 7.35 29.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.537 0.684 . . . . 74.140000000000001 110.431 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HA ' ' OG1' ' A' ' 20' ' ' THR . 97.9 m-85 -94.13 -15.61 24.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 72.219999999999999 111.959 -172.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.81 -34.46 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.721 0.638 . . . . 63.43 112.721 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.6 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -115.76 14.95 16.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.135 0.493 . . . . 73.239999999999995 111.459 -176.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.578 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.7 p -109.37 -172.97 2.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.279 -0.418 . . . . 73.109999999999999 110.273 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 64.7 mtt85 -68.04 1.44 2.74 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.208 0.447 . . . . 73.319999999999993 112.208 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.53 -5.26 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.332 -0.23 . . . . 75.129999999999995 111.117 -176.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.795 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 t30 -143.23 9.37 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.315 0.579 . . . . 72.109999999999999 111.247 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 20' ' ' THR . 51.1 mt -68.57 -28.06 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.92 -0.488 . . . . 72.409999999999997 111.784 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.85 -21.85 71.61 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.45 -0.881 . . . . 74.209999999999994 112.188 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 81.0 t80 -80.38 -21.75 42.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.558 0.218 . . . . 74.219999999999999 111.108 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.88 ' HA ' ' HE1' ' A' ' 27' ' ' MET . 11.0 mmt -51.13 -51.51 52.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.351 -0.386 . . . . 72.200000000000003 111.682 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.596 HG13 ' HA ' ' A' ' 170' ' ' ALA . 57.4 t -61.17 -43.5 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 72.439999999999998 111.044 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.28 -40.68 97.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.0 -0.546 . . . . 50.299999999999997 110.858 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.29 -41.2 98.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 74.430000000000007 110.61 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 27' ' ' MET . 66.5 t -62.97 -34.46 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.653 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.3 mt -64.34 -33.87 76.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.367 -0.378 . . . . 74.129999999999995 110.672 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -39.07 46.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.336 -0.393 . . . . 75.019999999999996 110.474 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.39 -40.12 96.2 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.629 . . . . 65.430000000000007 113.039 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' LEU . 11.0 ptm180 -66.24 -21.78 66.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.842 0.353 . . . . 75.150000000000006 110.812 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.16 -48.89 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.458 . . . . 73.409999999999997 110.317 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.24 38.12 2.53 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.96 -0.638 . . . . 64.219999999999999 112.161 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 m -126.12 146.09 50.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.303 . . . . 74.510000000000005 110.58 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.34 142.86 33.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 73.0 111.018 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.796 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 16.8 p90 -74.4 147.0 42.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 72.129999999999995 110.757 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.711 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -128.7 145.21 51.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.034 -0.358 . . . . 73.219999999999999 110.034 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.848 HG22 ' HG3' ' A' ' 49' ' ' GLU . 32.7 t -76.52 134.33 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.277 -0.42 . . . . 75.530000000000001 111.398 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -94.99 125.55 39.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.427 -0.583 . . . . 75.150000000000006 109.427 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.32 -36.55 84.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.379 . . . . 64.120000000000005 110.889 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -83.38 4.14 28.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 72.420000000000002 110.924 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m -125.59 -29.02 3.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.812 0.339 . . . . 70.540000000000006 111.308 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.37 29.23 73.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.961 -0.638 . . . . 72.200000000000003 111.812 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.52 37.19 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.614 0.245 . . . . 73.319999999999993 110.587 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.848 ' HG3' HG22 ' A' ' 42' ' ' VAL . 4.5 mp0 -85.68 131.22 34.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.54 . . . . 73.219999999999999 110.795 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.25 149.46 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 74.030000000000001 109.429 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.796 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.4 p -144.42 138.81 23.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 74.140000000000001 110.544 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.689 HG23 HG13 ' A' ' 61' ' ' VAL . 41.5 p -107.61 136.97 46.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 62.149999999999999 110.896 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.6 -166.02 13.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.929 -0.653 . . . . 74.420000000000002 111.914 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -131.21 105.82 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.486 -0.191 . . . . 73.530000000000001 110.486 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.112 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.2 pt? -96.68 115.91 28.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.835 -0.802 . . . . 73.540000000000006 108.835 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.58 -49.43 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.619 -0.719 . . . . 60.130000000000003 111.474 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.16 -33.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.261 -0.736 . . . . 73.239999999999995 111.261 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.8 148.06 50.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.968 -0.616 . . . . 63.509999999999998 111.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 m -70.83 114.8 9.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.992 -0.373 . . . . 74.239999999999995 109.992 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.112 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.5 p -97.02 127.14 49.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.568 -0.531 . . . . 73.340000000000003 109.568 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.689 HG13 HG23 ' A' ' 52' ' ' THR . 2.8 m -116.51 109.13 26.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.375 0.607 . . . . 73.420000000000002 110.27 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 7' ' ' VAL . 50.7 mt -96.14 120.52 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.376 -0.829 . . . . 75.430000000000007 110.022 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.85 129.85 51.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.364 -0.38 . . . . 64.310000000000002 110.659 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 8.2 ptmm? -115.91 121.45 34.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.281 -0.418 . . . . 74.409999999999997 110.541 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 27.3 Cg_exo -62.0 156.72 47.8 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.715 2.276 . . . . 73.140000000000001 111.362 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.585 ' HG3' ' N ' ' A' ' 67' ' ' CYS . 9.1 ptt180 -77.49 -55.9 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.442 -0.503 . . . . 73.25 110.345 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.585 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 21.1 p -167.5 173.63 8.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.748 -0.206 . . . . 73.519999999999996 110.469 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 t80 67.62 162.77 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.96 0.788 . . . . 75.430000000000007 112.188 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -21.15 25.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.861 -0.609 . . . . 73.150000000000006 112.272 -175.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -94.86 -38.64 10.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.724 0.297 . . . . 74.219999999999999 111.263 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.76 -26.45 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 72.319999999999993 111.121 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -45.0 95.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 72.349999999999994 110.478 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.09 -33.86 84.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.877 -0.678 . . . . 64.519999999999996 111.722 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -74.26 -8.42 56.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 74.430000000000007 111.244 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' A' ' 65' ' ' PRO . 82.8 mt-30 -103.96 -49.87 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 75.129999999999995 111.534 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.02 -29.95 42.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.814 0.302 . . . . 72.409999999999997 111.814 -176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.29 7.08 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.143 -0.551 . . . . 74.219999999999999 112.67 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.38 -37.69 94.49 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.908 2.406 . . . . 73.239999999999995 113.032 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 64.8 mt -58.08 -39.15 77.82 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.924 0.342 . . . . 74.400000000000006 111.924 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.85 -41.97 88.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 72.120000000000005 110.874 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -23.8 27.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.173 -0.467 . . . . 74.040000000000006 111.207 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -60.87 -46.65 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.212 0.529 . . . . 75.040000000000006 109.854 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.12 -14.99 48.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.713 -0.676 . . . . 74.0 110.281 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 60.67 47.71 7.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.606 0.717 . . . . 74.040000000000006 110.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.783 ' HB ' ' HG3' ' A' ' 4' ' ' PRO . 27.4 m -102.13 137.23 19.41 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.327 -0.852 . . . . 72.219999999999999 110.215 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.62 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 23.4 Cg_exo -64.58 137.7 55.88 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.623 2.216 . . . . 74.219999999999999 111.713 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -87.11 53.11 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.991 2.46 . . . . 74.239999999999995 113.574 -172.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.62 ' OE1' ' HB2' ' A' ' 86' ' ' PRO . 10.7 mp0 -59.28 -57.1 14.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 73.420000000000002 110.68 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.539 HE22 HD13 ' A' ' 5' ' ' LEU . 9.7 pt20 -144.03 102.45 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.541 0.686 . . . . 74.25 112.394 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.598 HD13 HD11 ' A' ' 125' ' ' LEU . 5.8 tt -98.18 115.58 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.36 -0.836 . . . . 72.319999999999993 109.129 170.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.44 117.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.947 -0.57 . . . . 75.319999999999993 110.801 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.556 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 44.7 t -97.24 103.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 72.430000000000007 109.23 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.422 HG23 ' HB ' ' A' ' 28' ' ' VAL . 58.0 mt -86.12 119.24 34.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.947 -0.57 . . . . 72.540000000000006 109.84 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.437 ' CE1' HD21 ' A' ' 118' ' ' LEU . 28.3 p80 -151.67 170.65 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.89 -0.596 . . . . 75.239999999999995 110.522 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.63 150.23 24.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.319 -0.623 . . . . 72.230000000000004 109.319 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.671 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 7.8 tp10 -124.99 119.81 29.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.94 0.4 . . . . 74.340000000000003 110.045 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.489 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 92.7 mt -82.39 -0.51 46.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 73.439999999999998 110.06 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 27.9 t70 -83.05 -11.01 58.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.358 -0.837 . . . . 71.010000000000005 110.459 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' A' ' 105' ' ' ARG . 12.4 tt -132.06 148.9 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.945 0.403 . . . . 74.519999999999996 111.347 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.37 145.57 21.89 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.354 -0.839 . . . . 74.409999999999997 112.43 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -62.15 126.42 27.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 72.400000000000006 110.374 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' N ' ' HD1' ' A' ' 101' ' ' PHE . . . 117.78 -19.29 11.33 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 75.349999999999994 113.404 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.452 HH12 ' CD ' ' A' ' 161' ' ' GLU . 59.3 mmt-85 -120.63 147.67 44.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.447 0.623 . . . . 73.439999999999998 111.069 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.2 mp -104.27 132.59 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.191 -0.459 . . . . 74.400000000000006 110.425 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.685 ' HB2' HD12 ' A' ' 99' ' ' ILE . 16.2 tpt180 -116.57 126.18 52.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 73.319999999999993 109.683 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.599 HD11 HG23 ' A' ' 188' ' ' VAL . 40.2 mt -97.48 111.29 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.266 0.555 . . . . 74.099999999999994 110.159 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' HB3' ' NE ' ' A' ' 134' ' ' ARG . 57.1 tptt -102.25 141.07 35.67 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.752 -1.203 . . . . 72.510000000000005 107.752 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.821 ' H ' HD22 ' A' ' 108' ' ' LEU . 1.1 pt? -75.55 -124.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.735 0.272 . . . . 73.430000000000007 111.735 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.909 ' HA3' ' HG3' ' A' ' 128' ' ' LYS . . . -82.01 142.03 22.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.431 -0.89 . . . . 62.039999999999999 112.584 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 153.4 5.86 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.716 -0.754 . . . . 75.329999999999998 112.321 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.53 77.06 0.32 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.672 -0.971 . . . . 72.329999999999998 110.672 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.99 144.1 22.04 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.382 -0.599 . . . . 72.420000000000002 109.382 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.0 -165.54 34.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.597 -0.811 . . . . 64.349999999999994 111.9 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.79 18.44 25.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.71 -0.757 . . . . 71.019999999999996 113.157 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -139.54 122.67 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.278 -0.542 . . . . 73.030000000000001 111.035 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.91 -52.5 60.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.984 -1.007 . . . . 60.210000000000001 112.107 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.35 -30.89 65.26 Favored Glycine 0 N--CA 1.46 0.29 0 CA-C-N 116.329 -0.396 . . . . 73.209999999999994 112.968 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.437 HD21 ' CE1' ' A' ' 94' ' ' HIS . 14.3 tp -60.52 -32.46 71.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.441 0.638 . . . . 74.019999999999996 110.673 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -79.23 -34.52 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 74.319999999999993 110.213 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.9 m -73.16 -44.39 60.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 63.329999999999998 111.406 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.03 -34.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 120.801 0.334 . . . . 73.299999999999997 111.14 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.46 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.978 0.418 . . . . 73.420000000000002 110.57 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 m -71.51 -23.59 61.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 62.509999999999998 110.884 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.4 -34.01 54.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 61.530000000000001 110.507 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.598 HD11 HD13 ' A' ' 90' ' ' ILE . 88.0 mt -80.59 -42.82 21.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.914 -0.584 . . . . 72.209999999999994 110.653 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.44 89.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.024 -0.608 . . . . 75.310000000000002 112.365 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.1 p -112.37 163.09 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 75.25 111.185 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.909 ' HG3' ' HA3' ' A' ' 109' ' ' GLY . 12.5 tppt? -83.47 -56.86 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.869 -0.605 . . . . 74.120000000000005 110.755 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.94 81.92 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.741 0.65 . . . . 71.299999999999997 110.964 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.762 ' HD1' HD11 ' A' ' 108' ' ' LEU . 67.7 m-85 -71.07 68.17 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.258 1.207 . . . . 74.409999999999997 114.258 -168.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 37.8 p-80 163.57 115.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.908 0.883 . . . . 74.019999999999996 111.843 162.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 92' ' ' VAL . 5.0 mpt_? -128.93 147.24 50.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 74.420000000000002 110.216 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.414 ' HB ' HG12 ' A' ' 93' ' ' ILE . 88.1 t -86.31 127.81 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.847 0.356 . . . . 64.400000000000006 111.032 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.671 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.0 mtt180 -131.37 109.75 10.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 71.209999999999994 110.563 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 54.4 mt -88.99 125.87 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 110.279 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.533 ' CA ' HG23 ' A' ' 99' ' ' ILE . . . -72.5 114.98 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.67 -0.776 . . . . 74.299999999999997 111.965 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 24' ' ' LEU . 22.8 t -119.81 10.43 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.764 0.792 . . . . 63.450000000000003 110.27 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 97' ' ' LEU . . . 138.19 172.22 12.47 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.214 -0.993 . . . . 62.409999999999997 112.97 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -101.48 162.31 20.88 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.784 -0.45 . . . . 75.439999999999998 109.784 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 36.1 Cg_exo -60.72 133.01 45.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.672 2.248 . . . . 64.219999999999999 112.243 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.606 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 55.2 Cg_endo -70.56 127.31 13.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.71 2.273 . . . . 73.109999999999999 112.156 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.08 43.11 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.886 -0.673 . . . . 74.120000000000005 112.555 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -163.35 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.007 0.432 . . . . 74.310000000000002 110.219 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -89.38 159.57 17.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.622 . . . . 75.430000000000007 110.82 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.8 140.98 97.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 71.439999999999998 110.994 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.13 -38.68 60.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.225 2.616 . . . . 72.120000000000005 113.082 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.412 ' HA ' HG22 ' A' ' 150' ' ' VAL . . . -70.19 -30.36 67.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.194 0.521 . . . . 62.219999999999999 110.655 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 151' ' ' LEU . . . -76.72 -18.52 58.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.65 -0.705 . . . . 74.150000000000006 110.226 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.606 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 59.7 t80 -84.54 -31.64 24.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 75.319999999999993 110.829 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 34.6 m -85.18 -6.02 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 72.409999999999997 112.245 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 4.4 pp -87.39 -8.35 56.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 74.129999999999995 110.182 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.64 171.11 8.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.228 -0.896 . . . . 74.219999999999999 109.669 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -170.7 87.44 0.12 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.9 0.381 . . . . 55.130000000000003 110.932 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -154.97 135.99 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.325 -0.398 . . . . 74.140000000000001 110.447 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -160.88 -164.84 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 71.120000000000005 108.243 175.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.404 ' H ' HG21 ' A' ' 155' ' ' THR . . . -96.42 -73.41 0.6 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.773 0.657 . . . . 62.210000000000001 112.773 -175.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.49 -43.2 8.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.261 0.553 . . . . 64.299999999999997 111.118 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -68.96 -21.6 64.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.493 -0.776 . . . . 72.409999999999997 110.515 -178.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -83.6 -15.26 49.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.622 -0.717 . . . . 73.549999999999997 110.361 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.46 -42.63 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 73.409999999999997 111.778 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.452 ' CD ' HH12 ' A' ' 103' ' ' ARG . 15.4 pt-20 -83.43 11.04 7.46 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.923 0.342 . . . . 64.400000000000006 111.923 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.624 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 87.0 t -54.03 -53.35 59.37 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.388 -0.369 . . . . 75.129999999999995 111.962 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 71.3 Cg_exo -52.03 -38.35 69.62 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.03 1.82 . . . . 72.340000000000003 112.511 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.0 m -68.6 -46.26 69.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 75.25 111.405 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.01 -24.83 24.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 121.098 -0.241 . . . . 70.439999999999998 111.452 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 162' ' ' VAL . 90.3 t -64.15 -43.74 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 73.239999999999995 110.047 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.82 -36.71 81.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 75.299999999999997 110.559 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.08 -51.54 53.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 72.219999999999999 110.657 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 73.340000000000003 111.535 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.52 -57.02 14.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 71.439999999999998 111.279 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.95 -26.7 62.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.485 -0.325 . . . . 74.209999999999994 111.181 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.505 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.87 -38.6 86.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.34 . . . . 74.5 110.539 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 m -66.96 -34.74 78.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.235 -0.439 . . . . 74.099999999999994 110.765 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.488 ' HA ' HD11 ' A' ' 55' ' ' LEU . 44.1 tt0 -71.91 -34.93 69.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.532 . . . . 74.510000000000005 109.853 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.29 -26.64 68.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 74.420000000000002 110.772 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 91.7 mt -64.74 -21.7 66.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 72.239999999999995 110.955 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.736 HD11 ' HB2' ' A' ' 5' ' ' LEU . 28.0 mm -80.75 -50.71 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 74.450000000000003 110.74 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.86 -38.83 61.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.801 -0.636 . . . . 63.049999999999997 112.403 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -99.02 -56.64 2.37 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.924 -0.311 . . . . 72.340000000000003 111.536 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 141.77 -124.99 2.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.44 -0.886 . . . . 62.409999999999997 112.117 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.83 -46.97 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.032 0.382 . . . . 71.340000000000003 112.032 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.817 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 30.2 tt0 -73.44 -61.33 1.44 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.095 0.406 . . . . 72.230000000000004 112.095 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.817 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 17.7 Cg_exo -67.18 -14.9 44.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.741 1.628 . . . . 75.140000000000001 111.884 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.57 14.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 60.450000000000003 111.144 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.553 ' HA ' HD13 ' A' ' 106' ' ' LEU . 10.0 pt20 -65.25 -27.94 69.01 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 121.112 -0.235 . . . . 73.439999999999998 110.876 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.501 ' HA ' ' NE2' ' A' ' 189' ' ' HIS . 65.7 t30 -59.53 -45.53 91.48 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.389 -0.369 . . . . 75.129999999999995 110.31 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.2 m -63.69 -38.26 90.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 75.329999999999998 110.882 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.599 HG23 HD11 ' A' ' 106' ' ' LEU . 59.2 t -61.71 -44.48 98.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 111.533 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.501 ' NE2' ' HA ' ' A' ' 186' ' ' ASN . 33.5 p80 -89.53 12.86 15.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.512 -0.475 . . . . 74.400000000000006 111.238 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.36 4.13 38.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.53 -0.305 . . . . 64.129999999999995 110.785 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 12.8 m0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.063 -0.97 . . . . 74.310000000000002 111.027 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.66 0.267 . . . . 70.349999999999994 110.574 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.99 146.02 40.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 73.430000000000007 110.543 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -97.11 139.7 21.65 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 64.140000000000001 109.725 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.23 89.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.778 1.652 . . . . 71.239999999999995 110.64 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.97 118.15 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.669 -0.696 . . . . 71.129999999999995 111.475 -172.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HA ' HG22 ' A' ' 61' ' ' VAL . 34.0 tp -91.86 105.13 17.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.743 -0.662 . . . . 72.010000000000005 109.542 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.642 ' HB ' HD21 ' A' ' 62' ' ' LEU . 40.5 t -114.89 112.9 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.199 0.523 . . . . 74.200000000000003 110.422 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.78 114.77 45.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.541 -0.754 . . . . 73.209999999999994 110.005 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.42 120.76 6.09 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.337 -1.105 . . . . 73.420000000000002 110.337 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.4 tp -94.66 81.4 3.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 72.430000000000007 110.477 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.49 107.36 0.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.636 -1.165 . . . . 60.310000000000002 110.75 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -87.49 144.38 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.859 0.361 . . . . 71.120000000000005 110.777 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.66 81.74 1.01 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.813 2.342 . . . . 75.510000000000005 111.685 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.515 ' H ' ' HB2' ' A' ' 18' ' ' ALA . . . -90.64 163.88 30.01 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.893 -0.67 . . . . 72.239999999999995 111.878 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.65 -14.85 33.63 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.715 2.277 . . . . 74.430000000000007 112.717 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -141.39 -45.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.2 0.445 . . . . 75.400000000000006 112.2 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' HA ' HG23 ' A' ' 20' ' ' THR . 54.4 p90 -76.25 -2.61 32.27 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.312 0.486 . . . . 75.329999999999998 112.312 -173.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB2' ' H ' ' A' ' 14' ' ' GLY . . . -88.85 -3.31 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 74.200000000000003 110.851 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.95 19.61 10.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.496 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 17' ' ' TYR . 12.8 t -138.35 -169.11 2.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 71.439999999999998 110.104 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.48 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 70.8 mtt180 -48.12 -26.49 1.89 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.198 0.814 . . . . 75.209999999999994 113.198 -174.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -81.94 12.41 4.12 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.224 -0.298 . . . . 72.510000000000005 111.785 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' MET . 27.4 p-10 -95.8 -5.04 42.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.236 . . . . 75.239999999999995 110.745 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 96.1 mt -52.73 -38.09 60.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.791 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -62.56 -30.06 75.45 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.131 -0.556 . . . . 75.230000000000004 112.657 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -91.5 -32.89 15.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.963 -0.139 . . . . 75.010000000000005 111.346 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.418 ' HE3' HG21 ' A' ' 166' ' ' VAL . 76.3 mtp -54.58 -40.15 68.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.145 0.794 . . . . 74.25 113.145 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.837 ' HB ' HD11 ' A' ' 93' ' ' ILE . 45.5 t -63.62 -46.3 95.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 71.109999999999999 110.41 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.08 79.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 74.120000000000005 110.324 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.87 -49.0 72.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.442 -0.799 . . . . 52.299999999999997 110.564 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.66 -43.38 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.836 -0.62 . . . . 72.239999999999995 110.934 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.7 mt -59.44 -40.79 87.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 111.221 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.63 64.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 70.299999999999997 110.976 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.11 -33.39 40.78 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.99 -0.624 . . . . 43.32 113.311 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.635 ' HG3' HD12 ' A' ' 36' ' ' ILE . 14.7 ptm180 -69.78 -25.97 64.06 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.256 0.528 . . . . 72.349999999999994 111.196 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 ' HG3' ' A' ' 35' ' ' ARG . 2.0 mp -88.31 -42.21 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.542 . . . . 72.340000000000003 109.686 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.51 58.53 2.27 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.81 -0.709 . . . . 73.230000000000004 112.219 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.8 m -134.7 145.69 48.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.666 0.27 . . . . 74.099999999999994 110.562 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.52 150.82 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 65.200000000000003 110.513 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 1.1 p90 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.834 -0.621 . . . . 70.239999999999995 111.086 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -113.85 134.14 54.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 73.109999999999999 110.188 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 49' ' ' GLU . 43.6 t -74.68 129.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 74.420000000000002 111.685 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.96 149.64 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 74.239999999999995 110.378 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -70.64 -72.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.146 -0.479 . . . . 73.519999999999996 111.419 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -68.16 -27.38 66.37 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 111.374 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -83.51 -28.2 28.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.474 -0.33 . . . . 65.450000000000003 111.024 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.25 11.83 53.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.093 -0.575 . . . . 75.5 112.452 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 64' ' ' LYS . . . -120.25 151.34 39.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.67 0.271 . . . . 74.140000000000001 110.947 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 45.7 mp0 -78.92 138.8 38.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.859 -0.61 . . . . 74.040000000000006 111.602 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.36 136.81 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 75.099999999999994 109.404 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 9.4 p -121.99 144.69 30.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.734 0.302 . . . . 75.129999999999995 110.442 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.792 HG22 HG11 ' A' ' 61' ' ' VAL . 7.2 p -118.14 144.52 45.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.335 -0.393 . . . . 73.219999999999999 111.319 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.53 -174.87 38.26 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.028 -0.606 . . . . 62.32 111.87 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 -109.92 126.05 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.808 -0.231 . . . . 74.530000000000001 110.524 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.124 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -105.48 108.8 20.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.838 -0.801 . . . . 72.209999999999994 108.838 174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.91 -51.93 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.618 -0.719 . . . . 72.450000000000003 111.526 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.37 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.008 -0.837 . . . . 73.209999999999994 111.008 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.474 ' O ' HD21 ' A' ' 55' ' ' LEU . 27.1 m -78.07 153.12 32.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.403 -0.399 . . . . 75.430000000000007 110.385 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.6 m -80.8 129.13 34.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.953 -0.388 . . . . 71.409999999999997 109.953 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.124 ' HB ' HD22 ' A' ' 55' ' ' LEU . 13.9 p -118.0 135.56 58.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.926 0.393 . . . . 63.509999999999998 110.508 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.792 HG11 HG22 ' A' ' 52' ' ' THR . 17.4 m -116.14 112.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.251 0.548 . . . . 74.329999999999998 109.965 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.642 HD21 ' HB ' ' A' ' 7' ' ' VAL . 84.3 mt -98.08 113.12 24.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 73.310000000000002 110.206 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.141 -0.481 . . . . 63.450000000000003 110.72 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 3.1 ptmm? -123.81 119.3 26.89 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.182 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.45 160.9 40.55 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.703 2.268 . . . . 74.239999999999995 112.894 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 7.83 10.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.628 -0.715 . . . . 74.349999999999994 110.141 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.6 t -146.32 -179.36 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 61.420000000000002 109.613 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.7 170.72 11.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.077 0.465 . . . . 74.420000000000002 111.626 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.99 -23.41 66.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.352 -0.84 . . . . 72.400000000000006 111.455 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.05 -43.39 63.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.142 0.496 . . . . 73.230000000000004 110.21 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -75.67 -56.89 4.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.659 -0.7 . . . . 72.239999999999995 110.228 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 m -47.33 -44.62 23.87 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.745 0.653 . . . . 74.109999999999999 112.662 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.75 94.1 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.902 -0.666 . . . . 71.030000000000001 113.053 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.37 3.07 40.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.79 0.293 . . . . 74.200000000000003 111.79 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.47 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 12.7 mm-40 -91.9 -43.78 9.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.571 -0.286 . . . . 75.030000000000001 111.274 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.43 -39.96 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.368 -0.378 . . . . 71.519999999999996 111.629 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.24 -63.51 5.21 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 116.176 -0.465 . . . . 60.149999999999999 112.965 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.01 -26.02 47.58 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.131 2.554 . . . . 61.350000000000001 113.164 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 28.8 mt -72.82 -40.44 65.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.529 0.204 . . . . 73.299999999999997 111.428 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.89 -39.24 88.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.422 0.63 . . . . 63.020000000000003 109.877 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -9.34 57.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.629 -0.714 . . . . 74.310000000000002 111.388 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -66.37 -43.98 84.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 72.549999999999997 109.204 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.81 3.81 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 72.140000000000001 109.707 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.7 p 45.41 54.47 7.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.923 -1.035 . . . . 74.340000000000003 112.553 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 80' ' ' ALA . 26.8 m -81.98 150.45 65.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 73.430000000000007 110.73 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 161.33 46.39 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.673 2.249 . . . . 74.109999999999999 111.72 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -48.1 111.85 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.269 2.646 . . . . 72.310000000000002 112.175 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -128.14 -173.97 3.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 71.150000000000006 111.44 -172.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -91.24 95.45 10.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 74.140000000000001 110.988 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 tt -76.02 110.85 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.462 0.648 . . . . 64.430000000000007 110.446 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 132.63 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 72.400000000000006 110.693 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 121' ' ' VAL . 67.5 t -129.35 129.44 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.676 -0.49 . . . . 63.049999999999997 109.676 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.837 HD11 ' HB ' ' A' ' 28' ' ' VAL . 36.4 mt -106.17 126.59 61.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.46 . . . . 64.219999999999999 110.111 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.425 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 67.3 t60 -159.03 174.22 15.26 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.589 -0.445 . . . . 75.340000000000003 111.825 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 2.1 p30 -83.7 152.69 24.6 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.436 -0.802 . . . . 72.010000000000005 111.332 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG3' ' H ' ' A' ' 98' ' ' ASP . 9.0 tp10 -145.37 136.67 24.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 65.310000000000002 110.767 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -83.89 -15.39 48.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.931 -0.577 . . . . 75.010000000000005 111.549 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.491 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.5 t70 -75.76 -22.61 56.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 75.319999999999993 112.267 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.67 HG13 ' HB2' ' A' ' 105' ' ' ARG . 46.6 mm -113.83 144.42 21.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.865 0.364 . . . . 74.319999999999993 111.876 -172.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 146.39 17.6 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.12 -0.945 . . . . 63.229999999999997 110.479 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.641 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 63.0 t80 -66.99 108.52 2.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 110.272 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 -16.27 6.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.617 -0.801 . . . . 64.439999999999998 112.668 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -107.41 151.24 25.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.796 -0.446 . . . . 74.5 109.796 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.68 135.77 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.811 0.339 . . . . 75.200000000000003 110.776 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.67 ' HB2' HG13 ' A' ' 99' ' ' ILE . 8.6 tpp180 -108.89 125.92 52.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.477 -0.564 . . . . 74.430000000000007 109.477 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.474 HD13 HG23 ' A' ' 188' ' ' VAL . 67.8 mt -97.67 134.0 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.908 0.385 . . . . 74.040000000000006 110.183 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.702 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -120.83 119.81 33.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.804 -0.634 . . . . 74.310000000000002 110.239 -177.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.723 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.5 pt? -103.5 -138.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.758 -0.46 . . . . 73.219999999999999 109.758 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 36.04 -145.82 0.07 OUTLIER Glycine 0 C--N 1.344 0.976 0 O-C-N 123.678 0.612 . . . . 73.409999999999997 113.411 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.86 127.99 8.35 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.486 -1.045 . . . . 73.319999999999993 110.486 162.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.04 107.93 3.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 71.230000000000004 113.756 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.91 101.51 12.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 73.239999999999995 110.108 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.88 -161.47 29.59 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.332 -1.107 . . . . 64.030000000000001 110.332 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.502 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . 64.47 15.62 59.56 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.823 -0.703 . . . . 75.25 112.157 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 m80 72.91 -76.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.442 0.697 . . . . 71.420000000000002 111.742 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -134.69 -59.48 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.381 0.511 . . . . 73.310000000000002 112.381 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -57.11 -30.2 60.49 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.581 -0.343 . . . . 60.009999999999998 113.5 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.502 HD13 ' HA3' ' A' ' 114' ' ' GLY . 0.9 OUTLIER -63.87 -41.13 97.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.174 0.512 . . . . 73.430000000000007 110.101 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -76.73 -37.86 55.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.198 -0.91 . . . . 73.109999999999999 110.614 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.5 m -61.95 -49.37 76.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 74.109999999999999 111.327 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.726 HG21 HG22 ' A' ' 92' ' ' VAL . 27.3 m -72.64 -21.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 75.109999999999999 111.412 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.24 -59.74 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 111.057 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.4 m -63.27 -40.65 97.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 63.020000000000003 111.697 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.95 68.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 55.25 111.669 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.4 tp -85.02 -27.94 26.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 75.409999999999997 110.258 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.23 22.98 75.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.77 . . . . 63.030000000000001 112.249 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.8 m -124.91 121.49 34.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 74.219999999999999 110.369 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 44.9 mtmt -115.65 -173.6 2.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.047 -0.723 . . . . 74.120000000000005 109.047 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 t30 63.03 79.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.147 0.975 . . . . 74.319999999999993 109.629 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.414 ' CE2' ' HA ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -145.88 -155.51 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.443 -1.253 . . . . 73.140000000000001 109.122 -176.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -149.0 110.04 4.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 75.329999999999998 110.409 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.49 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 2.3 mpt_? -104.55 146.85 28.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.774 -0.648 . . . . 71.239999999999995 109.88 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.18 102.44 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.986 -0.552 . . . . 74.340000000000003 110.292 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -96.64 97.26 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.786 -0.643 . . . . 75.219999999999999 109.386 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.08 128.53 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.86 -0.422 . . . . 74.120000000000005 109.86 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -64.11 123.31 27.75 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.627 -0.797 . . . . 73.5 111.816 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.437 ' HA ' ' HD1' ' A' ' 101' ' ' PHE . 9.8 p -96.84 0.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.216 0.532 . . . . 64.540000000000006 110.571 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 135.82 -87.32 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.5 -0.857 . . . . 54.140000000000001 112.84 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 2.0 ptp180 -172.57 165.36 3.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 122.169 0.188 . . . . 75.519999999999996 110.536 -175.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 139' ' ' ARG . 27.9 Cg_endo -64.67 120.2 7.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.344 2.03 . . . . 74.519999999999996 111.198 171.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.15 167.09 20.12 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.727 2.285 . . . . 73.109999999999999 112.904 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.87 -59.13 0.17 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.702 -0.761 . . . . 55.109999999999999 112.59 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -79.6 -29.49 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.764 0.283 . . . . 71.329999999999998 111.764 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.92 134.22 51.15 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.588 -0.445 . . . . 74.450000000000003 110.402 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.5 141.55 78.42 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.389 -0.823 . . . . 75.049999999999997 110.427 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.95 -38.05 12.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.759 2.973 . . . . 75.120000000000005 113.984 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -25.83 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.943 0.402 . . . . 72.400000000000006 110.95 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.96 -21.89 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.481 . . . . 73.310000000000002 110.2 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -72.73 -38.34 67.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.801 -0.636 . . . . 62.329999999999998 110.367 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.437 HG11 HG22 ' A' ' 137' ' ' VAL . 34.2 m -82.9 2.12 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.266 -0.425 . . . . 74.340000000000003 110.486 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.95 -24.14 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.551 . . . . 75.239999999999995 110.713 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -93.07 97.88 10.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.239 0.543 . . . . 61.439999999999998 110.92 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 20' ' ' THR . 32.9 p-10 -104.5 -7.43 19.79 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.009 -0.432 . . . . 65.310000000000002 110.897 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.1 52.87 2.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.222 -0.445 . . . . 73.140000000000001 110.092 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -75.16 -173.59 2.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.703 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.462 ' H ' HG23 ' A' ' 155' ' ' THR . . . -75.67 -71.32 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.807 0.336 . . . . 74.409999999999997 111.48 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.96 -37.49 11.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.355 0.597 . . . . 73.099999999999994 110.459 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.569 ' HB3' ' CD2' ' A' ' 101' ' ' PHE . 3.6 mp0 -58.9 -34.6 71.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.962 -1.017 . . . . 72.129999999999995 111.712 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -65.93 -26.48 67.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.083 0.468 . . . . 74.450000000000003 111.123 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.89 -15.39 36.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.367 -0.379 . . . . 75.239999999999995 111.641 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -116.1 15.49 16.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.768 0.285 . . . . 75.409999999999997 111.768 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.699 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 57.9 t -56.33 -56.05 35.7 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.253 0.464 . . . . 72.219999999999999 112.253 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -66.49 -31.38 42.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.738 1.625 . . . . 72.430000000000007 112.074 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.1 m -63.97 -45.56 88.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 74.319999999999993 111.794 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.3 pt -68.75 -32.05 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 75.230000000000004 111.156 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.418 HG21 ' HE3' ' A' ' 27' ' ' MET . 57.5 t -72.58 -37.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.34 -0.391 . . . . 74.5 110.43 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.48 -51.29 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 74.239999999999995 110.887 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.04 -36.36 77.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 71.430000000000007 111.068 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.46 97.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 75.430000000000007 111.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.58 95.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 110.952 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.25 -39.8 89.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 70.239999999999995 110.615 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.484 ' HB1' HG22 ' A' ' 188' ' ' VAL . . . -63.3 -35.76 81.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 110.73 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 60.8 m -65.85 -38.5 89.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 72.420000000000002 110.543 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -65.04 -39.03 92.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 75.219999999999999 110.045 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.65 -33.8 75.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.897 -0.592 . . . . 72.510000000000005 110.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.471 HD23 ' HB2' ' A' ' 184' ' ' ALA . 96.1 mt -61.41 -34.43 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 75.230000000000004 110.817 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 mm -80.7 -40.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 73.010000000000005 111.108 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.13 -43.87 64.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.333 0.494 . . . . 53.130000000000003 112.333 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -100.25 -49.86 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.946 0.403 . . . . 75.150000000000006 110.87 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 143.71 -168.63 26.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.503 -0.639 . . . . 52.340000000000003 111.503 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 182' ' ' GLU . 4.3 pp -104.13 -24.02 13.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.769 0.285 . . . . 75.329999999999998 110.83 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.706 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 34.4 tt0 -67.11 -57.23 11.43 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 111.845 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 83.4 Cg_endo -87.47 -29.63 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.833 1.688 . . . . 73.239999999999995 113.093 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.506 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -73.93 -31.43 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.508 -0.314 . . . . 75.010000000000005 111.823 -172.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -61.81 -29.57 70.25 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.123 0.487 . . . . 75.0 110.023 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.61 -48.38 64.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.635 -0.711 . . . . 64.200000000000003 109.846 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 36.0 m -56.26 -38.46 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.631 -0.713 . . . . 61.119999999999997 111.446 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 184' ' ' ALA . 82.7 t -57.24 -37.41 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.186 0.439 . . . . 71.510000000000005 112.186 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -104.14 -28.24 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.311 -0.555 . . . . 74.409999999999997 111.996 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -94.36 12.3 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.128 0.418 . . . . 60.119999999999997 112.128 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.466 ' HB2' ' O ' ' A' ' 187' ' ' THR . 3.8 t90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.479 -0.772 . . . . 75.129999999999995 110.17 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.115 -0.698 . . . . 75.329999999999998 109.115 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.04 60.96 6.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.848 0.356 . . . . 63.030000000000001 110.233 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -86.29 142.81 35.93 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.452 -0.34 . . . . 75.319999999999993 110.219 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.58 141.91 17.9 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.172 2.581 . . . . 71.430000000000007 113.577 -173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 55' ' ' LEU . 97.0 mt -86.14 126.75 34.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.259 -0.882 . . . . 74.049999999999997 109.577 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.632 HD21 HG21 ' A' ' 85' ' ' VAL . 37.1 tp -93.28 114.77 27.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.303 . . . . 75.140000000000001 110.499 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.647 ' HB ' HD23 ' A' ' 62' ' ' LEU . 41.2 t -120.69 121.69 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.34 -0.391 . . . . 73.129999999999995 110.12 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 60.2 t -104.02 116.19 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 73.530000000000001 110.56 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.96 122.92 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.963 -0.562 . . . . 75.010000000000005 111.703 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.684 ' HG ' ' HE2' ' A' ' 22' ' ' HIS . 58.3 tp -107.74 105.07 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.931 0.396 . . . . 75.510000000000005 111.12 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -97.3 -142.94 13.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 61.420000000000002 112.098 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.757 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . 15.9 m120 -134.58 129.37 19.46 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.619 0.21 . . . . 75.340000000000003 111.155 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -96.8 173.17 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.37 2.713 . . . . 74.150000000000006 111.716 170.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.78 -176.35 19.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.408 -0.901 . . . . 74.140000000000001 112.389 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 -67.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.054 2.502 . . . . 74.409999999999997 112.859 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -127.52 11.15 6.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 72.140000000000001 111.301 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -65.55 -18.47 65.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.796 0.331 . . . . 70.219999999999999 111.102 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.757 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -75.71 -1.4 24.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 65.319999999999993 111.386 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 153' ' ' ASN . 68.3 mmtt -107.16 26.75 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 75.540000000000006 109.878 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 151' ' ' LEU . 71.2 p -102.19 172.72 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.448 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -66.0 -19.38 65.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.294 . . . . 74.530000000000001 111.249 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.684 ' HE2' ' HG ' ' A' ' 10' ' ' LEU . 82.6 t60 -76.34 -9.08 58.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 70.129999999999995 110.986 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -8.08 12.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.715 0.293 . . . . 75.349999999999994 111.466 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 HD13 HG21 ' A' ' 135' ' ' ILE . 94.9 mt -63.42 -31.81 73.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.375 -0.375 . . . . 74.549999999999997 110.513 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.514 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -63.83 -26.64 70.21 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.948 -0.569 . . . . 75.340000000000003 112.142 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.608 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 74.3 t80 -90.74 -36.38 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.789 0.328 . . . . 65.319999999999993 110.517 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 mmt -57.36 -42.33 81.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.547 0.573 . . . . 75.420000000000002 112.547 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 93' ' ' ILE . 48.2 t -61.74 -38.83 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 70.430000000000007 110.5 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.96 -38.64 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 71.530000000000001 110.851 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -57.36 -46.57 83.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 72.540000000000006 111.334 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.03 -45.56 95.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 71.129999999999995 110.745 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 36' ' ' ILE . 94.5 mt -61.6 -44.51 96.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.349999999999994 110.903 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.65 -35.5 72.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 71.230000000000004 111.167 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.53 -42.17 93.74 Favored Glycine 0 N--CA 1.454 -0.163 0 C-N-CA 121.288 -0.482 . . . . 61.520000000000003 112.916 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.27 -21.05 64.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.623 0.249 . . . . 74.540000000000006 111.015 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.881 HD11 ' HA3' ' A' ' 53' ' ' GLY . 70.5 mt -83.58 -45.71 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.177 0.513 . . . . 74.230000000000004 109.936 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.46 23.12 10.52 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 72.400000000000006 112.17 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -118.35 158.18 25.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.796 0.331 . . . . 64.239999999999995 110.757 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.77 146.56 43.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.726 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.593 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 38.9 p90 -80.79 151.03 28.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 71.219999999999999 110.682 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.55 164.14 32.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.855 0.359 . . . . 74.409999999999997 110.935 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 49' ' ' GLU . 46.6 t -75.2 126.1 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.694 -0.685 . . . . 75.409999999999997 112.063 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -76.45 127.13 32.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 64.349999999999994 109.125 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 38.6 ttmt -67.45 -5.93 17.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 72.540000000000006 111.964 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -80.34 -76.96 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.817 0.341 . . . . 74.340000000000003 111.402 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -90.13 -16.88 28.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.391 -0.368 . . . . 74.109999999999999 111.906 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 5.87 69.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.445 -0.883 . . . . 72.030000000000001 111.714 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.94 143.56 28.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.285 -0.265 . . . . 53.240000000000002 110.285 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HG2' HG21 ' A' ' 42' ' ' VAL . 37.3 mt-10 -94.67 132.87 38.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 74.329999999999998 110.477 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 t -136.29 142.51 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.296 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.6 p -125.26 136.75 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.905 0.384 . . . . 75.129999999999995 110.641 175.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.439 HG21 HG12 ' A' ' 61' ' ' VAL . 2.0 p -97.58 149.79 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.901 -0.59 . . . . 74.219999999999999 111.094 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.881 ' HA3' HD11 ' A' ' 36' ' ' ILE . . . -179.07 -164.89 32.49 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.434 -0.889 . . . . 74.209999999999994 112.722 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -122.35 143.04 49.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.058 -0.349 . . . . 74.439999999999998 110.058 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.114 HD21 ' HB ' ' A' ' 60' ' ' VAL . 2.6 pt? -127.84 109.04 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 75.319999999999993 109.361 174.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.05 -45.82 0.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 65.319999999999993 111.65 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.28 -27.93 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 110.72 -0.952 . . . . 74.519999999999996 110.72 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 59' ' ' SER . 2.0 m -71.79 169.38 15.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.974 -0.613 . . . . 73.400000000000006 110.436 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.47 ' H ' HG22 ' A' ' 58' ' ' THR . 14.7 m -97.35 130.56 44.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.468 -0.567 . . . . 74.049999999999997 109.468 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.114 ' HB ' HD21 ' A' ' 55' ' ' LEU . 15.0 p -120.05 137.98 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 74.310000000000002 110.688 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 52' ' ' THR . 11.9 m -122.8 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.339 0.59 . . . . 72.409999999999997 109.847 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD23 ' HB ' ' A' ' 7' ' ' VAL . 77.9 mt -92.39 110.57 21.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.686 -0.688 . . . . 75.349999999999994 110.028 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -109.64 132.23 54.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.855 -0.612 . . . . 65.540000000000006 110.674 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -120.88 127.92 26.01 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 74.430000000000007 110.369 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.591 ' HG2' HD11 ' A' ' 10' ' ' LEU . 48.4 Cg_endo -70.34 168.05 23.41 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.345 2.03 . . . . 75.049999999999997 111.262 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -89.05 -60.54 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.837 -0.345 . . . . 75.329999999999998 110.726 -176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.1 p -167.11 172.38 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 64.319999999999993 110.541 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.444 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 10.1 t80 71.2 118.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.073 0.858 . . . . 73.109999999999999 111.336 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' A' ' 69' ' ' MET . 1.9 mpt? -53.29 -56.24 18.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.589 -0.732 . . . . 62.25 111.624 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 12.5 m120 -56.62 -46.57 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 74.409999999999997 111.114 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 5.6 mm-40 -64.18 -43.99 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 73.150000000000006 111.192 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 m -57.84 -39.01 76.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 73.150000000000006 110.908 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.678 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -64.61 -34.96 91.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.519 -0.848 . . . . 74.510000000000005 111.898 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 70' ' ' ASN . 44.8 mtp180 -86.98 -2.7 58.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 74.010000000000005 110.486 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 27.5 mm-40 -79.43 -32.74 42.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 73.010000000000005 110.225 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.98 -32.18 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.681 -0.69 . . . . 72.409999999999997 110.751 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -47.17 -68.28 1.21 Allowed Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.626 -0.715 . . . . 63.439999999999998 113.871 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 -41.06 42.02 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.308 2.006 . . . . 75.239999999999995 112.844 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.57 -31.6 72.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.453 -0.339 . . . . 74.200000000000003 111.842 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.95 84.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 54.509999999999998 111.156 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -26.75 29.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.422 -0.354 . . . . 75.439999999999998 110.853 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.32 -46.04 83.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 74.510000000000005 110.376 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.58 -3.88 45.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 75.099999999999994 110.649 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m 60.71 34.69 19.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.678 -0.692 . . . . 73.400000000000006 111.313 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.632 HG21 HD21 ' A' ' 6' ' ' LEU . 26.9 m -81.25 145.97 57.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.687 -0.688 . . . . 70.239999999999995 111.063 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 2.7 Cg_exo -76.49 131.06 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.95 2.434 . . . . 71.540000000000006 111.916 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.43 47.0 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.782 2.988 . . . . 74.120000000000005 113.306 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -139.88 -37.67 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 73.129999999999995 109.926 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -84.59 -6.82 59.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 75.140000000000001 111.353 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.98 130.0 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.378 0.609 . . . . 72.349999999999994 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.427 ' HB ' HG12 ' A' ' 7' ' ' VAL . 45.8 t -106.16 127.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.766 . . . . 71.319999999999993 110.111 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.674 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 40.0 t -114.7 110.18 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.072 -0.344 . . . . 75.209999999999994 110.072 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 28' ' ' VAL . 39.5 mt -87.9 116.88 30.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.502 -0.317 . . . . 74.200000000000003 110.657 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -142.6 161.03 39.12 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.557 0.343 . . . . 65.430000000000007 110.197 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HB2' HG22 ' A' ' 137' ' ' VAL . 10.8 p-10 -91.65 148.27 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.509 -0.314 . . . . 61.340000000000003 110.517 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.414 ' CD ' HH22 ' A' ' 134' ' ' ARG . 73.8 tt0 -124.96 128.23 48.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.222 0.534 . . . . 74.439999999999998 111.197 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.637 HD13 ' HD3' ' A' ' 141' ' ' PRO . 47.1 tp -81.95 -13.9 56.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.666 -0.697 . . . . 65.310000000000002 111.72 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.59 5.21 51.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.259 0.552 . . . . 73.340000000000003 111.433 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.75 146.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.323 -0.399 . . . . 72.230000000000004 110.559 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.15 154.29 23.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.061 -0.518 . . . . 75.409999999999997 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.511 ' N ' ' HA2' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -67.68 109.76 3.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 71.430000000000007 110.071 -176.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 114.87 -8.5 21.56 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 54.030000000000001 112.623 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -98.83 132.55 44.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.882 -0.414 . . . . 75.400000000000006 109.882 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.621 ' HB ' HG13 ' A' ' 188' ' ' VAL . 3.1 mp -101.04 129.54 51.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.236 -0.438 . . . . 65.140000000000001 110.061 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -108.79 127.79 54.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.017 -0.538 . . . . 75.329999999999998 110.449 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 131' ' ' HIS . 48.1 tp -97.66 132.29 43.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.376 -0.601 . . . . 75.340000000000003 109.376 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -155.07 122.11 5.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.288 -0.415 . . . . 74.540000000000006 110.109 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.654 ' H ' HD21 ' A' ' 108' ' ' LEU . 1.4 pt? -102.3 -136.16 0.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.679 -0.408 . . . . 72.099999999999994 109.955 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.607 ' N ' ' HA ' ' A' ' 129' ' ' ASN . . . 40.3 -149.12 0.17 Allowed Glycine 0 C--N 1.334 0.472 0 O-C-N 123.625 0.578 . . . . 71.0 113.11 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.24 10.56 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.068 -1.213 . . . . 72.230000000000004 110.068 164.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.12 156.46 28.03 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.942 -1.123 . . . . 63.5 112.914 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -93.57 -178.63 4.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.792 0.33 . . . . 74.439999999999998 110.138 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' HA3' ' NH2' ' A' ' 134' ' ' ARG . . . 115.14 62.53 0.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.796 -0.716 . . . . 74.420000000000002 111.601 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.08 -102.34 0.18 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.801 -0.714 . . . . 75.310000000000002 111.593 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -154.22 168.38 26.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.254 -0.647 . . . . 74.099999999999994 109.254 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -41.86 -53.46 3.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.774 0.671 . . . . 73.319999999999993 111.617 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.497 ' HA2' ' OG ' ' A' ' 120' ' ' SER . . . -67.04 2.33 5.15 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.022 -0.535 . . . . 72.420000000000002 114.205 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.401 HD21 ' HG2' ' A' ' 132' ' ' ARG . 1.4 tt -83.83 -43.91 14.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.395 0.617 . . . . 74.420000000000002 109.366 173.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -79.68 -21.07 45.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.173 -0.921 . . . . 72.030000000000001 111.274 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.497 ' OG ' ' HA2' ' A' ' 117' ' ' GLY . 10.0 m -55.53 -43.8 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 65.120000000000005 111.726 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.678 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -68.11 -30.79 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.838 0.352 . . . . 73.409999999999997 111.343 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.403 ' HB2' ' HG3' ' A' ' 128' ' ' LYS . . . -78.16 -30.2 49.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 70.140000000000001 111.036 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.4 m -84.07 -39.71 19.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.093 -0.503 . . . . 61.130000000000003 110.967 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.51 77.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 73.519999999999996 111.861 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.643 HD21 ' HZ ' ' A' ' 130' ' ' PHE . 29.3 tp -85.45 -31.12 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.48 . . . . 73.230000000000004 109.806 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.33 -12.58 66.49 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.551 -0.75 . . . . 75.340000000000003 112.555 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.8 m -106.89 137.45 44.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.783 0.325 . . . . 73.109999999999999 110.858 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 8.0 mptt -110.58 -161.81 0.77 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.506 -0.553 . . . . 74.430000000000007 109.506 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.607 ' HA ' ' N ' ' A' ' 109' ' ' GLY . 86.3 m-20 76.6 12.97 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.199 0.6 . . . . 64.230000000000004 111.329 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.643 ' HZ ' HD21 ' A' ' 125' ' ' LEU . 16.7 m-30 -71.59 136.77 47.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.374 -0.602 . . . . 75.420000000000002 109.374 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.464 ' HB2' HD12 ' A' ' 106' ' ' LEU . 4.3 p-80 -89.88 107.77 19.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.303 0.573 . . . . 74.430000000000007 110.352 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.674 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 5.5 mpt_? -94.32 141.28 28.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.631 . . . . 75.409999999999997 110.614 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.3 t -92.9 104.18 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.555 -0.905 . . . . 73.209999999999994 108.555 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 94' ' ' HIS . 9.1 mtp180 -106.45 114.75 29.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.659 . . . . 74.140000000000001 110.529 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 135' ' ' ILE . 4.1 mp -96.71 125.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.862 -0.422 . . . . 75.409999999999997 109.862 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -61.27 132.16 48.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.134 -0.555 . . . . 71.099999999999994 112.832 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 95' ' ' ASP . 23.9 t -86.44 -9.27 11.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.327 0.584 . . . . 74.510000000000005 111.035 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 117.37 -87.31 0.43 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.127 -1.035 . . . . 74.329999999999998 113.53 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -132.18 135.45 26.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.491 0.186 . . . . 75.319999999999993 111.229 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 29.2 Cg_endo -65.28 123.13 11.06 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.455 2.103 . . . . 73.310000000000002 111.113 171.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.948 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 14.3 Cg_exo -69.45 143.47 52.45 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.183 2.589 . . . . 75.239999999999995 112.58 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.66 -50.1 0.14 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.666 -0.778 . . . . 52.130000000000003 112.494 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -83.16 -32.67 26.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 74.340000000000003 111.405 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.541 ' HD3' ' HD1' ' A' ' 149' ' ' PHE . 4.7 ptmm? -114.81 158.84 21.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.868 -0.419 . . . . 72.329999999999998 109.868 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -52.87 131.91 48.37 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 123.549 0.531 . . . . 72.239999999999995 111.824 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.948 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 53.7 Cg_exo -53.3 -41.04 75.59 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.473 2.782 . . . . 75.349999999999994 113.45 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.37 39.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 74.010000000000005 110.423 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.34 -28.14 69.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 73.530000000000001 111.123 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.541 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 71.0 t80 -73.45 -23.17 60.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 71.019999999999996 110.528 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.41 -24.2 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.493 0.663 . . . . 70.329999999999998 109.924 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.482 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 9.3 mp -87.16 12.1 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.674 -0.694 . . . . 75.510000000000005 112.043 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 149' ' ' PHE . 10.5 pt-20 -110.35 136.66 49.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.54 . . . . 63.130000000000003 111.083 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.605 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 28.9 p-10 -104.52 34.03 3.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.715 -0.675 . . . . 74.549999999999997 110.584 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.24 140.57 49.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.032 -0.531 . . . . 74.120000000000005 111.134 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.573 ' HB ' ' OE1' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -169.58 -177.71 2.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.312 -0.996 . . . . 75.420000000000002 108.312 173.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.3 -71.14 0.68 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.69 -0.404 . . . . 74.420000000000002 111.956 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.57 -42.58 8.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 74.230000000000004 111.294 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.573 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 0.6 OUTLIER -72.26 -17.42 61.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.689 -0.687 . . . . 75.329999999999998 111.175 -174.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.433 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 11.8 tpp180 -70.02 -25.56 63.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 74.430000000000007 110.149 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.53 -13.7 42.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 73.25 111.146 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -85.04 -16.83 39.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.248 -0.433 . . . . 64.319999999999993 111.098 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.765 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 47.3 t -52.23 -58.67 10.63 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 65.109999999999999 112.218 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.765 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.0 Cg_exo -59.68 -34.14 96.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.992 1.794 . . . . 61.310000000000002 112.5 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 m -71.97 -46.27 57.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.941 -0.572 . . . . 72.230000000000004 111.744 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.442 ' CD1' ' HA2' ' A' ' 102' ' ' GLY . 43.0 pt -69.2 -32.41 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 73.150000000000006 112.003 -174.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 162' ' ' VAL . 87.1 t -58.08 -42.3 82.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 64.319999999999993 111.32 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.8 -46.63 68.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.383 -0.371 . . . . 73.409999999999997 111.481 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -24.34 60.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.624 -0.262 . . . . 74.530000000000001 111.25 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.17 85.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 55.109999999999999 110.559 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.48 94.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.556 . . . . 74.010000000000005 110.377 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.01 -43.73 98.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.67 -0.696 . . . . 73.439999999999998 110.969 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.13 95.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.356 . . . . 72.5 110.944 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.408 ' HA ' HD11 ' A' ' 176' ' ' LEU . 90.8 m -61.65 -41.59 97.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 72.040000000000006 111.05 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 55' ' ' LEU . 19.4 tt0 -71.56 -31.31 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.37 . . . . 74.150000000000006 110.372 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.43 -26.93 67.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.385 . . . . 73.340000000000003 110.418 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' A' ' 173' ' ' THR . 90.8 mt -61.81 -46.47 89.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 74.0 110.911 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.565 HG13 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -81.03 -32.88 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.017 0.437 . . . . 75.430000000000007 110.386 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.13 66.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.374 -0.376 . . . . 72.010000000000005 111.699 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 179' ' ' GLN . 6.1 tp60 -117.44 -61.49 1.69 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.657 -0.247 . . . . 74.319999999999993 111.004 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.29 177.12 35.05 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.233 -0.984 . . . . 55.310000000000002 112.101 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.621 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 3.9 pp -75.76 -20.51 58.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.492 0.187 . . . . 74.549999999999997 111.397 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.62 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 54.1 mt-10 -60.87 -61.64 7.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.65 0.611 . . . . 72.319999999999993 112.65 -172.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 71.5 Cg_endo -78.23 -31.12 3.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.592 1.528 . . . . 74.219999999999999 112.51 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.77 -58.01 5.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.1 -0.5 . . . . 70.439999999999998 111.535 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 24.8 pt20 -70.36 -24.81 63.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.699 -0.401 . . . . 74.430000000000007 110.697 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 9.9 t30 -52.25 -46.83 65.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.936 -0.574 . . . . 73.439999999999998 112.041 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -83.03 -32.62 26.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.869 -0.333 . . . . 74.340000000000003 111.232 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.621 HG13 ' HB ' ' A' ' 104' ' ' ILE . 44.4 t -69.51 -28.82 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.568 -0.287 . . . . 71.150000000000006 111.724 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -99.08 10.9 40.52 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.019 -0.672 . . . . 73.530000000000001 110.91 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -141.48 31.65 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.066 0.395 . . . . 72.209999999999994 112.066 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.308 -0.853 . . . . 75.239999999999995 109.997 174.66 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.82 0.343 . . . . 71.209999999999994 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -157.42 48.68 0.42 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.258 -0.428 . . . . 43.530000000000001 110.037 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.9 pm0 -86.39 107.2 12.55 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.372 0.606 . . . . 75.040000000000006 110.501 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HG2' HG23 ' A' ' 85' ' ' VAL . 83.8 Cg_endo -101.86 -167.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.944 3.096 . . . . 72.409999999999997 113.014 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 177' ' ' ILE . 55.9 tp -136.5 115.79 12.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.199 -0.91 . . . . 74.150000000000006 108.77 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.56 ' HA ' HG23 ' A' ' 61' ' ' VAL . 33.7 tp -90.82 104.4 16.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.47 -0.567 . . . . 73.239999999999995 109.47 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.644 ' HB ' HD22 ' A' ' 62' ' ' LEU . 43.3 t -111.63 122.06 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.258 -0.428 . . . . 64.319999999999993 110.54 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.57 114.77 47.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.938 -0.574 . . . . 72.340000000000003 109.753 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.1 121.16 6.19 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.681 -0.968 . . . . 70.329999999999998 110.681 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.88 124.0 44.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.017 0.437 . . . . 64.040000000000006 111.431 -172.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.81 -147.14 4.72 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.435 -0.666 . . . . 74.239999999999995 111.435 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -116.66 98.47 51.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.674 0.273 . . . . 75.040000000000006 111.208 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.0 118.37 5.39 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.689 2.259 . . . . 72.310000000000002 111.351 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 171.96 43.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.891 -0.671 . . . . 74.099999999999994 111.661 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.91 -72.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.843 2.362 . . . . 70.409999999999997 112.522 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -87.05 -15.01 39.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.41 0.624 . . . . 62.140000000000001 110.068 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -71.67 -23.62 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 74.129999999999995 111.546 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.36 -1.61 50.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.032 0.444 . . . . 75.439999999999998 110.98 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -108.86 15.56 23.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 73.040000000000006 110.454 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.746 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 65.6 p -101.85 -170.38 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.153 -0.476 . . . . 73.150000000000006 110.739 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -73.18 -4.94 36.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.909 0.385 . . . . 74.239999999999995 110.74 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -99.11 21.98 11.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.193 0.442 . . . . 75.25 112.193 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 27' ' ' MET . 39.2 p30 -101.37 -1.05 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.855 -0.338 . . . . 62.310000000000002 110.458 174.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.82 -37.12 70.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.969 -0.56 . . . . 74.219999999999999 111.381 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.547 ' HA2' HG21 ' A' ' 93' ' ' ILE . . . -62.54 -32.85 84.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.055 -0.593 . . . . 50.409999999999997 112.355 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -90.31 -24.61 20.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.793 -0.24 . . . . 75.340000000000003 111.239 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.83 ' HA ' ' HE1' ' A' ' 27' ' ' MET . 17.2 mmt -55.91 -51.42 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.786 0.327 . . . . 74.430000000000007 111.175 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 22.0 t -66.46 -40.71 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 72.140000000000001 110.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 74.010000000000005 111.666 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -60.33 -45.08 94.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 75.530000000000001 110.553 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.36 -43.82 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 71.329999999999998 110.77 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.5 mt -60.97 -39.32 89.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 75.239999999999995 111.156 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.77 -46.32 58.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 75.120000000000005 110.793 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.55 -34.41 89.87 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.766 -0.652 . . . . 75.109999999999999 113.42 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -20.27 62.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.033 0.416 . . . . 74.209999999999994 111.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 HD11 ' HA3' ' A' ' 53' ' ' GLY . 75.4 mt -87.05 -41.97 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.934 0.397 . . . . 74.510000000000005 110.151 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.23 60.22 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.821 -0.627 . . . . 74.120000000000005 111.914 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -100.45 140.65 34.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.801 0.334 . . . . 73.430000000000007 110.485 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.46 143.06 30.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.322 -0.399 . . . . 75.25 111.315 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.05 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 3.3 p90 -60.57 142.04 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 74.030000000000001 111.144 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 41' ' ' LYS . 25.0 mtpp -117.81 147.47 42.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 73.430000000000007 110.852 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.648 HG21 ' HG2' ' A' ' 49' ' ' GLU . 39.5 t -75.87 128.54 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.953 -0.567 . . . . 74.0 110.169 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.427 ' CD2' ' HB ' ' A' ' 50' ' ' VAL . 27.1 m-70 -85.4 117.03 24.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.423 -0.353 . . . . 72.409999999999997 110.331 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -71.47 81.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.588 0.709 . . . . 74.430000000000007 111.175 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -175.52 -70.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.266 -0.879 . . . . 75.230000000000004 109.484 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.52 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 13.0 m -86.81 -27.95 23.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.745 -0.661 . . . . 73.209999999999994 110.662 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.429 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . 94.55 10.71 57.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 51.32 112.405 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.661 ' HB3' HD12 ' A' ' 79' ' ' LEU . . . -97.49 157.59 15.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 73.019999999999996 110.788 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.648 ' HG2' HG21 ' A' ' 42' ' ' VAL . 32.9 mt-10 -103.28 127.91 50.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.866 -0.606 . . . . 73.099999999999994 111.039 -175.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.5 t -140.53 137.97 36.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 109.817 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.05 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.2 p -116.87 135.23 57.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.886 0.374 . . . . 72.409999999999997 111.097 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.563 HG23 HG13 ' A' ' 61' ' ' VAL . 20.2 p -100.85 108.13 19.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 75.120000000000005 110.492 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.459 ' HA3' HD11 ' A' ' 36' ' ' ILE . . . -127.72 -161.7 10.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.819 -0.705 . . . . 74.519999999999996 112.178 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -129.94 143.22 50.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.652 0.226 . . . . 71.340000000000003 110.548 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 1.1 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.0 pt? -142.28 121.17 12.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.184 -0.673 . . . . 73.439999999999998 109.184 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.8 -57.24 0.46 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.41 0.684 . . . . 75.310000000000002 111.862 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.37 -12.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.343 -0.456 . . . . 75.319999999999993 112.447 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.4 p -104.05 168.82 8.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.94 0.4 . . . . 71.319999999999993 110.899 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 t -90.86 99.64 12.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 71.140000000000001 110.565 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 1.1 ' HB ' HD22 ' A' ' 55' ' ' LEU . 11.6 p -76.17 129.94 36.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.54 -0.464 . . . . 75.450000000000003 109.872 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.563 HG13 HG23 ' A' ' 52' ' ' THR . 17.6 m -118.45 111.22 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.494 0.664 . . . . 74.409999999999997 110.12 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.644 HD22 ' HB ' ' A' ' 7' ' ' VAL . 87.5 mt -92.6 117.92 30.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.759 . . . . 71.200000000000003 110.28 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.43 125.33 51.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.933 -0.576 . . . . 65.299999999999997 109.802 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -117.92 136.19 23.68 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.093 -0.503 . . . . 74.129999999999995 111.102 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.45 137.82 62.14 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.986 2.457 . . . . 71.319999999999993 111.477 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 32.5 ttt-85 -85.56 -52.78 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.741 -0.384 . . . . 74.109999999999999 110.08 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.2 p -159.44 139.17 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.467 -0.333 . . . . 71.5 110.997 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.535 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 20.5 t80 71.06 133.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.096 0.873 . . . . 60.140000000000001 111.802 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.436 ' HB3' ' CA ' ' A' ' 117' ' ' GLY . 2.0 mpt? -62.07 -56.43 19.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 75.140000000000001 112.038 -174.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.28 -41.58 97.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.394 -0.366 . . . . 74.420000000000002 111.834 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 9.0 mm-40 -63.68 -30.11 71.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.386 -0.37 . . . . 71.109999999999999 110.89 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 m -63.52 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 74.230000000000004 110.697 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.491 ' HA2' HG11 ' A' ' 121' ' ' VAL . . . -63.08 -38.16 96.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.573 -0.822 . . . . 71.109999999999999 111.098 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.58 1.41 29.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.057 0.456 . . . . 74.530000000000001 110.594 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 13.0 mm-40 -97.37 -51.8 4.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.919 -0.582 . . . . 75.349999999999994 110.07 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.65 -41.03 91.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 64.519999999999996 111.531 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.64 -65.3 3.41 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.189 -0.459 . . . . 72.430000000000007 113.083 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.63 -39.94 87.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.792 2.328 . . . . 75.5 112.873 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.661 HD12 ' HB3' ' A' ' 48' ' ' ALA . 55.1 mt -64.7 -36.99 86.05 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.816 0.302 . . . . 70.409999999999997 111.816 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.22 -41.4 83.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.403 0.62 . . . . 75.310000000000002 110.337 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 -0.82 56.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 71.439999999999998 111.666 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -80.22 -49.05 12.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 74.409999999999997 110.564 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.547 ' CE2' ' HB ' ' A' ' 85' ' ' VAL . 40.0 p90 -108.45 9.42 27.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 74.019999999999996 110.86 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m 60.67 77.95 0.3 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.397 -0.82 . . . . 71.010000000000005 112.177 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.547 ' HB ' ' CE2' ' A' ' 83' ' ' TYR . 12.9 p -107.45 130.94 22.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.15 -0.477 . . . . 75.319999999999993 109.901 175.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.64 118.64 5.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.7 2.267 . . . . 70.299999999999997 112.4 178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.18 67.6 6.85 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.295 2.664 . . . . 64.439999999999998 112.097 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -146.04 -53.66 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 74.549999999999997 109.972 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -80.71 74.16 7.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.886 -0.597 . . . . 74.5 109.991 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -121.86 141.53 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 72.209999999999994 110.455 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.534 HG21 ' HE2' ' A' ' 131' ' ' HIS . 94.9 t -127.99 110.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.035 -0.53 . . . . 70.450000000000003 109.846 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.2 106.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.142 -0.318 . . . . 72.109999999999999 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.547 HG21 ' HA2' ' A' ' 25' ' ' GLY . 66.2 mt -94.97 117.34 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.349 -0.387 . . . . 75.349999999999994 110.259 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -154.78 161.21 41.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.923 0.392 . . . . 73.010000000000005 110.407 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.46 149.53 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 74.239999999999995 110.599 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.641 ' HB3' HG22 ' A' ' 99' ' ' ILE . 5.9 tp10 -123.41 109.09 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.399 -0.593 . . . . 74.120000000000005 109.399 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.761 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 6.1 mp -68.95 -34.19 74.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 75.230000000000004 111.793 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.96 -31.16 68.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.555 . . . . 72.400000000000006 112.186 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.641 HG22 ' HB3' ' A' ' 96' ' ' GLU . 14.8 tt -97.74 160.39 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.944 0.402 . . . . 74.219999999999999 111.461 -172.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.655 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 22.2 t70 -58.5 148.83 27.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.607 -0.724 . . . . 74.349999999999994 112.158 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 69.8 t80 -69.68 138.95 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.75 -0.659 . . . . 72.439999999999998 111.948 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.09 9.92 86.53 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.526 -0.761 . . . . 63.439999999999998 113.026 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -100.45 116.43 32.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.719 -0.474 . . . . 72.319999999999993 109.719 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.7 mp -79.98 106.43 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.446 -0.575 . . . . 65.030000000000001 109.446 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -109.06 150.06 28.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.98 -0.554 . . . . 75.329999999999998 109.905 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.757 HD12 ' HB2' ' A' ' 131' ' ' HIS . 15.1 tp -113.14 146.67 38.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.665 -0.494 . . . . 72.349999999999994 109.665 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 131' ' ' HIS . 38.0 tttm -147.34 153.92 40.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.569 -0.53 . . . . 71.310000000000002 109.569 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.736 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -125.05 -71.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.281 0.363 . . . . 74.430000000000007 111.446 -176.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.736 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -63.69 161.04 36.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.273 -0.489 . . . . 62.119999999999997 112.828 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.52 143.59 31.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.935 -0.65 . . . . 71.5 112.329 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.42 -176.64 42.06 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.298 -0.721 . . . . 71.209999999999994 111.298 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -81.07 150.13 28.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 73.219999999999999 110.723 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.79 -59.56 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.743 -1.343 . . . . 73.400000000000006 109.743 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.81 ' HA3' HD21 ' A' ' 118' ' ' LEU . . . -91.48 163.97 29.01 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.67 -0.972 . . . . 53.149999999999999 110.67 170.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.568 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 4.7 t-80 -119.09 -63.33 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.268 -0.573 . . . . 72.329999999999998 111.631 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -107.82 -71.16 0.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.809 -0.357 . . . . 64.129999999999995 111.882 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 69' ' ' MET . . . -51.62 -48.24 50.15 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.812 -0.631 . . . . 72.239999999999995 114.659 -167.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.81 HD21 ' HA3' ' A' ' 114' ' ' GLY . 3.5 pp -78.28 -19.36 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.293 -0.563 . . . . 72.439999999999998 111.827 -174.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 115' ' ' HIS . 18.1 mtp180 -81.11 -26.45 36.18 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.0 -0.28 . . . . 74.230000000000004 110.29 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -67.57 -50.17 59.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.458 -0.337 . . . . 75.019999999999996 110.705 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.491 HG11 ' HA2' ' A' ' 73' ' ' GLY . 29.4 m -65.87 -33.8 66.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 70.120000000000005 111.089 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.17 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.419 . . . . 73.120000000000005 111.118 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.1 m -82.07 -28.91 32.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 75.040000000000006 110.545 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.45 -43.46 81.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 74.209999999999994 110.711 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.89 -41.5 59.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 75.040000000000006 109.743 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.7 62.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.617 -0.72 . . . . 60.549999999999997 112.25 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.474 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 6.6 m -108.54 148.01 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.843 -0.429 . . . . 75.310000000000002 109.843 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 11.6 mptt -117.2 -155.83 0.6 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.349999999999994 109.11 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.427 ' H ' ' HB3' ' A' ' 128' ' ' LYS . 66.4 t30 73.88 9.96 4.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.797 0.808 . . . . 73.140000000000001 109.654 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -87.83 127.58 35.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.331 -0.849 . . . . 65.129999999999995 109.791 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.757 ' HB2' HD12 ' A' ' 106' ' ' LEU . 35.2 p-80 -73.05 120.41 18.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.359 0.599 . . . . 74.530000000000001 111.694 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.417 ' O ' HD11 ' A' ' 106' ' ' LEU . 43.0 mtm105 -95.21 139.77 31.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 110.451 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.85 104.16 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.449 -0.945 . . . . 64.530000000000001 108.449 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 53.5 mtp180 -100.92 107.86 19.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.456 -0.793 . . . . 75.150000000000006 110.377 -172.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.4 ' N ' HD13 ' A' ' 135' ' ' ILE . 4.3 mp -93.81 113.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.609 . . . . 75.349999999999994 109.357 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 100' ' ' ASP . . . -57.46 138.5 48.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.136 -0.554 . . . . 73.310000000000002 113.904 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.761 ' HB ' ' HA ' ' A' ' 97' ' ' LEU . 89.6 t -88.98 -20.35 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 74.129999999999995 110.588 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.453 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 130.33 -78.43 0.38 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.282 -0.961 . . . . 75.310000000000002 113.312 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.571 ' HD3' ' O ' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -163.7 158.78 17.17 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 110.048 -0.353 . . . . 75.230000000000004 110.048 -174.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.571 ' O ' ' HD3' ' A' ' 139' ' ' ARG . 51.4 Cg_exo -55.43 159.65 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.018 2.479 . . . . 73.109999999999999 112.616 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.465 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 49.2 Cg_endo -67.12 161.45 42.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.707 2.272 . . . . 74.519999999999996 112.877 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -86.87 1.97 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.73 . . . . 74.349999999999994 112.345 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -103.21 8.28 38.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 72.329999999999998 111.412 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -131.48 161.86 31.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.407 -0.361 . . . . 75.109999999999999 110.605 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.67 150.64 25.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.454 0.471 . . . . 70.439999999999998 111.445 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.88 -43.07 59.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.776 2.317 . . . . 70.439999999999998 112.075 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.25 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 61.530000000000001 111.072 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' A' ' 151' ' ' LEU . . . -83.54 -27.8 29.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.416 -0.356 . . . . 60.409999999999997 110.949 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 86.3 t80 -67.65 -35.36 78.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.150000000000006 110.223 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.746 ' O ' ' HB ' ' A' ' 20' ' ' THR . 35.5 m -84.86 -6.22 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 111.021 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.663 HD21 HG21 ' A' ' 20' ' ' THR . 11.1 mt -90.78 6.12 45.54 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.174 0.435 . . . . 64.319999999999993 112.174 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -93.27 167.44 11.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.487 -0.485 . . . . 71.019999999999996 110.054 175.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -149.5 148.9 29.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.544 -0.298 . . . . 71.109999999999999 111.301 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.764 ' HA ' ' HG2' ' A' ' 159' ' ' ARG . 84.4 m-85 66.89 96.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.477 1.11 . . . . 75.129999999999995 112.313 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.575 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 13.3 p -114.68 -166.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 75.209999999999994 109.572 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.2 -72.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.846 0.684 . . . . 73.319999999999993 112.846 -171.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.67 -56.46 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.157 0.429 . . . . 73.439999999999998 112.157 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -65.81 -23.73 66.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.756 -0.656 . . . . 75.549999999999997 111.878 -171.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.764 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 3.3 tpp180 -71.97 -28.05 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 75.209999999999994 110.396 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 163' ' ' PRO . . . -87.6 -11.11 49.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.957 -0.565 . . . . 71.129999999999995 110.183 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.6 -3.6 59.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.731 . . . . 75.109999999999999 111.058 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.68 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 95.8 t -57.87 -52.91 70.97 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.616 -0.265 . . . . 75.25 110.731 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 51.1 Cg_exo -55.84 -35.92 94.59 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.968 1.779 . . . . 73.439999999999998 111.977 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -64.35 -48.92 73.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 75.109999999999999 111.198 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 36.0 pt -79.93 -26.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 74.129999999999995 111.944 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.48 -31.91 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.882 -0.327 . . . . 71.349999999999994 110.698 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 44.8 mt-10 -64.68 -43.32 93.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.181 0.515 . . . . 73.439999999999998 109.621 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.63 -47.23 82.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.345 -0.843 . . . . 72.5 110.851 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.38 99.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.511 . . . . 73.439999999999998 111.547 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.12 96.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 73.409999999999997 110.783 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.42 -39.04 81.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 73.430000000000007 110.687 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.88 -42.03 98.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 52.240000000000002 111.062 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.6 m -61.62 -38.13 86.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 62.399999999999999 110.516 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -73.11 -34.01 65.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 72.25 110.252 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.2 tp -66.55 -27.3 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 73.519999999999996 110.832 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 92.0 mt -61.29 -33.73 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.340000000000003 110.5 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.463 HD13 HD13 ' A' ' 5' ' ' LEU . 38.0 mm -81.28 -46.62 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 71.299999999999997 110.938 176.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.79 -61.27 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 64.430000000000007 111.773 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 179' ' ' GLN . 6.5 tp60 -93.14 -44.62 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 72.439999999999998 110.576 -175.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' A' ' 183' ' ' PRO . . . 130.26 156.64 8.75 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.064 -0.814 . . . . 65.209999999999994 111.064 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.68 -27.73 66.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.164 0.482 . . . . 73.150000000000006 110.959 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.712 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 35.1 tt0 -72.5 -52.46 6.58 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.812 -0.631 . . . . 73.040000000000006 111.664 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.712 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 9.9 Cg_exo -73.89 -32.23 7.43 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.891 1.727 . . . . 63.030000000000001 112.895 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.531 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -64.3 -40.03 95.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 111.76 0.281 . . . . 74.219999999999999 111.76 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 9.9 pt20 -58.22 -30.75 66.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.645 0.259 . . . . 74.409999999999997 110.904 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.41 -47.86 74.81 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.617 -0.512 . . . . 72.319999999999993 109.617 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -59.03 -38.84 80.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.671 -0.695 . . . . 64.150000000000006 111.237 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 184' ' ' ALA . 99.5 t -58.47 -35.91 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.992 -0.549 . . . . 75.329999999999998 112.237 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.459 ' HD2' ' O ' ' A' ' 185' ' ' GLN . 9.4 p80 -106.8 15.22 25.79 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.116 -0.634 . . . . 73.109999999999999 110.675 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.86 6.52 47.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.103 -0.499 . . . . 72.439999999999998 111.496 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.489 -0.767 . . . . 74.430000000000007 110.105 176.303 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 1.1 pm0 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.902 0.382 . . . . 74.0 110.315 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.495 ' CD ' ' HD2' ' A' ' 86' ' ' PRO . 93.9 Cg_endo -96.23 162.01 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.026 2.484 . . . . 64.4 113.495 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.666 HD11 HG23 ' A' ' 91' ' ' VAL . 58.0 tp -89.45 122.78 32.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.168 -0.924 . . . . 71.42 108.797 172.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.73 105.37 17.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.484 -0.561 . . . . 73.1 109.484 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HB ' HD23 ' A' ' 62' ' ' LEU . 38.2 t -107.07 113.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 74.34 110.525 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 92' ' ' VAL . 58.3 t -109.86 118.1 56.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.669 -0.696 . . . . 74.34 109.716 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.27 122.72 7.45 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.201 -0.999 . . . . 74.32 111.779 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' HA3' ' A' ' 117' ' ' GLY . 46.5 tp -77.77 82.04 4.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.329 0.585 . . . . 62.25 109.79 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.695 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -164.2 101.73 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.271 -0.877 . . . . 43.43 111.104 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 65' ' ' PRO . 50.8 m-80 -88.38 146.94 38.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.494 -0.188 . . . . 72.04 110.494 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 25.5 Cg_exo -62.96 96.43 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 123.06 2.507 . . . . 73.43 112.697 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . -122.33 119.1 3.86 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.38 -0.827 . . . . 73.02 111.3 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.45 -54.12 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 124.359 3.373 . . . . 62.34 114.58 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -105.09 -30.08 9.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.439 0.533 . . . . 71.52 112.439 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 p90 -89.13 2.68 53.79 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.17 -0.612 . . . . 75.3 112.059 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 -1.51 52.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.893 0.377 . . . . 74.3 110.679 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.6 10.76 16.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.292 -0.413 . . . . 74.25 110.868 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 22' ' ' HIS . 6.2 t -105.1 -174.58 2.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.757 -0.377 . . . . 65.05 110.898 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 54.5 mtt180 -57.24 -20.94 30.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.61 0.596 . . . . 65.12 112.61 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.636 ' H ' HG23 ' A' ' 20' ' ' THR . 5.5 t-160 -91.65 14.05 16.27 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 72.15 111.609 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.17 1.06 57.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.837 -0.345 . . . . 65.23 110.379 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 88.0 mt -51.41 -48.11 62.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.745 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.76 93.34 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.958 -0.639 . . . . 71.31 112.846 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.695 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 77.9 t80 -80.35 -26.97 38.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.627 0.251 . . . . 64.02 110.824 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.586 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 7.2 mmt -55.18 -53.45 55.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.931 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.658 HG21 HG12 ' A' ' 93' ' ' ILE . 90.2 t -56.12 -45.57 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.76 0.314 . . . . 63.32 111.048 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -48.85 74.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 51.14 111.186 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.33 -40.02 96.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 52.52 110.814 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 HG12 ' A' ' 166' ' ' VAL . 45.0 t -67.4 -45.63 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 74.33 111.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.36 -45.14 94.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 73.53 110.482 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.53 -31.72 73.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 74.35 110.549 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -45.47 49.53 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.598 -0.728 . . . . 22.3 113.081 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HG3' HD12 ' A' ' 36' ' ' ILE . 13.1 ptp180 -70.36 -34.95 73.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.094 0.447 . . . . 74.13 110.933 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -71.65 -37.02 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.071 0.463 . . . . 74.12 110.117 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.17 53.44 2.66 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.74 -0.743 . . . . 44.0 112.202 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.6 m -147.6 144.82 28.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.651 0.263 . . . . 75.3 110.487 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.06 147.81 25.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.302 -0.408 . . . . 73.33 110.423 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.623 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 p90 -78.25 132.64 37.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 64.43 110.894 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -99.59 150.26 22.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.782 -0.645 . . . . 74.55 110.893 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 24.6 t -73.16 124.08 29.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 72.44 111.427 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -88.08 99.96 12.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 74.23 109.064 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -69.23 86.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 71.04 110.553 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -173.13 -62.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.07 -0.968 . . . . 72.55 109.189 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -99.48 -14.63 19.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.643 -0.708 . . . . 74.41 110.846 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.54 67.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.836 -0.697 . . . . 63.41 112.467 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.573 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -93.7 163.05 13.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.705 0.288 . . . . 33.12 110.767 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.936 ' HB2' ' HE3' ' A' ' 64' ' ' LYS . 29.8 mt-10 -124.04 131.48 53.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 61.32 110.274 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -133.33 139.14 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.521 . . . . 74.04 110.718 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 8.5 p -119.18 142.67 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.435 -0.348 . . . . 74.22 110.079 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.428 HG22 HG12 ' A' ' 61' ' ' VAL . 14.1 p -108.29 143.43 37.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.953 0.353 . . . . 74.45 111.953 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.18 -164.43 21.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.202 -0.523 . . . . 52.11 111.887 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -134.12 122.83 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.75 0.275 . . . . 64.21 110.622 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.053 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -111.16 119.1 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 51.43 109.486 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.02 -67.6 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.412 0.685 . . . . 54.32 111.656 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.43 12.79 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.982 -0.847 . . . . 40.44 110.982 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.525 ' O ' HD23 ' A' ' 55' ' ' LEU . 47.0 m -126.31 146.0 50.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 71.41 109.414 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 18.0 m -67.62 131.71 46.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.701 -0.481 . . . . 45.45 109.701 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.053 ' HB ' HD22 ' A' ' 55' ' ' LEU . 9.9 p -111.65 127.98 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.904 0.383 . . . . 75.05 110.132 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG12 HG22 ' A' ' 52' ' ' THR . 11.5 m -117.13 109.26 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.308 0.575 . . . . 73.03 109.846 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.515 HD23 ' HB ' ' A' ' 7' ' ' VAL . 78.3 mt -92.57 106.36 18.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.561 -0.745 . . . . 63.14 109.748 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 127.88 55.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.814 -0.63 . . . . 74.0 110.922 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.936 ' HE3' ' HB2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -123.63 143.6 42.14 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.11 -0.7 . . . . 51.14 109.11 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.815 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 14.6 Cg_exo -69.65 175.59 7.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.179 2.586 . . . . 54.14 113.598 -173.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 7.1 ptm180 -77.38 -61.81 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 64.34 110.949 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.665 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 24.6 p -169.49 166.79 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.55 -0.537 . . . . 72.23 109.55 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 16.0 t80 70.27 144.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.657 0.741 . . . . 71.51 112.595 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.5 -56.17 20.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 53.43 111.721 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.417 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 25.2 t-20 -58.04 -43.7 86.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.165 -0.471 . . . . 71.14 111.573 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 8.6 mm-40 -56.66 -41.57 77.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.132 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.5 m -57.5 -32.44 67.02 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.515 0.51 . . . . 65.21 111.306 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -65.16 -47.11 84.74 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.654 -0.784 . . . . 42.53 112.349 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 25.6 ptt180 -89.22 3.06 53.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.981 -0.288 . . . . 73.35 111.111 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.815 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 23.2 mm-40 -66.92 -38.24 85.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 71.21 110.783 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.11 -34.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.977 -0.556 . . . . 73.13 111.696 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.539 ' O ' ' HD3' ' A' ' 81' ' ' LYS . . . -54.18 -73.3 0.43 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.975 -0.557 . . . . 44.23 113.642 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 18.5 Cg_endo -59.79 -23.21 71.22 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.081 2.521 . . . . 72.14 113.407 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 48' ' ' ALA . 34.8 mt -75.41 -43.03 52.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.071 -0.252 . . . . 75.03 111.386 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.77 80.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 71.5 110.825 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 77' ' ' GLY . 2.2 mptp? -80.79 -26.34 37.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.771 -0.649 . . . . 72.31 110.037 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.6 t80 -56.6 -52.45 64.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.602 -0.726 . . . . 73.21 110.857 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -94.92 -1.2 53.06 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.849 -0.34 . . . . 71.41 110.709 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 63.12 90.95 0.07 Allowed 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.787 0.679 . . . . 64.54 110.731 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.27 123.7 76.83 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.472 -0.786 . . . . 65.43 112.414 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.617 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 5.9 Cg_exo -79.81 113.35 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.804 2.336 . . . . 74.03 109.452 162.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 24.9 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.853 2.368 . . . . 74.42 113.778 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -92.6 -57.74 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 74.43 109.721 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 130' ' ' PHE . 8.8 tt0 -173.64 148.99 1.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.942 -0.572 . . . . 72.05 109.861 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 tt -124.18 122.1 63.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.335 0.588 . . . . 71.54 110.935 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 5' ' ' LEU . 98.9 t -113.19 126.68 70.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 75.44 109.977 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.545 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 t -129.48 107.02 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.239 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.658 HG12 HG21 ' A' ' 28' ' ' VAL . 4.2 mp -84.5 133.74 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.702 -0.681 . . . . 53.24 109.329 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.631 ' CE1' HD13 ' A' ' 118' ' ' LEU . 18.2 p80 -151.8 179.58 8.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.895 0.379 . . . . 63.04 111.116 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.23 148.57 26.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.228 -0.897 . . . . 71.42 111.092 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -140.95 115.04 9.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 73.3 110.374 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 137' ' ' VAL . 95.5 mt -82.75 -14.16 55.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.632 -0.713 . . . . 72.33 112.458 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -94.39 -12.13 28.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.902 0.382 . . . . 65.22 110.984 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.591 HD11 ' HD2' ' A' ' 105' ' ' ARG . 46.3 mm -106.63 139.45 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 72.34 111.895 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.83 142.21 30.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.958 -1.019 . . . . 72.23 111.617 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.3 t80 -68.43 115.12 7.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 62.42 111.241 -173.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.07 -16.78 6.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.329 -0.938 . . . . 42.15 113.635 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -114.21 159.97 19.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.402 0.601 . . . . 64.05 111.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.23 129.32 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 73.15 111.444 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.735 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 75.2 ttt180 -109.3 125.39 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.052 -0.722 . . . . 43.1 109.052 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.23 118.26 35.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 71.01 111.35 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.79 161.43 26.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.161 -0.681 . . . . 73.04 109.161 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 129' ' ' ASN . 89.9 mt -66.78 -72.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.232 0.456 . . . . 73.35 112.232 -176.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.48 -126.19 3.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.364 -0.922 . . . . 70.53 113.56 -173.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.96 152.56 26.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.007 -0.616 . . . . 73.51 112.454 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.5 163.54 32.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.81 -0.71 . . . . 43.13 112.048 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.14 164.34 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.219 -0.289 . . . . 70.23 110.219 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -30.27 5.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.831 -0.7 . . . . 43.44 111.954 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.16 -170.58 24.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.952 -0.642 . . . . 55.43 111.649 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.406 ' CE1' HD11 ' A' ' 97' ' ' LEU . 39.4 m80 -103.14 -86.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.432 0.53 . . . . 72.0 112.432 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -118.24 -64.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.765 0.654 . . . . 73.44 112.765 -170.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.437 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -48.11 -49.43 24.29 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.495 0.497 . . . . 72.15 114.314 -168.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.7 pt? -57.77 -35.06 70.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 71.15 111.883 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.487 ' HG3' ' HG ' ' A' ' 118' ' ' LEU . 78.8 mtp180 -80.18 -40.05 28.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.065 -0.516 . . . . 63.52 110.484 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 45.0 m -69.6 -42.5 74.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.624 -0.716 . . . . 65.41 112.154 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.47 -27.93 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.88 0.326 . . . . 72.54 111.88 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.37 91.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 73.22 110.731 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 m -79.23 -22.62 44.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.03 -0.532 . . . . 71.42 111.163 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.43 77.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 72.45 111.176 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.86 -41.59 6.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.338 -0.392 . . . . 64.35 111.025 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.28 -5.83 63.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.792 -0.718 . . . . 73.42 111.835 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 52.7 m -125.38 126.8 45.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.936 0.398 . . . . 63.32 110.171 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.587 ' N ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.58 -160.91 1.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.031 -0.531 . . . . 74.44 109.825 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m-20 69.85 72.63 0.23 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.5 0.667 . . . . 75.4 111.204 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.402 ' HB3' ' HG3' ' A' ' 89' ' ' GLN . 85.6 m-85 -140.86 -82.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.222 -0.899 . . . . 65.41 109.411 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -152.29 103.69 2.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 74.02 110.327 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 132' ' ' ARG . 2.6 tpp180 -102.56 108.79 20.21 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 64.42 108.865 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 84.0 t -82.66 116.36 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.227 0.537 . . . . 73.24 111.211 -171.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.837 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 54.1 mtt180 -105.11 111.18 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.207 -0.906 . . . . 73.02 109.984 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 24' ' ' LEU . 58.4 mt -95.65 118.57 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.108 -0.701 . . . . 74.12 109.108 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -60.64 128.25 44.94 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.773 -0.727 . . . . 64.35 111.993 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 97' ' ' LEU . 8.9 p -98.51 -5.86 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 72.31 110.744 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.23 -108.5 0.93 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.643 -0.789 . . . . 73.51 112.402 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -153.98 157.13 32.49 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.418 -0.215 . . . . 73.44 110.418 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.93 135.01 56.67 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.718 2.279 . . . . 73.1 111.73 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.524 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 59.0 Cg_endo -73.29 164.76 34.38 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.77 2.313 . . . . 73.52 112.627 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -26.03 6.92 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.879 -0.677 . . . . 63.01 112.24 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -105.53 -66.96 0.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.731 0.301 . . . . 72.13 111.782 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.782 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -77.57 161.13 28.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.916 0.389 . . . . 72.12 111.621 -174.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.36 137.4 68.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.446 -0.797 . . . . 45.4 111.02 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.81 -44.7 30.81 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 55.42 113.417 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.26 -34.95 66.11 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.001 -0.28 . . . . 71.52 110.68 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.09 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 52.3 110.778 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.524 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 32.8 t80 -68.16 -26.56 65.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 72.52 110.318 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 25.3 t -81.66 -16.99 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.779 -0.646 . . . . 63.31 109.735 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.36 -11.25 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.716 -0.675 . . . . 73.21 110.858 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -113.64 104.66 12.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.17 0.509 . . . . 62.4 110.412 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.578 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 51.1 t30 -90.84 79.7 5.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 72.0 111.336 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -146.56 135.67 22.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 72.45 109.585 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -154.29 -171.62 3.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.915 -0.772 . . . . 73.31 108.915 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 155' ' ' THR . . . -92.46 -71.62 0.64 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.855 0.316 . . . . 73.3 111.855 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.01 -51.66 4.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 54.3 111.689 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 1.1 pm0 -69.26 -17.03 63.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.784 . . . . 71.24 111.468 -172.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -64.48 -27.07 68.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.736 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.59 -20.2 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.234 -0.439 . . . . 74.02 111.032 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.7 6.92 39.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 73.24 111.791 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.682 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 84.2 t -53.66 -55.09 38.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.087 0.403 . . . . 73.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.6 Cg_exo -53.62 -39.81 81.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.027 1.818 . . . . 75.51 112.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 m -65.62 -50.96 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.36 -0.382 . . . . 63.54 111.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.12 -32.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 64.11 111.401 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.54 HG12 HG21 ' A' ' 31' ' ' VAL . 75.7 t -69.05 -45.87 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.636 -0.256 . . . . 74.53 111.109 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -60.13 -41.35 92.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.282 . . . . 71.23 110.635 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.25 -37.61 78.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 71.14 111.261 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.12 74.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 70.11 110.884 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.21 -34.33 78.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 73.24 110.838 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.28 -42.98 64.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.753 -0.658 . . . . 52.14 110.633 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -65.99 -25.86 67.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 52.23 111.087 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.8 m -61.27 -37.96 85.03 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 54.32 110.404 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 55' ' ' LEU . 34.0 tt0 -73.1 -30.76 63.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 74.54 110.078 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.19 -28.44 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 73.13 110.366 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.7 mt -64.94 -25.39 67.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 75.0 110.822 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.564 HD11 HD13 ' A' ' 5' ' ' LEU . 26.7 mm -80.72 -51.21 16.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 63.22 110.733 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -73.3 -42.5 62.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.651 . . . . 62.11 112.313 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.441 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.9 tp60 -93.46 -62.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.766 0.317 . . . . 70.23 111.325 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.38 -129.8 3.24 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.65 -0.786 . . . . 70.44 112.21 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 182' ' ' GLU . 3.0 pp -124.01 -46.77 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 74.31 111.923 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.79 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 44.8 tt0 -74.19 -57.56 2.22 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.671 0.249 . . . . 73.32 111.671 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.3 Cg_exo -63.97 -25.34 66.8 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.515 1.477 . . . . 73.03 111.475 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -70.28 -50.18 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 65.51 110.89 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.1 pt20 -65.56 -30.57 71.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.907 0.384 . . . . 73.4 110.141 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.56 -45.01 95.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 55.33 109.837 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 91.2 m -59.74 -42.45 93.2 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.989 -0.55 . . . . 55.51 110.685 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 184' ' ' ALA . 58.7 t -66.43 -34.28 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.949 -0.568 . . . . 42.42 111.892 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.35 5.94 46.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.196 -0.315 . . . . 72.42 111.844 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.04 -17.91 38.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 70.44 111.066 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.361 -0.828 . . . . 71.43 109.986 178.997 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' ' 58' ' ' THR . 10.3 pt-20 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.341 0.591 . . . . 75.02 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 59' ' ' SER . 27.8 Cg_endo -96.57 113.39 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.56 2.84 . . . . 60.13 112.207 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 177' ' ' ILE . 45.7 tp -88.66 119.67 29.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.509 -0.314 . . . . 73.42 110.383 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.612 ' HA ' HG23 ' A' ' 61' ' ' VAL . 61.2 tp -92.67 107.12 18.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 72.32 109.861 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.653 ' HB ' HD23 ' A' ' 62' ' ' LEU . 42.7 t -98.05 117.36 42.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.025 -0.534 . . . . 71.34 109.756 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.24 114.84 41.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 74.44 110.002 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.83 122.75 7.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 53.53 111.732 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.67 100.06 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.864 0.364 . . . . 74.04 110.778 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.95 135.45 11.43 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.818 -0.628 . . . . 71.24 111.85 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 34.5 m-80 -139.32 129.04 14.25 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 110.225 -0.287 . . . . 74.54 110.225 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 31.8 Cg_exo -59.19 165.6 8.64 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.408 2.739 . . . . 74.33 113.483 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.63 111.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.748 -0.941 . . . . 75.41 110.748 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -45.22 -50.28 9.15 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.326 2.684 . . . . 70.24 113.155 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -100.98 -10.93 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.216 -0.447 . . . . 63.12 111.367 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 151' ' ' LEU . 39.7 m-85 -101.18 1.81 39.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 74.5 112.258 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.583 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -87.71 -15.06 38.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.04 0.448 . . . . 43.13 110.625 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -105.5 9.78 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 75.03 110.412 -175.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 153' ' ' ASN . 75.6 p -111.74 -169.5 1.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.389 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 62.9 mtt180 -67.08 -4.94 11.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.042 0.449 . . . . 75.25 111.013 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -76.0 -8.76 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 75.14 111.142 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 24.4 m-80 -134.38 32.34 3.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.756 -0.202 . . . . 71.23 111.509 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 137' ' ' VAL . 64.6 mt -58.29 -38.21 76.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.718 0.294 . . . . 65.33 111.437 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.36 87.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.837 -0.697 . . . . 65.01 112.303 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 64' ' ' LYS . 87.3 t80 -73.61 -32.72 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.611 0.244 . . . . 72.42 110.867 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.4 mmt -53.44 -47.43 69.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.043 -0.526 . . . . 73.43 111.263 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 48.2 t -66.09 -42.93 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.056 -0.52 . . . . 64.3 110.77 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -61.96 -40.47 95.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 64.22 110.909 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.69 -46.82 88.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 71.45 110.242 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -33.22 59.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 72.45 111.173 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 29' ' ' ALA . 64.9 mt -57.74 -50.06 74.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.128 -0.323 . . . . 65.14 110.128 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.85 68.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.52 . . . . 62.42 110.673 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.87 -48.39 66.78 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.617 -0.719 . . . . 54.41 112.894 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -73.9 -22.76 59.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.169 0.485 . . . . 71.34 111.054 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -45.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.401 . . . . 64.52 110.001 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.6 37.02 4.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.939 -0.648 . . . . 61.3 111.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.4 m -153.45 117.79 4.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.728 0.299 . . . . 74.15 110.486 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.04 145.3 32.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.325 -0.398 . . . . 45.13 110.887 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 1.06 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 5.1 p90 -68.55 145.63 53.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 72.31 111.644 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.41 145.33 48.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 64.25 110.436 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 49' ' ' GLU . 51.5 t -68.68 125.88 27.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.252 -0.431 . . . . 72.52 111.082 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -80.74 143.77 32.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 70.04 110.445 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 10.0 tmtt? -62.32 -63.91 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 65.4 111.129 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -74.0 -31.17 62.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.258 -0.428 . . . . 73.45 111.665 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 m -81.66 -28.04 33.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.859 0.361 . . . . 75.41 111.524 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.33 95.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.542 -0.837 . . . . 61.53 111.615 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.19 144.01 31.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.446 -0.205 . . . . 72.55 110.446 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HG3' HG22 ' A' ' 42' ' ' VAL . 2.6 mp0 -73.78 123.29 23.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.161 -0.472 . . . . 64.42 111.213 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.3 t -138.74 140.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.633 . . . . 71.05 109.662 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.06 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 14.5 p -136.84 148.43 26.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.301 . . . . 63.31 110.933 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.653 HG22 HG12 ' A' ' 61' ' ' VAL . 24.0 p -103.36 161.27 13.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.175 -0.466 . . . . 60.12 110.902 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.95 -161.28 30.66 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.133 -0.556 . . . . 73.1 111.799 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.607 ' HD2' ' HA ' ' A' ' 59' ' ' SER . 11.0 mmm180 -131.75 127.32 36.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.803 0.301 . . . . 73.02 110.201 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.086 HD22 ' HB ' ' A' ' 60' ' ' VAL . 1.6 pt? -121.78 119.03 30.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.578 . . . . 75.42 109.441 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . . . 58.45 10.16 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.767 -0.651 . . . . 71.24 112.667 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.07 -16.87 17.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.54 -0.838 . . . . 74.2 112.45 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' ' 3' ' ' GLU . 98.0 m -89.88 139.73 30.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.246 -0.279 . . . . 71.42 110.246 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 20.8 m -68.45 109.74 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.688 -0.486 . . . . 53.11 109.688 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.086 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -98.93 136.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.115 0.483 . . . . 64.22 111.058 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.653 HG12 HG22 ' A' ' 52' ' ' THR . 6.4 m -120.43 112.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.741 -0.663 . . . . 75.04 109.318 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD23 ' HB ' ' A' ' 7' ' ' VAL . 91.9 mt -91.91 109.58 20.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 70.41 109.629 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.7 129.3 51.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.02 -0.536 . . . . 74.41 110.964 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 3.4 ptmt -121.28 132.32 24.24 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.769 -0.65 . . . . 51.43 110.175 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 24.0 Cg_exo -64.34 155.88 63.17 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.46 2.107 . . . . 73.43 110.959 174.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 18.1 ptp180 -65.17 -59.74 3.77 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.927 -0.309 . . . . 63.32 110.958 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.494 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 5.0 p -169.44 152.31 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.896 -0.409 . . . . 55.42 109.896 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.2 t80 75.48 126.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.874 0.733 . . . . 74.41 111.393 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -60.81 -40.21 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.393 -0.821 . . . . 75.32 112.209 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.76 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 73.42 110.851 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 4.9 tm-20 -68.64 -38.15 80.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.872 -0.788 . . . . 72.42 108.872 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -64.66 -23.7 67.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.811 . . . . 61.4 111.237 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.09 -29.99 76.49 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.982 -0.554 . . . . 44.31 112.993 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 36.0 ptt180 -93.26 -1.9 55.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 73.32 110.585 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -93.93 -47.97 6.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.977 -0.556 . . . . 63.35 111.333 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.2 -33.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 32.31 112.051 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 -70.78 0.88 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.027 -0.606 . . . . 54.1 112.765 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.37 -29.19 88.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.885 2.39 . . . . 75.43 112.634 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.65 -49.0 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 73.05 111.467 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -62.98 -37.19 86.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 70.01 111.18 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -2.77 57.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.103 -0.498 . . . . 74.3 111.502 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.51 -33.12 70.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 75.23 110.265 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.505 ' OH ' ' HB2' ' A' ' 6' ' ' LEU . 42.6 p90 -109.05 18.69 20.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.714 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.5 m 57.84 69.72 0.71 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.382 -0.827 . . . . 70.01 112.692 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 80' ' ' ALA . 3.9 p -130.08 145.91 59.23 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.077 -0.249 . . . . 75.21 110.517 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.75 145.92 87.45 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.984 1.789 . . . . 74.34 109.406 163.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.27 83.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.811 2.341 . . . . 63.44 113.691 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -159.66 -173.7 4.26 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.198 0.999 . . . . 72.35 108.762 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.454 ' O ' HD12 ' A' ' 5' ' ' LEU . 23.9 mm-40 57.53 31.52 20.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.201 0.445 . . . . 72.12 112.201 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.5 tt -111.33 135.46 50.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.979 0.419 . . . . 73.42 110.636 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.18 122.9 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.629 . . . . 73.31 109.757 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.8 114.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.038 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 63.7 mt -100.1 121.76 51.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.078 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.624 ' CE1' ' HG2' ' A' ' 134' ' ' ARG . 6.1 p-80 -159.59 -176.25 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 75.32 111.1 -176.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.18 154.93 22.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.209 -0.905 . . . . 62.24 111.791 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 8.9 tp10 -133.88 126.4 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.366 -0.605 . . . . 73.52 109.366 167.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 137' ' ' VAL . 7.5 tt -82.97 -24.8 32.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 72.15 111.111 -172.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.93 4.38 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 70.21 111.342 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mm -111.15 140.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.506 -0.316 . . . . 62.01 110.689 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.1 136.35 35.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.801 -0.636 . . . . 74.33 112.179 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.636 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 72.5 t80 -63.08 128.91 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.744 . . . . 75.23 111.523 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 108.66 -14.21 35.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.626 -0.797 . . . . 53.42 113.415 172.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 69.7 mmt-85 -124.32 168.77 12.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.446 0.623 . . . . 72.32 110.83 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.46 133.38 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 75.01 111.373 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 10.6 tpp180 -113.56 127.73 56.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.79 -0.641 . . . . 74.22 109.388 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.48 153.3 18.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 74.23 111.026 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 112' ' ' GLU . 38.3 tptt -153.71 148.17 26.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.263 -0.643 . . . . 64.11 109.263 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.8 mp -123.59 -90.62 0.57 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.099 0.476 . . . . 73.45 111.141 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.51 106.08 2.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.177 -0.535 . . . . 54.14 112.413 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.44 151.25 5.4 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.91 -0.662 . . . . 72.44 111.734 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.63 78.33 1.61 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.963 -0.637 . . . . 53.23 111.675 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.441 ' H ' ' NH2' ' A' ' 132' ' ' ARG . 32.0 tt0 -120.79 122.39 40.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.093 -0.336 . . . . 75.43 110.093 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.587 ' HA2' ' OE1' ' A' ' 96' ' ' GLU . . . 152.03 134.89 2.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.383 -0.687 . . . . 71.15 111.383 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.84 2.69 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.555 -0.831 . . . . 71.22 114.258 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -152.82 140.85 20.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.444 0.622 . . . . 74.31 110.857 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -45.7 -55.29 6.64 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.624 0.972 . . . . 63.45 113.624 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.8 -41.18 19.76 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 114.793 0.677 . . . . 44.14 114.793 -166.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 132' ' ' ARG . 3.3 pp -67.0 -25.76 66.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.102 0.451 . . . . 75.04 111.8 -173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -39.57 26.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 74.24 110.238 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.8 m -67.1 -38.02 84.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 73.42 111.703 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.1 -33.34 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 75.5 111.058 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.78 -33.44 72.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 24.22 110.318 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -70.05 -21.86 63.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.613 -0.721 . . . . 74.34 110.775 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.39 -27.84 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 44.11 111.248 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -103.64 -41.43 5.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.083 -0.508 . . . . 74.33 110.695 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.02 -0.79 79.51 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.478 -0.649 . . . . 65.15 111.478 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.7 m -115.97 143.68 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.84 -0.43 . . . . 74.41 109.84 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -120.68 -161.93 0.92 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.297 -0.41 . . . . 72.34 109.9 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.52 18.86 2.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.658 0.742 . . . . 72.44 110.416 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 45.4 p90 -86.43 156.99 19.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.598 -0.728 . . . . 74.11 110.058 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -78.29 110.8 13.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 73.42 110.577 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 118' ' ' LEU . 32.0 ttp-105 -108.98 109.38 20.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.915 -0.584 . . . . 73.13 110.111 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 61.2 t -85.6 133.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.531 -0.758 . . . . 73.03 109.979 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.803 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 84.7 mtm180 -131.23 109.33 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.248 -0.433 . . . . 74.12 111.226 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.01 123.54 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 43.15 109.586 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.45 125.2 28.59 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.758 -0.734 . . . . 54.43 112.151 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 97' ' ' LEU . 24.4 m -88.73 -12.45 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.785 0.326 . . . . 63.42 111.089 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.636 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 138.14 -142.18 12.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.761 -0.733 . . . . 50.41 111.929 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 138' ' ' GLY . 12.0 mmm180 -131.8 149.55 73.73 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.166 -0.679 . . . . 75.44 109.166 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 52.1 Cg_exo -55.26 114.5 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.678 2.252 . . . . 73.53 112.157 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.2 Cg_endo -82.72 160.34 16.46 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.205 2.604 . . . . 63.43 112.508 -176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -18.71 9.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.928 -0.653 . . . . 53.11 112.245 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -87.14 -45.27 10.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.065 0.46 . . . . 71.1 110.52 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 32.7 pttt -119.65 144.02 47.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.648 -0.705 . . . . 73.42 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.62 139.64 89.44 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.751 -0.659 . . . . 62.25 110.868 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.09 -34.04 45.77 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.361 2.708 . . . . 50.31 113.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.6 61.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.099 0.476 . . . . 73.12 111.171 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.36 -18.78 29.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 54.33 110.454 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.426 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 63.9 t80 -69.32 -27.44 65.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 72.24 110.687 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.553 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.9 m -86.09 1.44 5.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.504 -0.316 . . . . 65.3 111.239 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 17' ' ' TYR . 79.5 mt -95.53 1.33 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.632 0.234 . . . . 74.43 111.632 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.18 150.44 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 74.1 110.312 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.769 ' HB3' HG22 ' A' ' 20' ' ' THR . 27.1 p-10 -129.44 30.01 5.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.508 . . . . 60.23 111.223 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -146.84 143.76 28.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.138 -0.319 . . . . 52.14 110.138 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.64 177.18 11.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.808 -1.182 . . . . 72.35 107.808 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.6 -72.41 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.416 0.553 . . . . 32.53 112.252 -173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.17 -46.91 5.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.334 0.588 . . . . 50.41 111.885 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 1.2 pm0 -67.91 -17.21 64.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 73.44 112.064 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -65.31 -25.24 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.677 0.275 . . . . 73.33 110.387 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.61 -17.12 54.55 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.273 -0.421 . . . . 75.23 111.592 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 165' ' ' ILE . 60.6 mt-10 -85.84 -20.38 29.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.102 -0.239 . . . . 75.31 110.912 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.73 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 58.8 t -52.17 -55.79 27.99 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.399 . . . . 62.33 112.079 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.73 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 34.9 Cg_exo -61.94 -23.91 76.37 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.103 1.869 . . . . 63.24 112.525 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.587 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 11.5 m -81.8 -46.05 14.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.44 . . . . 41.43 111.021 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.538 HG22 ' CZ3' ' A' ' 191' ' ' TRP . 40.2 pt -65.94 -30.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.377 -0.374 . . . . 74.02 111.936 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 162' ' ' VAL . 56.2 t -61.25 -48.26 89.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 61.34 110.623 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.73 -39.73 95.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 31.25 110.744 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 164' ' ' THR . 71.9 mm-40 -65.68 -41.85 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 63.21 110.5 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.9 80.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 61.45 110.686 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.73 88.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 71.32 110.474 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.55 -37.05 76.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 74.32 110.362 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.84 -30.33 70.77 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.151 -0.477 . . . . 64.24 111.091 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 63.0 m -62.48 -43.34 99.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 61.2 110.143 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 41.3 mt-10 -71.72 -28.95 64.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 60.5 109.996 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.8 tp -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 71.54 110.545 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 85.1 mt -65.42 -22.0 66.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.819 -0.628 . . . . 72.43 110.69 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 5' ' ' LEU . 3.3 mm -80.49 -49.68 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.841 -0.618 . . . . 70.42 111.421 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.36 -28.53 12.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.511 0.93 . . . . 51.43 113.511 -167.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -100.59 -77.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.462 -0.495 . . . . 65.51 111.964 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -131.65 134.56 7.73 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.923 -1.132 . . . . 62.12 113.338 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.1 -34.39 38.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.933 0.397 . . . . 73.05 109.953 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.622 ' HG2' ' HD3' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -120.92 -36.28 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.702 1.001 . . . . 74.24 113.702 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.622 ' HD3' ' HG2' ' A' ' 182' ' ' GLU . 84.5 Cg_endo -81.55 -5.03 12.47 Favored 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 121.177 1.456 . . . . 74.15 113.635 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 187' ' ' THR . . . -69.47 -31.72 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 72.34 111.33 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.2 pt20 -67.97 -19.43 64.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.682 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.11 -43.09 77.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.329 . . . . 74.22 111.121 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 184' ' ' ALA . 15.4 t -76.44 -19.38 58.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.685 0.279 . . . . 62.43 111.132 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.89 -40.44 52.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 74.21 110.917 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -84.19 1.39 44.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.927 -0.309 . . . . 72.22 111.255 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.35 -4.02 57.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.917 0.389 . . . . 63.4 110.873 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.538 ' CZ3' HG22 ' A' ' 165' ' ' ILE . 17.7 t90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.318 -0.849 . . . . 71.02 110.364 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.4 pt-20 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 121.051 0.453 . . . . 73.22 110.816 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 14.0 Cg_endo -92.31 113.56 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.623 2.882 . . . . 53.22 112.615 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.599 HD11 HG13 ' A' ' 177' ' ' ILE . 95.7 mt -72.21 114.9 10.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.543 -0.753 . . . . 74.34 110.689 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 85' ' ' VAL . 42.9 tp -93.68 104.66 16.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.008 -0.738 . . . . 70.43 109.008 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.637 ' HB ' HD23 ' A' ' 62' ' ' LEU . 47.9 t -109.94 123.79 66.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.334 -0.394 . . . . 62.45 110.175 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 57.8 t -110.13 114.82 48.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.668 . . . . 72.11 110.292 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.29 122.37 7.42 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.244 -0.742 . . . . 64.2 111.244 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.774 ' HG ' ' HE1' ' A' ' 22' ' ' HIS . 30.3 tp -85.92 82.73 8.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.363 0.601 . . . . 73.33 110.998 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -150.49 118.26 0.91 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.342 -0.845 . . . . 75.24 111.115 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.64 151.56 37.61 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.497 -0.186 . . . . 75.42 110.497 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.27 161.62 45.33 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.465 2.11 . . . . 74.31 112.464 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' HA3' ' HD1' ' A' ' 17' ' ' TYR . . . 148.75 142.74 3.67 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.852 -0.613 . . . . 61.21 111.782 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.33 -42.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.826 2.35 . . . . 64.02 112.216 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 20' ' ' THR . 8.0 p -90.76 -37.93 13.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.937 -0.574 . . . . 64.31 110.856 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HD1' ' HA3' ' A' ' 14' ' ' GLY . 84.9 m-85 -62.04 -35.09 77.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.896 -0.593 . . . . 73.22 112.281 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 -13.25 60.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 73.52 111.104 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -112.06 28.26 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 73.21 110.334 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.81 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 79.2 p -102.12 -176.39 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.841 -0.618 . . . . 72.33 110.906 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -86.41 -15.42 40.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.476 0.655 . . . . 73.42 109.503 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.774 ' HE1' ' HG ' ' A' ' 10' ' ' LEU . 14.8 t-80 -76.75 -22.25 54.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.145 -0.934 . . . . 74.14 110.405 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 27' ' ' MET . 65.7 t30 -73.78 -0.08 14.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.006 0.432 . . . . 73.51 111.266 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.39 -29.5 68.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.562 -0.29 . . . . 73.4 111.254 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.32 -30.71 78.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.926 -0.654 . . . . 72.51 112.49 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 67.2 t80 -90.36 -22.38 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.784 -0.244 . . . . 74.25 110.833 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' VAL . 26.2 mmt -50.49 -48.3 56.9 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.241 -0.436 . . . . 73.24 111.766 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.88 -46.86 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 64.11 110.803 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.31 82.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 51.54 111.388 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.4 -37.27 84.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.398 . . . . 74.33 111.04 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' MET . 62.6 t -65.51 -39.04 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.181 0.515 . . . . 71.21 109.852 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.85 -43.27 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.624 . . . . 75.34 110.698 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.22 90.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 72.0 110.906 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.49 91.26 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.982 -0.554 . . . . 72.14 112.878 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -70.13 -24.2 63.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.818 0.309 . . . . 73.14 111.206 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' A' ' 53' ' ' GLY . 82.7 mt -77.58 -49.77 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.409 -0.589 . . . . 73.42 109.409 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.99 62.19 1.07 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.84 -0.695 . . . . 52.54 112.425 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.4 m -156.3 144.62 19.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.919 0.39 . . . . 64.11 110.718 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.98 151.65 27.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 73.1 110.215 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.98 138.54 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.892 0.377 . . . . 73.33 110.672 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -101.36 126.6 48.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 75.53 110.043 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 t -78.1 129.75 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 74.13 110.301 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -68.79 102.71 1.6 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.622 -0.263 . . . . 61.5 110.776 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 58.7 tttm -64.11 88.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.121 -0.696 . . . . 74.23 109.121 172.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.8 tttp 174.22 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.928 -1.033 . . . . 74.53 109.021 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 p -125.15 -19.18 5.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.538 -0.755 . . . . 52.55 111.477 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.73 18.23 45.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 51.05 112.955 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.65 123.43 35.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.579 0.228 . . . . 74.33 110.654 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 2.2 mp0 -84.98 140.34 31.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 72.31 110.928 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 63' ' ' ALA . 97.6 t -139.4 137.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 73.42 110.404 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 6.9 p -118.91 145.49 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.709 -0.478 . . . . 74.44 109.709 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.54 HG23 HG12 ' A' ' 61' ' ' VAL . 1.6 m -116.71 142.59 46.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.232 -0.44 . . . . 63.53 111.637 -172.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -178.17 -161.53 26.39 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.173 -0.771 . . . . 60.01 111.173 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.97 ' HG2' ' HA ' ' A' ' 59' ' ' SER . 37.2 mtm180 -136.34 146.09 46.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.916 0.389 . . . . 72.0 110.684 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.59 103.05 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 73.54 109.698 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.19 -51.58 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.963 0.79 . . . . 75.54 111.713 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.21 -36.98 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.048 -0.821 . . . . 63.33 111.048 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 3' ' ' GLU . 4.1 m -68.58 151.56 46.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.439 0.295 . . . . 60.32 110.37 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.97 ' HA ' ' HG2' ' A' ' 54' ' ' ARG . 21.9 m -85.72 139.98 30.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.678 . . . . 70.31 109.171 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.35 132.1 52.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.368 0.604 . . . . 71.54 111.307 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.54 HG12 HG23 ' A' ' 52' ' ' THR . 8.3 m -117.68 115.5 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 42.41 109.333 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.637 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.7 mt -92.42 104.59 16.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.951 -0.568 . . . . 71.41 109.838 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -108.98 137.58 46.68 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 62.2 110.146 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -130.71 143.01 47.61 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 63.4 110.498 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.41 166.67 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.521 2.147 . . . . 64.43 111.635 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -84.8 -54.14 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.798 -0.361 . . . . 73.24 111.395 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.9 p -167.67 163.54 14.41 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.699 0.259 . . . . 71.21 111.699 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 69.41 163.81 0.24 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.976 0.797 . . . . 64.2 112.565 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.0 mmt -73.24 -56.61 4.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.922 -0.581 . . . . 72.23 110.946 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.08 -40.65 87.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.817 -0.629 . . . . 65.1 111.783 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 67' ' ' CYS . 42.7 mt-10 -59.84 -40.31 88.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.523 -0.308 . . . . 64.44 110.861 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -36.27 83.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.863 0.363 . . . . 64.21 110.53 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.88 -39.89 97.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.46 -0.656 . . . . 73.53 111.46 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.28 -0.54 19.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 75.13 110.726 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 23.0 mm-40 -103.53 -51.05 3.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 55.12 111.038 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.81 -34.69 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 70.15 111.31 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.32 -67.19 2.34 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.989 -0.55 . . . . 72.35 113.374 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.87 -27.6 59.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.692 2.261 . . . . 62.34 113.612 -177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 47.2 mt -57.5 -40.55 78.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.848 0.314 . . . . 73.24 111.848 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.73 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.022 0.439 . . . . 53.31 111.378 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.99 -7.41 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.354 -0.385 . . . . 73.13 111.235 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -79.12 -46.65 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.83 0.348 . . . . 73.02 110.128 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -93.03 1.45 57.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.148 -0.478 . . . . 73.44 111.232 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 60.46 37.57 19.74 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.686 0.617 . . . . 72.4 110.752 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.536 HG21 HD22 ' A' ' 6' ' ' LEU . 27.5 m -92.15 142.98 26.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.81 -0.632 . . . . 64.34 110.466 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.832 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 4.1 Cg_exo -77.0 133.9 14.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.68 2.253 . . . . 70.13 111.81 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.555 ' O ' HG22 ' A' ' 90' ' ' ILE . 36.2 Cg_endo -66.0 -4.56 10.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.974 2.45 . . . . 74.4 112.587 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.832 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.9 pt20 -71.62 -20.38 61.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.105 -0.498 . . . . 75.3 110.598 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.762 ' HG3' ' HG3' ' A' ' 88' ' ' GLN . 97.9 mt-30 -124.43 24.52 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.083 -0.508 . . . . 74.22 111.655 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 87' ' ' PRO . 13.1 tt -86.93 105.5 15.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.757 0.789 . . . . 74.5 110.176 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.77 113.38 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.369 -0.832 . . . . 72.24 110.631 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.62 114.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.408 -0.36 . . . . 72.0 110.157 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.507 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 58.3 mt -101.26 120.16 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.913 -0.585 . . . . 74.41 109.776 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.41 ' CE1' HD22 ' A' ' 118' ' ' LEU . 32.1 p80 -142.01 174.9 10.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.966 0.413 . . . . 72.22 111.349 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.21 148.28 26.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.219 -0.901 . . . . 54.34 109.529 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.695 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -139.5 128.85 24.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.079 0.466 . . . . 73.53 110.389 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.55 -33.93 25.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.68 -0.691 . . . . 73.35 111.681 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.53 -38.49 26.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 50.43 111.392 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.613 HG12 ' OE1' ' A' ' 96' ' ' GLU . 37.9 mm -65.58 143.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 43.1 111.628 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 12.1 m-20 -57.07 139.59 51.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.602 -0.726 . . . . 73.15 111.218 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.735 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 80.3 t80 -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 74.43 111.683 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 92.26 -24.38 22.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.656 -0.702 . . . . 62.44 112.825 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -90.92 130.92 36.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.145 0.498 . . . . 61.42 110.842 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 104' ' ' ILE . 3.7 mp -92.42 114.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.947 -0.76 . . . . 73.22 108.947 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -107.48 125.19 50.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 75.32 110.254 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.3 mt -103.89 135.19 45.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.616 -0.72 . . . . 74.15 110.526 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.26 156.54 45.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.944 -0.762 . . . . 74.12 108.944 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.37 -132.4 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.463 -0.569 . . . . 73.11 109.463 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.494 ' N ' ' HA ' ' A' ' 129' ' ' ASN . . . 49.34 -153.01 2.92 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.423 -0.418 . . . . 71.32 112.759 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.35 173.29 27.29 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.778 -0.929 . . . . 74.01 110.778 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 119' ' ' ARG . . . -83.55 85.49 1.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.146 -1.026 . . . . 64.32 111.922 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 -43.01 11.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.635 0.255 . . . . 72.11 111.268 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.84 109.23 2.87 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.146 -0.55 . . . . 75.43 112.343 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.48 -100.85 0.2 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.057 -0.592 . . . . 72.45 111.969 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -164.17 173.99 11.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.585 0.231 . . . . 74.13 111.322 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -40.21 -56.17 1.99 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.129 1.159 . . . . 74.2 114.129 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.44 -29.25 72.82 Favored Glycine 0 CA--C 1.509 -0.283 0 C-N-CA 121.233 -0.508 . . . . 61.11 112.476 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 23.5 tp -65.83 -38.67 89.53 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.426 -0.387 . . . . 54.44 110.68 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 111' ' ' GLY . 1.7 mpp_? -79.65 -23.25 42.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.76 -0.376 . . . . 70.13 110.625 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -66.95 -44.81 79.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 60.21 110.603 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.2 m -69.3 -27.77 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 72.43 110.798 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.16 -43.57 61.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.524 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -70.28 -25.52 63.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 65.13 111.589 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.68 92.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 31.43 110.643 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.52 -42.07 20.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.855 -0.611 . . . . 71.22 110.336 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.08 1.81 88.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.935 -0.65 . . . . 60.54 111.757 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.644 HG22 ' HE1' ' A' ' 130' ' ' PHE . 4.8 m -111.5 122.66 48.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.931 0.396 . . . . 72.12 110.308 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 53.7 mtmt -126.63 178.83 5.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.453 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.494 ' HA ' ' N ' ' A' ' 109' ' ' GLY . 22.8 m-20 75.35 67.71 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.862 0.726 . . . . 74.33 112.112 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.644 ' HE1' HG22 ' A' ' 127' ' ' THR . 60.5 m-85 -142.99 -87.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 74.11 111.337 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.488 ' C ' ' HD2' ' A' ' 132' ' ' ARG . 12.7 t60 -161.88 104.97 1.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.635 0.255 . . . . 34.01 110.644 -174.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.488 ' HD2' ' C ' ' A' ' 131' ' ' HIS . 2.6 mpt_? -114.27 141.03 48.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.529 0.204 . . . . 70.24 110.549 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 93.5 t -104.19 118.23 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 72.01 111.047 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.695 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 35.6 mtp180 -112.41 104.67 12.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.061 -0.518 . . . . 71.55 110.254 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.3 mt -85.81 115.09 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.85 -0.426 . . . . 63.43 109.85 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.31 118.77 11.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.902 -0.666 . . . . 73.05 112.651 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.52 -11.51 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 70.21 110.086 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 136.9 -77.55 0.34 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 73.52 113.326 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -170.73 165.6 5.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.983 -0.377 . . . . 72.03 109.983 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 53.1 Cg_exo -53.85 142.1 64.25 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.474 2.116 . . . . 73.34 111.279 171.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 25.3 Cg_exo -61.72 -66.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 123.027 2.485 . . . . 43.14 113.327 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.7 -69.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.589 -0.815 . . . . 51.12 112.438 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 143' ' ' ARG . 10.5 mmt180 -82.01 -70.07 0.57 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.85 0.357 . . . . 74.2 110.778 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.571 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -80.89 159.99 24.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 73.33 110.486 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.748 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 2.5 p30 -79.76 166.39 41.21 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.548 -0.296 . . . . 74.44 110.776 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.748 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 10.9 Cg_endo -53.79 -36.0 80.98 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.371 2.714 . . . . 35.52 113.986 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.15 77.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 72.44 110.603 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.91 -31.87 59.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.083 -0.508 . . . . 51.43 110.216 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.571 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 88.9 t80 -64.5 -42.81 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.567 -0.742 . . . . 71.23 111.321 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.81 ' O ' ' HB ' ' A' ' 20' ' ' THR . 34.9 m -83.28 -9.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.915 -0.314 . . . . 65.14 111.167 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 20' ' ' THR . 49.5 tp -83.75 -25.63 30.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.104 0.478 . . . . 74.24 111.136 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.04 176.68 8.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.962 0.41 . . . . 65.23 110.616 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -81.26 171.97 14.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 72.42 110.662 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 40.3 m-85 -65.44 145.13 56.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 73.34 110.097 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -68.92 162.2 27.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.284 -0.265 . . . . 73.4 110.284 -178.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.92 9.52 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.033 0.753 . . . . 65.21 113.033 -162.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.74 88.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.012 0.434 . . . . 62.33 112.13 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.572 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 2.2 pm0 -89.34 -16.58 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.077 -0.511 . . . . 74.5 111.655 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 155' ' ' THR . 60.2 ttt180 -61.04 -25.09 66.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 74.44 111.424 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.33 -14.4 62.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.283 -0.417 . . . . 75.01 111.919 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -111.4 5.97 20.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.742 0.306 . . . . 73.31 111.245 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 159' ' ' ARG . 94.8 t -63.82 -52.73 55.41 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.449 -0.341 . . . . 51.12 111.746 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 11.3 Cg_endo -55.53 -33.79 87.63 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.927 1.752 . . . . 70.14 111.873 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.7 m -65.95 -49.46 67.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.625 -0.716 . . . . 51.35 111.178 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 162' ' ' VAL . 35.3 pt -67.89 -30.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.431 -0.35 . . . . 72.33 111.42 -175.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.4 t -63.9 -45.47 96.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.402 . . . . 64.11 110.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -67.86 -37.6 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 71.24 110.812 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -63.65 -44.31 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 53.13 110.896 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.95 98.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 70.05 111.219 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.24 96.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.253 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.84 -44.14 86.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 73.03 110.522 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -64.3 -37.96 89.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 60.44 111.664 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 87.3 m -58.32 -40.36 81.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.865 0.364 . . . . 44.23 111.045 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.13 -40.03 90.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 71.33 110.235 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.55 -37.34 87.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 72.43 110.885 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 87.1 mt -60.18 -42.86 95.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 74.5 111.868 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.599 HG13 HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.87 -27.28 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 70.24 110.382 -176.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -83.96 -58.28 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.216 -0.447 . . . . 54.44 111.841 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -24.98 35.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 71.51 111.439 -175.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 113.89 -161.13 12.81 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.641 -0.79 . . . . 75.21 112.112 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.64 -68.8 0.68 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.741 0.305 . . . . 65.13 110.847 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.641 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.6 tt0 -55.02 -55.3 40.48 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.155 0.798 . . . . 75.12 113.155 -172.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 23.1 Cg_exo -65.16 -31.06 54.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.15 1.9 . . . . 64.35 113.087 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.43 -48.71 7.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.504 0.557 . . . . 72.51 112.504 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -20.23 65.7 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 121.216 -0.193 . . . . 74.22 111.51 -174.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -53.54 -51.08 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.415 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -72.28 -21.62 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 71.32 111.266 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.8 t -70.11 -24.2 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 73.53 111.283 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -116.91 13.38 14.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.882 0.372 . . . . 72.03 110.388 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.11 27.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.092 -0.503 . . . . 71.1 111.092 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.417 ' HH2' HG22 ' A' ' 165' ' ' ILE . 15.1 p-90 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.301 -0.857 . . . . 73.22 110.912 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 14.3 pt-20 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.252 0.548 . . . . 72.33 110.414 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 1.3 Cg_endo -83.71 110.19 1.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.805 2.337 . . . . 73.42 112.113 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 89' ' ' GLN . 36.7 tp -74.32 118.35 17.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 75.04 109.846 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HA ' HG23 ' A' ' 61' ' ' VAL . 69.8 tp -92.8 104.96 17.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.18 -0.464 . . . . 75.04 110.128 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HB ' HD23 ' A' ' 62' ' ' LEU . 44.9 t -105.58 121.27 57.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.246 -0.434 . . . . 72.33 110.408 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.95 114.87 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.754 -0.657 . . . . 74.23 109.902 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.85 123.15 6.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.846 -0.692 . . . . 73.33 111.846 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 96.16 1.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.846 0.355 . . . . 73.23 110.199 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -111.93 85.68 0.4 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.783 -0.723 . . . . 61.2 112.993 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 28.0 m-80 -100.89 117.75 61.91 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.995 -0.372 . . . . 71.03 109.995 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 3.0 Cg_exo -75.49 177.79 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.155 2.57 . . . . 74.13 112.369 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 17' ' ' TYR . . . 155.5 179.05 30.32 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.04 -0.6 . . . . 70.33 111.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.09 -71.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.885 2.39 . . . . 74.34 111.559 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.612 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 15.1 t -117.33 6.26 12.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.815 -0.809 . . . . 71.42 108.815 172.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.2 t80 -69.19 -26.09 64.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.778 -1.101 . . . . 75.22 110.313 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . . . -87.48 1.6 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 61.05 110.983 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -120.72 3.18 10.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.435 -178.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.832 ' HA ' ' HB3' ' A' ' 153' ' ' ASN . 14.9 t -103.7 -177.66 3.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.918 0.39 . . . . 73.13 111.875 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.614 ' HD3' HG13 ' A' ' 137' ' ' VAL . 61.6 mtt180 -64.92 -20.72 66.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.0 -0.546 . . . . 74.4 111.63 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.576 ' H ' HG23 ' A' ' 20' ' ' THR . 5.9 t60 -78.78 -7.99 58.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.972 0.415 . . . . 71.04 110.576 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.26 8.22 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 72.12 110.43 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 75.0 mt -55.74 -29.8 60.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.511 -0.313 . . . . 75.12 111.67 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.56 -33.05 86.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 72.03 112.462 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.642 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 87.5 t80 -88.36 -30.7 19.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.544 0.212 . . . . 72.44 110.718 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mmm -50.19 -42.89 52.12 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 62.24 111.993 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 t -69.53 -47.15 73.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.345 . . . . 75.43 110.789 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.57 74.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.29 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.3 -45.43 91.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 74.42 110.9 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.8 t -72.85 -36.82 53.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.592 . . . . 72.35 110.503 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.03 -44.99 96.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 61.44 110.876 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.83 80.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 55.3 110.554 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.59 95.21 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.866 -0.606 . . . . 74.42 112.832 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -21.57 54.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 117.044 0.422 . . . . 74.51 111.314 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.515 HD13 ' HA3' ' A' ' 53' ' ' GLY . 80.6 mt -77.84 -43.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.585 -0.524 . . . . 73.31 109.585 173.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.04 33.81 5.89 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.868 -0.682 . . . . 75.32 111.942 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -145.66 135.32 23.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.746 0.308 . . . . 64.11 110.253 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 148.44 24.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.287 -0.415 . . . . 74.3 110.693 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.781 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 11.1 p90 -66.31 124.72 23.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.61 . . . . 64.04 110.638 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 13.0 ptpt -101.1 143.88 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.608 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.629 HG22 ' HG2' ' A' ' 49' ' ' GLU . 19.7 t -81.69 135.55 24.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 72.2 111.584 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.36 104.51 16.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.932 -0.577 . . . . 72.53 109.97 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.48 90.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.9 -0.408 . . . . 75.11 109.9 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.5 tptt 174.34 -58.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.251 -0.886 . . . . 73.13 108.695 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -106.76 -14.33 15.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.345 -0.843 . . . . 74.12 110.519 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 83.76 3.9 89.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.943 -0.646 . . . . 21.13 112.348 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.38 144.29 28.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.821 0.344 . . . . 55.32 110.746 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.2 mt-10 -108.56 122.16 46.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.944 -0.571 . . . . 63.11 109.637 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -129.15 137.56 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.441 -0.345 . . . . 71.33 110.476 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.781 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 5.0 p -121.47 135.63 61.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.934 0.397 . . . . 75.4 110.2 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.784 HG22 HG12 ' A' ' 61' ' ' VAL . 11.9 p -106.71 136.58 46.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.132 -0.485 . . . . 70.31 110.982 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.515 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -160.7 -161.14 11.22 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.473 -0.87 . . . . 42.3 112.576 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 13.2 mmt180 -121.59 142.41 50.13 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 73.5 110.088 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.134 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -126.9 115.77 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.726 -0.842 . . . . 74.22 108.726 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.6 -36.83 0.31 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.706 -0.679 . . . . 62.52 111.305 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 165.88 -33.15 0.23 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.852 -0.899 . . . . 72.24 110.852 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 59' ' ' SER . 1.7 m -75.37 169.24 18.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.372 -0.414 . . . . 73.44 110.759 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . 2.9 m -79.78 131.46 35.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.753 0.311 . . . . 74.04 111.383 -175.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.134 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -127.06 137.42 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.94 -0.392 . . . . 74.23 109.94 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.784 HG12 HG22 ' A' ' 52' ' ' THR . 12.4 m -120.25 115.4 47.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.209 0.528 . . . . 74.4 110.532 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 61.9 mt -96.79 105.0 17.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 74.23 109.586 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.2 127.58 55.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.979 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 6.4 ptmt -119.15 126.69 26.91 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.221 -0.445 . . . . 73.33 110.393 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.761 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 39.6 Cg_exo -61.53 149.74 88.4 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.398 2.065 . . . . 65.1 110.619 173.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 25.7 ptt180 -64.55 -53.42 48.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 75.11 111.13 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 29.1 p -168.57 174.69 6.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.422 -0.214 . . . . 54.11 110.422 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.538 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 9.9 t80 75.27 138.27 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.047 0.842 . . . . 74.1 112.316 167.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.97 -52.69 62.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 61.45 111.322 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.56 -36.65 76.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.04 111.17 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 6.4 mt-10 -60.31 -43.55 96.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.705 -0.225 . . . . 64.15 110.821 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -54.87 -32.42 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.372 0.42 . . . . 63.12 111.341 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.799 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -67.47 -39.21 91.27 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.895 -0.669 . . . . 61.21 112.118 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' NH2' ' HG2' ' A' ' 71' ' ' GLU . 20.1 ptt180 -91.09 2.75 56.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 73.22 110.681 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.761 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 24.6 mm-40 -81.23 -51.89 7.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 74.23 110.22 174.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.17 -44.77 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.757 -0.656 . . . . 63.31 112.29 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.79 -66.23 2.7 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.135 -0.484 . . . . 75.42 113.674 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 -41.43 78.87 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.867 2.378 . . . . 71.1 113.0 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.03 -39.54 95.05 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.768 0.284 . . . . 63.31 111.768 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.38 91.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.0 0.428 . . . . 61.43 111.163 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.9 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.172 -0.467 . . . . 71.3 111.068 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.88 -42.12 97.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 71.2 109.696 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -82.16 -15.28 53.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.723 -0.671 . . . . 73.23 110.621 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m 62.37 34.68 15.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.762 -0.653 . . . . 53.12 110.515 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.4 m -100.29 143.99 27.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.757 -0.656 . . . . 62.24 110.635 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 10.5 Cg_exo -71.2 115.62 4.35 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.733 2.289 . . . . 64.1 111.574 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.39 33.28 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.185 2.59 . . . . 73.14 113.4 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -78.65 -48.75 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.339 -0.615 . . . . 74.43 109.339 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.537 ' HB3' HD12 ' A' ' 5' ' ' LEU . 1.8 mp0 -88.86 68.59 8.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.751 -0.659 . . . . 71.23 109.812 175.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.17 138.03 31.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.54 -0.755 . . . . 72.33 110.388 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.1 t -127.75 109.88 20.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 73.33 110.067 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.59 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 58.5 t -105.78 113.43 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.702 -0.481 . . . . 65.22 109.702 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 58.2 mt -93.46 122.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.062 -0.517 . . . . 75.01 110.396 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.424 ' HE1' ' CB ' ' A' ' 115' ' ' HIS . 16.7 t-80 -149.02 162.89 39.01 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.643 -0.423 . . . . 74.24 112.129 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 8.8 p-10 -90.34 139.28 30.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.465 -0.789 . . . . 53.41 110.314 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.848 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 75.8 mm-40 -137.23 140.38 41.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.911 0.386 . . . . 70.13 111.734 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.47 HD23 ' HB ' ' A' ' 137' ' ' VAL . 95.1 mt -84.22 -25.6 29.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.819 -0.628 . . . . 74.4 112.039 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.2 -34.47 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.468 0.651 . . . . 61.55 110.542 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.696 ' HB ' ' HA2' ' A' ' 136' ' ' GLY . 9.2 mt -84.64 139.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.473 -0.785 . . . . 71.4 109.999 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -67.08 144.77 55.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.883 -0.414 . . . . 72.33 109.883 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 65.7 t80 -63.37 124.4 21.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.773 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.88 -21.11 8.0 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.059 -1.067 . . . . 45.33 113.469 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -123.69 169.11 11.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.541 0.671 . . . . 62.42 111.234 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.619 HG12 HG13 ' A' ' 135' ' ' ILE . 65.9 mt -118.65 139.38 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.918 -0.583 . . . . 70.02 110.745 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 25.6 tpt180 -111.98 124.15 51.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.049 176.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.2 mt -108.21 127.25 53.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 61.35 110.181 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -154.8 151.03 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.49 -0.559 . . . . 71.05 109.49 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.888 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 1.3 pt? -67.3 -71.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 74.14 111.668 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.888 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -153.75 155.31 26.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.724 -0.55 . . . . 63.22 111.724 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.41 176.56 18.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.947 -0.644 . . . . 72.2 111.691 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.0 77.45 2.11 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.73 -0.748 . . . . 73.5 111.899 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -129.83 21.31 5.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.709 0.766 . . . . 73.35 109.341 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -145.78 95.42 0.17 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.457 -0.792 . . . . 62.43 112.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.99 67.5 3.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 62.02 112.112 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 96' ' ' GLU . 33.0 m80 -139.19 146.04 40.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 71.34 111.008 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.66 -55.15 38.77 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.642 -0.708 . . . . 75.44 111.95 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.72 -28.84 70.22 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.853 -0.612 . . . . 64.21 112.081 -168.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 74.43 110.127 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.98 -27.24 60.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.794 -0.639 . . . . 74.12 110.139 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.2 m -66.69 -52.17 47.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 73.5 110.766 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.799 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -66.33 -30.65 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.737 0.303 . . . . 62.4 110.84 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.02 71.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.32 111.138 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.4 m -84.62 -35.58 22.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 62.5 111.101 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.5 . . . . 63.1 111.269 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 -42.43 12.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.205 0.526 . . . . 74.23 110.076 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.13 -13.38 32.69 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.732 -0.667 . . . . 62.12 112.879 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 p -114.01 122.93 48.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.408 0.623 . . . . 72.13 111.624 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.6 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 4.5 mptt -99.75 -91.7 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.79 -1.189 . . . . 74.13 107.79 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 55.07 7.97 0.21 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.854 1.798 . . . . 73.35 115.854 162.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.31 -90.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.955 0.798 . . . . 72.44 111.923 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -175.92 135.38 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 63.31 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.59 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 10.5 mpt_? -121.49 124.53 44.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.083 -0.508 . . . . 71.41 110.056 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 59.1 t -83.9 104.07 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.688 -0.486 . . . . 64.22 109.688 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.848 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 49.1 mtm-85 -122.64 127.6 49.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.883 0.373 . . . . 61.33 110.53 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.619 HG13 HG12 ' A' ' 104' ' ' ILE . 3.8 mp -94.28 139.9 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.567 -0.742 . . . . 72.04 109.859 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.696 ' HA2' ' HB ' ' A' ' 99' ' ' ILE . . . -72.61 129.66 14.13 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.868 -0.682 . . . . 61.44 112.646 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.614 HG13 ' HD3' ' A' ' 21' ' ' ARG . 27.3 t -95.92 -11.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.316 0.579 . . . . 62.33 109.972 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.14 166.52 26.83 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.676 -0.773 . . . . 60.32 111.849 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.42 146.56 50.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.172 -0.307 . . . . 72.5 110.172 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.63 120.59 7.74 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.012 2.475 . . . . 64.13 113.122 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.91 158.94 40.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.239 2.626 . . . . 71.21 112.558 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.25 -24.66 6.73 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.855 -0.688 . . . . 53.22 112.805 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -83.82 -70.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.711 0.255 . . . . 73.45 110.738 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.59 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -89.29 157.11 18.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.465 -0.494 . . . . 75.2 110.594 178.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.28 133.0 92.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 64.15 111.738 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.56 -29.04 88.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.252 2.635 . . . . 61.32 113.06 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.463 . . . . 41.21 109.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' GLU . . . -69.36 -28.65 66.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.61 -0.723 . . . . 64.23 109.975 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.59 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 87.0 t80 -65.13 -29.59 70.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 74.31 110.809 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.3 -23.22 10.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 75.13 110.343 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.35 -26.01 30.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 63.24 111.081 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.545 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 8.9 pt-20 -87.31 153.28 21.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 74.15 110.501 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.832 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 34.9 p-10 -132.77 14.18 4.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 63.2 110.908 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -107.03 156.08 19.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 54.12 110.304 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -169.83 178.37 4.06 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.716 -1.216 . . . . 71.54 107.716 175.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.93 -72.95 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.234 -0.586 . . . . 72.03 111.074 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.57 -24.02 16.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.465 0.65 . . . . 73.42 110.194 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.538 ' HB2' ' CB ' ' A' ' 155' ' ' THR . 22.3 mp0 -68.6 -36.83 79.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.316 -0.856 . . . . 75.32 110.556 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 7.7 tpt180 -68.1 -17.61 64.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 72.33 110.501 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.07 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 73.41 110.919 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 165' ' ' ILE . 34.8 mt-10 -89.7 -5.42 57.06 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.179 -0.208 . . . . 70.44 111.534 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.679 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 85.2 t -56.32 -51.8 78.08 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.667 0.247 . . . . 73.22 111.667 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 23.9 Cg_exo -64.97 -29.52 57.44 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.761 1.64 . . . . 64.22 111.984 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.1 m -73.59 -40.25 64.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.761 -0.654 . . . . 75.4 111.83 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 135' ' ' ILE . 34.8 pt -64.93 -30.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 121.031 -0.268 . . . . 65.31 110.969 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.01 -39.34 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.418 . . . . 72.12 109.98 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 163' ' ' PRO . 8.8 mm-40 -58.59 -50.62 73.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.697 -0.683 . . . . 71.21 110.413 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -68.99 -32.88 72.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.745 -0.661 . . . . 74.44 111.232 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.39 78.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 73.45 110.606 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.86 95.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.154 -0.475 . . . . 63.11 110.497 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.99 -50.06 75.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 65.4 110.961 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.85 -44.97 96.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 72.54 111.702 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.5 m -56.32 -42.78 78.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 61.21 111.359 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.84 -29.45 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 61.23 110.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.11 -28.62 66.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 74.24 110.472 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.2 mt -60.04 -47.34 86.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.862 -0.608 . . . . 75.42 111.084 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 177' ' ' ILE . 0.0 OUTLIER -79.92 -37.37 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.545 . . . . 74.32 110.832 -175.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -77.79 -54.51 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.83 0.307 . . . . 44.43 111.83 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -94.34 -57.28 2.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.404 -0.362 . . . . 62.22 110.632 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 159.77 151.74 6.26 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.744 -0.741 . . . . 64.31 111.848 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 176' ' ' LEU . 4.0 pp -71.92 -24.55 61.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.841 0.353 . . . . 60.41 111.546 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.468 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 30.0 tt0 -82.9 -51.96 0.67 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.387 -0.369 . . . . 73.45 111.612 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 17.2 Cg_endo -59.9 -35.9 92.21 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.058 1.839 . . . . 70.2 112.168 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.434 ' HB3' HD23 ' A' ' 176' ' ' LEU . . . -64.14 -45.32 89.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.349 . . . . 72.11 110.331 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -54.72 -49.78 69.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.738 -0.664 . . . . 62.34 110.783 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -57.69 -35.93 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 74.5 110.861 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.2 m -70.69 -54.24 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 64.3 110.992 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.3 t -67.83 -43.32 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.61 0.596 . . . . 74.24 112.61 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -76.09 -3.81 38.03 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.667 -0.413 . . . . 63.33 111.39 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.98 22.08 8.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.096 0.474 . . . . 62.23 110.429 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.8 t90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.404 -0.808 . . . . 63.22 110.354 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.519 -0.549 . . . . 74.14 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.872 ' HB2' HG12 ' A' ' 85' ' ' VAL . 5.6 Cg_endo -87.8 118.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.77 2.314 . . . . 74.05 112.617 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.6 tp -88.0 121.14 30.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 72.04 109.651 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 90' ' ' ILE . 61.1 tp -92.87 117.5 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.969 -0.382 . . . . 64.1 109.969 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.76 ' HB ' HD23 ' A' ' 62' ' ' LEU . 46.4 t -113.53 118.06 57.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.655 -0.498 . . . . 62.43 109.655 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.53 114.96 45.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.886 -0.597 . . . . 65.02 109.97 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.516 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -105.9 122.17 7.02 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.568 -0.825 . . . . 70.02 111.674 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.79 89.59 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 75.2 110.711 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.843 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -142.75 110.55 0.62 Allowed Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.488 -0.778 . . . . 75.35 111.4 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.39 149.96 47.98 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.531 0.205 . . . . 70.01 110.664 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.691 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 73.7 Cg_endo -74.39 175.91 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.454 2.102 . . . . 60.12 111.791 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 17' ' ' TYR . . . 121.34 136.79 5.11 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.423 -0.894 . . . . 61.32 112.1 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.68 -28.7 82.73 Favored 'Trans proline' 0 C--O 1.225 -0.147 0 C-N-CA 123.159 2.573 . . . . 70.33 112.988 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 t -113.08 16.35 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 51.01 111.062 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' ' HA3' ' A' ' 14' ' ' GLY . 75.5 m-85 -106.28 -34.87 7.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 64.44 111.611 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.14 -4.5 25.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.247 0.832 . . . . 74.44 113.247 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -124.42 27.78 6.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.127 0.489 . . . . 72.51 110.753 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 69.5 p -102.5 -170.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.738 -0.665 . . . . 63.44 110.087 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 55.0 mtt180 -84.52 -0.73 54.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.986 0.422 . . . . 61.14 110.459 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -105.21 19.49 20.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 72.14 110.683 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -99.08 3.31 46.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.377 -0.374 . . . . 74.14 110.596 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.427 HD11 HG12 ' A' ' 137' ' ' VAL . 91.1 mt -55.67 -42.76 75.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.781 -0.645 . . . . 71.11 112.064 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.38 -37.75 94.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.65 -0.786 . . . . 25.3 112.004 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.843 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 75.4 t80 -73.21 -32.77 64.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.263 -0.273 . . . . 62.42 110.263 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.564 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 9.0 mmt -54.21 -54.02 45.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 74.32 111.692 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.95 -45.04 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 63.45 110.919 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.64 95.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 63.43 111.117 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.93 -42.27 97.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 62.11 110.978 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' MET . 90.4 t -61.88 -44.18 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.31 110.585 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.38 -40.9 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 73.34 110.8 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.24 86.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.942 0.401 . . . . 74.5 110.532 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.9 -42.51 85.74 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.769 -0.65 . . . . 71.04 113.01 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.3 ptm180 -68.05 -31.32 70.89 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.984 0.392 . . . . 65.23 111.371 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 63.11 109.945 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.31 43.29 4.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.95 -0.643 . . . . 72.41 112.265 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -129.56 158.62 38.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.671 0.272 . . . . 73.04 110.595 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.91 165.33 11.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 73.44 109.496 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.439 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 35.4 p90 -80.38 143.84 33.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.204 0.526 . . . . 73.34 111.339 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -106.44 133.46 51.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 73.23 109.336 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.57 124.23 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.348 . . . . 75.41 110.661 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -71.53 104.86 3.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.94 -0.573 . . . . 72.1 110.302 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 1.3 tmmt? -73.79 83.79 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.583 . . . . 64.43 109.734 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 170.84 -48.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.673 -1.148 . . . . 74.33 109.151 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -104.45 -28.43 11.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.465 -0.789 . . . . 74.13 110.702 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.2 9.49 73.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.852 -0.69 . . . . 75.4 111.475 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.29 134.23 34.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 34.53 111.131 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 8.8 mt-10 -91.67 131.95 36.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.793 -0.64 . . . . 71.03 110.291 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.31 137.15 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 73.51 110.494 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 62' ' ' LEU . 3.8 p -126.99 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.746 -0.464 . . . . 53.54 109.746 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.783 HG22 HG12 ' A' ' 61' ' ' VAL . 24.4 p -108.8 151.32 26.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 73.2 111.944 -173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.31 -161.81 20.37 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.752 -0.658 . . . . 65.1 111.612 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 20.3 mmt180 -133.15 139.17 46.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.751 -0.462 . . . . 52.41 109.751 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.07 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -130.18 116.7 18.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.659 0.266 . . . . 62.34 110.295 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 68.5 -27.96 0.15 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.672 0.789 . . . . 74.13 112.594 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 156.69 -30.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.537 -1.025 . . . . 72.4 110.537 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -79.36 157.22 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.674 -0.763 . . . . 73.32 109.785 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.678 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 14.0 t -83.21 136.09 34.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.332 -0.618 . . . . 74.34 109.332 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.07 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.9 p -117.43 124.23 72.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.211 0.529 . . . . 74.21 110.672 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 52' ' ' THR . 8.9 m -113.04 111.78 37.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.322 0.582 . . . . 72.04 109.71 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.76 HD23 ' HB ' ' A' ' 7' ' ' VAL . 54.7 mt -92.79 115.81 28.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.585 -0.734 . . . . 61.12 110.47 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.5 147.62 41.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 74.24 110.218 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 17.0 ptmt -132.96 131.78 22.1 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.336 -0.393 . . . . 61.24 111.081 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 12.4 Cg_endo -57.37 136.11 74.14 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.915 2.41 . . . . 53.24 111.187 172.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.691 ' HD2' ' HG3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -92.61 -59.96 1.94 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.82 -0.352 . . . . 51.33 111.512 -172.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.4 p -156.92 145.12 19.49 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.12 -0.232 . . . . 75.23 110.981 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.641 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 35.7 t80 66.43 115.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 124.177 0.923 . . . . 62.3 111.09 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.574 ' HG2' ' HB3' ' A' ' 116' ' ' ASN . 1.9 mpt? -51.71 -56.27 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.312 -0.858 . . . . 71.13 111.94 -174.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.641 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 47.9 t30 -55.26 -49.71 71.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.246 -0.434 . . . . 72.15 111.136 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 mm-40 -59.52 -49.9 76.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 63.25 111.127 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 76' ' ' VAL . 50.7 m -60.48 -40.78 92.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.322 -0.399 . . . . 75.24 111.142 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.53 -43.33 97.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.902 -0.665 . . . . 55.32 112.048 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -69.82 -32.95 71.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.752 0.31 . . . . 74.34 110.521 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 81.2 mm-40 -65.15 -28.28 69.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.919 -0.582 . . . . 70.14 111.858 -177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 72' ' ' SER . 55.6 t -65.66 -31.12 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 72.51 110.847 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.31 -69.62 1.21 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.962 -0.563 . . . . 72.43 112.993 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.91 -36.32 95.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.916 2.411 . . . . 73.35 112.77 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.52 -39.01 89.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 35.54 110.262 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.21 90.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 60.01 111.258 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -18.99 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.399 -0.364 . . . . 74.44 111.101 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.43 -37.32 80.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.357 -0.383 . . . . 71.4 110.548 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -101.53 4.17 40.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 74.42 111.321 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 m 63.44 31.93 14.71 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.888 -0.596 . . . . 71.53 111.546 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.872 HG12 ' HB2' ' A' ' 4' ' ' PRO . 16.7 m -81.78 143.35 50.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.383 . . . . 62.44 110.584 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 7.9 Cg_exo -73.64 137.85 25.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.679 2.253 . . . . 52.11 111.498 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.99 -10.76 24.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.812 2.342 . . . . 73.54 113.121 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.11 -26.96 18.04 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.034 -0.266 . . . . 73.51 110.486 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -95.09 62.68 2.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.258 0.551 . . . . 74.14 110.422 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.66 HD12 HD23 ' A' ' 6' ' ' LEU . 8.1 tt -140.41 117.34 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 64.35 110.57 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.17 114.38 35.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 63.22 110.182 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.587 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 48.4 t -96.99 108.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 70.25 110.824 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.528 HD13 ' HB ' ' A' ' 133' ' ' VAL . 44.0 mm -89.62 119.32 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.778 -0.646 . . . . 74.42 109.699 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -138.47 165.22 27.39 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.411 -0.516 . . . . 72.32 111.183 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.75 142.33 29.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 55.11 109.358 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.897 ' HG2' HG12 ' A' ' 99' ' ' ILE . 18.4 tp10 -127.34 123.23 35.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.838 0.351 . . . . 71.24 111.357 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.9 mt -84.21 -14.76 49.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 63.01 111.254 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.88 -31.99 17.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 71.14 111.646 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.897 HG12 ' HG2' ' A' ' 96' ' ' GLU . 29.0 mm -85.52 146.21 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 74.11 111.408 -173.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 103' ' ' ARG . 14.2 m-20 -64.31 153.28 38.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.631 -0.713 . . . . 50.41 111.04 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.1 111.29 4.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.131 -0.692 . . . . 75.31 109.131 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 165' ' ' ILE . . . 101.65 6.08 50.45 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.483 -0.865 . . . . 43.24 112.104 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 27.1 mmt180 -103.33 141.83 35.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.756 0.313 . . . . 74.53 110.778 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 mt -107.93 136.86 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.682 -0.859 . . . . 72.41 108.682 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.556 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -144.04 162.27 36.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 72.1 110.562 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.81 133.06 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.868 0.366 . . . . 73.04 110.359 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 57.1 tptt -106.52 105.06 14.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 64.1 109.869 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.881 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.2 pt? -78.59 -133.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.979 -0.555 . . . . 70.11 110.672 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.7 132.78 11.32 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.538 -0.839 . . . . 74.1 111.117 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 150.01 5.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.961 -1.114 . . . . 65.35 113.083 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.0 -153.34 29.44 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.176 -0.769 . . . . 55.3 111.176 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 78.85 -61.21 0.36 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.497 0.719 . . . . 75.05 111.92 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.25 115.82 5.01 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.116 -0.564 . . . . 42.12 112.068 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.09 -114.31 0.58 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.03 -0.828 . . . . 74.02 111.03 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -174.89 -82.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.495 0.188 . . . . 72.41 111.182 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.574 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 89.3 m-20 -130.78 -70.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.531 0.567 . . . . 65.42 112.531 -172.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.3 -17.8 80.12 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 121.063 -0.589 . . . . 55.44 112.055 -167.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.11 -30.62 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.981 -0.61 . . . . 61.12 110.649 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 119' ' ' ARG . 57.8 mtt180 -79.82 -29.15 40.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 72.11 111.12 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.9 m -75.31 -47.03 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 75.14 111.687 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.89 -21.98 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.53 -0.305 . . . . 73.32 111.585 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.82 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 51.11 111.599 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -70.6 -39.81 73.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.269 -0.423 . . . . 72.22 111.675 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.48 58.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 53.5 111.339 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.41 -41.83 62.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.319 -0.401 . . . . 62.32 110.996 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.96 2.42 52.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.878 -0.677 . . . . 72.45 112.039 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 m -131.19 121.02 24.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.792 0.33 . . . . 74.43 110.396 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -99.25 -64.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.714 -0.847 . . . . 75.31 108.714 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.7 t30 31.74 61.55 0.29 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.861 1.265 . . . . 73.03 114.099 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.806 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 84.2 m-85 70.57 -23.45 0.17 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.893 1.442 . . . . 74.21 114.893 166.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -79.98 53.64 1.73 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.607 0.966 . . . . 73.54 113.607 -169.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.587 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 1.3 mpp_? -137.35 111.26 8.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.8 -0.445 . . . . 75.13 109.8 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.528 ' HB ' HD13 ' A' ' 93' ' ' ILE . 57.6 t -85.24 131.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.081 0.467 . . . . 71.45 110.583 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HD3' ' HB3' ' A' ' 105' ' ' ARG . 49.0 mtp180 -106.18 117.28 33.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.679 -0.691 . . . . 73.33 110.027 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.58 118.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.938 -0.764 . . . . 63.34 108.938 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.31 12.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.668 . . . . 45.51 113.451 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.427 HG12 HD11 ' A' ' 24' ' ' LEU . 35.6 m -94.11 2.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 65.15 110.669 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.13 179.84 17.15 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.044 -0.598 . . . . 74.14 112.007 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.478 ' H ' ' HG3' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -70.69 149.95 95.33 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.469 0.135 . . . . 74.5 110.921 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.505 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 47.2 Cg_exo -37.74 128.55 0.82 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.253 3.302 . . . . 71.03 113.935 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.9 Cg_exo -73.69 135.07 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.477 2.784 . . . . 73.0 112.625 -177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -112.68 162.23 12.44 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.063 -0.815 . . . . 61.11 111.063 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.0 tpm_? 71.63 -75.21 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.132 0.573 . . . . 52.33 110.132 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.507 ' HD2' ' HD1' ' A' ' 149' ' ' PHE . 6.8 ptpp? -78.82 144.44 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.075 -0.342 . . . . 73.01 110.075 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.33 139.93 94.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.108 -0.497 . . . . 72.34 110.246 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.0 -28.89 19.99 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.254 2.636 . . . . 73.12 113.437 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -68.42 -36.19 78.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.377 . . . . 70.51 110.802 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.57 -25.64 30.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.466 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.507 ' HD1' ' HD2' ' A' ' 144' ' ' LYS . 90.3 t80 -62.28 -38.08 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.679 -0.692 . . . . 72.1 110.987 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.608 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.5 m -84.94 -0.61 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.395 . . . . 73.11 111.369 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 147' ' ' ALA . 73.1 mt -98.42 12.47 34.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 72.23 111.22 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 11.1 pt-20 -129.24 177.06 7.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.489 -0.323 . . . . 70.22 110.414 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -77.74 177.97 7.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.931 -0.577 . . . . 63.4 111.377 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.51 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 68.1 m-85 -80.06 165.05 22.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 74.43 110.81 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.648 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -75.95 -153.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.84 0.311 . . . . 74.2 111.84 -175.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.39 -70.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.059 0.392 . . . . 65.02 112.059 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.33 -44.66 35.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 72.55 111.386 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.93 -21.6 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.907 -0.588 . . . . 63.52 111.246 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 155' ' ' THR . 25.9 ttt180 -63.41 -24.1 67.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.025 0.44 . . . . 65.41 110.788 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.17 -19.54 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 64.52 111.032 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.86 -11.12 45.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 71.33 111.09 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 166' ' ' VAL . 47.9 t -60.98 -61.22 8.45 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.018 -0.537 . . . . 62.43 112.207 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 18.4 Cg_endo -59.05 -34.15 98.87 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.027 1.818 . . . . 74.41 112.601 -175.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.6 m -66.15 -39.3 89.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 75.11 111.763 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.837 HD13 ' HA2' ' A' ' 102' ' ' GLY . 43.6 pt -78.97 -30.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.762 -0.375 . . . . 61.13 110.848 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.1 t -62.68 -42.66 96.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.741 0.305 . . . . 62.21 110.64 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 46.6 mt-10 -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 74.32 110.834 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -73.5 -33.92 65.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 72.25 111.309 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.27 96.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 44.34 111.131 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.89 91.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 42.24 110.851 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.27 -35.74 76.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 61.41 111.422 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -62.21 -38.64 89.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.716 0.294 . . . . 71.24 110.759 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 54.8 m -60.48 -36.78 79.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 60.41 110.593 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.83 -33.95 57.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 64.41 110.576 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.29 -27.78 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 72.12 110.555 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.9 mt -63.13 -33.38 75.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.939 -0.573 . . . . 61.23 110.371 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.8 mm -80.47 -55.63 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 74.15 110.877 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.29 -54.67 37.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.689 -0.687 . . . . 74.53 112.1 -173.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.501 ' HG2' ' HB2' ' A' ' 183' ' ' PRO . 36.4 tt0 -93.33 -50.14 5.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.367 -0.379 . . . . 71.34 110.352 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.55 147.98 5.93 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.775 -0.726 . . . . 74.12 111.453 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 182' ' ' GLU . 4.2 pp -64.92 -27.28 68.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.895 0.348 . . . . 74.22 111.89 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.715 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 40.6 tt0 -76.95 -52.55 1.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.837 -0.165 . . . . 64.23 111.283 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.9 Cg_exo -65.17 -34.98 43.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.548 1.499 . . . . 70.3 112.56 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -73.52 -31.48 63.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.119 0.414 . . . . 75.3 112.119 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 12.2 pt20 -61.75 -21.25 64.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.874 -0.331 . . . . 63.11 110.825 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -55.06 -52.56 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.354 -0.61 . . . . 75.34 109.354 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -46.29 76.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 74.02 110.87 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 184' ' ' ALA . 10.7 t -67.58 -13.08 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.186 -0.461 . . . . 63.35 111.964 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -102.42 -22.67 14.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.344 0.498 . . . . 73.02 112.344 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.42 -25.88 6.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.704 0.631 . . . . 75.41 112.704 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.1 t90 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.233 -0.889 . . . . 64.44 110.374 -174.958 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.243 0.544 . . . . 63.43 110.95 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 Cg_endo -94.09 143.62 1.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.18 2.586 . . . . 71.22 112.587 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.24 120.69 39.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.418 -0.586 . . . . 45.22 109.418 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HB2' HE21 ' A' ' 88' ' ' GLN . 46.9 tp -92.13 105.23 17.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.26 -0.427 . . . . 71.33 109.989 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 62' ' ' LEU . 43.3 t -118.9 127.25 75.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 61.53 110.377 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.06 121.8 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.557 . . . . 70.03 110.115 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.98 122.04 6.53 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.317 -0.944 . . . . 55.25 111.65 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.3 tp -108.75 86.77 2.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.296 0.57 . . . . 74.34 110.243 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 147.42 18.61 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.344 -0.843 . . . . 62.13 111.416 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 1.7 p30 -93.33 109.61 41.39 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.958 0.409 . . . . 63.34 110.893 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 2.0 Cg_endo -82.05 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.861 2.374 . . . . 74.35 112.731 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.67 -151.68 28.52 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.719 -0.753 . . . . 61.13 112.083 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.24 -49.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.94 2.427 . . . . 73.01 112.795 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -107.26 -26.24 11.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 74.23 111.923 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 88.4 m-85 -71.44 -17.41 62.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.902 0.704 . . . . 64.55 112.902 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' C ' ' HD2' ' A' ' 19' ' ' LYS . . . -71.44 -7.0 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.927 0.343 . . . . 72.41 111.927 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HD2' ' C ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -123.12 20.09 9.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.643 -0.253 . . . . 72.32 111.021 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 75.6 p -101.34 178.02 4.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.602 0.239 . . . . 71.01 111.532 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.765 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 67.5 mtt180 -59.21 -23.54 62.37 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.077 0.465 . . . . 72.42 110.709 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.718 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 1.7 t-80 -98.23 17.23 19.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 70.11 111.492 -173.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.61 3.13 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.117 0.484 . . . . 62.42 110.405 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -52.76 -35.27 56.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 54.42 112.303 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -63.63 -25.65 69.07 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.136 -0.554 . . . . 41.12 112.984 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -90.32 -29.89 17.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.633 0.254 . . . . 74.23 110.864 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.574 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 7.2 mmt -54.74 -48.08 73.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.528 0.566 . . . . 73.4 112.528 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.826 ' HB ' HD13 ' A' ' 93' ' ' ILE . 44.7 t -62.03 -45.24 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.726 0.298 . . . . 64.34 111.139 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.07 89.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 74.33 111.112 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.24 -48.91 77.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 55.41 110.968 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.0 -38.56 83.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.225 -0.443 . . . . 64.44 111.031 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.0 mt -63.77 -47.1 82.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.602 -0.272 . . . . 44.32 110.922 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.94 85.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.969 0.414 . . . . 50.24 110.543 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.51 -39.73 86.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.719 -0.673 . . . . 72.21 113.601 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.928 ' HG3' HD12 ' A' ' 36' ' ' ILE . 15.2 ptp180 -68.79 -36.41 78.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.378 0.589 . . . . 64.24 111.825 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.928 HD12 ' HG3' ' A' ' 35' ' ' ARG . 3.0 mp -77.89 -36.69 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 71.44 109.623 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.9 48.15 3.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.896 -0.669 . . . . 74.2 111.976 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.31 162.33 17.66 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.786 0.327 . . . . 71.14 110.352 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.82 130.63 56.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 71.51 110.691 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.516 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 19.1 p90 -70.18 133.59 47.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 73.04 110.286 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.28 134.83 54.66 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.937 -0.574 . . . . 75.22 110.7 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 49' ' ' GLU . 43.5 t -72.83 118.07 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 71.25 110.202 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.49 93.38 3.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.195 -1.039 . . . . 64.31 108.195 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.46 79.73 2.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.978 0.894 . . . . 72.14 110.2 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -169.25 -53.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.763 -1.562 . . . . 61.13 106.915 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -93.71 -28.55 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.944 -1.025 . . . . 60.25 110.241 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 29.59 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.945 -0.645 . . . . 44.15 112.153 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.14 146.22 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.319 -0.252 . . . . 53.34 110.319 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.798 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.1 mt-10 -98.85 138.75 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.304 -0.407 . . . . 74.44 110.397 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 137.96 51.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 61.45 110.468 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' A' ' 62' ' ' LEU . 7.5 p -128.86 139.13 52.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.477 -0.329 . . . . 70.21 110.377 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 61' ' ' VAL . 17.4 p -101.49 177.74 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.728 0.299 . . . . 72.25 111.449 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.53 40.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.161 -0.543 . . . . 35.1 111.966 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.809 ' H ' HG12 ' A' ' 36' ' ' ILE . 18.0 mmt180 -133.54 130.1 37.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.721 0.296 . . . . 72.03 110.737 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.018 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.4 pt? -130.84 115.76 17.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.323 -0.621 . . . . 72.05 109.323 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.72 23.51 13.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.816 -0.629 . . . . 75.23 111.264 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.71 -30.88 8.87 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.073 -0.584 . . . . 74.53 111.665 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 55' ' ' LEU . 75.0 m -70.49 142.96 51.84 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.795 0.438 . . . . 75.44 110.453 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 5.1 p -79.85 122.17 26.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.686 0.279 . . . . 74.35 110.73 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.018 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -97.37 138.5 22.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.113 -0.328 . . . . 51.43 110.113 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 52' ' ' THR . 7.2 m -124.21 108.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.329 0.585 . . . . 71.53 110.193 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.704 HD23 ' HB ' ' A' ' 7' ' ' VAL . 79.9 mt -95.22 119.55 33.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.562 -0.744 . . . . 65.53 110.333 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.74 147.74 39.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.484 . . . . 72.13 110.637 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 16.0 ptmt -132.85 143.27 47.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 63.1 110.31 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 17.8 Cg_exo -67.45 160.21 48.88 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.74 2.293 . . . . 74.22 111.683 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 39.6 ttt-85 -70.67 -63.17 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 60.24 110.173 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 47.8 m -165.89 147.73 7.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.776 -0.647 . . . . 74.34 110.102 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 t80 70.62 162.05 0.24 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.68 0.752 . . . . 75.34 112.269 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 69' ' ' MET . 1.9 mpt? -79.6 -16.08 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 61.21 111.365 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -73.62 -50.05 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.269 -0.423 . . . . 61.24 110.125 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 18.7 mt-10 -68.9 -41.06 78.76 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.978 0.362 . . . . 74.42 111.978 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 p -52.36 -44.43 65.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.94 0.348 . . . . 63.05 111.94 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -68.8 -25.46 75.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 63.52 112.545 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -94.21 -7.12 43.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.551 0.215 . . . . 75.12 111.338 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 19.4 mm-40 -102.33 -52.72 3.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.64 -0.254 . . . . 75.3 111.477 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.26 -40.52 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 75.31 111.601 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.658 ' HA2' HD21 ' A' ' 125' ' ' LEU . . . -55.83 -66.22 2.99 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.074 -0.512 . . . . 50.0 112.919 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.29 -39.05 93.06 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.741 2.294 . . . . 62.42 113.025 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.19 -45.91 83.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.753 0.279 . . . . 65.11 111.753 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -44.2 71.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.217 0.532 . . . . 73.44 111.162 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -7.83 58.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.949 -0.568 . . . . 51.24 111.658 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -77.23 -53.99 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 53.31 110.163 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -89.07 5.25 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 73.13 110.397 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.6 m 60.32 84.13 0.13 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 62.53 113.241 171.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.49 142.26 27.29 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.852 -0.613 . . . . 71.14 109.498 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.77 172.14 16.86 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.51 2.14 . . . . 73.14 111.69 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 96.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.215 1.944 . . . . 61.24 111.463 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.558 HE21 ' HB2' ' A' ' 6' ' ' LEU . 12.8 pt20 -133.25 177.61 7.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.662 -0.699 . . . . 71.51 110.038 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -66.2 104.75 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 74.2 111.136 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.1 tt -93.65 112.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.788 -0.642 . . . . 74.52 109.696 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.1 t -100.17 111.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.664 -0.698 . . . . 72.13 110.855 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.538 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 57.9 t -99.38 116.54 42.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.496 -0.557 . . . . 73.03 109.496 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.826 HD13 ' HB ' ' A' ' 28' ' ' VAL . 35.3 mt -87.05 122.86 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 62.31 110.622 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 41.4 t-80 -151.68 170.89 18.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.813 0.34 . . . . 75.13 110.465 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.06 153.71 22.54 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.91 0.484 . . . . 73.35 111.108 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 9.1 tp10 -118.2 121.56 40.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.579 . . . . 62.43 110.907 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.5 mt -83.5 -21.17 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 73.31 110.877 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.65 -19.83 34.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 70.31 111.808 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.741 HG13 ' HB2' ' A' ' 105' ' ' ARG . 29.0 mm -107.64 139.52 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.532 -0.304 . . . . 61.41 111.443 -175.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.685 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 3.8 m-20 -55.78 152.17 10.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.501 -0.772 . . . . 74.32 111.405 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.589 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.4 t80 -67.55 109.2 3.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.649 -0.705 . . . . 62.2 110.421 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.776 ' HA2' HG21 ' A' ' 165' ' ' ILE . . . 137.46 -23.85 3.1 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.405 -0.902 . . . . 75.43 113.165 176.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -108.28 151.59 25.76 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.515 -0.403 . . . . 73.4 110.33 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.831 ' HB ' HG22 ' A' ' 188' ' ' VAL . 3.6 mp -105.29 136.87 37.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.156 0.503 . . . . 71.52 110.149 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.741 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.1 tpt180 -108.89 140.31 42.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.639 -0.71 . . . . 73.24 109.785 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 185' ' ' GLN . 98.3 mt -122.66 121.08 35.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.431 -0.35 . . . . 73.34 110.238 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -116.65 138.89 51.11 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.926 -0.398 . . . . 74.04 109.926 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.9 mp -79.5 -71.4 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.75 -0.659 . . . . 74.24 110.379 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.33 -144.53 6.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.004 -0.544 . . . . 73.21 112.913 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.01 156.26 35.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.959 -0.638 . . . . 50.32 112.665 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.12 152.76 13.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.94 -0.647 . . . . 53.15 111.747 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -67.74 139.9 56.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.285 -0.265 . . . . 71.23 110.285 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 143.62 60.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.032 -0.604 . . . . 71.42 112.16 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.22 2.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.298 -0.953 . . . . 75.41 113.254 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.7 m80 55.75 -101.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.677 0.621 . . . . 73.14 112.677 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.02 -69.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.099 0.777 . . . . 74.14 113.099 -166.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -47.09 92.51 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.178 -0.534 . . . . 65.15 112.708 -165.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.0 -47.5 82.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.313 -0.443 . . . . 50.31 111.737 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -79.93 -22.16 43.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.944 0.35 . . . . 65.42 111.944 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.575 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 73.5 m -61.87 -52.43 64.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 63.24 110.486 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.39 -28.85 36.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.009 0.433 . . . . 71.53 110.722 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.95 74.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 65.23 111.004 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -84.55 -38.06 20.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.397 -0.365 . . . . 71.32 111.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.32 -52.9 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 72.44 111.032 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.658 HD21 ' HA2' ' A' ' 77' ' ' GLY . 95.9 mt -78.7 -32.36 46.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.361 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.05 -5.53 66.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.004 -0.617 . . . . 73.45 112.447 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.3 m -114.23 121.89 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.358 0.599 . . . . 62.34 111.7 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.2 -93.99 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.392 -1.336 . . . . 65.22 107.392 168.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.24 -8.2 0.2 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.151 1.537 . . . . 72.21 115.151 159.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 75.0 m-85 -119.27 -107.96 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.428 0.558 . . . . 65.41 111.865 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -146.97 118.33 7.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 72.43 111.321 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.538 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 11.9 mpt_? -106.33 123.95 48.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 52.33 109.642 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.42 ' HA ' HD23 ' A' ' 106' ' ' LEU . 94.1 t -83.57 117.32 29.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 64.42 110.479 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.951 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.7 mtt180 -120.01 117.88 29.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.75 -0.659 . . . . 72.21 110.642 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.3 mp -91.09 117.61 34.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.631 -0.507 . . . . 70.4 109.631 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.37 130.53 41.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.206 -0.521 . . . . 63.15 113.156 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.83 -0.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.049 0.452 . . . . 71.21 111.074 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 111.8 -83.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.5 -0.857 . . . . 72.43 112.882 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -164.1 168.45 9.38 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.445 -0.206 . . . . 72.52 110.445 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.0 Cg_exo -59.38 135.56 65.99 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.243 1.962 . . . . 71.32 110.385 166.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.661 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 26.1 Cg_exo -61.76 -38.48 59.83 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.769 2.312 . . . . 72.25 112.603 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.1 -71.7 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.027 -0.606 . . . . 70.24 113.308 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -78.88 -31.11 45.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 64.53 111.274 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 8.0 ptmm? -116.36 152.8 33.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 74.23 109.836 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.84 134.18 95.97 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.446 -0.343 . . . . 73.41 111.194 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.661 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 81.2 Cg_exo -47.66 -44.4 26.2 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.63 2.887 . . . . 54.4 113.626 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.09 87.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.041 0.448 . . . . 65.4 110.729 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.46 -18.8 60.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.812 -0.631 . . . . 62.11 110.68 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 89.3 t80 -84.18 -34.82 23.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.156 -0.474 . . . . 71.34 111.048 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.718 ' HB ' ' HB2' ' A' ' 22' ' ' HIS . 34.1 m -84.66 -17.03 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.666 0.617 . . . . 51.25 112.666 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.18 -7.44 59.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.059 0.457 . . . . 74.24 111.473 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.512 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 4.1 pt-20 -111.06 172.84 6.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.985 -0.552 . . . . 72.13 109.555 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.765 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 33.1 p30 -142.27 -20.54 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.815 0.341 . . . . 64.24 111.349 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -62.63 114.06 3.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 74.42 111.245 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -145.41 179.85 7.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 71.3 108.757 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.07 -71.86 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 63.3 111.864 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.58 -43.65 7.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 65.35 111.582 -174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 1.6 pm0 -72.15 -19.83 61.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.463 -0.789 . . . . 62.55 112.229 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 155' ' ' THR . 19.1 tpt180 -69.75 -38.0 76.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 64.03 110.139 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.23 60.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.162 -0.472 . . . . 62.31 110.911 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.78 1.25 57.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 71.41 112.046 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 166' ' ' VAL . 89.1 t -57.01 -57.06 27.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.061 -0.256 . . . . 62.21 110.648 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.3 Cg_endo -60.23 -30.33 90.95 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.967 1.778 . . . . 74.44 112.055 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.1 m -67.0 -48.12 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 70.22 111.175 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.776 HG21 ' HA2' ' A' ' 102' ' ' GLY . 42.3 pt -74.24 -20.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.578 -0.283 . . . . 73.43 111.319 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 162' ' ' VAL . 70.0 t -62.8 -45.11 99.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.966 -0.383 . . . . 72.25 109.966 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -58.73 -46.93 86.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.09 -0.505 . . . . 42.43 110.037 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.65 -54.22 48.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.313 -0.858 . . . . 75.44 111.144 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.63 -40.91 89.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 63.41 111.566 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.37 -49.45 69.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 72.22 111.216 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.35 -31.41 60.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 73.21 111.907 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.702 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -59.74 -46.57 88.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.094 -0.335 . . . . 64.33 110.094 173.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.8 m -58.88 -40.21 83.73 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.257 -0.429 . . . . 72.34 110.903 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 55' ' ' LEU . 33.5 tt0 -65.94 -42.95 89.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 64.51 110.028 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.15 -25.79 65.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 75.31 111.195 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 86.9 mt -62.03 -32.28 72.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.498 -0.319 . . . . 71.21 111.271 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.448 HG21 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -80.14 -25.39 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.17 0.509 . . . . 54.34 110.047 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -86.32 -47.34 9.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.59 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 184' ' ' ALA . 24.2 tp60 -86.04 -59.5 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.476 -0.329 . . . . 74.51 110.207 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.66 -75.0 0.89 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.032 0.773 . . . . 75.44 115.032 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.6 tp -42.47 -69.81 0.12 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.209 1.188 . . . . 64.12 114.209 -163.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.67 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 tt0 -139.91 -59.45 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.481 0.549 . . . . 64.33 112.481 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HD2' ' H ' ' A' ' 182' ' ' GLU . 18.4 Cg_endo -59.12 -17.2 37.28 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.079 1.853 . . . . 51.24 112.853 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . . . -60.3 -58.79 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.474 -0.33 . . . . 71.24 111.243 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.445 ' HA ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -77.15 -28.42 54.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.802 -0.359 . . . . 72.04 111.181 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 183' ' ' PRO . 24.5 t-20 -57.75 -39.56 77.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.875 0.369 . . . . 74.0 110.61 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 84.8 m -65.1 -57.43 8.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.817 -0.629 . . . . 53.43 112.368 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.831 HG22 ' HB ' ' A' ' 104' ' ' ILE . 2.0 p -64.13 -18.87 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 113.499 0.926 . . . . 72.13 113.499 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -106.95 -6.93 17.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.152 -0.619 . . . . 70.2 111.723 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.42 4.29 3.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.431 0.53 . . . . 51.3 112.431 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.471 -0.776 . . . . 71.12 109.849 -179.149 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 108.685 -0.857 . . . . 74.35 108.685 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.812 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 62.0 Cg_endo -90.88 171.61 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.981 2.454 . . . . 72.02 113.277 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.757 ' HB2' HD11 ' A' ' 177' ' ' ILE . 49.2 tp -119.63 110.05 16.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.554 -0.748 . . . . 74.01 109.801 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.707 ' HA ' HG23 ' A' ' 61' ' ' VAL . 51.0 tp -92.53 107.95 19.61 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.874 -0.787 . . . . 72.41 108.874 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' A' ' 62' ' ' LEU . 49.4 t -100.83 116.72 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.795 -0.639 . . . . 72.34 110.731 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.71 114.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.465 -0.789 . . . . 73.31 109.302 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.41 122.26 7.29 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.211 -0.995 . . . . 42.22 111.985 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -79.01 91.38 4.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 73.32 109.689 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.815 ' HA2' ' HA ' ' A' ' 23' ' ' ASN . . . -152.66 122.24 1.28 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.561 -0.828 . . . . 70.54 112.376 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -112.34 98.05 41.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.792 -0.818 . . . . 71.55 108.792 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.75 58.65 4.03 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.581 2.854 . . . . 73.32 112.997 -172.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.08 175.0 39.7 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.521 -0.632 . . . . 50.31 111.521 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.26 -57.61 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.62 2.88 . . . . 71.3 113.515 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -107.38 7.35 29.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.537 0.684 . . . . 74.14 110.431 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HA ' ' OG1' ' A' ' 20' ' ' THR . 97.9 m-85 -94.13 -15.61 24.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 72.22 111.959 -172.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.81 -34.46 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.721 0.638 . . . . 63.43 112.721 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.657 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -115.76 14.95 16.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.135 0.493 . . . . 73.24 111.459 -176.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.7 p -109.37 -172.97 2.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.279 -0.418 . . . . 60.01 110.273 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.545 ' HG2' HG11 ' A' ' 137' ' ' VAL . 64.7 mtt85 -68.04 1.44 2.74 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.208 0.447 . . . . 63.24 112.208 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -95.53 -5.26 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.332 -0.23 . . . . 43.22 111.117 -176.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.815 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 t30 -143.23 9.37 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.315 0.579 . . . . 72.11 111.247 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 20' ' ' THR . 51.1 mt -68.57 -28.06 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.92 -0.488 . . . . 72.41 111.784 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.85 -21.85 71.61 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.45 -0.881 . . . . 62.24 112.188 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 81.0 t80 -80.38 -21.75 42.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.558 0.218 . . . . 71.03 111.108 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 31' ' ' VAL . 11.0 mmt -51.13 -51.51 52.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.351 -0.386 . . . . 62.42 111.682 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 170' ' ' ALA . 57.4 t -61.17 -43.5 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 72.44 111.044 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.28 -40.68 97.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.0 -0.546 . . . . 50.3 110.858 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.29 -41.2 98.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 74.43 110.61 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 27' ' ' MET . 66.5 t -62.97 -34.46 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 70.5 110.653 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 35' ' ' ARG . 93.3 mt -64.34 -33.87 76.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.367 -0.378 . . . . 74.13 110.672 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -39.07 46.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.336 -0.393 . . . . 75.02 110.474 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.39 -40.12 96.2 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.629 . . . . 65.43 113.039 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 32' ' ' LEU . 11.0 ptm180 -66.24 -21.78 66.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.842 0.353 . . . . 75.15 110.812 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.16 -48.89 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.458 . . . . 71.43 110.317 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.24 38.12 2.53 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.96 -0.638 . . . . 43.0 112.161 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 m -126.12 146.09 50.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.303 . . . . 74.51 110.58 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.34 142.86 33.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 73.0 111.018 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.807 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 16.8 p90 -74.4 147.0 42.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 71.45 110.757 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -128.7 145.21 51.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.034 -0.358 . . . . 71.13 110.034 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.886 HG22 ' HG3' ' A' ' 49' ' ' GLU . 32.7 t -76.52 134.33 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.277 -0.42 . . . . 72.41 111.398 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -94.99 125.55 39.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.427 -0.583 . . . . 75.15 109.427 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.32 -36.55 84.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.379 . . . . 64.12 110.889 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -83.38 4.14 28.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 72.42 110.924 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m -125.59 -29.02 3.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.812 0.339 . . . . 70.54 111.308 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.37 29.23 73.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.961 -0.638 . . . . 72.2 111.812 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.52 37.19 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.614 0.245 . . . . 62.21 110.587 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.886 ' HG3' HG22 ' A' ' 42' ' ' VAL . 4.5 mp0 -85.68 131.22 34.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.54 . . . . 63.5 110.795 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.25 149.46 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 70.03 109.429 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.807 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.4 p -144.42 138.81 23.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 74.14 110.544 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.722 HG22 HG12 ' A' ' 61' ' ' VAL . 41.5 p -107.61 136.97 46.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 62.15 110.896 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.6 -166.02 13.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.929 -0.653 . . . . 62.43 111.914 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -131.21 105.82 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.486 -0.191 . . . . 73.41 110.486 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.124 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.2 pt? -96.68 115.91 28.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.835 -0.802 . . . . 73.54 108.835 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.58 -49.43 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.619 -0.719 . . . . 60.13 111.474 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.16 -33.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.261 -0.736 . . . . 72.14 111.261 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.8 148.06 50.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.968 -0.616 . . . . 54.33 111.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 m -70.83 114.8 9.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.992 -0.373 . . . . 73.42 109.992 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.124 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.5 p -97.02 127.14 49.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.568 -0.531 . . . . 55.45 109.568 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 52' ' ' THR . 2.8 m -116.51 109.13 26.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.375 0.607 . . . . 71.11 110.27 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 7' ' ' VAL . 50.7 mt -96.14 120.52 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.376 -0.829 . . . . 75.43 110.022 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.85 129.85 51.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.364 -0.38 . . . . 63.1 110.659 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 8.2 ptmm? -115.91 121.45 34.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.281 -0.418 . . . . 74.41 110.541 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 27.3 Cg_exo -62.0 156.72 47.8 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.715 2.276 . . . . 61.53 111.362 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.591 ' HG3' ' N ' ' A' ' 67' ' ' CYS . 9.1 ptt180 -77.49 -55.9 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.442 -0.503 . . . . 65.52 110.345 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.591 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 21.1 p -167.5 173.63 8.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.748 -0.206 . . . . 70.05 110.469 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 t80 67.62 162.77 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.96 0.788 . . . . 71.35 112.188 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -21.15 25.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.861 -0.609 . . . . 62.14 112.272 -175.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -94.86 -38.64 10.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.724 0.297 . . . . 72.2 111.263 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.76 -26.45 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 63.24 111.121 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -45.0 95.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 72.35 110.478 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.09 -33.86 84.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.877 -0.678 . . . . 64.52 111.722 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -74.26 -8.42 56.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 73.41 111.244 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 65' ' ' PRO . 82.8 mt-30 -103.96 -49.87 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 75.13 111.534 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.02 -29.95 42.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.814 0.302 . . . . 70.25 111.814 -176.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.29 7.08 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.143 -0.551 . . . . 74.22 112.67 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.38 -37.69 94.49 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.908 2.406 . . . . 73.24 113.032 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 64.8 mt -58.08 -39.15 77.82 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.924 0.342 . . . . 74.4 111.924 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.85 -41.97 88.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 55.54 110.874 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -23.8 27.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.173 -0.467 . . . . 71.34 111.207 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -60.87 -46.65 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.212 0.529 . . . . 71.01 109.854 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.12 -14.99 48.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.713 -0.676 . . . . 74.0 110.281 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 60.67 47.71 7.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.606 0.717 . . . . 74.04 110.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.812 ' HB ' ' HG3' ' A' ' 4' ' ' PRO . 27.4 m -102.13 137.23 19.41 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.327 -0.852 . . . . 72.22 110.215 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.632 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 23.4 Cg_exo -64.58 137.7 55.88 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.623 2.216 . . . . 72.42 111.713 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 93.8 Cg_endo -87.11 53.11 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.991 2.46 . . . . 73.31 113.574 -172.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.632 ' OE1' ' HB2' ' A' ' 86' ' ' PRO . 10.7 mp0 -59.28 -57.1 14.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 62.11 110.68 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -144.03 102.45 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.541 0.686 . . . . 74.25 112.394 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.607 HD13 HD11 ' A' ' 125' ' ' LEU . 5.8 tt -98.18 115.58 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.36 -0.836 . . . . 55.32 109.129 170.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.44 117.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.947 -0.57 . . . . 75.32 110.801 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.604 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 44.7 t -97.24 103.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 72.43 109.23 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.434 HG21 ' HB ' ' A' ' 28' ' ' VAL . 58.0 mt -86.12 119.24 34.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.947 -0.57 . . . . 72.54 109.84 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.435 ' CE1' HD22 ' A' ' 118' ' ' LEU . 28.3 p80 -151.67 170.65 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.89 -0.596 . . . . 75.24 110.522 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.63 150.23 24.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.319 -0.623 . . . . 71.43 109.319 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.695 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 7.8 tp10 -124.99 119.81 29.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.94 0.4 . . . . 74.34 110.045 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 138' ' ' GLY . 92.7 mt -82.39 -0.51 46.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 54.24 110.06 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 27.9 t70 -83.05 -11.01 58.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.358 -0.837 . . . . 70.54 110.459 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 105' ' ' ARG . 12.4 tt -132.06 148.9 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.945 0.403 . . . . 65.11 111.347 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.37 145.57 21.89 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.354 -0.839 . . . . 74.41 112.43 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -62.15 126.42 27.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 72.4 110.374 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' N ' ' HD1' ' A' ' 101' ' ' PHE . . . 117.78 -19.29 11.33 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 75.35 113.404 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.459 HH12 ' CD ' ' A' ' 161' ' ' GLU . 59.3 mmt-85 -120.63 147.67 44.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.447 0.623 . . . . 71.52 111.069 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.2 mp -104.27 132.59 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.425 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.713 ' HB2' HD12 ' A' ' 99' ' ' ILE . 16.2 tpt180 -116.57 126.18 52.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 73.32 109.683 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 188' ' ' VAL . 40.2 mt -97.48 111.29 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.266 0.555 . . . . 74.1 110.159 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HB3' ' NE ' ' A' ' 134' ' ' ARG . 57.1 tptt -102.25 141.07 35.67 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.752 -1.203 . . . . 72.51 107.752 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.912 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.1 pt? -75.55 -124.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.735 0.272 . . . . 64.13 111.735 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.919 ' HA3' ' HG3' ' A' ' 128' ' ' LYS . . . -82.01 142.03 22.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.431 -0.89 . . . . 62.04 112.584 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 153.4 5.86 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.716 -0.754 . . . . 72.21 112.321 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.53 77.06 0.32 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.672 -0.971 . . . . 71.34 110.672 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.99 144.1 22.04 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.382 -0.599 . . . . 72.42 109.382 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.0 -165.54 34.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.597 -0.811 . . . . 64.35 111.9 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.79 18.44 25.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.71 -0.757 . . . . 71.02 113.157 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -139.54 122.67 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.278 -0.542 . . . . 73.03 111.035 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.91 -52.5 60.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.984 -1.007 . . . . 60.21 112.107 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.35 -30.89 65.26 Favored Glycine 0 N--CA 1.46 0.29 0 CA-C-N 116.329 -0.396 . . . . 73.2 112.968 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.435 HD22 ' CE1' ' A' ' 94' ' ' HIS . 14.3 tp -60.52 -32.46 71.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.441 0.638 . . . . 43.23 110.673 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -79.23 -34.52 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 74.32 110.213 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.9 m -73.16 -44.39 60.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 63.33 111.406 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.03 -34.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 120.801 0.334 . . . . 65.22 111.14 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.46 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.978 0.418 . . . . 73.42 110.57 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 m -71.51 -23.59 61.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 62.51 110.884 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.4 -34.01 54.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 43.33 110.507 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 90' ' ' ILE . 88.0 mt -80.59 -42.82 21.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.914 -0.584 . . . . 72.21 110.653 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.44 89.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.024 -0.608 . . . . 75.31 112.365 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.1 p -112.37 163.09 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 71.55 111.185 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.919 ' HG3' ' HA3' ' A' ' 109' ' ' GLY . 12.5 tppt? -83.47 -56.86 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.869 -0.605 . . . . 74.12 110.755 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.94 81.92 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.741 0.65 . . . . 71.3 110.964 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.77 ' HD1' HD12 ' A' ' 108' ' ' LEU . 67.7 m-85 -71.07 68.17 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.258 1.207 . . . . 74.41 114.258 -168.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 37.8 p-80 163.57 115.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.908 0.883 . . . . 74.02 111.843 162.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.604 ' HG3' ' H ' ' A' ' 92' ' ' VAL . 5.0 mpt_? -128.93 147.24 50.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 74.42 110.216 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 93' ' ' ILE . 88.1 t -86.31 127.81 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.847 0.356 . . . . 64.4 111.032 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.695 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.0 mtt180 -131.37 109.75 10.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 61.41 110.563 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 54.4 mt -88.99 125.87 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.133 -0.485 . . . . 65.44 110.279 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.54 ' CA ' HG23 ' A' ' 99' ' ' ILE . . . -72.5 114.98 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.67 -0.776 . . . . 73.21 111.965 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.547 HG11 HD12 ' A' ' 24' ' ' LEU . 22.8 t -119.81 10.43 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.764 0.792 . . . . 62.53 110.27 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 97' ' ' LEU . . . 138.19 172.22 12.47 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.214 -0.993 . . . . 62.41 112.97 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -101.48 162.31 20.88 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.784 -0.45 . . . . 75.44 109.784 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 36.1 Cg_exo -60.72 133.01 45.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.672 2.248 . . . . 63.14 112.243 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.621 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 55.2 Cg_endo -70.56 127.31 13.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.71 2.273 . . . . 73.11 112.156 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.08 43.11 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.886 -0.673 . . . . 71.45 112.555 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -163.35 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.007 0.432 . . . . 74.31 110.219 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -89.38 159.57 17.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.622 . . . . 75.43 110.82 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.8 140.98 97.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 71.44 110.994 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.13 -38.68 60.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.225 2.616 . . . . 55.1 113.082 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 150' ' ' VAL . . . -70.19 -30.36 67.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.194 0.521 . . . . 62.22 110.655 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 151' ' ' LEU . . . -76.72 -18.52 58.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.65 -0.705 . . . . 61.55 110.226 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.621 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 59.7 t80 -84.54 -31.64 24.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 60.04 110.829 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 34.6 m -85.18 -6.02 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 72.41 112.245 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 4.4 pp -87.39 -8.35 56.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 64.55 110.182 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.64 171.11 8.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.228 -0.896 . . . . 64.44 109.669 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -170.7 87.44 0.12 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.9 0.381 . . . . 55.13 110.932 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -154.97 135.99 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.325 -0.398 . . . . 74.14 110.447 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -164.84 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 43.21 108.243 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -96.42 -73.41 0.6 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.773 0.657 . . . . 62.04 112.773 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.49 -43.2 8.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.261 0.553 . . . . 64.3 111.118 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -68.96 -21.6 64.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.493 -0.776 . . . . 72.41 110.515 -178.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -83.6 -15.26 49.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.622 -0.717 . . . . 73.55 110.361 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.46 -42.63 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 62.24 111.778 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.459 ' CD ' HH12 ' A' ' 103' ' ' ARG . 15.4 pt-20 -83.43 11.04 7.46 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.923 0.342 . . . . 64.4 111.923 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.646 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 87.0 t -54.03 -53.35 59.37 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.388 -0.369 . . . . 75.13 111.962 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 71.3 Cg_exo -52.03 -38.35 69.62 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.03 1.82 . . . . 72.34 112.511 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.0 m -68.6 -46.26 69.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 70.42 111.405 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.01 -24.83 24.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 121.098 -0.241 . . . . 65.34 111.452 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 162' ' ' VAL . 90.3 t -64.15 -43.74 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 63.02 110.047 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.82 -36.71 81.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 75.3 110.559 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.08 -51.54 53.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 72.22 110.657 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 73.34 111.535 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.52 -57.02 14.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 44.32 111.279 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.95 -26.7 62.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.485 -0.325 . . . . 74.21 111.181 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.87 -38.6 86.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.34 . . . . 74.5 110.539 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 m -66.96 -34.74 78.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.235 -0.439 . . . . 53.24 110.765 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.465 ' HA ' HD12 ' A' ' 55' ' ' LEU . 44.1 tt0 -71.91 -34.93 69.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.532 . . . . 74.51 109.853 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.29 -26.64 68.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 74.42 110.772 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 91.7 mt -64.74 -21.7 66.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 64.11 110.955 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 5' ' ' LEU . 28.0 mm -80.75 -50.71 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 65.3 110.74 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.86 -38.83 61.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.801 -0.636 . . . . 55.1 112.403 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -99.02 -56.64 2.37 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.924 -0.311 . . . . 72.34 111.536 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 141.77 -124.99 2.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.44 -0.886 . . . . 60.22 112.117 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.83 -46.97 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.032 0.382 . . . . 61.15 112.032 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.819 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 30.2 tt0 -73.44 -61.33 1.44 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.095 0.406 . . . . 72.23 112.095 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 17.7 Cg_exo -67.18 -14.9 44.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.741 1.628 . . . . 62.14 111.884 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.57 14.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 60.45 111.144 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.583 ' HA ' HD12 ' A' ' 106' ' ' LEU . 18.6 pt20 -65.25 -27.94 69.01 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 121.112 -0.235 . . . . 62.04 110.876 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 189' ' ' HIS . 65.7 t30 -59.53 -45.53 91.48 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.389 -0.369 . . . . 75.13 110.31 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.2 m -63.69 -38.26 90.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 73.54 110.882 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 106' ' ' LEU . 59.2 t -61.71 -44.48 98.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.005 -0.543 . . . . 72.41 111.533 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.509 ' NE2' ' HA ' ' A' ' 186' ' ' ASN . 33.5 p80 -89.53 12.86 15.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.512 -0.475 . . . . 74.4 111.238 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.36 4.13 38.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.53 -0.305 . . . . 64.13 110.785 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 12.8 m0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.063 -0.97 . . . . 72.42 111.027 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.725 -0.472 . . . . 64.14 109.725 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.23 89.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.778 1.652 . . . . 51.21 110.64 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.97 118.15 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.669 -0.696 . . . . 62.1 111.475 -172.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.443 ' HA ' HG23 ' A' ' 61' ' ' VAL . 34.0 tp -91.86 105.13 17.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.743 -0.662 . . . . 65.22 109.542 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.652 ' HB ' HD23 ' A' ' 62' ' ' LEU . 40.5 t -114.89 112.9 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.199 0.523 . . . . 73.41 110.422 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.78 114.77 45.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.541 -0.754 . . . . 73.21 110.005 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.42 120.76 6.09 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.337 -1.105 . . . . 73.42 110.337 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.4 HD23 ' ND1' ' A' ' 94' ' ' HIS . 23.4 tp -94.66 81.4 3.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 41.43 110.477 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.49 107.36 0.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.636 -1.165 . . . . 35.12 110.75 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -87.49 144.38 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.859 0.361 . . . . 71.12 110.777 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.66 81.74 1.01 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.813 2.342 . . . . 75.51 111.685 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.564 ' H ' ' HB2' ' A' ' 18' ' ' ALA . . . -90.64 163.88 30.01 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.893 -0.67 . . . . 72.24 111.878 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.65 -14.85 33.63 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.715 2.277 . . . . 74.43 112.717 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -141.39 -45.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.2 0.445 . . . . 72.52 112.2 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HA ' HG22 ' A' ' 20' ' ' THR . 54.4 p90 -76.25 -2.61 32.27 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.312 0.486 . . . . 74.43 112.312 -173.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.564 ' HB2' ' H ' ' A' ' 14' ' ' GLY . . . -88.85 -3.31 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 74.2 110.851 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.95 19.61 10.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.496 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 17' ' ' TYR . 12.8 t -138.35 -169.11 2.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 71.44 110.104 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 70.8 mtt180 -48.12 -26.49 1.89 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.198 0.814 . . . . 74.2 113.198 -174.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -81.94 12.41 4.12 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.224 -0.298 . . . . 72.51 111.785 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 27' ' ' MET . 27.4 p-10 -95.8 -5.04 42.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.236 . . . . 75.24 110.745 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 96.1 mt -52.73 -38.09 60.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.175 -0.466 . . . . 60.12 111.791 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -62.56 -30.06 75.45 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.131 -0.556 . . . . 75.23 112.657 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -91.5 -32.89 15.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.963 -0.139 . . . . 75.01 111.346 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 76.3 mtp -54.58 -40.15 68.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.145 0.794 . . . . 71.34 113.145 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.851 ' HB ' HD13 ' A' ' 93' ' ' ILE . 45.5 t -63.62 -46.3 95.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 54.31 110.41 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.08 79.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 74.12 110.324 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.87 -49.0 72.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.442 -0.799 . . . . 52.3 110.564 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.66 -43.38 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.836 -0.62 . . . . 65.42 110.934 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.7 mt -59.44 -40.79 87.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 73.51 111.221 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.63 64.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 62.3 110.976 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.11 -33.39 40.78 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.99 -0.624 . . . . 43.11 113.311 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.63 ' HG3' HD12 ' A' ' 36' ' ' ILE . 14.7 ptm180 -69.78 -25.97 64.06 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.256 0.528 . . . . 71.02 111.196 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.63 HD12 ' HG3' ' A' ' 35' ' ' ARG . 2.0 mp -88.31 -42.21 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.542 . . . . 72.34 109.686 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.51 58.53 2.27 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.81 -0.709 . . . . 73.23 112.219 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.8 m -134.7 145.69 48.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.666 0.27 . . . . 54.34 110.562 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.52 150.82 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 65.2 110.513 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.696 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 1.1 p90 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.834 -0.621 . . . . 70.24 111.086 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -113.85 134.14 54.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 73.11 110.188 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 49' ' ' GLU . 43.6 t -74.68 129.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 74.42 111.685 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.96 149.64 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 65.15 110.378 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -70.64 -72.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.146 -0.479 . . . . 73.52 111.419 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -68.16 -27.38 66.37 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.213 -0.449 . . . . 73.53 111.374 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -83.51 -28.2 28.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.474 -0.33 . . . . 62.41 111.024 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.25 11.83 53.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.093 -0.575 . . . . 75.5 112.452 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -120.25 151.34 39.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.67 0.271 . . . . 43.22 110.947 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.696 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 45.7 mp0 -78.92 138.8 38.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.859 -0.61 . . . . 72.52 111.602 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.36 136.81 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 64.24 109.404 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 9.4 p -121.99 144.69 30.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.734 0.302 . . . . 61.05 110.442 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.824 HG22 HG12 ' A' ' 61' ' ' VAL . 7.2 p -118.14 144.52 45.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.335 -0.393 . . . . 73.22 111.319 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.53 -174.87 38.26 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.028 -0.606 . . . . 61.52 111.87 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 -109.92 126.05 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.808 -0.231 . . . . 74.53 110.524 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.152 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -105.48 108.8 20.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.838 -0.801 . . . . 72.21 108.838 174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.91 -51.93 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.618 -0.719 . . . . 60.22 111.526 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.37 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.008 -0.837 . . . . 73.21 111.008 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.485 ' O ' HD23 ' A' ' 55' ' ' LEU . 27.1 m -78.07 153.12 32.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.403 -0.399 . . . . 75.43 110.385 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.6 m -80.8 129.13 34.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.953 -0.388 . . . . 71.41 109.953 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.152 ' HB ' HD22 ' A' ' 55' ' ' LEU . 13.9 p -118.0 135.56 58.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.926 0.393 . . . . 54.14 110.508 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.824 HG12 HG22 ' A' ' 52' ' ' THR . 17.4 m -116.14 112.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.251 0.548 . . . . 73.3 109.965 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.3 mt -98.08 113.12 24.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 70.43 110.206 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.141 -0.481 . . . . 63.45 110.72 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 3.1 ptmm? -123.81 119.3 26.89 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.182 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.45 160.9 40.55 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.703 2.268 . . . . 54.32 112.894 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 7.83 10.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.628 -0.715 . . . . 60.21 110.141 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.6 t -146.32 -179.36 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 61.42 109.613 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.7 170.72 11.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.077 0.465 . . . . 64.13 111.626 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.99 -23.41 66.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.352 -0.84 . . . . 72.4 111.455 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.05 -43.39 63.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.142 0.496 . . . . 73.23 110.21 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -75.67 -56.89 4.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.659 -0.7 . . . . 72.24 110.228 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 m -47.33 -44.62 23.87 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.745 0.653 . . . . 65.42 112.662 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.75 94.1 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.902 -0.666 . . . . 71.03 113.053 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.37 3.07 40.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.79 0.293 . . . . 65.04 111.79 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.478 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 12.7 mm-40 -91.9 -43.78 9.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.571 -0.286 . . . . 71.51 111.274 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.43 -39.96 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.368 -0.378 . . . . 71.3 111.629 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 125' ' ' LEU . . . -55.24 -63.51 5.21 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 116.176 -0.465 . . . . 53.14 112.965 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.01 -26.02 47.58 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.131 2.554 . . . . 61.35 113.164 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 28.8 mt -72.82 -40.44 65.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.529 0.204 . . . . 64.01 111.428 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.89 -39.24 88.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.422 0.63 . . . . 63.02 109.877 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -9.34 57.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.629 -0.714 . . . . 74.31 111.388 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -66.37 -43.98 84.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 72.31 109.204 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.81 3.81 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 71.33 109.707 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.7 p 45.41 54.47 7.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.923 -1.035 . . . . 74.34 112.553 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 80' ' ' ALA . 26.8 m -81.98 150.45 65.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 73.43 110.73 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 161.33 46.39 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.673 2.249 . . . . 44.12 111.72 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -48.1 111.85 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.269 2.646 . . . . 72.24 112.175 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.432 ' NE2' ' HB2' ' A' ' 6' ' ' LEU . 9.5 pt20 -128.14 -173.97 3.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 71.15 111.44 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -91.24 95.45 10.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 74.14 110.988 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 tt -76.02 110.85 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.462 0.648 . . . . 63.1 110.446 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 132.63 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 64.34 110.693 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.745 HG21 HG21 ' A' ' 121' ' ' VAL . 67.5 t -129.35 129.44 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.676 -0.49 . . . . 53.31 109.676 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.851 HD13 ' HB ' ' A' ' 28' ' ' VAL . 36.4 mt -106.17 126.59 61.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.46 . . . . 64.22 110.111 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.4 ' ND1' HD23 ' A' ' 10' ' ' LEU . 67.3 t60 -159.03 174.22 15.26 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.589 -0.445 . . . . 74.11 111.825 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -83.7 152.69 24.6 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.436 -0.802 . . . . 72.01 111.332 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.556 ' HG3' ' H ' ' A' ' 98' ' ' ASP . 9.0 tp10 -145.37 136.67 24.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 60.33 110.767 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.402 HD23 ' CG1' ' A' ' 137' ' ' VAL . 97.0 mt -83.89 -15.39 48.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.931 -0.577 . . . . 53.02 111.549 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.556 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.5 t70 -75.76 -22.61 56.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 75.32 112.267 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.694 HG13 ' HB2' ' A' ' 105' ' ' ARG . 46.6 mm -113.83 144.42 21.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.865 0.364 . . . . 74.32 111.876 -172.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 146.39 17.6 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.12 -0.945 . . . . 62.41 110.479 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 63.0 t80 -66.99 108.52 2.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 74.43 110.272 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 -16.27 6.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.617 -0.801 . . . . 62.43 112.668 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -107.41 151.24 25.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.796 -0.446 . . . . 73.51 109.796 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.68 135.77 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.811 0.339 . . . . 72.24 110.776 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HB2' HG13 ' A' ' 99' ' ' ILE . 8.6 tpp180 -108.89 125.92 52.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.477 -0.564 . . . . 60.41 109.477 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 188' ' ' VAL . 67.8 mt -97.67 134.0 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.908 0.385 . . . . 70.11 110.183 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.724 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -120.83 119.81 33.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.804 -0.634 . . . . 70.41 110.239 -177.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.777 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.5 pt? -103.5 -138.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.758 -0.46 . . . . 73.22 109.758 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 36.04 -145.82 0.07 OUTLIER Glycine 0 C--N 1.344 0.976 0 O-C-N 123.678 0.612 . . . . 72.34 113.411 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.86 127.99 8.35 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.486 -1.045 . . . . 52.4 110.486 162.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.04 107.93 3.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 71.23 113.756 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.91 101.51 12.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 72.22 110.108 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.88 -161.47 29.59 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.332 -1.107 . . . . 64.03 110.332 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.517 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . 64.47 15.62 59.56 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.823 -0.703 . . . . 75.25 112.157 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 m80 72.91 -76.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.442 0.697 . . . . 71.41 111.742 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -134.69 -59.48 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.381 0.511 . . . . 73.31 112.381 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 121' ' ' VAL . . . -57.11 -30.2 60.49 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.581 -0.343 . . . . 55.02 113.5 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.517 HD12 ' HA3' ' A' ' 114' ' ' GLY . 0.9 OUTLIER -63.87 -41.13 97.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.174 0.512 . . . . 72.24 110.101 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -76.73 -37.86 55.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.198 -0.91 . . . . 65.52 110.614 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.5 m -61.95 -49.37 76.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 74.1 111.327 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.745 HG21 HG21 ' A' ' 92' ' ' VAL . 27.3 m -72.64 -21.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.412 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.24 -59.74 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 72.3 111.057 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.4 m -63.27 -40.65 97.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 63.02 111.697 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.95 68.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 51.03 111.669 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.421 HD13 ' HA2' ' A' ' 77' ' ' GLY . 53.4 tp -85.02 -27.94 26.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 75.41 110.258 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.23 22.98 75.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.77 . . . . 63.03 112.249 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.8 m -124.91 121.49 34.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 61.02 110.369 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 44.9 mtmt -115.65 -173.6 2.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.047 -0.723 . . . . 73.53 109.047 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 t30 63.03 79.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.147 0.975 . . . . 74.32 109.629 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -145.88 -155.51 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.443 -1.253 . . . . 72.31 109.122 -176.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -149.0 110.04 4.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 75.33 110.409 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.523 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 2.3 mpt_? -104.55 146.85 28.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.774 -0.648 . . . . 53.31 109.88 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.18 102.44 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.986 -0.552 . . . . 74.34 110.292 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 64.4 mtp180 -96.64 97.26 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.786 -0.643 . . . . 65.11 109.386 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 135' ' ' ILE . 5.1 mp -80.08 128.53 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.86 -0.422 . . . . 71.42 109.86 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -64.11 123.31 27.75 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.627 -0.797 . . . . 73.05 111.816 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 150' ' ' VAL . 9.8 p -96.84 0.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.216 0.532 . . . . 64.54 110.571 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 135.82 -87.32 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.5 -0.857 . . . . 54.14 112.84 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 2.0 ptp180 -172.57 165.36 3.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 122.169 0.188 . . . . 75.43 110.536 -175.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 139' ' ' ARG . 27.9 Cg_endo -64.67 120.2 7.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.344 2.03 . . . . 64.25 111.198 171.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.15 167.09 20.12 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.727 2.285 . . . . 64.14 112.904 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.87 -59.13 0.17 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.702 -0.761 . . . . 55.11 112.59 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -79.6 -29.49 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.764 0.283 . . . . 71.33 111.764 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.45 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -107.92 134.22 51.15 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.588 -0.445 . . . . 73.11 110.402 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.5 141.55 78.42 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.389 -0.823 . . . . 75.05 110.427 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.95 -38.05 12.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.759 2.973 . . . . 75.12 113.984 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -25.83 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.943 0.402 . . . . 72.4 110.95 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.96 -21.89 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.481 . . . . 72.52 110.2 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -72.73 -38.34 67.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.801 -0.636 . . . . 62.33 110.367 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 137' ' ' VAL . 34.2 m -82.9 2.12 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.266 -0.425 . . . . 74.34 110.486 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.95 -24.14 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.551 . . . . 71.23 110.713 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -93.07 97.88 10.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.239 0.543 . . . . 61.44 110.92 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 20' ' ' THR . 32.9 p-10 -104.5 -7.43 19.79 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.009 -0.432 . . . . 54.42 110.897 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.1 52.87 2.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.222 -0.445 . . . . 72.03 110.092 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -75.16 -173.59 2.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.703 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.444 ' H ' HG22 ' A' ' 155' ' ' THR . . . -75.67 -71.32 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.807 0.336 . . . . 74.41 111.48 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.96 -37.49 11.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.355 0.597 . . . . 73.1 110.459 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 101' ' ' PHE . 3.6 mp0 -58.9 -34.6 71.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.962 -1.017 . . . . 72.13 111.712 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -65.93 -26.48 67.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.083 0.468 . . . . 74.45 111.123 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.89 -15.39 36.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.367 -0.379 . . . . 75.24 111.641 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -116.1 15.49 16.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.768 0.285 . . . . 75.41 111.768 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.711 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 57.9 t -56.33 -56.05 35.7 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.253 0.464 . . . . 64.04 112.253 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -66.49 -31.38 42.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.738 1.625 . . . . 63.42 112.074 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.1 m -63.97 -45.56 88.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 52.11 111.794 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.3 pt -68.75 -32.05 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 72.53 111.156 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.58 -37.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.34 -0.391 . . . . 72.5 110.43 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.48 -51.29 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 74.24 110.887 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -69.04 -36.36 77.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 71.43 111.068 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.46 97.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 75.43 111.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.58 95.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.952 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.25 -39.8 89.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 70.24 110.615 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.507 ' HB1' HG22 ' A' ' 188' ' ' VAL . . . -63.3 -35.76 81.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.73 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 60.8 m -65.85 -38.5 89.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 71.33 110.543 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -65.04 -39.03 92.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 73.4 110.045 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.65 -33.8 75.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.897 -0.592 . . . . 72.12 110.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.1 mt -61.41 -34.43 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 74.24 110.817 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.612 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 mm -80.7 -40.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 61.41 111.108 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.13 -43.87 64.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.333 0.494 . . . . 53.13 112.333 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -100.25 -49.86 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.946 0.403 . . . . 75.15 110.87 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 143.71 -168.63 26.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.503 -0.639 . . . . 52.34 111.503 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 182' ' ' GLU . 4.3 pp -104.13 -24.02 13.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.769 0.285 . . . . 73.23 110.83 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.717 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 34.4 tt0 -67.11 -57.23 11.43 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.199 -0.455 . . . . 75.32 111.845 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 83.4 Cg_endo -87.47 -29.63 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.833 1.688 . . . . 73.24 113.093 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -73.93 -31.43 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.508 -0.314 . . . . 75.01 111.823 -172.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -61.81 -29.57 70.25 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.123 0.487 . . . . 75.0 110.023 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.61 -48.38 64.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.635 -0.711 . . . . 53.02 109.846 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 36.0 m -56.26 -38.46 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.631 -0.713 . . . . 40.14 111.446 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 184' ' ' ALA . 82.7 t -57.24 -37.41 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.186 0.439 . . . . 71.51 112.186 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -104.14 -28.24 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.311 -0.555 . . . . 74.41 111.996 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -94.36 12.3 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.128 0.418 . . . . 43.13 112.128 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.488 ' HB2' ' O ' ' A' ' 187' ' ' THR . 3.8 t90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.479 -0.772 . . . . 75.13 110.17 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.5 pm0 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.793 0.33 . . . . 75.32 110.219 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 5.7 Cg_exo -78.58 141.91 17.9 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.172 2.581 . . . . 35.14 113.577 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.713 HD12 HD21 ' A' ' 55' ' ' LEU . 97.0 mt -86.14 126.75 34.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.259 -0.882 . . . . 72.55 109.577 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.633 HD22 HG21 ' A' ' 85' ' ' VAL . 37.1 tp -93.28 114.77 27.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.303 . . . . 65.12 110.499 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' A' ' 62' ' ' LEU . 41.2 t -120.69 121.69 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.34 -0.391 . . . . 32.41 110.12 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 60.2 t -104.02 116.19 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 64.51 110.56 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.96 122.92 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.963 -0.562 . . . . 75.01 111.703 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.634 HD13 ' HG2' ' A' ' 65' ' ' PRO . 58.3 tp -107.74 105.07 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.931 0.396 . . . . 43.31 111.12 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.63 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -97.3 -142.94 13.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 61.42 112.098 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.777 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . 15.9 m120 -134.58 129.37 19.46 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.619 0.21 . . . . 75.34 111.155 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 68.6 Cg_endo -96.8 173.17 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.37 2.713 . . . . 74.15 111.716 170.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.78 -176.35 19.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.408 -0.901 . . . . 65.3 112.389 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 -67.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.054 2.502 . . . . 74.41 112.859 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -127.52 11.15 6.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 72.14 111.301 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 43.1 m-85 -65.55 -18.47 65.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.796 0.331 . . . . 62.45 111.102 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -75.71 -1.4 24.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 44.54 111.386 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 153' ' ' ASN . 68.3 mmtt -107.16 26.75 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 62.21 109.878 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 151' ' ' LEU . 71.2 p -102.19 172.72 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 65.24 110.448 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -66.0 -19.38 65.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.294 . . . . 52.33 111.249 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -76.34 -9.08 58.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 70.13 110.986 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -64.41 -8.08 12.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.715 0.293 . . . . 75.35 111.466 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 135' ' ' ILE . 94.9 mt -63.42 -31.81 73.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.375 -0.375 . . . . 74.55 110.513 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -63.83 -26.64 70.21 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.948 -0.569 . . . . 75.34 112.142 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.63 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 74.3 t80 -90.74 -36.38 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.789 0.328 . . . . 65.32 110.517 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 mmt -57.36 -42.33 81.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.547 0.573 . . . . 75.42 112.547 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.619 ' HB ' HD13 ' A' ' 93' ' ' ILE . 48.2 t -61.74 -38.83 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 70.43 110.5 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.96 -38.64 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 53.42 110.851 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -57.36 -46.57 83.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 72.54 111.334 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG21 HG12 ' A' ' 166' ' ' VAL . 65.6 t -60.03 -45.56 95.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 71.13 110.745 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 36' ' ' ILE . 94.5 mt -61.6 -44.51 96.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.35 110.903 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.65 -35.5 72.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 71.23 111.167 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.53 -42.17 93.74 Favored Glycine 0 N--CA 1.454 -0.163 0 C-N-CA 121.288 -0.482 . . . . 53.52 112.916 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.27 -21.05 64.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.623 0.249 . . . . 72.41 111.015 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.883 HD13 ' HA3' ' A' ' 53' ' ' GLY . 70.5 mt -83.58 -45.71 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.177 0.513 . . . . 74.23 109.936 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.46 23.12 10.52 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 70.32 112.17 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -118.35 158.18 25.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.796 0.331 . . . . 35.44 110.757 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.77 146.56 43.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 71.41 110.726 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.603 ' CA ' ' HB ' ' A' ' 51' ' ' VAL . 38.9 p90 -80.79 151.03 28.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 62.4 110.682 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.55 164.14 32.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.855 0.359 . . . . 64.42 110.935 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 49' ' ' GLU . 46.6 t -75.2 126.1 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.694 -0.685 . . . . 74.42 112.063 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -76.45 127.13 32.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 64.35 109.125 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 38.6 ttmt -67.45 -5.93 17.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 45.01 111.964 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -80.34 -76.96 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.817 0.341 . . . . 74.34 111.402 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -90.13 -16.88 28.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.391 -0.368 . . . . 74.11 111.906 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 5.87 69.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.445 -0.883 . . . . 72.03 111.714 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.94 143.56 28.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.285 -0.265 . . . . 53.24 110.285 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.495 ' HG2' HG22 ' A' ' 42' ' ' VAL . 37.3 mt-10 -94.67 132.87 38.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 74.33 110.477 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 t -136.29 142.51 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.296 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.603 ' HB ' ' CA ' ' A' ' 40' ' ' PHE . 7.6 p -125.26 136.75 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.905 0.384 . . . . 75.13 110.641 175.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.481 HG22 HG12 ' A' ' 61' ' ' VAL . 2.0 p -97.58 149.79 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.901 -0.59 . . . . 74.22 111.094 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.883 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -179.07 -164.89 32.49 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.434 -0.889 . . . . 73.31 112.722 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -122.35 143.04 49.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.058 -0.349 . . . . 73.12 110.058 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.141 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.6 pt? -127.84 109.04 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 74.25 109.361 174.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.05 -45.82 0.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 61.52 111.65 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.28 -27.93 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 110.72 -0.952 . . . . 74.44 110.72 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 59' ' ' SER . 2.0 m -71.79 169.38 15.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.974 -0.613 . . . . 73.4 110.436 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 58' ' ' THR . 14.7 m -97.35 130.56 44.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.468 -0.567 . . . . 74.05 109.468 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.141 ' HB ' HD22 ' A' ' 55' ' ' LEU . 15.0 p -120.05 137.98 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 44.34 110.688 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 52' ' ' THR . 11.9 m -122.8 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.339 0.59 . . . . 72.41 109.847 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 7' ' ' VAL . 77.9 mt -92.39 110.57 21.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.686 -0.688 . . . . 75.35 110.028 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -109.64 132.23 54.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.855 -0.612 . . . . 65.54 110.674 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -120.88 127.92 26.01 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 74.43 110.369 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.634 ' HG2' HD13 ' A' ' 10' ' ' LEU . 48.4 Cg_endo -70.34 168.05 23.41 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.345 2.03 . . . . 75.05 111.262 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 66' ' ' ARG . 8.0 ttt180 -89.05 -60.54 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.837 -0.345 . . . . 75.33 110.726 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.1 p -167.11 172.38 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 24.3 110.541 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.46 ' HD1' ' H ' ' A' ' 71' ' ' GLU . 10.1 t80 71.2 118.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.073 0.858 . . . . 73.11 111.336 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -53.29 -56.24 18.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.589 -0.732 . . . . 51.52 111.624 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 12.5 m120 -56.62 -46.57 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 74.41 111.114 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.628 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 5.6 mm-40 -64.18 -43.99 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 45.15 111.192 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 m -57.84 -39.01 76.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 73.15 110.908 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.656 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -64.61 -34.96 91.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.519 -0.848 . . . . 74.51 111.898 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' ASN . 44.8 mtp180 -86.98 -2.7 58.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 62.55 110.486 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 27.5 mm-40 -79.43 -32.74 42.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 73.01 110.225 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.98 -32.18 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.681 -0.69 . . . . 72.41 110.751 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -47.17 -68.28 1.21 Allowed Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.626 -0.715 . . . . 52.43 113.871 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 -41.06 42.02 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.308 2.006 . . . . 75.24 112.844 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.57 -31.6 72.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.453 -0.339 . . . . 74.2 111.842 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.95 84.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 52.01 111.156 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -26.75 29.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.422 -0.354 . . . . 72.32 110.853 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.32 -46.04 83.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 64.22 110.376 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.58 -3.88 45.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 75.1 110.649 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m 60.71 34.69 19.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.678 -0.692 . . . . 73.4 111.313 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 6' ' ' LEU . 26.9 m -81.25 145.97 57.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.687 -0.688 . . . . 70.24 111.063 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 2.7 Cg_exo -76.49 131.06 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.95 2.434 . . . . 63.41 111.916 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 23.4 Cg_exo -66.43 47.0 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.782 2.988 . . . . 72.41 113.306 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -139.88 -37.67 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 72.34 109.926 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -84.59 -6.82 59.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 75.14 111.353 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.98 130.0 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.378 0.609 . . . . 72.35 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 7' ' ' VAL . 45.8 t -106.16 127.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.766 . . . . 62.02 110.111 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.705 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 40.0 t -114.7 110.18 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.072 -0.344 . . . . 73.44 110.072 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.619 HD13 ' HB ' ' A' ' 28' ' ' VAL . 39.5 mt -87.9 116.88 30.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.502 -0.317 . . . . 73.31 110.657 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -142.6 161.03 39.12 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.557 0.343 . . . . 65.43 110.197 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 137' ' ' VAL . 10.8 p-10 -91.65 148.27 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.509 -0.314 . . . . 61.34 110.517 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 73.8 tt0 -124.96 128.23 48.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.222 0.534 . . . . 73.42 111.197 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.675 HD11 ' HD3' ' A' ' 141' ' ' PRO . 47.1 tp -81.95 -13.9 56.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.666 -0.697 . . . . 65.31 111.72 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.59 5.21 51.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.259 0.552 . . . . 73.34 111.433 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.75 146.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.323 -0.399 . . . . 72.23 110.559 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.15 154.29 23.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.061 -0.518 . . . . 75.41 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.515 ' N ' ' HA2' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -67.68 109.76 3.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 63.23 110.071 -176.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.453 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 114.87 -8.5 21.56 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 54.03 112.623 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -98.83 132.55 44.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.882 -0.414 . . . . 73.52 109.882 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.629 ' HB ' HG11 ' A' ' 188' ' ' VAL . 3.1 mp -101.04 129.54 51.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.236 -0.438 . . . . 54.41 110.061 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 105' ' ' ARG . 10.2 tpt180 -108.79 127.79 54.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.017 -0.538 . . . . 75.33 110.449 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 131' ' ' HIS . 48.1 tp -97.66 132.29 43.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.376 -0.601 . . . . 72.23 109.376 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -155.07 122.11 5.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.288 -0.415 . . . . 73.32 110.109 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.732 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.4 pt? -102.3 -136.16 0.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.679 -0.408 . . . . 72.1 109.955 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.662 ' H ' ' HA ' ' A' ' 129' ' ' ASN . . . 40.3 -149.12 0.17 Allowed Glycine 0 C--N 1.334 0.472 0 O-C-N 123.625 0.578 . . . . 71.0 113.11 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.24 10.56 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.068 -1.213 . . . . 65.12 110.068 164.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.12 156.46 28.03 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.942 -1.123 . . . . 53.05 112.914 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -93.57 -178.63 4.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.792 0.33 . . . . 74.44 110.138 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' HA3' ' NH2' ' A' ' 134' ' ' ARG . . . 115.14 62.53 0.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.796 -0.716 . . . . 64.41 111.601 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.08 -102.34 0.18 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.801 -0.714 . . . . 75.31 111.593 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -154.22 168.38 26.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.254 -0.647 . . . . 74.1 109.254 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -41.86 -53.46 3.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.774 0.671 . . . . 73.32 111.617 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 120' ' ' SER . . . -67.04 2.33 5.15 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.022 -0.535 . . . . 72.42 114.205 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.83 -43.91 14.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.395 0.617 . . . . 72.34 109.366 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -79.68 -21.07 45.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.173 -0.921 . . . . 70.41 111.274 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.499 ' OG ' ' HA2' ' A' ' 117' ' ' GLY . 10.0 m -55.53 -43.8 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 65.12 111.726 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.656 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -68.11 -30.79 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.838 0.352 . . . . 73.41 111.343 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.416 ' HB1' ' HG3' ' A' ' 128' ' ' LYS . . . -78.16 -30.2 49.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 70.14 111.036 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.4 m -84.07 -39.71 19.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.093 -0.503 . . . . 51.1 110.967 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.51 77.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 73.31 111.861 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.654 HD23 ' HZ ' ' A' ' 130' ' ' PHE . 29.3 tp -85.45 -31.12 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.48 . . . . 73.23 109.806 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.33 -12.58 66.49 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.551 -0.75 . . . . 75.34 112.555 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.8 m -106.89 137.45 44.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.783 0.325 . . . . 61.1 110.858 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 8.0 mptt -110.58 -161.81 0.77 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.506 -0.553 . . . . 74.2 109.506 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.662 ' HA ' ' H ' ' A' ' 109' ' ' GLY . 86.3 m-20 76.6 12.97 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.199 0.6 . . . . 63.34 111.329 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.654 ' HZ ' HD23 ' A' ' 125' ' ' LEU . 16.7 m-30 -71.59 136.77 47.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.374 -0.602 . . . . 75.42 109.374 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.524 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.8 p80 -89.88 107.77 19.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.303 0.573 . . . . 64.54 110.352 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.705 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 5.5 mpt_? -94.32 141.28 28.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.631 . . . . 71.42 110.614 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.3 t -92.9 104.18 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.555 -0.905 . . . . 73.04 108.555 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 94' ' ' HIS . 9.1 mtp180 -106.45 114.75 29.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.659 . . . . 71.14 110.529 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.1 mp -96.71 125.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.862 -0.422 . . . . 62.31 109.862 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -61.27 132.16 48.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.134 -0.555 . . . . 60.2 112.832 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 95' ' ' ASP . 23.9 t -86.44 -9.27 11.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.327 0.584 . . . . 71.41 111.035 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.515 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 117.37 -87.31 0.43 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.127 -1.035 . . . . 74.21 113.53 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -132.18 135.45 26.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.491 0.186 . . . . 74.15 111.229 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 29.2 Cg_endo -65.28 123.13 11.06 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.455 2.103 . . . . 73.31 111.113 171.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.948 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 14.3 Cg_exo -69.45 143.47 52.45 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.183 2.589 . . . . 20.33 112.58 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.66 -50.1 0.14 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.666 -0.778 . . . . 52.13 112.494 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -83.16 -32.67 26.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 72.5 111.405 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.542 ' HD3' ' HD1' ' A' ' 149' ' ' PHE . 4.7 ptmm? -114.81 158.84 21.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.868 -0.419 . . . . 70.22 109.868 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 20.3 t70 -52.87 131.91 48.37 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 123.549 0.531 . . . . 72.24 111.824 -175.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.948 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 53.7 Cg_exo -53.3 -41.04 75.59 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.473 2.782 . . . . 75.35 113.45 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.37 39.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 71.43 110.423 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.34 -28.14 69.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 73.31 111.123 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.542 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 71.0 t80 -73.45 -23.17 60.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 71.02 110.528 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.41 -24.2 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.493 0.663 . . . . 70.33 109.924 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.488 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 9.3 mp -87.16 12.1 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.674 -0.694 . . . . 52.41 112.043 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 149' ' ' PHE . 10.5 pt-20 -110.35 136.66 49.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.54 . . . . 63.13 111.083 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 28.9 p-10 -104.52 34.03 3.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.715 -0.675 . . . . 65.23 110.584 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.24 140.57 49.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.032 -0.531 . . . . 73.33 111.134 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.578 ' HB ' ' OE1' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -169.58 -177.71 2.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.312 -0.996 . . . . 75.42 108.312 173.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.3 -71.14 0.68 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.69 -0.404 . . . . 74.42 111.956 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.57 -42.58 8.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 71.33 111.294 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.578 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 0.6 OUTLIER -72.26 -17.42 61.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.689 -0.687 . . . . 75.33 111.175 -174.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.431 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 11.8 tpp180 -70.02 -25.56 63.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 74.43 110.149 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.53 -13.7 42.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 54.11 111.146 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -85.04 -16.83 39.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.248 -0.433 . . . . 64.32 111.098 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.766 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 47.3 t -52.23 -58.67 10.63 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 65.11 112.218 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.766 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.0 Cg_exo -59.68 -34.14 96.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.992 1.794 . . . . 55.14 112.5 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 m -71.97 -46.27 57.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.941 -0.572 . . . . 72.15 111.744 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.453 ' CD1' ' HA2' ' A' ' 102' ' ' GLY . 43.0 pt -69.2 -32.41 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 63.54 112.003 -174.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 162' ' ' VAL . 87.1 t -58.08 -42.3 82.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 42.45 111.32 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.8 -46.63 68.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.383 -0.371 . . . . 62.44 111.481 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -24.34 60.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.624 -0.262 . . . . 74.53 111.25 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.17 85.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 53.14 110.559 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.48 94.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.556 . . . . 74.01 110.377 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.01 -43.73 98.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.67 -0.696 . . . . 73.44 110.969 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.13 95.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.356 . . . . 63.34 110.944 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.423 ' HA ' HD12 ' A' ' 176' ' ' LEU . 90.8 m -61.65 -41.59 97.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 71.01 111.05 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.409 ' OE1' ' HB2' ' A' ' 55' ' ' LEU . 19.4 tt0 -71.56 -31.31 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.37 . . . . 74.15 110.372 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.43 -26.93 67.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.385 . . . . 73.34 110.418 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 173' ' ' THR . 90.8 mt -61.81 -46.47 89.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 64.54 110.911 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.564 HG13 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -81.03 -32.88 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.017 0.437 . . . . 75.43 110.386 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.13 66.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.374 -0.376 . . . . 61.14 111.699 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.434 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.1 tp60 -117.44 -61.49 1.69 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.657 -0.247 . . . . 74.32 111.004 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.29 177.12 35.05 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.233 -0.984 . . . . 55.31 112.101 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 3.9 pp -75.76 -20.51 58.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.492 0.187 . . . . 74.55 111.397 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.659 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 54.1 mt-10 -60.87 -61.64 7.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.65 0.611 . . . . 61.05 112.65 -172.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 71.5 Cg_endo -78.23 -31.12 3.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.592 1.528 . . . . 74.22 112.51 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.77 -58.01 5.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.1 -0.5 . . . . 52.34 111.535 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 24.8 pt20 -70.36 -24.81 63.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.699 -0.401 . . . . 74.43 110.697 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 9.9 t30 -52.25 -46.83 65.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.936 -0.574 . . . . 73.44 112.041 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -83.03 -32.62 26.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.869 -0.333 . . . . 74.34 111.232 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 104' ' ' ILE . 44.4 t -69.51 -28.82 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.568 -0.287 . . . . 71.15 111.724 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -99.08 10.9 40.52 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.019 -0.672 . . . . 73.53 110.91 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -141.48 31.65 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.066 0.395 . . . . 62.34 112.066 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.308 -0.853 . . . . 75.24 109.997 174.66 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.9 pm0 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.372 0.606 . . . . 62.13 110.501 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.546 ' HG2' HG23 ' A' ' 85' ' ' VAL . 83.8 Cg_endo -101.86 -167.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.944 3.096 . . . . 62.22 113.014 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 177' ' ' ILE . 55.9 tp -136.5 115.79 12.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.199 -0.91 . . . . 74.15 108.77 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.572 ' HA ' HG23 ' A' ' 61' ' ' VAL . 33.7 tp -90.82 104.4 16.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.47 -0.567 . . . . 72.03 109.47 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.666 ' HB ' HD23 ' A' ' 62' ' ' LEU . 43.3 t -111.63 122.06 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.258 -0.428 . . . . 64.11 110.54 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.57 114.77 47.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.938 -0.574 . . . . 71.1 109.753 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.1 121.16 6.19 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.681 -0.968 . . . . 70.33 110.681 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.88 124.0 44.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.017 0.437 . . . . 64.02 111.431 -172.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.81 -147.14 4.72 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.435 -0.666 . . . . 74.24 111.435 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -116.66 98.47 51.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.674 0.273 . . . . 63.34 111.208 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.0 118.37 5.39 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.689 2.259 . . . . 62.34 111.351 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 171.96 43.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.891 -0.671 . . . . 74.1 111.661 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.91 -72.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.843 2.362 . . . . 70.41 112.522 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -87.05 -15.01 39.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.41 0.624 . . . . 51.12 110.068 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -71.67 -23.62 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 74.13 111.546 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.36 -1.61 50.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.032 0.444 . . . . 73.04 110.98 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -108.86 15.56 23.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 73.04 110.454 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 65.6 p -101.85 -170.38 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.153 -0.476 . . . . 51.31 110.739 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -73.18 -4.94 36.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.909 0.385 . . . . 73.45 110.74 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -99.11 21.98 11.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.193 0.442 . . . . 72.54 112.193 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' MET . 39.2 p30 -101.37 -1.05 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.855 -0.338 . . . . 52.45 110.458 174.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.82 -37.12 70.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.969 -0.56 . . . . 74.2 111.381 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -62.54 -32.85 84.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.055 -0.593 . . . . 50.41 112.355 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -90.31 -24.61 20.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.793 -0.24 . . . . 75.34 111.239 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.503 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 17.2 mmt -55.91 -51.42 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.786 0.327 . . . . 74.43 111.175 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 22.0 t -66.46 -40.71 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 65.15 110.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 74.01 111.666 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -60.33 -45.08 94.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 75.53 110.553 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.36 -43.82 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 71.33 110.77 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.5 mt -60.97 -39.32 89.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 75.24 111.156 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.77 -46.32 58.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 60.11 110.793 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.55 -34.41 89.87 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.766 -0.652 . . . . 75.11 113.42 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -20.27 62.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.033 0.416 . . . . 74.21 111.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.473 HD13 ' HA3' ' A' ' 53' ' ' GLY . 75.4 mt -87.05 -41.97 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.934 0.397 . . . . 74.13 110.151 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.23 60.22 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.821 -0.627 . . . . 74.12 111.914 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -100.45 140.65 34.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.801 0.334 . . . . 61.14 110.485 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.46 143.06 30.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.322 -0.399 . . . . 74.51 111.315 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 1.061 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 3.3 p90 -60.57 142.04 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 72.25 111.144 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -117.81 147.47 42.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 73.43 110.852 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG22 ' HG2' ' A' ' 49' ' ' GLU . 39.5 t -75.87 128.54 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.953 -0.567 . . . . 63.22 110.169 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.437 ' CD2' ' HB ' ' A' ' 50' ' ' VAL . 27.1 m-70 -85.4 117.03 24.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.423 -0.353 . . . . 72.41 110.331 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -71.47 81.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.588 0.709 . . . . 74.25 111.175 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -175.52 -70.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.266 -0.879 . . . . 74.43 109.484 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.538 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 13.0 m -86.81 -27.95 23.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.745 -0.661 . . . . 55.11 110.662 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . 94.55 10.71 57.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 33.41 112.405 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -97.49 157.59 15.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 33.03 110.788 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.655 ' HG2' HG22 ' A' ' 42' ' ' VAL . 32.9 mt-10 -103.28 127.91 50.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.866 -0.606 . . . . 73.1 111.039 -175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.5 t -140.53 137.97 36.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 72.13 109.817 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.061 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.2 p -116.87 135.23 57.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.886 0.374 . . . . 72.41 111.097 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.581 HG22 HG12 ' A' ' 61' ' ' VAL . 20.2 p -100.85 108.13 19.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 75.12 110.492 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.473 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -127.72 -161.7 10.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.819 -0.705 . . . . 73.54 112.178 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -129.94 143.22 50.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.652 0.226 . . . . 70.43 110.548 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.081 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.0 pt? -142.28 121.17 12.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.184 -0.673 . . . . 73.44 109.184 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.8 -57.24 0.46 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.41 0.684 . . . . 75.31 111.862 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.37 -12.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.343 -0.456 . . . . 75.32 112.447 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.4 p -104.05 168.82 8.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.94 0.4 . . . . 71.32 110.899 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 t -90.86 99.64 12.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.565 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.081 ' HB ' HD22 ' A' ' 55' ' ' LEU . 11.6 p -76.17 129.94 36.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.54 -0.464 . . . . 63.13 109.872 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 52' ' ' THR . 17.6 m -118.45 111.22 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.494 0.664 . . . . 70.44 110.12 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD23 ' HB ' ' A' ' 7' ' ' VAL . 87.5 mt -92.6 117.92 30.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.759 . . . . 71.2 110.28 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.43 125.33 51.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.933 -0.576 . . . . 65.3 109.802 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -117.92 136.19 23.68 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.093 -0.503 . . . . 73.43 111.102 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.45 137.82 62.14 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.986 2.457 . . . . 71.32 111.477 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 32.5 ttt-85 -85.56 -52.78 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.741 -0.384 . . . . 74.11 110.08 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.2 p -159.44 139.17 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.467 -0.333 . . . . 54.52 110.997 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.548 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 20.5 t80 71.06 133.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.096 0.873 . . . . 55.5 111.802 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.446 ' HB3' ' CA ' ' A' ' 117' ' ' GLY . 2.0 mpt? -62.07 -56.43 19.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 75.14 112.038 -174.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.28 -41.58 97.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.394 -0.366 . . . . 74.42 111.834 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 9.0 mm-40 -63.68 -30.11 71.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.386 -0.37 . . . . 71.11 110.89 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 m -63.52 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 74.23 110.697 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.08 -38.16 96.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.573 -0.822 . . . . 35.23 111.098 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.58 1.41 29.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.057 0.456 . . . . 74.53 110.594 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 13.0 mm-40 -97.37 -51.8 4.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.919 -0.582 . . . . 74.31 110.07 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.65 -41.03 91.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 44.35 111.531 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.64 -65.3 3.41 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.189 -0.459 . . . . 72.43 113.083 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.63 -39.94 87.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.792 2.328 . . . . 75.12 112.873 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 48' ' ' ALA . 55.1 mt -64.7 -36.99 86.05 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.816 0.302 . . . . 61.32 111.816 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.22 -41.4 83.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.403 0.62 . . . . 50.22 110.337 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 -0.82 56.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 61.11 111.666 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -80.22 -49.05 12.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 71.22 110.564 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.551 ' CE2' ' HB ' ' A' ' 85' ' ' VAL . 40.0 p90 -108.45 9.42 27.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 74.02 110.86 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m 60.67 77.95 0.3 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.397 -0.82 . . . . 52.44 112.177 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 83' ' ' TYR . 12.9 p -107.45 130.94 22.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.15 -0.477 . . . . 44.43 109.901 175.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 22.3 Cg_endo -62.64 118.64 5.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.7 2.267 . . . . 70.3 112.4 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 2.8 Cg_exo -76.18 67.6 6.85 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.295 2.664 . . . . 64.44 112.097 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -146.04 -53.66 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 74.55 109.972 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -80.71 74.16 7.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.886 -0.597 . . . . 74.31 109.991 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -121.86 141.53 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 64.4 110.455 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG23 HD11 ' A' ' 5' ' ' LEU . 94.9 t -127.99 110.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.035 -0.53 . . . . 70.45 109.846 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.2 106.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.142 -0.318 . . . . 54.24 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.538 HG22 ' HA2' ' A' ' 25' ' ' GLY . 66.2 mt -94.97 117.34 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.349 -0.387 . . . . 75.35 110.259 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -154.78 161.21 41.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.923 0.392 . . . . 73.01 110.407 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.46 149.53 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 74.24 110.599 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.634 ' HB3' HG22 ' A' ' 99' ' ' ILE . 5.9 tp10 -123.41 109.09 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.399 -0.593 . . . . 62.21 109.399 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.765 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 6.1 mp -68.95 -34.19 74.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 75.23 111.793 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.96 -31.16 68.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.555 . . . . 52.35 112.186 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.634 HG22 ' HB3' ' A' ' 96' ' ' GLU . 14.8 tt -97.74 160.39 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.944 0.402 . . . . 65.51 111.461 -172.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.662 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 22.2 t70 -58.5 148.83 27.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.607 -0.724 . . . . 74.2 112.158 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 69.8 t80 -69.68 138.95 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.75 -0.659 . . . . 72.15 111.948 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.09 9.92 86.53 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.526 -0.761 . . . . 63.44 113.026 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -100.45 116.43 32.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.719 -0.474 . . . . 63.2 109.719 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.7 mp -79.98 106.43 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.446 -0.575 . . . . 61.41 109.446 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -109.06 150.06 28.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.98 -0.554 . . . . 73.21 109.905 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 131' ' ' HIS . 15.1 tp -113.14 146.67 38.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.665 -0.494 . . . . 72.35 109.665 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 131' ' ' HIS . 38.0 tttm -147.34 153.92 40.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.569 -0.53 . . . . 61.34 109.569 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.738 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -125.05 -71.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.281 0.363 . . . . 74.43 111.446 -176.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.738 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -63.69 161.04 36.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.273 -0.489 . . . . 62.12 112.828 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.52 143.59 31.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.935 -0.65 . . . . 61.53 112.329 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.42 -176.64 42.06 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.298 -0.721 . . . . 62.35 111.298 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -81.07 150.13 28.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 73.22 110.723 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.79 -59.56 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.743 -1.343 . . . . 73.4 109.743 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.836 ' HA3' HD21 ' A' ' 118' ' ' LEU . . . -91.48 163.97 29.01 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.67 -0.972 . . . . 53.15 110.67 170.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.575 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 4.7 t-80 -119.09 -63.33 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.268 -0.573 . . . . 51.43 111.631 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -107.82 -71.16 0.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.809 -0.357 . . . . 64.13 111.882 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 69' ' ' MET . . . -51.62 -48.24 50.15 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.812 -0.631 . . . . 72.24 114.659 -167.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.836 HD21 ' HA3' ' A' ' 114' ' ' GLY . 3.5 pp -78.28 -19.36 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.293 -0.563 . . . . 72.44 111.827 -174.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.575 ' HD3' ' O ' ' A' ' 115' ' ' HIS . 18.1 mtp180 -81.11 -26.45 36.18 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.0 -0.28 . . . . 43.32 110.29 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -67.57 -50.17 59.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.458 -0.337 . . . . 75.02 110.705 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.508 HG12 ' HA2' ' A' ' 73' ' ' GLY . 29.4 m -65.87 -33.8 66.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 70.12 111.089 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.17 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.419 . . . . 73.12 111.118 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.1 m -82.07 -28.91 32.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 75.04 110.545 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.45 -43.46 81.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.711 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.89 -41.5 59.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 75.04 109.743 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.7 62.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.617 -0.72 . . . . 43.04 112.25 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.481 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 6.6 m -108.54 148.01 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.843 -0.429 . . . . 73.02 109.843 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 11.6 mptt -117.2 -155.83 0.6 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.35 109.11 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.4 t30 73.88 9.96 4.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.797 0.808 . . . . 73.14 109.654 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -87.83 127.58 35.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.331 -0.849 . . . . 65.13 109.791 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.76 ' HB2' HD11 ' A' ' 106' ' ' LEU . 35.2 p-80 -73.05 120.41 18.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.359 0.599 . . . . 74.53 111.694 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 106' ' ' LEU . 43.0 mtm105 -95.21 139.77 31.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.635 -0.711 . . . . 72.41 110.451 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.85 104.16 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.449 -0.945 . . . . 64.53 108.449 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.485 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 53.5 mtp180 -100.92 107.86 19.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.456 -0.793 . . . . 73.13 110.377 -172.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.3 mp -93.81 113.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.609 . . . . 75.35 109.357 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 100' ' ' ASP . . . -57.46 138.5 48.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.136 -0.554 . . . . 73.31 113.904 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.765 ' HB ' ' HA ' ' A' ' 97' ' ' LEU . 89.6 t -88.98 -20.35 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 62.25 110.588 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 130.33 -78.43 0.38 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.282 -0.961 . . . . 75.31 113.312 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.587 ' HD3' ' O ' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -163.7 158.78 17.17 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 110.048 -0.353 . . . . 75.23 110.048 -174.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.587 ' O ' ' HD3' ' A' ' 139' ' ' ARG . 51.4 Cg_exo -55.43 159.65 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.018 2.479 . . . . 73.11 112.616 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 49.2 Cg_endo -67.12 161.45 42.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.707 2.272 . . . . 74.52 112.877 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -86.87 1.97 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.73 . . . . 72.23 112.345 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -103.21 8.28 38.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 72.33 111.412 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -131.48 161.86 31.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.407 -0.361 . . . . 64.54 110.605 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.67 150.64 25.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.454 0.471 . . . . 64.24 111.445 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.88 -43.07 59.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.776 2.317 . . . . 70.44 112.075 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.25 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 60.02 111.072 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 151' ' ' LEU . . . -83.54 -27.8 29.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.416 -0.356 . . . . 60.41 110.949 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 86.3 t80 -67.65 -35.36 78.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.15 110.223 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.752 ' O ' ' HB ' ' A' ' 20' ' ' THR . 35.5 m -84.86 -6.22 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 74.1 111.021 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.697 HD23 HG21 ' A' ' 20' ' ' THR . 11.1 mt -90.78 6.12 45.54 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.174 0.435 . . . . 64.32 112.174 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -93.27 167.44 11.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.487 -0.485 . . . . 71.02 110.054 175.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -149.5 148.9 29.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.544 -0.298 . . . . 71.11 111.301 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.789 ' HA ' ' HG2' ' A' ' 159' ' ' ARG . 84.4 m-85 66.89 96.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.477 1.11 . . . . 75.13 112.313 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 13.3 p -114.68 -166.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 75.21 109.572 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.2 -72.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.846 0.684 . . . . 64.12 112.846 -171.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.67 -56.46 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.157 0.429 . . . . 63.4 112.157 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.474 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -65.81 -23.73 66.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.756 -0.656 . . . . 75.55 111.878 -171.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.789 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 3.3 tpp180 -71.97 -28.05 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 75.21 110.396 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.432 ' O ' ' HD2' ' A' ' 163' ' ' PRO . . . -87.6 -11.11 49.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.957 -0.565 . . . . 61.41 110.183 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.6 -3.6 59.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.731 . . . . 75.11 111.058 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.695 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 95.8 t -57.87 -52.91 70.97 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.616 -0.265 . . . . 71.34 110.731 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 51.1 Cg_exo -55.84 -35.92 94.59 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.968 1.779 . . . . 73.44 111.977 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -64.35 -48.92 73.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 45.54 111.198 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 36.0 pt -79.93 -26.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 74.13 111.944 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 163' ' ' PRO . 9.3 p -68.48 -31.91 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.882 -0.327 . . . . 43.21 110.698 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 44.8 mt-10 -64.68 -43.32 93.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.181 0.515 . . . . 73.44 109.621 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.63 -47.23 82.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.345 -0.843 . . . . 61.25 110.851 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.38 99.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.511 . . . . 73.44 111.547 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.12 96.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 73.41 110.783 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.42 -39.04 81.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 73.43 110.687 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.88 -42.03 98.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 44.33 111.062 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.6 m -61.62 -38.13 86.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 62.21 110.516 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -73.11 -34.01 65.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 72.25 110.252 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.2 tp -66.55 -27.3 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 73.52 110.832 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 92.0 mt -61.29 -33.73 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.5 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 5' ' ' LEU . 38.0 mm -81.28 -46.62 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 53.3 110.938 176.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.79 -61.27 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 33.02 111.773 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.432 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.5 tp60 -93.14 -44.62 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 72.44 110.576 -175.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 183' ' ' PRO . . . 130.26 156.64 8.75 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.064 -0.814 . . . . 54.31 111.064 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.68 -27.73 66.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.164 0.482 . . . . 63.21 110.959 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.714 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 35.1 tt0 -72.5 -52.46 6.58 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.812 -0.631 . . . . 73.04 111.664 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 9.9 Cg_exo -73.89 -32.23 7.43 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.891 1.727 . . . . 62.14 112.895 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -64.3 -40.03 95.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 111.76 0.281 . . . . 54.42 111.76 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 9.9 pt20 -58.22 -30.75 66.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.645 0.259 . . . . 74.41 110.904 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.41 -47.86 74.81 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.617 -0.512 . . . . 72.32 109.617 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -59.03 -38.84 80.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.671 -0.695 . . . . 61.4 111.237 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 184' ' ' ALA . 99.5 t -58.47 -35.91 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.992 -0.549 . . . . 61.31 112.237 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -106.8 15.22 25.79 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.116 -0.634 . . . . 71.33 110.675 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.86 6.52 47.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.103 -0.499 . . . . 72.44 111.496 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.489 -0.767 . . . . 73.23 110.105 176.303 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 22.3 ptt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 111.218 0.081 . . . . 73.35 111.218 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.552 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -166.73 22.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.974 0.416 . . . . 62.13 111.145 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 1.1 pm0 -87.05 130.51 47.9 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.252 -0.431 . . . . 74.0 110.315 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' CD ' ' HD2' ' A' ' 86' ' ' PRO . 93.9 Cg_endo -96.23 162.01 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.026 2.484 . . . . 64.4 113.495 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.666 HD11 HG23 ' A' ' 91' ' ' VAL . 58.0 tp -89.45 122.78 32.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.168 -0.924 . . . . 71.42 108.797 172.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.73 105.37 17.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.484 -0.561 . . . . 73.1 109.484 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HB ' HD23 ' A' ' 62' ' ' LEU . 38.2 t -107.07 113.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 74.34 110.525 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 92' ' ' VAL . 58.3 t -109.86 118.1 56.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.669 -0.696 . . . . 74.34 109.716 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.27 122.72 7.45 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.201 -0.999 . . . . 74.32 111.779 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' HA3' ' A' ' 117' ' ' GLY . 46.5 tp -77.77 82.04 4.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.329 0.585 . . . . 62.25 109.79 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.695 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -164.2 101.73 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.271 -0.877 . . . . 43.43 111.104 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 65' ' ' PRO . 50.8 m-80 -88.38 146.94 38.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.494 -0.188 . . . . 72.04 110.494 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 25.5 Cg_exo -62.96 96.43 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 123.06 2.507 . . . . 73.43 112.697 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . -122.33 119.1 3.86 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.38 -0.827 . . . . 73.02 111.3 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.45 -54.12 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 124.359 3.373 . . . . 62.34 114.58 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -105.09 -30.08 9.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.439 0.533 . . . . 71.52 112.439 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 p90 -89.13 2.68 53.79 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.17 -0.612 . . . . 75.3 112.059 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 -1.51 52.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.893 0.377 . . . . 74.3 110.679 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.6 10.76 16.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.292 -0.413 . . . . 74.25 110.868 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 22' ' ' HIS . 6.2 t -105.1 -174.58 2.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.757 -0.377 . . . . 65.05 110.898 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 54.5 mtt180 -57.24 -20.94 30.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.61 0.596 . . . . 65.12 112.61 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.636 ' H ' HG23 ' A' ' 20' ' ' THR . 5.5 t-160 -91.65 14.05 16.27 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 72.15 111.609 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.17 1.06 57.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.837 -0.345 . . . . 65.23 110.379 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 88.0 mt -51.41 -48.11 62.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.745 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.76 93.34 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.958 -0.639 . . . . 71.31 112.846 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.695 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 77.9 t80 -80.35 -26.97 38.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.627 0.251 . . . . 64.02 110.824 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.586 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 7.2 mmt -55.18 -53.45 55.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.931 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.658 HG21 HG12 ' A' ' 93' ' ' ILE . 90.2 t -56.12 -45.57 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.76 0.314 . . . . 63.32 111.048 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -48.85 74.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 51.14 111.186 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.33 -40.02 96.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 52.52 110.814 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 HG12 ' A' ' 166' ' ' VAL . 45.0 t -67.4 -45.63 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 74.33 111.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.36 -45.14 94.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 73.53 110.482 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.53 -31.72 73.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 74.35 110.549 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -45.47 49.53 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.598 -0.728 . . . . 22.3 113.081 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HG3' HD12 ' A' ' 36' ' ' ILE . 13.1 ptp180 -70.36 -34.95 73.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.094 0.447 . . . . 74.13 110.933 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -71.65 -37.02 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.071 0.463 . . . . 74.12 110.117 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.17 53.44 2.66 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.74 -0.743 . . . . 44.0 112.202 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.6 m -147.6 144.82 28.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.651 0.263 . . . . 75.3 110.487 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.06 147.81 25.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.302 -0.408 . . . . 73.33 110.423 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.623 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 p90 -78.25 132.64 37.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 64.43 110.894 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -99.59 150.26 22.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.782 -0.645 . . . . 74.55 110.893 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 24.6 t -73.16 124.08 29.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 72.44 111.427 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -88.08 99.96 12.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 74.23 109.064 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -69.23 86.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 71.04 110.553 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -173.13 -62.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.07 -0.968 . . . . 72.55 109.189 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -99.48 -14.63 19.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.643 -0.708 . . . . 74.41 110.846 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.54 67.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.836 -0.697 . . . . 63.41 112.467 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.573 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -93.7 163.05 13.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.705 0.288 . . . . 33.12 110.767 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.936 ' HB2' ' HE3' ' A' ' 64' ' ' LYS . 29.8 mt-10 -124.04 131.48 53.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 61.32 110.274 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -133.33 139.14 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.521 . . . . 74.04 110.718 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 8.5 p -119.18 142.67 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.435 -0.348 . . . . 74.22 110.079 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.428 HG22 HG12 ' A' ' 61' ' ' VAL . 14.1 p -108.29 143.43 37.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.953 0.353 . . . . 74.45 111.953 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.18 -164.43 21.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.202 -0.523 . . . . 52.11 111.887 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -134.12 122.83 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.75 0.275 . . . . 64.21 110.622 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.053 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -111.16 119.1 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 51.43 109.486 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.02 -67.6 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.412 0.685 . . . . 54.32 111.656 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.43 12.79 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.982 -0.847 . . . . 40.44 110.982 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.525 ' O ' HD23 ' A' ' 55' ' ' LEU . 47.0 m -126.31 146.0 50.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 71.41 109.414 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 18.0 m -67.62 131.71 46.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.701 -0.481 . . . . 45.45 109.701 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.053 ' HB ' HD22 ' A' ' 55' ' ' LEU . 9.9 p -111.65 127.98 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.904 0.383 . . . . 75.05 110.132 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG12 HG22 ' A' ' 52' ' ' THR . 11.5 m -117.13 109.26 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.308 0.575 . . . . 73.03 109.846 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.515 HD23 ' HB ' ' A' ' 7' ' ' VAL . 78.3 mt -92.57 106.36 18.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.561 -0.745 . . . . 63.14 109.748 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 127.88 55.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.814 -0.63 . . . . 74.0 110.922 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.936 ' HE3' ' HB2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -123.63 143.6 42.14 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.11 -0.7 . . . . 51.14 109.11 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.815 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 14.6 Cg_exo -69.65 175.59 7.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.179 2.586 . . . . 54.14 113.598 -173.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 7.1 ptm180 -77.38 -61.81 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 64.34 110.949 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.665 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 24.6 p -169.49 166.79 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.55 -0.537 . . . . 72.23 109.55 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 16.0 t80 70.27 144.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.657 0.741 . . . . 71.51 112.595 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.5 -56.17 20.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 53.43 111.721 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.417 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 25.2 t-20 -58.04 -43.7 86.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.165 -0.471 . . . . 71.14 111.573 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 8.6 mm-40 -56.66 -41.57 77.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.132 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.5 m -57.5 -32.44 67.02 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.515 0.51 . . . . 65.21 111.306 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -65.16 -47.11 84.74 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.654 -0.784 . . . . 42.53 112.349 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 25.6 ptt180 -89.22 3.06 53.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.981 -0.288 . . . . 73.35 111.111 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.815 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 23.2 mm-40 -66.92 -38.24 85.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 71.21 110.783 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.11 -34.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.977 -0.556 . . . . 73.13 111.696 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.539 ' O ' ' HD3' ' A' ' 81' ' ' LYS . . . -54.18 -73.3 0.43 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.975 -0.557 . . . . 44.23 113.642 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 18.5 Cg_endo -59.79 -23.21 71.22 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.081 2.521 . . . . 72.14 113.407 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 48' ' ' ALA . 34.8 mt -75.41 -43.03 52.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.071 -0.252 . . . . 75.03 111.386 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.77 80.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 71.5 110.825 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 77' ' ' GLY . 2.2 mptp? -80.79 -26.34 37.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.771 -0.649 . . . . 72.31 110.037 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.6 t80 -56.6 -52.45 64.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.602 -0.726 . . . . 73.21 110.857 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -94.92 -1.2 53.06 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.849 -0.34 . . . . 71.41 110.709 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 63.12 90.95 0.07 Allowed 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.787 0.679 . . . . 64.54 110.731 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.27 123.7 76.83 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.472 -0.786 . . . . 65.43 112.414 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.617 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 5.9 Cg_exo -79.81 113.35 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.804 2.336 . . . . 74.03 109.452 162.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 24.9 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.853 2.368 . . . . 74.42 113.778 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -92.6 -57.74 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 74.43 109.721 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 130' ' ' PHE . 8.8 tt0 -173.64 148.99 1.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.942 -0.572 . . . . 72.05 109.861 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 tt -124.18 122.1 63.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.335 0.588 . . . . 71.54 110.935 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 5' ' ' LEU . 98.9 t -113.19 126.68 70.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 75.44 109.977 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.545 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 t -129.48 107.02 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.239 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.658 HG12 HG21 ' A' ' 28' ' ' VAL . 4.2 mp -84.5 133.74 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.702 -0.681 . . . . 53.24 109.329 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.631 ' CE1' HD13 ' A' ' 118' ' ' LEU . 18.2 p80 -151.8 179.58 8.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.895 0.379 . . . . 63.04 111.116 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.23 148.57 26.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.228 -0.897 . . . . 71.42 111.092 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -140.95 115.04 9.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 73.3 110.374 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 137' ' ' VAL . 95.5 mt -82.75 -14.16 55.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.632 -0.713 . . . . 72.33 112.458 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -94.39 -12.13 28.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.902 0.382 . . . . 65.22 110.984 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.591 HD11 ' HD2' ' A' ' 105' ' ' ARG . 46.3 mm -106.63 139.45 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 72.34 111.895 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.83 142.21 30.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.958 -1.019 . . . . 72.23 111.617 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.3 t80 -68.43 115.12 7.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 62.42 111.241 -173.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.07 -16.78 6.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.329 -0.938 . . . . 42.15 113.635 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -114.21 159.97 19.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.402 0.601 . . . . 64.05 111.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.23 129.32 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 73.15 111.444 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.735 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 75.2 ttt180 -109.3 125.39 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.052 -0.722 . . . . 43.1 109.052 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.23 118.26 35.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 71.01 111.35 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.79 161.43 26.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.161 -0.681 . . . . 73.04 109.161 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 129' ' ' ASN . 89.9 mt -66.78 -72.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.232 0.456 . . . . 73.35 112.232 -176.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.48 -126.19 3.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.364 -0.922 . . . . 70.53 113.56 -173.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.96 152.56 26.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.007 -0.616 . . . . 73.51 112.454 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.5 163.54 32.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.81 -0.71 . . . . 43.13 112.048 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.14 164.34 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.219 -0.289 . . . . 70.23 110.219 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -30.27 5.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.831 -0.7 . . . . 43.44 111.954 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.16 -170.58 24.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.952 -0.642 . . . . 55.43 111.649 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.406 ' CE1' HD11 ' A' ' 97' ' ' LEU . 39.4 m80 -103.14 -86.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.432 0.53 . . . . 72.0 112.432 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -118.24 -64.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.765 0.654 . . . . 73.44 112.765 -170.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.437 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -48.11 -49.43 24.29 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.495 0.497 . . . . 72.15 114.314 -168.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.7 pt? -57.77 -35.06 70.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 71.15 111.883 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.487 ' HG3' ' HG ' ' A' ' 118' ' ' LEU . 78.8 mtp180 -80.18 -40.05 28.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.065 -0.516 . . . . 63.52 110.484 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 45.0 m -69.6 -42.5 74.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.624 -0.716 . . . . 65.41 112.154 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.47 -27.93 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.88 0.326 . . . . 72.54 111.88 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.37 91.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 73.22 110.731 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 m -79.23 -22.62 44.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.03 -0.532 . . . . 71.42 111.163 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.43 77.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 72.45 111.176 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.86 -41.59 6.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.338 -0.392 . . . . 64.35 111.025 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.28 -5.83 63.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.792 -0.718 . . . . 73.42 111.835 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 52.7 m -125.38 126.8 45.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.936 0.398 . . . . 63.32 110.171 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.587 ' N ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.58 -160.91 1.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.031 -0.531 . . . . 74.44 109.825 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m-20 69.85 72.63 0.23 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.5 0.667 . . . . 75.4 111.204 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.402 ' HB3' ' HG3' ' A' ' 89' ' ' GLN . 85.6 m-85 -140.86 -82.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.222 -0.899 . . . . 65.41 109.411 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -152.29 103.69 2.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 74.02 110.327 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 132' ' ' ARG . 2.6 tpp180 -102.56 108.79 20.21 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 64.42 108.865 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 84.0 t -82.66 116.36 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.227 0.537 . . . . 73.24 111.211 -171.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.837 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 54.1 mtt180 -105.11 111.18 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.207 -0.906 . . . . 73.02 109.984 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 24' ' ' LEU . 58.4 mt -95.65 118.57 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.108 -0.701 . . . . 74.12 109.108 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -60.64 128.25 44.94 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.773 -0.727 . . . . 64.35 111.993 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 97' ' ' LEU . 8.9 p -98.51 -5.86 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 72.31 110.744 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.23 -108.5 0.93 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.643 -0.789 . . . . 73.51 112.402 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -153.98 157.13 32.49 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.418 -0.215 . . . . 73.44 110.418 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.93 135.01 56.67 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.718 2.279 . . . . 73.1 111.73 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.524 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 59.0 Cg_endo -73.29 164.76 34.38 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.77 2.313 . . . . 73.52 112.627 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -26.03 6.92 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.879 -0.677 . . . . 63.01 112.24 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -105.53 -66.96 0.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.731 0.301 . . . . 72.13 111.782 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.782 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -77.57 161.13 28.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.916 0.389 . . . . 72.12 111.621 -174.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.36 137.4 68.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.446 -0.797 . . . . 45.4 111.02 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.81 -44.7 30.81 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 55.42 113.417 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.26 -34.95 66.11 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.001 -0.28 . . . . 71.52 110.68 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.09 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 52.3 110.778 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.524 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 32.8 t80 -68.16 -26.56 65.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 72.52 110.318 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 25.3 t -81.66 -16.99 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.779 -0.646 . . . . 63.31 109.735 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.36 -11.25 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.716 -0.675 . . . . 73.21 110.858 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -113.64 104.66 12.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.17 0.509 . . . . 62.4 110.412 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.578 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 51.1 t30 -90.84 79.7 5.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 72.0 111.336 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -146.56 135.67 22.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 72.45 109.585 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -154.29 -171.62 3.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.915 -0.772 . . . . 73.31 108.915 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 155' ' ' THR . . . -92.46 -71.62 0.64 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.855 0.316 . . . . 73.3 111.855 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.01 -51.66 4.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 54.3 111.689 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 1.1 pm0 -69.26 -17.03 63.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.784 . . . . 71.24 111.468 -172.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -64.48 -27.07 68.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.736 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.59 -20.2 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.234 -0.439 . . . . 74.02 111.032 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.7 6.92 39.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 73.24 111.791 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.682 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 84.2 t -53.66 -55.09 38.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.087 0.403 . . . . 73.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.6 Cg_exo -53.62 -39.81 81.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.027 1.818 . . . . 75.51 112.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 m -65.62 -50.96 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.36 -0.382 . . . . 63.54 111.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.12 -32.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 64.11 111.401 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.54 HG12 HG21 ' A' ' 31' ' ' VAL . 75.7 t -69.05 -45.87 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.636 -0.256 . . . . 74.53 111.109 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -60.13 -41.35 92.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.282 . . . . 71.23 110.635 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.25 -37.61 78.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 71.14 111.261 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.12 74.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 70.11 110.884 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.21 -34.33 78.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 73.24 110.838 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.28 -42.98 64.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.753 -0.658 . . . . 52.14 110.633 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -65.99 -25.86 67.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 52.23 111.087 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.8 m -61.27 -37.96 85.03 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 54.32 110.404 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 55' ' ' LEU . 34.0 tt0 -73.1 -30.76 63.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 74.54 110.078 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.19 -28.44 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 73.13 110.366 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.7 mt -64.94 -25.39 67.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 75.0 110.822 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.564 HD11 HD13 ' A' ' 5' ' ' LEU . 26.7 mm -80.72 -51.21 16.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 63.22 110.733 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -73.3 -42.5 62.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.651 . . . . 62.11 112.313 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.441 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.9 tp60 -93.46 -62.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.766 0.317 . . . . 70.23 111.325 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.38 -129.8 3.24 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.65 -0.786 . . . . 70.44 112.21 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 182' ' ' GLU . 3.0 pp -124.01 -46.77 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 74.31 111.923 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.79 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 44.8 tt0 -74.19 -57.56 2.22 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.671 0.249 . . . . 73.32 111.671 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.3 Cg_exo -63.97 -25.34 66.8 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.515 1.477 . . . . 73.03 111.475 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -70.28 -50.18 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 65.51 110.89 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.1 pt20 -65.56 -30.57 71.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.907 0.384 . . . . 73.4 110.141 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.56 -45.01 95.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 55.33 109.837 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 91.2 m -59.74 -42.45 93.2 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.989 -0.55 . . . . 55.51 110.685 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 184' ' ' ALA . 58.7 t -66.43 -34.28 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.949 -0.568 . . . . 42.42 111.892 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.35 5.94 46.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.196 -0.315 . . . . 72.42 111.844 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.04 -17.91 38.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 70.44 111.066 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.361 -0.828 . . . . 71.43 109.986 178.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 110.303 -0.258 . . . . 72.4 110.303 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.91 145.79 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.179 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' ' 58' ' ' THR . 10.3 pt-20 -104.24 116.83 60.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.341 0.591 . . . . 75.02 111.199 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 59' ' ' SER . 27.8 Cg_endo -96.57 113.39 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.56 2.84 . . . . 60.13 112.207 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 177' ' ' ILE . 45.7 tp -88.66 119.67 29.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.509 -0.314 . . . . 73.42 110.383 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.612 ' HA ' HG23 ' A' ' 61' ' ' VAL . 61.2 tp -92.67 107.12 18.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 72.32 109.861 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.653 ' HB ' HD23 ' A' ' 62' ' ' LEU . 42.7 t -98.05 117.36 42.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.025 -0.534 . . . . 71.34 109.756 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.24 114.84 41.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 74.44 110.002 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.83 122.75 7.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 53.53 111.732 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.67 100.06 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.864 0.364 . . . . 74.04 110.778 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.95 135.45 11.43 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.818 -0.628 . . . . 71.24 111.85 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 34.5 m-80 -139.32 129.04 14.25 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 110.225 -0.287 . . . . 74.54 110.225 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 31.8 Cg_exo -59.19 165.6 8.64 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.408 2.739 . . . . 74.33 113.483 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.63 111.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.748 -0.941 . . . . 75.41 110.748 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -45.22 -50.28 9.15 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.326 2.684 . . . . 70.24 113.155 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -100.98 -10.93 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.216 -0.447 . . . . 63.12 111.367 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 151' ' ' LEU . 39.7 m-85 -101.18 1.81 39.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 74.5 112.258 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.583 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -87.71 -15.06 38.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.04 0.448 . . . . 43.13 110.625 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -105.5 9.78 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 75.03 110.412 -175.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 153' ' ' ASN . 75.6 p -111.74 -169.5 1.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.389 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 62.9 mtt180 -67.08 -4.94 11.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.042 0.449 . . . . 75.25 111.013 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -76.0 -8.76 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 75.14 111.142 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 24.4 m-80 -134.38 32.34 3.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.756 -0.202 . . . . 71.23 111.509 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 137' ' ' VAL . 64.6 mt -58.29 -38.21 76.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.718 0.294 . . . . 65.33 111.437 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.36 87.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.837 -0.697 . . . . 65.01 112.303 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 64' ' ' LYS . 87.3 t80 -73.61 -32.72 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.611 0.244 . . . . 72.42 110.867 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.4 mmt -53.44 -47.43 69.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.043 -0.526 . . . . 73.43 111.263 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 48.2 t -66.09 -42.93 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.056 -0.52 . . . . 64.3 110.77 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -61.96 -40.47 95.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 64.22 110.909 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.69 -46.82 88.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 71.45 110.242 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -33.22 59.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 72.45 111.173 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 29' ' ' ALA . 64.9 mt -57.74 -50.06 74.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.128 -0.323 . . . . 65.14 110.128 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.85 68.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.52 . . . . 62.42 110.673 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.87 -48.39 66.78 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.617 -0.719 . . . . 54.41 112.894 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -73.9 -22.76 59.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.169 0.485 . . . . 71.34 111.054 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -45.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.401 . . . . 64.52 110.001 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.6 37.02 4.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.939 -0.648 . . . . 61.3 111.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.4 m -153.45 117.79 4.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.728 0.299 . . . . 74.15 110.486 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.04 145.3 32.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.325 -0.398 . . . . 45.13 110.887 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 1.06 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 5.1 p90 -68.55 145.63 53.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 72.31 111.644 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.41 145.33 48.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 64.25 110.436 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 49' ' ' GLU . 51.5 t -68.68 125.88 27.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.252 -0.431 . . . . 72.52 111.082 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -80.74 143.77 32.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 70.04 110.445 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 10.0 tmtt? -62.32 -63.91 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 65.4 111.129 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -74.0 -31.17 62.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.258 -0.428 . . . . 73.45 111.665 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 m -81.66 -28.04 33.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.859 0.361 . . . . 75.41 111.524 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.33 95.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.542 -0.837 . . . . 61.53 111.615 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.19 144.01 31.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.446 -0.205 . . . . 72.55 110.446 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HG3' HG22 ' A' ' 42' ' ' VAL . 2.6 mp0 -73.78 123.29 23.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.161 -0.472 . . . . 64.42 111.213 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.3 t -138.74 140.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.633 . . . . 71.05 109.662 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.06 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 14.5 p -136.84 148.43 26.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.301 . . . . 63.31 110.933 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.653 HG22 HG12 ' A' ' 61' ' ' VAL . 24.0 p -103.36 161.27 13.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.175 -0.466 . . . . 60.12 110.902 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.95 -161.28 30.66 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.133 -0.556 . . . . 73.1 111.799 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.607 ' HD2' ' HA ' ' A' ' 59' ' ' SER . 11.0 mmm180 -131.75 127.32 36.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.803 0.301 . . . . 73.02 110.201 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.086 HD22 ' HB ' ' A' ' 60' ' ' VAL . 1.6 pt? -121.78 119.03 30.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.578 . . . . 75.42 109.441 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . . . 58.45 10.16 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.767 -0.651 . . . . 71.24 112.667 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.07 -16.87 17.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.54 -0.838 . . . . 74.2 112.45 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' ' 3' ' ' GLU . 98.0 m -89.88 139.73 30.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.246 -0.279 . . . . 71.42 110.246 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 20.8 m -68.45 109.74 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.688 -0.486 . . . . 53.11 109.688 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.086 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -98.93 136.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.115 0.483 . . . . 64.22 111.058 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.653 HG12 HG22 ' A' ' 52' ' ' THR . 6.4 m -120.43 112.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.741 -0.663 . . . . 75.04 109.318 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD23 ' HB ' ' A' ' 7' ' ' VAL . 91.9 mt -91.91 109.58 20.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 70.41 109.629 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.7 129.3 51.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.02 -0.536 . . . . 74.41 110.964 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 3.4 ptmt -121.28 132.32 24.24 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.769 -0.65 . . . . 51.43 110.175 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 24.0 Cg_exo -64.34 155.88 63.17 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.46 2.107 . . . . 73.43 110.959 174.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 18.1 ptp180 -65.17 -59.74 3.77 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.927 -0.309 . . . . 63.32 110.958 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.494 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 5.0 p -169.44 152.31 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.896 -0.409 . . . . 55.42 109.896 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.2 t80 75.48 126.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.874 0.733 . . . . 74.41 111.393 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -60.81 -40.21 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.393 -0.821 . . . . 75.32 112.209 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.76 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 73.42 110.851 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 4.9 tm-20 -68.64 -38.15 80.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.872 -0.788 . . . . 72.42 108.872 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -64.66 -23.7 67.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.811 . . . . 61.4 111.237 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.09 -29.99 76.49 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.982 -0.554 . . . . 44.31 112.993 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 36.0 ptt180 -93.26 -1.9 55.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 73.32 110.585 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -93.93 -47.97 6.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.977 -0.556 . . . . 63.35 111.333 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.2 -33.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 32.31 112.051 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 -70.78 0.88 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.027 -0.606 . . . . 54.1 112.765 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.37 -29.19 88.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.885 2.39 . . . . 75.43 112.634 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.65 -49.0 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 73.05 111.467 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -62.98 -37.19 86.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 70.01 111.18 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -2.77 57.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.103 -0.498 . . . . 74.3 111.502 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.51 -33.12 70.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 75.23 110.265 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.505 ' OH ' ' HB2' ' A' ' 6' ' ' LEU . 42.6 p90 -109.05 18.69 20.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.714 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.5 m 57.84 69.72 0.71 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.382 -0.827 . . . . 70.01 112.692 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 80' ' ' ALA . 3.9 p -130.08 145.91 59.23 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.077 -0.249 . . . . 75.21 110.517 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.75 145.92 87.45 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.984 1.789 . . . . 74.34 109.406 163.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.27 83.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.811 2.341 . . . . 63.44 113.691 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -159.66 -173.7 4.26 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.198 0.999 . . . . 72.35 108.762 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.454 ' O ' HD12 ' A' ' 5' ' ' LEU . 23.9 mm-40 57.53 31.52 20.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.201 0.445 . . . . 72.12 112.201 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.5 tt -111.33 135.46 50.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.979 0.419 . . . . 73.42 110.636 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.18 122.9 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.629 . . . . 73.31 109.757 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.8 114.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.038 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 63.7 mt -100.1 121.76 51.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.078 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.624 ' CE1' ' HG2' ' A' ' 134' ' ' ARG . 6.1 p-80 -159.59 -176.25 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 75.32 111.1 -176.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.18 154.93 22.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.209 -0.905 . . . . 62.24 111.791 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 8.9 tp10 -133.88 126.4 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.366 -0.605 . . . . 73.52 109.366 167.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 137' ' ' VAL . 7.5 tt -82.97 -24.8 32.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 72.15 111.111 -172.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.93 4.38 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 70.21 111.342 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mm -111.15 140.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.506 -0.316 . . . . 62.01 110.689 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.1 136.35 35.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.801 -0.636 . . . . 74.33 112.179 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.636 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 72.5 t80 -63.08 128.91 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.744 . . . . 75.23 111.523 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 108.66 -14.21 35.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.626 -0.797 . . . . 53.42 113.415 172.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 69.7 mmt-85 -124.32 168.77 12.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.446 0.623 . . . . 72.32 110.83 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.46 133.38 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 75.01 111.373 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 10.6 tpp180 -113.56 127.73 56.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.79 -0.641 . . . . 74.22 109.388 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.48 153.3 18.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 74.23 111.026 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 112' ' ' GLU . 38.3 tptt -153.71 148.17 26.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.263 -0.643 . . . . 64.11 109.263 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.8 mp -123.59 -90.62 0.57 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.099 0.476 . . . . 73.45 111.141 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.51 106.08 2.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.177 -0.535 . . . . 54.14 112.413 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.44 151.25 5.4 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.91 -0.662 . . . . 72.44 111.734 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.63 78.33 1.61 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.963 -0.637 . . . . 53.23 111.675 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.441 ' H ' ' NH2' ' A' ' 132' ' ' ARG . 32.0 tt0 -120.79 122.39 40.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.093 -0.336 . . . . 75.43 110.093 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.587 ' HA2' ' OE1' ' A' ' 96' ' ' GLU . . . 152.03 134.89 2.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.383 -0.687 . . . . 71.15 111.383 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.84 2.69 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.555 -0.831 . . . . 71.22 114.258 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -152.82 140.85 20.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.444 0.622 . . . . 74.31 110.857 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -45.7 -55.29 6.64 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.624 0.972 . . . . 63.45 113.624 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.8 -41.18 19.76 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 114.793 0.677 . . . . 44.14 114.793 -166.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 132' ' ' ARG . 3.3 pp -67.0 -25.76 66.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.102 0.451 . . . . 75.04 111.8 -173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -39.57 26.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 74.24 110.238 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.8 m -67.1 -38.02 84.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 73.42 111.703 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.1 -33.34 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 75.5 111.058 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.78 -33.44 72.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 24.22 110.318 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -70.05 -21.86 63.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.613 -0.721 . . . . 74.34 110.775 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.39 -27.84 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 44.11 111.248 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -103.64 -41.43 5.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.083 -0.508 . . . . 74.33 110.695 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.02 -0.79 79.51 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.478 -0.649 . . . . 65.15 111.478 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.7 m -115.97 143.68 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.84 -0.43 . . . . 74.41 109.84 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -120.68 -161.93 0.92 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.297 -0.41 . . . . 72.34 109.9 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.52 18.86 2.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.658 0.742 . . . . 72.44 110.416 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 45.4 p90 -86.43 156.99 19.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.598 -0.728 . . . . 74.11 110.058 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -78.29 110.8 13.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 73.42 110.577 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 118' ' ' LEU . 32.0 ttp-105 -108.98 109.38 20.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.915 -0.584 . . . . 73.13 110.111 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 61.2 t -85.6 133.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.531 -0.758 . . . . 73.03 109.979 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.803 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 84.7 mtm180 -131.23 109.33 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.248 -0.433 . . . . 74.12 111.226 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.01 123.54 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 43.15 109.586 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.45 125.2 28.59 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.758 -0.734 . . . . 54.43 112.151 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 97' ' ' LEU . 24.4 m -88.73 -12.45 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.785 0.326 . . . . 63.42 111.089 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.636 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 138.14 -142.18 12.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.761 -0.733 . . . . 50.41 111.929 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 138' ' ' GLY . 12.0 mmm180 -131.8 149.55 73.73 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.166 -0.679 . . . . 75.44 109.166 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 52.1 Cg_exo -55.26 114.5 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.678 2.252 . . . . 73.53 112.157 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.2 Cg_endo -82.72 160.34 16.46 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.205 2.604 . . . . 63.43 112.508 -176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -18.71 9.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.928 -0.653 . . . . 53.11 112.245 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -87.14 -45.27 10.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.065 0.46 . . . . 71.1 110.52 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 32.7 pttt -119.65 144.02 47.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.648 -0.705 . . . . 73.42 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.62 139.64 89.44 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.751 -0.659 . . . . 62.25 110.868 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.09 -34.04 45.77 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.361 2.708 . . . . 50.31 113.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.6 61.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.099 0.476 . . . . 73.12 111.171 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.36 -18.78 29.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 54.33 110.454 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.426 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 63.9 t80 -69.32 -27.44 65.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 72.24 110.687 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.553 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.9 m -86.09 1.44 5.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.504 -0.316 . . . . 65.3 111.239 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 17' ' ' TYR . 79.5 mt -95.53 1.33 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.632 0.234 . . . . 74.43 111.632 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.18 150.44 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 74.1 110.312 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.769 ' HB3' HG22 ' A' ' 20' ' ' THR . 27.1 p-10 -129.44 30.01 5.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.508 . . . . 60.23 111.223 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -146.84 143.76 28.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.138 -0.319 . . . . 52.14 110.138 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.64 177.18 11.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.808 -1.182 . . . . 72.35 107.808 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.6 -72.41 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.416 0.553 . . . . 32.53 112.252 -173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.17 -46.91 5.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.334 0.588 . . . . 50.41 111.885 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 1.2 pm0 -67.91 -17.21 64.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 73.44 112.064 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -65.31 -25.24 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.677 0.275 . . . . 73.33 110.387 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.61 -17.12 54.55 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.273 -0.421 . . . . 75.23 111.592 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 165' ' ' ILE . 60.6 mt-10 -85.84 -20.38 29.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.102 -0.239 . . . . 75.31 110.912 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.73 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 58.8 t -52.17 -55.79 27.99 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.399 . . . . 62.33 112.079 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.73 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 34.9 Cg_exo -61.94 -23.91 76.37 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.103 1.869 . . . . 63.24 112.525 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.587 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 11.5 m -81.8 -46.05 14.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.44 . . . . 41.43 111.021 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.538 HG22 ' CZ3' ' A' ' 191' ' ' TRP . 40.2 pt -65.94 -30.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.377 -0.374 . . . . 74.02 111.936 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 162' ' ' VAL . 56.2 t -61.25 -48.26 89.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 61.34 110.623 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.73 -39.73 95.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 31.25 110.744 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 164' ' ' THR . 71.9 mm-40 -65.68 -41.85 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 63.21 110.5 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.9 80.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 61.45 110.686 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.73 88.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 71.32 110.474 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.55 -37.05 76.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 74.32 110.362 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.84 -30.33 70.77 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.151 -0.477 . . . . 64.24 111.091 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 63.0 m -62.48 -43.34 99.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 61.2 110.143 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 41.3 mt-10 -71.72 -28.95 64.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 60.5 109.996 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.8 tp -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 71.54 110.545 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 85.1 mt -65.42 -22.0 66.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.819 -0.628 . . . . 72.43 110.69 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 5' ' ' LEU . 3.3 mm -80.49 -49.68 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.841 -0.618 . . . . 70.42 111.421 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.36 -28.53 12.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.511 0.93 . . . . 51.43 113.511 -167.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -100.59 -77.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.462 -0.495 . . . . 65.51 111.964 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -131.65 134.56 7.73 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.923 -1.132 . . . . 62.12 113.338 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.1 -34.39 38.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.933 0.397 . . . . 73.05 109.953 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.622 ' HG2' ' HD3' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -120.92 -36.28 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.702 1.001 . . . . 74.24 113.702 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.622 ' HD3' ' HG2' ' A' ' 182' ' ' GLU . 84.5 Cg_endo -81.55 -5.03 12.47 Favored 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 121.177 1.456 . . . . 74.15 113.635 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 187' ' ' THR . . . -69.47 -31.72 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 72.34 111.33 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.2 pt20 -67.97 -19.43 64.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.682 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.11 -43.09 77.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.329 . . . . 74.22 111.121 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 184' ' ' ALA . 15.4 t -76.44 -19.38 58.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.685 0.279 . . . . 62.43 111.132 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.89 -40.44 52.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 74.21 110.917 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -84.19 1.39 44.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.927 -0.309 . . . . 72.22 111.255 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.35 -4.02 57.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.917 0.389 . . . . 63.4 110.873 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.538 ' CZ3' HG22 ' A' ' 165' ' ' ILE . 17.7 t90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.318 -0.849 . . . . 71.02 110.364 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.166 -0.309 . . . . 52.52 110.166 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.74 111.65 3.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.327 . . . . 70.32 110.46 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.4 pt-20 -89.66 116.82 67.31 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.027 -0.533 . . . . 73.22 110.816 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 14.0 Cg_endo -92.31 113.56 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.623 2.882 . . . . 53.22 112.615 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.599 HD11 HG13 ' A' ' 177' ' ' ILE . 95.7 mt -72.21 114.9 10.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.543 -0.753 . . . . 74.34 110.689 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 85' ' ' VAL . 42.9 tp -93.68 104.66 16.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.008 -0.738 . . . . 70.43 109.008 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.637 ' HB ' HD23 ' A' ' 62' ' ' LEU . 47.9 t -109.94 123.79 66.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.334 -0.394 . . . . 62.45 110.175 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 57.8 t -110.13 114.82 48.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.668 . . . . 72.11 110.292 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.29 122.37 7.42 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.244 -0.742 . . . . 64.2 111.244 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.774 ' HG ' ' HE1' ' A' ' 22' ' ' HIS . 30.3 tp -85.92 82.73 8.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.363 0.601 . . . . 73.33 110.998 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -150.49 118.26 0.91 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.342 -0.845 . . . . 75.24 111.115 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.64 151.56 37.61 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.497 -0.186 . . . . 75.42 110.497 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.27 161.62 45.33 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.465 2.11 . . . . 74.31 112.464 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' HA3' ' HD1' ' A' ' 17' ' ' TYR . . . 148.75 142.74 3.67 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.852 -0.613 . . . . 61.21 111.782 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.33 -42.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.826 2.35 . . . . 64.02 112.216 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 20' ' ' THR . 8.0 p -90.76 -37.93 13.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.937 -0.574 . . . . 64.31 110.856 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HD1' ' HA3' ' A' ' 14' ' ' GLY . 84.9 m-85 -62.04 -35.09 77.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.896 -0.593 . . . . 73.22 112.281 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 -13.25 60.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 73.52 111.104 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -112.06 28.26 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 73.21 110.334 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.81 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 79.2 p -102.12 -176.39 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.841 -0.618 . . . . 72.33 110.906 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -86.41 -15.42 40.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.476 0.655 . . . . 73.42 109.503 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.774 ' HE1' ' HG ' ' A' ' 10' ' ' LEU . 14.8 t-80 -76.75 -22.25 54.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.145 -0.934 . . . . 74.14 110.405 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 27' ' ' MET . 65.7 t30 -73.78 -0.08 14.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.006 0.432 . . . . 73.51 111.266 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.39 -29.5 68.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.562 -0.29 . . . . 73.4 111.254 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.32 -30.71 78.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.926 -0.654 . . . . 72.51 112.49 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 67.2 t80 -90.36 -22.38 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.784 -0.244 . . . . 74.25 110.833 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' VAL . 26.2 mmt -50.49 -48.3 56.9 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.241 -0.436 . . . . 73.24 111.766 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.88 -46.86 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 64.11 110.803 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.31 82.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 51.54 111.388 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.4 -37.27 84.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.398 . . . . 74.33 111.04 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' MET . 62.6 t -65.51 -39.04 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.181 0.515 . . . . 71.21 109.852 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.85 -43.27 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.624 . . . . 75.34 110.698 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.22 90.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 72.0 110.906 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.49 91.26 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.982 -0.554 . . . . 72.14 112.878 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -70.13 -24.2 63.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.818 0.309 . . . . 73.14 111.206 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' A' ' 53' ' ' GLY . 82.7 mt -77.58 -49.77 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.409 -0.589 . . . . 73.42 109.409 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.99 62.19 1.07 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.84 -0.695 . . . . 52.54 112.425 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.4 m -156.3 144.62 19.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.919 0.39 . . . . 64.11 110.718 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.98 151.65 27.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 73.1 110.215 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.98 138.54 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.892 0.377 . . . . 73.33 110.672 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -101.36 126.6 48.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 75.53 110.043 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 t -78.1 129.75 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 74.13 110.301 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -68.79 102.71 1.6 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.622 -0.263 . . . . 61.5 110.776 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 58.7 tttm -64.11 88.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.121 -0.696 . . . . 74.23 109.121 172.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.8 tttp 174.22 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.928 -1.033 . . . . 74.53 109.021 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 p -125.15 -19.18 5.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.538 -0.755 . . . . 52.55 111.477 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.73 18.23 45.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 51.05 112.955 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.65 123.43 35.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.579 0.228 . . . . 74.33 110.654 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 2.2 mp0 -84.98 140.34 31.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 72.31 110.928 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 63' ' ' ALA . 97.6 t -139.4 137.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 73.42 110.404 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 6.9 p -118.91 145.49 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.709 -0.478 . . . . 74.44 109.709 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.54 HG23 HG12 ' A' ' 61' ' ' VAL . 1.6 m -116.71 142.59 46.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.232 -0.44 . . . . 63.53 111.637 -172.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -178.17 -161.53 26.39 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.173 -0.771 . . . . 60.01 111.173 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.97 ' HG2' ' HA ' ' A' ' 59' ' ' SER . 37.2 mtm180 -136.34 146.09 46.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.916 0.389 . . . . 72.0 110.684 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.59 103.05 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 73.54 109.698 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.19 -51.58 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.963 0.79 . . . . 75.54 111.713 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.21 -36.98 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.048 -0.821 . . . . 63.33 111.048 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 3' ' ' GLU . 4.1 m -68.58 151.56 46.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.439 0.295 . . . . 60.32 110.37 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.97 ' HA ' ' HG2' ' A' ' 54' ' ' ARG . 21.9 m -85.72 139.98 30.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.678 . . . . 70.31 109.171 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.35 132.1 52.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.368 0.604 . . . . 71.54 111.307 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.54 HG12 HG23 ' A' ' 52' ' ' THR . 8.3 m -117.68 115.5 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 42.41 109.333 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.637 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.7 mt -92.42 104.59 16.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.951 -0.568 . . . . 71.41 109.838 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -108.98 137.58 46.68 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 62.2 110.146 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -130.71 143.01 47.61 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 63.4 110.498 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.41 166.67 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.521 2.147 . . . . 64.43 111.635 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -84.8 -54.14 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.798 -0.361 . . . . 73.24 111.395 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.9 p -167.67 163.54 14.41 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.699 0.259 . . . . 71.21 111.699 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 69.41 163.81 0.24 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.976 0.797 . . . . 64.2 112.565 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.0 mmt -73.24 -56.61 4.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.922 -0.581 . . . . 72.23 110.946 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.08 -40.65 87.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.817 -0.629 . . . . 65.1 111.783 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 67' ' ' CYS . 42.7 mt-10 -59.84 -40.31 88.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.523 -0.308 . . . . 64.44 110.861 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -36.27 83.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.863 0.363 . . . . 64.21 110.53 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.88 -39.89 97.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.46 -0.656 . . . . 73.53 111.46 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.28 -0.54 19.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 75.13 110.726 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 23.0 mm-40 -103.53 -51.05 3.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 55.12 111.038 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.81 -34.69 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 70.15 111.31 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.32 -67.19 2.34 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.989 -0.55 . . . . 72.35 113.374 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.87 -27.6 59.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.692 2.261 . . . . 62.34 113.612 -177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 47.2 mt -57.5 -40.55 78.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.848 0.314 . . . . 73.24 111.848 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.73 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.022 0.439 . . . . 53.31 111.378 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.99 -7.41 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.354 -0.385 . . . . 73.13 111.235 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -79.12 -46.65 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.83 0.348 . . . . 73.02 110.128 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -93.03 1.45 57.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.148 -0.478 . . . . 73.44 111.232 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 60.46 37.57 19.74 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.686 0.617 . . . . 72.4 110.752 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.536 HG21 HD22 ' A' ' 6' ' ' LEU . 27.5 m -92.15 142.98 26.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.81 -0.632 . . . . 64.34 110.466 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.832 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 4.1 Cg_exo -77.0 133.9 14.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.68 2.253 . . . . 70.13 111.81 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.555 ' O ' HG22 ' A' ' 90' ' ' ILE . 36.2 Cg_endo -66.0 -4.56 10.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.974 2.45 . . . . 74.4 112.587 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.832 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.9 pt20 -71.62 -20.38 61.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.105 -0.498 . . . . 75.3 110.598 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.762 ' HG3' ' HG3' ' A' ' 88' ' ' GLN . 97.9 mt-30 -124.43 24.52 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.083 -0.508 . . . . 74.22 111.655 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 87' ' ' PRO . 13.1 tt -86.93 105.5 15.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.757 0.789 . . . . 74.5 110.176 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.77 113.38 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.369 -0.832 . . . . 72.24 110.631 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.62 114.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.408 -0.36 . . . . 72.0 110.157 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.507 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 58.3 mt -101.26 120.16 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.913 -0.585 . . . . 74.41 109.776 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.41 ' CE1' HD22 ' A' ' 118' ' ' LEU . 32.1 p80 -142.01 174.9 10.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.966 0.413 . . . . 72.22 111.349 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.21 148.28 26.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.219 -0.901 . . . . 54.34 109.529 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.695 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -139.5 128.85 24.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.079 0.466 . . . . 73.53 110.389 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.55 -33.93 25.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.68 -0.691 . . . . 73.35 111.681 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.53 -38.49 26.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 50.43 111.392 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.613 HG12 ' OE1' ' A' ' 96' ' ' GLU . 37.9 mm -65.58 143.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 43.1 111.628 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 12.1 m-20 -57.07 139.59 51.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.602 -0.726 . . . . 73.15 111.218 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.735 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 80.3 t80 -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 74.43 111.683 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 92.26 -24.38 22.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.656 -0.702 . . . . 62.44 112.825 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -90.92 130.92 36.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.145 0.498 . . . . 61.42 110.842 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 104' ' ' ILE . 3.7 mp -92.42 114.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.947 -0.76 . . . . 73.22 108.947 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -107.48 125.19 50.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 75.32 110.254 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.3 mt -103.89 135.19 45.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.616 -0.72 . . . . 74.15 110.526 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.26 156.54 45.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.944 -0.762 . . . . 74.12 108.944 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.37 -132.4 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.463 -0.569 . . . . 73.11 109.463 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.494 ' N ' ' HA ' ' A' ' 129' ' ' ASN . . . 49.34 -153.01 2.92 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.423 -0.418 . . . . 71.32 112.759 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.35 173.29 27.29 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.778 -0.929 . . . . 74.01 110.778 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 119' ' ' ARG . . . -83.55 85.49 1.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.146 -1.026 . . . . 64.32 111.922 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 -43.01 11.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.635 0.255 . . . . 72.11 111.268 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.84 109.23 2.87 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.146 -0.55 . . . . 75.43 112.343 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.48 -100.85 0.2 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.057 -0.592 . . . . 72.45 111.969 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -164.17 173.99 11.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.585 0.231 . . . . 74.13 111.322 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -40.21 -56.17 1.99 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.129 1.159 . . . . 74.2 114.129 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.44 -29.25 72.82 Favored Glycine 0 CA--C 1.509 -0.283 0 C-N-CA 121.233 -0.508 . . . . 61.11 112.476 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 23.5 tp -65.83 -38.67 89.53 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.426 -0.387 . . . . 54.44 110.68 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 111' ' ' GLY . 1.7 mpp_? -79.65 -23.25 42.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.76 -0.376 . . . . 70.13 110.625 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -66.95 -44.81 79.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 60.21 110.603 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.2 m -69.3 -27.77 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 72.43 110.798 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.16 -43.57 61.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.524 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -70.28 -25.52 63.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 65.13 111.589 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.68 92.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 31.43 110.643 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.52 -42.07 20.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.855 -0.611 . . . . 71.22 110.336 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.08 1.81 88.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.935 -0.65 . . . . 60.54 111.757 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.644 HG22 ' HE1' ' A' ' 130' ' ' PHE . 4.8 m -111.5 122.66 48.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.931 0.396 . . . . 72.12 110.308 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 53.7 mtmt -126.63 178.83 5.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.453 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.494 ' HA ' ' N ' ' A' ' 109' ' ' GLY . 22.8 m-20 75.35 67.71 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.862 0.726 . . . . 74.33 112.112 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.644 ' HE1' HG22 ' A' ' 127' ' ' THR . 60.5 m-85 -142.99 -87.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 74.11 111.337 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.488 ' C ' ' HD2' ' A' ' 132' ' ' ARG . 12.7 t60 -161.88 104.97 1.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.635 0.255 . . . . 34.01 110.644 -174.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.488 ' HD2' ' C ' ' A' ' 131' ' ' HIS . 2.6 mpt_? -114.27 141.03 48.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.529 0.204 . . . . 70.24 110.549 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 93.5 t -104.19 118.23 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 72.01 111.047 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.695 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 35.6 mtp180 -112.41 104.67 12.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.061 -0.518 . . . . 71.55 110.254 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.3 mt -85.81 115.09 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.85 -0.426 . . . . 63.43 109.85 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.31 118.77 11.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.902 -0.666 . . . . 73.05 112.651 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.52 -11.51 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 70.21 110.086 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 136.9 -77.55 0.34 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 73.52 113.326 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -170.73 165.6 5.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.983 -0.377 . . . . 72.03 109.983 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 53.1 Cg_exo -53.85 142.1 64.25 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.474 2.116 . . . . 73.34 111.279 171.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 25.3 Cg_exo -61.72 -66.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 123.027 2.485 . . . . 43.14 113.327 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.7 -69.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.589 -0.815 . . . . 51.12 112.438 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 143' ' ' ARG . 10.5 mmt180 -82.01 -70.07 0.57 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.85 0.357 . . . . 74.2 110.778 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.571 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -80.89 159.99 24.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 73.33 110.486 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.748 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 2.5 p30 -79.76 166.39 41.21 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.548 -0.296 . . . . 74.44 110.776 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.748 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 10.9 Cg_endo -53.79 -36.0 80.98 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.371 2.714 . . . . 35.52 113.986 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.15 77.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 72.44 110.603 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.91 -31.87 59.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.083 -0.508 . . . . 51.43 110.216 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.571 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 88.9 t80 -64.5 -42.81 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.567 -0.742 . . . . 71.23 111.321 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.81 ' O ' ' HB ' ' A' ' 20' ' ' THR . 34.9 m -83.28 -9.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.915 -0.314 . . . . 65.14 111.167 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 20' ' ' THR . 49.5 tp -83.75 -25.63 30.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.104 0.478 . . . . 74.24 111.136 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.04 176.68 8.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.962 0.41 . . . . 65.23 110.616 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -81.26 171.97 14.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 72.42 110.662 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 40.3 m-85 -65.44 145.13 56.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 73.34 110.097 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -68.92 162.2 27.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.284 -0.265 . . . . 73.4 110.284 -178.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.92 9.52 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.033 0.753 . . . . 65.21 113.033 -162.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.74 88.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.012 0.434 . . . . 62.33 112.13 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.572 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 2.2 pm0 -89.34 -16.58 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.077 -0.511 . . . . 74.5 111.655 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 155' ' ' THR . 60.2 ttt180 -61.04 -25.09 66.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 74.44 111.424 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.33 -14.4 62.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.283 -0.417 . . . . 75.01 111.919 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -111.4 5.97 20.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.742 0.306 . . . . 73.31 111.245 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 159' ' ' ARG . 94.8 t -63.82 -52.73 55.41 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.449 -0.341 . . . . 51.12 111.746 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 11.3 Cg_endo -55.53 -33.79 87.63 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.927 1.752 . . . . 70.14 111.873 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.7 m -65.95 -49.46 67.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.625 -0.716 . . . . 51.35 111.178 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 162' ' ' VAL . 35.3 pt -67.89 -30.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.431 -0.35 . . . . 72.33 111.42 -175.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.4 t -63.9 -45.47 96.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.402 . . . . 64.11 110.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -67.86 -37.6 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 71.24 110.812 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -63.65 -44.31 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 53.13 110.896 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.95 98.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 70.05 111.219 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.24 96.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.253 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.84 -44.14 86.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 73.03 110.522 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -64.3 -37.96 89.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 60.44 111.664 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 87.3 m -58.32 -40.36 81.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.865 0.364 . . . . 44.23 111.045 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.13 -40.03 90.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 71.33 110.235 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.55 -37.34 87.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 72.43 110.885 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 87.1 mt -60.18 -42.86 95.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 74.5 111.868 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.599 HG13 HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.87 -27.28 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 70.24 110.382 -176.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -83.96 -58.28 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.216 -0.447 . . . . 54.44 111.841 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -24.98 35.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 71.51 111.439 -175.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 113.89 -161.13 12.81 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.641 -0.79 . . . . 75.21 112.112 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.64 -68.8 0.68 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.741 0.305 . . . . 65.13 110.847 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.641 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.6 tt0 -55.02 -55.3 40.48 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.155 0.798 . . . . 75.12 113.155 -172.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 23.1 Cg_exo -65.16 -31.06 54.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.15 1.9 . . . . 64.35 113.087 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.43 -48.71 7.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.504 0.557 . . . . 72.51 112.504 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -20.23 65.7 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 121.216 -0.193 . . . . 74.22 111.51 -174.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -53.54 -51.08 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.415 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -72.28 -21.62 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 71.32 111.266 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.8 t -70.11 -24.2 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 73.53 111.283 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -116.91 13.38 14.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.882 0.372 . . . . 72.03 110.388 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.11 27.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.092 -0.503 . . . . 71.1 111.092 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.417 ' HH2' HG22 ' A' ' 165' ' ' ILE . 15.1 p-90 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.301 -0.857 . . . . 73.22 110.912 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.163 -0.31 . . . . 64.12 110.163 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.06 116.73 20.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 62.02 110.092 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 14.3 pt-20 -85.24 118.22 70.35 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.252 0.548 . . . . 72.33 110.414 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 1.3 Cg_endo -83.71 110.19 1.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.805 2.337 . . . . 73.42 112.113 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 89' ' ' GLN . 36.7 tp -74.32 118.35 17.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 75.04 109.846 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HA ' HG23 ' A' ' 61' ' ' VAL . 69.8 tp -92.8 104.96 17.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.18 -0.464 . . . . 75.04 110.128 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HB ' HD23 ' A' ' 62' ' ' LEU . 44.9 t -105.58 121.27 57.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.246 -0.434 . . . . 72.33 110.408 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.95 114.87 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.754 -0.657 . . . . 74.23 109.902 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.85 123.15 6.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.846 -0.692 . . . . 73.33 111.846 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 96.16 1.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.846 0.355 . . . . 73.23 110.199 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -111.93 85.68 0.4 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.783 -0.723 . . . . 61.2 112.993 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 28.0 m-80 -100.89 117.75 61.91 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.995 -0.372 . . . . 71.03 109.995 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 3.0 Cg_exo -75.49 177.79 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.155 2.57 . . . . 74.13 112.369 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 17' ' ' TYR . . . 155.5 179.05 30.32 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.04 -0.6 . . . . 70.33 111.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.09 -71.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.885 2.39 . . . . 74.34 111.559 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.612 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 15.1 t -117.33 6.26 12.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.815 -0.809 . . . . 71.42 108.815 172.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.2 t80 -69.19 -26.09 64.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.778 -1.101 . . . . 75.22 110.313 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . . . -87.48 1.6 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 61.05 110.983 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -120.72 3.18 10.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.435 -178.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.832 ' HA ' ' HB3' ' A' ' 153' ' ' ASN . 14.9 t -103.7 -177.66 3.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.918 0.39 . . . . 73.13 111.875 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.614 ' HD3' HG13 ' A' ' 137' ' ' VAL . 61.6 mtt180 -64.92 -20.72 66.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.0 -0.546 . . . . 74.4 111.63 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.576 ' H ' HG23 ' A' ' 20' ' ' THR . 5.9 t60 -78.78 -7.99 58.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.972 0.415 . . . . 71.04 110.576 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.26 8.22 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 72.12 110.43 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 75.0 mt -55.74 -29.8 60.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.511 -0.313 . . . . 75.12 111.67 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.56 -33.05 86.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 72.03 112.462 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 87.5 t80 -88.36 -30.7 19.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.544 0.212 . . . . 72.44 110.718 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mmm -50.19 -42.89 52.12 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 62.24 111.993 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 t -69.53 -47.15 73.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.345 . . . . 75.43 110.789 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.57 74.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.29 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.3 -45.43 91.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 74.42 110.9 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.8 t -72.85 -36.82 53.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.592 . . . . 72.35 110.503 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.03 -44.99 96.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 61.44 110.876 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.83 80.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 55.3 110.554 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.59 95.21 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.866 -0.606 . . . . 74.42 112.832 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -21.57 54.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 117.044 0.422 . . . . 74.51 111.314 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.515 HD13 ' HA3' ' A' ' 53' ' ' GLY . 80.6 mt -77.84 -43.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.585 -0.524 . . . . 73.31 109.585 173.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.04 33.81 5.89 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.868 -0.682 . . . . 75.32 111.942 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -145.66 135.32 23.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.746 0.308 . . . . 64.11 110.253 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 148.44 24.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.287 -0.415 . . . . 74.3 110.693 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.781 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 11.1 p90 -66.31 124.72 23.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.61 . . . . 64.04 110.638 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 13.0 ptpt -101.1 143.88 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.608 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.629 HG22 ' HG2' ' A' ' 49' ' ' GLU . 19.7 t -81.69 135.55 24.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 72.2 111.584 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.36 104.51 16.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.932 -0.577 . . . . 72.53 109.97 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.48 90.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.9 -0.408 . . . . 75.11 109.9 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.5 tptt 174.34 -58.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.251 -0.886 . . . . 73.13 108.695 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -106.76 -14.33 15.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.345 -0.843 . . . . 74.12 110.519 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 83.76 3.9 89.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.943 -0.646 . . . . 21.13 112.348 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.38 144.29 28.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.821 0.344 . . . . 55.32 110.746 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.2 mt-10 -108.56 122.16 46.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.944 -0.571 . . . . 63.11 109.637 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -129.15 137.56 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.441 -0.345 . . . . 71.33 110.476 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.781 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 5.0 p -121.47 135.63 61.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.934 0.397 . . . . 75.4 110.2 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.784 HG22 HG12 ' A' ' 61' ' ' VAL . 11.9 p -106.71 136.58 46.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.132 -0.485 . . . . 70.31 110.982 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.515 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -160.7 -161.14 11.22 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.473 -0.87 . . . . 42.3 112.576 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 13.2 mmt180 -121.59 142.41 50.13 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 73.5 110.088 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.134 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -126.9 115.77 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.726 -0.842 . . . . 74.22 108.726 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.6 -36.83 0.31 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.706 -0.679 . . . . 62.52 111.305 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 165.88 -33.15 0.23 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.852 -0.899 . . . . 72.24 110.852 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 59' ' ' SER . 1.7 m -75.37 169.24 18.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.372 -0.414 . . . . 73.44 110.759 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . 2.9 m -79.78 131.46 35.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.753 0.311 . . . . 74.04 111.383 -175.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.134 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -127.06 137.42 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.94 -0.392 . . . . 74.23 109.94 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.784 HG12 HG22 ' A' ' 52' ' ' THR . 12.4 m -120.25 115.4 47.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.209 0.528 . . . . 74.4 110.532 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 61.9 mt -96.79 105.0 17.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 74.23 109.586 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.2 127.58 55.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.979 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 6.4 ptmt -119.15 126.69 26.91 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.221 -0.445 . . . . 73.33 110.393 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.761 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 39.6 Cg_exo -61.53 149.74 88.4 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.398 2.065 . . . . 65.1 110.619 173.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 25.7 ptt180 -64.55 -53.42 48.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 75.11 111.13 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 29.1 p -168.57 174.69 6.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.422 -0.214 . . . . 54.11 110.422 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.538 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 9.9 t80 75.27 138.27 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.047 0.842 . . . . 74.1 112.316 167.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.97 -52.69 62.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 61.45 111.322 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.56 -36.65 76.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.04 111.17 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 6.4 mt-10 -60.31 -43.55 96.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.705 -0.225 . . . . 64.15 110.821 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -54.87 -32.42 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.372 0.42 . . . . 63.12 111.341 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.799 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -67.47 -39.21 91.27 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.895 -0.669 . . . . 61.21 112.118 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' NH2' ' HG2' ' A' ' 71' ' ' GLU . 20.1 ptt180 -91.09 2.75 56.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 73.22 110.681 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.761 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 24.6 mm-40 -81.23 -51.89 7.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 74.23 110.22 174.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.17 -44.77 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.757 -0.656 . . . . 63.31 112.29 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.79 -66.23 2.7 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.135 -0.484 . . . . 75.42 113.674 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 -41.43 78.87 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.867 2.378 . . . . 71.1 113.0 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.03 -39.54 95.05 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.768 0.284 . . . . 63.31 111.768 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.38 91.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.0 0.428 . . . . 61.43 111.163 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.9 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.172 -0.467 . . . . 71.3 111.068 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.88 -42.12 97.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 71.2 109.696 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -82.16 -15.28 53.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.723 -0.671 . . . . 73.23 110.621 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m 62.37 34.68 15.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.762 -0.653 . . . . 53.12 110.515 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.4 m -100.29 143.99 27.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.757 -0.656 . . . . 62.24 110.635 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 10.5 Cg_exo -71.2 115.62 4.35 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.733 2.289 . . . . 64.1 111.574 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.39 33.28 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.185 2.59 . . . . 73.14 113.4 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -78.65 -48.75 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.339 -0.615 . . . . 74.43 109.339 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.537 ' HB3' HD12 ' A' ' 5' ' ' LEU . 1.8 mp0 -88.86 68.59 8.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.751 -0.659 . . . . 71.23 109.812 175.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.17 138.03 31.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.54 -0.755 . . . . 72.33 110.388 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.1 t -127.75 109.88 20.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 73.33 110.067 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.59 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 58.5 t -105.78 113.43 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.702 -0.481 . . . . 65.22 109.702 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 58.2 mt -93.46 122.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.062 -0.517 . . . . 75.01 110.396 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.424 ' HE1' ' CB ' ' A' ' 115' ' ' HIS . 16.7 t-80 -149.02 162.89 39.01 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.643 -0.423 . . . . 74.24 112.129 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 8.8 p-10 -90.34 139.28 30.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.465 -0.789 . . . . 53.41 110.314 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.848 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 75.8 mm-40 -137.23 140.38 41.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.911 0.386 . . . . 70.13 111.734 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.47 HD23 ' HB ' ' A' ' 137' ' ' VAL . 95.1 mt -84.22 -25.6 29.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.819 -0.628 . . . . 74.4 112.039 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.2 -34.47 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.468 0.651 . . . . 61.55 110.542 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.696 ' HB ' ' HA2' ' A' ' 136' ' ' GLY . 9.2 mt -84.64 139.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.473 -0.785 . . . . 71.4 109.999 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -67.08 144.77 55.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.883 -0.414 . . . . 72.33 109.883 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 65.7 t80 -63.37 124.4 21.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.773 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.88 -21.11 8.0 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.059 -1.067 . . . . 45.33 113.469 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -123.69 169.11 11.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.541 0.671 . . . . 62.42 111.234 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.619 HG12 HG13 ' A' ' 135' ' ' ILE . 65.9 mt -118.65 139.38 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.918 -0.583 . . . . 70.02 110.745 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 25.6 tpt180 -111.98 124.15 51.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.049 176.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.2 mt -108.21 127.25 53.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 61.35 110.181 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -154.8 151.03 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.49 -0.559 . . . . 71.05 109.49 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.888 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 1.3 pt? -67.3 -71.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 74.14 111.668 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.888 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -153.75 155.31 26.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.724 -0.55 . . . . 63.22 111.724 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.41 176.56 18.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.947 -0.644 . . . . 72.2 111.691 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.0 77.45 2.11 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.73 -0.748 . . . . 73.5 111.899 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -129.83 21.31 5.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.709 0.766 . . . . 73.35 109.341 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -145.78 95.42 0.17 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.457 -0.792 . . . . 62.43 112.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.99 67.5 3.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 62.02 112.112 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 96' ' ' GLU . 33.0 m80 -139.19 146.04 40.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 71.34 111.008 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.66 -55.15 38.77 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.642 -0.708 . . . . 75.44 111.95 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.72 -28.84 70.22 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.853 -0.612 . . . . 64.21 112.081 -168.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 74.43 110.127 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.98 -27.24 60.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.794 -0.639 . . . . 74.12 110.139 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.2 m -66.69 -52.17 47.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 73.5 110.766 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.799 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -66.33 -30.65 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.737 0.303 . . . . 62.4 110.84 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.02 71.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.32 111.138 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.4 m -84.62 -35.58 22.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 62.5 111.101 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.5 . . . . 63.1 111.269 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 -42.43 12.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.205 0.526 . . . . 74.23 110.076 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.13 -13.38 32.69 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.732 -0.667 . . . . 62.12 112.879 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 p -114.01 122.93 48.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.408 0.623 . . . . 72.13 111.624 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.6 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 4.5 mptt -99.75 -91.7 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.79 -1.189 . . . . 74.13 107.79 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 55.07 7.97 0.21 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.854 1.798 . . . . 73.35 115.854 162.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.31 -90.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.955 0.798 . . . . 72.44 111.923 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -175.92 135.38 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 63.31 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.59 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 10.5 mpt_? -121.49 124.53 44.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.083 -0.508 . . . . 71.41 110.056 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 59.1 t -83.9 104.07 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.688 -0.486 . . . . 64.22 109.688 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.848 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 49.1 mtm-85 -122.64 127.6 49.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.883 0.373 . . . . 61.33 110.53 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.619 HG13 HG12 ' A' ' 104' ' ' ILE . 3.8 mp -94.28 139.9 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.567 -0.742 . . . . 72.04 109.859 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.696 ' HA2' ' HB ' ' A' ' 99' ' ' ILE . . . -72.61 129.66 14.13 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.868 -0.682 . . . . 61.44 112.646 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.614 HG13 ' HD3' ' A' ' 21' ' ' ARG . 27.3 t -95.92 -11.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.316 0.579 . . . . 62.33 109.972 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.14 166.52 26.83 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.676 -0.773 . . . . 60.32 111.849 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.42 146.56 50.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.172 -0.307 . . . . 72.5 110.172 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.63 120.59 7.74 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.012 2.475 . . . . 64.13 113.122 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.91 158.94 40.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.239 2.626 . . . . 71.21 112.558 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.25 -24.66 6.73 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.855 -0.688 . . . . 53.22 112.805 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -83.82 -70.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.711 0.255 . . . . 73.45 110.738 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.59 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -89.29 157.11 18.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.465 -0.494 . . . . 75.2 110.594 178.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.28 133.0 92.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 64.15 111.738 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.56 -29.04 88.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.252 2.635 . . . . 61.32 113.06 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.463 . . . . 41.21 109.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' GLU . . . -69.36 -28.65 66.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.61 -0.723 . . . . 64.23 109.975 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.59 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 87.0 t80 -65.13 -29.59 70.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 74.31 110.809 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.3 -23.22 10.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 75.13 110.343 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.35 -26.01 30.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 63.24 111.081 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.545 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 8.9 pt-20 -87.31 153.28 21.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 74.15 110.501 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.832 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 34.9 p-10 -132.77 14.18 4.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 63.2 110.908 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -107.03 156.08 19.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 54.12 110.304 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -169.83 178.37 4.06 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.716 -1.216 . . . . 71.54 107.716 175.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.93 -72.95 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.234 -0.586 . . . . 72.03 111.074 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.57 -24.02 16.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.465 0.65 . . . . 73.42 110.194 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.538 ' HB2' ' CB ' ' A' ' 155' ' ' THR . 22.3 mp0 -68.6 -36.83 79.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.316 -0.856 . . . . 75.32 110.556 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 7.7 tpt180 -68.1 -17.61 64.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 72.33 110.501 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.07 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 73.41 110.919 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 165' ' ' ILE . 34.8 mt-10 -89.7 -5.42 57.06 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.179 -0.208 . . . . 70.44 111.534 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.679 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 85.2 t -56.32 -51.8 78.08 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.667 0.247 . . . . 73.22 111.667 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 23.9 Cg_exo -64.97 -29.52 57.44 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.761 1.64 . . . . 64.22 111.984 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.1 m -73.59 -40.25 64.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.761 -0.654 . . . . 75.4 111.83 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 135' ' ' ILE . 34.8 pt -64.93 -30.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 121.031 -0.268 . . . . 65.31 110.969 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.01 -39.34 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.418 . . . . 72.12 109.98 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 163' ' ' PRO . 8.8 mm-40 -58.59 -50.62 73.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.697 -0.683 . . . . 71.21 110.413 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -68.99 -32.88 72.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.745 -0.661 . . . . 74.44 111.232 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.39 78.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 73.45 110.606 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.86 95.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.154 -0.475 . . . . 63.11 110.497 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.99 -50.06 75.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 65.4 110.961 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.85 -44.97 96.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 72.54 111.702 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.5 m -56.32 -42.78 78.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 61.21 111.359 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.84 -29.45 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 61.23 110.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.11 -28.62 66.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 74.24 110.472 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.2 mt -60.04 -47.34 86.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.862 -0.608 . . . . 75.42 111.084 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 177' ' ' ILE . 0.0 OUTLIER -79.92 -37.37 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.545 . . . . 74.32 110.832 -175.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -77.79 -54.51 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.83 0.307 . . . . 44.43 111.83 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -94.34 -57.28 2.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.404 -0.362 . . . . 62.22 110.632 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 159.77 151.74 6.26 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.744 -0.741 . . . . 64.31 111.848 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 176' ' ' LEU . 4.0 pp -71.92 -24.55 61.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.841 0.353 . . . . 60.41 111.546 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.468 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 30.0 tt0 -82.9 -51.96 0.67 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.387 -0.369 . . . . 73.45 111.612 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 17.2 Cg_endo -59.9 -35.9 92.21 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.058 1.839 . . . . 70.2 112.168 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.434 ' HB3' HD23 ' A' ' 176' ' ' LEU . . . -64.14 -45.32 89.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.349 . . . . 72.11 110.331 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -54.72 -49.78 69.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.738 -0.664 . . . . 62.34 110.783 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -57.69 -35.93 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 74.5 110.861 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.2 m -70.69 -54.24 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 64.3 110.992 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.3 t -67.83 -43.32 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.61 0.596 . . . . 74.24 112.61 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -76.09 -3.81 38.03 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.667 -0.413 . . . . 63.33 111.39 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.98 22.08 8.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.096 0.474 . . . . 62.23 110.429 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.8 t90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.404 -0.808 . . . . 63.22 110.354 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.812 -0.44 . . . . 53.45 109.812 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.72 130.13 45.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 53.01 110.763 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.6 155.57 56.41 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.519 -0.549 . . . . 74.14 109.519 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.872 ' HB2' HG12 ' A' ' 85' ' ' VAL . 5.6 Cg_endo -87.8 118.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.77 2.314 . . . . 74.05 112.617 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.6 tp -88.0 121.14 30.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 72.04 109.651 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 90' ' ' ILE . 61.1 tp -92.87 117.5 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.969 -0.382 . . . . 64.1 109.969 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.76 ' HB ' HD23 ' A' ' 62' ' ' LEU . 46.4 t -113.53 118.06 57.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.655 -0.498 . . . . 62.43 109.655 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.53 114.96 45.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.886 -0.597 . . . . 65.02 109.97 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -105.9 122.17 7.02 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.568 -0.825 . . . . 70.02 111.674 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.79 89.59 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 75.2 110.711 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.843 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -142.75 110.55 0.62 Allowed Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.488 -0.778 . . . . 75.35 111.4 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.39 149.96 47.98 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.531 0.205 . . . . 70.01 110.664 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.691 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 73.7 Cg_endo -74.39 175.91 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.454 2.102 . . . . 60.12 111.791 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 17' ' ' TYR . . . 121.34 136.79 5.11 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.423 -0.894 . . . . 61.32 112.1 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.68 -28.7 82.73 Favored 'Trans proline' 0 C--O 1.225 -0.147 0 C-N-CA 123.159 2.573 . . . . 70.33 112.988 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 t -113.08 16.35 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 51.01 111.062 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' ' HA3' ' A' ' 14' ' ' GLY . 75.5 m-85 -106.28 -34.87 7.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 64.44 111.611 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.14 -4.5 25.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.247 0.832 . . . . 74.44 113.247 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -124.42 27.78 6.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.127 0.489 . . . . 72.51 110.753 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 69.5 p -102.5 -170.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.738 -0.665 . . . . 63.44 110.087 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 55.0 mtt180 -84.52 -0.73 54.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.986 0.422 . . . . 61.14 110.459 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -105.21 19.49 20.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 72.14 110.683 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -99.08 3.31 46.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.377 -0.374 . . . . 74.14 110.596 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.427 HD11 HG12 ' A' ' 137' ' ' VAL . 91.1 mt -55.67 -42.76 75.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.781 -0.645 . . . . 71.11 112.064 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.38 -37.75 94.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.65 -0.786 . . . . 25.3 112.004 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.843 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 75.4 t80 -73.21 -32.77 64.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.263 -0.273 . . . . 62.42 110.263 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.564 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 9.0 mmt -54.21 -54.02 45.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 74.32 111.692 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.95 -45.04 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 63.45 110.919 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.64 95.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 63.43 111.117 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.93 -42.27 97.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 62.11 110.978 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' MET . 90.4 t -61.88 -44.18 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.31 110.585 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.38 -40.9 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 73.34 110.8 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.24 86.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.942 0.401 . . . . 74.5 110.532 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.9 -42.51 85.74 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.769 -0.65 . . . . 71.04 113.01 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.3 ptm180 -68.05 -31.32 70.89 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.984 0.392 . . . . 65.23 111.371 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 63.11 109.945 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.31 43.29 4.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.95 -0.643 . . . . 72.41 112.265 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -129.56 158.62 38.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.671 0.272 . . . . 73.04 110.595 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.91 165.33 11.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 73.44 109.496 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.439 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 35.4 p90 -80.38 143.84 33.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.204 0.526 . . . . 73.34 111.339 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -106.44 133.46 51.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 73.23 109.336 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.57 124.23 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.348 . . . . 75.41 110.661 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -71.53 104.86 3.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.94 -0.573 . . . . 72.1 110.302 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 1.3 tmmt? -73.79 83.79 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.583 . . . . 64.43 109.734 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 170.84 -48.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.673 -1.148 . . . . 74.33 109.151 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -104.45 -28.43 11.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.465 -0.789 . . . . 74.13 110.702 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.2 9.49 73.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.852 -0.69 . . . . 75.4 111.475 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.29 134.23 34.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 34.53 111.131 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 8.8 mt-10 -91.67 131.95 36.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.793 -0.64 . . . . 71.03 110.291 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.31 137.15 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 73.51 110.494 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 62' ' ' LEU . 3.8 p -126.99 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.746 -0.464 . . . . 53.54 109.746 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.783 HG22 HG12 ' A' ' 61' ' ' VAL . 24.4 p -108.8 151.32 26.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 73.2 111.944 -173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.31 -161.81 20.37 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.752 -0.658 . . . . 65.1 111.612 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 20.3 mmt180 -133.15 139.17 46.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.751 -0.462 . . . . 52.41 109.751 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.07 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -130.18 116.7 18.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.659 0.266 . . . . 62.34 110.295 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 68.5 -27.96 0.15 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.672 0.789 . . . . 74.13 112.594 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 156.69 -30.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.537 -1.025 . . . . 72.4 110.537 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -79.36 157.22 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.674 -0.763 . . . . 73.32 109.785 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.678 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 14.0 t -83.21 136.09 34.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.332 -0.618 . . . . 74.34 109.332 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.07 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.9 p -117.43 124.23 72.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.211 0.529 . . . . 74.21 110.672 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 52' ' ' THR . 8.9 m -113.04 111.78 37.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.322 0.582 . . . . 72.04 109.71 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.76 HD23 ' HB ' ' A' ' 7' ' ' VAL . 54.7 mt -92.79 115.81 28.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.585 -0.734 . . . . 61.12 110.47 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.5 147.62 41.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 74.24 110.218 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 17.0 ptmt -132.96 131.78 22.1 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.336 -0.393 . . . . 61.24 111.081 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 12.4 Cg_endo -57.37 136.11 74.14 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.915 2.41 . . . . 53.24 111.187 172.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.691 ' HD2' ' HG3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -92.61 -59.96 1.94 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.82 -0.352 . . . . 51.33 111.512 -172.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.4 p -156.92 145.12 19.49 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.12 -0.232 . . . . 75.23 110.981 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.641 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 35.7 t80 66.43 115.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 124.177 0.923 . . . . 62.3 111.09 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.574 ' HG2' ' HB3' ' A' ' 116' ' ' ASN . 1.9 mpt? -51.71 -56.27 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.312 -0.858 . . . . 71.13 111.94 -174.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.641 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 47.9 t30 -55.26 -49.71 71.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.246 -0.434 . . . . 72.15 111.136 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 mm-40 -59.52 -49.9 76.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 63.25 111.127 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 76' ' ' VAL . 50.7 m -60.48 -40.78 92.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.322 -0.399 . . . . 75.24 111.142 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.53 -43.33 97.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.902 -0.665 . . . . 55.32 112.048 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -69.82 -32.95 71.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.752 0.31 . . . . 74.34 110.521 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 81.2 mm-40 -65.15 -28.28 69.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.919 -0.582 . . . . 70.14 111.858 -177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 72' ' ' SER . 55.6 t -65.66 -31.12 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 72.51 110.847 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.31 -69.62 1.21 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.962 -0.563 . . . . 72.43 112.993 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.91 -36.32 95.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.916 2.411 . . . . 73.35 112.77 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.52 -39.01 89.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 35.54 110.262 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.21 90.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 60.01 111.258 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -18.99 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.399 -0.364 . . . . 74.44 111.101 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.43 -37.32 80.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.357 -0.383 . . . . 71.4 110.548 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -101.53 4.17 40.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 74.42 111.321 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 m 63.44 31.93 14.71 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.888 -0.596 . . . . 71.53 111.546 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.872 HG12 ' HB2' ' A' ' 4' ' ' PRO . 16.7 m -81.78 143.35 50.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.383 . . . . 62.44 110.584 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 7.9 Cg_exo -73.64 137.85 25.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.679 2.253 . . . . 52.11 111.498 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.99 -10.76 24.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.812 2.342 . . . . 73.54 113.121 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.11 -26.96 18.04 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.034 -0.266 . . . . 73.51 110.486 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -95.09 62.68 2.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.258 0.551 . . . . 74.14 110.422 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.66 HD12 HD23 ' A' ' 6' ' ' LEU . 8.1 tt -140.41 117.34 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 64.35 110.57 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.17 114.38 35.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 63.22 110.182 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.587 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 48.4 t -96.99 108.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 70.25 110.824 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.528 HD13 ' HB ' ' A' ' 133' ' ' VAL . 44.0 mm -89.62 119.32 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.778 -0.646 . . . . 74.42 109.699 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -138.47 165.22 27.39 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.411 -0.516 . . . . 72.32 111.183 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.75 142.33 29.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 55.11 109.358 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.897 ' HG2' HG12 ' A' ' 99' ' ' ILE . 18.4 tp10 -127.34 123.23 35.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.838 0.351 . . . . 71.24 111.357 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.9 mt -84.21 -14.76 49.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 63.01 111.254 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.88 -31.99 17.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 71.14 111.646 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.897 HG12 ' HG2' ' A' ' 96' ' ' GLU . 29.0 mm -85.52 146.21 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 74.11 111.408 -173.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 103' ' ' ARG . 14.2 m-20 -64.31 153.28 38.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.631 -0.713 . . . . 50.41 111.04 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.1 111.29 4.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.131 -0.692 . . . . 75.31 109.131 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 165' ' ' ILE . . . 101.65 6.08 50.45 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.483 -0.865 . . . . 43.24 112.104 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 27.1 mmt180 -103.33 141.83 35.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.756 0.313 . . . . 74.53 110.778 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 mt -107.93 136.86 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.682 -0.859 . . . . 72.41 108.682 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.556 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -144.04 162.27 36.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 72.1 110.562 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.81 133.06 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.868 0.366 . . . . 73.04 110.359 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 57.1 tptt -106.52 105.06 14.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 64.1 109.869 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.881 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.2 pt? -78.59 -133.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.979 -0.555 . . . . 70.11 110.672 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.7 132.78 11.32 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.538 -0.839 . . . . 74.1 111.117 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 150.01 5.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.961 -1.114 . . . . 65.35 113.083 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.0 -153.34 29.44 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.176 -0.769 . . . . 55.3 111.176 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 78.85 -61.21 0.36 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.497 0.719 . . . . 75.05 111.92 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.25 115.82 5.01 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.116 -0.564 . . . . 42.12 112.068 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.09 -114.31 0.58 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.03 -0.828 . . . . 74.02 111.03 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -174.89 -82.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.495 0.188 . . . . 72.41 111.182 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.574 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 89.3 m-20 -130.78 -70.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.531 0.567 . . . . 65.42 112.531 -172.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.3 -17.8 80.12 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 121.063 -0.589 . . . . 55.44 112.055 -167.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.11 -30.62 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.981 -0.61 . . . . 61.12 110.649 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 119' ' ' ARG . 57.8 mtt180 -79.82 -29.15 40.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 72.11 111.12 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.9 m -75.31 -47.03 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 75.14 111.687 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.89 -21.98 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.53 -0.305 . . . . 73.32 111.585 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.82 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 51.11 111.599 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -70.6 -39.81 73.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.269 -0.423 . . . . 72.22 111.675 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.48 58.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 53.5 111.339 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.41 -41.83 62.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.319 -0.401 . . . . 62.32 110.996 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.96 2.42 52.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.878 -0.677 . . . . 72.45 112.039 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 m -131.19 121.02 24.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.792 0.33 . . . . 74.43 110.396 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -99.25 -64.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.714 -0.847 . . . . 75.31 108.714 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.7 t30 31.74 61.55 0.29 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.861 1.265 . . . . 73.03 114.099 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.806 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 84.2 m-85 70.57 -23.45 0.17 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.893 1.442 . . . . 74.21 114.893 166.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -79.98 53.64 1.73 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.607 0.966 . . . . 73.54 113.607 -169.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.587 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 1.3 mpp_? -137.35 111.26 8.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.8 -0.445 . . . . 75.13 109.8 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.528 ' HB ' HD13 ' A' ' 93' ' ' ILE . 57.6 t -85.24 131.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.081 0.467 . . . . 71.45 110.583 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HD3' ' HB3' ' A' ' 105' ' ' ARG . 49.0 mtp180 -106.18 117.28 33.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.679 -0.691 . . . . 73.33 110.027 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.58 118.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.938 -0.764 . . . . 63.34 108.938 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.31 12.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.668 . . . . 45.51 113.451 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.427 HG12 HD11 ' A' ' 24' ' ' LEU . 35.6 m -94.11 2.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 65.15 110.669 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.13 179.84 17.15 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.044 -0.598 . . . . 74.14 112.007 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.478 ' H ' ' HG3' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -70.69 149.95 95.33 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.469 0.135 . . . . 74.5 110.921 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.505 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 47.2 Cg_exo -37.74 128.55 0.82 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.253 3.302 . . . . 71.03 113.935 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.9 Cg_exo -73.69 135.07 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.477 2.784 . . . . 73.0 112.625 -177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -112.68 162.23 12.44 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.063 -0.815 . . . . 61.11 111.063 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.0 tpm_? 71.63 -75.21 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.132 0.573 . . . . 52.33 110.132 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.507 ' HD2' ' HD1' ' A' ' 149' ' ' PHE . 6.8 ptpp? -78.82 144.44 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.075 -0.342 . . . . 73.01 110.075 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.33 139.93 94.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.108 -0.497 . . . . 72.34 110.246 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.0 -28.89 19.99 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.254 2.636 . . . . 73.12 113.437 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -68.42 -36.19 78.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.377 . . . . 70.51 110.802 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.57 -25.64 30.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.466 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.507 ' HD1' ' HD2' ' A' ' 144' ' ' LYS . 90.3 t80 -62.28 -38.08 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.679 -0.692 . . . . 72.1 110.987 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.608 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.5 m -84.94 -0.61 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.395 . . . . 73.11 111.369 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 147' ' ' ALA . 73.1 mt -98.42 12.47 34.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 72.23 111.22 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 11.1 pt-20 -129.24 177.06 7.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.489 -0.323 . . . . 70.22 110.414 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -77.74 177.97 7.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.931 -0.577 . . . . 63.4 111.377 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.51 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 68.1 m-85 -80.06 165.05 22.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 74.43 110.81 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.648 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -75.95 -153.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.84 0.311 . . . . 74.2 111.84 -175.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.39 -70.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.059 0.392 . . . . 65.02 112.059 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.33 -44.66 35.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 72.55 111.386 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.93 -21.6 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.907 -0.588 . . . . 63.52 111.246 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 155' ' ' THR . 25.9 ttt180 -63.41 -24.1 67.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.025 0.44 . . . . 65.41 110.788 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.17 -19.54 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 64.52 111.032 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.86 -11.12 45.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 71.33 111.09 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 166' ' ' VAL . 47.9 t -60.98 -61.22 8.45 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.018 -0.537 . . . . 62.43 112.207 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 18.4 Cg_endo -59.05 -34.15 98.87 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.027 1.818 . . . . 74.41 112.601 -175.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.6 m -66.15 -39.3 89.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 75.11 111.763 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.837 HD13 ' HA2' ' A' ' 102' ' ' GLY . 43.6 pt -78.97 -30.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.762 -0.375 . . . . 61.13 110.848 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.1 t -62.68 -42.66 96.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.741 0.305 . . . . 62.21 110.64 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 46.6 mt-10 -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 74.32 110.834 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -73.5 -33.92 65.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 72.25 111.309 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.27 96.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 44.34 111.131 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.89 91.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 42.24 110.851 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.27 -35.74 76.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 61.41 111.422 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -62.21 -38.64 89.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.716 0.294 . . . . 71.24 110.759 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 54.8 m -60.48 -36.78 79.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 60.41 110.593 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.83 -33.95 57.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 64.41 110.576 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.29 -27.78 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 72.12 110.555 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.9 mt -63.13 -33.38 75.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.939 -0.573 . . . . 61.23 110.371 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.8 mm -80.47 -55.63 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 74.15 110.877 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.29 -54.67 37.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.689 -0.687 . . . . 74.53 112.1 -173.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.501 ' HG2' ' HB2' ' A' ' 183' ' ' PRO . 36.4 tt0 -93.33 -50.14 5.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.367 -0.379 . . . . 71.34 110.352 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.55 147.98 5.93 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.775 -0.726 . . . . 74.12 111.453 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 182' ' ' GLU . 4.2 pp -64.92 -27.28 68.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.895 0.348 . . . . 74.22 111.89 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.715 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 40.6 tt0 -76.95 -52.55 1.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.837 -0.165 . . . . 64.23 111.283 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.9 Cg_exo -65.17 -34.98 43.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.548 1.499 . . . . 70.3 112.56 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -73.52 -31.48 63.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.119 0.414 . . . . 75.3 112.119 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 12.2 pt20 -61.75 -21.25 64.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.874 -0.331 . . . . 63.11 110.825 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -55.06 -52.56 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.354 -0.61 . . . . 75.34 109.354 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -46.29 76.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 74.02 110.87 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 184' ' ' ALA . 10.7 t -67.58 -13.08 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.186 -0.461 . . . . 63.35 111.964 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -102.42 -22.67 14.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.344 0.498 . . . . 73.02 112.344 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.42 -25.88 6.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.704 0.631 . . . . 75.41 112.704 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.1 t90 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.233 -0.889 . . . . 64.44 110.374 -174.958 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 111.391 0.145 . . . . 73.41 111.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.26 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.583 0.552 . . . . 53.24 110.761 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.9 OUTLIER -86.0 125.02 69.73 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.243 0.544 . . . . 63.43 110.95 -175.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 Cg_endo -94.09 143.62 1.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.18 2.586 . . . . 71.22 112.587 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.24 120.69 39.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.418 -0.586 . . . . 45.22 109.418 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HB2' HE21 ' A' ' 88' ' ' GLN . 46.9 tp -92.13 105.23 17.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.26 -0.427 . . . . 71.33 109.989 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 62' ' ' LEU . 43.3 t -118.9 127.25 75.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 61.53 110.377 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.06 121.8 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.557 . . . . 70.03 110.115 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.98 122.04 6.53 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.317 -0.944 . . . . 55.25 111.65 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.3 tp -108.75 86.77 2.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.296 0.57 . . . . 74.34 110.243 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 147.42 18.61 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.344 -0.843 . . . . 62.13 111.416 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 1.7 p30 -93.33 109.61 41.39 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.958 0.409 . . . . 63.34 110.893 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 2.0 Cg_endo -82.05 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.861 2.374 . . . . 74.35 112.731 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.67 -151.68 28.52 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.719 -0.753 . . . . 61.13 112.083 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.24 -49.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.94 2.427 . . . . 73.01 112.795 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -107.26 -26.24 11.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 74.23 111.923 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 88.4 m-85 -71.44 -17.41 62.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.902 0.704 . . . . 64.55 112.902 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' C ' ' HD2' ' A' ' 19' ' ' LYS . . . -71.44 -7.0 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.927 0.343 . . . . 72.41 111.927 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HD2' ' C ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -123.12 20.09 9.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.643 -0.253 . . . . 72.32 111.021 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 75.6 p -101.34 178.02 4.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.602 0.239 . . . . 71.01 111.532 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.765 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 67.5 mtt180 -59.21 -23.54 62.37 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.077 0.465 . . . . 72.42 110.709 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.718 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 1.7 t-80 -98.23 17.23 19.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 70.11 111.492 -173.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.61 3.13 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.117 0.484 . . . . 62.42 110.405 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -52.76 -35.27 56.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 54.42 112.303 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -63.63 -25.65 69.07 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.136 -0.554 . . . . 41.12 112.984 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -90.32 -29.89 17.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.633 0.254 . . . . 74.23 110.864 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.574 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 7.2 mmt -54.74 -48.08 73.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.528 0.566 . . . . 73.4 112.528 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.826 ' HB ' HD13 ' A' ' 93' ' ' ILE . 44.7 t -62.03 -45.24 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.726 0.298 . . . . 64.34 111.139 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.07 89.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 74.33 111.112 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.24 -48.91 77.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 55.41 110.968 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.0 -38.56 83.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.225 -0.443 . . . . 64.44 111.031 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.0 mt -63.77 -47.1 82.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.602 -0.272 . . . . 44.32 110.922 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.94 85.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.969 0.414 . . . . 50.24 110.543 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.51 -39.73 86.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.719 -0.673 . . . . 72.21 113.601 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.928 ' HG3' HD12 ' A' ' 36' ' ' ILE . 15.2 ptp180 -68.79 -36.41 78.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.378 0.589 . . . . 64.24 111.825 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.928 HD12 ' HG3' ' A' ' 35' ' ' ARG . 3.0 mp -77.89 -36.69 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 71.44 109.623 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.9 48.15 3.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.896 -0.669 . . . . 74.2 111.976 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.31 162.33 17.66 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.786 0.327 . . . . 71.14 110.352 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.82 130.63 56.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 71.51 110.691 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.516 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 19.1 p90 -70.18 133.59 47.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 73.04 110.286 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.28 134.83 54.66 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.937 -0.574 . . . . 75.22 110.7 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 49' ' ' GLU . 43.5 t -72.83 118.07 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 71.25 110.202 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.49 93.38 3.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.195 -1.039 . . . . 64.31 108.195 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.46 79.73 2.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.978 0.894 . . . . 72.14 110.2 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -169.25 -53.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.763 -1.562 . . . . 61.13 106.915 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -93.71 -28.55 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.944 -1.025 . . . . 60.25 110.241 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 29.59 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.945 -0.645 . . . . 44.15 112.153 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.14 146.22 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.319 -0.252 . . . . 53.34 110.319 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.798 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.1 mt-10 -98.85 138.75 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.304 -0.407 . . . . 74.44 110.397 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 137.96 51.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 61.45 110.468 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' A' ' 62' ' ' LEU . 7.5 p -128.86 139.13 52.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.477 -0.329 . . . . 70.21 110.377 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 61' ' ' VAL . 17.4 p -101.49 177.74 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.728 0.299 . . . . 72.25 111.449 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.53 40.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.161 -0.543 . . . . 35.1 111.966 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.809 ' H ' HG12 ' A' ' 36' ' ' ILE . 18.0 mmt180 -133.54 130.1 37.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.721 0.296 . . . . 72.03 110.737 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.018 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.4 pt? -130.84 115.76 17.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.323 -0.621 . . . . 72.05 109.323 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.72 23.51 13.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.816 -0.629 . . . . 75.23 111.264 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.71 -30.88 8.87 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.073 -0.584 . . . . 74.53 111.665 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 55' ' ' LEU . 75.0 m -70.49 142.96 51.84 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.795 0.438 . . . . 75.44 110.453 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 5.1 p -79.85 122.17 26.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.686 0.279 . . . . 74.35 110.73 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.018 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -97.37 138.5 22.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.113 -0.328 . . . . 51.43 110.113 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 52' ' ' THR . 7.2 m -124.21 108.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.329 0.585 . . . . 71.53 110.193 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.704 HD23 ' HB ' ' A' ' 7' ' ' VAL . 79.9 mt -95.22 119.55 33.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.562 -0.744 . . . . 65.53 110.333 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.74 147.74 39.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.484 . . . . 72.13 110.637 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 16.0 ptmt -132.85 143.27 47.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 63.1 110.31 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 17.8 Cg_exo -67.45 160.21 48.88 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.74 2.293 . . . . 74.22 111.683 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 39.6 ttt-85 -70.67 -63.17 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 60.24 110.173 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 47.8 m -165.89 147.73 7.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.776 -0.647 . . . . 74.34 110.102 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 t80 70.62 162.05 0.24 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.68 0.752 . . . . 75.34 112.269 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 69' ' ' MET . 1.9 mpt? -79.6 -16.08 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 61.21 111.365 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -73.62 -50.05 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.269 -0.423 . . . . 61.24 110.125 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 18.7 mt-10 -68.9 -41.06 78.76 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.978 0.362 . . . . 74.42 111.978 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 p -52.36 -44.43 65.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.94 0.348 . . . . 63.05 111.94 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -68.8 -25.46 75.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 63.52 112.545 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -94.21 -7.12 43.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.551 0.215 . . . . 75.12 111.338 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 19.4 mm-40 -102.33 -52.72 3.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.64 -0.254 . . . . 75.3 111.477 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.26 -40.52 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 75.31 111.601 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.658 ' HA2' HD21 ' A' ' 125' ' ' LEU . . . -55.83 -66.22 2.99 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.074 -0.512 . . . . 50.0 112.919 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.29 -39.05 93.06 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.741 2.294 . . . . 62.42 113.025 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.19 -45.91 83.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.753 0.279 . . . . 65.11 111.753 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -44.2 71.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.217 0.532 . . . . 73.44 111.162 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -7.83 58.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.949 -0.568 . . . . 51.24 111.658 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -77.23 -53.99 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 53.31 110.163 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -89.07 5.25 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 73.13 110.397 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.6 m 60.32 84.13 0.13 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 62.53 113.241 171.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.49 142.26 27.29 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.852 -0.613 . . . . 71.14 109.498 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.77 172.14 16.86 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.51 2.14 . . . . 73.14 111.69 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 96.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.215 1.944 . . . . 61.24 111.463 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.558 HE21 ' HB2' ' A' ' 6' ' ' LEU . 12.8 pt20 -133.25 177.61 7.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.662 -0.699 . . . . 71.51 110.038 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -66.2 104.75 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 74.2 111.136 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.1 tt -93.65 112.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.788 -0.642 . . . . 74.52 109.696 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.1 t -100.17 111.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.664 -0.698 . . . . 72.13 110.855 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.538 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 57.9 t -99.38 116.54 42.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.496 -0.557 . . . . 73.03 109.496 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.826 HD13 ' HB ' ' A' ' 28' ' ' VAL . 35.3 mt -87.05 122.86 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 62.31 110.622 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 41.4 t-80 -151.68 170.89 18.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.813 0.34 . . . . 75.13 110.465 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.06 153.71 22.54 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.91 0.484 . . . . 73.35 111.108 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 9.1 tp10 -118.2 121.56 40.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.579 . . . . 62.43 110.907 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.5 mt -83.5 -21.17 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 73.31 110.877 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.65 -19.83 34.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 70.31 111.808 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.741 HG13 ' HB2' ' A' ' 105' ' ' ARG . 29.0 mm -107.64 139.52 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.532 -0.304 . . . . 61.41 111.443 -175.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.685 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 3.8 m-20 -55.78 152.17 10.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.501 -0.772 . . . . 74.32 111.405 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.589 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.4 t80 -67.55 109.2 3.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.649 -0.705 . . . . 62.2 110.421 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.776 ' HA2' HG21 ' A' ' 165' ' ' ILE . . . 137.46 -23.85 3.1 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.405 -0.902 . . . . 75.43 113.165 176.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -108.28 151.59 25.76 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.515 -0.403 . . . . 73.4 110.33 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.831 ' HB ' HG22 ' A' ' 188' ' ' VAL . 3.6 mp -105.29 136.87 37.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.156 0.503 . . . . 71.52 110.149 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.741 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.1 tpt180 -108.89 140.31 42.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.639 -0.71 . . . . 73.24 109.785 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 185' ' ' GLN . 98.3 mt -122.66 121.08 35.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.431 -0.35 . . . . 73.34 110.238 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -116.65 138.89 51.11 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.926 -0.398 . . . . 74.04 109.926 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.9 mp -79.5 -71.4 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.75 -0.659 . . . . 74.24 110.379 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.33 -144.53 6.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.004 -0.544 . . . . 73.21 112.913 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.01 156.26 35.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.959 -0.638 . . . . 50.32 112.665 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.12 152.76 13.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.94 -0.647 . . . . 53.15 111.747 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -67.74 139.9 56.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.285 -0.265 . . . . 71.23 110.285 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 143.62 60.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.032 -0.604 . . . . 71.42 112.16 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.22 2.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.298 -0.953 . . . . 75.41 113.254 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.7 m80 55.75 -101.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.677 0.621 . . . . 73.14 112.677 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.02 -69.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.099 0.777 . . . . 74.14 113.099 -166.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -47.09 92.51 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.178 -0.534 . . . . 65.15 112.708 -165.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.0 -47.5 82.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.313 -0.443 . . . . 50.31 111.737 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -79.93 -22.16 43.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.944 0.35 . . . . 65.42 111.944 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.575 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 73.5 m -61.87 -52.43 64.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 63.24 110.486 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.39 -28.85 36.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.009 0.433 . . . . 71.53 110.722 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.95 74.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 65.23 111.004 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -84.55 -38.06 20.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.397 -0.365 . . . . 71.32 111.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.32 -52.9 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 72.44 111.032 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.658 HD21 ' HA2' ' A' ' 77' ' ' GLY . 95.9 mt -78.7 -32.36 46.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.361 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.05 -5.53 66.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.004 -0.617 . . . . 73.45 112.447 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.3 m -114.23 121.89 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.358 0.599 . . . . 62.34 111.7 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.2 -93.99 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.392 -1.336 . . . . 65.22 107.392 168.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.24 -8.2 0.2 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.151 1.537 . . . . 72.21 115.151 159.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 75.0 m-85 -119.27 -107.96 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.428 0.558 . . . . 65.41 111.865 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -146.97 118.33 7.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 72.43 111.321 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.538 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 11.9 mpt_? -106.33 123.95 48.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 52.33 109.642 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.42 ' HA ' HD23 ' A' ' 106' ' ' LEU . 94.1 t -83.57 117.32 29.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 64.42 110.479 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.951 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.7 mtt180 -120.01 117.88 29.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.75 -0.659 . . . . 72.21 110.642 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.3 mp -91.09 117.61 34.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.631 -0.507 . . . . 70.4 109.631 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.37 130.53 41.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.206 -0.521 . . . . 63.15 113.156 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.83 -0.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.049 0.452 . . . . 71.21 111.074 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 111.8 -83.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.5 -0.857 . . . . 72.43 112.882 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -164.1 168.45 9.38 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.445 -0.206 . . . . 72.52 110.445 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.0 Cg_exo -59.38 135.56 65.99 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.243 1.962 . . . . 71.32 110.385 166.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.661 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 26.1 Cg_exo -61.76 -38.48 59.83 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.769 2.312 . . . . 72.25 112.603 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.1 -71.7 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.027 -0.606 . . . . 70.24 113.308 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -78.88 -31.11 45.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 64.53 111.274 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 8.0 ptmm? -116.36 152.8 33.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 74.23 109.836 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.84 134.18 95.97 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.446 -0.343 . . . . 73.41 111.194 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.661 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 81.2 Cg_exo -47.66 -44.4 26.2 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.63 2.887 . . . . 54.4 113.626 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.09 87.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.041 0.448 . . . . 65.4 110.729 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.46 -18.8 60.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.812 -0.631 . . . . 62.11 110.68 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 89.3 t80 -84.18 -34.82 23.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.156 -0.474 . . . . 71.34 111.048 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.718 ' HB ' ' HB2' ' A' ' 22' ' ' HIS . 34.1 m -84.66 -17.03 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.666 0.617 . . . . 51.25 112.666 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.18 -7.44 59.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.059 0.457 . . . . 74.24 111.473 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.512 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 4.1 pt-20 -111.06 172.84 6.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.985 -0.552 . . . . 72.13 109.555 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.765 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 33.1 p30 -142.27 -20.54 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.815 0.341 . . . . 64.24 111.349 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -62.63 114.06 3.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 74.42 111.245 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -145.41 179.85 7.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 71.3 108.757 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.07 -71.86 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 63.3 111.864 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.58 -43.65 7.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 65.35 111.582 -174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 1.6 pm0 -72.15 -19.83 61.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.463 -0.789 . . . . 62.55 112.229 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 155' ' ' THR . 19.1 tpt180 -69.75 -38.0 76.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 64.03 110.139 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.23 60.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.162 -0.472 . . . . 62.31 110.911 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.78 1.25 57.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 71.41 112.046 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 166' ' ' VAL . 89.1 t -57.01 -57.06 27.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.061 -0.256 . . . . 62.21 110.648 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.3 Cg_endo -60.23 -30.33 90.95 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.967 1.778 . . . . 74.44 112.055 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.1 m -67.0 -48.12 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 70.22 111.175 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.776 HG21 ' HA2' ' A' ' 102' ' ' GLY . 42.3 pt -74.24 -20.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.578 -0.283 . . . . 73.43 111.319 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 162' ' ' VAL . 70.0 t -62.8 -45.11 99.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.966 -0.383 . . . . 72.25 109.966 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -58.73 -46.93 86.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.09 -0.505 . . . . 42.43 110.037 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.65 -54.22 48.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.313 -0.858 . . . . 75.44 111.144 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.63 -40.91 89.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 63.41 111.566 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.37 -49.45 69.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 72.22 111.216 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.35 -31.41 60.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 73.21 111.907 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.702 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -59.74 -46.57 88.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.094 -0.335 . . . . 64.33 110.094 173.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.8 m -58.88 -40.21 83.73 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.257 -0.429 . . . . 72.34 110.903 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 55' ' ' LEU . 33.5 tt0 -65.94 -42.95 89.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 64.51 110.028 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.15 -25.79 65.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 75.31 111.195 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 86.9 mt -62.03 -32.28 72.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.498 -0.319 . . . . 71.21 111.271 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.448 HG21 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -80.14 -25.39 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.17 0.509 . . . . 54.34 110.047 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -86.32 -47.34 9.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.59 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 184' ' ' ALA . 24.2 tp60 -86.04 -59.5 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.476 -0.329 . . . . 74.51 110.207 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.66 -75.0 0.89 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.032 0.773 . . . . 75.44 115.032 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.6 tp -42.47 -69.81 0.12 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.209 1.188 . . . . 64.12 114.209 -163.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.67 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 tt0 -139.91 -59.45 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.481 0.549 . . . . 64.33 112.481 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HD2' ' H ' ' A' ' 182' ' ' GLU . 18.4 Cg_endo -59.12 -17.2 37.28 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.079 1.853 . . . . 51.24 112.853 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . . . -60.3 -58.79 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.474 -0.33 . . . . 71.24 111.243 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.445 ' HA ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -77.15 -28.42 54.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.802 -0.359 . . . . 72.04 111.181 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 183' ' ' PRO . 24.5 t-20 -57.75 -39.56 77.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.875 0.369 . . . . 74.0 110.61 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 84.8 m -65.1 -57.43 8.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.817 -0.629 . . . . 53.43 112.368 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.831 HG22 ' HB ' ' A' ' 104' ' ' ILE . 2.0 p -64.13 -18.87 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 113.499 0.926 . . . . 72.13 113.499 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -106.95 -6.93 17.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.152 -0.619 . . . . 70.2 111.723 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.42 4.29 3.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.431 0.53 . . . . 51.3 112.431 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.471 -0.776 . . . . 71.12 109.849 -179.149 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 2' ' ' ALA . 21.1 ptt? . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.575 0.226 . . . . 74.31 111.134 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.588 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -139.31 42.53 2.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.022 0.439 . . . . 73.15 110.672 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 0.4 OUTLIER -106.25 81.61 0.83 Allowed Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.685 -0.857 . . . . 74.35 108.685 171.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.812 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 62.0 Cg_endo -90.88 171.61 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.981 2.454 . . . . 72.02 113.277 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.757 ' HB2' HD11 ' A' ' 177' ' ' ILE . 49.2 tp -119.63 110.05 16.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.554 -0.748 . . . . 74.01 109.801 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.707 ' HA ' HG23 ' A' ' 61' ' ' VAL . 51.0 tp -92.53 107.95 19.61 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.874 -0.787 . . . . 72.41 108.874 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' A' ' 62' ' ' LEU . 49.4 t -100.83 116.72 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.795 -0.639 . . . . 72.34 110.731 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.71 114.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.465 -0.789 . . . . 73.31 109.302 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.41 122.26 7.29 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.211 -0.995 . . . . 42.22 111.985 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -79.01 91.38 4.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 73.32 109.689 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.815 ' HA2' ' HA ' ' A' ' 23' ' ' ASN . . . -152.66 122.24 1.28 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.561 -0.828 . . . . 70.54 112.376 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -112.34 98.05 41.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.792 -0.818 . . . . 71.55 108.792 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.75 58.65 4.03 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.581 2.854 . . . . 73.32 112.997 -172.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.08 175.0 39.7 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.521 -0.632 . . . . 50.31 111.521 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.26 -57.61 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.62 2.88 . . . . 71.3 113.515 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -107.38 7.35 29.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.537 0.684 . . . . 74.14 110.431 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HA ' ' OG1' ' A' ' 20' ' ' THR . 97.9 m-85 -94.13 -15.61 24.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 72.22 111.959 -172.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.81 -34.46 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.721 0.638 . . . . 63.43 112.721 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.657 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -115.76 14.95 16.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.135 0.493 . . . . 73.24 111.459 -176.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.7 p -109.37 -172.97 2.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.279 -0.418 . . . . 60.01 110.273 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.545 ' HG2' HG11 ' A' ' 137' ' ' VAL . 64.7 mtt85 -68.04 1.44 2.74 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.208 0.447 . . . . 63.24 112.208 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -95.53 -5.26 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.332 -0.23 . . . . 43.22 111.117 -176.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.815 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 t30 -143.23 9.37 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.315 0.579 . . . . 72.11 111.247 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 20' ' ' THR . 51.1 mt -68.57 -28.06 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.92 -0.488 . . . . 72.41 111.784 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.85 -21.85 71.61 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.45 -0.881 . . . . 62.24 112.188 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 81.0 t80 -80.38 -21.75 42.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.558 0.218 . . . . 71.03 111.108 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 31' ' ' VAL . 11.0 mmt -51.13 -51.51 52.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.351 -0.386 . . . . 62.42 111.682 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 170' ' ' ALA . 57.4 t -61.17 -43.5 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 72.44 111.044 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.28 -40.68 97.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.0 -0.546 . . . . 50.3 110.858 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.29 -41.2 98.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 74.43 110.61 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 27' ' ' MET . 66.5 t -62.97 -34.46 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 70.5 110.653 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 35' ' ' ARG . 93.3 mt -64.34 -33.87 76.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.367 -0.378 . . . . 74.13 110.672 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -39.07 46.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.336 -0.393 . . . . 75.02 110.474 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.39 -40.12 96.2 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.629 . . . . 65.43 113.039 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 32' ' ' LEU . 11.0 ptm180 -66.24 -21.78 66.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.842 0.353 . . . . 75.15 110.812 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.16 -48.89 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.458 . . . . 71.43 110.317 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.24 38.12 2.53 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.96 -0.638 . . . . 43.0 112.161 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 m -126.12 146.09 50.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.303 . . . . 74.51 110.58 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.34 142.86 33.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 73.0 111.018 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.807 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 16.8 p90 -74.4 147.0 42.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 71.45 110.757 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -128.7 145.21 51.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.034 -0.358 . . . . 71.13 110.034 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.886 HG22 ' HG3' ' A' ' 49' ' ' GLU . 32.7 t -76.52 134.33 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.277 -0.42 . . . . 72.41 111.398 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -94.99 125.55 39.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.427 -0.583 . . . . 75.15 109.427 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.32 -36.55 84.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.379 . . . . 64.12 110.889 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -83.38 4.14 28.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 72.42 110.924 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m -125.59 -29.02 3.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.812 0.339 . . . . 70.54 111.308 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.37 29.23 73.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.961 -0.638 . . . . 72.2 111.812 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.52 37.19 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.614 0.245 . . . . 62.21 110.587 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.886 ' HG3' HG22 ' A' ' 42' ' ' VAL . 4.5 mp0 -85.68 131.22 34.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.54 . . . . 63.5 110.795 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.25 149.46 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 70.03 109.429 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.807 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.4 p -144.42 138.81 23.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 74.14 110.544 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.722 HG22 HG12 ' A' ' 61' ' ' VAL . 41.5 p -107.61 136.97 46.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 62.15 110.896 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.6 -166.02 13.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.929 -0.653 . . . . 62.43 111.914 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -131.21 105.82 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.486 -0.191 . . . . 73.41 110.486 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.124 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.2 pt? -96.68 115.91 28.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.835 -0.802 . . . . 73.54 108.835 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.58 -49.43 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.619 -0.719 . . . . 60.13 111.474 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.16 -33.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.261 -0.736 . . . . 72.14 111.261 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.8 148.06 50.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.968 -0.616 . . . . 54.33 111.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 m -70.83 114.8 9.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.992 -0.373 . . . . 73.42 109.992 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.124 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.5 p -97.02 127.14 49.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.568 -0.531 . . . . 55.45 109.568 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 52' ' ' THR . 2.8 m -116.51 109.13 26.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.375 0.607 . . . . 71.11 110.27 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 7' ' ' VAL . 50.7 mt -96.14 120.52 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.376 -0.829 . . . . 75.43 110.022 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.85 129.85 51.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.364 -0.38 . . . . 63.1 110.659 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 8.2 ptmm? -115.91 121.45 34.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.281 -0.418 . . . . 74.41 110.541 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 27.3 Cg_exo -62.0 156.72 47.8 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.715 2.276 . . . . 61.53 111.362 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.591 ' HG3' ' N ' ' A' ' 67' ' ' CYS . 9.1 ptt180 -77.49 -55.9 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.442 -0.503 . . . . 65.52 110.345 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.591 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 21.1 p -167.5 173.63 8.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.748 -0.206 . . . . 70.05 110.469 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 t80 67.62 162.77 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.96 0.788 . . . . 71.35 112.188 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -21.15 25.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.861 -0.609 . . . . 62.14 112.272 -175.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -94.86 -38.64 10.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.724 0.297 . . . . 72.2 111.263 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.76 -26.45 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 63.24 111.121 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -45.0 95.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 72.35 110.478 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.09 -33.86 84.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.877 -0.678 . . . . 64.52 111.722 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -74.26 -8.42 56.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 73.41 111.244 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 65' ' ' PRO . 82.8 mt-30 -103.96 -49.87 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 75.13 111.534 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.02 -29.95 42.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.814 0.302 . . . . 70.25 111.814 -176.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.29 7.08 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.143 -0.551 . . . . 74.22 112.67 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.38 -37.69 94.49 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.908 2.406 . . . . 73.24 113.032 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 64.8 mt -58.08 -39.15 77.82 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.924 0.342 . . . . 74.4 111.924 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.85 -41.97 88.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 55.54 110.874 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -23.8 27.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.173 -0.467 . . . . 71.34 111.207 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -60.87 -46.65 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.212 0.529 . . . . 71.01 109.854 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.12 -14.99 48.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.713 -0.676 . . . . 74.0 110.281 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 60.67 47.71 7.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.606 0.717 . . . . 74.04 110.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.812 ' HB ' ' HG3' ' A' ' 4' ' ' PRO . 27.4 m -102.13 137.23 19.41 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.327 -0.852 . . . . 72.22 110.215 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.632 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 23.4 Cg_exo -64.58 137.7 55.88 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.623 2.216 . . . . 72.42 111.713 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 93.8 Cg_endo -87.11 53.11 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.991 2.46 . . . . 73.31 113.574 -172.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.632 ' OE1' ' HB2' ' A' ' 86' ' ' PRO . 10.7 mp0 -59.28 -57.1 14.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 62.11 110.68 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -144.03 102.45 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.541 0.686 . . . . 74.25 112.394 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.607 HD13 HD11 ' A' ' 125' ' ' LEU . 5.8 tt -98.18 115.58 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.36 -0.836 . . . . 55.32 109.129 170.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.44 117.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.947 -0.57 . . . . 75.32 110.801 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.604 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 44.7 t -97.24 103.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 72.43 109.23 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.434 HG21 ' HB ' ' A' ' 28' ' ' VAL . 58.0 mt -86.12 119.24 34.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.947 -0.57 . . . . 72.54 109.84 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.435 ' CE1' HD22 ' A' ' 118' ' ' LEU . 28.3 p80 -151.67 170.65 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.89 -0.596 . . . . 75.24 110.522 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.63 150.23 24.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.319 -0.623 . . . . 71.43 109.319 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.695 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 7.8 tp10 -124.99 119.81 29.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.94 0.4 . . . . 74.34 110.045 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 138' ' ' GLY . 92.7 mt -82.39 -0.51 46.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 54.24 110.06 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 27.9 t70 -83.05 -11.01 58.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.358 -0.837 . . . . 70.54 110.459 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 105' ' ' ARG . 12.4 tt -132.06 148.9 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.945 0.403 . . . . 65.11 111.347 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.37 145.57 21.89 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.354 -0.839 . . . . 74.41 112.43 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -62.15 126.42 27.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 72.4 110.374 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' N ' ' HD1' ' A' ' 101' ' ' PHE . . . 117.78 -19.29 11.33 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 75.35 113.404 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.459 HH12 ' CD ' ' A' ' 161' ' ' GLU . 59.3 mmt-85 -120.63 147.67 44.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.447 0.623 . . . . 71.52 111.069 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.2 mp -104.27 132.59 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.425 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.713 ' HB2' HD12 ' A' ' 99' ' ' ILE . 16.2 tpt180 -116.57 126.18 52.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 73.32 109.683 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 188' ' ' VAL . 40.2 mt -97.48 111.29 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.266 0.555 . . . . 74.1 110.159 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HB3' ' NE ' ' A' ' 134' ' ' ARG . 57.1 tptt -102.25 141.07 35.67 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.752 -1.203 . . . . 72.51 107.752 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.912 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.1 pt? -75.55 -124.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.735 0.272 . . . . 64.13 111.735 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.919 ' HA3' ' HG3' ' A' ' 128' ' ' LYS . . . -82.01 142.03 22.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.431 -0.89 . . . . 62.04 112.584 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 153.4 5.86 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.716 -0.754 . . . . 72.21 112.321 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.53 77.06 0.32 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.672 -0.971 . . . . 71.34 110.672 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.99 144.1 22.04 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.382 -0.599 . . . . 72.42 109.382 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.0 -165.54 34.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.597 -0.811 . . . . 64.35 111.9 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.79 18.44 25.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.71 -0.757 . . . . 71.02 113.157 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -139.54 122.67 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.278 -0.542 . . . . 73.03 111.035 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.91 -52.5 60.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.984 -1.007 . . . . 60.21 112.107 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.35 -30.89 65.26 Favored Glycine 0 N--CA 1.46 0.29 0 CA-C-N 116.329 -0.396 . . . . 73.2 112.968 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.435 HD22 ' CE1' ' A' ' 94' ' ' HIS . 14.3 tp -60.52 -32.46 71.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.441 0.638 . . . . 43.23 110.673 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -79.23 -34.52 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 74.32 110.213 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.9 m -73.16 -44.39 60.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 63.33 111.406 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.03 -34.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 120.801 0.334 . . . . 65.22 111.14 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.46 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.978 0.418 . . . . 73.42 110.57 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 m -71.51 -23.59 61.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 62.51 110.884 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.4 -34.01 54.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 43.33 110.507 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 90' ' ' ILE . 88.0 mt -80.59 -42.82 21.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.914 -0.584 . . . . 72.21 110.653 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.44 89.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.024 -0.608 . . . . 75.31 112.365 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.1 p -112.37 163.09 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 71.55 111.185 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.919 ' HG3' ' HA3' ' A' ' 109' ' ' GLY . 12.5 tppt? -83.47 -56.86 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.869 -0.605 . . . . 74.12 110.755 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.94 81.92 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.741 0.65 . . . . 71.3 110.964 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.77 ' HD1' HD12 ' A' ' 108' ' ' LEU . 67.7 m-85 -71.07 68.17 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.258 1.207 . . . . 74.41 114.258 -168.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 37.8 p-80 163.57 115.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.908 0.883 . . . . 74.02 111.843 162.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.604 ' HG3' ' H ' ' A' ' 92' ' ' VAL . 5.0 mpt_? -128.93 147.24 50.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 74.42 110.216 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 93' ' ' ILE . 88.1 t -86.31 127.81 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.847 0.356 . . . . 64.4 111.032 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.695 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.0 mtt180 -131.37 109.75 10.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 61.41 110.563 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 54.4 mt -88.99 125.87 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.133 -0.485 . . . . 65.44 110.279 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.54 ' CA ' HG23 ' A' ' 99' ' ' ILE . . . -72.5 114.98 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.67 -0.776 . . . . 73.21 111.965 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.547 HG11 HD12 ' A' ' 24' ' ' LEU . 22.8 t -119.81 10.43 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.764 0.792 . . . . 62.53 110.27 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 97' ' ' LEU . . . 138.19 172.22 12.47 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.214 -0.993 . . . . 62.41 112.97 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -101.48 162.31 20.88 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.784 -0.45 . . . . 75.44 109.784 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 36.1 Cg_exo -60.72 133.01 45.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.672 2.248 . . . . 63.14 112.243 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.621 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 55.2 Cg_endo -70.56 127.31 13.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.71 2.273 . . . . 73.11 112.156 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.08 43.11 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.886 -0.673 . . . . 71.45 112.555 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -163.35 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.007 0.432 . . . . 74.31 110.219 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -89.38 159.57 17.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.622 . . . . 75.43 110.82 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.8 140.98 97.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 71.44 110.994 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.13 -38.68 60.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.225 2.616 . . . . 55.1 113.082 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 150' ' ' VAL . . . -70.19 -30.36 67.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.194 0.521 . . . . 62.22 110.655 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 151' ' ' LEU . . . -76.72 -18.52 58.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.65 -0.705 . . . . 61.55 110.226 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.621 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 59.7 t80 -84.54 -31.64 24.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 60.04 110.829 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 34.6 m -85.18 -6.02 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 72.41 112.245 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 4.4 pp -87.39 -8.35 56.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 64.55 110.182 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.64 171.11 8.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.228 -0.896 . . . . 64.44 109.669 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -170.7 87.44 0.12 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.9 0.381 . . . . 55.13 110.932 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -154.97 135.99 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.325 -0.398 . . . . 74.14 110.447 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -164.84 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 43.21 108.243 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -96.42 -73.41 0.6 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.773 0.657 . . . . 62.04 112.773 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.49 -43.2 8.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.261 0.553 . . . . 64.3 111.118 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -68.96 -21.6 64.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.493 -0.776 . . . . 72.41 110.515 -178.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -83.6 -15.26 49.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.622 -0.717 . . . . 73.55 110.361 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.46 -42.63 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 62.24 111.778 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.459 ' CD ' HH12 ' A' ' 103' ' ' ARG . 15.4 pt-20 -83.43 11.04 7.46 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.923 0.342 . . . . 64.4 111.923 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.646 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 87.0 t -54.03 -53.35 59.37 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.388 -0.369 . . . . 75.13 111.962 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 71.3 Cg_exo -52.03 -38.35 69.62 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.03 1.82 . . . . 72.34 112.511 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.0 m -68.6 -46.26 69.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 70.42 111.405 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.01 -24.83 24.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 121.098 -0.241 . . . . 65.34 111.452 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 162' ' ' VAL . 90.3 t -64.15 -43.74 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 63.02 110.047 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.82 -36.71 81.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 75.3 110.559 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.08 -51.54 53.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 72.22 110.657 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 73.34 111.535 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.52 -57.02 14.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 44.32 111.279 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.95 -26.7 62.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.485 -0.325 . . . . 74.21 111.181 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.87 -38.6 86.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.34 . . . . 74.5 110.539 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 m -66.96 -34.74 78.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.235 -0.439 . . . . 53.24 110.765 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.465 ' HA ' HD12 ' A' ' 55' ' ' LEU . 44.1 tt0 -71.91 -34.93 69.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.532 . . . . 74.51 109.853 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.29 -26.64 68.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 74.42 110.772 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 91.7 mt -64.74 -21.7 66.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 64.11 110.955 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 5' ' ' LEU . 28.0 mm -80.75 -50.71 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 65.3 110.74 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.86 -38.83 61.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.801 -0.636 . . . . 55.1 112.403 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -99.02 -56.64 2.37 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.924 -0.311 . . . . 72.34 111.536 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 141.77 -124.99 2.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.44 -0.886 . . . . 60.22 112.117 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.83 -46.97 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.032 0.382 . . . . 61.15 112.032 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.819 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 30.2 tt0 -73.44 -61.33 1.44 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.095 0.406 . . . . 72.23 112.095 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 17.7 Cg_exo -67.18 -14.9 44.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.741 1.628 . . . . 62.14 111.884 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.57 14.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 60.45 111.144 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.583 ' HA ' HD12 ' A' ' 106' ' ' LEU . 18.6 pt20 -65.25 -27.94 69.01 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 121.112 -0.235 . . . . 62.04 110.876 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 189' ' ' HIS . 65.7 t30 -59.53 -45.53 91.48 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.389 -0.369 . . . . 75.13 110.31 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.2 m -63.69 -38.26 90.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 73.54 110.882 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 106' ' ' LEU . 59.2 t -61.71 -44.48 98.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.005 -0.543 . . . . 72.41 111.533 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.509 ' NE2' ' HA ' ' A' ' 186' ' ' ASN . 33.5 p80 -89.53 12.86 15.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.512 -0.475 . . . . 74.4 111.238 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.36 4.13 38.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.53 -0.305 . . . . 64.13 110.785 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 12.8 m0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.063 -0.97 . . . . 72.42 111.027 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.66 0.267 . . . . 70.35 110.574 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.99 146.02 40.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 54.33 110.543 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -97.11 139.7 21.65 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 64.14 109.725 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.23 89.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.778 1.652 . . . . 51.21 110.64 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.97 118.15 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.669 -0.696 . . . . 62.1 111.475 -172.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.443 ' HA ' HG23 ' A' ' 61' ' ' VAL . 34.0 tp -91.86 105.13 17.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.743 -0.662 . . . . 65.22 109.542 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.652 ' HB ' HD23 ' A' ' 62' ' ' LEU . 40.5 t -114.89 112.9 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.199 0.523 . . . . 73.41 110.422 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.78 114.77 45.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.541 -0.754 . . . . 73.21 110.005 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.42 120.76 6.09 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.337 -1.105 . . . . 73.42 110.337 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.4 HD23 ' ND1' ' A' ' 94' ' ' HIS . 23.4 tp -94.66 81.4 3.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 41.43 110.477 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.49 107.36 0.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.636 -1.165 . . . . 35.12 110.75 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -87.49 144.38 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.859 0.361 . . . . 71.12 110.777 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.66 81.74 1.01 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.813 2.342 . . . . 75.51 111.685 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.564 ' H ' ' HB2' ' A' ' 18' ' ' ALA . . . -90.64 163.88 30.01 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.893 -0.67 . . . . 72.24 111.878 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.65 -14.85 33.63 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.715 2.277 . . . . 74.43 112.717 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -141.39 -45.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.2 0.445 . . . . 72.52 112.2 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HA ' HG22 ' A' ' 20' ' ' THR . 54.4 p90 -76.25 -2.61 32.27 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.312 0.486 . . . . 74.43 112.312 -173.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.564 ' HB2' ' H ' ' A' ' 14' ' ' GLY . . . -88.85 -3.31 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 74.2 110.851 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.95 19.61 10.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.496 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 17' ' ' TYR . 12.8 t -138.35 -169.11 2.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 71.44 110.104 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 70.8 mtt180 -48.12 -26.49 1.89 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.198 0.814 . . . . 74.2 113.198 -174.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -81.94 12.41 4.12 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.224 -0.298 . . . . 72.51 111.785 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 27' ' ' MET . 27.4 p-10 -95.8 -5.04 42.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.236 . . . . 75.24 110.745 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 96.1 mt -52.73 -38.09 60.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.175 -0.466 . . . . 60.12 111.791 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -62.56 -30.06 75.45 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.131 -0.556 . . . . 75.23 112.657 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -91.5 -32.89 15.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.963 -0.139 . . . . 75.01 111.346 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 76.3 mtp -54.58 -40.15 68.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.145 0.794 . . . . 71.34 113.145 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.851 ' HB ' HD13 ' A' ' 93' ' ' ILE . 45.5 t -63.62 -46.3 95.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 54.31 110.41 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.08 79.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 74.12 110.324 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.87 -49.0 72.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.442 -0.799 . . . . 52.3 110.564 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.66 -43.38 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.836 -0.62 . . . . 65.42 110.934 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.7 mt -59.44 -40.79 87.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 73.51 111.221 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.63 64.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 62.3 110.976 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.11 -33.39 40.78 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.99 -0.624 . . . . 43.11 113.311 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.63 ' HG3' HD12 ' A' ' 36' ' ' ILE . 14.7 ptm180 -69.78 -25.97 64.06 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.256 0.528 . . . . 71.02 111.196 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.63 HD12 ' HG3' ' A' ' 35' ' ' ARG . 2.0 mp -88.31 -42.21 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.542 . . . . 72.34 109.686 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.51 58.53 2.27 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.81 -0.709 . . . . 73.23 112.219 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.8 m -134.7 145.69 48.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.666 0.27 . . . . 54.34 110.562 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.52 150.82 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 65.2 110.513 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.696 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 1.1 p90 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.834 -0.621 . . . . 70.24 111.086 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -113.85 134.14 54.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 73.11 110.188 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 49' ' ' GLU . 43.6 t -74.68 129.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 74.42 111.685 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.96 149.64 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 65.15 110.378 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -70.64 -72.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.146 -0.479 . . . . 73.52 111.419 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -68.16 -27.38 66.37 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.213 -0.449 . . . . 73.53 111.374 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -83.51 -28.2 28.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.474 -0.33 . . . . 62.41 111.024 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.25 11.83 53.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.093 -0.575 . . . . 75.5 112.452 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -120.25 151.34 39.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.67 0.271 . . . . 43.22 110.947 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.696 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 45.7 mp0 -78.92 138.8 38.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.859 -0.61 . . . . 72.52 111.602 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.36 136.81 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 64.24 109.404 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 9.4 p -121.99 144.69 30.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.734 0.302 . . . . 61.05 110.442 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.824 HG22 HG12 ' A' ' 61' ' ' VAL . 7.2 p -118.14 144.52 45.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.335 -0.393 . . . . 73.22 111.319 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.53 -174.87 38.26 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.028 -0.606 . . . . 61.52 111.87 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 -109.92 126.05 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.808 -0.231 . . . . 74.53 110.524 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.152 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -105.48 108.8 20.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.838 -0.801 . . . . 72.21 108.838 174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.91 -51.93 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.618 -0.719 . . . . 60.22 111.526 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.37 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.008 -0.837 . . . . 73.21 111.008 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.485 ' O ' HD23 ' A' ' 55' ' ' LEU . 27.1 m -78.07 153.12 32.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.403 -0.399 . . . . 75.43 110.385 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.6 m -80.8 129.13 34.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.953 -0.388 . . . . 71.41 109.953 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.152 ' HB ' HD22 ' A' ' 55' ' ' LEU . 13.9 p -118.0 135.56 58.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.926 0.393 . . . . 54.14 110.508 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.824 HG12 HG22 ' A' ' 52' ' ' THR . 17.4 m -116.14 112.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.251 0.548 . . . . 73.3 109.965 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.3 mt -98.08 113.12 24.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 70.43 110.206 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.141 -0.481 . . . . 63.45 110.72 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 3.1 ptmm? -123.81 119.3 26.89 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.182 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.45 160.9 40.55 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.703 2.268 . . . . 54.32 112.894 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 7.83 10.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.628 -0.715 . . . . 60.21 110.141 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.6 t -146.32 -179.36 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 61.42 109.613 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.7 170.72 11.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.077 0.465 . . . . 64.13 111.626 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.99 -23.41 66.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.352 -0.84 . . . . 72.4 111.455 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.05 -43.39 63.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.142 0.496 . . . . 73.23 110.21 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -75.67 -56.89 4.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.659 -0.7 . . . . 72.24 110.228 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 m -47.33 -44.62 23.87 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.745 0.653 . . . . 65.42 112.662 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.75 94.1 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.902 -0.666 . . . . 71.03 113.053 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.37 3.07 40.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.79 0.293 . . . . 65.04 111.79 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.478 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 12.7 mm-40 -91.9 -43.78 9.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.571 -0.286 . . . . 71.51 111.274 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.43 -39.96 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.368 -0.378 . . . . 71.3 111.629 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 125' ' ' LEU . . . -55.24 -63.51 5.21 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 116.176 -0.465 . . . . 53.14 112.965 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.01 -26.02 47.58 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.131 2.554 . . . . 61.35 113.164 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 28.8 mt -72.82 -40.44 65.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.529 0.204 . . . . 64.01 111.428 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.89 -39.24 88.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.422 0.63 . . . . 63.02 109.877 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -9.34 57.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.629 -0.714 . . . . 74.31 111.388 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -66.37 -43.98 84.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 72.31 109.204 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.81 3.81 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 71.33 109.707 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.7 p 45.41 54.47 7.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.923 -1.035 . . . . 74.34 112.553 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 80' ' ' ALA . 26.8 m -81.98 150.45 65.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 73.43 110.73 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 161.33 46.39 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.673 2.249 . . . . 44.12 111.72 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -48.1 111.85 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.269 2.646 . . . . 72.24 112.175 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.432 ' NE2' ' HB2' ' A' ' 6' ' ' LEU . 9.5 pt20 -128.14 -173.97 3.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 71.15 111.44 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -91.24 95.45 10.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 74.14 110.988 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 tt -76.02 110.85 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.462 0.648 . . . . 63.1 110.446 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 132.63 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 64.34 110.693 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.745 HG21 HG21 ' A' ' 121' ' ' VAL . 67.5 t -129.35 129.44 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.676 -0.49 . . . . 53.31 109.676 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.851 HD13 ' HB ' ' A' ' 28' ' ' VAL . 36.4 mt -106.17 126.59 61.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.46 . . . . 64.22 110.111 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' ND1' HD23 ' A' ' 10' ' ' LEU . 67.3 t60 -159.03 174.22 15.26 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.589 -0.445 . . . . 74.11 111.825 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -83.7 152.69 24.6 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.436 -0.802 . . . . 72.01 111.332 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.556 ' HG3' ' H ' ' A' ' 98' ' ' ASP . 9.0 tp10 -145.37 136.67 24.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 60.33 110.767 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.402 HD23 ' CG1' ' A' ' 137' ' ' VAL . 97.0 mt -83.89 -15.39 48.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.931 -0.577 . . . . 53.02 111.549 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.556 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.5 t70 -75.76 -22.61 56.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 75.32 112.267 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.694 HG13 ' HB2' ' A' ' 105' ' ' ARG . 46.6 mm -113.83 144.42 21.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.865 0.364 . . . . 74.32 111.876 -172.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 146.39 17.6 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.12 -0.945 . . . . 62.41 110.479 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 63.0 t80 -66.99 108.52 2.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 74.43 110.272 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 -16.27 6.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.617 -0.801 . . . . 62.43 112.668 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -107.41 151.24 25.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.796 -0.446 . . . . 73.51 109.796 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.68 135.77 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.811 0.339 . . . . 72.24 110.776 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HB2' HG13 ' A' ' 99' ' ' ILE . 8.6 tpp180 -108.89 125.92 52.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.477 -0.564 . . . . 60.41 109.477 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 188' ' ' VAL . 67.8 mt -97.67 134.0 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.908 0.385 . . . . 70.11 110.183 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.724 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -120.83 119.81 33.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.804 -0.634 . . . . 70.41 110.239 -177.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.777 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.5 pt? -103.5 -138.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.758 -0.46 . . . . 73.22 109.758 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 36.04 -145.82 0.07 OUTLIER Glycine 0 C--N 1.344 0.976 0 O-C-N 123.678 0.612 . . . . 72.34 113.411 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.86 127.99 8.35 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.486 -1.045 . . . . 52.4 110.486 162.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.04 107.93 3.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 71.23 113.756 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.91 101.51 12.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 72.22 110.108 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.88 -161.47 29.59 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.332 -1.107 . . . . 64.03 110.332 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.517 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . 64.47 15.62 59.56 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.823 -0.703 . . . . 75.25 112.157 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 m80 72.91 -76.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.442 0.697 . . . . 71.41 111.742 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -134.69 -59.48 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.381 0.511 . . . . 73.31 112.381 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 121' ' ' VAL . . . -57.11 -30.2 60.49 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.581 -0.343 . . . . 55.02 113.5 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.517 HD12 ' HA3' ' A' ' 114' ' ' GLY . 0.9 OUTLIER -63.87 -41.13 97.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.174 0.512 . . . . 72.24 110.101 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -76.73 -37.86 55.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.198 -0.91 . . . . 65.52 110.614 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.5 m -61.95 -49.37 76.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 74.1 111.327 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.745 HG21 HG21 ' A' ' 92' ' ' VAL . 27.3 m -72.64 -21.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.412 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.24 -59.74 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 72.3 111.057 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.4 m -63.27 -40.65 97.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 63.02 111.697 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.95 68.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 51.03 111.669 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.421 HD13 ' HA2' ' A' ' 77' ' ' GLY . 53.4 tp -85.02 -27.94 26.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 75.41 110.258 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.23 22.98 75.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.77 . . . . 63.03 112.249 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.8 m -124.91 121.49 34.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 61.02 110.369 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 44.9 mtmt -115.65 -173.6 2.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.047 -0.723 . . . . 73.53 109.047 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 t30 63.03 79.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.147 0.975 . . . . 74.32 109.629 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -145.88 -155.51 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.443 -1.253 . . . . 72.31 109.122 -176.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -149.0 110.04 4.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 75.33 110.409 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.523 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 2.3 mpt_? -104.55 146.85 28.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.774 -0.648 . . . . 53.31 109.88 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.18 102.44 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.986 -0.552 . . . . 74.34 110.292 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 64.4 mtp180 -96.64 97.26 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.786 -0.643 . . . . 65.11 109.386 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 135' ' ' ILE . 5.1 mp -80.08 128.53 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.86 -0.422 . . . . 71.42 109.86 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -64.11 123.31 27.75 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.627 -0.797 . . . . 73.05 111.816 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 150' ' ' VAL . 9.8 p -96.84 0.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.216 0.532 . . . . 64.54 110.571 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 135.82 -87.32 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.5 -0.857 . . . . 54.14 112.84 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 2.0 ptp180 -172.57 165.36 3.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 122.169 0.188 . . . . 75.43 110.536 -175.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 139' ' ' ARG . 27.9 Cg_endo -64.67 120.2 7.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.344 2.03 . . . . 64.25 111.198 171.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.15 167.09 20.12 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.727 2.285 . . . . 64.14 112.904 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.87 -59.13 0.17 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.702 -0.761 . . . . 55.11 112.59 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -79.6 -29.49 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.764 0.283 . . . . 71.33 111.764 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.45 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -107.92 134.22 51.15 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.588 -0.445 . . . . 73.11 110.402 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.5 141.55 78.42 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.389 -0.823 . . . . 75.05 110.427 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.95 -38.05 12.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.759 2.973 . . . . 75.12 113.984 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -25.83 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.943 0.402 . . . . 72.4 110.95 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.96 -21.89 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.481 . . . . 72.52 110.2 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -72.73 -38.34 67.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.801 -0.636 . . . . 62.33 110.367 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 137' ' ' VAL . 34.2 m -82.9 2.12 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.266 -0.425 . . . . 74.34 110.486 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.95 -24.14 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.551 . . . . 71.23 110.713 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -93.07 97.88 10.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.239 0.543 . . . . 61.44 110.92 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 20' ' ' THR . 32.9 p-10 -104.5 -7.43 19.79 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.009 -0.432 . . . . 54.42 110.897 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.1 52.87 2.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.222 -0.445 . . . . 72.03 110.092 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -75.16 -173.59 2.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.703 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.444 ' H ' HG22 ' A' ' 155' ' ' THR . . . -75.67 -71.32 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.807 0.336 . . . . 74.41 111.48 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.96 -37.49 11.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.355 0.597 . . . . 73.1 110.459 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 101' ' ' PHE . 3.6 mp0 -58.9 -34.6 71.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.962 -1.017 . . . . 72.13 111.712 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -65.93 -26.48 67.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.083 0.468 . . . . 74.45 111.123 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.89 -15.39 36.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.367 -0.379 . . . . 75.24 111.641 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -116.1 15.49 16.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.768 0.285 . . . . 75.41 111.768 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.711 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 57.9 t -56.33 -56.05 35.7 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.253 0.464 . . . . 64.04 112.253 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -66.49 -31.38 42.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.738 1.625 . . . . 63.42 112.074 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.1 m -63.97 -45.56 88.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 52.11 111.794 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.3 pt -68.75 -32.05 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 72.53 111.156 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.58 -37.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.34 -0.391 . . . . 72.5 110.43 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.48 -51.29 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 74.24 110.887 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -69.04 -36.36 77.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 71.43 111.068 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.46 97.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 75.43 111.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.58 95.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.952 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.25 -39.8 89.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 70.24 110.615 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.507 ' HB1' HG22 ' A' ' 188' ' ' VAL . . . -63.3 -35.76 81.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.73 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 60.8 m -65.85 -38.5 89.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 71.33 110.543 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -65.04 -39.03 92.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 73.4 110.045 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.65 -33.8 75.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.897 -0.592 . . . . 72.12 110.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.1 mt -61.41 -34.43 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 74.24 110.817 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.612 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 mm -80.7 -40.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 61.41 111.108 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.13 -43.87 64.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.333 0.494 . . . . 53.13 112.333 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -100.25 -49.86 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.946 0.403 . . . . 75.15 110.87 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 143.71 -168.63 26.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.503 -0.639 . . . . 52.34 111.503 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 182' ' ' GLU . 4.3 pp -104.13 -24.02 13.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.769 0.285 . . . . 73.23 110.83 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.717 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 34.4 tt0 -67.11 -57.23 11.43 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.199 -0.455 . . . . 75.32 111.845 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 83.4 Cg_endo -87.47 -29.63 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.833 1.688 . . . . 73.24 113.093 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -73.93 -31.43 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.508 -0.314 . . . . 75.01 111.823 -172.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -61.81 -29.57 70.25 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.123 0.487 . . . . 75.0 110.023 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.61 -48.38 64.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.635 -0.711 . . . . 53.02 109.846 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 36.0 m -56.26 -38.46 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.631 -0.713 . . . . 40.14 111.446 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 184' ' ' ALA . 82.7 t -57.24 -37.41 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.186 0.439 . . . . 71.51 112.186 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -104.14 -28.24 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.311 -0.555 . . . . 74.41 111.996 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -94.36 12.3 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.128 0.418 . . . . 43.13 112.128 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.488 ' HB2' ' O ' ' A' ' 187' ' ' THR . 3.8 t90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.479 -0.772 . . . . 75.13 110.17 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.115 -0.698 . . . . 75.33 109.115 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.04 60.96 6.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.848 0.356 . . . . 63.03 110.233 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.5 pm0 -86.29 142.81 35.93 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.452 -0.34 . . . . 75.32 110.219 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 5.7 Cg_exo -78.58 141.91 17.9 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.172 2.581 . . . . 35.14 113.577 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.713 HD12 HD21 ' A' ' 55' ' ' LEU . 97.0 mt -86.14 126.75 34.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.259 -0.882 . . . . 72.55 109.577 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.633 HD22 HG21 ' A' ' 85' ' ' VAL . 37.1 tp -93.28 114.77 27.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.303 . . . . 65.12 110.499 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' A' ' 62' ' ' LEU . 41.2 t -120.69 121.69 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.34 -0.391 . . . . 32.41 110.12 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 60.2 t -104.02 116.19 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 64.51 110.56 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.96 122.92 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.963 -0.562 . . . . 75.01 111.703 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.634 HD13 ' HG2' ' A' ' 65' ' ' PRO . 58.3 tp -107.74 105.07 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.931 0.396 . . . . 43.31 111.12 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.63 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -97.3 -142.94 13.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 61.42 112.098 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.777 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . 15.9 m120 -134.58 129.37 19.46 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.619 0.21 . . . . 75.34 111.155 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 68.6 Cg_endo -96.8 173.17 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.37 2.713 . . . . 74.15 111.716 170.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.78 -176.35 19.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.408 -0.901 . . . . 65.3 112.389 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 -67.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.054 2.502 . . . . 74.41 112.859 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -127.52 11.15 6.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 72.14 111.301 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 43.1 m-85 -65.55 -18.47 65.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.796 0.331 . . . . 62.45 111.102 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -75.71 -1.4 24.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 44.54 111.386 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 153' ' ' ASN . 68.3 mmtt -107.16 26.75 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 62.21 109.878 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 151' ' ' LEU . 71.2 p -102.19 172.72 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 65.24 110.448 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -66.0 -19.38 65.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.294 . . . . 52.33 111.249 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -76.34 -9.08 58.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 70.13 110.986 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -64.41 -8.08 12.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.715 0.293 . . . . 75.35 111.466 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 135' ' ' ILE . 94.9 mt -63.42 -31.81 73.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.375 -0.375 . . . . 74.55 110.513 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -63.83 -26.64 70.21 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.948 -0.569 . . . . 75.34 112.142 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.63 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 74.3 t80 -90.74 -36.38 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.789 0.328 . . . . 65.32 110.517 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 mmt -57.36 -42.33 81.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.547 0.573 . . . . 75.42 112.547 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.619 ' HB ' HD13 ' A' ' 93' ' ' ILE . 48.2 t -61.74 -38.83 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 70.43 110.5 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.96 -38.64 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 53.42 110.851 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -57.36 -46.57 83.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 72.54 111.334 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG21 HG12 ' A' ' 166' ' ' VAL . 65.6 t -60.03 -45.56 95.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 71.13 110.745 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 36' ' ' ILE . 94.5 mt -61.6 -44.51 96.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.35 110.903 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.65 -35.5 72.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 71.23 111.167 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.53 -42.17 93.74 Favored Glycine 0 N--CA 1.454 -0.163 0 C-N-CA 121.288 -0.482 . . . . 53.52 112.916 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.27 -21.05 64.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.623 0.249 . . . . 72.41 111.015 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.883 HD13 ' HA3' ' A' ' 53' ' ' GLY . 70.5 mt -83.58 -45.71 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.177 0.513 . . . . 74.23 109.936 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.46 23.12 10.52 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 70.32 112.17 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -118.35 158.18 25.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.796 0.331 . . . . 35.44 110.757 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.77 146.56 43.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 71.41 110.726 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.603 ' CA ' ' HB ' ' A' ' 51' ' ' VAL . 38.9 p90 -80.79 151.03 28.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 62.4 110.682 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.55 164.14 32.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.855 0.359 . . . . 64.42 110.935 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 49' ' ' GLU . 46.6 t -75.2 126.1 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.694 -0.685 . . . . 74.42 112.063 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -76.45 127.13 32.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 64.35 109.125 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 38.6 ttmt -67.45 -5.93 17.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 45.01 111.964 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -80.34 -76.96 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.817 0.341 . . . . 74.34 111.402 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -90.13 -16.88 28.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.391 -0.368 . . . . 74.11 111.906 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 5.87 69.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.445 -0.883 . . . . 72.03 111.714 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.94 143.56 28.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.285 -0.265 . . . . 53.24 110.285 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' HG2' HG22 ' A' ' 42' ' ' VAL . 37.3 mt-10 -94.67 132.87 38.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 74.33 110.477 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 t -136.29 142.51 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.296 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.603 ' HB ' ' CA ' ' A' ' 40' ' ' PHE . 7.6 p -125.26 136.75 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.905 0.384 . . . . 75.13 110.641 175.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.481 HG22 HG12 ' A' ' 61' ' ' VAL . 2.0 p -97.58 149.79 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.901 -0.59 . . . . 74.22 111.094 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.883 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -179.07 -164.89 32.49 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.434 -0.889 . . . . 73.31 112.722 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -122.35 143.04 49.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.058 -0.349 . . . . 73.12 110.058 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.141 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.6 pt? -127.84 109.04 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 74.25 109.361 174.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.05 -45.82 0.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 61.52 111.65 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.28 -27.93 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 110.72 -0.952 . . . . 74.44 110.72 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 59' ' ' SER . 2.0 m -71.79 169.38 15.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.974 -0.613 . . . . 73.4 110.436 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 58' ' ' THR . 14.7 m -97.35 130.56 44.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.468 -0.567 . . . . 74.05 109.468 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.141 ' HB ' HD22 ' A' ' 55' ' ' LEU . 15.0 p -120.05 137.98 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 44.34 110.688 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 52' ' ' THR . 11.9 m -122.8 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.339 0.59 . . . . 72.41 109.847 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 7' ' ' VAL . 77.9 mt -92.39 110.57 21.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.686 -0.688 . . . . 75.35 110.028 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -109.64 132.23 54.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.855 -0.612 . . . . 65.54 110.674 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -120.88 127.92 26.01 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 74.43 110.369 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.634 ' HG2' HD13 ' A' ' 10' ' ' LEU . 48.4 Cg_endo -70.34 168.05 23.41 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.345 2.03 . . . . 75.05 111.262 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 66' ' ' ARG . 8.0 ttt180 -89.05 -60.54 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.837 -0.345 . . . . 75.33 110.726 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.1 p -167.11 172.38 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 24.3 110.541 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.46 ' HD1' ' H ' ' A' ' 71' ' ' GLU . 10.1 t80 71.2 118.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.073 0.858 . . . . 73.11 111.336 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -53.29 -56.24 18.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.589 -0.732 . . . . 51.52 111.624 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 12.5 m120 -56.62 -46.57 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 74.41 111.114 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.628 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 5.6 mm-40 -64.18 -43.99 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 45.15 111.192 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 m -57.84 -39.01 76.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 73.15 110.908 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.656 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -64.61 -34.96 91.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.519 -0.848 . . . . 74.51 111.898 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' ASN . 44.8 mtp180 -86.98 -2.7 58.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 62.55 110.486 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 27.5 mm-40 -79.43 -32.74 42.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 73.01 110.225 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.98 -32.18 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.681 -0.69 . . . . 72.41 110.751 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -47.17 -68.28 1.21 Allowed Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.626 -0.715 . . . . 52.43 113.871 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 -41.06 42.02 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.308 2.006 . . . . 75.24 112.844 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.57 -31.6 72.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.453 -0.339 . . . . 74.2 111.842 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.95 84.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 52.01 111.156 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -26.75 29.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.422 -0.354 . . . . 72.32 110.853 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.32 -46.04 83.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 64.22 110.376 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.58 -3.88 45.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 75.1 110.649 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m 60.71 34.69 19.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.678 -0.692 . . . . 73.4 111.313 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 6' ' ' LEU . 26.9 m -81.25 145.97 57.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.687 -0.688 . . . . 70.24 111.063 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 2.7 Cg_exo -76.49 131.06 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.95 2.434 . . . . 63.41 111.916 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 23.4 Cg_exo -66.43 47.0 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.782 2.988 . . . . 72.41 113.306 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -139.88 -37.67 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 72.34 109.926 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -84.59 -6.82 59.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 75.14 111.353 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.98 130.0 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.378 0.609 . . . . 72.35 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 7' ' ' VAL . 45.8 t -106.16 127.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.766 . . . . 62.02 110.111 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.705 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 40.0 t -114.7 110.18 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.072 -0.344 . . . . 73.44 110.072 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.619 HD13 ' HB ' ' A' ' 28' ' ' VAL . 39.5 mt -87.9 116.88 30.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.502 -0.317 . . . . 73.31 110.657 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -142.6 161.03 39.12 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.557 0.343 . . . . 65.43 110.197 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 137' ' ' VAL . 10.8 p-10 -91.65 148.27 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.509 -0.314 . . . . 61.34 110.517 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 73.8 tt0 -124.96 128.23 48.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.222 0.534 . . . . 73.42 111.197 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.675 HD11 ' HD3' ' A' ' 141' ' ' PRO . 47.1 tp -81.95 -13.9 56.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.666 -0.697 . . . . 65.31 111.72 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.59 5.21 51.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.259 0.552 . . . . 73.34 111.433 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.75 146.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.323 -0.399 . . . . 72.23 110.559 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.15 154.29 23.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.061 -0.518 . . . . 75.41 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.515 ' N ' ' HA2' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -67.68 109.76 3.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 63.23 110.071 -176.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.453 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 114.87 -8.5 21.56 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 54.03 112.623 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -98.83 132.55 44.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.882 -0.414 . . . . 73.52 109.882 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.629 ' HB ' HG11 ' A' ' 188' ' ' VAL . 3.1 mp -101.04 129.54 51.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.236 -0.438 . . . . 54.41 110.061 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 105' ' ' ARG . 10.2 tpt180 -108.79 127.79 54.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.017 -0.538 . . . . 75.33 110.449 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 131' ' ' HIS . 48.1 tp -97.66 132.29 43.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.376 -0.601 . . . . 72.23 109.376 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -155.07 122.11 5.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.288 -0.415 . . . . 73.32 110.109 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.732 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.4 pt? -102.3 -136.16 0.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.679 -0.408 . . . . 72.1 109.955 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.662 ' H ' ' HA ' ' A' ' 129' ' ' ASN . . . 40.3 -149.12 0.17 Allowed Glycine 0 C--N 1.334 0.472 0 O-C-N 123.625 0.578 . . . . 71.0 113.11 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.24 10.56 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.068 -1.213 . . . . 65.12 110.068 164.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.12 156.46 28.03 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.942 -1.123 . . . . 53.05 112.914 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -93.57 -178.63 4.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.792 0.33 . . . . 74.44 110.138 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' HA3' ' NH2' ' A' ' 134' ' ' ARG . . . 115.14 62.53 0.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.796 -0.716 . . . . 64.41 111.601 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.08 -102.34 0.18 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.801 -0.714 . . . . 75.31 111.593 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -154.22 168.38 26.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.254 -0.647 . . . . 74.1 109.254 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -41.86 -53.46 3.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.774 0.671 . . . . 73.32 111.617 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 120' ' ' SER . . . -67.04 2.33 5.15 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.022 -0.535 . . . . 72.42 114.205 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.83 -43.91 14.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.395 0.617 . . . . 72.34 109.366 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -79.68 -21.07 45.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.173 -0.921 . . . . 70.41 111.274 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.499 ' OG ' ' HA2' ' A' ' 117' ' ' GLY . 10.0 m -55.53 -43.8 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 65.12 111.726 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.656 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -68.11 -30.79 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.838 0.352 . . . . 73.41 111.343 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.416 ' HB1' ' HG3' ' A' ' 128' ' ' LYS . . . -78.16 -30.2 49.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 70.14 111.036 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.4 m -84.07 -39.71 19.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.093 -0.503 . . . . 51.1 110.967 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.51 77.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 73.31 111.861 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.654 HD23 ' HZ ' ' A' ' 130' ' ' PHE . 29.3 tp -85.45 -31.12 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.48 . . . . 73.23 109.806 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.33 -12.58 66.49 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.551 -0.75 . . . . 75.34 112.555 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.8 m -106.89 137.45 44.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.783 0.325 . . . . 61.1 110.858 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 8.0 mptt -110.58 -161.81 0.77 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.506 -0.553 . . . . 74.2 109.506 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.662 ' HA ' ' H ' ' A' ' 109' ' ' GLY . 86.3 m-20 76.6 12.97 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.199 0.6 . . . . 63.34 111.329 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.654 ' HZ ' HD23 ' A' ' 125' ' ' LEU . 16.7 m-30 -71.59 136.77 47.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.374 -0.602 . . . . 75.42 109.374 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.524 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.8 p80 -89.88 107.77 19.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.303 0.573 . . . . 64.54 110.352 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.705 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 5.5 mpt_? -94.32 141.28 28.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.631 . . . . 71.42 110.614 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.3 t -92.9 104.18 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.555 -0.905 . . . . 73.04 108.555 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 94' ' ' HIS . 9.1 mtp180 -106.45 114.75 29.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.659 . . . . 71.14 110.529 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.1 mp -96.71 125.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.862 -0.422 . . . . 62.31 109.862 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -61.27 132.16 48.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.134 -0.555 . . . . 60.2 112.832 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 95' ' ' ASP . 23.9 t -86.44 -9.27 11.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.327 0.584 . . . . 71.41 111.035 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.515 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 117.37 -87.31 0.43 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.127 -1.035 . . . . 74.21 113.53 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -132.18 135.45 26.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.491 0.186 . . . . 74.15 111.229 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 29.2 Cg_endo -65.28 123.13 11.06 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.455 2.103 . . . . 73.31 111.113 171.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.948 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 14.3 Cg_exo -69.45 143.47 52.45 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.183 2.589 . . . . 20.33 112.58 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.66 -50.1 0.14 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.666 -0.778 . . . . 52.13 112.494 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -83.16 -32.67 26.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 72.5 111.405 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.542 ' HD3' ' HD1' ' A' ' 149' ' ' PHE . 4.7 ptmm? -114.81 158.84 21.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.868 -0.419 . . . . 70.22 109.868 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 20.3 t70 -52.87 131.91 48.37 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 123.549 0.531 . . . . 72.24 111.824 -175.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.948 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 53.7 Cg_exo -53.3 -41.04 75.59 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.473 2.782 . . . . 75.35 113.45 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.37 39.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 71.43 110.423 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.34 -28.14 69.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 73.31 111.123 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.542 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 71.0 t80 -73.45 -23.17 60.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 71.02 110.528 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.41 -24.2 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.493 0.663 . . . . 70.33 109.924 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.488 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 9.3 mp -87.16 12.1 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.674 -0.694 . . . . 52.41 112.043 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 149' ' ' PHE . 10.5 pt-20 -110.35 136.66 49.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.54 . . . . 63.13 111.083 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 28.9 p-10 -104.52 34.03 3.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.715 -0.675 . . . . 65.23 110.584 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.24 140.57 49.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.032 -0.531 . . . . 73.33 111.134 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.578 ' HB ' ' OE1' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -169.58 -177.71 2.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.312 -0.996 . . . . 75.42 108.312 173.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.3 -71.14 0.68 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.69 -0.404 . . . . 74.42 111.956 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.57 -42.58 8.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 71.33 111.294 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.578 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 0.6 OUTLIER -72.26 -17.42 61.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.689 -0.687 . . . . 75.33 111.175 -174.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.431 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 11.8 tpp180 -70.02 -25.56 63.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 74.43 110.149 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.53 -13.7 42.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 54.11 111.146 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -85.04 -16.83 39.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.248 -0.433 . . . . 64.32 111.098 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.766 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 47.3 t -52.23 -58.67 10.63 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 65.11 112.218 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.766 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.0 Cg_exo -59.68 -34.14 96.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.992 1.794 . . . . 55.14 112.5 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 m -71.97 -46.27 57.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.941 -0.572 . . . . 72.15 111.744 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.453 ' CD1' ' HA2' ' A' ' 102' ' ' GLY . 43.0 pt -69.2 -32.41 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 63.54 112.003 -174.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 162' ' ' VAL . 87.1 t -58.08 -42.3 82.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 42.45 111.32 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.8 -46.63 68.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.383 -0.371 . . . . 62.44 111.481 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -24.34 60.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.624 -0.262 . . . . 74.53 111.25 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.17 85.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 53.14 110.559 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.48 94.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.556 . . . . 74.01 110.377 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.01 -43.73 98.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.67 -0.696 . . . . 73.44 110.969 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.13 95.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.356 . . . . 63.34 110.944 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.423 ' HA ' HD12 ' A' ' 176' ' ' LEU . 90.8 m -61.65 -41.59 97.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 71.01 111.05 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.409 ' OE1' ' HB2' ' A' ' 55' ' ' LEU . 19.4 tt0 -71.56 -31.31 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.37 . . . . 74.15 110.372 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.43 -26.93 67.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.385 . . . . 73.34 110.418 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 173' ' ' THR . 90.8 mt -61.81 -46.47 89.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 64.54 110.911 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.564 HG13 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -81.03 -32.88 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.017 0.437 . . . . 75.43 110.386 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.13 66.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.374 -0.376 . . . . 61.14 111.699 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.434 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.1 tp60 -117.44 -61.49 1.69 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.657 -0.247 . . . . 74.32 111.004 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.29 177.12 35.05 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.233 -0.984 . . . . 55.31 112.101 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 3.9 pp -75.76 -20.51 58.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.492 0.187 . . . . 74.55 111.397 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.659 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 54.1 mt-10 -60.87 -61.64 7.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.65 0.611 . . . . 61.05 112.65 -172.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 71.5 Cg_endo -78.23 -31.12 3.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.592 1.528 . . . . 74.22 112.51 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.77 -58.01 5.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.1 -0.5 . . . . 52.34 111.535 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 24.8 pt20 -70.36 -24.81 63.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.699 -0.401 . . . . 74.43 110.697 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 9.9 t30 -52.25 -46.83 65.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.936 -0.574 . . . . 73.44 112.041 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -83.03 -32.62 26.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.869 -0.333 . . . . 74.34 111.232 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 104' ' ' ILE . 44.4 t -69.51 -28.82 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.568 -0.287 . . . . 71.15 111.724 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -99.08 10.9 40.52 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.019 -0.672 . . . . 73.53 110.91 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -141.48 31.65 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.066 0.395 . . . . 62.34 112.066 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.308 -0.853 . . . . 75.24 109.997 174.66 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.82 0.343 . . . . 71.21 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -157.42 48.68 0.42 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.258 -0.428 . . . . 35.32 110.037 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.9 pm0 -86.39 107.2 12.55 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.372 0.606 . . . . 62.13 110.501 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.546 ' HG2' HG23 ' A' ' 85' ' ' VAL . 83.8 Cg_endo -101.86 -167.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.944 3.096 . . . . 62.22 113.014 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 177' ' ' ILE . 55.9 tp -136.5 115.79 12.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.199 -0.91 . . . . 74.15 108.77 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.572 ' HA ' HG23 ' A' ' 61' ' ' VAL . 33.7 tp -90.82 104.4 16.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.47 -0.567 . . . . 72.03 109.47 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.666 ' HB ' HD23 ' A' ' 62' ' ' LEU . 43.3 t -111.63 122.06 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.258 -0.428 . . . . 64.11 110.54 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.57 114.77 47.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.938 -0.574 . . . . 71.1 109.753 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.1 121.16 6.19 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.681 -0.968 . . . . 70.33 110.681 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.88 124.0 44.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.017 0.437 . . . . 64.02 111.431 -172.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.81 -147.14 4.72 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.435 -0.666 . . . . 74.24 111.435 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -116.66 98.47 51.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.674 0.273 . . . . 63.34 111.208 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.0 118.37 5.39 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.689 2.259 . . . . 62.34 111.351 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 171.96 43.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.891 -0.671 . . . . 74.1 111.661 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.91 -72.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.843 2.362 . . . . 70.41 112.522 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -87.05 -15.01 39.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.41 0.624 . . . . 51.12 110.068 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -71.67 -23.62 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 74.13 111.546 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.36 -1.61 50.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.032 0.444 . . . . 73.04 110.98 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -108.86 15.56 23.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 73.04 110.454 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 65.6 p -101.85 -170.38 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.153 -0.476 . . . . 51.31 110.739 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -73.18 -4.94 36.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.909 0.385 . . . . 73.45 110.74 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -99.11 21.98 11.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.193 0.442 . . . . 72.54 112.193 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' MET . 39.2 p30 -101.37 -1.05 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.855 -0.338 . . . . 52.45 110.458 174.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.82 -37.12 70.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.969 -0.56 . . . . 74.2 111.381 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -62.54 -32.85 84.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.055 -0.593 . . . . 50.41 112.355 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -90.31 -24.61 20.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.793 -0.24 . . . . 75.34 111.239 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.503 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 17.2 mmt -55.91 -51.42 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.786 0.327 . . . . 74.43 111.175 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 22.0 t -66.46 -40.71 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 65.15 110.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 74.01 111.666 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -60.33 -45.08 94.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 75.53 110.553 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.36 -43.82 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 71.33 110.77 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.5 mt -60.97 -39.32 89.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 75.24 111.156 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.77 -46.32 58.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 60.11 110.793 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.55 -34.41 89.87 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.766 -0.652 . . . . 75.11 113.42 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -20.27 62.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.033 0.416 . . . . 74.21 111.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.473 HD13 ' HA3' ' A' ' 53' ' ' GLY . 75.4 mt -87.05 -41.97 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.934 0.397 . . . . 74.13 110.151 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.23 60.22 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.821 -0.627 . . . . 74.12 111.914 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -100.45 140.65 34.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.801 0.334 . . . . 61.14 110.485 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.46 143.06 30.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.322 -0.399 . . . . 74.51 111.315 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 1.061 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 3.3 p90 -60.57 142.04 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 72.25 111.144 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -117.81 147.47 42.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 73.43 110.852 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG22 ' HG2' ' A' ' 49' ' ' GLU . 39.5 t -75.87 128.54 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.953 -0.567 . . . . 63.22 110.169 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.437 ' CD2' ' HB ' ' A' ' 50' ' ' VAL . 27.1 m-70 -85.4 117.03 24.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.423 -0.353 . . . . 72.41 110.331 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -71.47 81.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.588 0.709 . . . . 74.25 111.175 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -175.52 -70.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.266 -0.879 . . . . 74.43 109.484 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.538 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 13.0 m -86.81 -27.95 23.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.745 -0.661 . . . . 55.11 110.662 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . 94.55 10.71 57.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 33.41 112.405 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -97.49 157.59 15.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 33.03 110.788 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.655 ' HG2' HG22 ' A' ' 42' ' ' VAL . 32.9 mt-10 -103.28 127.91 50.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.866 -0.606 . . . . 73.1 111.039 -175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.5 t -140.53 137.97 36.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 72.13 109.817 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.061 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.2 p -116.87 135.23 57.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.886 0.374 . . . . 72.41 111.097 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.581 HG22 HG12 ' A' ' 61' ' ' VAL . 20.2 p -100.85 108.13 19.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 75.12 110.492 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -127.72 -161.7 10.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.819 -0.705 . . . . 73.54 112.178 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -129.94 143.22 50.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.652 0.226 . . . . 70.43 110.548 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.081 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.0 pt? -142.28 121.17 12.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.184 -0.673 . . . . 73.44 109.184 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.8 -57.24 0.46 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.41 0.684 . . . . 75.31 111.862 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.37 -12.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.343 -0.456 . . . . 75.32 112.447 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.4 p -104.05 168.82 8.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.94 0.4 . . . . 71.32 110.899 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 t -90.86 99.64 12.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.565 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.081 ' HB ' HD22 ' A' ' 55' ' ' LEU . 11.6 p -76.17 129.94 36.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.54 -0.464 . . . . 63.13 109.872 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 52' ' ' THR . 17.6 m -118.45 111.22 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.494 0.664 . . . . 70.44 110.12 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD23 ' HB ' ' A' ' 7' ' ' VAL . 87.5 mt -92.6 117.92 30.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.759 . . . . 71.2 110.28 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.43 125.33 51.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.933 -0.576 . . . . 65.3 109.802 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -117.92 136.19 23.68 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.093 -0.503 . . . . 73.43 111.102 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.45 137.82 62.14 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.986 2.457 . . . . 71.32 111.477 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 32.5 ttt-85 -85.56 -52.78 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.741 -0.384 . . . . 74.11 110.08 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.2 p -159.44 139.17 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.467 -0.333 . . . . 54.52 110.997 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.548 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 20.5 t80 71.06 133.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.096 0.873 . . . . 55.5 111.802 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.446 ' HB3' ' CA ' ' A' ' 117' ' ' GLY . 2.0 mpt? -62.07 -56.43 19.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 75.14 112.038 -174.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.28 -41.58 97.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.394 -0.366 . . . . 74.42 111.834 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 9.0 mm-40 -63.68 -30.11 71.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.386 -0.37 . . . . 71.11 110.89 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 m -63.52 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 74.23 110.697 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.08 -38.16 96.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.573 -0.822 . . . . 35.23 111.098 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.58 1.41 29.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.057 0.456 . . . . 74.53 110.594 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 13.0 mm-40 -97.37 -51.8 4.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.919 -0.582 . . . . 74.31 110.07 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.65 -41.03 91.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 44.35 111.531 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.64 -65.3 3.41 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.189 -0.459 . . . . 72.43 113.083 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.63 -39.94 87.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.792 2.328 . . . . 75.12 112.873 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 48' ' ' ALA . 55.1 mt -64.7 -36.99 86.05 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.816 0.302 . . . . 61.32 111.816 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.22 -41.4 83.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.403 0.62 . . . . 50.22 110.337 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 -0.82 56.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 61.11 111.666 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -80.22 -49.05 12.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 71.22 110.564 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.551 ' CE2' ' HB ' ' A' ' 85' ' ' VAL . 40.0 p90 -108.45 9.42 27.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 74.02 110.86 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m 60.67 77.95 0.3 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.397 -0.82 . . . . 52.44 112.177 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 83' ' ' TYR . 12.9 p -107.45 130.94 22.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.15 -0.477 . . . . 44.43 109.901 175.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 22.3 Cg_endo -62.64 118.64 5.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.7 2.267 . . . . 70.3 112.4 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 2.8 Cg_exo -76.18 67.6 6.85 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.295 2.664 . . . . 64.44 112.097 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -146.04 -53.66 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 74.55 109.972 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -80.71 74.16 7.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.886 -0.597 . . . . 74.31 109.991 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -121.86 141.53 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 64.4 110.455 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG23 HD11 ' A' ' 5' ' ' LEU . 94.9 t -127.99 110.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.035 -0.53 . . . . 70.45 109.846 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.2 106.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.142 -0.318 . . . . 54.24 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.538 HG22 ' HA2' ' A' ' 25' ' ' GLY . 66.2 mt -94.97 117.34 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.349 -0.387 . . . . 75.35 110.259 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -154.78 161.21 41.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.923 0.392 . . . . 73.01 110.407 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.46 149.53 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 74.24 110.599 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.634 ' HB3' HG22 ' A' ' 99' ' ' ILE . 5.9 tp10 -123.41 109.09 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.399 -0.593 . . . . 62.21 109.399 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.765 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 6.1 mp -68.95 -34.19 74.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 75.23 111.793 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.96 -31.16 68.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.555 . . . . 52.35 112.186 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.634 HG22 ' HB3' ' A' ' 96' ' ' GLU . 14.8 tt -97.74 160.39 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.944 0.402 . . . . 65.51 111.461 -172.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.662 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 22.2 t70 -58.5 148.83 27.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.607 -0.724 . . . . 74.2 112.158 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 69.8 t80 -69.68 138.95 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.75 -0.659 . . . . 72.15 111.948 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.09 9.92 86.53 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.526 -0.761 . . . . 63.44 113.026 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -100.45 116.43 32.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.719 -0.474 . . . . 63.2 109.719 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.7 mp -79.98 106.43 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.446 -0.575 . . . . 61.41 109.446 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -109.06 150.06 28.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.98 -0.554 . . . . 73.21 109.905 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 131' ' ' HIS . 15.1 tp -113.14 146.67 38.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.665 -0.494 . . . . 72.35 109.665 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 131' ' ' HIS . 38.0 tttm -147.34 153.92 40.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.569 -0.53 . . . . 61.34 109.569 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.738 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -125.05 -71.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.281 0.363 . . . . 74.43 111.446 -176.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.738 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -63.69 161.04 36.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.273 -0.489 . . . . 62.12 112.828 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.52 143.59 31.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.935 -0.65 . . . . 61.53 112.329 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.42 -176.64 42.06 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.298 -0.721 . . . . 62.35 111.298 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -81.07 150.13 28.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 73.22 110.723 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.79 -59.56 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.743 -1.343 . . . . 73.4 109.743 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.836 ' HA3' HD21 ' A' ' 118' ' ' LEU . . . -91.48 163.97 29.01 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.67 -0.972 . . . . 53.15 110.67 170.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.575 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 4.7 t-80 -119.09 -63.33 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.268 -0.573 . . . . 51.43 111.631 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -107.82 -71.16 0.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.809 -0.357 . . . . 64.13 111.882 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 69' ' ' MET . . . -51.62 -48.24 50.15 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.812 -0.631 . . . . 72.24 114.659 -167.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.836 HD21 ' HA3' ' A' ' 114' ' ' GLY . 3.5 pp -78.28 -19.36 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.293 -0.563 . . . . 72.44 111.827 -174.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.575 ' HD3' ' O ' ' A' ' 115' ' ' HIS . 18.1 mtp180 -81.11 -26.45 36.18 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.0 -0.28 . . . . 43.32 110.29 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -67.57 -50.17 59.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.458 -0.337 . . . . 75.02 110.705 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.508 HG12 ' HA2' ' A' ' 73' ' ' GLY . 29.4 m -65.87 -33.8 66.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 70.12 111.089 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.17 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.419 . . . . 73.12 111.118 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.1 m -82.07 -28.91 32.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 75.04 110.545 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.45 -43.46 81.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.711 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.89 -41.5 59.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 75.04 109.743 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.7 62.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.617 -0.72 . . . . 43.04 112.25 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.481 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 6.6 m -108.54 148.01 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.843 -0.429 . . . . 73.02 109.843 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 11.6 mptt -117.2 -155.83 0.6 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.35 109.11 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.4 t30 73.88 9.96 4.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.797 0.808 . . . . 73.14 109.654 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -87.83 127.58 35.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.331 -0.849 . . . . 65.13 109.791 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.76 ' HB2' HD11 ' A' ' 106' ' ' LEU . 35.2 p-80 -73.05 120.41 18.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.359 0.599 . . . . 74.53 111.694 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 106' ' ' LEU . 43.0 mtm105 -95.21 139.77 31.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.635 -0.711 . . . . 72.41 110.451 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.85 104.16 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.449 -0.945 . . . . 64.53 108.449 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.485 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 53.5 mtp180 -100.92 107.86 19.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.456 -0.793 . . . . 73.13 110.377 -172.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.3 mp -93.81 113.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.609 . . . . 75.35 109.357 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 100' ' ' ASP . . . -57.46 138.5 48.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.136 -0.554 . . . . 73.31 113.904 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.765 ' HB ' ' HA ' ' A' ' 97' ' ' LEU . 89.6 t -88.98 -20.35 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 62.25 110.588 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 130.33 -78.43 0.38 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.282 -0.961 . . . . 75.31 113.312 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.587 ' HD3' ' O ' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -163.7 158.78 17.17 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 110.048 -0.353 . . . . 75.23 110.048 -174.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.587 ' O ' ' HD3' ' A' ' 139' ' ' ARG . 51.4 Cg_exo -55.43 159.65 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.018 2.479 . . . . 73.11 112.616 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 49.2 Cg_endo -67.12 161.45 42.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.707 2.272 . . . . 74.52 112.877 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -86.87 1.97 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.73 . . . . 72.23 112.345 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -103.21 8.28 38.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 72.33 111.412 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -131.48 161.86 31.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.407 -0.361 . . . . 64.54 110.605 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.67 150.64 25.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.454 0.471 . . . . 64.24 111.445 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.88 -43.07 59.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.776 2.317 . . . . 70.44 112.075 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.25 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 60.02 111.072 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 151' ' ' LEU . . . -83.54 -27.8 29.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.416 -0.356 . . . . 60.41 110.949 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 86.3 t80 -67.65 -35.36 78.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.15 110.223 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.752 ' O ' ' HB ' ' A' ' 20' ' ' THR . 35.5 m -84.86 -6.22 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 74.1 111.021 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.697 HD23 HG21 ' A' ' 20' ' ' THR . 11.1 mt -90.78 6.12 45.54 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.174 0.435 . . . . 64.32 112.174 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -93.27 167.44 11.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.487 -0.485 . . . . 71.02 110.054 175.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -149.5 148.9 29.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.544 -0.298 . . . . 71.11 111.301 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.789 ' HA ' ' HG2' ' A' ' 159' ' ' ARG . 84.4 m-85 66.89 96.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.477 1.11 . . . . 75.13 112.313 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 13.3 p -114.68 -166.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 75.21 109.572 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.2 -72.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.846 0.684 . . . . 64.12 112.846 -171.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.67 -56.46 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.157 0.429 . . . . 63.4 112.157 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.474 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -65.81 -23.73 66.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.756 -0.656 . . . . 75.55 111.878 -171.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.789 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 3.3 tpp180 -71.97 -28.05 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 75.21 110.396 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.432 ' O ' ' HD2' ' A' ' 163' ' ' PRO . . . -87.6 -11.11 49.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.957 -0.565 . . . . 61.41 110.183 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.6 -3.6 59.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.731 . . . . 75.11 111.058 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.695 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 95.8 t -57.87 -52.91 70.97 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.616 -0.265 . . . . 71.34 110.731 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 51.1 Cg_exo -55.84 -35.92 94.59 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.968 1.779 . . . . 73.44 111.977 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -64.35 -48.92 73.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 45.54 111.198 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 36.0 pt -79.93 -26.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 74.13 111.944 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 163' ' ' PRO . 9.3 p -68.48 -31.91 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.882 -0.327 . . . . 43.21 110.698 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 44.8 mt-10 -64.68 -43.32 93.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.181 0.515 . . . . 73.44 109.621 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.63 -47.23 82.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.345 -0.843 . . . . 61.25 110.851 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.38 99.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.511 . . . . 73.44 111.547 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.12 96.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 73.41 110.783 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.42 -39.04 81.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 73.43 110.687 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.88 -42.03 98.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 44.33 111.062 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.6 m -61.62 -38.13 86.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 62.21 110.516 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -73.11 -34.01 65.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 72.25 110.252 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.2 tp -66.55 -27.3 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 73.52 110.832 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 92.0 mt -61.29 -33.73 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.5 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 5' ' ' LEU . 38.0 mm -81.28 -46.62 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 53.3 110.938 176.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.79 -61.27 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 33.02 111.773 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.432 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.5 tp60 -93.14 -44.62 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 72.44 110.576 -175.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 183' ' ' PRO . . . 130.26 156.64 8.75 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.064 -0.814 . . . . 54.31 111.064 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.68 -27.73 66.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.164 0.482 . . . . 63.21 110.959 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.714 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 35.1 tt0 -72.5 -52.46 6.58 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.812 -0.631 . . . . 73.04 111.664 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 9.9 Cg_exo -73.89 -32.23 7.43 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.891 1.727 . . . . 62.14 112.895 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -64.3 -40.03 95.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 111.76 0.281 . . . . 54.42 111.76 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 9.9 pt20 -58.22 -30.75 66.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.645 0.259 . . . . 74.41 110.904 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.41 -47.86 74.81 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.617 -0.512 . . . . 72.32 109.617 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -59.03 -38.84 80.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.671 -0.695 . . . . 61.4 111.237 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 184' ' ' ALA . 99.5 t -58.47 -35.91 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.992 -0.549 . . . . 61.31 112.237 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -106.8 15.22 25.79 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.116 -0.634 . . . . 71.33 110.675 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.86 6.52 47.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.103 -0.499 . . . . 72.44 111.496 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.489 -0.767 . . . . 73.23 110.105 176.303 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 1.1 pm0 . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.902 0.382 . . . . 74.0 110.315 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.495 ' CD ' ' HD2' ' A' ' 86' ' ' PRO . 93.9 Cg_endo -96.23 162.01 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.026 2.484 . . . . 64.4 113.495 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.666 HD11 HG23 ' A' ' 91' ' ' VAL . 58.0 tp -89.45 122.78 32.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.168 -0.924 . . . . 71.42 108.797 172.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.73 105.37 17.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.484 -0.561 . . . . 73.1 109.484 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HB ' HD23 ' A' ' 62' ' ' LEU . 38.2 t -107.07 113.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 74.34 110.525 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 92' ' ' VAL . 58.3 t -109.86 118.1 56.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.669 -0.696 . . . . 74.34 109.716 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.27 122.72 7.45 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.201 -0.999 . . . . 74.32 111.779 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' HA3' ' A' ' 117' ' ' GLY . 46.5 tp -77.77 82.04 4.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.329 0.585 . . . . 62.25 109.79 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.695 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -164.2 101.73 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.271 -0.877 . . . . 43.43 111.104 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 65' ' ' PRO . 50.8 m-80 -88.38 146.94 38.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.494 -0.188 . . . . 72.04 110.494 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 25.5 Cg_exo -62.96 96.43 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 123.06 2.507 . . . . 73.43 112.697 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . -122.33 119.1 3.86 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.38 -0.827 . . . . 73.02 111.3 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.45 -54.12 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 124.359 3.373 . . . . 62.34 114.58 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -105.09 -30.08 9.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.439 0.533 . . . . 71.52 112.439 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 p90 -89.13 2.68 53.79 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.17 -0.612 . . . . 75.3 112.059 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 -1.51 52.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.893 0.377 . . . . 74.3 110.679 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.6 10.76 16.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.292 -0.413 . . . . 74.25 110.868 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 22' ' ' HIS . 6.2 t -105.1 -174.58 2.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.757 -0.377 . . . . 65.05 110.898 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 54.5 mtt180 -57.24 -20.94 30.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.61 0.596 . . . . 65.12 112.61 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.636 ' H ' HG23 ' A' ' 20' ' ' THR . 5.5 t-160 -91.65 14.05 16.27 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 72.15 111.609 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.17 1.06 57.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.837 -0.345 . . . . 65.23 110.379 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 88.0 mt -51.41 -48.11 62.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.745 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.76 93.34 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.958 -0.639 . . . . 71.31 112.846 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.695 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 77.9 t80 -80.35 -26.97 38.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.627 0.251 . . . . 64.02 110.824 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.586 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 7.2 mmt -55.18 -53.45 55.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.931 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.658 HG21 HG12 ' A' ' 93' ' ' ILE . 90.2 t -56.12 -45.57 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.76 0.314 . . . . 63.32 111.048 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -48.85 74.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 51.14 111.186 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.33 -40.02 96.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 52.52 110.814 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 HG12 ' A' ' 166' ' ' VAL . 45.0 t -67.4 -45.63 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 74.33 111.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.36 -45.14 94.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 73.53 110.482 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.53 -31.72 73.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 74.35 110.549 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -45.47 49.53 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.598 -0.728 . . . . 22.3 113.081 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HG3' HD12 ' A' ' 36' ' ' ILE . 13.1 ptp180 -70.36 -34.95 73.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.094 0.447 . . . . 74.13 110.933 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -71.65 -37.02 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.071 0.463 . . . . 74.12 110.117 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.17 53.44 2.66 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.74 -0.743 . . . . 44.0 112.202 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.6 m -147.6 144.82 28.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.651 0.263 . . . . 75.3 110.487 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.06 147.81 25.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.302 -0.408 . . . . 73.33 110.423 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.623 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 p90 -78.25 132.64 37.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 64.43 110.894 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -99.59 150.26 22.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.782 -0.645 . . . . 74.55 110.893 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 24.6 t -73.16 124.08 29.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 72.44 111.427 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -88.08 99.96 12.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 74.23 109.064 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -69.23 86.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 71.04 110.553 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -173.13 -62.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.07 -0.968 . . . . 72.55 109.189 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -99.48 -14.63 19.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.643 -0.708 . . . . 74.41 110.846 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.54 67.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.836 -0.697 . . . . 63.41 112.467 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.573 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -93.7 163.05 13.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.705 0.288 . . . . 33.12 110.767 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.936 ' HB2' ' HE3' ' A' ' 64' ' ' LYS . 29.8 mt-10 -124.04 131.48 53.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 61.32 110.274 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -133.33 139.14 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.521 . . . . 74.04 110.718 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 8.5 p -119.18 142.67 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.435 -0.348 . . . . 74.22 110.079 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.428 HG22 HG12 ' A' ' 61' ' ' VAL . 14.1 p -108.29 143.43 37.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.953 0.353 . . . . 74.45 111.953 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.18 -164.43 21.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.202 -0.523 . . . . 52.11 111.887 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -134.12 122.83 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.75 0.275 . . . . 64.21 110.622 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.053 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -111.16 119.1 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 51.43 109.486 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.02 -67.6 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.412 0.685 . . . . 54.32 111.656 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.43 12.79 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.982 -0.847 . . . . 40.44 110.982 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.525 ' O ' HD23 ' A' ' 55' ' ' LEU . 47.0 m -126.31 146.0 50.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 71.41 109.414 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 18.0 m -67.62 131.71 46.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.701 -0.481 . . . . 45.45 109.701 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.053 ' HB ' HD22 ' A' ' 55' ' ' LEU . 9.9 p -111.65 127.98 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.904 0.383 . . . . 75.05 110.132 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG12 HG22 ' A' ' 52' ' ' THR . 11.5 m -117.13 109.26 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.308 0.575 . . . . 73.03 109.846 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.515 HD23 ' HB ' ' A' ' 7' ' ' VAL . 78.3 mt -92.57 106.36 18.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.561 -0.745 . . . . 63.14 109.748 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 127.88 55.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.814 -0.63 . . . . 74.0 110.922 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.936 ' HE3' ' HB2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -123.63 143.6 42.14 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.11 -0.7 . . . . 51.14 109.11 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.815 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 14.6 Cg_exo -69.65 175.59 7.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.179 2.586 . . . . 54.14 113.598 -173.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 7.1 ptm180 -77.38 -61.81 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 64.34 110.949 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.665 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 24.6 p -169.49 166.79 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.55 -0.537 . . . . 72.23 109.55 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 16.0 t80 70.27 144.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.657 0.741 . . . . 71.51 112.595 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.5 -56.17 20.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 53.43 111.721 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.417 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 25.2 t-20 -58.04 -43.7 86.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.165 -0.471 . . . . 71.14 111.573 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 8.6 mm-40 -56.66 -41.57 77.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.132 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.5 m -57.5 -32.44 67.02 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.515 0.51 . . . . 65.21 111.306 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -65.16 -47.11 84.74 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.654 -0.784 . . . . 42.53 112.349 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 25.6 ptt180 -89.22 3.06 53.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.981 -0.288 . . . . 73.35 111.111 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.815 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 23.2 mm-40 -66.92 -38.24 85.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 71.21 110.783 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.11 -34.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.977 -0.556 . . . . 73.13 111.696 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.539 ' O ' ' HD3' ' A' ' 81' ' ' LYS . . . -54.18 -73.3 0.43 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.975 -0.557 . . . . 44.23 113.642 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 18.5 Cg_endo -59.79 -23.21 71.22 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.081 2.521 . . . . 72.14 113.407 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 48' ' ' ALA . 34.8 mt -75.41 -43.03 52.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.071 -0.252 . . . . 75.03 111.386 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.77 80.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 71.5 110.825 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 77' ' ' GLY . 2.2 mptp? -80.79 -26.34 37.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.771 -0.649 . . . . 72.31 110.037 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.6 t80 -56.6 -52.45 64.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.602 -0.726 . . . . 73.21 110.857 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -94.92 -1.2 53.06 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.849 -0.34 . . . . 71.41 110.709 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 63.12 90.95 0.07 Allowed 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.787 0.679 . . . . 64.54 110.731 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.27 123.7 76.83 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.472 -0.786 . . . . 65.43 112.414 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.617 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 5.9 Cg_exo -79.81 113.35 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.804 2.336 . . . . 74.03 109.452 162.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 24.9 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.853 2.368 . . . . 74.42 113.778 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -92.6 -57.74 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 74.43 109.721 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 130' ' ' PHE . 8.8 tt0 -173.64 148.99 1.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.942 -0.572 . . . . 72.05 109.861 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 tt -124.18 122.1 63.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.335 0.588 . . . . 71.54 110.935 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 5' ' ' LEU . 98.9 t -113.19 126.68 70.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 75.44 109.977 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.545 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 t -129.48 107.02 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.239 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.658 HG12 HG21 ' A' ' 28' ' ' VAL . 4.2 mp -84.5 133.74 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.702 -0.681 . . . . 53.24 109.329 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.506 ' CE1' ' HG3' ' A' ' 132' ' ' ARG . 57.0 p-80 -151.8 179.58 8.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.895 0.379 . . . . 63.04 111.116 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.23 148.57 26.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.228 -0.897 . . . . 71.42 111.092 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -140.95 115.04 9.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 73.3 110.374 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 137' ' ' VAL . 95.5 mt -82.75 -14.16 55.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.632 -0.713 . . . . 72.33 112.458 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -94.39 -12.13 28.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.902 0.382 . . . . 65.22 110.984 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.591 HD11 ' HD2' ' A' ' 105' ' ' ARG . 46.3 mm -106.63 139.45 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 72.34 111.895 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.83 142.21 30.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.958 -1.019 . . . . 72.23 111.617 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.3 t80 -68.43 115.12 7.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 62.42 111.241 -173.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.07 -16.78 6.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.329 -0.938 . . . . 42.15 113.635 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -114.21 159.97 19.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.402 0.601 . . . . 64.05 111.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.23 129.32 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 73.15 111.444 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.735 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 75.2 ttt180 -109.3 125.39 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.052 -0.722 . . . . 43.1 109.052 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.23 118.26 35.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 71.01 111.35 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.79 161.43 26.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.161 -0.681 . . . . 73.04 109.161 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 129' ' ' ASN . 89.9 mt -66.78 -72.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.232 0.456 . . . . 73.35 112.232 -176.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.48 -126.19 3.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.364 -0.922 . . . . 70.53 113.56 -173.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.96 152.56 26.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.007 -0.616 . . . . 73.51 112.454 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.5 163.54 32.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.81 -0.71 . . . . 43.13 112.048 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.14 164.34 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.219 -0.289 . . . . 70.23 110.219 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -30.27 5.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.831 -0.7 . . . . 43.44 111.954 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.16 -170.58 24.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.952 -0.642 . . . . 55.43 111.649 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.406 ' CE1' HD11 ' A' ' 97' ' ' LEU . 39.4 m80 -103.14 -86.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.432 0.53 . . . . 72.0 112.432 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -118.24 -64.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.765 0.654 . . . . 73.44 112.765 -170.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.437 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -48.11 -49.43 24.29 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.495 0.497 . . . . 72.15 114.314 -168.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.7 pt? -57.77 -35.06 70.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 71.15 111.883 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.487 ' HG3' ' HG ' ' A' ' 118' ' ' LEU . 78.8 mtp180 -80.18 -40.05 28.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.065 -0.516 . . . . 63.52 110.484 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 45.0 m -69.6 -42.5 74.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.624 -0.716 . . . . 65.41 112.154 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.47 -27.93 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.88 0.326 . . . . 72.54 111.88 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.37 91.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 73.22 110.731 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 m -79.23 -22.62 44.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.03 -0.532 . . . . 71.42 111.163 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.43 77.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 72.45 111.176 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.86 -41.59 6.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.338 -0.392 . . . . 64.35 111.025 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.28 -5.83 63.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.792 -0.718 . . . . 73.42 111.835 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 52.7 m -125.38 126.8 45.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.936 0.398 . . . . 63.32 110.171 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.587 ' N ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.58 -160.91 1.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.031 -0.531 . . . . 74.44 109.825 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m-20 69.85 72.63 0.23 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.5 0.667 . . . . 75.4 111.204 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.402 ' HB3' ' HG3' ' A' ' 89' ' ' GLN . 85.6 m-85 -140.86 -82.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.222 -0.899 . . . . 65.41 109.411 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -152.29 103.69 2.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 74.02 110.327 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.506 ' HG3' ' CE1' ' A' ' 94' ' ' HIS . 2.6 tpp180 -102.56 108.79 20.21 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 64.42 108.865 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 84.0 t -82.66 116.36 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.227 0.537 . . . . 73.24 111.211 -171.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.837 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 54.1 mtt180 -105.11 111.18 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.207 -0.906 . . . . 73.02 109.984 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 24' ' ' LEU . 58.4 mt -95.65 118.57 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.108 -0.701 . . . . 74.12 109.108 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -60.64 128.25 44.94 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.773 -0.727 . . . . 64.35 111.993 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 97' ' ' LEU . 8.9 p -98.51 -5.86 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 72.31 110.744 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.23 -108.5 0.93 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.643 -0.789 . . . . 73.51 112.402 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -153.98 157.13 32.49 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.418 -0.215 . . . . 73.44 110.418 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.93 135.01 56.67 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.718 2.279 . . . . 73.1 111.73 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.524 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 59.0 Cg_endo -73.29 164.76 34.38 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.77 2.313 . . . . 73.52 112.627 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -26.03 6.92 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.879 -0.677 . . . . 63.01 112.24 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -105.53 -66.96 0.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.731 0.301 . . . . 72.13 111.782 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.782 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -77.57 161.13 28.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.916 0.389 . . . . 72.12 111.621 -174.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.36 137.4 68.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.446 -0.797 . . . . 45.4 111.02 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.81 -44.7 30.81 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 55.42 113.417 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.26 -34.95 66.11 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.001 -0.28 . . . . 71.52 110.68 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.09 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 52.3 110.778 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.524 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 32.8 t80 -68.16 -26.56 65.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 72.52 110.318 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 25.3 t -81.66 -16.99 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.779 -0.646 . . . . 63.31 109.735 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.36 -11.25 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.716 -0.675 . . . . 73.21 110.858 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -113.64 104.66 12.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.17 0.509 . . . . 62.4 110.412 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.578 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 51.1 t30 -90.84 79.7 5.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 72.0 111.336 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -146.56 135.67 22.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 72.45 109.585 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -154.29 -171.62 3.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.915 -0.772 . . . . 73.31 108.915 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 155' ' ' THR . . . -92.46 -71.62 0.64 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.855 0.316 . . . . 73.3 111.855 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.01 -51.66 4.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 54.3 111.689 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 1.1 pm0 -69.26 -17.03 63.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.784 . . . . 71.24 111.468 -172.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -64.48 -27.07 68.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.736 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.59 -20.2 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.234 -0.439 . . . . 74.02 111.032 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.7 6.92 39.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 73.24 111.791 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.682 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 84.2 t -53.66 -55.09 38.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.087 0.403 . . . . 73.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.6 Cg_exo -53.62 -39.81 81.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.027 1.818 . . . . 75.51 112.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 m -65.62 -50.96 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.36 -0.382 . . . . 63.54 111.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.12 -32.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 64.11 111.401 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.54 HG12 HG21 ' A' ' 31' ' ' VAL . 75.7 t -69.05 -45.87 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.636 -0.256 . . . . 74.53 111.109 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -60.13 -41.35 92.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.282 . . . . 71.23 110.635 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.25 -37.61 78.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 71.14 111.261 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.12 74.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 70.11 110.884 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.21 -34.33 78.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 73.24 110.838 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.28 -42.98 64.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.753 -0.658 . . . . 52.14 110.633 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -65.99 -25.86 67.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 52.23 111.087 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.8 m -61.27 -37.96 85.03 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 54.32 110.404 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 55' ' ' LEU . 34.0 tt0 -73.1 -30.76 63.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 74.54 110.078 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.19 -28.44 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 73.13 110.366 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.7 mt -64.94 -25.39 67.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 75.0 110.822 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.564 HD11 HD13 ' A' ' 5' ' ' LEU . 26.7 mm -80.72 -51.21 16.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 63.22 110.733 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -73.3 -42.5 62.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.651 . . . . 62.11 112.313 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.441 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.9 tp60 -93.46 -62.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.766 0.317 . . . . 70.23 111.325 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.38 -129.8 3.24 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.65 -0.786 . . . . 70.44 112.21 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 182' ' ' GLU . 3.0 pp -124.01 -46.77 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 74.31 111.923 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.79 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 44.8 tt0 -74.19 -57.56 2.22 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.671 0.249 . . . . 73.32 111.671 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.3 Cg_exo -63.97 -25.34 66.8 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.515 1.477 . . . . 73.03 111.475 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -70.28 -50.18 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 65.51 110.89 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.1 pt20 -65.56 -30.57 71.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.907 0.384 . . . . 73.4 110.141 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.56 -45.01 95.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 55.33 109.837 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 91.2 m -59.74 -42.45 93.2 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.989 -0.55 . . . . 55.51 110.685 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 184' ' ' ALA . 58.7 t -66.43 -34.28 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.949 -0.568 . . . . 42.42 111.892 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.35 5.94 46.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.196 -0.315 . . . . 72.42 111.844 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.04 -17.91 38.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 70.44 111.066 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.361 -0.828 . . . . 71.43 109.986 178.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' ' 58' ' ' THR . 10.3 pt-20 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.341 0.591 . . . . 75.02 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 59' ' ' SER . 27.8 Cg_endo -96.57 113.39 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.56 2.84 . . . . 60.13 112.207 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 177' ' ' ILE . 45.7 tp -88.66 119.67 29.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.509 -0.314 . . . . 73.42 110.383 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.612 ' HA ' HG23 ' A' ' 61' ' ' VAL . 61.2 tp -92.67 107.12 18.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 72.32 109.861 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.653 ' HB ' HD23 ' A' ' 62' ' ' LEU . 42.7 t -98.05 117.36 42.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.025 -0.534 . . . . 71.34 109.756 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.24 114.84 41.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 74.44 110.002 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.83 122.75 7.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 53.53 111.732 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.67 100.06 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.864 0.364 . . . . 74.04 110.778 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.95 135.45 11.43 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.818 -0.628 . . . . 71.24 111.85 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 34.5 m-80 -139.32 129.04 14.25 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 110.225 -0.287 . . . . 74.54 110.225 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 31.8 Cg_exo -59.19 165.6 8.64 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.408 2.739 . . . . 74.33 113.483 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.63 111.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.748 -0.941 . . . . 75.41 110.748 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -45.22 -50.28 9.15 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.326 2.684 . . . . 70.24 113.155 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -100.98 -10.93 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.216 -0.447 . . . . 63.12 111.367 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 151' ' ' LEU . 39.7 m-85 -101.18 1.81 39.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 74.5 112.258 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.583 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -87.71 -15.06 38.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.04 0.448 . . . . 43.13 110.625 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -105.5 9.78 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 75.03 110.412 -175.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 153' ' ' ASN . 75.6 p -111.74 -169.5 1.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.389 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 62.9 mtt180 -67.08 -4.94 11.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.042 0.449 . . . . 75.25 111.013 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -76.0 -8.76 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 75.14 111.142 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 24.4 m-80 -134.38 32.34 3.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.756 -0.202 . . . . 71.23 111.509 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 137' ' ' VAL . 64.6 mt -58.29 -38.21 76.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.718 0.294 . . . . 65.33 111.437 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.36 87.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.837 -0.697 . . . . 65.01 112.303 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 64' ' ' LYS . 87.3 t80 -73.61 -32.72 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.611 0.244 . . . . 72.42 110.867 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.4 mmt -53.44 -47.43 69.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.043 -0.526 . . . . 73.43 111.263 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 48.2 t -66.09 -42.93 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.056 -0.52 . . . . 64.3 110.77 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -61.96 -40.47 95.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 64.22 110.909 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.69 -46.82 88.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 71.45 110.242 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -33.22 59.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 72.45 111.173 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 29' ' ' ALA . 64.9 mt -57.74 -50.06 74.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.128 -0.323 . . . . 65.14 110.128 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.85 68.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.52 . . . . 62.42 110.673 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.87 -48.39 66.78 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.617 -0.719 . . . . 54.41 112.894 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -73.9 -22.76 59.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.169 0.485 . . . . 71.34 111.054 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -45.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.401 . . . . 64.52 110.001 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.6 37.02 4.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.939 -0.648 . . . . 61.3 111.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.4 m -153.45 117.79 4.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.728 0.299 . . . . 74.15 110.486 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.04 145.3 32.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.325 -0.398 . . . . 45.13 110.887 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 1.06 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 5.1 p90 -68.55 145.63 53.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 72.31 111.644 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.41 145.33 48.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 64.25 110.436 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 49' ' ' GLU . 51.5 t -68.68 125.88 27.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.252 -0.431 . . . . 72.52 111.082 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -80.74 143.77 32.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 70.04 110.445 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 10.0 tmtt? -62.32 -63.91 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 65.4 111.129 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -74.0 -31.17 62.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.258 -0.428 . . . . 73.45 111.665 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 m -81.66 -28.04 33.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.859 0.361 . . . . 75.41 111.524 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.33 95.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.542 -0.837 . . . . 61.53 111.615 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.19 144.01 31.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.446 -0.205 . . . . 72.55 110.446 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HG3' HG22 ' A' ' 42' ' ' VAL . 2.6 mp0 -73.78 123.29 23.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.161 -0.472 . . . . 64.42 111.213 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.3 t -138.74 140.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.633 . . . . 71.05 109.662 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.06 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 14.5 p -136.84 148.43 26.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.301 . . . . 63.31 110.933 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.653 HG22 HG12 ' A' ' 61' ' ' VAL . 24.0 p -103.36 161.27 13.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.175 -0.466 . . . . 60.12 110.902 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.95 -161.28 30.66 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.133 -0.556 . . . . 73.1 111.799 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.607 ' HD2' ' HA ' ' A' ' 59' ' ' SER . 11.0 mmm180 -131.75 127.32 36.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.803 0.301 . . . . 73.02 110.201 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.086 HD22 ' HB ' ' A' ' 60' ' ' VAL . 1.6 pt? -121.78 119.03 30.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.578 . . . . 75.42 109.441 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . . . 58.45 10.16 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.767 -0.651 . . . . 71.24 112.667 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.07 -16.87 17.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.54 -0.838 . . . . 74.2 112.45 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' ' 3' ' ' GLU . 98.0 m -89.88 139.73 30.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.246 -0.279 . . . . 71.42 110.246 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 20.8 m -68.45 109.74 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.688 -0.486 . . . . 53.11 109.688 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.086 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -98.93 136.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.115 0.483 . . . . 64.22 111.058 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.653 HG12 HG22 ' A' ' 52' ' ' THR . 6.4 m -120.43 112.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.741 -0.663 . . . . 75.04 109.318 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD23 ' HB ' ' A' ' 7' ' ' VAL . 91.9 mt -91.91 109.58 20.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 70.41 109.629 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.7 129.3 51.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.02 -0.536 . . . . 74.41 110.964 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 3.4 ptmt -121.28 132.32 24.24 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.769 -0.65 . . . . 51.43 110.175 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 24.0 Cg_exo -64.34 155.88 63.17 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.46 2.107 . . . . 73.43 110.959 174.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 18.1 ptp180 -65.17 -59.74 3.77 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.927 -0.309 . . . . 63.32 110.958 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.494 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 5.0 p -169.44 152.31 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.896 -0.409 . . . . 55.42 109.896 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.2 t80 75.48 126.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.874 0.733 . . . . 74.41 111.393 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -60.81 -40.21 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.393 -0.821 . . . . 75.32 112.209 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.76 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 73.42 110.851 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 4.9 tm-20 -68.64 -38.15 80.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.872 -0.788 . . . . 72.42 108.872 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -64.66 -23.7 67.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.811 . . . . 61.4 111.237 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.09 -29.99 76.49 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.982 -0.554 . . . . 44.31 112.993 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 36.0 ptt180 -93.26 -1.9 55.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 73.32 110.585 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -93.93 -47.97 6.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.977 -0.556 . . . . 63.35 111.333 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.2 -33.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 32.31 112.051 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 -70.78 0.88 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.027 -0.606 . . . . 54.1 112.765 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.37 -29.19 88.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.885 2.39 . . . . 75.43 112.634 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.65 -49.0 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 73.05 111.467 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -62.98 -37.19 86.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 70.01 111.18 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -2.77 57.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.103 -0.498 . . . . 74.3 111.502 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.51 -33.12 70.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 75.23 110.265 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.505 ' OH ' ' HB2' ' A' ' 6' ' ' LEU . 42.6 p90 -109.05 18.69 20.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.714 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.5 m 57.84 69.72 0.71 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.382 -0.827 . . . . 70.01 112.692 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 80' ' ' ALA . 3.9 p -130.08 145.91 59.23 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.077 -0.249 . . . . 75.21 110.517 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.75 145.92 87.45 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.984 1.789 . . . . 74.34 109.406 163.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.27 83.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.811 2.341 . . . . 63.44 113.691 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -159.66 -173.7 4.26 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.198 0.999 . . . . 72.35 108.762 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.483 ' NE2' ' HB2' ' A' ' 3' ' ' GLU . 14.5 mm100 57.53 31.52 20.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.201 0.445 . . . . 72.12 112.201 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.5 tt -111.33 135.46 50.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.979 0.419 . . . . 73.42 110.636 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.18 122.9 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.629 . . . . 73.31 109.757 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.8 114.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.038 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 63.7 mt -100.1 121.76 51.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.078 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.624 ' CE1' ' HG2' ' A' ' 134' ' ' ARG . 6.1 p-80 -159.59 -176.25 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 75.32 111.1 -176.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.18 154.93 22.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.209 -0.905 . . . . 62.24 111.791 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 8.9 tp10 -133.88 126.4 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.366 -0.605 . . . . 73.52 109.366 167.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 137' ' ' VAL . 7.5 tt -82.97 -24.8 32.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 72.15 111.111 -172.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.93 4.38 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 70.21 111.342 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mm -111.15 140.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.506 -0.316 . . . . 62.01 110.689 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.1 136.35 35.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.801 -0.636 . . . . 74.33 112.179 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.636 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 72.5 t80 -63.08 128.91 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.744 . . . . 75.23 111.523 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 108.66 -14.21 35.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.626 -0.797 . . . . 53.42 113.415 172.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 69.7 mmt-85 -124.32 168.77 12.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.446 0.623 . . . . 72.32 110.83 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.46 133.38 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 75.01 111.373 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 10.6 tpp180 -113.56 127.73 56.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.79 -0.641 . . . . 74.22 109.388 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.48 153.3 18.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 74.23 111.026 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 112' ' ' GLU . 38.3 tptt -153.71 148.17 26.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.263 -0.643 . . . . 64.11 109.263 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.8 mp -123.59 -90.62 0.57 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.099 0.476 . . . . 73.45 111.141 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.51 106.08 2.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.177 -0.535 . . . . 54.14 112.413 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.44 151.25 5.4 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.91 -0.662 . . . . 72.44 111.734 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.63 78.33 1.61 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.963 -0.637 . . . . 53.23 111.675 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.441 ' H ' ' NH2' ' A' ' 132' ' ' ARG . 32.0 tt0 -120.79 122.39 40.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.093 -0.336 . . . . 75.43 110.093 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.587 ' HA2' ' OE1' ' A' ' 96' ' ' GLU . . . 152.03 134.89 2.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.383 -0.687 . . . . 71.15 111.383 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.84 2.69 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.555 -0.831 . . . . 71.22 114.258 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -152.82 140.85 20.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.444 0.622 . . . . 74.31 110.857 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -45.7 -55.29 6.64 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.624 0.972 . . . . 63.45 113.624 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.8 -41.18 19.76 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 114.793 0.677 . . . . 44.14 114.793 -166.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 132' ' ' ARG . 3.3 pp -67.0 -25.76 66.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.102 0.451 . . . . 75.04 111.8 -173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -39.57 26.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 74.24 110.238 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.8 m -67.1 -38.02 84.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 73.42 111.703 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.1 -33.34 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 75.5 111.058 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.78 -33.44 72.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 24.22 110.318 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -70.05 -21.86 63.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.613 -0.721 . . . . 74.34 110.775 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.39 -27.84 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 44.11 111.248 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -103.64 -41.43 5.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.083 -0.508 . . . . 74.33 110.695 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.02 -0.79 79.51 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.478 -0.649 . . . . 65.15 111.478 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.7 m -115.97 143.68 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.84 -0.43 . . . . 74.41 109.84 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -120.68 -161.93 0.92 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.297 -0.41 . . . . 72.34 109.9 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.52 18.86 2.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.658 0.742 . . . . 72.44 110.416 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 45.4 p90 -86.43 156.99 19.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.598 -0.728 . . . . 74.11 110.058 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -78.29 110.8 13.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 73.42 110.577 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 118' ' ' LEU . 32.0 ttp-105 -108.98 109.38 20.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.915 -0.584 . . . . 73.13 110.111 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 61.2 t -85.6 133.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.531 -0.758 . . . . 73.03 109.979 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.803 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 84.7 mtm180 -131.23 109.33 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.248 -0.433 . . . . 74.12 111.226 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.01 123.54 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 43.15 109.586 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.45 125.2 28.59 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.758 -0.734 . . . . 54.43 112.151 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 97' ' ' LEU . 24.4 m -88.73 -12.45 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.785 0.326 . . . . 63.42 111.089 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.636 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 138.14 -142.18 12.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.761 -0.733 . . . . 50.41 111.929 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 138' ' ' GLY . 12.0 mmm180 -131.8 149.55 73.73 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.166 -0.679 . . . . 75.44 109.166 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 52.1 Cg_exo -55.26 114.5 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.678 2.252 . . . . 73.53 112.157 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.2 Cg_endo -82.72 160.34 16.46 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.205 2.604 . . . . 63.43 112.508 -176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -18.71 9.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.928 -0.653 . . . . 53.11 112.245 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -87.14 -45.27 10.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.065 0.46 . . . . 71.1 110.52 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 32.7 pttt -119.65 144.02 47.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.648 -0.705 . . . . 73.42 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.62 139.64 89.44 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.751 -0.659 . . . . 62.25 110.868 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.09 -34.04 45.77 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.361 2.708 . . . . 50.31 113.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.6 61.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.099 0.476 . . . . 73.12 111.171 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.36 -18.78 29.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 54.33 110.454 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.426 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 63.9 t80 -69.32 -27.44 65.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 72.24 110.687 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.553 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.9 m -86.09 1.44 5.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.504 -0.316 . . . . 65.3 111.239 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 17' ' ' TYR . 79.5 mt -95.53 1.33 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.632 0.234 . . . . 74.43 111.632 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.18 150.44 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 74.1 110.312 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.769 ' HB3' HG22 ' A' ' 20' ' ' THR . 27.1 p-10 -129.44 30.01 5.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.508 . . . . 60.23 111.223 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -146.84 143.76 28.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.138 -0.319 . . . . 52.14 110.138 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.64 177.18 11.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.808 -1.182 . . . . 72.35 107.808 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.6 -72.41 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.416 0.553 . . . . 32.53 112.252 -173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.17 -46.91 5.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.334 0.588 . . . . 50.41 111.885 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 1.2 pm0 -67.91 -17.21 64.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 73.44 112.064 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -65.31 -25.24 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.677 0.275 . . . . 73.33 110.387 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.61 -17.12 54.55 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.273 -0.421 . . . . 75.23 111.592 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 165' ' ' ILE . 60.6 mt-10 -85.84 -20.38 29.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.102 -0.239 . . . . 75.31 110.912 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.73 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 58.8 t -52.17 -55.79 27.99 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.399 . . . . 62.33 112.079 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.73 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 34.9 Cg_exo -61.94 -23.91 76.37 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.103 1.869 . . . . 63.24 112.525 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.587 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 11.5 m -81.8 -46.05 14.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.44 . . . . 41.43 111.021 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.538 HG22 ' CZ3' ' A' ' 191' ' ' TRP . 40.2 pt -65.94 -30.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.377 -0.374 . . . . 74.02 111.936 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 162' ' ' VAL . 56.2 t -61.25 -48.26 89.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 61.34 110.623 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.73 -39.73 95.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 31.25 110.744 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 164' ' ' THR . 71.9 mm-40 -65.68 -41.85 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 63.21 110.5 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.9 80.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 61.45 110.686 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.73 88.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 71.32 110.474 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.55 -37.05 76.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 74.32 110.362 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.84 -30.33 70.77 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.151 -0.477 . . . . 64.24 111.091 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 63.0 m -62.48 -43.34 99.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 61.2 110.143 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 41.3 mt-10 -71.72 -28.95 64.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 60.5 109.996 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.8 tp -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 71.54 110.545 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 85.1 mt -65.42 -22.0 66.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.819 -0.628 . . . . 72.43 110.69 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 5' ' ' LEU . 3.3 mm -80.49 -49.68 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.841 -0.618 . . . . 70.42 111.421 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.36 -28.53 12.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.511 0.93 . . . . 51.43 113.511 -167.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -100.59 -77.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.462 -0.495 . . . . 65.51 111.964 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -131.65 134.56 7.73 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.923 -1.132 . . . . 62.12 113.338 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.1 -34.39 38.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.933 0.397 . . . . 73.05 109.953 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.622 ' HG2' ' HD3' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -120.92 -36.28 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.702 1.001 . . . . 74.24 113.702 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.622 ' HD3' ' HG2' ' A' ' 182' ' ' GLU . 84.5 Cg_endo -81.55 -5.03 12.47 Favored 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 121.177 1.456 . . . . 74.15 113.635 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 187' ' ' THR . . . -69.47 -31.72 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 72.34 111.33 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.2 pt20 -67.97 -19.43 64.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.682 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -56.11 -43.09 77.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.329 . . . . 74.22 111.121 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 184' ' ' ALA . 15.4 t -76.44 -19.38 58.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.685 0.279 . . . . 62.43 111.132 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.89 -40.44 52.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 74.21 110.917 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -84.19 1.39 44.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.927 -0.309 . . . . 72.22 111.255 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.35 -4.02 57.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.917 0.389 . . . . 63.4 110.873 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.538 ' CZ3' HG22 ' A' ' 165' ' ' ILE . 17.7 t90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.318 -0.849 . . . . 71.02 110.364 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.4 pt-20 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 121.051 0.453 . . . . 73.22 110.816 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 14.0 Cg_endo -92.31 113.56 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.623 2.882 . . . . 53.22 112.615 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.599 HD11 HG13 ' A' ' 177' ' ' ILE . 95.7 mt -72.21 114.9 10.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.543 -0.753 . . . . 74.34 110.689 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 85' ' ' VAL . 42.9 tp -93.68 104.66 16.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.008 -0.738 . . . . 70.43 109.008 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.637 ' HB ' HD23 ' A' ' 62' ' ' LEU . 47.9 t -109.94 123.79 66.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.334 -0.394 . . . . 62.45 110.175 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 57.8 t -110.13 114.82 48.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.668 . . . . 72.11 110.292 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.29 122.37 7.42 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.244 -0.742 . . . . 64.2 111.244 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.774 ' HG ' ' HE1' ' A' ' 22' ' ' HIS . 30.3 tp -85.92 82.73 8.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.363 0.601 . . . . 73.33 110.998 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -150.49 118.26 0.91 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.342 -0.845 . . . . 75.24 111.115 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.64 151.56 37.61 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.497 -0.186 . . . . 75.42 110.497 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.27 161.62 45.33 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.465 2.11 . . . . 74.31 112.464 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' HA3' ' HD1' ' A' ' 17' ' ' TYR . . . 148.75 142.74 3.67 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.852 -0.613 . . . . 61.21 111.782 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.33 -42.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.826 2.35 . . . . 64.02 112.216 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 20' ' ' THR . 8.0 p -90.76 -37.93 13.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.937 -0.574 . . . . 64.31 110.856 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HD1' ' HA3' ' A' ' 14' ' ' GLY . 84.9 m-85 -62.04 -35.09 77.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.896 -0.593 . . . . 73.22 112.281 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 -13.25 60.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 73.52 111.104 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -112.06 28.26 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 73.21 110.334 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.81 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 79.2 p -102.12 -176.39 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.841 -0.618 . . . . 72.33 110.906 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -86.41 -15.42 40.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.476 0.655 . . . . 73.42 109.503 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.774 ' HE1' ' HG ' ' A' ' 10' ' ' LEU . 14.8 t-80 -76.75 -22.25 54.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.145 -0.934 . . . . 74.14 110.405 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 27' ' ' MET . 65.7 t30 -73.78 -0.08 14.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.006 0.432 . . . . 73.51 111.266 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.39 -29.5 68.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.562 -0.29 . . . . 73.4 111.254 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.32 -30.71 78.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.926 -0.654 . . . . 72.51 112.49 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 67.2 t80 -90.36 -22.38 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.784 -0.244 . . . . 74.25 110.833 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' VAL . 26.2 mmt -50.49 -48.3 56.9 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.241 -0.436 . . . . 73.24 111.766 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.88 -46.86 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 64.11 110.803 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.31 82.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 51.54 111.388 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.4 -37.27 84.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.398 . . . . 74.33 111.04 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' MET . 62.6 t -65.51 -39.04 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.181 0.515 . . . . 71.21 109.852 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.85 -43.27 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.624 . . . . 75.34 110.698 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.22 90.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 72.0 110.906 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.49 91.26 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.982 -0.554 . . . . 72.14 112.878 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -70.13 -24.2 63.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.818 0.309 . . . . 73.14 111.206 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' A' ' 53' ' ' GLY . 82.7 mt -77.58 -49.77 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.409 -0.589 . . . . 73.42 109.409 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.99 62.19 1.07 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.84 -0.695 . . . . 52.54 112.425 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.4 m -156.3 144.62 19.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.919 0.39 . . . . 64.11 110.718 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.98 151.65 27.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 73.1 110.215 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.98 138.54 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.892 0.377 . . . . 73.33 110.672 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -101.36 126.6 48.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 75.53 110.043 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 t -78.1 129.75 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 74.13 110.301 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -68.79 102.71 1.6 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.622 -0.263 . . . . 61.5 110.776 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 58.7 tttm -64.11 88.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.121 -0.696 . . . . 74.23 109.121 172.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.8 tttp 174.22 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.928 -1.033 . . . . 74.53 109.021 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 p -125.15 -19.18 5.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.538 -0.755 . . . . 52.55 111.477 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.73 18.23 45.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 51.05 112.955 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.65 123.43 35.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.579 0.228 . . . . 74.33 110.654 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 2.2 mp0 -84.98 140.34 31.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 72.31 110.928 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 63' ' ' ALA . 97.6 t -139.4 137.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 73.42 110.404 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 6.9 p -118.91 145.49 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.709 -0.478 . . . . 74.44 109.709 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.54 HG23 HG12 ' A' ' 61' ' ' VAL . 1.6 m -116.71 142.59 46.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.232 -0.44 . . . . 63.53 111.637 -172.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -178.17 -161.53 26.39 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.173 -0.771 . . . . 60.01 111.173 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.97 ' HG2' ' HA ' ' A' ' 59' ' ' SER . 37.2 mtm180 -136.34 146.09 46.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.916 0.389 . . . . 72.0 110.684 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.59 103.05 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 73.54 109.698 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.19 -51.58 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.963 0.79 . . . . 75.54 111.713 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.21 -36.98 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.048 -0.821 . . . . 63.33 111.048 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 3' ' ' GLU . 4.1 m -68.58 151.56 46.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.439 0.295 . . . . 60.32 110.37 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.97 ' HA ' ' HG2' ' A' ' 54' ' ' ARG . 21.9 m -85.72 139.98 30.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.678 . . . . 70.31 109.171 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.35 132.1 52.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.368 0.604 . . . . 71.54 111.307 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.54 HG12 HG23 ' A' ' 52' ' ' THR . 8.3 m -117.68 115.5 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 42.41 109.333 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.637 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.7 mt -92.42 104.59 16.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.951 -0.568 . . . . 71.41 109.838 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -108.98 137.58 46.68 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 62.2 110.146 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -130.71 143.01 47.61 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 63.4 110.498 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.41 166.67 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.521 2.147 . . . . 64.43 111.635 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -84.8 -54.14 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.798 -0.361 . . . . 73.24 111.395 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.9 p -167.67 163.54 14.41 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.699 0.259 . . . . 71.21 111.699 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 69.41 163.81 0.24 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.976 0.797 . . . . 64.2 112.565 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.0 mmt -73.24 -56.61 4.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.922 -0.581 . . . . 72.23 110.946 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.08 -40.65 87.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.817 -0.629 . . . . 65.1 111.783 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 67' ' ' CYS . 42.7 mt-10 -59.84 -40.31 88.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.523 -0.308 . . . . 64.44 110.861 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -36.27 83.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.863 0.363 . . . . 64.21 110.53 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.88 -39.89 97.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.46 -0.656 . . . . 73.53 111.46 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.28 -0.54 19.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 75.13 110.726 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 23.0 mm-40 -103.53 -51.05 3.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 55.12 111.038 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.81 -34.69 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 70.15 111.31 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.32 -67.19 2.34 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.989 -0.55 . . . . 72.35 113.374 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.87 -27.6 59.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.692 2.261 . . . . 62.34 113.612 -177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 47.2 mt -57.5 -40.55 78.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.848 0.314 . . . . 73.24 111.848 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.73 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.022 0.439 . . . . 53.31 111.378 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.99 -7.41 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.354 -0.385 . . . . 73.13 111.235 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -79.12 -46.65 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.83 0.348 . . . . 73.02 110.128 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -93.03 1.45 57.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.148 -0.478 . . . . 73.44 111.232 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 60.46 37.57 19.74 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.686 0.617 . . . . 72.4 110.752 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.536 HG21 HD22 ' A' ' 6' ' ' LEU . 27.5 m -92.15 142.98 26.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.81 -0.632 . . . . 64.34 110.466 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.832 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 4.1 Cg_exo -77.0 133.9 14.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.68 2.253 . . . . 70.13 111.81 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.555 ' O ' HG22 ' A' ' 90' ' ' ILE . 36.2 Cg_endo -66.0 -4.56 10.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.974 2.45 . . . . 74.4 112.587 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.832 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.9 pt20 -71.62 -20.38 61.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.105 -0.498 . . . . 75.3 110.598 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.762 ' HG3' ' HG3' ' A' ' 88' ' ' GLN . 97.9 mt-30 -124.43 24.52 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.083 -0.508 . . . . 74.22 111.655 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 87' ' ' PRO . 13.1 tt -86.93 105.5 15.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.757 0.789 . . . . 74.5 110.176 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.77 113.38 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.369 -0.832 . . . . 72.24 110.631 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.62 114.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.408 -0.36 . . . . 72.0 110.157 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.507 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 58.3 mt -101.26 120.16 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.913 -0.585 . . . . 74.41 109.776 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.41 ' CE1' HD22 ' A' ' 118' ' ' LEU . 32.1 p80 -142.01 174.9 10.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.966 0.413 . . . . 72.22 111.349 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.21 148.28 26.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.219 -0.901 . . . . 54.34 109.529 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.695 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -139.5 128.85 24.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.079 0.466 . . . . 73.53 110.389 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.55 -33.93 25.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.68 -0.691 . . . . 73.35 111.681 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.53 -38.49 26.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 50.43 111.392 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.613 HG12 ' OE1' ' A' ' 96' ' ' GLU . 37.9 mm -65.58 143.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 43.1 111.628 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 12.1 m-20 -57.07 139.59 51.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.602 -0.726 . . . . 73.15 111.218 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.735 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 80.3 t80 -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 74.43 111.683 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 92.26 -24.38 22.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.656 -0.702 . . . . 62.44 112.825 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -90.92 130.92 36.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.145 0.498 . . . . 61.42 110.842 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 104' ' ' ILE . 3.7 mp -92.42 114.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.947 -0.76 . . . . 73.22 108.947 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -107.48 125.19 50.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 75.32 110.254 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.3 mt -103.89 135.19 45.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.616 -0.72 . . . . 74.15 110.526 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.26 156.54 45.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.944 -0.762 . . . . 74.12 108.944 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.37 -132.4 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.463 -0.569 . . . . 73.11 109.463 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.494 ' N ' ' HA ' ' A' ' 129' ' ' ASN . . . 49.34 -153.01 2.92 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.423 -0.418 . . . . 71.32 112.759 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.35 173.29 27.29 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.778 -0.929 . . . . 74.01 110.778 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 119' ' ' ARG . . . -83.55 85.49 1.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.146 -1.026 . . . . 64.32 111.922 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 -43.01 11.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.635 0.255 . . . . 72.11 111.268 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.84 109.23 2.87 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.146 -0.55 . . . . 75.43 112.343 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.48 -100.85 0.2 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.057 -0.592 . . . . 72.45 111.969 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -164.17 173.99 11.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.585 0.231 . . . . 74.13 111.322 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -40.21 -56.17 1.99 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.129 1.159 . . . . 74.2 114.129 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.44 -29.25 72.82 Favored Glycine 0 CA--C 1.509 -0.283 0 C-N-CA 121.233 -0.508 . . . . 61.11 112.476 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 23.5 tp -65.83 -38.67 89.53 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.426 -0.387 . . . . 54.44 110.68 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 111' ' ' GLY . 1.7 mpp_? -79.65 -23.25 42.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.76 -0.376 . . . . 70.13 110.625 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -66.95 -44.81 79.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 60.21 110.603 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.2 m -69.3 -27.77 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 72.43 110.798 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.16 -43.57 61.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.524 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -70.28 -25.52 63.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 65.13 111.589 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.68 92.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 31.43 110.643 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.52 -42.07 20.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.855 -0.611 . . . . 71.22 110.336 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.08 1.81 88.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.935 -0.65 . . . . 60.54 111.757 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.644 HG22 ' HE1' ' A' ' 130' ' ' PHE . 4.8 m -111.5 122.66 48.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.931 0.396 . . . . 72.12 110.308 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 53.7 mtmt -126.63 178.83 5.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.453 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.494 ' HA ' ' N ' ' A' ' 109' ' ' GLY . 22.8 m-20 75.35 67.71 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.862 0.726 . . . . 74.33 112.112 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.644 ' HE1' HG22 ' A' ' 127' ' ' THR . 60.5 m-85 -142.99 -87.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 74.11 111.337 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.488 ' C ' ' HD2' ' A' ' 132' ' ' ARG . 12.7 t60 -161.88 104.97 1.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.635 0.255 . . . . 34.01 110.644 -174.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.488 ' HD2' ' C ' ' A' ' 131' ' ' HIS . 2.6 mpt_? -114.27 141.03 48.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.529 0.204 . . . . 70.24 110.549 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 93.5 t -104.19 118.23 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 72.01 111.047 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.695 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 35.6 mtp180 -112.41 104.67 12.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.061 -0.518 . . . . 71.55 110.254 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.3 mt -85.81 115.09 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.85 -0.426 . . . . 63.43 109.85 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.31 118.77 11.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.902 -0.666 . . . . 73.05 112.651 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.52 -11.51 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 70.21 110.086 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 136.9 -77.55 0.34 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 73.52 113.326 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -170.73 165.6 5.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.983 -0.377 . . . . 72.03 109.983 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 53.1 Cg_exo -53.85 142.1 64.25 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.474 2.116 . . . . 73.34 111.279 171.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 25.3 Cg_exo -61.72 -66.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 123.027 2.485 . . . . 43.14 113.327 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.7 -69.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.589 -0.815 . . . . 51.12 112.438 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 143' ' ' ARG . 10.5 mmt180 -82.01 -70.07 0.57 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.85 0.357 . . . . 74.2 110.778 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.571 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -80.89 159.99 24.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 73.33 110.486 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.748 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 2.5 p30 -79.76 166.39 41.21 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.548 -0.296 . . . . 74.44 110.776 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.748 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 10.9 Cg_endo -53.79 -36.0 80.98 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.371 2.714 . . . . 35.52 113.986 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.15 77.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 72.44 110.603 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.91 -31.87 59.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.083 -0.508 . . . . 51.43 110.216 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.571 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 88.9 t80 -64.5 -42.81 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.567 -0.742 . . . . 71.23 111.321 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.81 ' O ' ' HB ' ' A' ' 20' ' ' THR . 34.9 m -83.28 -9.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.915 -0.314 . . . . 65.14 111.167 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 20' ' ' THR . 49.5 tp -83.75 -25.63 30.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.104 0.478 . . . . 74.24 111.136 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.04 176.68 8.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.962 0.41 . . . . 65.23 110.616 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -81.26 171.97 14.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 72.42 110.662 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 40.3 m-85 -65.44 145.13 56.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 73.34 110.097 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -68.92 162.2 27.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.284 -0.265 . . . . 73.4 110.284 -178.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.92 9.52 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.033 0.753 . . . . 65.21 113.033 -162.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.74 88.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.012 0.434 . . . . 62.33 112.13 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.572 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 2.2 pm0 -89.34 -16.58 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.077 -0.511 . . . . 74.5 111.655 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 155' ' ' THR . 60.2 ttt180 -61.04 -25.09 66.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 74.44 111.424 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.33 -14.4 62.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.283 -0.417 . . . . 75.01 111.919 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -111.4 5.97 20.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.742 0.306 . . . . 73.31 111.245 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 159' ' ' ARG . 94.8 t -63.82 -52.73 55.41 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.449 -0.341 . . . . 51.12 111.746 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 11.3 Cg_endo -55.53 -33.79 87.63 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.927 1.752 . . . . 70.14 111.873 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.7 m -65.95 -49.46 67.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.625 -0.716 . . . . 51.35 111.178 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 162' ' ' VAL . 35.3 pt -67.89 -30.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.431 -0.35 . . . . 72.33 111.42 -175.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.4 t -63.9 -45.47 96.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.402 . . . . 64.11 110.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -67.86 -37.6 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 71.24 110.812 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -63.65 -44.31 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 53.13 110.896 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.95 98.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 70.05 111.219 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.24 96.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.253 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.84 -44.14 86.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 73.03 110.522 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -64.3 -37.96 89.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 60.44 111.664 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 87.3 m -58.32 -40.36 81.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.865 0.364 . . . . 44.23 111.045 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.13 -40.03 90.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 71.33 110.235 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.55 -37.34 87.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 72.43 110.885 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 87.1 mt -60.18 -42.86 95.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 74.5 111.868 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.599 HG13 HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.87 -27.28 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 70.24 110.382 -176.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -83.96 -58.28 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.216 -0.447 . . . . 54.44 111.841 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -24.98 35.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 71.51 111.439 -175.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 113.89 -161.13 12.81 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.641 -0.79 . . . . 75.21 112.112 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.64 -68.8 0.68 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.741 0.305 . . . . 65.13 110.847 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.641 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.6 tt0 -55.02 -55.3 40.48 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.155 0.798 . . . . 75.12 113.155 -172.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 23.1 Cg_exo -65.16 -31.06 54.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.15 1.9 . . . . 64.35 113.087 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.43 -48.71 7.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.504 0.557 . . . . 72.51 112.504 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -20.23 65.7 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 121.216 -0.193 . . . . 74.22 111.51 -174.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -53.54 -51.08 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.415 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -72.28 -21.62 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 71.32 111.266 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.8 t -70.11 -24.2 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 73.53 111.283 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -116.91 13.38 14.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.882 0.372 . . . . 72.03 110.388 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.11 27.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.092 -0.503 . . . . 71.1 111.092 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.417 ' HH2' HG22 ' A' ' 165' ' ' ILE . 15.1 p-90 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.301 -0.857 . . . . 73.22 110.912 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 14.3 pt-20 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.252 0.548 . . . . 72.33 110.414 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 1.3 Cg_endo -83.71 110.19 1.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.805 2.337 . . . . 73.42 112.113 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 89' ' ' GLN . 36.7 tp -74.32 118.35 17.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 75.04 109.846 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HA ' HG23 ' A' ' 61' ' ' VAL . 69.8 tp -92.8 104.96 17.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.18 -0.464 . . . . 75.04 110.128 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HB ' HD23 ' A' ' 62' ' ' LEU . 44.9 t -105.58 121.27 57.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.246 -0.434 . . . . 72.33 110.408 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.95 114.87 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.754 -0.657 . . . . 74.23 109.902 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.85 123.15 6.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.846 -0.692 . . . . 73.33 111.846 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 96.16 1.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.846 0.355 . . . . 73.23 110.199 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -111.93 85.68 0.4 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.783 -0.723 . . . . 61.2 112.993 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 28.0 m-80 -100.89 117.75 61.91 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.995 -0.372 . . . . 71.03 109.995 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 3.0 Cg_exo -75.49 177.79 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.155 2.57 . . . . 74.13 112.369 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 17' ' ' TYR . . . 155.5 179.05 30.32 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.04 -0.6 . . . . 70.33 111.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.09 -71.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.885 2.39 . . . . 74.34 111.559 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.612 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 15.1 t -117.33 6.26 12.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.815 -0.809 . . . . 71.42 108.815 172.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.2 t80 -69.19 -26.09 64.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.778 -1.101 . . . . 75.22 110.313 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . . . -87.48 1.6 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 61.05 110.983 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -120.72 3.18 10.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.435 -178.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.832 ' HA ' ' HB3' ' A' ' 153' ' ' ASN . 14.9 t -103.7 -177.66 3.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.918 0.39 . . . . 73.13 111.875 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.614 ' HD3' HG13 ' A' ' 137' ' ' VAL . 61.6 mtt180 -64.92 -20.72 66.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.0 -0.546 . . . . 74.4 111.63 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.576 ' H ' HG23 ' A' ' 20' ' ' THR . 5.9 t60 -78.78 -7.99 58.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.972 0.415 . . . . 71.04 110.576 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.26 8.22 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 72.12 110.43 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 75.0 mt -55.74 -29.8 60.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.511 -0.313 . . . . 75.12 111.67 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.56 -33.05 86.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 72.03 112.462 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.642 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 87.5 t80 -88.36 -30.7 19.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.544 0.212 . . . . 72.44 110.718 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mmm -50.19 -42.89 52.12 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 62.24 111.993 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 t -69.53 -47.15 73.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.345 . . . . 75.43 110.789 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.57 74.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.29 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.3 -45.43 91.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 74.42 110.9 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.8 t -72.85 -36.82 53.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.592 . . . . 72.35 110.503 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.03 -44.99 96.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 61.44 110.876 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.83 80.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 55.3 110.554 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.59 95.21 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.866 -0.606 . . . . 74.42 112.832 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -21.57 54.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 117.044 0.422 . . . . 74.51 111.314 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.515 HD13 ' HA3' ' A' ' 53' ' ' GLY . 80.6 mt -77.84 -43.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.585 -0.524 . . . . 73.31 109.585 173.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.04 33.81 5.89 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.868 -0.682 . . . . 75.32 111.942 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -145.66 135.32 23.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.746 0.308 . . . . 64.11 110.253 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 148.44 24.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.287 -0.415 . . . . 74.3 110.693 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.781 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 11.1 p90 -66.31 124.72 23.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.61 . . . . 64.04 110.638 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 13.0 ptpt -101.1 143.88 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.608 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.629 HG22 ' HG2' ' A' ' 49' ' ' GLU . 19.7 t -81.69 135.55 24.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 72.2 111.584 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.36 104.51 16.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.932 -0.577 . . . . 72.53 109.97 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.48 90.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.9 -0.408 . . . . 75.11 109.9 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.5 tptt 174.34 -58.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.251 -0.886 . . . . 73.13 108.695 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -106.76 -14.33 15.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.345 -0.843 . . . . 74.12 110.519 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 83.76 3.9 89.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.943 -0.646 . . . . 21.13 112.348 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.38 144.29 28.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.821 0.344 . . . . 55.32 110.746 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.2 mt-10 -108.56 122.16 46.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.944 -0.571 . . . . 63.11 109.637 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -129.15 137.56 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.441 -0.345 . . . . 71.33 110.476 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.781 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 5.0 p -121.47 135.63 61.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.934 0.397 . . . . 75.4 110.2 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.784 HG22 HG12 ' A' ' 61' ' ' VAL . 11.9 p -106.71 136.58 46.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.132 -0.485 . . . . 70.31 110.982 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.515 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -160.7 -161.14 11.22 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.473 -0.87 . . . . 42.3 112.576 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 13.2 mmt180 -121.59 142.41 50.13 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 73.5 110.088 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.134 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -126.9 115.77 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.726 -0.842 . . . . 74.22 108.726 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.6 -36.83 0.31 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.706 -0.679 . . . . 62.52 111.305 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 165.88 -33.15 0.23 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.852 -0.899 . . . . 72.24 110.852 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 59' ' ' SER . 1.7 m -75.37 169.24 18.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.372 -0.414 . . . . 73.44 110.759 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . 2.9 m -79.78 131.46 35.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.753 0.311 . . . . 74.04 111.383 -175.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.134 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -127.06 137.42 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.94 -0.392 . . . . 74.23 109.94 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.784 HG12 HG22 ' A' ' 52' ' ' THR . 12.4 m -120.25 115.4 47.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.209 0.528 . . . . 74.4 110.532 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 61.9 mt -96.79 105.0 17.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 74.23 109.586 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.2 127.58 55.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.979 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 6.4 ptmt -119.15 126.69 26.91 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.221 -0.445 . . . . 73.33 110.393 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.761 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 39.6 Cg_exo -61.53 149.74 88.4 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.398 2.065 . . . . 65.1 110.619 173.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 25.7 ptt180 -64.55 -53.42 48.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 75.11 111.13 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 29.1 p -168.57 174.69 6.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.422 -0.214 . . . . 54.11 110.422 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.538 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 9.9 t80 75.27 138.27 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.047 0.842 . . . . 74.1 112.316 167.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.97 -52.69 62.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 61.45 111.322 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.56 -36.65 76.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.04 111.17 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 6.4 mt-10 -60.31 -43.55 96.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.705 -0.225 . . . . 64.15 110.821 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -54.87 -32.42 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.372 0.42 . . . . 63.12 111.341 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.799 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -67.47 -39.21 91.27 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.895 -0.669 . . . . 61.21 112.118 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' NH2' ' HG2' ' A' ' 71' ' ' GLU . 20.1 ptt180 -91.09 2.75 56.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 73.22 110.681 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.761 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 24.6 mm-40 -81.23 -51.89 7.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 74.23 110.22 174.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.17 -44.77 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.757 -0.656 . . . . 63.31 112.29 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.79 -66.23 2.7 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.135 -0.484 . . . . 75.42 113.674 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 -41.43 78.87 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.867 2.378 . . . . 71.1 113.0 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.03 -39.54 95.05 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.768 0.284 . . . . 63.31 111.768 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.38 91.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.0 0.428 . . . . 61.43 111.163 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.9 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.172 -0.467 . . . . 71.3 111.068 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.88 -42.12 97.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 71.2 109.696 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -82.16 -15.28 53.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.723 -0.671 . . . . 73.23 110.621 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m 62.37 34.68 15.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.762 -0.653 . . . . 53.12 110.515 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.4 m -100.29 143.99 27.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.757 -0.656 . . . . 62.24 110.635 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 10.5 Cg_exo -71.2 115.62 4.35 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.733 2.289 . . . . 64.1 111.574 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.39 33.28 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.185 2.59 . . . . 73.14 113.4 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -78.65 -48.75 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.339 -0.615 . . . . 74.43 109.339 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.537 ' HB3' HD12 ' A' ' 5' ' ' LEU . 1.8 mp0 -88.86 68.59 8.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.751 -0.659 . . . . 71.23 109.812 175.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.17 138.03 31.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.54 -0.755 . . . . 72.33 110.388 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.1 t -127.75 109.88 20.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 73.33 110.067 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.59 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 58.5 t -105.78 113.43 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.702 -0.481 . . . . 65.22 109.702 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 58.2 mt -93.46 122.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.062 -0.517 . . . . 75.01 110.396 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.424 ' HE1' ' CB ' ' A' ' 115' ' ' HIS . 16.7 t-80 -149.02 162.89 39.01 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.643 -0.423 . . . . 74.24 112.129 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 8.8 p-10 -90.34 139.28 30.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.465 -0.789 . . . . 53.41 110.314 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.848 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 75.8 mm-40 -137.23 140.38 41.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.911 0.386 . . . . 70.13 111.734 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.47 HD23 ' HB ' ' A' ' 137' ' ' VAL . 95.1 mt -84.22 -25.6 29.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.819 -0.628 . . . . 74.4 112.039 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.2 -34.47 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.468 0.651 . . . . 61.55 110.542 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.696 ' HB ' ' HA2' ' A' ' 136' ' ' GLY . 9.2 mt -84.64 139.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.473 -0.785 . . . . 71.4 109.999 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -67.08 144.77 55.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.883 -0.414 . . . . 72.33 109.883 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 65.7 t80 -63.37 124.4 21.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.773 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.88 -21.11 8.0 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.059 -1.067 . . . . 45.33 113.469 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -123.69 169.11 11.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.541 0.671 . . . . 62.42 111.234 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.619 HG12 HG13 ' A' ' 135' ' ' ILE . 65.9 mt -118.65 139.38 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.918 -0.583 . . . . 70.02 110.745 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 25.6 tpt180 -111.98 124.15 51.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.049 176.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.2 mt -108.21 127.25 53.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 61.35 110.181 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -154.8 151.03 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.49 -0.559 . . . . 71.05 109.49 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.888 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 1.3 pt? -67.3 -71.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 74.14 111.668 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.888 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -153.75 155.31 26.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.724 -0.55 . . . . 63.22 111.724 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.41 176.56 18.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.947 -0.644 . . . . 72.2 111.691 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.0 77.45 2.11 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.73 -0.748 . . . . 73.5 111.899 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -129.83 21.31 5.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.709 0.766 . . . . 73.35 109.341 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -145.78 95.42 0.17 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.457 -0.792 . . . . 62.43 112.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.99 67.5 3.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 62.02 112.112 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 96' ' ' GLU . 33.0 m80 -139.19 146.04 40.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 71.34 111.008 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.66 -55.15 38.77 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.642 -0.708 . . . . 75.44 111.95 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.72 -28.84 70.22 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.853 -0.612 . . . . 64.21 112.081 -168.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 74.43 110.127 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.98 -27.24 60.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.794 -0.639 . . . . 74.12 110.139 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.2 m -66.69 -52.17 47.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 73.5 110.766 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.799 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -66.33 -30.65 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.737 0.303 . . . . 62.4 110.84 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.02 71.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.32 111.138 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.4 m -84.62 -35.58 22.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 62.5 111.101 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.5 . . . . 63.1 111.269 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 -42.43 12.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.205 0.526 . . . . 74.23 110.076 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.13 -13.38 32.69 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.732 -0.667 . . . . 62.12 112.879 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 p -114.01 122.93 48.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.408 0.623 . . . . 72.13 111.624 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.6 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 4.5 mptt -99.75 -91.7 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.79 -1.189 . . . . 74.13 107.79 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 55.07 7.97 0.21 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.854 1.798 . . . . 73.35 115.854 162.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.31 -90.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.955 0.798 . . . . 72.44 111.923 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -175.92 135.38 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 63.31 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.59 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 10.5 mpt_? -121.49 124.53 44.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.083 -0.508 . . . . 71.41 110.056 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 59.1 t -83.9 104.07 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.688 -0.486 . . . . 64.22 109.688 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.848 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 49.1 mtm-85 -122.64 127.6 49.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.883 0.373 . . . . 61.33 110.53 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.619 HG13 HG12 ' A' ' 104' ' ' ILE . 3.8 mp -94.28 139.9 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.567 -0.742 . . . . 72.04 109.859 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.696 ' HA2' ' HB ' ' A' ' 99' ' ' ILE . . . -72.61 129.66 14.13 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.868 -0.682 . . . . 61.44 112.646 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.614 HG13 ' HD3' ' A' ' 21' ' ' ARG . 27.3 t -95.92 -11.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.316 0.579 . . . . 62.33 109.972 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.14 166.52 26.83 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.676 -0.773 . . . . 60.32 111.849 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.42 146.56 50.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.172 -0.307 . . . . 72.5 110.172 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.63 120.59 7.74 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.012 2.475 . . . . 64.13 113.122 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.91 158.94 40.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.239 2.626 . . . . 71.21 112.558 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.25 -24.66 6.73 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.855 -0.688 . . . . 53.22 112.805 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -83.82 -70.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.711 0.255 . . . . 73.45 110.738 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.59 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -89.29 157.11 18.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.465 -0.494 . . . . 75.2 110.594 178.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.28 133.0 92.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 64.15 111.738 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.56 -29.04 88.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.252 2.635 . . . . 61.32 113.06 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.463 . . . . 41.21 109.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' GLU . . . -69.36 -28.65 66.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.61 -0.723 . . . . 64.23 109.975 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.59 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 87.0 t80 -65.13 -29.59 70.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 74.31 110.809 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.3 -23.22 10.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 75.13 110.343 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.35 -26.01 30.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 63.24 111.081 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.545 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 8.9 pt-20 -87.31 153.28 21.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 74.15 110.501 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.832 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 34.9 p-10 -132.77 14.18 4.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 63.2 110.908 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -107.03 156.08 19.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 54.12 110.304 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -169.83 178.37 4.06 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.716 -1.216 . . . . 71.54 107.716 175.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.93 -72.95 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.234 -0.586 . . . . 72.03 111.074 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.57 -24.02 16.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.465 0.65 . . . . 73.42 110.194 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.538 ' HB2' ' CB ' ' A' ' 155' ' ' THR . 22.3 mp0 -68.6 -36.83 79.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.316 -0.856 . . . . 75.32 110.556 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 7.7 tpt180 -68.1 -17.61 64.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 72.33 110.501 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.07 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 73.41 110.919 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 165' ' ' ILE . 34.8 mt-10 -89.7 -5.42 57.06 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.179 -0.208 . . . . 70.44 111.534 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.679 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 85.2 t -56.32 -51.8 78.08 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.667 0.247 . . . . 73.22 111.667 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 23.9 Cg_exo -64.97 -29.52 57.44 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.761 1.64 . . . . 64.22 111.984 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.1 m -73.59 -40.25 64.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.761 -0.654 . . . . 75.4 111.83 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 135' ' ' ILE . 34.8 pt -64.93 -30.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 121.031 -0.268 . . . . 65.31 110.969 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.01 -39.34 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.418 . . . . 72.12 109.98 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 163' ' ' PRO . 8.8 mm-40 -58.59 -50.62 73.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.697 -0.683 . . . . 71.21 110.413 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.99 -32.88 72.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.745 -0.661 . . . . 74.44 111.232 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.39 78.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 73.45 110.606 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.86 95.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.154 -0.475 . . . . 63.11 110.497 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.99 -50.06 75.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 65.4 110.961 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.85 -44.97 96.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 72.54 111.702 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.5 m -56.32 -42.78 78.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 61.21 111.359 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.84 -29.45 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 61.23 110.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.11 -28.62 66.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 74.24 110.472 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.2 mt -60.04 -47.34 86.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.862 -0.608 . . . . 75.42 111.084 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 177' ' ' ILE . 0.0 OUTLIER -79.92 -37.37 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.545 . . . . 74.32 110.832 -175.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -77.79 -54.51 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.83 0.307 . . . . 44.43 111.83 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -94.34 -57.28 2.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.404 -0.362 . . . . 62.22 110.632 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 159.77 151.74 6.26 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.744 -0.741 . . . . 64.31 111.848 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 176' ' ' LEU . 4.0 pp -71.92 -24.55 61.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.841 0.353 . . . . 60.41 111.546 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.468 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 30.0 tt0 -82.9 -51.96 0.67 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.387 -0.369 . . . . 73.45 111.612 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 17.2 Cg_endo -59.9 -35.9 92.21 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.058 1.839 . . . . 70.2 112.168 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.434 ' HB3' HD23 ' A' ' 176' ' ' LEU . . . -64.14 -45.32 89.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.349 . . . . 72.11 110.331 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -54.72 -49.78 69.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.738 -0.664 . . . . 62.34 110.783 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 189' ' ' HIS . 57.8 t30 -57.69 -35.93 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 74.5 110.861 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.2 m -70.69 -54.24 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 64.3 110.992 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.3 t -67.83 -43.32 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.61 0.596 . . . . 74.24 112.61 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 186' ' ' ASN . 1.3 p80 -76.09 -3.81 38.03 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.667 -0.413 . . . . 63.33 111.39 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.98 22.08 8.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.096 0.474 . . . . 62.23 110.429 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.8 t90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.404 -0.808 . . . . 63.22 110.354 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.519 -0.549 . . . . 74.14 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.872 ' HB2' HG12 ' A' ' 85' ' ' VAL . 5.6 Cg_endo -87.8 118.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.77 2.314 . . . . 74.05 112.617 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.6 tp -88.0 121.14 30.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 72.04 109.651 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 90' ' ' ILE . 61.1 tp -92.87 117.5 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.969 -0.382 . . . . 64.1 109.969 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.76 ' HB ' HD23 ' A' ' 62' ' ' LEU . 46.4 t -113.53 118.06 57.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.655 -0.498 . . . . 62.43 109.655 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.53 114.96 45.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.886 -0.597 . . . . 65.02 109.97 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.516 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -105.9 122.17 7.02 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.568 -0.825 . . . . 70.02 111.674 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.79 89.59 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 75.2 110.711 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.843 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -142.75 110.55 0.62 Allowed Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.488 -0.778 . . . . 75.35 111.4 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.39 149.96 47.98 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.531 0.205 . . . . 70.01 110.664 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.691 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 73.7 Cg_endo -74.39 175.91 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.454 2.102 . . . . 60.12 111.791 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 17' ' ' TYR . . . 121.34 136.79 5.11 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.423 -0.894 . . . . 61.32 112.1 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.68 -28.7 82.73 Favored 'Trans proline' 0 C--O 1.225 -0.147 0 C-N-CA 123.159 2.573 . . . . 70.33 112.988 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 t -113.08 16.35 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 51.01 111.062 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' ' HA3' ' A' ' 14' ' ' GLY . 75.5 m-85 -106.28 -34.87 7.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 64.44 111.611 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.14 -4.5 25.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.247 0.832 . . . . 74.44 113.247 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -124.42 27.78 6.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.127 0.489 . . . . 72.51 110.753 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 69.5 p -102.5 -170.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.738 -0.665 . . . . 63.44 110.087 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 55.0 mtt180 -84.52 -0.73 54.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.986 0.422 . . . . 61.14 110.459 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -105.21 19.49 20.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 72.14 110.683 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -99.08 3.31 46.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.377 -0.374 . . . . 74.14 110.596 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.427 HD11 HG12 ' A' ' 137' ' ' VAL . 91.1 mt -55.67 -42.76 75.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.781 -0.645 . . . . 71.11 112.064 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.38 -37.75 94.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.65 -0.786 . . . . 25.3 112.004 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.843 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 75.4 t80 -73.21 -32.77 64.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.263 -0.273 . . . . 62.42 110.263 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.564 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 9.0 mmt -54.21 -54.02 45.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 74.32 111.692 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.95 -45.04 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 63.45 110.919 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.64 95.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 63.43 111.117 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.93 -42.27 97.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 62.11 110.978 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' MET . 90.4 t -61.88 -44.18 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.31 110.585 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.38 -40.9 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 73.34 110.8 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.24 86.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.942 0.401 . . . . 74.5 110.532 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.9 -42.51 85.74 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.769 -0.65 . . . . 71.04 113.01 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.3 ptm180 -68.05 -31.32 70.89 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.984 0.392 . . . . 65.23 111.371 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 63.11 109.945 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.31 43.29 4.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.95 -0.643 . . . . 72.41 112.265 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -129.56 158.62 38.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.671 0.272 . . . . 73.04 110.595 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.91 165.33 11.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 73.44 109.496 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.439 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 35.4 p90 -80.38 143.84 33.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.204 0.526 . . . . 73.34 111.339 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -106.44 133.46 51.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 73.23 109.336 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.57 124.23 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.348 . . . . 75.41 110.661 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -71.53 104.86 3.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.94 -0.573 . . . . 72.1 110.302 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 1.3 tmmt? -73.79 83.79 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.583 . . . . 64.43 109.734 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 170.84 -48.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.673 -1.148 . . . . 74.33 109.151 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -104.45 -28.43 11.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.465 -0.789 . . . . 74.13 110.702 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.2 9.49 73.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.852 -0.69 . . . . 75.4 111.475 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.29 134.23 34.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 34.53 111.131 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 8.8 mt-10 -91.67 131.95 36.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.793 -0.64 . . . . 71.03 110.291 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.31 137.15 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 73.51 110.494 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 62' ' ' LEU . 3.8 p -126.99 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.746 -0.464 . . . . 53.54 109.746 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.783 HG22 HG12 ' A' ' 61' ' ' VAL . 24.4 p -108.8 151.32 26.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 73.2 111.944 -173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.31 -161.81 20.37 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.752 -0.658 . . . . 65.1 111.612 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 20.3 mmt180 -133.15 139.17 46.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.751 -0.462 . . . . 52.41 109.751 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.07 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -130.18 116.7 18.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.659 0.266 . . . . 62.34 110.295 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 68.5 -27.96 0.15 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.672 0.789 . . . . 74.13 112.594 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 156.69 -30.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.537 -1.025 . . . . 72.4 110.537 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -79.36 157.22 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.674 -0.763 . . . . 73.32 109.785 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.678 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 14.0 t -83.21 136.09 34.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.332 -0.618 . . . . 74.34 109.332 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.07 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.9 p -117.43 124.23 72.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.211 0.529 . . . . 74.21 110.672 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 52' ' ' THR . 8.9 m -113.04 111.78 37.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.322 0.582 . . . . 72.04 109.71 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.76 HD23 ' HB ' ' A' ' 7' ' ' VAL . 54.7 mt -92.79 115.81 28.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.585 -0.734 . . . . 61.12 110.47 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.5 147.62 41.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 74.24 110.218 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 17.0 ptmt -132.96 131.78 22.1 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.336 -0.393 . . . . 61.24 111.081 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 12.4 Cg_endo -57.37 136.11 74.14 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.915 2.41 . . . . 53.24 111.187 172.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.691 ' HD2' ' HG3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -92.61 -59.96 1.94 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.82 -0.352 . . . . 51.33 111.512 -172.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.4 p -156.92 145.12 19.49 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.12 -0.232 . . . . 75.23 110.981 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.641 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 35.7 t80 66.43 115.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 124.177 0.923 . . . . 62.3 111.09 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.574 ' HG2' ' HB3' ' A' ' 116' ' ' ASN . 1.9 mpt? -51.71 -56.27 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.312 -0.858 . . . . 71.13 111.94 -174.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.641 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 47.9 t30 -55.26 -49.71 71.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.246 -0.434 . . . . 72.15 111.136 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 mm-40 -59.52 -49.9 76.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 63.25 111.127 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 76' ' ' VAL . 50.7 m -60.48 -40.78 92.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.322 -0.399 . . . . 75.24 111.142 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.53 -43.33 97.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.902 -0.665 . . . . 55.32 112.048 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -69.82 -32.95 71.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.752 0.31 . . . . 74.34 110.521 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 81.2 mm-40 -65.15 -28.28 69.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.919 -0.582 . . . . 70.14 111.858 -177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 72' ' ' SER . 55.6 t -65.66 -31.12 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 72.51 110.847 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.31 -69.62 1.21 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.962 -0.563 . . . . 72.43 112.993 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.91 -36.32 95.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.916 2.411 . . . . 73.35 112.77 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.52 -39.01 89.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 35.54 110.262 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.21 90.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 60.01 111.258 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -18.99 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.399 -0.364 . . . . 74.44 111.101 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.43 -37.32 80.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.357 -0.383 . . . . 71.4 110.548 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -101.53 4.17 40.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 74.42 111.321 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 m 63.44 31.93 14.71 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.888 -0.596 . . . . 71.53 111.546 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.872 HG12 ' HB2' ' A' ' 4' ' ' PRO . 16.7 m -81.78 143.35 50.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.383 . . . . 62.44 110.584 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 7.9 Cg_exo -73.64 137.85 25.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.679 2.253 . . . . 52.11 111.498 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.99 -10.76 24.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.812 2.342 . . . . 73.54 113.121 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.11 -26.96 18.04 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.034 -0.266 . . . . 73.51 110.486 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -95.09 62.68 2.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.258 0.551 . . . . 74.14 110.422 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.66 HD12 HD23 ' A' ' 6' ' ' LEU . 8.1 tt -140.41 117.34 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 64.35 110.57 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.17 114.38 35.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 63.22 110.182 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.587 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 48.4 t -96.99 108.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 70.25 110.824 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.528 HD13 ' HB ' ' A' ' 133' ' ' VAL . 44.0 mm -89.62 119.32 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.778 -0.646 . . . . 74.42 109.699 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -138.47 165.22 27.39 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.411 -0.516 . . . . 72.32 111.183 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.75 142.33 29.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 55.11 109.358 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.897 ' HG2' HG12 ' A' ' 99' ' ' ILE . 18.4 tp10 -127.34 123.23 35.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.838 0.351 . . . . 71.24 111.357 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.9 mt -84.21 -14.76 49.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 63.01 111.254 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.88 -31.99 17.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 71.14 111.646 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.897 HG12 ' HG2' ' A' ' 96' ' ' GLU . 29.0 mm -85.52 146.21 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 74.11 111.408 -173.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 103' ' ' ARG . 14.2 m-20 -64.31 153.28 38.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.631 -0.713 . . . . 50.41 111.04 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.1 111.29 4.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.131 -0.692 . . . . 75.31 109.131 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 165' ' ' ILE . . . 101.65 6.08 50.45 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.483 -0.865 . . . . 43.24 112.104 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 27.1 mmt180 -103.33 141.83 35.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.756 0.313 . . . . 74.53 110.778 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 mt -107.93 136.86 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.682 -0.859 . . . . 72.41 108.682 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.556 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -144.04 162.27 36.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 72.1 110.562 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.81 133.06 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.868 0.366 . . . . 73.04 110.359 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 57.1 tptt -106.52 105.06 14.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 64.1 109.869 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.881 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.2 pt? -78.59 -133.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.979 -0.555 . . . . 70.11 110.672 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.7 132.78 11.32 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.538 -0.839 . . . . 74.1 111.117 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 150.01 5.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.961 -1.114 . . . . 65.35 113.083 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.0 -153.34 29.44 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.176 -0.769 . . . . 55.3 111.176 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 78.85 -61.21 0.36 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.497 0.719 . . . . 75.05 111.92 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.25 115.82 5.01 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.116 -0.564 . . . . 42.12 112.068 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.09 -114.31 0.58 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.03 -0.828 . . . . 74.02 111.03 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -174.89 -82.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.495 0.188 . . . . 72.41 111.182 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.574 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 14.6 m120 -130.78 -70.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.531 0.567 . . . . 65.42 112.531 -172.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.3 -17.8 80.12 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 121.063 -0.589 . . . . 55.44 112.055 -167.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.11 -30.62 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.981 -0.61 . . . . 61.12 110.649 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 119' ' ' ARG . 57.8 mtt180 -79.82 -29.15 40.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 72.11 111.12 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.9 m -75.31 -47.03 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 75.14 111.687 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.89 -21.98 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.53 -0.305 . . . . 73.32 111.585 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.82 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 51.11 111.599 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -70.6 -39.81 73.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.269 -0.423 . . . . 72.22 111.675 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.48 58.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 53.5 111.339 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.41 -41.83 62.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.319 -0.401 . . . . 62.32 110.996 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.96 2.42 52.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.878 -0.677 . . . . 72.45 112.039 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 m -131.19 121.02 24.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.792 0.33 . . . . 74.43 110.396 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -99.25 -64.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.714 -0.847 . . . . 75.31 108.714 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.7 t30 31.74 61.55 0.29 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.861 1.265 . . . . 73.03 114.099 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.806 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 84.2 m-85 70.57 -23.45 0.17 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.893 1.442 . . . . 74.21 114.893 166.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -79.98 53.64 1.73 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.607 0.966 . . . . 73.54 113.607 -169.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.587 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 1.3 mpp_? -137.35 111.26 8.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.8 -0.445 . . . . 75.13 109.8 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.528 ' HB ' HD13 ' A' ' 93' ' ' ILE . 57.6 t -85.24 131.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.081 0.467 . . . . 71.45 110.583 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HD3' ' HB3' ' A' ' 105' ' ' ARG . 49.0 mtp180 -106.18 117.28 33.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.679 -0.691 . . . . 73.33 110.027 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.58 118.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.938 -0.764 . . . . 63.34 108.938 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.31 12.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.668 . . . . 45.51 113.451 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.427 HG12 HD11 ' A' ' 24' ' ' LEU . 35.6 m -94.11 2.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 65.15 110.669 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.13 179.84 17.15 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.044 -0.598 . . . . 74.14 112.007 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.478 ' H ' ' HG3' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -70.69 149.95 95.33 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.469 0.135 . . . . 74.5 110.921 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.505 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 47.2 Cg_exo -37.74 128.55 0.82 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.253 3.302 . . . . 71.03 113.935 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.9 Cg_exo -73.69 135.07 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.477 2.784 . . . . 73.0 112.625 -177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -112.68 162.23 12.44 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.063 -0.815 . . . . 61.11 111.063 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.0 tpm_? 71.63 -75.21 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.132 0.573 . . . . 52.33 110.132 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.507 ' HD2' ' HD1' ' A' ' 149' ' ' PHE . 6.8 ptpp? -78.82 144.44 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.075 -0.342 . . . . 73.01 110.075 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.33 139.93 94.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.108 -0.497 . . . . 72.34 110.246 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.0 -28.89 19.99 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.254 2.636 . . . . 73.12 113.437 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -68.42 -36.19 78.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.377 . . . . 70.51 110.802 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.57 -25.64 30.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.466 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.507 ' HD1' ' HD2' ' A' ' 144' ' ' LYS . 90.3 t80 -62.28 -38.08 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.679 -0.692 . . . . 72.1 110.987 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.608 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.5 m -84.94 -0.61 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.395 . . . . 73.11 111.369 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 147' ' ' ALA . 73.1 mt -98.42 12.47 34.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 72.23 111.22 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 11.1 pt-20 -129.24 177.06 7.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.489 -0.323 . . . . 70.22 110.414 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -77.74 177.97 7.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.931 -0.577 . . . . 63.4 111.377 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.51 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 68.1 m-85 -80.06 165.05 22.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 74.43 110.81 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.648 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -75.95 -153.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.84 0.311 . . . . 74.2 111.84 -175.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.39 -70.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.059 0.392 . . . . 65.02 112.059 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.33 -44.66 35.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 72.55 111.386 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.93 -21.6 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.907 -0.588 . . . . 63.52 111.246 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 155' ' ' THR . 25.9 ttt180 -63.41 -24.1 67.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.025 0.44 . . . . 65.41 110.788 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.17 -19.54 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 64.52 111.032 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.86 -11.12 45.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 71.33 111.09 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 166' ' ' VAL . 47.9 t -60.98 -61.22 8.45 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.018 -0.537 . . . . 62.43 112.207 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 18.4 Cg_endo -59.05 -34.15 98.87 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.027 1.818 . . . . 74.41 112.601 -175.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.6 m -66.15 -39.3 89.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 75.11 111.763 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.837 HD13 ' HA2' ' A' ' 102' ' ' GLY . 43.6 pt -78.97 -30.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.762 -0.375 . . . . 61.13 110.848 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.1 t -62.68 -42.66 96.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.741 0.305 . . . . 62.21 110.64 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 46.6 mt-10 -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 74.32 110.834 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -73.5 -33.92 65.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 72.25 111.309 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.27 96.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 44.34 111.131 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.89 91.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 42.24 110.851 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.27 -35.74 76.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 61.41 111.422 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -62.21 -38.64 89.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.716 0.294 . . . . 71.24 110.759 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 54.8 m -60.48 -36.78 79.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 60.41 110.593 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.83 -33.95 57.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 64.41 110.576 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.29 -27.78 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 72.12 110.555 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.9 mt -63.13 -33.38 75.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.939 -0.573 . . . . 61.23 110.371 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.8 mm -80.47 -55.63 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 74.15 110.877 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.29 -54.67 37.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.689 -0.687 . . . . 74.53 112.1 -173.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.501 ' HG2' ' HB2' ' A' ' 183' ' ' PRO . 36.4 tt0 -93.33 -50.14 5.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.367 -0.379 . . . . 71.34 110.352 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.55 147.98 5.93 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.775 -0.726 . . . . 74.12 111.453 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 182' ' ' GLU . 4.2 pp -64.92 -27.28 68.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.895 0.348 . . . . 74.22 111.89 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.715 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 40.6 tt0 -76.95 -52.55 1.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.837 -0.165 . . . . 64.23 111.283 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.9 Cg_exo -65.17 -34.98 43.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.548 1.499 . . . . 70.3 112.56 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -73.52 -31.48 63.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.119 0.414 . . . . 75.3 112.119 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 12.2 pt20 -61.75 -21.25 64.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.874 -0.331 . . . . 63.11 110.825 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -55.06 -52.56 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.354 -0.61 . . . . 75.34 109.354 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -46.29 76.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 74.02 110.87 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 184' ' ' ALA . 10.7 t -67.58 -13.08 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.186 -0.461 . . . . 63.35 111.964 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -102.42 -22.67 14.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.344 0.498 . . . . 73.02 112.344 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.42 -25.88 6.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.704 0.631 . . . . 75.41 112.704 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.1 t90 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.233 -0.889 . . . . 64.44 110.374 -174.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.243 0.544 . . . . 63.43 110.95 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 Cg_endo -94.09 143.62 1.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.18 2.586 . . . . 71.22 112.587 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.24 120.69 39.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.418 -0.586 . . . . 45.22 109.418 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HB2' HE21 ' A' ' 88' ' ' GLN . 46.9 tp -92.13 105.23 17.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.26 -0.427 . . . . 71.33 109.989 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 62' ' ' LEU . 43.3 t -118.9 127.25 75.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 61.53 110.377 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.06 121.8 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.557 . . . . 70.03 110.115 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.98 122.04 6.53 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.317 -0.944 . . . . 55.25 111.65 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.3 tp -108.75 86.77 2.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.296 0.57 . . . . 74.34 110.243 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 147.42 18.61 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.344 -0.843 . . . . 62.13 111.416 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.922 HD22 ' HB3' ' A' ' 17' ' ' TYR . 1.1 p-10 -93.33 109.61 41.39 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.958 0.409 . . . . 63.34 110.893 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 2.0 Cg_endo -82.05 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.861 2.374 . . . . 74.35 112.731 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.67 -151.68 28.52 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.719 -0.753 . . . . 61.13 112.083 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.24 -49.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.94 2.427 . . . . 73.01 112.795 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -107.26 -26.24 11.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 74.23 111.923 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.922 ' HB3' HD22 ' A' ' 12' ' ' ASN . 88.4 m-85 -71.44 -17.41 62.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.902 0.704 . . . . 64.55 112.902 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' C ' ' HD2' ' A' ' 19' ' ' LYS . . . -71.44 -7.0 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.927 0.343 . . . . 72.41 111.927 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HD2' ' C ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -123.12 20.09 9.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.643 -0.253 . . . . 72.32 111.021 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 75.6 p -101.34 178.02 4.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.602 0.239 . . . . 71.01 111.532 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.765 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 67.5 mtt180 -59.21 -23.54 62.37 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.077 0.465 . . . . 72.42 110.709 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.718 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 1.7 t-80 -98.23 17.23 19.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 70.11 111.492 -173.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.61 3.13 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.117 0.484 . . . . 62.42 110.405 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -52.76 -35.27 56.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 54.42 112.303 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -63.63 -25.65 69.07 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.136 -0.554 . . . . 41.12 112.984 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -90.32 -29.89 17.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.633 0.254 . . . . 74.23 110.864 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.574 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 7.2 mmt -54.74 -48.08 73.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.528 0.566 . . . . 73.4 112.528 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.826 ' HB ' HD13 ' A' ' 93' ' ' ILE . 44.7 t -62.03 -45.24 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.726 0.298 . . . . 64.34 111.139 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.07 89.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 74.33 111.112 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.24 -48.91 77.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 55.41 110.968 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.0 -38.56 83.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.225 -0.443 . . . . 64.44 111.031 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.0 mt -63.77 -47.1 82.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.602 -0.272 . . . . 44.32 110.922 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.94 85.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.969 0.414 . . . . 50.24 110.543 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.51 -39.73 86.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.719 -0.673 . . . . 72.21 113.601 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.928 ' HG3' HD12 ' A' ' 36' ' ' ILE . 15.2 ptp180 -68.79 -36.41 78.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.378 0.589 . . . . 64.24 111.825 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.928 HD12 ' HG3' ' A' ' 35' ' ' ARG . 3.0 mp -77.89 -36.69 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 71.44 109.623 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.9 48.15 3.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.896 -0.669 . . . . 74.2 111.976 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.31 162.33 17.66 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.786 0.327 . . . . 71.14 110.352 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.82 130.63 56.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 71.51 110.691 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.516 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 19.1 p90 -70.18 133.59 47.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 73.04 110.286 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.28 134.83 54.66 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.937 -0.574 . . . . 75.22 110.7 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 49' ' ' GLU . 43.5 t -72.83 118.07 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 71.25 110.202 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.49 93.38 3.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.195 -1.039 . . . . 64.31 108.195 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.46 79.73 2.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.978 0.894 . . . . 72.14 110.2 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -169.25 -53.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.763 -1.562 . . . . 61.13 106.915 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -93.71 -28.55 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.944 -1.025 . . . . 60.25 110.241 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 29.59 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.945 -0.645 . . . . 44.15 112.153 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.14 146.22 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.319 -0.252 . . . . 53.34 110.319 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.798 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.1 mt-10 -98.85 138.75 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.304 -0.407 . . . . 74.44 110.397 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 137.96 51.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 61.45 110.468 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' A' ' 62' ' ' LEU . 7.5 p -128.86 139.13 52.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.477 -0.329 . . . . 70.21 110.377 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 61' ' ' VAL . 17.4 p -101.49 177.74 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.728 0.299 . . . . 72.25 111.449 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.53 40.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.161 -0.543 . . . . 35.1 111.966 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.809 ' H ' HG12 ' A' ' 36' ' ' ILE . 18.0 mmt180 -133.54 130.1 37.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.721 0.296 . . . . 72.03 110.737 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.018 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.4 pt? -130.84 115.76 17.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.323 -0.621 . . . . 72.05 109.323 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.72 23.51 13.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.816 -0.629 . . . . 75.23 111.264 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.71 -30.88 8.87 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.073 -0.584 . . . . 74.53 111.665 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 55' ' ' LEU . 75.0 m -70.49 142.96 51.84 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.795 0.438 . . . . 75.44 110.453 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 5.1 p -79.85 122.17 26.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.686 0.279 . . . . 74.35 110.73 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.018 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -97.37 138.5 22.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.113 -0.328 . . . . 51.43 110.113 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 52' ' ' THR . 7.2 m -124.21 108.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.329 0.585 . . . . 71.53 110.193 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.704 HD23 ' HB ' ' A' ' 7' ' ' VAL . 79.9 mt -95.22 119.55 33.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.562 -0.744 . . . . 65.53 110.333 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.74 147.74 39.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.484 . . . . 72.13 110.637 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 16.0 ptmt -132.85 143.27 47.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 63.1 110.31 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 17.8 Cg_exo -67.45 160.21 48.88 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.74 2.293 . . . . 74.22 111.683 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 39.6 ttt-85 -70.67 -63.17 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 60.24 110.173 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 47.8 m -165.89 147.73 7.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.776 -0.647 . . . . 74.34 110.102 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 t80 70.62 162.05 0.24 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.68 0.752 . . . . 75.34 112.269 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 69' ' ' MET . 1.9 mpt? -79.6 -16.08 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 61.21 111.365 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -73.62 -50.05 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.269 -0.423 . . . . 61.24 110.125 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 18.7 mt-10 -68.9 -41.06 78.76 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.978 0.362 . . . . 74.42 111.978 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 p -52.36 -44.43 65.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.94 0.348 . . . . 63.05 111.94 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -68.8 -25.46 75.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 63.52 112.545 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -94.21 -7.12 43.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.551 0.215 . . . . 75.12 111.338 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 19.4 mm-40 -102.33 -52.72 3.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.64 -0.254 . . . . 75.3 111.477 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.26 -40.52 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 75.31 111.601 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.658 ' HA2' HD21 ' A' ' 125' ' ' LEU . . . -55.83 -66.22 2.99 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.074 -0.512 . . . . 50.0 112.919 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.29 -39.05 93.06 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.741 2.294 . . . . 62.42 113.025 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.19 -45.91 83.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.753 0.279 . . . . 65.11 111.753 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -44.2 71.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.217 0.532 . . . . 73.44 111.162 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -7.83 58.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.949 -0.568 . . . . 51.24 111.658 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -77.23 -53.99 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 53.31 110.163 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -89.07 5.25 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 73.13 110.397 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.6 m 60.32 84.13 0.13 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 62.53 113.241 171.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.49 142.26 27.29 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.852 -0.613 . . . . 71.14 109.498 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.77 172.14 16.86 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.51 2.14 . . . . 73.14 111.69 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 96.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.215 1.944 . . . . 61.24 111.463 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.558 HE21 ' HB2' ' A' ' 6' ' ' LEU . 12.8 pt20 -133.25 177.61 7.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.662 -0.699 . . . . 71.51 110.038 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -66.2 104.75 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 74.2 111.136 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.1 tt -93.65 112.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.788 -0.642 . . . . 74.52 109.696 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.1 t -100.17 111.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.664 -0.698 . . . . 72.13 110.855 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.538 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 57.9 t -99.38 116.54 42.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.496 -0.557 . . . . 73.03 109.496 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.826 HD13 ' HB ' ' A' ' 28' ' ' VAL . 35.3 mt -87.05 122.86 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 62.31 110.622 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 41.4 t-80 -151.68 170.89 18.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.813 0.34 . . . . 75.13 110.465 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.06 153.71 22.54 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.91 0.484 . . . . 73.35 111.108 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 9.1 tp10 -118.2 121.56 40.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.579 . . . . 62.43 110.907 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.5 mt -83.5 -21.17 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 73.31 110.877 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.65 -19.83 34.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 70.31 111.808 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.741 HG13 ' HB2' ' A' ' 105' ' ' ARG . 29.0 mm -107.64 139.52 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.532 -0.304 . . . . 61.41 111.443 -175.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.685 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 3.8 m-20 -55.78 152.17 10.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.501 -0.772 . . . . 74.32 111.405 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.589 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.4 t80 -67.55 109.2 3.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.649 -0.705 . . . . 62.2 110.421 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.776 ' HA2' HG21 ' A' ' 165' ' ' ILE . . . 137.46 -23.85 3.1 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.405 -0.902 . . . . 75.43 113.165 176.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -108.28 151.59 25.76 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.515 -0.403 . . . . 73.4 110.33 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.831 ' HB ' HG22 ' A' ' 188' ' ' VAL . 3.6 mp -105.29 136.87 37.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.156 0.503 . . . . 71.52 110.149 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.741 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.1 tpt180 -108.89 140.31 42.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.639 -0.71 . . . . 73.24 109.785 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 185' ' ' GLN . 98.3 mt -122.66 121.08 35.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.431 -0.35 . . . . 73.34 110.238 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -116.65 138.89 51.11 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.926 -0.398 . . . . 74.04 109.926 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.9 mp -79.5 -71.4 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.75 -0.659 . . . . 74.24 110.379 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.33 -144.53 6.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.004 -0.544 . . . . 73.21 112.913 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.01 156.26 35.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.959 -0.638 . . . . 50.32 112.665 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.12 152.76 13.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.94 -0.647 . . . . 53.15 111.747 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -67.74 139.9 56.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.285 -0.265 . . . . 71.23 110.285 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 143.62 60.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.032 -0.604 . . . . 71.42 112.16 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.22 2.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.298 -0.953 . . . . 75.41 113.254 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.7 m80 55.75 -101.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.677 0.621 . . . . 73.14 112.677 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.02 -69.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.099 0.777 . . . . 74.14 113.099 -166.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -47.09 92.51 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.178 -0.534 . . . . 65.15 112.708 -165.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.0 -47.5 82.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.313 -0.443 . . . . 50.31 111.737 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -79.93 -22.16 43.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.944 0.35 . . . . 65.42 111.944 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.575 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 73.5 m -61.87 -52.43 64.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 63.24 110.486 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.39 -28.85 36.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.009 0.433 . . . . 71.53 110.722 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.95 74.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 65.23 111.004 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -84.55 -38.06 20.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.397 -0.365 . . . . 71.32 111.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.32 -52.9 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 72.44 111.032 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.658 HD21 ' HA2' ' A' ' 77' ' ' GLY . 95.9 mt -78.7 -32.36 46.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.361 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.05 -5.53 66.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.004 -0.617 . . . . 73.45 112.447 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.3 m -114.23 121.89 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.358 0.599 . . . . 62.34 111.7 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.2 -93.99 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.392 -1.336 . . . . 65.22 107.392 168.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.24 -8.2 0.2 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.151 1.537 . . . . 72.21 115.151 159.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 75.0 m-85 -119.27 -107.96 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.428 0.558 . . . . 65.41 111.865 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -146.97 118.33 7.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 72.43 111.321 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.538 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 11.9 mpt_? -106.33 123.95 48.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 52.33 109.642 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.42 ' HA ' HD23 ' A' ' 106' ' ' LEU . 94.1 t -83.57 117.32 29.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 64.42 110.479 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.951 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.7 mtt180 -120.01 117.88 29.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.75 -0.659 . . . . 72.21 110.642 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.3 mp -91.09 117.61 34.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.631 -0.507 . . . . 70.4 109.631 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.37 130.53 41.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.206 -0.521 . . . . 63.15 113.156 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.83 -0.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.049 0.452 . . . . 71.21 111.074 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 111.8 -83.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.5 -0.857 . . . . 72.43 112.882 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -164.1 168.45 9.38 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.445 -0.206 . . . . 72.52 110.445 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.0 Cg_exo -59.38 135.56 65.99 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.243 1.962 . . . . 71.32 110.385 166.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.661 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 26.1 Cg_exo -61.76 -38.48 59.83 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.769 2.312 . . . . 72.25 112.603 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.1 -71.7 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.027 -0.606 . . . . 70.24 113.308 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -78.88 -31.11 45.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 64.53 111.274 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 8.0 ptmm? -116.36 152.8 33.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 74.23 109.836 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.84 134.18 95.97 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.446 -0.343 . . . . 73.41 111.194 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.661 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 81.2 Cg_exo -47.66 -44.4 26.2 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.63 2.887 . . . . 54.4 113.626 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.09 87.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.041 0.448 . . . . 65.4 110.729 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.46 -18.8 60.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.812 -0.631 . . . . 62.11 110.68 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 89.3 t80 -84.18 -34.82 23.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.156 -0.474 . . . . 71.34 111.048 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.718 ' HB ' ' HB2' ' A' ' 22' ' ' HIS . 34.1 m -84.66 -17.03 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.666 0.617 . . . . 51.25 112.666 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.18 -7.44 59.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.059 0.457 . . . . 74.24 111.473 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.512 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 4.1 pt-20 -111.06 172.84 6.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.985 -0.552 . . . . 72.13 109.555 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.765 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 33.1 p30 -142.27 -20.54 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.815 0.341 . . . . 64.24 111.349 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -62.63 114.06 3.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 74.42 111.245 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -145.41 179.85 7.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 71.3 108.757 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.07 -71.86 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 63.3 111.864 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.58 -43.65 7.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 65.35 111.582 -174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 1.6 pm0 -72.15 -19.83 61.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.463 -0.789 . . . . 62.55 112.229 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 155' ' ' THR . 19.1 tpt180 -69.75 -38.0 76.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 64.03 110.139 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.23 60.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.162 -0.472 . . . . 62.31 110.911 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.78 1.25 57.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 71.41 112.046 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 166' ' ' VAL . 89.1 t -57.01 -57.06 27.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.061 -0.256 . . . . 62.21 110.648 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.3 Cg_endo -60.23 -30.33 90.95 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.967 1.778 . . . . 74.44 112.055 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.1 m -67.0 -48.12 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 70.22 111.175 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.776 HG21 ' HA2' ' A' ' 102' ' ' GLY . 42.3 pt -74.24 -20.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.578 -0.283 . . . . 73.43 111.319 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 162' ' ' VAL . 70.0 t -62.8 -45.11 99.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.966 -0.383 . . . . 72.25 109.966 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -58.73 -46.93 86.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.09 -0.505 . . . . 42.43 110.037 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.65 -54.22 48.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.313 -0.858 . . . . 75.44 111.144 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.63 -40.91 89.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 63.41 111.566 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.37 -49.45 69.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 72.22 111.216 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.35 -31.41 60.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 73.21 111.907 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.702 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -59.74 -46.57 88.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.094 -0.335 . . . . 64.33 110.094 173.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.8 m -58.88 -40.21 83.73 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.257 -0.429 . . . . 72.34 110.903 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 55' ' ' LEU . 33.5 tt0 -65.94 -42.95 89.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 64.51 110.028 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.15 -25.79 65.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 75.31 111.195 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 86.9 mt -62.03 -32.28 72.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.498 -0.319 . . . . 71.21 111.271 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.448 HG21 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -80.14 -25.39 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.17 0.509 . . . . 54.34 110.047 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -86.32 -47.34 9.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.59 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 184' ' ' ALA . 24.2 tp60 -86.04 -59.5 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.476 -0.329 . . . . 74.51 110.207 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.66 -75.0 0.89 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.032 0.773 . . . . 75.44 115.032 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.6 tp -42.47 -69.81 0.12 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.209 1.188 . . . . 64.12 114.209 -163.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.67 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 tt0 -139.91 -59.45 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.481 0.549 . . . . 64.33 112.481 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HD2' ' H ' ' A' ' 182' ' ' GLU . 18.4 Cg_endo -59.12 -17.2 37.28 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.079 1.853 . . . . 51.24 112.853 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . . . -60.3 -58.79 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.474 -0.33 . . . . 71.24 111.243 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.52 ' O ' ' HD2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -77.15 -28.42 54.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.802 -0.359 . . . . 72.04 111.181 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 183' ' ' PRO . 24.5 t-20 -57.75 -39.56 77.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.875 0.369 . . . . 74.0 110.61 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 84.8 m -65.1 -57.43 8.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.817 -0.629 . . . . 53.43 112.368 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.831 HG22 ' HB ' ' A' ' 104' ' ' ILE . 2.0 p -64.13 -18.87 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 113.499 0.926 . . . . 72.13 113.499 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.52 ' HD2' ' O ' ' A' ' 185' ' ' GLN . 9.0 p80 -106.95 -6.93 17.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.152 -0.619 . . . . 70.2 111.723 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.42 4.29 3.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.431 0.53 . . . . 51.3 112.431 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.471 -0.776 . . . . 71.12 109.849 -179.149 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 108.685 -0.857 . . . . 74.35 108.685 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.812 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 62.0 Cg_endo -90.88 171.61 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.981 2.454 . . . . 72.02 113.277 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.757 ' HB2' HD11 ' A' ' 177' ' ' ILE . 49.2 tp -119.63 110.05 16.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.554 -0.748 . . . . 74.01 109.801 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.707 ' HA ' HG23 ' A' ' 61' ' ' VAL . 51.0 tp -92.53 107.95 19.61 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.874 -0.787 . . . . 72.41 108.874 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' A' ' 62' ' ' LEU . 49.4 t -100.83 116.72 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.795 -0.639 . . . . 72.34 110.731 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.71 114.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.465 -0.789 . . . . 73.31 109.302 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.41 122.26 7.29 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.211 -0.995 . . . . 42.22 111.985 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -79.01 91.38 4.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 73.32 109.689 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.815 ' HA2' ' HA ' ' A' ' 23' ' ' ASN . . . -152.66 122.24 1.28 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.561 -0.828 . . . . 70.54 112.376 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -112.34 98.05 41.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.792 -0.818 . . . . 71.55 108.792 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.75 58.65 4.03 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.581 2.854 . . . . 73.32 112.997 -172.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.08 175.0 39.7 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.521 -0.632 . . . . 50.31 111.521 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.26 -57.61 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.62 2.88 . . . . 71.3 113.515 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -107.38 7.35 29.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.537 0.684 . . . . 74.14 110.431 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HA ' ' OG1' ' A' ' 20' ' ' THR . 97.9 m-85 -94.13 -15.61 24.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 72.22 111.959 -172.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.81 -34.46 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.721 0.638 . . . . 63.43 112.721 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.657 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -115.76 14.95 16.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.135 0.493 . . . . 73.24 111.459 -176.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.7 p -109.37 -172.97 2.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.279 -0.418 . . . . 60.01 110.273 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.545 ' HG2' HG11 ' A' ' 137' ' ' VAL . 64.7 mtt85 -68.04 1.44 2.74 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.208 0.447 . . . . 63.24 112.208 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -95.53 -5.26 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.332 -0.23 . . . . 43.22 111.117 -176.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.815 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 t30 -143.23 9.37 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.315 0.579 . . . . 72.11 111.247 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 20' ' ' THR . 51.1 mt -68.57 -28.06 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.92 -0.488 . . . . 72.41 111.784 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.85 -21.85 71.61 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.45 -0.881 . . . . 62.24 112.188 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 81.0 t80 -80.38 -21.75 42.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.558 0.218 . . . . 71.03 111.108 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 31' ' ' VAL . 11.0 mmt -51.13 -51.51 52.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.351 -0.386 . . . . 62.42 111.682 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 170' ' ' ALA . 57.4 t -61.17 -43.5 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 72.44 111.044 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.28 -40.68 97.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.0 -0.546 . . . . 50.3 110.858 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.29 -41.2 98.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 74.43 110.61 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 27' ' ' MET . 66.5 t -62.97 -34.46 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 70.5 110.653 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 35' ' ' ARG . 93.3 mt -64.34 -33.87 76.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.367 -0.378 . . . . 74.13 110.672 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -39.07 46.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.336 -0.393 . . . . 75.02 110.474 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.39 -40.12 96.2 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.629 . . . . 65.43 113.039 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 32' ' ' LEU . 11.0 ptm180 -66.24 -21.78 66.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.842 0.353 . . . . 75.15 110.812 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.16 -48.89 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.458 . . . . 71.43 110.317 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.24 38.12 2.53 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.96 -0.638 . . . . 43.0 112.161 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 m -126.12 146.09 50.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.303 . . . . 74.51 110.58 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.34 142.86 33.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 73.0 111.018 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.807 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 16.8 p90 -74.4 147.0 42.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 71.45 110.757 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -128.7 145.21 51.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.034 -0.358 . . . . 71.13 110.034 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.886 HG22 ' HG3' ' A' ' 49' ' ' GLU . 32.7 t -76.52 134.33 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.277 -0.42 . . . . 72.41 111.398 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -94.99 125.55 39.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.427 -0.583 . . . . 75.15 109.427 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.32 -36.55 84.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.379 . . . . 64.12 110.889 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -83.38 4.14 28.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 72.42 110.924 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m -125.59 -29.02 3.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.812 0.339 . . . . 70.54 111.308 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.37 29.23 73.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.961 -0.638 . . . . 72.2 111.812 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.52 37.19 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.614 0.245 . . . . 62.21 110.587 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.886 ' HG3' HG22 ' A' ' 42' ' ' VAL . 4.5 mp0 -85.68 131.22 34.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.54 . . . . 63.5 110.795 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.25 149.46 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 70.03 109.429 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.807 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.4 p -144.42 138.81 23.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 74.14 110.544 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.722 HG22 HG12 ' A' ' 61' ' ' VAL . 41.5 p -107.61 136.97 46.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 62.15 110.896 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.6 -166.02 13.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.929 -0.653 . . . . 62.43 111.914 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -131.21 105.82 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.486 -0.191 . . . . 73.41 110.486 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.124 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.2 pt? -96.68 115.91 28.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.835 -0.802 . . . . 73.54 108.835 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.58 -49.43 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.619 -0.719 . . . . 60.13 111.474 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.16 -33.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.261 -0.736 . . . . 72.14 111.261 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.8 148.06 50.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.968 -0.616 . . . . 54.33 111.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 m -70.83 114.8 9.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.992 -0.373 . . . . 73.42 109.992 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.124 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.5 p -97.02 127.14 49.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.568 -0.531 . . . . 55.45 109.568 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 52' ' ' THR . 2.8 m -116.51 109.13 26.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.375 0.607 . . . . 71.11 110.27 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 7' ' ' VAL . 50.7 mt -96.14 120.52 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.376 -0.829 . . . . 75.43 110.022 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.85 129.85 51.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.364 -0.38 . . . . 63.1 110.659 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 8.2 ptmm? -115.91 121.45 34.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.281 -0.418 . . . . 74.41 110.541 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 27.3 Cg_exo -62.0 156.72 47.8 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.715 2.276 . . . . 61.53 111.362 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.591 ' HG3' ' N ' ' A' ' 67' ' ' CYS . 9.1 ptt180 -77.49 -55.9 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.442 -0.503 . . . . 65.52 110.345 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.591 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 21.1 p -167.5 173.63 8.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.748 -0.206 . . . . 70.05 110.469 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 t80 67.62 162.77 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.96 0.788 . . . . 71.35 112.188 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -21.15 25.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.861 -0.609 . . . . 62.14 112.272 -175.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -94.86 -38.64 10.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.724 0.297 . . . . 72.2 111.263 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.76 -26.45 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 63.24 111.121 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -45.0 95.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 72.35 110.478 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.09 -33.86 84.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.877 -0.678 . . . . 64.52 111.722 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -74.26 -8.42 56.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 73.41 111.244 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 65' ' ' PRO . 82.8 mt-30 -103.96 -49.87 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 75.13 111.534 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.02 -29.95 42.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.814 0.302 . . . . 70.25 111.814 -176.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.29 7.08 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.143 -0.551 . . . . 74.22 112.67 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.38 -37.69 94.49 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.908 2.406 . . . . 73.24 113.032 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 64.8 mt -58.08 -39.15 77.82 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.924 0.342 . . . . 74.4 111.924 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.85 -41.97 88.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 55.54 110.874 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -23.8 27.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.173 -0.467 . . . . 71.34 111.207 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -60.87 -46.65 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.212 0.529 . . . . 71.01 109.854 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.12 -14.99 48.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.713 -0.676 . . . . 74.0 110.281 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 60.67 47.71 7.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.606 0.717 . . . . 74.04 110.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.812 ' HB ' ' HG3' ' A' ' 4' ' ' PRO . 27.4 m -102.13 137.23 19.41 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.327 -0.852 . . . . 72.22 110.215 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.632 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 23.4 Cg_exo -64.58 137.7 55.88 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.623 2.216 . . . . 72.42 111.713 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 93.8 Cg_endo -87.11 53.11 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.991 2.46 . . . . 73.31 113.574 -172.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.632 ' OE1' ' HB2' ' A' ' 86' ' ' PRO . 10.7 mp0 -59.28 -57.1 14.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 62.11 110.68 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.588 HE21 HD13 ' A' ' 5' ' ' LEU . 9.7 pt20 -144.03 102.45 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.541 0.686 . . . . 74.25 112.394 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.607 HD13 HD11 ' A' ' 125' ' ' LEU . 5.8 tt -98.18 115.58 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.36 -0.836 . . . . 55.32 109.129 170.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.44 117.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.947 -0.57 . . . . 75.32 110.801 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.604 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 44.7 t -97.24 103.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 72.43 109.23 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.434 HG21 ' HB ' ' A' ' 28' ' ' VAL . 58.0 mt -86.12 119.24 34.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.947 -0.57 . . . . 72.54 109.84 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.435 ' CE1' HD22 ' A' ' 118' ' ' LEU . 28.3 p80 -151.67 170.65 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.89 -0.596 . . . . 75.24 110.522 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.63 150.23 24.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.319 -0.623 . . . . 71.43 109.319 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.695 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 7.8 tp10 -124.99 119.81 29.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.94 0.4 . . . . 74.34 110.045 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 138' ' ' GLY . 92.7 mt -82.39 -0.51 46.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 54.24 110.06 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 27.9 t70 -83.05 -11.01 58.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.358 -0.837 . . . . 70.54 110.459 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 105' ' ' ARG . 12.4 tt -132.06 148.9 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.945 0.403 . . . . 65.11 111.347 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.37 145.57 21.89 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.354 -0.839 . . . . 74.41 112.43 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -62.15 126.42 27.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 72.4 110.374 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' N ' ' HD1' ' A' ' 101' ' ' PHE . . . 117.78 -19.29 11.33 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 75.35 113.404 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.459 HH12 ' CD ' ' A' ' 161' ' ' GLU . 59.3 mmt-85 -120.63 147.67 44.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.447 0.623 . . . . 71.52 111.069 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.2 mp -104.27 132.59 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.425 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.713 ' HB2' HD12 ' A' ' 99' ' ' ILE . 16.2 tpt180 -116.57 126.18 52.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 73.32 109.683 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 188' ' ' VAL . 40.2 mt -97.48 111.29 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.266 0.555 . . . . 74.1 110.159 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HB3' ' NE ' ' A' ' 134' ' ' ARG . 57.1 tptt -102.25 141.07 35.67 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.752 -1.203 . . . . 72.51 107.752 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.912 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.1 pt? -75.55 -124.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.735 0.272 . . . . 64.13 111.735 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.919 ' HA3' ' HG3' ' A' ' 128' ' ' LYS . . . -82.01 142.03 22.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.431 -0.89 . . . . 62.04 112.584 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 153.4 5.86 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.716 -0.754 . . . . 72.21 112.321 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.53 77.06 0.32 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.672 -0.971 . . . . 71.34 110.672 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.99 144.1 22.04 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.382 -0.599 . . . . 72.42 109.382 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.0 -165.54 34.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.597 -0.811 . . . . 64.35 111.9 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.79 18.44 25.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.71 -0.757 . . . . 71.02 113.157 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -139.54 122.67 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.278 -0.542 . . . . 73.03 111.035 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.91 -52.5 60.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.984 -1.007 . . . . 60.21 112.107 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.35 -30.89 65.26 Favored Glycine 0 N--CA 1.46 0.29 0 CA-C-N 116.329 -0.396 . . . . 73.2 112.968 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.435 HD22 ' CE1' ' A' ' 94' ' ' HIS . 14.3 tp -60.52 -32.46 71.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.441 0.638 . . . . 43.23 110.673 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -79.23 -34.52 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 74.32 110.213 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.9 m -73.16 -44.39 60.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 63.33 111.406 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.03 -34.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 120.801 0.334 . . . . 65.22 111.14 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.46 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.978 0.418 . . . . 73.42 110.57 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 m -71.51 -23.59 61.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 62.51 110.884 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.4 -34.01 54.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 43.33 110.507 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 90' ' ' ILE . 88.0 mt -80.59 -42.82 21.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.914 -0.584 . . . . 72.21 110.653 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.44 89.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.024 -0.608 . . . . 75.31 112.365 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.1 p -112.37 163.09 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 71.55 111.185 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.919 ' HG3' ' HA3' ' A' ' 109' ' ' GLY . 12.5 tppt? -83.47 -56.86 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.869 -0.605 . . . . 74.12 110.755 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.94 81.92 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.741 0.65 . . . . 71.3 110.964 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.77 ' HD1' HD12 ' A' ' 108' ' ' LEU . 67.7 m-85 -71.07 68.17 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.258 1.207 . . . . 74.41 114.258 -168.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 37.8 p-80 163.57 115.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.908 0.883 . . . . 74.02 111.843 162.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.604 ' HG3' ' H ' ' A' ' 92' ' ' VAL . 5.0 mpt_? -128.93 147.24 50.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 74.42 110.216 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 93' ' ' ILE . 88.1 t -86.31 127.81 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.847 0.356 . . . . 64.4 111.032 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.695 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.0 mtt180 -131.37 109.75 10.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 61.41 110.563 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 54.4 mt -88.99 125.87 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.133 -0.485 . . . . 65.44 110.279 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.54 ' CA ' HG23 ' A' ' 99' ' ' ILE . . . -72.5 114.98 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.67 -0.776 . . . . 73.21 111.965 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.547 HG11 HD12 ' A' ' 24' ' ' LEU . 22.8 t -119.81 10.43 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.764 0.792 . . . . 62.53 110.27 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 97' ' ' LEU . . . 138.19 172.22 12.47 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.214 -0.993 . . . . 62.41 112.97 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -101.48 162.31 20.88 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.784 -0.45 . . . . 75.44 109.784 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 36.1 Cg_exo -60.72 133.01 45.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.672 2.248 . . . . 63.14 112.243 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.621 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 55.2 Cg_endo -70.56 127.31 13.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.71 2.273 . . . . 73.11 112.156 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.08 43.11 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.886 -0.673 . . . . 71.45 112.555 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -163.35 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.007 0.432 . . . . 74.31 110.219 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -89.38 159.57 17.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.622 . . . . 75.43 110.82 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.8 140.98 97.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 71.44 110.994 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.13 -38.68 60.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.225 2.616 . . . . 55.1 113.082 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 150' ' ' VAL . . . -70.19 -30.36 67.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.194 0.521 . . . . 62.22 110.655 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 151' ' ' LEU . . . -76.72 -18.52 58.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.65 -0.705 . . . . 61.55 110.226 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.621 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 59.7 t80 -84.54 -31.64 24.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 60.04 110.829 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 34.6 m -85.18 -6.02 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 72.41 112.245 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 4.4 pp -87.39 -8.35 56.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 64.55 110.182 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.64 171.11 8.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.228 -0.896 . . . . 64.44 109.669 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -170.7 87.44 0.12 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.9 0.381 . . . . 55.13 110.932 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -154.97 135.99 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.325 -0.398 . . . . 74.14 110.447 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -164.84 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 43.21 108.243 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -96.42 -73.41 0.6 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.773 0.657 . . . . 62.04 112.773 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.49 -43.2 8.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.261 0.553 . . . . 64.3 111.118 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -68.96 -21.6 64.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.493 -0.776 . . . . 72.41 110.515 -178.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -83.6 -15.26 49.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.622 -0.717 . . . . 73.55 110.361 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.46 -42.63 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 62.24 111.778 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.459 ' CD ' HH12 ' A' ' 103' ' ' ARG . 15.4 pt-20 -83.43 11.04 7.46 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.923 0.342 . . . . 64.4 111.923 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.646 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 87.0 t -54.03 -53.35 59.37 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.388 -0.369 . . . . 75.13 111.962 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 71.3 Cg_exo -52.03 -38.35 69.62 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.03 1.82 . . . . 72.34 112.511 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.0 m -68.6 -46.26 69.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 70.42 111.405 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.01 -24.83 24.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 121.098 -0.241 . . . . 65.34 111.452 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 162' ' ' VAL . 90.3 t -64.15 -43.74 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 63.02 110.047 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.82 -36.71 81.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 75.3 110.559 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.08 -51.54 53.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 72.22 110.657 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 73.34 111.535 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.52 -57.02 14.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 44.32 111.279 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.95 -26.7 62.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.485 -0.325 . . . . 74.21 111.181 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.87 -38.6 86.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.34 . . . . 74.5 110.539 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 m -66.96 -34.74 78.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.235 -0.439 . . . . 53.24 110.765 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.465 ' HA ' HD12 ' A' ' 55' ' ' LEU . 44.1 tt0 -71.91 -34.93 69.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.532 . . . . 74.51 109.853 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.29 -26.64 68.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 74.42 110.772 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 91.7 mt -64.74 -21.7 66.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 64.11 110.955 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 5' ' ' LEU . 28.0 mm -80.75 -50.71 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 65.3 110.74 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.86 -38.83 61.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.801 -0.636 . . . . 55.1 112.403 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -99.02 -56.64 2.37 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.924 -0.311 . . . . 72.34 111.536 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 141.77 -124.99 2.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.44 -0.886 . . . . 60.22 112.117 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.83 -46.97 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.032 0.382 . . . . 61.15 112.032 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.819 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 30.2 tt0 -73.44 -61.33 1.44 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.095 0.406 . . . . 72.23 112.095 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 17.7 Cg_exo -67.18 -14.9 44.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.741 1.628 . . . . 62.14 111.884 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.57 14.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 60.45 111.144 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.583 ' HA ' HD12 ' A' ' 106' ' ' LEU . 10.0 pt20 -65.25 -27.94 69.01 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 121.112 -0.235 . . . . 62.04 110.876 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 189' ' ' HIS . 65.7 t30 -59.53 -45.53 91.48 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.389 -0.369 . . . . 75.13 110.31 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.2 m -63.69 -38.26 90.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 73.54 110.882 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 106' ' ' LEU . 59.2 t -61.71 -44.48 98.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.005 -0.543 . . . . 72.41 111.533 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.509 ' NE2' ' HA ' ' A' ' 186' ' ' ASN . 33.5 p80 -89.53 12.86 15.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.512 -0.475 . . . . 74.4 111.238 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.36 4.13 38.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.53 -0.305 . . . . 64.13 110.785 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 12.8 m0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.063 -0.97 . . . . 72.42 111.027 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.725 -0.472 . . . . 64.14 109.725 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.23 89.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.778 1.652 . . . . 51.21 110.64 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.97 118.15 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.669 -0.696 . . . . 62.1 111.475 -172.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.443 ' HA ' HG23 ' A' ' 61' ' ' VAL . 34.0 tp -91.86 105.13 17.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.743 -0.662 . . . . 65.22 109.542 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.652 ' HB ' HD23 ' A' ' 62' ' ' LEU . 40.5 t -114.89 112.9 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.199 0.523 . . . . 73.41 110.422 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.78 114.77 45.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.541 -0.754 . . . . 73.21 110.005 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.42 120.76 6.09 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.337 -1.105 . . . . 73.42 110.337 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.4 HD23 ' ND1' ' A' ' 94' ' ' HIS . 23.4 tp -94.66 81.4 3.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 41.43 110.477 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.49 107.36 0.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.636 -1.165 . . . . 35.12 110.75 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -87.49 144.38 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.859 0.361 . . . . 71.12 110.777 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.66 81.74 1.01 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.813 2.342 . . . . 75.51 111.685 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.564 ' H ' ' HB2' ' A' ' 18' ' ' ALA . . . -90.64 163.88 30.01 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.893 -0.67 . . . . 72.24 111.878 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.65 -14.85 33.63 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.715 2.277 . . . . 74.43 112.717 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -141.39 -45.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.2 0.445 . . . . 72.52 112.2 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HA ' HG22 ' A' ' 20' ' ' THR . 54.4 p90 -76.25 -2.61 32.27 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.312 0.486 . . . . 74.43 112.312 -173.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.564 ' HB2' ' H ' ' A' ' 14' ' ' GLY . . . -88.85 -3.31 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 74.2 110.851 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.95 19.61 10.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.496 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 17' ' ' TYR . 12.8 t -138.35 -169.11 2.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 71.44 110.104 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 70.8 mtt180 -48.12 -26.49 1.89 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.198 0.814 . . . . 74.2 113.198 -174.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -81.94 12.41 4.12 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.224 -0.298 . . . . 72.51 111.785 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 27' ' ' MET . 27.4 p-10 -95.8 -5.04 42.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.236 . . . . 75.24 110.745 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 96.1 mt -52.73 -38.09 60.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.175 -0.466 . . . . 60.12 111.791 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -62.56 -30.06 75.45 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.131 -0.556 . . . . 75.23 112.657 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -91.5 -32.89 15.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.963 -0.139 . . . . 75.01 111.346 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 76.3 mtp -54.58 -40.15 68.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.145 0.794 . . . . 71.34 113.145 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.851 ' HB ' HD13 ' A' ' 93' ' ' ILE . 45.5 t -63.62 -46.3 95.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 54.31 110.41 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.08 79.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 74.12 110.324 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.87 -49.0 72.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.442 -0.799 . . . . 52.3 110.564 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.66 -43.38 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.836 -0.62 . . . . 65.42 110.934 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.7 mt -59.44 -40.79 87.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 73.51 111.221 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.63 64.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 62.3 110.976 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.11 -33.39 40.78 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.99 -0.624 . . . . 43.11 113.311 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.63 ' HG3' HD12 ' A' ' 36' ' ' ILE . 14.7 ptm180 -69.78 -25.97 64.06 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.256 0.528 . . . . 71.02 111.196 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.63 HD12 ' HG3' ' A' ' 35' ' ' ARG . 2.0 mp -88.31 -42.21 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.542 . . . . 72.34 109.686 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.51 58.53 2.27 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.81 -0.709 . . . . 73.23 112.219 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.8 m -134.7 145.69 48.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.666 0.27 . . . . 54.34 110.562 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.52 150.82 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 65.2 110.513 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.696 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 1.1 p90 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.834 -0.621 . . . . 70.24 111.086 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -113.85 134.14 54.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 73.11 110.188 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 49' ' ' GLU . 43.6 t -74.68 129.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 74.42 111.685 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.96 149.64 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 65.15 110.378 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -70.64 -72.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.146 -0.479 . . . . 73.52 111.419 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -68.16 -27.38 66.37 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.213 -0.449 . . . . 73.53 111.374 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -83.51 -28.2 28.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.474 -0.33 . . . . 62.41 111.024 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.25 11.83 53.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.093 -0.575 . . . . 75.5 112.452 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -120.25 151.34 39.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.67 0.271 . . . . 43.22 110.947 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.696 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 45.7 mp0 -78.92 138.8 38.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.859 -0.61 . . . . 72.52 111.602 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.36 136.81 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 64.24 109.404 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 9.4 p -121.99 144.69 30.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.734 0.302 . . . . 61.05 110.442 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.824 HG22 HG12 ' A' ' 61' ' ' VAL . 7.2 p -118.14 144.52 45.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.335 -0.393 . . . . 73.22 111.319 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.53 -174.87 38.26 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.028 -0.606 . . . . 61.52 111.87 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 -109.92 126.05 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.808 -0.231 . . . . 74.53 110.524 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.152 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -105.48 108.8 20.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.838 -0.801 . . . . 72.21 108.838 174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.91 -51.93 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.618 -0.719 . . . . 60.22 111.526 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.37 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.008 -0.837 . . . . 73.21 111.008 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.485 ' O ' HD23 ' A' ' 55' ' ' LEU . 27.1 m -78.07 153.12 32.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.403 -0.399 . . . . 75.43 110.385 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.6 m -80.8 129.13 34.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.953 -0.388 . . . . 71.41 109.953 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.152 ' HB ' HD22 ' A' ' 55' ' ' LEU . 13.9 p -118.0 135.56 58.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.926 0.393 . . . . 54.14 110.508 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.824 HG12 HG22 ' A' ' 52' ' ' THR . 17.4 m -116.14 112.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.251 0.548 . . . . 73.3 109.965 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.3 mt -98.08 113.12 24.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 70.43 110.206 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.141 -0.481 . . . . 63.45 110.72 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 3.1 ptmm? -123.81 119.3 26.89 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.182 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.45 160.9 40.55 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.703 2.268 . . . . 54.32 112.894 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 7.83 10.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.628 -0.715 . . . . 60.21 110.141 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.6 t -146.32 -179.36 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 61.42 109.613 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.7 170.72 11.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.077 0.465 . . . . 64.13 111.626 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.99 -23.41 66.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.352 -0.84 . . . . 72.4 111.455 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.05 -43.39 63.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.142 0.496 . . . . 73.23 110.21 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -75.67 -56.89 4.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.659 -0.7 . . . . 72.24 110.228 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 m -47.33 -44.62 23.87 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.745 0.653 . . . . 65.42 112.662 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.75 94.1 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.902 -0.666 . . . . 71.03 113.053 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.37 3.07 40.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.79 0.293 . . . . 65.04 111.79 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.478 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 12.7 mm-40 -91.9 -43.78 9.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.571 -0.286 . . . . 71.51 111.274 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.43 -39.96 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.368 -0.378 . . . . 71.3 111.629 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 125' ' ' LEU . . . -55.24 -63.51 5.21 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 116.176 -0.465 . . . . 53.14 112.965 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.01 -26.02 47.58 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.131 2.554 . . . . 61.35 113.164 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 28.8 mt -72.82 -40.44 65.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.529 0.204 . . . . 64.01 111.428 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.89 -39.24 88.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.422 0.63 . . . . 63.02 109.877 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -9.34 57.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.629 -0.714 . . . . 74.31 111.388 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -66.37 -43.98 84.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 72.31 109.204 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.81 3.81 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 71.33 109.707 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.7 p 45.41 54.47 7.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.923 -1.035 . . . . 74.34 112.553 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 80' ' ' ALA . 26.8 m -81.98 150.45 65.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 73.43 110.73 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 161.33 46.39 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.673 2.249 . . . . 44.12 111.72 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -48.1 111.85 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.269 2.646 . . . . 72.24 112.175 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -128.14 -173.97 3.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 71.15 111.44 -172.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -91.24 95.45 10.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 74.14 110.988 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 tt -76.02 110.85 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.462 0.648 . . . . 63.1 110.446 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 132.63 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 64.34 110.693 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.745 HG21 HG21 ' A' ' 121' ' ' VAL . 67.5 t -129.35 129.44 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.676 -0.49 . . . . 53.31 109.676 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.851 HD13 ' HB ' ' A' ' 28' ' ' VAL . 36.4 mt -106.17 126.59 61.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.46 . . . . 64.22 110.111 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.4 ' ND1' HD23 ' A' ' 10' ' ' LEU . 67.3 t60 -159.03 174.22 15.26 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.589 -0.445 . . . . 74.11 111.825 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -83.7 152.69 24.6 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.436 -0.802 . . . . 72.01 111.332 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.556 ' HG3' ' H ' ' A' ' 98' ' ' ASP . 9.0 tp10 -145.37 136.67 24.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 60.33 110.767 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.402 HD23 ' CG1' ' A' ' 137' ' ' VAL . 97.0 mt -83.89 -15.39 48.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.931 -0.577 . . . . 53.02 111.549 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.556 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.5 t70 -75.76 -22.61 56.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 75.32 112.267 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.694 HG13 ' HB2' ' A' ' 105' ' ' ARG . 46.6 mm -113.83 144.42 21.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.865 0.364 . . . . 74.32 111.876 -172.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 146.39 17.6 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.12 -0.945 . . . . 62.41 110.479 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 63.0 t80 -66.99 108.52 2.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 74.43 110.272 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 -16.27 6.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.617 -0.801 . . . . 62.43 112.668 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -107.41 151.24 25.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.796 -0.446 . . . . 73.51 109.796 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.68 135.77 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.811 0.339 . . . . 72.24 110.776 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HB2' HG13 ' A' ' 99' ' ' ILE . 8.6 tpp180 -108.89 125.92 52.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.477 -0.564 . . . . 60.41 109.477 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 188' ' ' VAL . 67.8 mt -97.67 134.0 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.908 0.385 . . . . 70.11 110.183 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.724 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -120.83 119.81 33.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.804 -0.634 . . . . 70.41 110.239 -177.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.777 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.5 pt? -103.5 -138.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.758 -0.46 . . . . 73.22 109.758 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 36.04 -145.82 0.07 OUTLIER Glycine 0 C--N 1.344 0.976 0 O-C-N 123.678 0.612 . . . . 72.34 113.411 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.86 127.99 8.35 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.486 -1.045 . . . . 52.4 110.486 162.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.04 107.93 3.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 71.23 113.756 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.91 101.51 12.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 72.22 110.108 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.88 -161.47 29.59 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.332 -1.107 . . . . 64.03 110.332 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.517 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . 64.47 15.62 59.56 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.823 -0.703 . . . . 75.25 112.157 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 m80 72.91 -76.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.442 0.697 . . . . 71.41 111.742 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -134.69 -59.48 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.381 0.511 . . . . 73.31 112.381 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 121' ' ' VAL . . . -57.11 -30.2 60.49 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.581 -0.343 . . . . 55.02 113.5 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.517 HD12 ' HA3' ' A' ' 114' ' ' GLY . 0.9 OUTLIER -63.87 -41.13 97.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.174 0.512 . . . . 72.24 110.101 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -76.73 -37.86 55.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.198 -0.91 . . . . 65.52 110.614 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.5 m -61.95 -49.37 76.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 74.1 111.327 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.745 HG21 HG21 ' A' ' 92' ' ' VAL . 27.3 m -72.64 -21.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.412 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.24 -59.74 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 72.3 111.057 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.4 m -63.27 -40.65 97.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 63.02 111.697 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.95 68.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 51.03 111.669 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.421 HD13 ' HA2' ' A' ' 77' ' ' GLY . 53.4 tp -85.02 -27.94 26.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 75.41 110.258 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.23 22.98 75.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.77 . . . . 63.03 112.249 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.8 m -124.91 121.49 34.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 61.02 110.369 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 44.9 mtmt -115.65 -173.6 2.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.047 -0.723 . . . . 73.53 109.047 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 t30 63.03 79.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.147 0.975 . . . . 74.32 109.629 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -145.88 -155.51 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.443 -1.253 . . . . 72.31 109.122 -176.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -149.0 110.04 4.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 75.33 110.409 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.523 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 2.3 mpt_? -104.55 146.85 28.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.774 -0.648 . . . . 53.31 109.88 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.18 102.44 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.986 -0.552 . . . . 74.34 110.292 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 64.4 mtp180 -96.64 97.26 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.786 -0.643 . . . . 65.11 109.386 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 135' ' ' ILE . 5.1 mp -80.08 128.53 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.86 -0.422 . . . . 71.42 109.86 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -64.11 123.31 27.75 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.627 -0.797 . . . . 73.05 111.816 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 150' ' ' VAL . 9.8 p -96.84 0.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.216 0.532 . . . . 64.54 110.571 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 135.82 -87.32 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.5 -0.857 . . . . 54.14 112.84 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 2.0 ptp180 -172.57 165.36 3.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 122.169 0.188 . . . . 75.43 110.536 -175.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 139' ' ' ARG . 27.9 Cg_endo -64.67 120.2 7.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.344 2.03 . . . . 64.25 111.198 171.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.15 167.09 20.12 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.727 2.285 . . . . 64.14 112.904 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.87 -59.13 0.17 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.702 -0.761 . . . . 55.11 112.59 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -79.6 -29.49 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.764 0.283 . . . . 71.33 111.764 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.45 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -107.92 134.22 51.15 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.588 -0.445 . . . . 73.11 110.402 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.5 141.55 78.42 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.389 -0.823 . . . . 75.05 110.427 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.95 -38.05 12.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.759 2.973 . . . . 75.12 113.984 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -25.83 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.943 0.402 . . . . 72.4 110.95 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.96 -21.89 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.481 . . . . 72.52 110.2 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -72.73 -38.34 67.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.801 -0.636 . . . . 62.33 110.367 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 137' ' ' VAL . 34.2 m -82.9 2.12 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.266 -0.425 . . . . 74.34 110.486 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.95 -24.14 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.551 . . . . 71.23 110.713 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -93.07 97.88 10.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.239 0.543 . . . . 61.44 110.92 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 20' ' ' THR . 32.9 p-10 -104.5 -7.43 19.79 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.009 -0.432 . . . . 54.42 110.897 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.1 52.87 2.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.222 -0.445 . . . . 72.03 110.092 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -75.16 -173.59 2.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.703 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.444 ' H ' HG22 ' A' ' 155' ' ' THR . . . -75.67 -71.32 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.807 0.336 . . . . 74.41 111.48 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.96 -37.49 11.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.355 0.597 . . . . 73.1 110.459 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 101' ' ' PHE . 3.6 mp0 -58.9 -34.6 71.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.962 -1.017 . . . . 72.13 111.712 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -65.93 -26.48 67.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.083 0.468 . . . . 74.45 111.123 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.89 -15.39 36.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.367 -0.379 . . . . 75.24 111.641 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -116.1 15.49 16.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.768 0.285 . . . . 75.41 111.768 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.711 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 57.9 t -56.33 -56.05 35.7 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.253 0.464 . . . . 64.04 112.253 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -66.49 -31.38 42.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.738 1.625 . . . . 63.42 112.074 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.1 m -63.97 -45.56 88.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 52.11 111.794 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.3 pt -68.75 -32.05 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 72.53 111.156 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.58 -37.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.34 -0.391 . . . . 72.5 110.43 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.48 -51.29 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 74.24 110.887 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.04 -36.36 77.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 71.43 111.068 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.46 97.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 75.43 111.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.58 95.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.952 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.25 -39.8 89.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 70.24 110.615 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.507 ' HB1' HG22 ' A' ' 188' ' ' VAL . . . -63.3 -35.76 81.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.73 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 60.8 m -65.85 -38.5 89.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 71.33 110.543 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -65.04 -39.03 92.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 73.4 110.045 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.65 -33.8 75.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.897 -0.592 . . . . 72.12 110.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.1 mt -61.41 -34.43 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 74.24 110.817 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.612 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 mm -80.7 -40.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 61.41 111.108 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.13 -43.87 64.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.333 0.494 . . . . 53.13 112.333 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -100.25 -49.86 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.946 0.403 . . . . 75.15 110.87 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 143.71 -168.63 26.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.503 -0.639 . . . . 52.34 111.503 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 182' ' ' GLU . 4.3 pp -104.13 -24.02 13.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.769 0.285 . . . . 73.23 110.83 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.717 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 34.4 tt0 -67.11 -57.23 11.43 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.199 -0.455 . . . . 75.32 111.845 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 83.4 Cg_endo -87.47 -29.63 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.833 1.688 . . . . 73.24 113.093 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -73.93 -31.43 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.508 -0.314 . . . . 75.01 111.823 -172.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -61.81 -29.57 70.25 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.123 0.487 . . . . 75.0 110.023 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.61 -48.38 64.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.635 -0.711 . . . . 53.02 109.846 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 36.0 m -56.26 -38.46 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.631 -0.713 . . . . 40.14 111.446 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 184' ' ' ALA . 82.7 t -57.24 -37.41 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.186 0.439 . . . . 71.51 112.186 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -104.14 -28.24 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.311 -0.555 . . . . 74.41 111.996 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -94.36 12.3 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.128 0.418 . . . . 43.13 112.128 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.488 ' HB2' ' O ' ' A' ' 187' ' ' THR . 3.8 t90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.479 -0.772 . . . . 75.13 110.17 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.5 pm0 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.793 0.33 . . . . 75.32 110.219 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 5.7 Cg_exo -78.58 141.91 17.9 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.172 2.581 . . . . 35.14 113.577 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.713 HD12 HD21 ' A' ' 55' ' ' LEU . 97.0 mt -86.14 126.75 34.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.259 -0.882 . . . . 72.55 109.577 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.633 HD22 HG21 ' A' ' 85' ' ' VAL . 37.1 tp -93.28 114.77 27.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.303 . . . . 65.12 110.499 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' A' ' 62' ' ' LEU . 41.2 t -120.69 121.69 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.34 -0.391 . . . . 32.41 110.12 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 60.2 t -104.02 116.19 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 64.51 110.56 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.96 122.92 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.963 -0.562 . . . . 75.01 111.703 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.634 HD13 ' HG2' ' A' ' 65' ' ' PRO . 58.3 tp -107.74 105.07 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.931 0.396 . . . . 43.31 111.12 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.63 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -97.3 -142.94 13.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 61.42 112.098 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.777 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . 15.9 m120 -134.58 129.37 19.46 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.619 0.21 . . . . 75.34 111.155 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 68.6 Cg_endo -96.8 173.17 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.37 2.713 . . . . 74.15 111.716 170.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.78 -176.35 19.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.408 -0.901 . . . . 65.3 112.389 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 -67.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.054 2.502 . . . . 74.41 112.859 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -127.52 11.15 6.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 72.14 111.301 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 43.1 m-85 -65.55 -18.47 65.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.796 0.331 . . . . 62.45 111.102 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -75.71 -1.4 24.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 44.54 111.386 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 153' ' ' ASN . 68.3 mmtt -107.16 26.75 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 62.21 109.878 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 151' ' ' LEU . 71.2 p -102.19 172.72 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 65.24 110.448 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -66.0 -19.38 65.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.294 . . . . 52.33 111.249 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -76.34 -9.08 58.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 70.13 110.986 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -8.08 12.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.715 0.293 . . . . 75.35 111.466 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 135' ' ' ILE . 94.9 mt -63.42 -31.81 73.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.375 -0.375 . . . . 74.55 110.513 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -63.83 -26.64 70.21 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.948 -0.569 . . . . 75.34 112.142 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.63 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 74.3 t80 -90.74 -36.38 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.789 0.328 . . . . 65.32 110.517 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 mmt -57.36 -42.33 81.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.547 0.573 . . . . 75.42 112.547 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.619 ' HB ' HD13 ' A' ' 93' ' ' ILE . 48.2 t -61.74 -38.83 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 70.43 110.5 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.96 -38.64 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 53.42 110.851 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -57.36 -46.57 83.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 72.54 111.334 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG21 HG12 ' A' ' 166' ' ' VAL . 65.6 t -60.03 -45.56 95.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 71.13 110.745 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 36' ' ' ILE . 94.5 mt -61.6 -44.51 96.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.35 110.903 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.65 -35.5 72.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 71.23 111.167 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.53 -42.17 93.74 Favored Glycine 0 N--CA 1.454 -0.163 0 C-N-CA 121.288 -0.482 . . . . 53.52 112.916 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.27 -21.05 64.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.623 0.249 . . . . 72.41 111.015 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.883 HD13 ' HA3' ' A' ' 53' ' ' GLY . 70.5 mt -83.58 -45.71 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.177 0.513 . . . . 74.23 109.936 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.46 23.12 10.52 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 70.32 112.17 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -118.35 158.18 25.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.796 0.331 . . . . 35.44 110.757 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.77 146.56 43.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 71.41 110.726 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.603 ' CA ' ' HB ' ' A' ' 51' ' ' VAL . 38.9 p90 -80.79 151.03 28.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 62.4 110.682 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.55 164.14 32.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.855 0.359 . . . . 64.42 110.935 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 49' ' ' GLU . 46.6 t -75.2 126.1 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.694 -0.685 . . . . 74.42 112.063 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -76.45 127.13 32.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 64.35 109.125 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 38.6 ttmt -67.45 -5.93 17.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 45.01 111.964 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -80.34 -76.96 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.817 0.341 . . . . 74.34 111.402 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -90.13 -16.88 28.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.391 -0.368 . . . . 74.11 111.906 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 5.87 69.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.445 -0.883 . . . . 72.03 111.714 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.94 143.56 28.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.285 -0.265 . . . . 53.24 110.285 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.495 ' HG2' HG22 ' A' ' 42' ' ' VAL . 37.3 mt-10 -94.67 132.87 38.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 74.33 110.477 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 t -136.29 142.51 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.296 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.603 ' HB ' ' CA ' ' A' ' 40' ' ' PHE . 7.6 p -125.26 136.75 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.905 0.384 . . . . 75.13 110.641 175.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.481 HG22 HG12 ' A' ' 61' ' ' VAL . 2.0 p -97.58 149.79 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.901 -0.59 . . . . 74.22 111.094 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.883 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -179.07 -164.89 32.49 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.434 -0.889 . . . . 73.31 112.722 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -122.35 143.04 49.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.058 -0.349 . . . . 73.12 110.058 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.141 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.6 pt? -127.84 109.04 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 74.25 109.361 174.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.05 -45.82 0.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 61.52 111.65 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.28 -27.93 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 110.72 -0.952 . . . . 74.44 110.72 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 59' ' ' SER . 2.0 m -71.79 169.38 15.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.974 -0.613 . . . . 73.4 110.436 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 58' ' ' THR . 14.7 m -97.35 130.56 44.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.468 -0.567 . . . . 74.05 109.468 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.141 ' HB ' HD22 ' A' ' 55' ' ' LEU . 15.0 p -120.05 137.98 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 44.34 110.688 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 52' ' ' THR . 11.9 m -122.8 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.339 0.59 . . . . 72.41 109.847 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 7' ' ' VAL . 77.9 mt -92.39 110.57 21.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.686 -0.688 . . . . 75.35 110.028 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -109.64 132.23 54.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.855 -0.612 . . . . 65.54 110.674 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -120.88 127.92 26.01 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 74.43 110.369 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.634 ' HG2' HD13 ' A' ' 10' ' ' LEU . 48.4 Cg_endo -70.34 168.05 23.41 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.345 2.03 . . . . 75.05 111.262 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 66' ' ' ARG . 8.0 ttt180 -89.05 -60.54 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.837 -0.345 . . . . 75.33 110.726 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.1 p -167.11 172.38 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 24.3 110.541 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.46 ' HD1' ' H ' ' A' ' 71' ' ' GLU . 10.1 t80 71.2 118.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.073 0.858 . . . . 73.11 111.336 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -53.29 -56.24 18.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.589 -0.732 . . . . 51.52 111.624 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 12.5 m120 -56.62 -46.57 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 74.41 111.114 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.628 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 5.6 mm-40 -64.18 -43.99 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 45.15 111.192 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 m -57.84 -39.01 76.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 73.15 110.908 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.656 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -64.61 -34.96 91.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.519 -0.848 . . . . 74.51 111.898 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' ASN . 44.8 mtp180 -86.98 -2.7 58.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 62.55 110.486 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 27.5 mm-40 -79.43 -32.74 42.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 73.01 110.225 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.98 -32.18 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.681 -0.69 . . . . 72.41 110.751 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -47.17 -68.28 1.21 Allowed Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.626 -0.715 . . . . 52.43 113.871 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 -41.06 42.02 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.308 2.006 . . . . 75.24 112.844 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.57 -31.6 72.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.453 -0.339 . . . . 74.2 111.842 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.95 84.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 52.01 111.156 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -26.75 29.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.422 -0.354 . . . . 72.32 110.853 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.32 -46.04 83.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 64.22 110.376 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.58 -3.88 45.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 75.1 110.649 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m 60.71 34.69 19.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.678 -0.692 . . . . 73.4 111.313 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 6' ' ' LEU . 26.9 m -81.25 145.97 57.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.687 -0.688 . . . . 70.24 111.063 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 2.7 Cg_exo -76.49 131.06 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.95 2.434 . . . . 63.41 111.916 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 23.4 Cg_exo -66.43 47.0 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.782 2.988 . . . . 72.41 113.306 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -139.88 -37.67 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 72.34 109.926 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -84.59 -6.82 59.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 75.14 111.353 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.98 130.0 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.378 0.609 . . . . 72.35 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 7' ' ' VAL . 45.8 t -106.16 127.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.766 . . . . 62.02 110.111 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.705 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 40.0 t -114.7 110.18 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.072 -0.344 . . . . 73.44 110.072 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.619 HD13 ' HB ' ' A' ' 28' ' ' VAL . 39.5 mt -87.9 116.88 30.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.502 -0.317 . . . . 73.31 110.657 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -142.6 161.03 39.12 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.557 0.343 . . . . 65.43 110.197 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 137' ' ' VAL . 10.8 p-10 -91.65 148.27 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.509 -0.314 . . . . 61.34 110.517 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 73.8 tt0 -124.96 128.23 48.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.222 0.534 . . . . 73.42 111.197 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.675 HD11 ' HD3' ' A' ' 141' ' ' PRO . 47.1 tp -81.95 -13.9 56.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.666 -0.697 . . . . 65.31 111.72 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.59 5.21 51.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.259 0.552 . . . . 73.34 111.433 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.75 146.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.323 -0.399 . . . . 72.23 110.559 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.15 154.29 23.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.061 -0.518 . . . . 75.41 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.515 ' N ' ' HA2' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -67.68 109.76 3.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 63.23 110.071 -176.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.453 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 114.87 -8.5 21.56 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 54.03 112.623 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -98.83 132.55 44.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.882 -0.414 . . . . 73.52 109.882 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.629 ' HB ' HG11 ' A' ' 188' ' ' VAL . 3.1 mp -101.04 129.54 51.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.236 -0.438 . . . . 54.41 110.061 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 105' ' ' ARG . 10.2 tpt180 -108.79 127.79 54.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.017 -0.538 . . . . 75.33 110.449 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 131' ' ' HIS . 48.1 tp -97.66 132.29 43.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.376 -0.601 . . . . 72.23 109.376 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -155.07 122.11 5.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.288 -0.415 . . . . 73.32 110.109 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.732 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.4 pt? -102.3 -136.16 0.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.679 -0.408 . . . . 72.1 109.955 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.662 ' H ' ' HA ' ' A' ' 129' ' ' ASN . . . 40.3 -149.12 0.17 Allowed Glycine 0 C--N 1.334 0.472 0 O-C-N 123.625 0.578 . . . . 71.0 113.11 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.24 10.56 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.068 -1.213 . . . . 65.12 110.068 164.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.12 156.46 28.03 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.942 -1.123 . . . . 53.05 112.914 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -93.57 -178.63 4.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.792 0.33 . . . . 74.44 110.138 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' HA3' ' NH2' ' A' ' 134' ' ' ARG . . . 115.14 62.53 0.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.796 -0.716 . . . . 64.41 111.601 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.08 -102.34 0.18 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.801 -0.714 . . . . 75.31 111.593 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -154.22 168.38 26.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.254 -0.647 . . . . 74.1 109.254 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -41.86 -53.46 3.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.774 0.671 . . . . 73.32 111.617 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 120' ' ' SER . . . -67.04 2.33 5.15 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.022 -0.535 . . . . 72.42 114.205 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.83 -43.91 14.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.395 0.617 . . . . 72.34 109.366 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -79.68 -21.07 45.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.173 -0.921 . . . . 70.41 111.274 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.499 ' OG ' ' HA2' ' A' ' 117' ' ' GLY . 10.0 m -55.53 -43.8 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 65.12 111.726 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.656 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -68.11 -30.79 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.838 0.352 . . . . 73.41 111.343 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.416 ' HB1' ' HG3' ' A' ' 128' ' ' LYS . . . -78.16 -30.2 49.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 70.14 111.036 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.4 m -84.07 -39.71 19.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.093 -0.503 . . . . 51.1 110.967 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.51 77.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 73.31 111.861 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.654 HD23 ' HZ ' ' A' ' 130' ' ' PHE . 29.3 tp -85.45 -31.12 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.48 . . . . 73.23 109.806 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.33 -12.58 66.49 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.551 -0.75 . . . . 75.34 112.555 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.8 m -106.89 137.45 44.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.783 0.325 . . . . 61.1 110.858 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 8.0 mptt -110.58 -161.81 0.77 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.506 -0.553 . . . . 74.2 109.506 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.662 ' HA ' ' H ' ' A' ' 109' ' ' GLY . 86.3 m-20 76.6 12.97 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.199 0.6 . . . . 63.34 111.329 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.654 ' HZ ' HD23 ' A' ' 125' ' ' LEU . 16.7 m-30 -71.59 136.77 47.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.374 -0.602 . . . . 75.42 109.374 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.524 ' HB2' HD11 ' A' ' 106' ' ' LEU . 4.3 p-80 -89.88 107.77 19.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.303 0.573 . . . . 64.54 110.352 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.705 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 5.5 mpt_? -94.32 141.28 28.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.631 . . . . 71.42 110.614 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.3 t -92.9 104.18 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.555 -0.905 . . . . 73.04 108.555 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 94' ' ' HIS . 9.1 mtp180 -106.45 114.75 29.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.659 . . . . 71.14 110.529 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.1 mp -96.71 125.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.862 -0.422 . . . . 62.31 109.862 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -61.27 132.16 48.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.134 -0.555 . . . . 60.2 112.832 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 95' ' ' ASP . 23.9 t -86.44 -9.27 11.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.327 0.584 . . . . 71.41 111.035 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.515 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 117.37 -87.31 0.43 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.127 -1.035 . . . . 74.21 113.53 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -132.18 135.45 26.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.491 0.186 . . . . 74.15 111.229 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 29.2 Cg_endo -65.28 123.13 11.06 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.455 2.103 . . . . 73.31 111.113 171.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.948 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 14.3 Cg_exo -69.45 143.47 52.45 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.183 2.589 . . . . 20.33 112.58 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.66 -50.1 0.14 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.666 -0.778 . . . . 52.13 112.494 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -83.16 -32.67 26.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 72.5 111.405 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.542 ' HD3' ' HD1' ' A' ' 149' ' ' PHE . 4.7 ptmm? -114.81 158.84 21.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.868 -0.419 . . . . 70.22 109.868 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 20.3 t70 -52.87 131.91 48.37 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 123.549 0.531 . . . . 72.24 111.824 -175.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.948 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 53.7 Cg_exo -53.3 -41.04 75.59 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.473 2.782 . . . . 75.35 113.45 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.37 39.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 71.43 110.423 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.34 -28.14 69.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 73.31 111.123 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.542 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 71.0 t80 -73.45 -23.17 60.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 71.02 110.528 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.41 -24.2 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.493 0.663 . . . . 70.33 109.924 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.488 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 9.3 mp -87.16 12.1 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.674 -0.694 . . . . 52.41 112.043 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 149' ' ' PHE . 10.5 pt-20 -110.35 136.66 49.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.54 . . . . 63.13 111.083 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 28.9 p-10 -104.52 34.03 3.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.715 -0.675 . . . . 65.23 110.584 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.24 140.57 49.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.032 -0.531 . . . . 73.33 111.134 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.578 ' HB ' ' OE1' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -169.58 -177.71 2.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.312 -0.996 . . . . 75.42 108.312 173.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.3 -71.14 0.68 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.69 -0.404 . . . . 74.42 111.956 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.57 -42.58 8.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 71.33 111.294 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.578 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 0.6 OUTLIER -72.26 -17.42 61.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.689 -0.687 . . . . 75.33 111.175 -174.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.431 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 11.8 tpp180 -70.02 -25.56 63.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 74.43 110.149 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.53 -13.7 42.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 54.11 111.146 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -85.04 -16.83 39.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.248 -0.433 . . . . 64.32 111.098 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.766 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 47.3 t -52.23 -58.67 10.63 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 65.11 112.218 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.766 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.0 Cg_exo -59.68 -34.14 96.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.992 1.794 . . . . 55.14 112.5 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 m -71.97 -46.27 57.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.941 -0.572 . . . . 72.15 111.744 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.453 ' CD1' ' HA2' ' A' ' 102' ' ' GLY . 43.0 pt -69.2 -32.41 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 63.54 112.003 -174.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 162' ' ' VAL . 87.1 t -58.08 -42.3 82.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 42.45 111.32 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.8 -46.63 68.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.383 -0.371 . . . . 62.44 111.481 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -24.34 60.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.624 -0.262 . . . . 74.53 111.25 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.17 85.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 53.14 110.559 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.48 94.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.556 . . . . 74.01 110.377 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.01 -43.73 98.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.67 -0.696 . . . . 73.44 110.969 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.13 95.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.356 . . . . 63.34 110.944 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.423 ' HA ' HD12 ' A' ' 176' ' ' LEU . 90.8 m -61.65 -41.59 97.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 71.01 111.05 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.409 ' OE1' ' HB2' ' A' ' 55' ' ' LEU . 19.4 tt0 -71.56 -31.31 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.37 . . . . 74.15 110.372 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.43 -26.93 67.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.385 . . . . 73.34 110.418 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 173' ' ' THR . 90.8 mt -61.81 -46.47 89.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 64.54 110.911 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.564 HG13 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -81.03 -32.88 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.017 0.437 . . . . 75.43 110.386 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.13 66.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.374 -0.376 . . . . 61.14 111.699 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.434 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.1 tp60 -117.44 -61.49 1.69 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.657 -0.247 . . . . 74.32 111.004 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.29 177.12 35.05 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.233 -0.984 . . . . 55.31 112.101 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 3.9 pp -75.76 -20.51 58.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.492 0.187 . . . . 74.55 111.397 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.659 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 54.1 mt-10 -60.87 -61.64 7.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.65 0.611 . . . . 61.05 112.65 -172.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 71.5 Cg_endo -78.23 -31.12 3.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.592 1.528 . . . . 74.22 112.51 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.77 -58.01 5.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.1 -0.5 . . . . 52.34 111.535 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 24.8 pt20 -70.36 -24.81 63.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.699 -0.401 . . . . 74.43 110.697 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 9.9 t30 -52.25 -46.83 65.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.936 -0.574 . . . . 73.44 112.041 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -83.03 -32.62 26.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.869 -0.333 . . . . 74.34 111.232 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 104' ' ' ILE . 44.4 t -69.51 -28.82 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.568 -0.287 . . . . 71.15 111.724 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -99.08 10.9 40.52 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.019 -0.672 . . . . 73.53 110.91 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -141.48 31.65 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.066 0.395 . . . . 62.34 112.066 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.308 -0.853 . . . . 75.24 109.997 174.66 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.9 pm0 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.372 0.606 . . . . 62.13 110.501 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.546 ' HG2' HG23 ' A' ' 85' ' ' VAL . 83.8 Cg_endo -101.86 -167.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.944 3.096 . . . . 62.22 113.014 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 177' ' ' ILE . 55.9 tp -136.5 115.79 12.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.199 -0.91 . . . . 74.15 108.77 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.572 ' HA ' HG23 ' A' ' 61' ' ' VAL . 33.7 tp -90.82 104.4 16.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.47 -0.567 . . . . 72.03 109.47 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.666 ' HB ' HD23 ' A' ' 62' ' ' LEU . 43.3 t -111.63 122.06 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.258 -0.428 . . . . 64.11 110.54 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.57 114.77 47.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.938 -0.574 . . . . 71.1 109.753 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.1 121.16 6.19 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.681 -0.968 . . . . 70.33 110.681 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.88 124.0 44.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.017 0.437 . . . . 64.02 111.431 -172.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.81 -147.14 4.72 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.435 -0.666 . . . . 74.24 111.435 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -116.66 98.47 51.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.674 0.273 . . . . 63.34 111.208 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.0 118.37 5.39 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.689 2.259 . . . . 62.34 111.351 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 171.96 43.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.891 -0.671 . . . . 74.1 111.661 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.91 -72.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.843 2.362 . . . . 70.41 112.522 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -87.05 -15.01 39.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.41 0.624 . . . . 51.12 110.068 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -71.67 -23.62 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 74.13 111.546 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.36 -1.61 50.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.032 0.444 . . . . 73.04 110.98 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -108.86 15.56 23.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 73.04 110.454 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 65.6 p -101.85 -170.38 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.153 -0.476 . . . . 51.31 110.739 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -73.18 -4.94 36.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.909 0.385 . . . . 73.45 110.74 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -99.11 21.98 11.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.193 0.442 . . . . 72.54 112.193 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' MET . 39.2 p30 -101.37 -1.05 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.855 -0.338 . . . . 52.45 110.458 174.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.82 -37.12 70.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.969 -0.56 . . . . 74.2 111.381 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -62.54 -32.85 84.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.055 -0.593 . . . . 50.41 112.355 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -90.31 -24.61 20.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.793 -0.24 . . . . 75.34 111.239 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.503 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 17.2 mmt -55.91 -51.42 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.786 0.327 . . . . 74.43 111.175 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 22.0 t -66.46 -40.71 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 65.15 110.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 74.01 111.666 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -60.33 -45.08 94.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 75.53 110.553 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.36 -43.82 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 71.33 110.77 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.5 mt -60.97 -39.32 89.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 75.24 111.156 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.77 -46.32 58.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 60.11 110.793 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.55 -34.41 89.87 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.766 -0.652 . . . . 75.11 113.42 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -20.27 62.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.033 0.416 . . . . 74.21 111.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.473 HD13 ' HA3' ' A' ' 53' ' ' GLY . 75.4 mt -87.05 -41.97 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.934 0.397 . . . . 74.13 110.151 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.23 60.22 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.821 -0.627 . . . . 74.12 111.914 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -100.45 140.65 34.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.801 0.334 . . . . 61.14 110.485 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.46 143.06 30.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.322 -0.399 . . . . 74.51 111.315 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 1.061 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 3.3 p90 -60.57 142.04 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 72.25 111.144 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -117.81 147.47 42.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 73.43 110.852 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG22 ' HG2' ' A' ' 49' ' ' GLU . 39.5 t -75.87 128.54 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.953 -0.567 . . . . 63.22 110.169 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.437 ' CD2' ' HB ' ' A' ' 50' ' ' VAL . 27.1 m-70 -85.4 117.03 24.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.423 -0.353 . . . . 72.41 110.331 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -71.47 81.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.588 0.709 . . . . 74.25 111.175 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -175.52 -70.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.266 -0.879 . . . . 74.43 109.484 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.538 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 13.0 m -86.81 -27.95 23.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.745 -0.661 . . . . 55.11 110.662 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . 94.55 10.71 57.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 33.41 112.405 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -97.49 157.59 15.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 33.03 110.788 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.655 ' HG2' HG22 ' A' ' 42' ' ' VAL . 32.9 mt-10 -103.28 127.91 50.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.866 -0.606 . . . . 73.1 111.039 -175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.5 t -140.53 137.97 36.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 72.13 109.817 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.061 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.2 p -116.87 135.23 57.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.886 0.374 . . . . 72.41 111.097 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.581 HG22 HG12 ' A' ' 61' ' ' VAL . 20.2 p -100.85 108.13 19.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 75.12 110.492 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.473 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -127.72 -161.7 10.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.819 -0.705 . . . . 73.54 112.178 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -129.94 143.22 50.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.652 0.226 . . . . 70.43 110.548 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.081 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.0 pt? -142.28 121.17 12.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.184 -0.673 . . . . 73.44 109.184 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.8 -57.24 0.46 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.41 0.684 . . . . 75.31 111.862 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.37 -12.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.343 -0.456 . . . . 75.32 112.447 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.4 p -104.05 168.82 8.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.94 0.4 . . . . 71.32 110.899 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 t -90.86 99.64 12.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.565 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.081 ' HB ' HD22 ' A' ' 55' ' ' LEU . 11.6 p -76.17 129.94 36.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.54 -0.464 . . . . 63.13 109.872 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 52' ' ' THR . 17.6 m -118.45 111.22 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.494 0.664 . . . . 70.44 110.12 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD23 ' HB ' ' A' ' 7' ' ' VAL . 87.5 mt -92.6 117.92 30.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.759 . . . . 71.2 110.28 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.43 125.33 51.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.933 -0.576 . . . . 65.3 109.802 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -117.92 136.19 23.68 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.093 -0.503 . . . . 73.43 111.102 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.45 137.82 62.14 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.986 2.457 . . . . 71.32 111.477 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 32.5 ttt-85 -85.56 -52.78 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.741 -0.384 . . . . 74.11 110.08 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.2 p -159.44 139.17 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.467 -0.333 . . . . 54.52 110.997 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.548 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 20.5 t80 71.06 133.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.096 0.873 . . . . 55.5 111.802 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.446 ' HB3' ' CA ' ' A' ' 117' ' ' GLY . 2.0 mpt? -62.07 -56.43 19.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 75.14 112.038 -174.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.28 -41.58 97.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.394 -0.366 . . . . 74.42 111.834 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 9.0 mm-40 -63.68 -30.11 71.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.386 -0.37 . . . . 71.11 110.89 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 m -63.52 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 74.23 110.697 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.08 -38.16 96.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.573 -0.822 . . . . 35.23 111.098 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.58 1.41 29.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.057 0.456 . . . . 74.53 110.594 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 13.0 mm-40 -97.37 -51.8 4.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.919 -0.582 . . . . 74.31 110.07 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.65 -41.03 91.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 44.35 111.531 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.64 -65.3 3.41 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.189 -0.459 . . . . 72.43 113.083 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.63 -39.94 87.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.792 2.328 . . . . 75.12 112.873 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 48' ' ' ALA . 55.1 mt -64.7 -36.99 86.05 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.816 0.302 . . . . 61.32 111.816 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.22 -41.4 83.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.403 0.62 . . . . 50.22 110.337 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 -0.82 56.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 61.11 111.666 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -80.22 -49.05 12.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 71.22 110.564 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.551 ' CE2' ' HB ' ' A' ' 85' ' ' VAL . 40.0 p90 -108.45 9.42 27.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 74.02 110.86 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m 60.67 77.95 0.3 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.397 -0.82 . . . . 52.44 112.177 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 83' ' ' TYR . 12.9 p -107.45 130.94 22.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.15 -0.477 . . . . 44.43 109.901 175.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 22.3 Cg_endo -62.64 118.64 5.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.7 2.267 . . . . 70.3 112.4 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 2.8 Cg_exo -76.18 67.6 6.85 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.295 2.664 . . . . 64.44 112.097 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -146.04 -53.66 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 74.55 109.972 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -80.71 74.16 7.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.886 -0.597 . . . . 74.31 109.991 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -121.86 141.53 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 64.4 110.455 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG23 HD11 ' A' ' 5' ' ' LEU . 94.9 t -127.99 110.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.035 -0.53 . . . . 70.45 109.846 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.2 106.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.142 -0.318 . . . . 54.24 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.538 HG22 ' HA2' ' A' ' 25' ' ' GLY . 66.2 mt -94.97 117.34 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.349 -0.387 . . . . 75.35 110.259 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -154.78 161.21 41.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.923 0.392 . . . . 73.01 110.407 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.46 149.53 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 74.24 110.599 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.634 ' HB3' HG22 ' A' ' 99' ' ' ILE . 5.9 tp10 -123.41 109.09 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.399 -0.593 . . . . 62.21 109.399 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.765 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 6.1 mp -68.95 -34.19 74.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 75.23 111.793 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.96 -31.16 68.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.555 . . . . 52.35 112.186 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.634 HG22 ' HB3' ' A' ' 96' ' ' GLU . 14.8 tt -97.74 160.39 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.944 0.402 . . . . 65.51 111.461 -172.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.662 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 22.2 t70 -58.5 148.83 27.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.607 -0.724 . . . . 74.2 112.158 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 69.8 t80 -69.68 138.95 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.75 -0.659 . . . . 72.15 111.948 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.09 9.92 86.53 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.526 -0.761 . . . . 63.44 113.026 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -100.45 116.43 32.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.719 -0.474 . . . . 63.2 109.719 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.7 mp -79.98 106.43 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.446 -0.575 . . . . 61.41 109.446 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -109.06 150.06 28.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.98 -0.554 . . . . 73.21 109.905 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 131' ' ' HIS . 15.1 tp -113.14 146.67 38.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.665 -0.494 . . . . 72.35 109.665 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 131' ' ' HIS . 38.0 tttm -147.34 153.92 40.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.569 -0.53 . . . . 61.34 109.569 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.738 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -125.05 -71.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.281 0.363 . . . . 74.43 111.446 -176.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.738 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -63.69 161.04 36.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.273 -0.489 . . . . 62.12 112.828 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.52 143.59 31.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.935 -0.65 . . . . 61.53 112.329 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.42 -176.64 42.06 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.298 -0.721 . . . . 62.35 111.298 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -81.07 150.13 28.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 73.22 110.723 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.79 -59.56 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.743 -1.343 . . . . 73.4 109.743 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.836 ' HA3' HD21 ' A' ' 118' ' ' LEU . . . -91.48 163.97 29.01 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.67 -0.972 . . . . 53.15 110.67 170.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.575 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 4.7 t-80 -119.09 -63.33 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.268 -0.573 . . . . 51.43 111.631 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -107.82 -71.16 0.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.809 -0.357 . . . . 64.13 111.882 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 69' ' ' MET . . . -51.62 -48.24 50.15 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.812 -0.631 . . . . 72.24 114.659 -167.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.836 HD21 ' HA3' ' A' ' 114' ' ' GLY . 3.5 pp -78.28 -19.36 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.293 -0.563 . . . . 72.44 111.827 -174.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.575 ' HD3' ' O ' ' A' ' 115' ' ' HIS . 18.1 mtp180 -81.11 -26.45 36.18 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.0 -0.28 . . . . 43.32 110.29 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -67.57 -50.17 59.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.458 -0.337 . . . . 75.02 110.705 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.508 HG12 ' HA2' ' A' ' 73' ' ' GLY . 29.4 m -65.87 -33.8 66.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 70.12 111.089 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.17 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.419 . . . . 73.12 111.118 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.1 m -82.07 -28.91 32.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 75.04 110.545 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.45 -43.46 81.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.711 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.89 -41.5 59.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 75.04 109.743 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.7 62.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.617 -0.72 . . . . 43.04 112.25 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.481 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 6.6 m -108.54 148.01 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.843 -0.429 . . . . 73.02 109.843 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 11.6 mptt -117.2 -155.83 0.6 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.35 109.11 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.4 t30 73.88 9.96 4.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.797 0.808 . . . . 73.14 109.654 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -87.83 127.58 35.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.331 -0.849 . . . . 65.13 109.791 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.76 ' HB2' HD11 ' A' ' 106' ' ' LEU . 35.2 p-80 -73.05 120.41 18.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.359 0.599 . . . . 74.53 111.694 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 106' ' ' LEU . 43.0 mtm105 -95.21 139.77 31.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.635 -0.711 . . . . 72.41 110.451 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.85 104.16 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.449 -0.945 . . . . 64.53 108.449 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.485 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 53.5 mtp180 -100.92 107.86 19.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.456 -0.793 . . . . 73.13 110.377 -172.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.3 mp -93.81 113.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.609 . . . . 75.35 109.357 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 100' ' ' ASP . . . -57.46 138.5 48.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.136 -0.554 . . . . 73.31 113.904 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.765 ' HB ' ' HA ' ' A' ' 97' ' ' LEU . 89.6 t -88.98 -20.35 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 62.25 110.588 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 130.33 -78.43 0.38 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.282 -0.961 . . . . 75.31 113.312 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.587 ' HD3' ' O ' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -163.7 158.78 17.17 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 110.048 -0.353 . . . . 75.23 110.048 -174.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.587 ' O ' ' HD3' ' A' ' 139' ' ' ARG . 51.4 Cg_exo -55.43 159.65 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.018 2.479 . . . . 73.11 112.616 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 49.2 Cg_endo -67.12 161.45 42.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.707 2.272 . . . . 74.52 112.877 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -86.87 1.97 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.73 . . . . 72.23 112.345 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -103.21 8.28 38.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 72.33 111.412 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -131.48 161.86 31.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.407 -0.361 . . . . 64.54 110.605 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.67 150.64 25.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.454 0.471 . . . . 64.24 111.445 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.88 -43.07 59.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.776 2.317 . . . . 70.44 112.075 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.25 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 60.02 111.072 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 151' ' ' LEU . . . -83.54 -27.8 29.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.416 -0.356 . . . . 60.41 110.949 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 86.3 t80 -67.65 -35.36 78.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.15 110.223 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.752 ' O ' ' HB ' ' A' ' 20' ' ' THR . 35.5 m -84.86 -6.22 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 74.1 111.021 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.697 HD23 HG21 ' A' ' 20' ' ' THR . 11.1 mt -90.78 6.12 45.54 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.174 0.435 . . . . 64.32 112.174 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -93.27 167.44 11.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.487 -0.485 . . . . 71.02 110.054 175.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -149.5 148.9 29.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.544 -0.298 . . . . 71.11 111.301 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.789 ' HA ' ' HG2' ' A' ' 159' ' ' ARG . 84.4 m-85 66.89 96.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.477 1.11 . . . . 75.13 112.313 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 13.3 p -114.68 -166.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 75.21 109.572 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.2 -72.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.846 0.684 . . . . 64.12 112.846 -171.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.67 -56.46 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.157 0.429 . . . . 63.4 112.157 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.474 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -65.81 -23.73 66.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.756 -0.656 . . . . 75.55 111.878 -171.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.789 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 3.3 tpp180 -71.97 -28.05 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 75.21 110.396 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.432 ' O ' ' HD2' ' A' ' 163' ' ' PRO . . . -87.6 -11.11 49.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.957 -0.565 . . . . 61.41 110.183 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.6 -3.6 59.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.731 . . . . 75.11 111.058 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.695 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 95.8 t -57.87 -52.91 70.97 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.616 -0.265 . . . . 71.34 110.731 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 51.1 Cg_exo -55.84 -35.92 94.59 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.968 1.779 . . . . 73.44 111.977 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -64.35 -48.92 73.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 45.54 111.198 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 36.0 pt -79.93 -26.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 74.13 111.944 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 163' ' ' PRO . 9.3 p -68.48 -31.91 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.882 -0.327 . . . . 43.21 110.698 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 44.8 mt-10 -64.68 -43.32 93.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.181 0.515 . . . . 73.44 109.621 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.63 -47.23 82.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.345 -0.843 . . . . 61.25 110.851 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.38 99.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.511 . . . . 73.44 111.547 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.12 96.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 73.41 110.783 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.42 -39.04 81.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 73.43 110.687 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.88 -42.03 98.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 44.33 111.062 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.6 m -61.62 -38.13 86.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 62.21 110.516 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -73.11 -34.01 65.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 72.25 110.252 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.2 tp -66.55 -27.3 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 73.52 110.832 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 92.0 mt -61.29 -33.73 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.5 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 5' ' ' LEU . 38.0 mm -81.28 -46.62 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 53.3 110.938 176.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.79 -61.27 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 33.02 111.773 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.432 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.5 tp60 -93.14 -44.62 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 72.44 110.576 -175.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 183' ' ' PRO . . . 130.26 156.64 8.75 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.064 -0.814 . . . . 54.31 111.064 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.68 -27.73 66.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.164 0.482 . . . . 63.21 110.959 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.714 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 35.1 tt0 -72.5 -52.46 6.58 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.812 -0.631 . . . . 73.04 111.664 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 9.9 Cg_exo -73.89 -32.23 7.43 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.891 1.727 . . . . 62.14 112.895 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -64.3 -40.03 95.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 111.76 0.281 . . . . 54.42 111.76 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 9.9 pt20 -58.22 -30.75 66.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.645 0.259 . . . . 74.41 110.904 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.41 -47.86 74.81 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.617 -0.512 . . . . 72.32 109.617 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -59.03 -38.84 80.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.671 -0.695 . . . . 61.4 111.237 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 184' ' ' ALA . 99.5 t -58.47 -35.91 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.992 -0.549 . . . . 61.31 112.237 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.458 ' HD2' ' O ' ' A' ' 185' ' ' GLN . 9.4 p80 -106.8 15.22 25.79 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.116 -0.634 . . . . 71.33 110.675 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.86 6.52 47.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.103 -0.499 . . . . 72.44 111.496 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.489 -0.767 . . . . 73.23 110.105 176.303 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 22.3 ptt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 111.218 0.081 . . . . 73.35 111.218 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.552 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -166.73 22.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.974 0.416 . . . . 62.13 111.145 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 86' ' ' PRO . 1.1 pm0 -87.05 130.51 47.9 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.252 -0.431 . . . . 74.0 110.315 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' CD ' ' HD2' ' A' ' 86' ' ' PRO . 93.9 Cg_endo -96.23 162.01 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.026 2.484 . . . . 64.4 113.495 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.666 HD11 HG23 ' A' ' 91' ' ' VAL . 58.0 tp -89.45 122.78 32.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.168 -0.924 . . . . 71.42 108.797 172.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.3 tp -91.73 105.37 17.67 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.484 -0.561 . . . . 73.1 109.484 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HB ' HD23 ' A' ' 62' ' ' LEU . 38.2 t -107.07 113.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 74.34 110.525 -178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 92' ' ' VAL . 58.3 t -109.86 118.1 56.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.669 -0.696 . . . . 74.34 109.716 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.27 122.72 7.45 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.201 -0.999 . . . . 74.32 111.779 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.437 HD13 ' HA3' ' A' ' 117' ' ' GLY . 46.5 tp -77.77 82.04 4.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.329 0.585 . . . . 62.25 109.79 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.695 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -164.2 101.73 0.19 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.271 -0.877 . . . . 43.43 111.104 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 65' ' ' PRO . 50.8 m-80 -88.38 146.94 38.84 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.494 -0.188 . . . . 72.04 110.494 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 25.5 Cg_exo -62.96 96.43 0.17 Allowed 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 123.06 2.507 . . . . 73.43 112.697 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . -122.33 119.1 3.86 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.38 -0.827 . . . . 73.02 111.3 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.45 -54.12 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 124.359 3.373 . . . . 62.34 114.58 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -105.09 -30.08 9.98 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.439 0.533 . . . . 71.52 112.439 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 p90 -89.13 2.68 53.79 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.17 -0.612 . . . . 75.3 112.059 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.02 -1.51 52.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.893 0.377 . . . . 74.3 110.679 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.6 10.76 16.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.292 -0.413 . . . . 74.25 110.868 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 22' ' ' HIS . 6.2 t -105.1 -174.58 2.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.757 -0.377 . . . . 65.05 110.898 -175.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.578 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 54.5 mtt180 -57.24 -20.94 30.53 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.61 0.596 . . . . 65.12 112.61 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.636 ' H ' HG23 ' A' ' 20' ' ' THR . 5.5 t-160 -91.65 14.05 16.27 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 72.15 111.609 -175.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.17 1.06 57.38 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.837 -0.345 . . . . 65.23 110.379 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 88.0 mt -51.41 -48.11 62.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.745 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.0 -36.76 93.34 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.958 -0.639 . . . . 71.31 112.846 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.695 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 77.9 t80 -80.35 -26.97 38.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.627 0.251 . . . . 64.02 110.824 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.586 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 7.2 mmt -55.18 -53.45 55.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 72.31 111.931 -178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.658 HG21 HG12 ' A' ' 93' ' ' ILE . 90.2 t -56.12 -45.57 80.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.76 0.314 . . . . 63.32 111.048 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -48.85 74.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 51.14 111.186 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.33 -40.02 96.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 52.52 110.814 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 HG12 ' A' ' 166' ' ' VAL . 45.0 t -67.4 -45.63 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 74.33 111.323 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.4 mt -60.36 -45.14 94.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 73.53 110.482 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.53 -31.72 73.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 74.35 110.549 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -45.47 49.53 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.598 -0.728 . . . . 22.3 113.081 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HG3' HD12 ' A' ' 36' ' ' ILE . 13.1 ptp180 -70.36 -34.95 73.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.094 0.447 . . . . 74.13 110.933 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -71.65 -37.02 61.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.071 0.463 . . . . 74.12 110.117 175.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.17 53.44 2.66 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.74 -0.743 . . . . 44.0 112.202 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 58.6 m -147.6 144.82 28.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.651 0.263 . . . . 75.3 110.487 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.06 147.81 25.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.302 -0.408 . . . . 73.33 110.423 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.623 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 2.9 p90 -78.25 132.64 37.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.09 0.471 . . . . 64.43 110.894 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -99.59 150.26 22.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.782 -0.645 . . . . 74.55 110.893 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 24.6 t -73.16 124.08 29.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.603 -0.726 . . . . 72.44 111.427 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -88.08 99.96 12.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.064 -0.717 . . . . 74.23 109.064 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -69.23 86.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 71.04 110.553 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -173.13 -62.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.07 -0.968 . . . . 72.55 109.189 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -99.48 -14.63 19.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.643 -0.708 . . . . 74.41 110.846 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.38 7.54 67.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.836 -0.697 . . . . 63.41 112.467 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.573 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -93.7 163.05 13.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.705 0.288 . . . . 33.12 110.767 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.936 ' HB2' ' HE3' ' A' ' 64' ' ' LYS . 29.8 mt-10 -124.04 131.48 53.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.319 -0.401 . . . . 61.32 110.274 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -133.33 139.14 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.055 -0.521 . . . . 74.04 110.718 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 8.5 p -119.18 142.67 33.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.435 -0.348 . . . . 74.22 110.079 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.428 HG22 HG12 ' A' ' 61' ' ' VAL . 14.1 p -108.29 143.43 37.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.953 0.353 . . . . 74.45 111.953 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.18 -164.43 21.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.202 -0.523 . . . . 52.11 111.887 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -134.12 122.83 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.75 0.275 . . . . 64.21 110.622 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.053 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -111.16 119.1 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.486 -0.561 . . . . 51.43 109.486 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.02 -67.6 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.412 0.685 . . . . 54.32 111.656 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.43 12.79 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.982 -0.847 . . . . 40.44 110.982 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.525 ' O ' HD23 ' A' ' 55' ' ' LEU . 47.0 m -126.31 146.0 50.2 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 71.41 109.414 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 4' ' ' PRO . 18.0 m -67.62 131.71 46.13 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.701 -0.481 . . . . 45.45 109.701 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.053 ' HB ' HD22 ' A' ' 55' ' ' LEU . 9.9 p -111.65 127.98 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.904 0.383 . . . . 75.05 110.132 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG12 HG22 ' A' ' 52' ' ' THR . 11.5 m -117.13 109.26 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.308 0.575 . . . . 73.03 109.846 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.515 HD23 ' HB ' ' A' ' 7' ' ' VAL . 78.3 mt -92.57 106.36 18.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.561 -0.745 . . . . 63.14 109.748 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 127.88 55.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.814 -0.63 . . . . 74.0 110.922 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.936 ' HE3' ' HB2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -123.63 143.6 42.14 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.11 -0.7 . . . . 51.14 109.11 174.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.815 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 14.6 Cg_exo -69.65 175.59 7.81 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.179 2.586 . . . . 54.14 113.598 -173.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 7.1 ptm180 -77.38 -61.81 1.86 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.621 -0.718 . . . . 64.34 110.949 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.665 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 24.6 p -169.49 166.79 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.55 -0.537 . . . . 72.23 109.55 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 16.0 t80 70.27 144.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.657 0.741 . . . . 71.51 112.595 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.5 -56.17 20.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.482 -0.781 . . . . 53.43 111.721 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.417 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 25.2 t-20 -58.04 -43.7 86.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.165 -0.471 . . . . 71.14 111.573 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 8.6 mm-40 -56.66 -41.57 77.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.132 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.5 m -57.5 -32.44 67.02 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.515 0.51 . . . . 65.21 111.306 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -65.16 -47.11 84.74 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.654 -0.784 . . . . 42.53 112.349 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 25.6 ptt180 -89.22 3.06 53.24 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.981 -0.288 . . . . 73.35 111.111 -177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.815 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 23.2 mm-40 -66.92 -38.24 85.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 71.21 110.783 175.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.0 t -72.11 -34.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.977 -0.556 . . . . 73.13 111.696 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.539 ' O ' ' HD3' ' A' ' 81' ' ' LYS . . . -54.18 -73.3 0.43 Allowed Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.975 -0.557 . . . . 44.23 113.642 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 74' ' ' ARG . 18.5 Cg_endo -59.79 -23.21 71.22 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.081 2.521 . . . . 72.14 113.407 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 48' ' ' ALA . 34.8 mt -75.41 -43.03 52.12 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.071 -0.252 . . . . 75.03 111.386 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.77 80.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.55 . . . . 71.5 110.825 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 77' ' ' GLY . 2.2 mptp? -80.79 -26.34 37.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.771 -0.649 . . . . 72.31 110.037 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 78' ' ' PRO . 61.6 t80 -56.6 -52.45 64.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.602 -0.726 . . . . 73.21 110.857 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -94.92 -1.2 53.06 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.849 -0.34 . . . . 71.41 110.709 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 m 63.12 90.95 0.07 Allowed 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.787 0.679 . . . . 64.54 110.731 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.27 123.7 76.83 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.472 -0.786 . . . . 65.43 112.414 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.617 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 5.9 Cg_exo -79.81 113.35 3.02 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.804 2.336 . . . . 74.03 109.452 162.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 24.9 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.853 2.368 . . . . 74.42 113.778 -171.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -92.6 -57.74 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.708 -0.678 . . . . 74.43 109.721 171.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 130' ' ' PHE . 8.8 tt0 -173.64 148.99 1.57 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.942 -0.572 . . . . 72.05 109.861 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.1 tt -124.18 122.1 63.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.335 0.588 . . . . 71.54 110.935 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 5' ' ' LEU . 98.9 t -113.19 126.68 70.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.576 -0.738 . . . . 75.44 109.977 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.545 HG22 ' HB ' ' A' ' 8' ' ' VAL . 82.0 t -129.48 107.02 14.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.239 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.658 HG12 HG21 ' A' ' 28' ' ' VAL . 4.2 mp -84.5 133.74 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.702 -0.681 . . . . 53.24 109.329 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.506 ' CE1' ' HG3' ' A' ' 132' ' ' ARG . 57.0 p-80 -151.8 179.58 8.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.895 0.379 . . . . 63.04 111.116 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.23 148.57 26.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.228 -0.897 . . . . 71.42 111.092 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -140.95 115.04 9.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.968 0.413 . . . . 73.3 110.374 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.631 HD23 HG11 ' A' ' 137' ' ' VAL . 95.5 mt -82.75 -14.16 55.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.632 -0.713 . . . . 72.33 112.458 -173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -94.39 -12.13 28.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.902 0.382 . . . . 65.22 110.984 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.591 HD11 ' HD2' ' A' ' 105' ' ' ARG . 46.3 mm -106.63 139.45 28.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 72.34 111.895 -175.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -54.83 142.21 30.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.958 -1.019 . . . . 72.23 111.617 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.3 t80 -68.43 115.12 7.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.841 -0.618 . . . . 62.42 111.241 -173.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.07 -16.78 6.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.329 -0.938 . . . . 42.15 113.635 174.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -114.21 159.97 19.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.402 0.601 . . . . 64.05 111.694 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -108.23 129.32 62.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.478 -0.783 . . . . 73.15 111.444 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.735 ' HB3' ' HB2' ' A' ' 134' ' ' ARG . 75.2 ttt180 -109.3 125.39 52.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.052 -0.722 . . . . 43.1 109.052 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -110.23 118.26 35.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.787 0.327 . . . . 71.01 111.35 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.79 161.43 26.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.161 -0.681 . . . . 73.04 109.161 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 129' ' ' ASN . 89.9 mt -66.78 -72.48 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.232 0.456 . . . . 73.35 112.232 -176.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.48 -126.19 3.7 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.364 -0.922 . . . . 70.53 113.56 -173.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.96 152.56 26.02 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.007 -0.616 . . . . 73.51 112.454 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.5 163.54 32.75 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.81 -0.71 . . . . 43.13 112.048 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.14 164.34 18.26 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.219 -0.289 . . . . 70.23 110.219 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.85 -30.27 5.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.831 -0.7 . . . . 43.44 111.954 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.16 -170.58 24.06 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.952 -0.642 . . . . 55.43 111.649 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.406 ' CE1' HD11 ' A' ' 97' ' ' LEU . 39.4 m80 -103.14 -86.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.432 0.53 . . . . 72.0 112.432 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -118.24 -64.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.765 0.654 . . . . 73.44 112.765 -170.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.437 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -48.11 -49.43 24.29 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 123.495 0.497 . . . . 72.15 114.314 -168.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.7 pt? -57.77 -35.06 70.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 71.15 111.883 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.487 ' HG3' ' HG ' ' A' ' 118' ' ' LEU . 78.8 mtp180 -80.18 -40.05 28.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.065 -0.516 . . . . 63.52 110.484 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 45.0 m -69.6 -42.5 74.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.624 -0.716 . . . . 65.41 112.154 -176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 m -63.47 -27.93 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.88 0.326 . . . . 72.54 111.88 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.17 -43.37 91.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.922 0.391 . . . . 73.22 110.731 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.7 m -79.23 -22.62 44.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.03 -0.532 . . . . 71.42 111.163 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.43 77.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 72.45 111.176 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.86 -41.59 6.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.338 -0.392 . . . . 64.35 111.025 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.28 -5.83 63.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.792 -0.718 . . . . 73.42 111.835 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 52.7 m -125.38 126.8 45.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.936 0.398 . . . . 63.32 110.171 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.587 ' N ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.58 -160.91 1.11 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.031 -0.531 . . . . 74.44 109.825 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 108' ' ' LEU . 88.4 m-20 69.85 72.63 0.23 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.5 0.667 . . . . 75.4 111.204 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.402 ' HB3' ' HG3' ' A' ' 89' ' ' GLN . 85.6 m-85 -140.86 -82.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.222 -0.899 . . . . 65.41 109.411 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -152.29 103.69 2.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 74.02 110.327 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.506 ' HG3' ' CE1' ' A' ' 94' ' ' HIS . 2.6 tpp180 -102.56 108.79 20.21 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.865 -0.791 . . . . 64.42 108.865 175.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 84.0 t -82.66 116.36 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.227 0.537 . . . . 73.24 111.211 -171.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.837 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 54.1 mtt180 -105.11 111.18 23.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.207 -0.906 . . . . 73.02 109.984 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 24' ' ' LEU . 58.4 mt -95.65 118.57 42.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.108 -0.701 . . . . 74.12 109.108 174.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -60.64 128.25 44.94 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.773 -0.727 . . . . 64.35 111.993 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.631 HG11 HD23 ' A' ' 97' ' ' LEU . 8.9 p -98.51 -5.86 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.165 0.507 . . . . 72.31 110.744 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.23 -108.5 0.93 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.643 -0.789 . . . . 73.51 112.402 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -153.98 157.13 32.49 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 110.418 -0.215 . . . . 73.44 110.418 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.93 135.01 56.67 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.718 2.279 . . . . 73.1 111.73 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.524 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 59.0 Cg_endo -73.29 164.76 34.38 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.77 2.313 . . . . 73.52 112.627 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -26.03 6.92 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.879 -0.677 . . . . 63.01 112.24 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -105.53 -66.96 0.95 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.731 0.301 . . . . 72.13 111.782 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.782 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -77.57 161.13 28.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.916 0.389 . . . . 72.12 111.621 -174.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -55.36 137.4 68.72 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.446 -0.797 . . . . 45.4 111.02 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.81 -44.7 30.81 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 55.42 113.417 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.26 -34.95 66.11 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.001 -0.28 . . . . 71.52 110.68 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.09 73.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 52.3 110.778 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.524 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 32.8 t80 -68.16 -26.56 65.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.983 -0.553 . . . . 72.52 110.318 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 25.3 t -81.66 -16.99 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.779 -0.646 . . . . 63.31 109.735 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.36 -11.25 56.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.716 -0.675 . . . . 73.21 110.858 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -113.64 104.66 12.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.17 0.509 . . . . 62.4 110.412 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.578 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 51.1 t30 -90.84 79.7 5.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 72.0 111.336 -174.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -146.56 135.67 22.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 72.45 109.585 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -154.29 -171.62 3.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.915 -0.772 . . . . 73.31 108.915 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 155' ' ' THR . . . -92.46 -71.62 0.64 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.855 0.316 . . . . 73.3 111.855 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.01 -51.66 4.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.186 0.517 . . . . 54.3 111.689 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 101' ' ' PHE . 1.1 pm0 -69.26 -17.03 63.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.784 . . . . 71.24 111.468 -172.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -64.48 -27.07 68.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.736 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.59 -20.2 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.234 -0.439 . . . . 74.02 111.032 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.7 6.92 39.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 73.24 111.791 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.682 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 84.2 t -53.66 -55.09 38.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.087 0.403 . . . . 73.0 112.087 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.6 Cg_exo -53.62 -39.81 81.59 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.027 1.818 . . . . 75.51 112.505 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 47.8 m -65.62 -50.96 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.36 -0.382 . . . . 63.54 111.216 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.12 -32.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 64.11 111.401 -175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.54 HG12 HG21 ' A' ' 31' ' ' VAL . 75.7 t -69.05 -45.87 79.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.636 -0.256 . . . . 74.53 111.109 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -60.13 -41.35 92.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.691 0.282 . . . . 71.23 110.635 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.25 -37.61 78.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.416 . . . . 71.14 111.261 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.12 74.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 70.11 110.884 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.21 -34.33 78.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.017 -0.538 . . . . 73.24 110.838 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.28 -42.98 64.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.753 -0.658 . . . . 52.14 110.633 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -65.99 -25.86 67.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 52.23 111.087 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.8 m -61.27 -37.96 85.03 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 54.32 110.404 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 55' ' ' LEU . 34.0 tt0 -73.1 -30.76 63.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 74.54 110.078 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 tp -66.19 -28.44 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 73.13 110.366 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.7 mt -64.94 -25.39 67.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.954 -0.566 . . . . 75.0 110.822 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.564 HD11 HD13 ' A' ' 5' ' ' LEU . 26.7 mm -80.72 -51.21 16.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.895 -0.593 . . . . 63.22 110.733 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -73.3 -42.5 62.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.769 -0.651 . . . . 62.11 112.313 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.441 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.9 tp60 -93.46 -62.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.766 0.317 . . . . 70.23 111.325 -174.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 148.38 -129.8 3.24 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.65 -0.786 . . . . 70.44 112.21 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 182' ' ' GLU . 3.0 pp -124.01 -46.77 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 74.31 111.923 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.79 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 44.8 tt0 -74.19 -57.56 2.22 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.671 0.249 . . . . 73.32 111.671 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.3 Cg_exo -63.97 -25.34 66.8 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.515 1.477 . . . . 73.03 111.475 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -70.28 -50.18 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 65.51 110.89 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.1 pt20 -65.56 -30.57 71.33 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.907 0.384 . . . . 73.4 110.141 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -61.56 -45.01 95.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 55.33 109.837 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 91.2 m -59.74 -42.45 93.2 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.989 -0.55 . . . . 55.51 110.685 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 184' ' ' ALA . 58.7 t -66.43 -34.28 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.949 -0.568 . . . . 42.42 111.892 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.35 5.94 46.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.196 -0.315 . . . . 72.42 111.844 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.04 -17.91 38.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 70.44 111.066 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.361 -0.828 . . . . 71.43 109.986 178.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 110.303 -0.258 . . . . 72.4 110.303 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.91 145.79 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 73.31 110.179 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.675 ' HG3' HG23 ' A' ' 58' ' ' THR . 10.3 pt-20 -104.24 116.83 60.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.341 0.591 . . . . 75.02 111.199 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 59' ' ' SER . 27.8 Cg_endo -96.57 113.39 0.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.56 2.84 . . . . 60.13 112.207 175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.634 HD13 HD11 ' A' ' 177' ' ' ILE . 45.7 tp -88.66 119.67 29.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.509 -0.314 . . . . 73.42 110.383 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.612 ' HA ' HG23 ' A' ' 61' ' ' VAL . 61.2 tp -92.67 107.12 18.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 72.32 109.861 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.653 ' HB ' HD23 ' A' ' 62' ' ' LEU . 42.7 t -98.05 117.36 42.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.025 -0.534 . . . . 71.34 109.756 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.24 114.84 41.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.021 -0.536 . . . . 74.44 110.002 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.83 122.75 7.52 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.819 -0.705 . . . . 53.53 111.732 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.67 100.06 5.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.864 0.364 . . . . 74.04 110.778 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.95 135.45 11.43 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.818 -0.628 . . . . 71.24 111.85 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 34.5 m-80 -139.32 129.04 14.25 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 110.225 -0.287 . . . . 74.54 110.225 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 31.8 Cg_exo -59.19 165.6 8.64 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.408 2.739 . . . . 74.33 113.483 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.63 111.0 0.49 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.748 -0.941 . . . . 75.41 110.748 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -45.22 -50.28 9.15 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.326 2.684 . . . . 70.24 113.155 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -100.98 -10.93 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.216 -0.447 . . . . 63.12 111.367 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 151' ' ' LEU . 39.7 m-85 -101.18 1.81 39.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 74.5 112.258 -169.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.583 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -87.71 -15.06 38.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.04 0.448 . . . . 43.13 110.625 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -105.5 9.78 33.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.745 -0.661 . . . . 75.03 110.412 -175.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 153' ' ' ASN . 75.6 p -111.74 -169.5 1.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.125 -0.489 . . . . 72.01 111.389 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 62.9 mtt180 -67.08 -4.94 11.26 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.042 0.449 . . . . 75.25 111.013 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -76.0 -8.76 57.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 75.14 111.142 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 24.4 m-80 -134.38 32.34 3.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.756 -0.202 . . . . 71.23 111.509 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 137' ' ' VAL . 64.6 mt -58.29 -38.21 76.57 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.718 0.294 . . . . 65.33 111.437 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.36 87.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.837 -0.697 . . . . 65.01 112.303 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HE1' ' HD2' ' A' ' 64' ' ' LYS . 87.3 t80 -73.61 -32.72 64.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.611 0.244 . . . . 72.42 110.867 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.4 mmt -53.44 -47.43 69.69 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.043 -0.526 . . . . 73.43 111.263 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 48.2 t -66.09 -42.93 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.056 -0.52 . . . . 64.3 110.77 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -61.96 -40.47 95.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 64.22 110.909 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.69 -46.82 88.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.763 -0.653 . . . . 71.45 110.242 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -33.22 59.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 72.45 111.173 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 29' ' ' ALA . 64.9 mt -57.74 -50.06 74.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.128 -0.323 . . . . 65.14 110.128 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.25 -32.85 68.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.52 . . . . 62.42 110.673 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.87 -48.39 66.78 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.617 -0.719 . . . . 54.41 112.894 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -73.9 -22.76 59.59 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.169 0.485 . . . . 71.34 111.054 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -76.16 -45.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.401 . . . . 64.52 110.001 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.6 37.02 4.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.939 -0.648 . . . . 61.3 111.964 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.4 m -153.45 117.79 4.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.728 0.299 . . . . 74.15 110.486 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.04 145.3 32.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.325 -0.398 . . . . 45.13 110.887 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 1.06 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 5.1 p90 -68.55 145.63 53.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.95 -0.568 . . . . 72.31 111.644 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -123.41 145.33 48.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 64.25 110.436 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 49' ' ' GLU . 51.5 t -68.68 125.88 27.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.252 -0.431 . . . . 72.52 111.082 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -80.74 143.77 32.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 70.04 110.445 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 44' ' ' LYS . 10.0 tmtt? -62.32 -63.91 1.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 65.4 111.129 -174.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -74.0 -31.17 62.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.258 -0.428 . . . . 73.45 111.665 -170.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 m -81.66 -28.04 33.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.859 0.361 . . . . 75.41 111.524 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.65 38.33 95.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.542 -0.837 . . . . 61.53 111.615 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.19 144.01 31.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.446 -0.205 . . . . 72.55 110.446 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HG3' HG22 ' A' ' 42' ' ' VAL . 2.6 mp0 -73.78 123.29 23.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.161 -0.472 . . . . 64.42 111.213 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.3 t -138.74 140.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.806 -0.633 . . . . 71.05 109.662 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.06 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 14.5 p -136.84 148.43 26.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.301 . . . . 63.31 110.933 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.653 HG22 HG12 ' A' ' 61' ' ' VAL . 24.0 p -103.36 161.27 13.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.175 -0.466 . . . . 60.12 110.902 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.95 -161.28 30.66 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.133 -0.556 . . . . 73.1 111.799 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.607 ' HD2' ' HA ' ' A' ' 59' ' ' SER . 11.0 mmm180 -131.75 127.32 36.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.803 0.301 . . . . 73.02 110.201 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.086 HD22 ' HB ' ' A' ' 60' ' ' VAL . 1.6 pt? -121.78 119.03 30.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.578 . . . . 75.42 109.441 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 174' ' ' GLU . . . 58.45 10.16 1.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.767 -0.651 . . . . 71.24 112.667 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.07 -16.87 17.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.54 -0.838 . . . . 74.2 112.45 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.675 HG23 ' HG3' ' A' ' 3' ' ' GLU . 98.0 m -89.88 139.73 30.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.246 -0.279 . . . . 71.42 110.246 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.607 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 20.8 m -68.45 109.74 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.688 -0.486 . . . . 53.11 109.688 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.086 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -98.93 136.08 31.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.115 0.483 . . . . 64.22 111.058 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.653 HG12 HG22 ' A' ' 52' ' ' THR . 6.4 m -120.43 112.18 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.741 -0.663 . . . . 75.04 109.318 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD23 ' HB ' ' A' ' 7' ' ' VAL . 91.9 mt -91.91 109.58 20.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 70.41 109.629 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.7 129.3 51.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.02 -0.536 . . . . 74.41 110.964 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 3.4 ptmt -121.28 132.32 24.24 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.769 -0.65 . . . . 51.43 110.175 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 24.0 Cg_exo -64.34 155.88 63.17 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.46 2.107 . . . . 73.43 110.959 174.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 18.1 ptp180 -65.17 -59.74 3.77 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.927 -0.309 . . . . 63.32 110.958 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.494 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 5.0 p -169.44 152.31 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.896 -0.409 . . . . 55.42 109.896 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.2 t80 75.48 126.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.874 0.733 . . . . 74.41 111.393 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -60.81 -40.21 91.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.393 -0.821 . . . . 75.32 112.209 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.76 -28.39 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 73.42 110.851 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 74' ' ' ARG . 4.9 tm-20 -68.64 -38.15 80.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.872 -0.788 . . . . 72.42 108.872 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -64.66 -23.7 67.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.415 -0.811 . . . . 61.4 111.237 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.09 -29.99 76.49 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.982 -0.554 . . . . 44.31 112.993 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 36.0 ptt180 -93.26 -1.9 55.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.004 0.43 . . . . 73.32 110.585 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -93.93 -47.97 6.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.977 -0.556 . . . . 63.35 111.333 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.2 -33.58 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 32.31 112.051 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.5 -70.78 0.88 Allowed Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.027 -0.606 . . . . 54.1 112.765 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.37 -29.19 88.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.885 2.39 . . . . 75.43 112.634 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -58.65 -49.0 79.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 73.05 111.467 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.461 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -62.98 -37.19 86.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 70.01 111.18 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -2.77 57.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.103 -0.498 . . . . 74.3 111.502 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -70.51 -33.12 70.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 75.23 110.265 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.505 ' OH ' ' HB2' ' A' ' 6' ' ' LEU . 42.6 p90 -109.05 18.69 20.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.714 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.5 m 57.84 69.72 0.71 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.382 -0.827 . . . . 70.01 112.692 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 80' ' ' ALA . 3.9 p -130.08 145.91 59.23 Favored Pre-proline 0 C--N 1.326 -0.448 0 C-N-CA 121.077 -0.249 . . . . 75.21 110.517 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.75 145.92 87.45 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.984 1.789 . . . . 74.34 109.406 163.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.27 83.0 0.05 OUTLIER 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.811 2.341 . . . . 63.44 113.691 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -159.66 -173.7 4.26 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.198 0.999 . . . . 72.35 108.762 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.483 ' NE2' ' HB2' ' A' ' 3' ' ' GLU . 14.5 mm100 57.53 31.52 20.42 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.201 0.445 . . . . 72.12 112.201 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.5 tt -111.33 135.46 50.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.979 0.419 . . . . 73.42 110.636 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.18 122.9 54.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.815 -0.629 . . . . 73.31 109.757 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.8 114.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 74.54 111.038 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 63.7 mt -100.1 121.76 51.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.078 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.624 ' CE1' ' HG2' ' A' ' 134' ' ' ARG . 6.1 p-80 -159.59 -176.25 5.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.94 0.4 . . . . 75.32 111.1 -176.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -84.18 154.93 22.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.209 -0.905 . . . . 62.24 111.791 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 8.9 tp10 -133.88 126.4 30.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.366 -0.605 . . . . 73.52 109.366 167.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 137' ' ' VAL . 7.5 tt -82.97 -24.8 32.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 72.15 111.111 -172.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -93.93 4.38 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 70.21 111.342 -174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.5 mm -111.15 140.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.506 -0.316 . . . . 62.01 110.689 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.1 136.35 35.81 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.801 -0.636 . . . . 74.33 112.179 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.636 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 72.5 t80 -63.08 128.91 38.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.744 . . . . 75.23 111.523 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 108.66 -14.21 35.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.626 -0.797 . . . . 53.42 113.415 172.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 69.7 mmt-85 -124.32 168.77 12.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.446 0.623 . . . . 72.32 110.83 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.46 133.38 65.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.955 0.407 . . . . 75.01 111.373 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 10.6 tpp180 -113.56 127.73 56.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.79 -0.641 . . . . 74.22 109.388 174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 46.1 tp -97.48 153.3 18.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 74.23 111.026 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 112' ' ' GLU . 38.3 tptt -153.71 148.17 26.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.263 -0.643 . . . . 64.11 109.263 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.8 mp -123.59 -90.62 0.57 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.099 0.476 . . . . 73.45 111.141 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.51 106.08 2.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.177 -0.535 . . . . 54.14 112.413 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.44 151.25 5.4 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.91 -0.662 . . . . 72.44 111.734 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -89.63 78.33 1.61 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.963 -0.637 . . . . 53.23 111.675 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.441 ' H ' ' NH2' ' A' ' 132' ' ' ARG . 32.0 tt0 -120.79 122.39 40.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.093 -0.336 . . . . 75.43 110.093 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.587 ' HA2' ' OE1' ' A' ' 96' ' ' GLU . . . 152.03 134.89 2.17 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.383 -0.687 . . . . 71.15 111.383 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.84 2.69 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.555 -0.831 . . . . 71.22 114.258 -171.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -152.82 140.85 20.29 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.444 0.622 . . . . 74.31 110.857 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -45.7 -55.29 6.64 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.624 0.972 . . . . 63.45 113.624 -174.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.8 -41.18 19.76 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 114.793 0.677 . . . . 44.14 114.793 -166.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 132' ' ' ARG . 3.3 pp -67.0 -25.76 66.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.102 0.451 . . . . 75.04 111.8 -173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -39.57 26.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.232 0.539 . . . . 74.24 110.238 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.8 m -67.1 -38.02 84.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.508 -0.769 . . . . 73.42 111.703 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.1 -33.34 60.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 75.5 111.058 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.78 -33.44 72.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 24.22 110.318 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -70.05 -21.86 63.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.613 -0.721 . . . . 74.34 110.775 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.39 -27.84 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.002 0.429 . . . . 44.11 111.248 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.8 mt -103.64 -41.43 5.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.083 -0.508 . . . . 74.33 110.695 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.02 -0.79 79.51 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.478 -0.649 . . . . 65.15 111.478 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.7 m -115.97 143.68 45.11 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.84 -0.43 . . . . 74.41 109.84 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -120.68 -161.93 0.92 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.297 -0.41 . . . . 72.34 109.9 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.52 18.86 2.79 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.658 0.742 . . . . 72.44 110.416 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 45.4 p90 -86.43 156.99 19.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.598 -0.728 . . . . 74.11 110.058 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -78.29 110.8 13.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.093 0.473 . . . . 73.42 110.577 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.526 ' HD2' ' HB2' ' A' ' 118' ' ' LEU . 32.0 ttp-105 -108.98 109.38 20.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.915 -0.584 . . . . 73.13 110.111 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 61.2 t -85.6 133.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.531 -0.758 . . . . 73.03 109.979 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.803 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 84.7 mtm180 -131.23 109.33 10.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.248 -0.433 . . . . 74.12 111.226 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.01 123.54 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 43.15 109.586 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.45 125.2 28.59 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.758 -0.734 . . . . 54.43 112.151 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 97' ' ' LEU . 24.4 m -88.73 -12.45 10.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.785 0.326 . . . . 63.42 111.089 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.636 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 138.14 -142.18 12.91 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.761 -0.733 . . . . 50.41 111.929 -177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.488 ' HD2' ' O ' ' A' ' 138' ' ' GLY . 12.0 mmm180 -131.8 149.55 73.73 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.166 -0.679 . . . . 75.44 109.166 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 52.1 Cg_exo -55.26 114.5 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.678 2.252 . . . . 73.53 112.157 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.2 Cg_endo -82.72 160.34 16.46 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.205 2.604 . . . . 63.43 112.508 -176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -18.71 9.08 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.928 -0.653 . . . . 53.11 112.245 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -87.14 -45.27 10.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.065 0.46 . . . . 71.1 110.52 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 32.7 pttt -119.65 144.02 47.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.648 -0.705 . . . . 73.42 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.62 139.64 89.44 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.751 -0.659 . . . . 62.25 110.868 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.09 -34.04 45.77 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.361 2.708 . . . . 50.31 113.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.6 61.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.099 0.476 . . . . 73.12 111.171 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.36 -18.78 29.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 54.33 110.454 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.426 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 63.9 t80 -69.32 -27.44 65.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.525 . . . . 72.24 110.687 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.553 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.9 m -86.09 1.44 5.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.504 -0.316 . . . . 65.3 111.239 177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 17' ' ' TYR . 79.5 mt -95.53 1.33 53.83 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.632 0.234 . . . . 74.43 111.632 -176.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.18 150.44 25.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.954 0.407 . . . . 74.1 110.312 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.769 ' HB3' HG22 ' A' ' 20' ' ' THR . 27.1 p-10 -129.44 30.01 5.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.508 . . . . 60.23 111.223 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -146.84 143.76 28.83 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.138 -0.319 . . . . 52.14 110.138 -176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.64 177.18 11.68 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.808 -1.182 . . . . 72.35 107.808 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.6 -72.41 0.4 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.416 0.553 . . . . 32.53 112.252 -173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -97.17 -46.91 5.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.334 0.588 . . . . 50.41 111.885 -175.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 1.2 pm0 -67.91 -17.21 64.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 73.44 112.064 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -65.31 -25.24 67.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.677 0.275 . . . . 73.33 110.387 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.61 -17.12 54.55 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.273 -0.421 . . . . 75.23 111.592 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 165' ' ' ILE . 60.6 mt-10 -85.84 -20.38 29.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.102 -0.239 . . . . 75.31 110.912 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.73 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 58.8 t -52.17 -55.79 27.99 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.399 . . . . 62.33 112.079 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.73 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 34.9 Cg_exo -61.94 -23.91 76.37 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.103 1.869 . . . . 63.24 112.525 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.587 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 11.5 m -81.8 -46.05 14.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.233 -0.44 . . . . 41.43 111.021 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.538 HG22 ' CZ3' ' A' ' 191' ' ' TRP . 40.2 pt -65.94 -30.64 50.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.377 -0.374 . . . . 74.02 111.936 -174.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 162' ' ' VAL . 56.2 t -61.25 -48.26 89.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 61.34 110.623 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.73 -39.73 95.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 31.25 110.744 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 164' ' ' THR . 71.9 mm-40 -65.68 -41.85 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 63.21 110.5 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.21 -36.9 80.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.427 . . . . 61.45 110.686 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.73 88.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.008 -0.542 . . . . 71.32 110.474 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.55 -37.05 76.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.027 -0.533 . . . . 74.32 110.362 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.84 -30.33 70.77 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.151 -0.477 . . . . 64.24 111.091 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 63.0 m -62.48 -43.34 99.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.901 0.381 . . . . 61.2 110.143 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 41.3 mt-10 -71.72 -28.95 64.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.323 0.582 . . . . 60.5 109.996 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.8 tp -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.543 -0.753 . . . . 71.54 110.545 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 85.1 mt -65.42 -22.0 66.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.819 -0.628 . . . . 72.43 110.69 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 5' ' ' LEU . 3.3 mm -80.49 -49.68 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.841 -0.618 . . . . 70.42 111.421 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -101.36 -28.53 12.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.511 0.93 . . . . 51.43 113.511 -167.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -100.59 -77.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.462 -0.495 . . . . 65.51 111.964 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -131.65 134.56 7.73 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.923 -1.132 . . . . 62.12 113.338 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.1 -34.39 38.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.933 0.397 . . . . 73.05 109.953 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.622 ' HG2' ' HD3' ' A' ' 183' ' ' PRO . 1.0 OUTLIER -120.92 -36.28 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.702 1.001 . . . . 74.24 113.702 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.622 ' HD3' ' HG2' ' A' ' 182' ' ' GLU . 84.5 Cg_endo -81.55 -5.03 12.47 Favored 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 121.177 1.456 . . . . 74.15 113.635 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.469 ' O ' HG22 ' A' ' 187' ' ' THR . . . -69.47 -31.72 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 72.34 111.33 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 13.2 pt20 -67.97 -19.43 64.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 75.44 111.682 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -56.11 -43.09 77.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.329 . . . . 74.22 111.121 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 184' ' ' ALA . 15.4 t -76.44 -19.38 58.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.685 0.279 . . . . 62.43 111.132 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.89 -40.44 52.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 74.21 110.917 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -84.19 1.39 44.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.927 -0.309 . . . . 72.22 111.255 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.35 -4.02 57.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.917 0.389 . . . . 63.4 110.873 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.538 ' CZ3' HG22 ' A' ' 165' ' ' ILE . 17.7 t90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.318 -0.849 . . . . 71.02 110.364 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.166 -0.309 . . . . 52.52 110.166 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.74 111.65 3.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.327 . . . . 70.32 110.46 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.4 pt-20 -89.66 116.82 67.31 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.027 -0.533 . . . . 73.22 110.816 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 14.0 Cg_endo -92.31 113.56 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.623 2.882 . . . . 53.22 112.615 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.599 HD11 HG13 ' A' ' 177' ' ' ILE . 95.7 mt -72.21 114.9 10.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.543 -0.753 . . . . 74.34 110.689 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 85' ' ' VAL . 42.9 tp -93.68 104.66 16.75 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.008 -0.738 . . . . 70.43 109.008 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.637 ' HB ' HD23 ' A' ' 62' ' ' LEU . 47.9 t -109.94 123.79 66.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.334 -0.394 . . . . 62.45 110.175 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 57.8 t -110.13 114.82 48.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.731 -0.668 . . . . 72.11 110.292 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.29 122.37 7.42 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.244 -0.742 . . . . 64.2 111.244 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.774 ' HG ' ' HE1' ' A' ' 22' ' ' HIS . 30.3 tp -85.92 82.73 8.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.363 0.601 . . . . 73.33 110.998 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -150.49 118.26 0.91 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.342 -0.845 . . . . 75.24 111.115 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.64 151.56 37.61 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.497 -0.186 . . . . 75.42 110.497 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -70.27 161.62 45.33 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.465 2.11 . . . . 74.31 112.464 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' HA3' ' HD1' ' A' ' 17' ' ' TYR . . . 148.75 142.74 3.67 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.852 -0.613 . . . . 61.21 111.782 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.33 -42.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.826 2.35 . . . . 64.02 112.216 -177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.452 ' O ' HG23 ' A' ' 20' ' ' THR . 8.0 p -90.76 -37.93 13.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.937 -0.574 . . . . 64.31 110.856 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HD1' ' HA3' ' A' ' 14' ' ' GLY . 84.9 m-85 -62.04 -35.09 77.54 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.896 -0.593 . . . . 73.22 112.281 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 -13.25 60.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.933 0.397 . . . . 73.52 111.104 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -112.06 28.26 8.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 73.21 110.334 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.81 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 79.2 p -102.12 -176.39 3.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.841 -0.618 . . . . 72.33 110.906 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -86.41 -15.42 40.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.476 0.655 . . . . 73.42 109.503 173.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.774 ' HE1' ' HG ' ' A' ' 10' ' ' LEU . 14.8 t-80 -76.75 -22.25 54.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.145 -0.934 . . . . 74.14 110.405 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 27' ' ' MET . 65.7 t30 -73.78 -0.08 14.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.006 0.432 . . . . 73.51 111.266 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 mt -60.39 -29.5 68.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.562 -0.29 . . . . 73.4 111.254 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.32 -30.71 78.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.926 -0.654 . . . . 72.51 112.49 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 67.2 t80 -90.36 -22.38 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.784 -0.244 . . . . 74.25 110.833 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 31' ' ' VAL . 26.2 mmt -50.49 -48.3 56.9 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.241 -0.436 . . . . 73.24 111.766 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.88 -46.86 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.336 -0.393 . . . . 64.11 110.803 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.31 82.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 51.54 111.388 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.4 -37.27 84.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.935 0.398 . . . . 74.33 111.04 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' MET . 62.6 t -65.51 -39.04 83.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.181 0.515 . . . . 71.21 109.852 176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.85 -43.27 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.624 . . . . 75.34 110.698 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.22 90.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.788 0.328 . . . . 72.0 110.906 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -43.49 91.26 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.982 -0.554 . . . . 72.14 112.878 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -70.13 -24.2 63.14 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.818 0.309 . . . . 73.14 111.206 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' A' ' 53' ' ' GLY . 82.7 mt -77.58 -49.77 21.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.409 -0.589 . . . . 73.42 109.409 173.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.99 62.19 1.07 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.84 -0.695 . . . . 52.54 112.425 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.4 m -156.3 144.62 19.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.919 0.39 . . . . 64.11 110.718 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.98 151.65 27.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.92 -0.582 . . . . 73.1 110.215 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.98 138.54 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.892 0.377 . . . . 73.33 110.672 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -101.36 126.6 48.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 75.53 110.043 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 t -78.1 129.75 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 74.13 110.301 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -68.79 102.71 1.6 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.622 -0.263 . . . . 61.5 110.776 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 58.7 tttm -64.11 88.46 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.121 -0.696 . . . . 74.23 109.121 172.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 47.8 tttp 174.22 -54.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.928 -1.033 . . . . 74.53 109.021 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.8 p -125.15 -19.18 5.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.538 -0.755 . . . . 52.55 111.477 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.73 18.23 45.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.657 -0.783 . . . . 51.05 112.955 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.65 123.43 35.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.579 0.228 . . . . 74.33 110.654 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 2.2 mp0 -84.98 140.34 31.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.406 -0.361 . . . . 72.31 110.928 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 63' ' ' ALA . 97.6 t -139.4 137.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 73.42 110.404 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 6.9 p -118.91 145.49 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.709 -0.478 . . . . 74.44 109.709 174.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.54 HG23 HG12 ' A' ' 61' ' ' VAL . 1.6 m -116.71 142.59 46.71 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.232 -0.44 . . . . 63.53 111.637 -172.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -178.17 -161.53 26.39 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.173 -0.771 . . . . 60.01 111.173 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.97 ' HG2' ' HA ' ' A' ' 59' ' ' SER . 37.2 mtm180 -136.34 146.09 46.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.916 0.389 . . . . 72.0 110.684 176.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.59 103.05 11.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.551 -0.75 . . . . 73.54 109.698 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.19 -51.58 0.65 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.963 0.79 . . . . 75.54 111.713 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.21 -36.98 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.048 -0.821 . . . . 63.33 111.048 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.456 HG23 ' HG3' ' A' ' 3' ' ' GLU . 4.1 m -68.58 151.56 46.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.439 0.295 . . . . 60.32 110.37 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.97 ' HA ' ' HG2' ' A' ' 54' ' ' ARG . 21.9 m -85.72 139.98 30.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.171 -0.678 . . . . 70.31 109.171 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.35 132.1 52.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.368 0.604 . . . . 71.54 111.307 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.54 HG12 HG23 ' A' ' 52' ' ' THR . 8.3 m -117.68 115.5 48.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 42.41 109.333 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.637 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.7 mt -92.42 104.59 16.9 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.951 -0.568 . . . . 71.41 109.838 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -108.98 137.58 46.68 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 62.2 110.146 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -130.71 143.01 47.61 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 63.4 110.498 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.41 166.67 29.27 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.521 2.147 . . . . 64.43 111.635 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -84.8 -54.14 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.798 -0.361 . . . . 73.24 111.395 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 71' ' ' GLU . 13.9 p -167.67 163.54 14.41 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.699 0.259 . . . . 71.21 111.699 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.3 t80 69.41 163.81 0.24 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.976 0.797 . . . . 64.2 112.565 170.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.0 mmt -73.24 -56.61 4.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.922 -0.581 . . . . 72.23 110.946 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -67.08 -40.65 87.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.817 -0.629 . . . . 65.1 111.783 -173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 67' ' ' CYS . 42.7 mt-10 -59.84 -40.31 88.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.523 -0.308 . . . . 64.44 110.861 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -63.24 -36.27 83.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.863 0.363 . . . . 64.21 110.53 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.88 -39.89 97.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.46 -0.656 . . . . 73.53 111.46 175.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.28 -0.54 19.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 75.13 110.726 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 23.0 mm-40 -103.53 -51.05 3.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.315 -0.402 . . . . 55.12 111.038 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -60.81 -34.69 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 70.15 111.31 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.32 -67.19 2.34 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.989 -0.55 . . . . 72.35 113.374 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.87 -27.6 59.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.692 2.261 . . . . 62.34 113.612 -177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 47.2 mt -57.5 -40.55 78.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 111.848 0.314 . . . . 73.24 111.848 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.47 -49.73 73.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.022 0.439 . . . . 53.31 111.378 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -84.99 -7.41 59.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.354 -0.385 . . . . 73.13 111.235 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -79.12 -46.65 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.83 0.348 . . . . 73.02 110.128 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -93.03 1.45 57.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.148 -0.478 . . . . 73.44 111.232 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 60.46 37.57 19.74 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 123.686 0.617 . . . . 72.4 110.752 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.536 HG21 HD22 ' A' ' 6' ' ' LEU . 27.5 m -92.15 142.98 26.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.81 -0.632 . . . . 64.34 110.466 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.832 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 4.1 Cg_exo -77.0 133.9 14.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.68 2.253 . . . . 70.13 111.81 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.555 ' O ' HG22 ' A' ' 90' ' ' ILE . 36.2 Cg_endo -66.0 -4.56 10.39 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.974 2.45 . . . . 74.4 112.587 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.832 ' HG2' ' HB2' ' A' ' 86' ' ' PRO . 13.9 pt20 -71.62 -20.38 61.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.105 -0.498 . . . . 75.3 110.598 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.762 ' HG3' ' HG3' ' A' ' 88' ' ' GLN . 97.9 mt-30 -124.43 24.52 7.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.083 -0.508 . . . . 74.22 111.655 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 87' ' ' PRO . 13.1 tt -86.93 105.5 15.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.757 0.789 . . . . 74.5 110.176 175.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.77 113.38 36.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.369 -0.832 . . . . 72.24 110.631 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.62 114.39 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.408 -0.36 . . . . 72.0 110.157 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.507 ' HA ' ' HB ' ' A' ' 133' ' ' VAL . 58.3 mt -101.26 120.16 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.913 -0.585 . . . . 74.41 109.776 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.41 ' CE1' HD22 ' A' ' 118' ' ' LEU . 32.1 p80 -142.01 174.9 10.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.966 0.413 . . . . 72.22 111.349 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.21 148.28 26.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.219 -0.901 . . . . 54.34 109.529 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.695 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -139.5 128.85 24.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.079 0.466 . . . . 73.53 110.389 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.55 -33.93 25.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.68 -0.691 . . . . 73.35 111.681 -173.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.53 -38.49 26.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.153 -0.476 . . . . 50.43 111.392 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.613 HG12 ' OE1' ' A' ' 96' ' ' GLU . 37.9 mm -65.58 143.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.061 0.458 . . . . 43.1 111.628 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 12.1 m-20 -57.07 139.59 51.88 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.602 -0.726 . . . . 73.15 111.218 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.735 ' HB2' ' HA2' ' A' ' 138' ' ' GLY . 80.3 t80 -57.92 132.9 54.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 74.43 111.683 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 92.26 -24.38 22.59 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.656 -0.702 . . . . 62.44 112.825 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -90.92 130.92 36.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.145 0.498 . . . . 61.42 110.842 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 104' ' ' ILE . 3.7 mp -92.42 114.38 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.947 -0.76 . . . . 73.22 108.947 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.5 tpt85 -107.48 125.19 50.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.118 0.485 . . . . 75.32 110.254 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.3 mt -103.89 135.19 45.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.616 -0.72 . . . . 74.15 110.526 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -142.26 156.54 45.29 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.944 -0.762 . . . . 74.12 108.944 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.37 -132.4 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.463 -0.569 . . . . 73.11 109.463 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.494 ' N ' ' HA ' ' A' ' 129' ' ' ASN . . . 49.34 -153.01 2.92 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.423 -0.418 . . . . 71.32 112.759 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.35 173.29 27.29 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.778 -0.929 . . . . 74.01 110.778 169.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 119' ' ' ARG . . . -83.55 85.49 1.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.146 -1.026 . . . . 64.32 111.922 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.68 -43.01 11.62 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.635 0.255 . . . . 72.11 111.268 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -79.84 109.23 2.87 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.146 -0.55 . . . . 75.43 112.343 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.48 -100.85 0.2 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.057 -0.592 . . . . 72.45 111.969 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -164.17 173.99 11.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.585 0.231 . . . . 74.13 111.322 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -40.21 -56.17 1.99 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.129 1.159 . . . . 74.2 114.129 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.44 -29.25 72.82 Favored Glycine 0 CA--C 1.509 -0.283 0 C-N-CA 121.233 -0.508 . . . . 61.11 112.476 -170.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 23.5 tp -65.83 -38.67 89.53 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.426 -0.387 . . . . 54.44 110.68 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 111' ' ' GLY . 1.7 mpp_? -79.65 -23.25 42.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.76 -0.376 . . . . 70.13 110.625 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.0 m -66.95 -44.81 79.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 60.21 110.603 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.2 m -69.3 -27.77 35.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 72.43 110.798 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.16 -43.57 61.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 64.11 110.524 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.0 m -70.28 -25.52 63.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 65.13 111.589 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.35 -42.68 92.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 31.43 110.643 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.52 -42.07 20.76 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.855 -0.611 . . . . 71.22 110.336 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.08 1.81 88.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.935 -0.65 . . . . 60.54 111.757 -176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.644 HG22 ' HE1' ' A' ' 130' ' ' PHE . 4.8 m -111.5 122.66 48.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.931 0.396 . . . . 72.12 110.308 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 129' ' ' ASN . 53.7 mtmt -126.63 178.83 5.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.453 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.494 ' HA ' ' N ' ' A' ' 109' ' ' GLY . 22.8 m-20 75.35 67.71 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.862 0.726 . . . . 74.33 112.112 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.644 ' HE1' HG22 ' A' ' 127' ' ' THR . 60.5 m-85 -142.99 -87.87 0.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.971 -0.559 . . . . 74.11 111.337 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.488 ' C ' ' HD2' ' A' ' 132' ' ' ARG . 12.7 t60 -161.88 104.97 1.19 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.635 0.255 . . . . 34.01 110.644 -174.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.488 ' HD2' ' C ' ' A' ' 131' ' ' HIS . 2.6 mpt_? -114.27 141.03 48.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.529 0.204 . . . . 70.24 110.549 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 93.5 t -104.19 118.23 51.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.942 0.401 . . . . 72.01 111.047 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.695 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 35.6 mtp180 -112.41 104.67 12.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.061 -0.518 . . . . 71.55 110.254 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.3 mt -85.81 115.09 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.85 -0.426 . . . . 63.43 109.85 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.31 118.77 11.48 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.902 -0.666 . . . . 73.05 112.651 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.2 t -87.52 -11.51 10.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.356 0.598 . . . . 70.21 110.086 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.735 ' HA2' ' HB2' ' A' ' 101' ' ' PHE . . . 136.9 -77.55 0.34 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.428 -0.891 . . . . 73.52 113.326 175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -170.73 165.6 5.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.983 -0.377 . . . . 72.03 109.983 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 53.1 Cg_exo -53.85 142.1 64.25 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.474 2.116 . . . . 73.34 111.279 171.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 25.3 Cg_exo -61.72 -66.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 123.027 2.485 . . . . 43.14 113.327 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.7 -69.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.589 -0.815 . . . . 51.12 112.438 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 143' ' ' ARG . 10.5 mmt180 -82.01 -70.07 0.57 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.85 0.357 . . . . 74.2 110.778 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.571 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -80.89 159.99 24.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.545 . . . . 73.33 110.486 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.748 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 2.5 p30 -79.76 166.39 41.21 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.548 -0.296 . . . . 74.44 110.776 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.748 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 10.9 Cg_endo -53.79 -36.0 80.98 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.371 2.714 . . . . 35.52 113.986 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.15 77.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 72.44 110.603 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.91 -31.87 59.36 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.083 -0.508 . . . . 51.43 110.216 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.571 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 88.9 t80 -64.5 -42.81 95.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.567 -0.742 . . . . 71.23 111.321 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.81 ' O ' ' HB ' ' A' ' 20' ' ' THR . 34.9 m -83.28 -9.75 11.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.915 -0.314 . . . . 65.14 111.167 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 20' ' ' THR . 49.5 tp -83.75 -25.63 30.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.104 0.478 . . . . 74.24 111.136 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.04 176.68 8.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.962 0.41 . . . . 65.23 110.616 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -81.26 171.97 14.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 72.42 110.662 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 40.3 m-85 -65.44 145.13 56.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.09 -0.505 . . . . 73.34 110.097 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.749 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -68.92 162.2 27.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.284 -0.265 . . . . 73.4 110.284 -178.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.92 9.52 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.033 0.753 . . . . 65.21 113.033 -162.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.74 88.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.012 0.434 . . . . 62.33 112.13 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.572 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 2.2 pm0 -89.34 -16.58 30.72 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.077 -0.511 . . . . 74.5 111.655 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.749 ' HB2' ' O ' ' A' ' 155' ' ' THR . 60.2 ttt180 -61.04 -25.09 66.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 74.44 111.424 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.33 -14.4 62.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.283 -0.417 . . . . 75.01 111.919 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -111.4 5.97 20.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.742 0.306 . . . . 73.31 111.245 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 159' ' ' ARG . 94.8 t -63.82 -52.73 55.41 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.449 -0.341 . . . . 51.12 111.746 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 11.3 Cg_endo -55.53 -33.79 87.63 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.927 1.752 . . . . 70.14 111.873 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.7 m -65.95 -49.46 67.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.625 -0.716 . . . . 51.35 111.178 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 162' ' ' VAL . 35.3 pt -67.89 -30.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.431 -0.35 . . . . 72.33 111.42 -175.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.4 t -63.9 -45.47 96.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.943 0.402 . . . . 64.11 110.405 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -67.86 -37.6 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.036 -0.529 . . . . 71.24 110.812 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -63.65 -44.31 94.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 53.13 110.896 176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.95 98.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 70.05 111.219 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.24 96.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.194 -0.457 . . . . 74.41 111.253 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.84 -44.14 86.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 73.03 110.522 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.625 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -64.3 -37.96 89.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.878 -0.601 . . . . 60.44 111.664 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 87.3 m -58.32 -40.36 81.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.865 0.364 . . . . 44.23 111.045 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.13 -40.03 90.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.223 0.535 . . . . 71.33 110.235 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 34.7 tp -64.55 -37.34 87.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 72.43 110.885 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 87.1 mt -60.18 -42.86 95.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 74.5 111.868 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.599 HG13 HD11 ' A' ' 5' ' ' LEU . 0.3 OUTLIER -77.87 -27.28 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.12 0.486 . . . . 70.24 110.382 -176.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -83.96 -58.28 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.216 -0.447 . . . . 54.44 111.841 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -24.98 35.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 71.51 111.439 -175.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 113.89 -161.13 12.81 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.641 -0.79 . . . . 75.21 112.112 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.64 -68.8 0.68 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.741 0.305 . . . . 65.13 110.847 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.641 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.6 tt0 -55.02 -55.3 40.48 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.155 0.798 . . . . 75.12 113.155 -172.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 23.1 Cg_exo -65.16 -31.06 54.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.15 1.9 . . . . 64.35 113.087 -176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -88.43 -48.71 7.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.504 0.557 . . . . 72.51 112.504 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -20.23 65.7 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 121.216 -0.193 . . . . 74.22 111.51 -174.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -53.54 -51.08 64.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.415 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -72.28 -21.62 61.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 71.32 111.266 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.8 t -70.11 -24.2 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 73.53 111.283 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -116.91 13.38 14.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.882 0.372 . . . . 72.03 110.388 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.11 27.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.092 -0.503 . . . . 71.1 111.092 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.417 ' HH2' HG22 ' A' ' 165' ' ' ILE . 15.1 p-90 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.301 -0.857 . . . . 73.22 110.912 -176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.163 -0.31 . . . . 64.12 110.163 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.06 116.73 20.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.412 -0.358 . . . . 62.02 110.092 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 14.3 pt-20 -85.24 118.22 70.35 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.252 0.548 . . . . 72.33 110.414 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 1.3 Cg_endo -83.71 110.19 1.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.805 2.337 . . . . 73.42 112.113 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.537 HD12 ' HB3' ' A' ' 89' ' ' GLN . 36.7 tp -74.32 118.35 17.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 75.04 109.846 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HA ' HG23 ' A' ' 61' ' ' VAL . 69.8 tp -92.8 104.96 17.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.18 -0.464 . . . . 75.04 110.128 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.487 ' HB ' HD23 ' A' ' 62' ' ' LEU . 44.9 t -105.58 121.27 57.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.246 -0.434 . . . . 72.33 110.408 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.95 114.87 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.754 -0.657 . . . . 74.23 109.902 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.85 123.15 6.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.846 -0.692 . . . . 73.33 111.846 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 96.16 1.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.846 0.355 . . . . 73.23 110.199 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -111.93 85.68 0.4 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.783 -0.723 . . . . 61.2 112.993 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 28.0 m-80 -100.89 117.75 61.91 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.995 -0.372 . . . . 71.03 109.995 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 3.0 Cg_exo -75.49 177.79 8.21 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.155 2.57 . . . . 74.13 112.369 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 17' ' ' TYR . . . 155.5 179.05 30.32 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.04 -0.6 . . . . 70.33 111.616 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.09 -71.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.885 2.39 . . . . 74.34 111.559 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.612 ' HA ' ' HD3' ' A' ' 19' ' ' LYS . 15.1 t -117.33 6.26 12.67 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.815 -0.809 . . . . 71.42 108.815 172.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' HB3' ' HA3' ' A' ' 14' ' ' GLY . 37.2 t80 -69.19 -26.09 64.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.778 -1.101 . . . . 75.22 110.313 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' HA ' ' A' ' 13' ' ' PRO . . . -87.48 1.6 53.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 61.05 110.983 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -120.72 3.18 10.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.435 -178.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.832 ' HA ' ' HB3' ' A' ' 153' ' ' ASN . 14.9 t -103.7 -177.66 3.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.918 0.39 . . . . 73.13 111.875 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.614 ' HD3' HG13 ' A' ' 137' ' ' VAL . 61.6 mtt180 -64.92 -20.72 66.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.0 -0.546 . . . . 74.4 111.63 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.576 ' H ' HG23 ' A' ' 20' ' ' THR . 5.9 t60 -78.78 -7.99 58.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.972 0.415 . . . . 71.04 110.576 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.26 8.22 29.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 72.12 110.43 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 75.0 mt -55.74 -29.8 60.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.511 -0.313 . . . . 75.12 111.67 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.56 -33.05 86.2 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.891 -0.671 . . . . 72.03 112.462 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 87.5 t80 -88.36 -30.7 19.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.544 0.212 . . . . 72.44 110.718 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mmm -50.19 -42.89 52.12 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 62.24 111.993 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.5 t -69.53 -47.15 73.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.823 0.345 . . . . 75.43 110.789 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.57 74.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 72.5 111.29 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.3 -45.43 91.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.883 -0.599 . . . . 74.42 110.9 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.8 t -72.85 -36.82 53.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.592 . . . . 72.35 110.503 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -61.03 -44.99 96.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 61.44 110.876 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.83 80.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 55.3 110.554 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.05 -40.59 95.21 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.866 -0.606 . . . . 74.42 112.832 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -21.57 54.93 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 117.044 0.422 . . . . 74.51 111.314 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.515 HD13 ' HA3' ' A' ' 53' ' ' GLY . 80.6 mt -77.84 -43.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.585 -0.524 . . . . 73.31 109.585 173.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.04 33.81 5.89 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.868 -0.682 . . . . 75.32 111.942 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -145.66 135.32 23.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.746 0.308 . . . . 64.11 110.253 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 148.44 24.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.287 -0.415 . . . . 74.3 110.693 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.781 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 11.1 p90 -66.31 124.72 23.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.857 -0.61 . . . . 64.04 110.638 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 13.0 ptpt -101.1 143.88 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.608 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.629 HG22 ' HG2' ' A' ' 49' ' ' GLU . 19.7 t -81.69 135.55 24.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.713 -0.676 . . . . 72.2 111.584 -172.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.36 104.51 16.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.932 -0.577 . . . . 72.53 109.97 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -70.48 90.21 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.9 -0.408 . . . . 75.11 109.9 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.5 tptt 174.34 -58.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.251 -0.886 . . . . 73.13 108.695 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -106.76 -14.33 15.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.345 -0.843 . . . . 74.12 110.519 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 83.76 3.9 89.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.943 -0.646 . . . . 21.13 112.348 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.38 144.29 28.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.821 0.344 . . . . 55.32 110.746 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.2 mt-10 -108.56 122.16 46.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.944 -0.571 . . . . 63.11 109.637 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 t -129.15 137.56 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.441 -0.345 . . . . 71.33 110.476 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.781 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 5.0 p -121.47 135.63 61.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.934 0.397 . . . . 75.4 110.2 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.784 HG22 HG12 ' A' ' 61' ' ' VAL . 11.9 p -106.71 136.58 46.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.132 -0.485 . . . . 70.31 110.982 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.515 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -160.7 -161.14 11.22 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.473 -0.87 . . . . 42.3 112.576 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 57' ' ' GLY . 13.2 mmt180 -121.59 142.41 50.13 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 73.5 110.088 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.134 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -126.9 115.77 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.726 -0.842 . . . . 74.22 108.726 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.6 -36.83 0.31 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.706 -0.679 . . . . 62.52 111.305 -171.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 165.88 -33.15 0.23 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.852 -0.899 . . . . 72.24 110.852 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 59' ' ' SER . 1.7 m -75.37 169.24 18.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.372 -0.414 . . . . 73.44 110.759 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.483 ' H ' HG22 ' A' ' 58' ' ' THR . 2.9 m -79.78 131.46 35.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.753 0.311 . . . . 74.04 111.383 -175.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.134 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -127.06 137.42 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.94 -0.392 . . . . 74.23 109.94 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.784 HG12 HG22 ' A' ' 52' ' ' THR . 12.4 m -120.25 115.4 47.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.209 0.528 . . . . 74.4 110.532 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 61.9 mt -96.79 105.0 17.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.794 -0.639 . . . . 74.23 109.586 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.2 127.58 55.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.236 -0.438 . . . . 74.41 110.979 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 64' ' ' LYS . 6.4 ptmt -119.15 126.69 26.91 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.221 -0.445 . . . . 73.33 110.393 175.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.761 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 39.6 Cg_exo -61.53 149.74 88.4 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.398 2.065 . . . . 65.1 110.619 173.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 25.7 ptt180 -64.55 -53.42 48.16 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 75.11 111.13 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 29.1 p -168.57 174.69 6.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.422 -0.214 . . . . 54.11 110.422 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.538 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 9.9 t80 75.27 138.27 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.047 0.842 . . . . 74.1 112.316 167.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -62.97 -52.69 62.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.39 -0.823 . . . . 61.45 111.322 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.56 -36.65 76.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.04 111.17 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 6.4 mt-10 -60.31 -43.55 96.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.705 -0.225 . . . . 64.15 110.821 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -54.87 -32.42 60.77 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.372 0.42 . . . . 63.12 111.341 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.799 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -67.47 -39.21 91.27 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.895 -0.669 . . . . 61.21 112.118 178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' NH2' ' HG2' ' A' ' 71' ' ' GLU . 20.1 ptt180 -91.09 2.75 56.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.904 0.383 . . . . 73.22 110.681 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.761 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 24.6 mm-40 -81.23 -51.89 7.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 74.23 110.22 174.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.17 -44.77 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.757 -0.656 . . . . 63.31 112.29 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.79 -66.23 2.7 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.135 -0.484 . . . . 75.42 113.674 -176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.06 -41.43 78.87 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.867 2.378 . . . . 71.1 113.0 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -63.03 -39.54 95.05 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.768 0.284 . . . . 63.31 111.768 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.53 -45.38 91.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.0 0.428 . . . . 61.43 111.163 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.9 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.172 -0.467 . . . . 71.3 111.068 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -63.88 -42.12 97.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 71.2 109.696 175.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -82.16 -15.28 53.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.723 -0.671 . . . . 73.23 110.621 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m 62.37 34.68 15.49 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.762 -0.653 . . . . 53.12 110.515 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.4 m -100.29 143.99 27.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.757 -0.656 . . . . 62.24 110.635 -177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 10.5 Cg_exo -71.2 115.62 4.35 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.733 2.289 . . . . 64.1 111.574 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.39 33.28 0.38 Allowed 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.185 2.59 . . . . 73.14 113.4 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -78.65 -48.75 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.339 -0.615 . . . . 74.43 109.339 176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.537 ' HB3' HD12 ' A' ' 5' ' ' LEU . 1.8 mp0 -88.86 68.59 8.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.751 -0.659 . . . . 71.23 109.812 175.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.17 138.03 31.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.54 -0.755 . . . . 72.33 110.388 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.1 t -127.75 109.88 20.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.958 -0.564 . . . . 73.33 110.067 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.59 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 58.5 t -105.78 113.43 42.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.702 -0.481 . . . . 65.22 109.702 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 58.2 mt -93.46 122.51 45.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.062 -0.517 . . . . 75.01 110.396 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.424 ' HE1' ' CB ' ' A' ' 115' ' ' HIS . 16.7 t-80 -149.02 162.89 39.01 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.643 -0.423 . . . . 74.24 112.129 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HB2' ' CG2' ' A' ' 137' ' ' VAL . 8.8 p-10 -90.34 139.28 30.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.465 -0.789 . . . . 53.41 110.314 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.848 ' HG3' ' HE ' ' A' ' 134' ' ' ARG . 75.8 mm-40 -137.23 140.38 41.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.911 0.386 . . . . 70.13 111.734 177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.47 HD23 ' HB ' ' A' ' 137' ' ' VAL . 95.1 mt -84.22 -25.6 29.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.819 -0.628 . . . . 74.4 112.039 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.2 -34.47 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.468 0.651 . . . . 61.55 110.542 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.696 ' HB ' ' HA2' ' A' ' 136' ' ' GLY . 9.2 mt -84.64 139.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.473 -0.785 . . . . 71.4 109.999 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -67.08 144.77 55.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.883 -0.414 . . . . 72.33 109.883 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 65.7 t80 -63.37 124.4 21.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 75.14 110.773 -176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.88 -21.11 8.0 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.059 -1.067 . . . . 45.33 113.469 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -123.69 169.11 11.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.541 0.671 . . . . 62.42 111.234 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.619 HG12 HG13 ' A' ' 135' ' ' ILE . 65.9 mt -118.65 139.38 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.918 -0.583 . . . . 70.02 110.745 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.444 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 25.6 tpt180 -111.98 124.15 51.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.049 176.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.2 mt -108.21 127.25 53.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.043 -0.526 . . . . 61.35 110.181 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -154.8 151.03 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.49 -0.559 . . . . 71.05 109.49 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.888 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 1.3 pt? -67.3 -71.93 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.415 . . . . 74.14 111.668 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.888 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -153.75 155.31 26.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.724 -0.55 . . . . 63.22 111.724 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.41 176.56 18.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.947 -0.644 . . . . 72.2 111.691 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.0 77.45 2.11 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.73 -0.748 . . . . 73.5 111.899 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -129.83 21.31 5.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.709 0.766 . . . . 73.35 109.341 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -145.78 95.42 0.17 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.457 -0.792 . . . . 62.43 112.287 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.99 67.5 3.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 62.02 112.112 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 96' ' ' GLU . 33.0 m80 -139.19 146.04 40.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 71.34 111.008 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.66 -55.15 38.77 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.642 -0.708 . . . . 75.44 111.95 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.72 -28.84 70.22 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-N 115.853 -0.612 . . . . 64.21 112.081 -168.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.14 -36.56 79.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 74.43 110.127 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -73.98 -27.24 60.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.794 -0.639 . . . . 74.12 110.139 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.2 m -66.69 -52.17 47.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 73.5 110.766 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.799 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -66.33 -30.65 50.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 120.737 0.303 . . . . 62.4 110.84 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.02 71.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.32 111.138 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.4 m -84.62 -35.58 22.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 62.5 111.101 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.101 -0.5 . . . . 63.1 111.269 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 -42.43 12.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.205 0.526 . . . . 74.23 110.076 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.13 -13.38 32.69 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.732 -0.667 . . . . 62.12 112.879 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 p -114.01 122.93 48.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.408 0.623 . . . . 72.13 111.624 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.6 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 4.5 mptt -99.75 -91.7 0.29 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.79 -1.189 . . . . 74.13 107.79 174.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 55.07 7.97 0.21 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.854 1.798 . . . . 73.35 115.854 162.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.31 -90.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.955 0.798 . . . . 72.44 111.923 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -175.92 135.38 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 63.31 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.59 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 10.5 mpt_? -121.49 124.53 44.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.083 -0.508 . . . . 71.41 110.056 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 59.1 t -83.9 104.07 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.688 -0.486 . . . . 64.22 109.688 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.848 ' HE ' ' HG3' ' A' ' 96' ' ' GLU . 49.1 mtm-85 -122.64 127.6 49.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.883 0.373 . . . . 61.33 110.53 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.619 HG13 HG12 ' A' ' 104' ' ' ILE . 3.8 mp -94.28 139.9 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.567 -0.742 . . . . 72.04 109.859 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.696 ' HA2' ' HB ' ' A' ' 99' ' ' ILE . . . -72.61 129.66 14.13 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.868 -0.682 . . . . 61.44 112.646 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.614 HG13 ' HD3' ' A' ' 21' ' ' ARG . 27.3 t -95.92 -11.99 8.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.316 0.579 . . . . 62.33 109.972 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.14 166.52 26.83 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.676 -0.773 . . . . 60.32 111.849 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -83.42 146.56 50.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.172 -0.307 . . . . 72.5 110.172 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.63 120.59 7.74 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.012 2.475 . . . . 64.13 113.122 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.91 158.94 40.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.239 2.626 . . . . 71.21 112.558 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -106.25 -24.66 6.73 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.855 -0.688 . . . . 53.22 112.805 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -83.82 -70.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.711 0.255 . . . . 73.45 110.738 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.59 ' HE3' ' HD1' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -89.29 157.11 18.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.465 -0.494 . . . . 75.2 110.594 178.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.28 133.0 92.8 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.761 -0.654 . . . . 64.15 111.738 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.56 -29.04 88.91 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.252 2.635 . . . . 61.32 113.06 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.463 . . . . 41.21 109.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 152' ' ' GLU . . . -69.36 -28.65 66.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.61 -0.723 . . . . 64.23 109.975 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.59 ' HD1' ' HE3' ' A' ' 144' ' ' LYS . 87.0 t80 -65.13 -29.59 70.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.595 -0.729 . . . . 74.31 110.809 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.3 -23.22 10.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.285 0.564 . . . . 75.13 110.343 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.35 -26.01 30.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 63.24 111.081 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.545 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 8.9 pt-20 -87.31 153.28 21.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 74.15 110.501 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.832 ' HB3' ' HA ' ' A' ' 20' ' ' THR . 34.9 p-10 -132.77 14.18 4.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 63.2 110.908 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -107.03 156.08 19.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 54.12 110.304 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.538 ' CB ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -169.83 178.37 4.06 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.716 -1.216 . . . . 71.54 107.716 175.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.93 -72.95 0.44 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.234 -0.586 . . . . 72.03 111.074 -177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.57 -24.02 16.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.465 0.65 . . . . 73.42 110.194 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.538 ' HB2' ' CB ' ' A' ' 155' ' ' THR . 22.3 mp0 -68.6 -36.83 79.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.316 -0.856 . . . . 75.32 110.556 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.553 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 7.7 tpt180 -68.1 -17.61 64.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 72.33 110.501 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -78.44 -26.07 46.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 73.41 110.919 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 165' ' ' ILE . 34.8 mt-10 -89.7 -5.42 57.06 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 121.179 -0.208 . . . . 70.44 111.534 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.679 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 85.2 t -56.32 -51.8 78.08 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.667 0.247 . . . . 73.22 111.667 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.679 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 23.9 Cg_exo -64.97 -29.52 57.44 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.761 1.64 . . . . 64.22 111.984 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 26.1 m -73.59 -40.25 64.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.761 -0.654 . . . . 75.4 111.83 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 135' ' ' ILE . 34.8 pt -64.93 -30.98 51.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 121.031 -0.268 . . . . 65.31 110.969 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.01 -39.34 83.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.979 0.418 . . . . 72.12 109.98 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 163' ' ' PRO . 8.8 mm-40 -58.59 -50.62 73.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.697 -0.683 . . . . 71.21 110.413 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.99 -32.88 72.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.745 -0.661 . . . . 74.44 111.232 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.78 -46.39 78.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.289 . . . . 73.45 110.606 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.86 95.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.154 -0.475 . . . . 63.11 110.497 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.99 -50.06 75.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 65.4 110.961 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.85 -44.97 96.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.942 -0.572 . . . . 72.54 111.702 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 91.5 m -56.32 -42.78 78.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 61.21 111.359 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.84 -29.45 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 61.23 110.515 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.11 -28.62 66.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 74.24 110.472 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.2 mt -60.04 -47.34 86.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.862 -0.608 . . . . 75.42 111.084 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 177' ' ' ILE . 0.0 OUTLIER -79.92 -37.37 17.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.545 . . . . 74.32 110.832 -175.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -77.79 -54.51 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.83 0.307 . . . . 44.43 111.83 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -94.34 -57.28 2.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.404 -0.362 . . . . 62.22 110.632 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 159.77 151.74 6.26 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.744 -0.741 . . . . 64.31 111.848 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 176' ' ' LEU . 4.0 pp -71.92 -24.55 61.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.841 0.353 . . . . 60.41 111.546 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.468 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 30.0 tt0 -82.9 -51.96 0.67 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.387 -0.369 . . . . 73.45 111.612 -176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 17.2 Cg_endo -59.9 -35.9 92.21 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.058 1.839 . . . . 70.2 112.168 175.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.434 ' HB3' HD23 ' A' ' 176' ' ' LEU . . . -64.14 -45.32 89.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.834 0.349 . . . . 72.11 110.331 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -54.72 -49.78 69.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.738 -0.664 . . . . 62.34 110.783 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.414 ' HA ' ' HD2' ' A' ' 189' ' ' HIS . 57.8 t30 -57.69 -35.93 71.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.898 -0.592 . . . . 74.5 110.861 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 36.2 m -70.69 -54.24 12.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.087 -0.506 . . . . 64.3 110.992 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 64.3 t -67.83 -43.32 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.61 0.596 . . . . 74.24 112.61 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 186' ' ' ASN . 1.3 p80 -76.09 -3.81 38.03 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.667 -0.413 . . . . 63.33 111.39 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.98 22.08 8.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.096 0.474 . . . . 62.23 110.429 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.8 t90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.404 -0.808 . . . . 63.22 110.354 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.812 -0.44 . . . . 53.45 109.812 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.72 130.13 45.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.775 0.322 . . . . 53.01 110.763 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.6 155.57 56.41 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.519 -0.549 . . . . 74.14 109.519 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.872 ' HB2' HG12 ' A' ' 85' ' ' VAL . 5.6 Cg_endo -87.8 118.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.77 2.314 . . . . 74.05 112.617 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.6 tp -88.0 121.14 30.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.027 -0.533 . . . . 72.04 109.651 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 90' ' ' ILE . 61.1 tp -92.87 117.5 30.1 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.969 -0.382 . . . . 64.1 109.969 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.76 ' HB ' HD23 ' A' ' 62' ' ' LEU . 46.4 t -113.53 118.06 57.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.655 -0.498 . . . . 62.43 109.655 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.53 114.96 45.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.886 -0.597 . . . . 65.02 109.97 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.516 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -105.9 122.17 7.02 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.568 -0.825 . . . . 70.02 111.674 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.79 89.59 1.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.211 0.529 . . . . 75.2 110.711 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.843 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -142.75 110.55 0.62 Allowed Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.488 -0.778 . . . . 75.35 111.4 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -87.39 149.96 47.98 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.531 0.205 . . . . 70.01 110.664 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.691 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 73.7 Cg_endo -74.39 175.91 10.37 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.454 2.102 . . . . 60.12 111.791 177.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 17' ' ' TYR . . . 121.34 136.79 5.11 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.423 -0.894 . . . . 61.32 112.1 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.68 -28.7 82.73 Favored 'Trans proline' 0 C--O 1.225 -0.147 0 C-N-CA 123.159 2.573 . . . . 70.33 112.988 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.9 t -113.08 16.35 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 51.01 111.062 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' ' HA3' ' A' ' 14' ' ' GLY . 75.5 m-85 -106.28 -34.87 7.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 64.44 111.611 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.14 -4.5 25.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.247 0.832 . . . . 74.44 113.247 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -124.42 27.78 6.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.127 0.489 . . . . 72.51 110.753 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 69.5 p -102.5 -170.16 1.77 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.738 -0.665 . . . . 63.44 110.087 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 150' ' ' VAL . 55.0 mtt180 -84.52 -0.73 54.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.986 0.422 . . . . 61.14 110.459 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -105.21 19.49 20.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.97 0.414 . . . . 72.14 110.683 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -99.08 3.31 46.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.377 -0.374 . . . . 74.14 110.596 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.427 HD11 HG12 ' A' ' 137' ' ' VAL . 91.1 mt -55.67 -42.76 75.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.781 -0.645 . . . . 71.11 112.064 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -64.38 -37.75 94.89 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.65 -0.786 . . . . 25.3 112.004 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.843 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 75.4 t80 -73.21 -32.77 64.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.263 -0.273 . . . . 62.42 110.263 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.564 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 9.0 mmt -54.21 -54.02 45.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 74.32 111.692 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.95 -45.04 95.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 63.45 110.919 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.84 -41.64 95.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 63.43 111.117 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.93 -42.27 97.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 62.11 110.978 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 27' ' ' MET . 90.4 t -61.88 -44.18 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.31 110.585 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.38 -40.9 94.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 73.34 110.8 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.24 86.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.942 0.401 . . . . 74.5 110.532 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.9 -42.51 85.74 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.769 -0.65 . . . . 71.04 113.01 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.3 ptm180 -68.05 -31.32 70.89 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.984 0.392 . . . . 65.23 111.371 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' A' ' 35' ' ' ARG . 1.7 mp -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 63.11 109.945 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.31 43.29 4.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.95 -0.643 . . . . 72.41 112.265 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 m -129.56 158.62 38.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.671 0.272 . . . . 73.04 110.595 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.91 165.33 11.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.934 -0.575 . . . . 73.44 109.496 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.439 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 35.4 p90 -80.38 143.84 33.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.204 0.526 . . . . 73.34 111.339 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -106.44 133.46 51.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.626 -0.716 . . . . 73.23 109.336 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.57 124.23 40.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.348 . . . . 75.41 110.661 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -71.53 104.86 3.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.94 -0.573 . . . . 72.1 110.302 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 1.3 tmmt? -73.79 83.79 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.583 . . . . 64.43 109.734 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 170.84 -48.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.673 -1.148 . . . . 74.33 109.151 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -104.45 -28.43 11.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.465 -0.789 . . . . 74.13 110.702 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.2 9.49 73.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.852 -0.69 . . . . 75.4 111.475 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.29 134.23 34.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.79 0.329 . . . . 34.53 111.131 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 8.8 mt-10 -91.67 131.95 36.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.793 -0.64 . . . . 71.03 110.291 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.31 137.15 52.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 73.51 110.494 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 62' ' ' LEU . 3.8 p -126.99 136.49 60.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.746 -0.464 . . . . 53.54 109.746 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.783 HG22 HG12 ' A' ' 61' ' ' VAL . 24.4 p -108.8 151.32 26.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 73.2 111.944 -173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.31 -161.81 20.37 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.752 -0.658 . . . . 65.1 111.612 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.678 ' HD3' ' HA ' ' A' ' 59' ' ' SER . 20.3 mmt180 -133.15 139.17 46.91 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.751 -0.462 . . . . 52.41 109.751 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.07 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -130.18 116.7 18.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.659 0.266 . . . . 62.34 110.295 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 68.5 -27.96 0.15 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.672 0.789 . . . . 74.13 112.594 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 156.69 -30.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.537 -1.025 . . . . 72.4 110.537 -177.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.0 m -79.36 157.22 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.674 -0.763 . . . . 73.32 109.785 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.678 ' HA ' ' HD3' ' A' ' 54' ' ' ARG . 14.0 t -83.21 136.09 34.54 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.332 -0.618 . . . . 74.34 109.332 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.07 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.9 p -117.43 124.23 72.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.211 0.529 . . . . 74.21 110.672 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 52' ' ' THR . 8.9 m -113.04 111.78 37.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.322 0.582 . . . . 72.04 109.71 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.76 HD23 ' HB ' ' A' ' 7' ' ' VAL . 54.7 mt -92.79 115.81 28.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.585 -0.734 . . . . 61.12 110.47 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.5 147.62 41.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 74.24 110.218 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 17.0 ptmt -132.96 131.78 22.1 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.336 -0.393 . . . . 61.24 111.081 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 12.4 Cg_endo -57.37 136.11 74.14 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.915 2.41 . . . . 53.24 111.187 172.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.691 ' HD2' ' HG3' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -92.61 -59.96 1.94 Allowed 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.82 -0.352 . . . . 51.33 111.512 -172.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.4 p -156.92 145.12 19.49 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.12 -0.232 . . . . 75.23 110.981 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.641 ' CE1' ' HB3' ' A' ' 70' ' ' ASN . 35.7 t80 66.43 115.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 O-C-N 124.177 0.923 . . . . 62.3 111.09 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.574 ' HG2' ' HB3' ' A' ' 116' ' ' ASN . 1.9 mpt? -51.71 -56.27 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.312 -0.858 . . . . 71.13 111.94 -174.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.641 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 47.9 t30 -55.26 -49.71 71.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.246 -0.434 . . . . 72.15 111.136 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 mm-40 -59.52 -49.9 76.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 63.25 111.127 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 76' ' ' VAL . 50.7 m -60.48 -40.78 92.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.322 -0.399 . . . . 75.24 111.142 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.53 -43.33 97.67 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.902 -0.665 . . . . 55.32 112.048 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -69.82 -32.95 71.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.752 0.31 . . . . 74.34 110.521 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 81.2 mm-40 -65.15 -28.28 69.31 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.919 -0.582 . . . . 70.14 111.858 -177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 72' ' ' SER . 55.6 t -65.66 -31.12 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 72.51 110.847 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.31 -69.62 1.21 Allowed Glycine 0 CA--C 1.522 0.487 0 CA-C-N 115.962 -0.563 . . . . 72.43 112.993 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.91 -36.32 95.46 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.916 2.411 . . . . 73.35 112.77 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.52 -39.01 89.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 35.54 110.262 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.21 90.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.11 -0.496 . . . . 60.01 111.258 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -18.99 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.399 -0.364 . . . . 74.44 111.101 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -68.43 -37.32 80.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.357 -0.383 . . . . 71.4 110.548 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -101.53 4.17 40.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 74.42 111.321 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 m 63.44 31.93 14.71 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.888 -0.596 . . . . 71.53 111.546 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.872 HG12 ' HB2' ' A' ' 4' ' ' PRO . 16.7 m -81.78 143.35 50.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.905 0.383 . . . . 62.44 110.584 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 7.9 Cg_exo -73.64 137.85 25.69 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.679 2.253 . . . . 52.11 111.498 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.99 -10.76 24.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.812 2.342 . . . . 73.54 113.121 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.11 -26.96 18.04 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 121.034 -0.266 . . . . 73.51 110.486 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -95.09 62.68 2.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.258 0.551 . . . . 74.14 110.422 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.66 HD12 HD23 ' A' ' 6' ' ' LEU . 8.1 tt -140.41 117.34 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.691 -0.686 . . . . 64.35 110.57 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.17 114.38 35.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.087 -0.506 . . . . 63.22 110.182 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.587 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 48.4 t -96.99 108.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 70.25 110.824 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.528 HD13 ' HB ' ' A' ' 133' ' ' VAL . 44.0 mm -89.62 119.32 36.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.778 -0.646 . . . . 74.42 109.699 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -138.47 165.22 27.39 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.411 -0.516 . . . . 72.32 111.183 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.75 142.33 29.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 55.11 109.358 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.897 ' HG2' HG12 ' A' ' 99' ' ' ILE . 18.4 tp10 -127.34 123.23 35.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.838 0.351 . . . . 71.24 111.357 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.9 mt -84.21 -14.76 49.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.933 -0.576 . . . . 63.01 111.254 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.88 -31.99 17.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.191 -0.459 . . . . 71.14 111.646 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.897 HG12 ' HG2' ' A' ' 96' ' ' GLU . 29.0 mm -85.52 146.21 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.074 0.464 . . . . 74.11 111.408 -173.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 103' ' ' ARG . 14.2 m-20 -64.31 153.28 38.77 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.631 -0.713 . . . . 50.41 111.04 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.1 111.29 4.38 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.131 -0.692 . . . . 75.31 109.131 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.837 ' HA2' HD13 ' A' ' 165' ' ' ILE . . . 101.65 6.08 50.45 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.483 -0.865 . . . . 43.24 112.104 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 27.1 mmt180 -103.33 141.83 35.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.756 0.313 . . . . 74.53 110.778 177.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 mt -107.93 136.86 41.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.682 -0.859 . . . . 72.41 108.682 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.556 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -144.04 162.27 36.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.115 -0.234 . . . . 72.1 110.562 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.81 133.06 54.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.868 0.366 . . . . 73.04 110.359 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 57.1 tptt -106.52 105.06 14.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 64.1 109.869 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.881 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.2 pt? -78.59 -133.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.979 -0.555 . . . . 70.11 110.672 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.7 132.78 11.32 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.538 -0.839 . . . . 74.1 111.117 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 150.01 5.17 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.961 -1.114 . . . . 65.35 113.083 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.0 -153.34 29.44 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.176 -0.769 . . . . 55.3 111.176 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 78.85 -61.21 0.36 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.497 0.719 . . . . 75.05 111.92 171.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.25 115.82 5.01 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.116 -0.564 . . . . 42.12 112.068 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.09 -114.31 0.58 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 111.03 -0.828 . . . . 74.02 111.03 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -174.89 -82.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.495 0.188 . . . . 72.41 111.182 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.574 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 14.6 m120 -130.78 -70.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.531 0.567 . . . . 65.42 112.531 -172.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.3 -17.8 80.12 Favored Glycine 0 CA--C 1.504 -0.596 0 C-N-CA 121.063 -0.589 . . . . 55.44 112.055 -167.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.11 -30.62 70.47 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.981 -0.61 . . . . 61.12 110.649 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 119' ' ' ARG . 57.8 mtt180 -79.82 -29.15 40.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.074 -0.512 . . . . 72.11 111.12 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.9 m -75.31 -47.03 29.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.317 -0.401 . . . . 75.14 111.687 -173.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -69.89 -21.98 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.53 -0.305 . . . . 73.32 111.585 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.82 93.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 51.11 111.599 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -70.6 -39.81 73.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.269 -0.423 . . . . 72.22 111.675 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.48 58.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.365 -0.38 . . . . 53.5 111.339 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.41 -41.83 62.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.319 -0.401 . . . . 62.32 110.996 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.96 2.42 52.15 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.878 -0.677 . . . . 72.45 112.039 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.2 m -131.19 121.02 24.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.792 0.33 . . . . 74.43 110.396 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -99.25 -64.77 1.01 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.714 -0.847 . . . . 75.31 108.714 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.7 t30 31.74 61.55 0.29 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.861 1.265 . . . . 73.03 114.099 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.806 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 84.2 m-85 70.57 -23.45 0.17 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.893 1.442 . . . . 74.21 114.893 166.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -79.98 53.64 1.73 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.607 0.966 . . . . 73.54 113.607 -169.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.587 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 1.3 mpp_? -137.35 111.26 8.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.8 -0.445 . . . . 75.13 109.8 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.528 ' HB ' HD13 ' A' ' 93' ' ' ILE . 57.6 t -85.24 131.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.081 0.467 . . . . 71.45 110.583 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HD3' ' HB3' ' A' ' 105' ' ' ARG . 49.0 mtp180 -106.18 117.28 33.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.679 -0.691 . . . . 73.33 110.027 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.5 mp -105.58 118.53 53.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.938 -0.764 . . . . 63.34 108.938 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.31 12.49 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.668 . . . . 45.51 113.451 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.427 HG12 HD11 ' A' ' 24' ' ' LEU . 35.6 m -94.11 2.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.883 0.373 . . . . 65.15 110.669 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.13 179.84 17.15 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.044 -0.598 . . . . 74.14 112.007 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.478 ' H ' ' HG3' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -70.69 149.95 95.33 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.469 0.135 . . . . 74.5 110.921 178.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.505 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 47.2 Cg_exo -37.74 128.55 0.82 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.253 3.302 . . . . 71.03 113.935 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.9 Cg_exo -73.69 135.07 21.17 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.477 2.784 . . . . 73.0 112.625 -177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -112.68 162.23 12.44 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.063 -0.815 . . . . 61.11 111.063 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.434 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 2.0 tpm_? 71.63 -75.21 0.08 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.132 0.573 . . . . 52.33 110.132 -178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.507 ' HD2' ' HD1' ' A' ' 149' ' ' PHE . 6.8 ptpp? -78.82 144.44 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.075 -0.342 . . . . 73.01 110.075 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -67.33 139.93 94.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.108 -0.497 . . . . 72.34 110.246 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.0 -28.89 19.99 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.254 2.636 . . . . 73.12 113.437 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -68.42 -36.19 78.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.377 . . . . 70.51 110.802 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.57 -25.64 30.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.316 -0.402 . . . . 74.25 110.466 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.507 ' HD1' ' HD2' ' A' ' 144' ' ' LYS . 90.3 t80 -62.28 -38.08 87.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.679 -0.692 . . . . 72.1 110.987 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.608 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 33.5 m -84.94 -0.61 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.395 . . . . 73.11 111.369 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 147' ' ' ALA . 73.1 mt -98.42 12.47 34.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 72.23 111.22 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 11.1 pt-20 -129.24 177.06 7.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.489 -0.323 . . . . 70.22 110.414 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -77.74 177.97 7.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.931 -0.577 . . . . 63.4 111.377 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.51 ' HB2' ' HG3' ' A' ' 159' ' ' ARG . 68.1 m-85 -80.06 165.05 22.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.874 -0.603 . . . . 74.43 110.81 -177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.648 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 0.1 OUTLIER -75.95 -153.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.84 0.311 . . . . 74.2 111.84 -175.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.39 -70.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.059 0.392 . . . . 65.02 112.059 -173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -76.33 -44.66 35.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 72.55 111.386 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -59.93 -21.6 61.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.907 -0.588 . . . . 63.52 111.246 -177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.648 ' HB2' ' O ' ' A' ' 155' ' ' THR . 25.9 ttt180 -63.41 -24.1 67.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.025 0.44 . . . . 65.41 110.788 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.17 -19.54 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 64.52 111.032 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.86 -11.12 45.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.283 -0.417 . . . . 71.33 111.09 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 166' ' ' VAL . 47.9 t -60.98 -61.22 8.45 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.018 -0.537 . . . . 62.43 112.207 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 18.4 Cg_endo -59.05 -34.15 98.87 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.027 1.818 . . . . 74.41 112.601 -175.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.6 m -66.15 -39.3 89.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 75.11 111.763 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.837 HD13 ' HA2' ' A' ' 102' ' ' GLY . 43.6 pt -78.97 -30.0 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.762 -0.375 . . . . 61.13 110.848 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.1 t -62.68 -42.66 96.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.741 0.305 . . . . 62.21 110.64 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 46.6 mt-10 -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 74.32 110.834 177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -73.5 -33.92 65.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.924 -0.58 . . . . 72.25 111.309 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.27 96.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 44.34 111.131 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.83 -43.89 91.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.113 -0.494 . . . . 42.24 110.851 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.27 -35.74 76.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 61.41 111.422 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -62.21 -38.64 89.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.716 0.294 . . . . 71.24 110.759 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 54.8 m -60.48 -36.78 79.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 60.41 110.593 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -76.83 -33.95 57.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 64.41 110.576 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.29 -27.78 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 72.12 110.555 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 84.9 mt -63.13 -33.38 75.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.939 -0.573 . . . . 61.23 110.371 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.8 mm -80.47 -55.63 8.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.844 -0.616 . . . . 74.15 110.877 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.29 -54.67 37.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.689 -0.687 . . . . 74.53 112.1 -173.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.501 ' HG2' ' HB2' ' A' ' 183' ' ' PRO . 36.4 tt0 -93.33 -50.14 5.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.367 -0.379 . . . . 71.34 110.352 -176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 132.55 147.98 5.93 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.775 -0.726 . . . . 74.12 111.453 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 182' ' ' GLU . 4.2 pp -64.92 -27.28 68.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.895 0.348 . . . . 74.22 111.89 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.715 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 40.6 tt0 -76.95 -52.55 1.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.837 -0.165 . . . . 64.23 111.283 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 24.9 Cg_exo -65.17 -34.98 43.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.548 1.499 . . . . 70.3 112.56 175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.475 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -73.52 -31.48 63.71 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.119 0.414 . . . . 75.3 112.119 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 12.2 pt20 -61.75 -21.25 64.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.874 -0.331 . . . . 63.11 110.825 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -55.06 -52.56 62.8 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.354 -0.61 . . . . 75.34 109.354 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 63.0 m -66.63 -46.29 76.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 74.02 110.87 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 184' ' ' ALA . 10.7 t -67.58 -13.08 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.186 -0.461 . . . . 63.35 111.964 -174.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -102.42 -22.67 14.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.344 0.498 . . . . 73.02 112.344 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -118.42 -25.88 6.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.704 0.631 . . . . 75.41 112.704 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.1 t90 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.233 -0.889 . . . . 64.44 110.374 -174.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 111.391 0.145 . . . . 73.41 111.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.26 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.583 0.552 . . . . 53.24 110.761 -173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.9 OUTLIER -86.0 125.02 69.73 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.243 0.544 . . . . 63.43 110.95 -175.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 59' ' ' SER . 61.2 Cg_endo -94.09 143.62 1.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 123.18 2.586 . . . . 71.22 112.587 175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.24 120.69 39.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.418 -0.586 . . . . 45.22 109.418 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.558 ' HB2' HE21 ' A' ' 88' ' ' GLN . 46.9 tp -92.13 105.23 17.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.26 -0.427 . . . . 71.33 109.989 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.704 ' HB ' HD23 ' A' ' 62' ' ' LEU . 43.3 t -118.9 127.25 75.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.223 -0.444 . . . . 61.53 110.377 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.06 121.8 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.557 . . . . 70.03 110.115 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.98 122.04 6.53 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.317 -0.944 . . . . 55.25 111.65 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.3 tp -108.75 86.77 2.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.296 0.57 . . . . 74.34 110.243 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -131.6 147.42 18.61 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.344 -0.843 . . . . 62.13 111.416 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.922 HD22 ' HB3' ' A' ' 17' ' ' TYR . 1.1 p-10 -93.33 109.61 41.39 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.958 0.409 . . . . 63.34 110.893 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 2.0 Cg_endo -82.05 -80.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.861 2.374 . . . . 74.35 112.731 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.67 -151.68 28.52 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.719 -0.753 . . . . 61.13 112.083 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.24 -49.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.94 2.427 . . . . 73.01 112.795 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -107.26 -26.24 11.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 74.23 111.923 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.922 ' HB3' HD22 ' A' ' 12' ' ' ASN . 88.4 m-85 -71.44 -17.41 62.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.902 0.704 . . . . 64.55 112.902 -168.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' C ' ' HD2' ' A' ' 19' ' ' LYS . . . -71.44 -7.0 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.927 0.343 . . . . 72.41 111.927 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HD2' ' C ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -123.12 20.09 9.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.643 -0.253 . . . . 72.32 111.021 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 75.6 p -101.34 178.02 4.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.602 0.239 . . . . 71.01 111.532 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.765 ' HG3' ' HA ' ' A' ' 153' ' ' ASN . 67.5 mtt180 -59.21 -23.54 62.37 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.077 0.465 . . . . 72.42 110.709 176.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.718 ' HB2' ' HB ' ' A' ' 150' ' ' VAL . 1.7 t-80 -98.23 17.23 19.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.206 -0.452 . . . . 70.11 111.492 -173.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.61 3.13 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.117 0.484 . . . . 62.42 110.405 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.9 mt -52.76 -35.27 56.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 54.42 112.303 -176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -63.63 -25.65 69.07 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.136 -0.554 . . . . 41.12 112.984 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -90.32 -29.89 17.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.633 0.254 . . . . 74.23 110.864 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.574 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 7.2 mmt -54.74 -48.08 73.01 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.528 0.566 . . . . 73.4 112.528 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.826 ' HB ' HD13 ' A' ' 93' ' ' ILE . 44.7 t -62.03 -45.24 99.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.726 0.298 . . . . 64.34 111.139 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.07 89.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 74.33 111.112 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.24 -48.91 77.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 55.41 110.968 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -65.0 -38.56 83.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.225 -0.443 . . . . 64.44 111.031 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 83.0 mt -63.77 -47.1 82.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.602 -0.272 . . . . 44.32 110.922 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.94 85.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.969 0.414 . . . . 50.24 110.543 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.51 -39.73 86.78 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.719 -0.673 . . . . 72.21 113.601 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.928 ' HG3' HD12 ' A' ' 36' ' ' ILE . 15.2 ptp180 -68.79 -36.41 78.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.378 0.589 . . . . 64.24 111.825 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.928 HD12 ' HG3' ' A' ' 35' ' ' ARG . 3.0 mp -77.89 -36.69 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 71.44 109.623 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.9 48.15 3.96 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.896 -0.669 . . . . 74.2 111.976 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.31 162.33 17.66 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.786 0.327 . . . . 71.14 110.352 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.82 130.63 56.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 71.51 110.691 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.516 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 19.1 p90 -70.18 133.59 47.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.182 -0.463 . . . . 73.04 110.286 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.28 134.83 54.66 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.937 -0.574 . . . . 75.22 110.7 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 49' ' ' GLU . 43.5 t -72.83 118.07 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.771 -0.65 . . . . 71.25 110.202 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -76.49 93.38 3.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.195 -1.039 . . . . 64.31 108.195 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.1 ttpp -75.46 79.73 2.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.978 0.894 . . . . 72.14 110.2 -172.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -169.25 -53.95 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.763 -1.562 . . . . 61.13 106.915 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -93.71 -28.55 15.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.944 -1.025 . . . . 60.25 110.241 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 29.59 14.62 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.945 -0.645 . . . . 44.15 112.153 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.14 146.22 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.319 -0.252 . . . . 53.34 110.319 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.798 ' HG2' HG22 ' A' ' 42' ' ' VAL . 36.1 mt-10 -98.85 138.75 35.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.304 -0.407 . . . . 74.44 110.397 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.75 137.96 51.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.43 -0.35 . . . . 61.45 110.468 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.55 HG13 ' HB2' ' A' ' 62' ' ' LEU . 7.5 p -128.86 139.13 52.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.477 -0.329 . . . . 70.21 110.377 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 61' ' ' VAL . 17.4 p -101.49 177.74 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.728 0.299 . . . . 72.25 111.449 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.52 -167.53 40.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.161 -0.543 . . . . 35.1 111.966 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.809 ' H ' HG12 ' A' ' 36' ' ' ILE . 18.0 mmt180 -133.54 130.1 37.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.721 0.296 . . . . 72.03 110.737 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.018 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.4 pt? -130.84 115.76 17.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.323 -0.621 . . . . 72.05 109.323 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.72 23.51 13.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.816 -0.629 . . . . 75.23 111.264 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.71 -30.88 8.87 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.073 -0.584 . . . . 74.53 111.665 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 55' ' ' LEU . 75.0 m -70.49 142.96 51.84 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.795 0.438 . . . . 75.44 110.453 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 5.1 p -79.85 122.17 26.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.686 0.279 . . . . 74.35 110.73 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.018 ' HB ' HD22 ' A' ' 55' ' ' LEU . 12.1 p -97.37 138.5 22.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.113 -0.328 . . . . 51.43 110.113 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 52' ' ' THR . 7.2 m -124.21 108.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.329 0.585 . . . . 71.53 110.193 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.704 HD23 ' HB ' ' A' ' 7' ' ' VAL . 79.9 mt -95.22 119.55 33.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.562 -0.744 . . . . 65.53 110.333 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.74 147.74 39.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.484 . . . . 72.13 110.637 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.529 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 16.0 ptmt -132.85 143.27 47.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.093 -0.503 . . . . 63.1 110.31 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 17.8 Cg_exo -67.45 160.21 48.88 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.74 2.293 . . . . 74.22 111.683 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 39.6 ttt-85 -70.67 -63.17 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 60.24 110.173 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 47.8 m -165.89 147.73 7.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.776 -0.647 . . . . 74.34 110.102 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 t80 70.62 162.05 0.24 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.68 0.752 . . . . 75.34 112.269 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.4 ' N ' ' SD ' ' A' ' 69' ' ' MET . 1.9 mpt? -79.6 -16.08 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.615 -0.72 . . . . 61.21 111.365 -177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -73.62 -50.05 23.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.269 -0.423 . . . . 61.24 110.125 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 18.7 mt-10 -68.9 -41.06 78.76 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.978 0.362 . . . . 74.42 111.978 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 p -52.36 -44.43 65.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.94 0.348 . . . . 63.05 111.94 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.575 ' HA3' ' HB3' ' A' ' 120' ' ' SER . . . -68.8 -25.46 75.18 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 63.52 112.545 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -94.21 -7.12 43.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.551 0.215 . . . . 75.12 111.338 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 19.4 mm-40 -102.33 -52.72 3.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.64 -0.254 . . . . 75.3 111.477 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.26 -40.52 81.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 75.31 111.601 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.658 ' HA2' HD21 ' A' ' 125' ' ' LEU . . . -55.83 -66.22 2.99 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.074 -0.512 . . . . 50.0 112.919 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.29 -39.05 93.06 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.741 2.294 . . . . 62.42 113.025 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 mt -57.19 -45.91 83.33 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.753 0.279 . . . . 65.11 111.753 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -44.2 71.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.217 0.532 . . . . 73.44 111.162 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -7.83 58.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.949 -0.568 . . . . 51.24 111.658 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -77.23 -53.99 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 53.31 110.163 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -89.07 5.25 45.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.984 0.421 . . . . 73.13 110.397 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.6 m 60.32 84.13 0.13 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 62.53 113.241 171.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.49 142.26 27.29 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.852 -0.613 . . . . 71.14 109.498 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.77 172.14 16.86 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.51 2.14 . . . . 73.14 111.69 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 96.38 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.215 1.944 . . . . 61.24 111.463 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.558 HE21 ' HB2' ' A' ' 6' ' ' LEU . 12.8 pt20 -133.25 177.61 7.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.662 -0.699 . . . . 71.51 110.038 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -66.2 104.75 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.912 0.387 . . . . 74.2 111.136 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.1 tt -93.65 112.81 27.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.788 -0.642 . . . . 74.52 109.696 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.1 t -100.17 111.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.664 -0.698 . . . . 72.13 110.855 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.538 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 57.9 t -99.38 116.54 42.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.496 -0.557 . . . . 73.03 109.496 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.826 HD13 ' HB ' ' A' ' 28' ' ' VAL . 35.3 mt -87.05 122.86 39.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.096 -0.502 . . . . 62.31 110.622 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.637 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 41.4 t-80 -151.68 170.89 18.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.813 0.34 . . . . 75.13 110.465 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.06 153.71 22.54 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.91 0.484 . . . . 73.35 111.108 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.951 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 9.1 tp10 -118.2 121.56 40.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.925 -0.579 . . . . 62.43 110.907 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.5 mt -83.5 -21.17 32.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 73.31 110.877 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.65 -19.83 34.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.493 . . . . 70.31 111.808 -175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.741 HG13 ' HB2' ' A' ' 105' ' ' ARG . 29.0 mm -107.64 139.52 29.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.532 -0.304 . . . . 61.41 111.443 -175.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.685 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 3.8 m-20 -55.78 152.17 10.12 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.501 -0.772 . . . . 74.32 111.405 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.589 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 1.4 t80 -67.55 109.2 3.15 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.649 -0.705 . . . . 62.2 110.421 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.776 ' HA2' HG21 ' A' ' 165' ' ' ILE . . . 137.46 -23.85 3.1 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.405 -0.902 . . . . 75.43 113.165 176.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -108.28 151.59 25.76 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.515 -0.403 . . . . 73.4 110.33 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.831 ' HB ' HG22 ' A' ' 188' ' ' VAL . 3.6 mp -105.29 136.87 37.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.156 0.503 . . . . 71.52 110.149 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.741 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.1 tpt180 -108.89 140.31 42.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.639 -0.71 . . . . 73.24 109.785 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 185' ' ' GLN . 98.3 mt -122.66 121.08 35.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.431 -0.35 . . . . 73.34 110.238 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -116.65 138.89 51.11 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.926 -0.398 . . . . 74.04 109.926 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 130' ' ' PHE . 6.9 mp -79.5 -71.4 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.75 -0.659 . . . . 74.24 110.379 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.33 -144.53 6.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 116.004 -0.544 . . . . 73.21 112.913 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.01 156.26 35.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.959 -0.638 . . . . 50.32 112.665 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.12 152.76 13.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.94 -0.647 . . . . 53.15 111.747 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -67.74 139.9 56.7 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.285 -0.265 . . . . 71.23 110.285 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 143.62 60.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.032 -0.604 . . . . 71.42 112.16 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.59 -21.22 2.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.298 -0.953 . . . . 75.41 113.254 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 30.7 m80 55.75 -101.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.677 0.621 . . . . 73.14 112.677 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.02 -69.89 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.099 0.777 . . . . 74.14 113.099 -166.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.74 -47.09 92.51 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 121.178 -0.534 . . . . 65.15 112.708 -165.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.0 -47.5 82.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.313 -0.443 . . . . 50.31 111.737 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -79.93 -22.16 43.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.944 0.35 . . . . 65.42 111.944 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.575 ' HB3' ' HA3' ' A' ' 73' ' ' GLY . 73.5 m -61.87 -52.43 64.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.661 0.267 . . . . 63.24 110.486 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.39 -28.85 36.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.009 0.433 . . . . 71.53 110.722 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.95 74.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 65.23 111.004 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 m -84.55 -38.06 20.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.397 -0.365 . . . . 71.32 111.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.32 -52.9 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 72.44 111.032 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.658 HD21 ' HA2' ' A' ' 77' ' ' GLY . 95.9 mt -78.7 -32.36 46.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.149 -0.478 . . . . 73.53 110.361 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.05 -5.53 66.08 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.004 -0.617 . . . . 73.45 112.447 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.3 m -114.23 121.89 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.358 0.599 . . . . 62.34 111.7 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.2 -93.99 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.392 -1.336 . . . . 65.22 107.392 168.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m120 64.24 -8.2 0.2 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.151 1.537 . . . . 72.21 115.151 159.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 108' ' ' LEU . 75.0 m-85 -119.27 -107.96 0.36 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.428 0.558 . . . . 65.41 111.865 -173.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -146.97 118.33 7.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 72.43 111.321 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.538 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 11.9 mpt_? -106.33 123.95 48.85 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 52.33 109.642 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.42 ' HA ' HD23 ' A' ' 106' ' ' LEU . 94.1 t -83.57 117.32 29.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 64.42 110.479 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.951 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.7 mtt180 -120.01 117.88 29.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.75 -0.659 . . . . 72.21 110.642 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.3 mp -91.09 117.61 34.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.631 -0.507 . . . . 70.4 109.631 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.37 130.53 41.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.206 -0.521 . . . . 63.15 113.156 -176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.7 m -100.83 -0.72 10.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.049 0.452 . . . . 71.21 111.074 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 111.8 -83.9 0.34 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.5 -0.857 . . . . 72.43 112.882 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -164.1 168.45 9.38 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.445 -0.206 . . . . 72.52 110.445 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.0 Cg_exo -59.38 135.56 65.99 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.243 1.962 . . . . 71.32 110.385 166.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.661 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 26.1 Cg_exo -61.76 -38.48 59.83 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.769 2.312 . . . . 72.25 112.603 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.1 -71.7 2.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.027 -0.606 . . . . 70.24 113.308 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -78.88 -31.11 45.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 64.53 111.274 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 8.0 ptmm? -116.36 152.8 33.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.836 -0.431 . . . . 74.23 109.836 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.84 134.18 95.97 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.446 -0.343 . . . . 73.41 111.194 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.661 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 81.2 Cg_exo -47.66 -44.4 26.2 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.63 2.887 . . . . 54.4 113.626 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.09 87.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.041 0.448 . . . . 65.4 110.729 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.46 -18.8 60.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.812 -0.631 . . . . 62.11 110.68 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 89.3 t80 -84.18 -34.82 23.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.156 -0.474 . . . . 71.34 111.048 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.718 ' HB ' ' HB2' ' A' ' 22' ' ' HIS . 34.1 m -84.66 -17.03 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.666 0.617 . . . . 51.25 112.666 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.18 -7.44 59.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.059 0.457 . . . . 74.24 111.473 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.512 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 4.1 pt-20 -111.06 172.84 6.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.985 -0.552 . . . . 72.13 109.555 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.765 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 33.1 p30 -142.27 -20.54 0.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.815 0.341 . . . . 64.24 111.349 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -62.63 114.06 3.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 74.42 111.245 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -145.41 179.85 7.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.757 -0.831 . . . . 71.3 108.757 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.07 -71.86 0.42 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 63.3 111.864 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.58 -43.65 7.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 65.35 111.582 -174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 1.6 pm0 -72.15 -19.83 61.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.463 -0.789 . . . . 62.55 112.229 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 155' ' ' THR . 19.1 tpt180 -69.75 -38.0 76.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 64.03 110.139 175.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.0 -27.23 60.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.162 -0.472 . . . . 62.31 110.911 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.78 1.25 57.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.127 -0.488 . . . . 71.41 112.046 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 166' ' ' VAL . 89.1 t -57.01 -57.06 27.14 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 121.061 -0.256 . . . . 62.21 110.648 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.3 Cg_endo -60.23 -30.33 90.95 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 121.967 1.778 . . . . 74.44 112.055 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.1 m -67.0 -48.12 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 70.22 111.175 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.776 HG21 ' HA2' ' A' ' 102' ' ' GLY . 42.3 pt -74.24 -20.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.578 -0.283 . . . . 73.43 111.319 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 162' ' ' VAL . 70.0 t -62.8 -45.11 99.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.966 -0.383 . . . . 72.25 109.966 174.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -58.73 -46.93 86.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.09 -0.505 . . . . 42.43 110.037 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.65 -54.22 48.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.313 -0.858 . . . . 75.44 111.144 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.63 -40.91 89.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 63.41 111.566 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.704 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -65.37 -49.45 69.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.346 -0.388 . . . . 72.22 111.216 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.35 -31.41 60.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.367 -0.379 . . . . 73.21 111.907 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.702 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -59.74 -46.57 88.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.094 -0.335 . . . . 64.33 110.094 173.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.8 m -58.88 -40.21 83.73 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.257 -0.429 . . . . 72.34 110.903 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 55' ' ' LEU . 33.5 tt0 -65.94 -42.95 89.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 64.51 110.028 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 49.3 tp -68.15 -25.79 65.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 75.31 111.195 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 86.9 mt -62.03 -32.28 72.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.498 -0.319 . . . . 71.21 111.271 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.448 HG21 ' HG ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -80.14 -25.39 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.17 0.509 . . . . 54.34 110.047 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -86.32 -47.34 9.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.081 -0.509 . . . . 73.21 111.59 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 184' ' ' ALA . 24.2 tp60 -86.04 -59.5 2.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.476 -0.329 . . . . 74.51 110.207 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.66 -75.0 0.89 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.032 0.773 . . . . 75.44 115.032 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 52.6 tp -42.47 -69.81 0.12 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.209 1.188 . . . . 64.12 114.209 -163.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.67 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 38.0 tt0 -139.91 -59.45 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 112.481 0.549 . . . . 64.33 112.481 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HD2' ' H ' ' A' ' 182' ' ' GLU . 18.4 Cg_endo -59.12 -17.2 37.28 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.079 1.853 . . . . 51.24 112.853 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' A' ' 179' ' ' GLN . . . -60.3 -58.79 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.474 -0.33 . . . . 71.24 111.243 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.52 ' O ' ' HD2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -77.15 -28.42 54.18 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.802 -0.359 . . . . 72.04 111.181 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 183' ' ' PRO . 24.5 t-20 -57.75 -39.56 77.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.875 0.369 . . . . 74.0 110.61 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 84.8 m -65.1 -57.43 8.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.817 -0.629 . . . . 53.43 112.368 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.831 HG22 ' HB ' ' A' ' 104' ' ' ILE . 2.0 p -64.13 -18.87 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 113.499 0.926 . . . . 72.13 113.499 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.52 ' HD2' ' O ' ' A' ' 185' ' ' GLN . 9.0 p80 -106.95 -6.93 17.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.152 -0.619 . . . . 70.2 111.723 -177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -132.42 4.29 3.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.431 0.53 . . . . 51.3 112.431 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 15.9 t90 . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.471 -0.776 . . . . 71.12 109.849 -179.149 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 2' ' ' ALA . 21.1 ptt? . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.575 0.226 . . . . 74.31 111.134 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.588 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -139.31 42.53 2.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.022 0.439 . . . . 73.15 110.672 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 0.4 OUTLIER -106.25 81.61 0.83 Allowed Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 108.685 -0.857 . . . . 74.35 108.685 171.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.812 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 62.0 Cg_endo -90.88 171.61 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.981 2.454 . . . . 72.02 113.277 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.757 ' HB2' HD11 ' A' ' 177' ' ' ILE . 49.2 tp -119.63 110.05 16.39 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.554 -0.748 . . . . 74.01 109.801 176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.707 ' HA ' HG23 ' A' ' 61' ' ' VAL . 51.0 tp -92.53 107.95 19.61 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.874 -0.787 . . . . 72.41 108.874 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' A' ' 62' ' ' LEU . 49.4 t -100.83 116.72 44.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.795 -0.639 . . . . 72.34 110.731 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -102.71 114.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.465 -0.789 . . . . 73.31 109.302 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.41 122.26 7.29 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.211 -0.995 . . . . 42.22 111.985 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -79.01 91.38 4.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.164 0.507 . . . . 73.32 109.689 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.815 ' HA2' ' HA ' ' A' ' 23' ' ' ASN . . . -152.66 122.24 1.28 Allowed Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.561 -0.828 . . . . 70.54 112.376 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -112.34 98.05 41.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.792 -0.818 . . . . 71.55 108.792 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.75 58.65 4.03 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.581 2.854 . . . . 73.32 112.997 -172.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.08 175.0 39.7 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.521 -0.632 . . . . 50.31 111.521 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.26 -57.61 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.62 2.88 . . . . 71.3 113.515 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -107.38 7.35 29.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.537 0.684 . . . . 74.14 110.431 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HA ' ' OG1' ' A' ' 20' ' ' THR . 97.9 m-85 -94.13 -15.61 24.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 72.22 111.959 -172.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.81 -34.46 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.721 0.638 . . . . 63.43 112.721 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.657 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -115.76 14.95 16.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.135 0.493 . . . . 73.24 111.459 -176.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.7 p -109.37 -172.97 2.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.279 -0.418 . . . . 60.01 110.273 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.545 ' HG2' HG11 ' A' ' 137' ' ' VAL . 64.7 mtt85 -68.04 1.44 2.74 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.208 0.447 . . . . 63.24 112.208 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -95.53 -5.26 43.19 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.332 -0.23 . . . . 43.22 111.117 -176.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.815 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 t30 -143.23 9.37 1.66 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.315 0.579 . . . . 72.11 111.247 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 20' ' ' THR . 51.1 mt -68.57 -28.06 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.92 -0.488 . . . . 72.41 111.784 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.85 -21.85 71.61 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.45 -0.881 . . . . 62.24 112.188 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 81.0 t80 -80.38 -21.75 42.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.558 0.218 . . . . 71.03 111.108 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 31' ' ' VAL . 11.0 mmt -51.13 -51.51 52.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.351 -0.386 . . . . 62.42 111.682 -176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 170' ' ' ALA . 57.4 t -61.17 -43.5 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 72.44 111.044 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.28 -40.68 97.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.0 -0.546 . . . . 50.3 110.858 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.29 -41.2 98.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.396 . . . . 74.43 110.61 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 27' ' ' MET . 66.5 t -62.97 -34.46 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 70.5 110.653 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 35' ' ' ARG . 93.3 mt -64.34 -33.87 76.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.367 -0.378 . . . . 74.13 110.672 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.67 -39.07 46.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.336 -0.393 . . . . 75.02 110.474 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.39 -40.12 96.2 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.815 -0.629 . . . . 65.43 113.039 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 32' ' ' LEU . 11.0 ptm180 -66.24 -21.78 66.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.842 0.353 . . . . 75.15 110.812 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -90.16 -48.89 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.063 0.458 . . . . 71.43 110.317 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.24 38.12 2.53 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.96 -0.638 . . . . 43.0 112.161 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 m -126.12 146.09 50.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.737 0.303 . . . . 74.51 110.58 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.34 142.86 33.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 73.0 111.018 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.807 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 16.8 p90 -74.4 147.0 42.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.021 -0.536 . . . . 71.45 110.757 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -128.7 145.21 51.23 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.034 -0.358 . . . . 71.13 110.034 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.886 HG22 ' HG3' ' A' ' 49' ' ' GLU . 32.7 t -76.52 134.33 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.277 -0.42 . . . . 72.41 111.398 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -94.99 125.55 39.73 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.427 -0.583 . . . . 75.15 109.427 169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -63.32 -36.55 84.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.379 . . . . 64.12 110.889 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -83.38 4.14 28.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.984 -0.553 . . . . 72.42 110.924 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.4 m -125.59 -29.02 3.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.812 0.339 . . . . 70.54 111.308 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.37 29.23 73.04 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.961 -0.638 . . . . 72.2 111.812 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.62 153.52 37.19 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.614 0.245 . . . . 62.21 110.587 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.886 ' HG3' HG22 ' A' ' 42' ' ' VAL . 4.5 mp0 -85.68 131.22 34.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.54 . . . . 63.5 110.795 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.25 149.46 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 70.03 109.429 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.807 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.4 p -144.42 138.81 23.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.86 0.362 . . . . 74.14 110.544 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.722 HG22 HG12 ' A' ' 61' ' ' VAL . 41.5 p -107.61 136.97 46.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.09 -0.504 . . . . 62.15 110.896 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.6 -166.02 13.23 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.929 -0.653 . . . . 62.43 111.914 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -131.21 105.82 7.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.486 -0.191 . . . . 73.41 110.486 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.124 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.2 pt? -96.68 115.91 28.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.835 -0.802 . . . . 73.54 108.835 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.58 -49.43 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.619 -0.719 . . . . 60.13 111.474 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.16 -33.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.261 -0.736 . . . . 72.14 111.261 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -68.8 148.06 50.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.968 -0.616 . . . . 54.33 111.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.4 m -70.83 114.8 9.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.992 -0.373 . . . . 73.42 109.992 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.124 ' HB ' HD22 ' A' ' 55' ' ' LEU . 10.5 p -97.02 127.14 49.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.568 -0.531 . . . . 55.45 109.568 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.722 HG12 HG22 ' A' ' 52' ' ' THR . 2.8 m -116.51 109.13 26.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.375 0.607 . . . . 71.11 110.27 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 7' ' ' VAL . 50.7 mt -96.14 120.52 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.376 -0.829 . . . . 75.43 110.022 -177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.85 129.85 51.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.364 -0.38 . . . . 63.1 110.659 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 8.2 ptmm? -115.91 121.45 34.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.281 -0.418 . . . . 74.41 110.541 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HA ' ' OE1' ' A' ' 75' ' ' GLN . 27.3 Cg_exo -62.0 156.72 47.8 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.715 2.276 . . . . 61.53 111.362 177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.591 ' HG3' ' N ' ' A' ' 67' ' ' CYS . 9.1 ptt180 -77.49 -55.9 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.442 -0.503 . . . . 65.52 110.345 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.591 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 21.1 p -167.5 173.63 8.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.748 -0.206 . . . . 70.05 110.469 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 t80 67.62 162.77 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.96 0.788 . . . . 71.35 112.188 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -21.15 25.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.861 -0.609 . . . . 62.14 112.272 -175.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -94.86 -38.64 10.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.724 0.297 . . . . 72.2 111.263 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.76 -26.45 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 63.24 111.121 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -45.0 95.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 72.35 110.478 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.09 -33.86 84.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.877 -0.678 . . . . 64.52 111.722 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -74.26 -8.42 56.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 73.41 111.244 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' A' ' 65' ' ' PRO . 82.8 mt-30 -103.96 -49.87 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.321 -0.4 . . . . 75.13 111.534 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.02 -29.95 42.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 111.814 0.302 . . . . 70.25 111.814 -176.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.2 -61.29 7.08 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.143 -0.551 . . . . 74.22 112.67 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.38 -37.69 94.49 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.908 2.406 . . . . 73.24 113.032 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 64.8 mt -58.08 -39.15 77.82 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.924 0.342 . . . . 74.4 111.924 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.85 -41.97 88.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 55.54 110.874 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -23.8 27.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.173 -0.467 . . . . 71.34 111.207 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -60.87 -46.65 89.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.212 0.529 . . . . 71.01 109.854 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -84.12 -14.99 48.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.713 -0.676 . . . . 74.0 110.281 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m 60.67 47.71 7.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.606 0.717 . . . . 74.04 110.73 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.812 ' HB ' ' HG3' ' A' ' 4' ' ' PRO . 27.4 m -102.13 137.23 19.41 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.327 -0.852 . . . . 72.22 110.215 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.632 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 23.4 Cg_exo -64.58 137.7 55.88 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.623 2.216 . . . . 72.42 111.713 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 93.8 Cg_endo -87.11 53.11 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.991 2.46 . . . . 73.31 113.574 -172.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.632 ' OE1' ' HB2' ' A' ' 86' ' ' PRO . 10.7 mp0 -59.28 -57.1 14.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.777 0.322 . . . . 62.11 110.68 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.588 HE21 HD13 ' A' ' 5' ' ' LEU . 9.7 pt20 -144.03 102.45 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.541 0.686 . . . . 74.25 112.394 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.607 HD13 HD11 ' A' ' 125' ' ' LEU . 5.8 tt -98.18 115.58 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.36 -0.836 . . . . 55.32 109.129 170.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.44 117.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.947 -0.57 . . . . 75.32 110.801 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.604 ' H ' ' HG3' ' A' ' 132' ' ' ARG . 44.7 t -97.24 103.24 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.23 -0.656 . . . . 72.43 109.23 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.434 HG21 ' HB ' ' A' ' 28' ' ' VAL . 58.0 mt -86.12 119.24 34.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.947 -0.57 . . . . 72.54 109.84 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.435 ' CE1' HD22 ' A' ' 118' ' ' LEU . 28.3 p80 -151.67 170.65 19.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.89 -0.596 . . . . 75.24 110.522 -176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -85.63 150.23 24.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.319 -0.623 . . . . 71.43 109.319 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.695 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 7.8 tp10 -124.99 119.81 29.77 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.94 0.4 . . . . 74.34 110.045 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 138' ' ' GLY . 92.7 mt -82.39 -0.51 46.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 54.24 110.06 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 27.9 t70 -83.05 -11.01 58.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.358 -0.837 . . . . 70.54 110.459 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 105' ' ' ARG . 12.4 tt -132.06 148.9 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.945 0.403 . . . . 65.11 111.347 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.37 145.57 21.89 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.354 -0.839 . . . . 74.41 112.43 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -62.15 126.42 27.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 72.4 110.374 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' N ' ' HD1' ' A' ' 101' ' ' PHE . . . 117.78 -19.29 11.33 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 75.35 113.404 173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.459 HH12 ' CD ' ' A' ' 161' ' ' GLU . 59.3 mmt-85 -120.63 147.67 44.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.447 0.623 . . . . 71.52 111.069 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 104' ' ' ILE . 4.2 mp -104.27 132.59 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.191 -0.459 . . . . 74.4 110.425 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.713 ' HB2' HD12 ' A' ' 99' ' ' ILE . 16.2 tpt180 -116.57 126.18 52.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.038 -0.528 . . . . 73.32 109.683 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 188' ' ' VAL . 40.2 mt -97.48 111.29 23.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.266 0.555 . . . . 74.1 110.159 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HB3' ' NE ' ' A' ' 134' ' ' ARG . 57.1 tptt -102.25 141.07 35.67 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.752 -1.203 . . . . 72.51 107.752 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.912 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.1 pt? -75.55 -124.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.735 0.272 . . . . 64.13 111.735 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.919 ' HA3' ' HG3' ' A' ' 128' ' ' LYS . . . -82.01 142.03 22.08 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.431 -0.89 . . . . 62.04 112.584 -173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 144.18 153.4 5.86 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.716 -0.754 . . . . 72.21 112.321 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.53 77.06 0.32 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.672 -0.971 . . . . 71.34 110.672 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.99 144.1 22.04 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.382 -0.599 . . . . 72.42 109.382 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.0 -165.54 34.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.597 -0.811 . . . . 64.35 111.9 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.79 18.44 25.93 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.71 -0.757 . . . . 71.02 113.157 -176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -139.54 122.67 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.278 -0.542 . . . . 73.03 111.035 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -53.91 -52.5 60.36 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.984 -1.007 . . . . 60.21 112.107 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.35 -30.89 65.26 Favored Glycine 0 N--CA 1.46 0.29 0 CA-C-N 116.329 -0.396 . . . . 73.2 112.968 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.435 HD22 ' CE1' ' A' ' 94' ' ' HIS . 14.3 tp -60.52 -32.46 71.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.441 0.638 . . . . 43.23 110.673 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -79.23 -34.52 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.581 -0.736 . . . . 74.32 110.213 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.9 m -73.16 -44.39 60.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 63.33 111.406 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 m -62.03 -34.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-O 120.801 0.334 . . . . 65.22 111.14 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.6 -36.46 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.978 0.418 . . . . 73.42 110.57 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.2 m -71.51 -23.59 61.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 62.51 110.884 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.4 -34.01 54.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.999 0.428 . . . . 43.33 110.507 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 90' ' ' ILE . 88.0 mt -80.59 -42.82 21.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.914 -0.584 . . . . 72.21 110.653 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.81 6.44 89.07 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.024 -0.608 . . . . 75.31 112.365 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.1 p -112.37 163.09 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.913 0.387 . . . . 71.55 111.185 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.919 ' HG3' ' HA3' ' A' ' 109' ' ' GLY . 12.5 tppt? -83.47 -56.86 3.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.869 -0.605 . . . . 74.12 110.755 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.4 m120 55.94 81.92 0.11 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.741 0.65 . . . . 71.3 110.964 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.77 ' HD1' HD12 ' A' ' 108' ' ' LEU . 67.7 m-85 -71.07 68.17 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.258 1.207 . . . . 74.41 114.258 -168.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 37.8 p-80 163.57 115.94 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.908 0.883 . . . . 74.02 111.843 162.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.604 ' HG3' ' H ' ' A' ' 92' ' ' VAL . 5.0 mpt_? -128.93 147.24 50.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 74.42 110.216 174.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 93' ' ' ILE . 88.1 t -86.31 127.81 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 120.847 0.356 . . . . 64.4 111.032 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.695 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 50.0 mtt180 -131.37 109.75 10.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.406 . . . . 61.41 110.563 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 54.4 mt -88.99 125.87 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.133 -0.485 . . . . 65.44 110.279 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.54 ' CA ' HG23 ' A' ' 99' ' ' ILE . . . -72.5 114.98 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.67 -0.776 . . . . 73.21 111.965 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.547 HG11 HD12 ' A' ' 24' ' ' LEU . 22.8 t -119.81 10.43 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.764 0.792 . . . . 62.53 110.27 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 97' ' ' LEU . . . 138.19 172.22 12.47 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.214 -0.993 . . . . 62.41 112.97 173.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -101.48 162.31 20.88 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.784 -0.45 . . . . 75.44 109.784 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 97' ' ' LEU . 36.1 Cg_exo -60.72 133.01 45.71 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.672 2.248 . . . . 63.14 112.243 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.621 ' HG3' ' HB2' ' A' ' 149' ' ' PHE . 55.2 Cg_endo -70.56 127.31 13.78 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.71 2.273 . . . . 73.11 112.156 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.08 43.11 3.19 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.886 -0.673 . . . . 71.45 112.555 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -163.35 -63.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.007 0.432 . . . . 74.31 110.219 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -89.38 159.57 17.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.833 -0.622 . . . . 75.43 110.82 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.8 140.98 97.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.381 . . . . 71.44 110.994 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.13 -38.68 60.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.225 2.616 . . . . 55.1 113.082 177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 150' ' ' VAL . . . -70.19 -30.36 67.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.194 0.521 . . . . 62.22 110.655 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 151' ' ' LEU . . . -76.72 -18.52 58.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.65 -0.705 . . . . 61.55 110.226 176.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.621 ' HB2' ' HG3' ' A' ' 141' ' ' PRO . 59.7 t80 -84.54 -31.64 24.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 60.04 110.829 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 34.6 m -85.18 -6.02 10.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.245 0.461 . . . . 72.41 112.245 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 148' ' ' ALA . 4.4 pp -87.39 -8.35 56.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.265 0.555 . . . . 64.55 110.182 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -119.64 171.11 8.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.228 -0.896 . . . . 64.44 109.669 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -170.7 87.44 0.12 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.9 0.381 . . . . 55.13 110.932 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -154.97 135.99 13.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.325 -0.398 . . . . 74.14 110.447 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -164.84 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.243 -1.021 . . . . 43.21 108.243 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -96.42 -73.41 0.6 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.773 0.657 . . . . 62.04 112.773 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.49 -43.2 8.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.261 0.553 . . . . 64.3 111.118 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -68.96 -21.6 64.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.493 -0.776 . . . . 72.41 110.515 -178.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 tpt85 -83.6 -15.26 49.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.622 -0.717 . . . . 73.55 110.361 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.46 -42.63 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 62.24 111.778 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.459 ' CD ' HH12 ' A' ' 103' ' ' ARG . 15.4 pt-20 -83.43 11.04 7.46 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.923 0.342 . . . . 64.4 111.923 -175.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.646 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 87.0 t -54.03 -53.35 59.37 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.388 -0.369 . . . . 75.13 111.962 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 71.3 Cg_exo -52.03 -38.35 69.62 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.03 1.82 . . . . 72.34 112.511 178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.0 m -68.6 -46.26 69.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 70.42 111.405 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 pt -71.01 -24.83 24.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 121.098 -0.241 . . . . 65.34 111.452 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 162' ' ' VAL . 90.3 t -64.15 -43.74 97.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 110.047 -0.353 . . . . 63.02 110.047 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.82 -36.71 81.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.924 -0.58 . . . . 75.3 110.559 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -67.08 -51.54 53.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 72.22 110.657 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -32.54 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 73.34 111.535 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.597 ' HA ' HG13 ' A' ' 28' ' ' VAL . . . -59.52 -57.02 14.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 44.32 111.279 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.95 -26.7 62.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.485 -0.325 . . . . 74.21 111.181 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.516 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -60.87 -38.6 86.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.34 . . . . 74.5 110.539 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.1 m -66.96 -34.74 78.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.235 -0.439 . . . . 53.24 110.765 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.465 ' HA ' HD12 ' A' ' 55' ' ' LEU . 44.1 tt0 -71.91 -34.93 69.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.532 . . . . 74.51 109.853 176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.29 -26.64 68.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 74.42 110.772 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 91.7 mt -64.74 -21.7 66.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 64.11 110.955 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 5' ' ' LEU . 28.0 mm -80.75 -50.71 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.171 0.51 . . . . 65.3 110.74 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.86 -38.83 61.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.801 -0.636 . . . . 55.1 112.403 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -99.02 -56.64 2.37 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.924 -0.311 . . . . 72.34 111.536 -176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 141.77 -124.99 2.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.44 -0.886 . . . . 60.22 112.117 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.83 -46.97 1.39 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.032 0.382 . . . . 61.15 112.032 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.819 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 30.2 tt0 -73.44 -61.33 1.44 Allowed Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.095 0.406 . . . . 72.23 112.095 -172.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 17.7 Cg_exo -67.18 -14.9 44.82 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.741 1.628 . . . . 62.14 111.884 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.57 14.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 60.45 111.144 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.583 ' HA ' HD12 ' A' ' 106' ' ' LEU . 10.0 pt20 -65.25 -27.94 69.01 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 121.112 -0.235 . . . . 62.04 110.876 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.509 ' HA ' ' NE2' ' A' ' 189' ' ' HIS . 65.7 t30 -59.53 -45.53 91.48 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.389 -0.369 . . . . 75.13 110.31 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 58.2 m -63.69 -38.26 90.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.832 -0.622 . . . . 73.54 110.882 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 106' ' ' LEU . 59.2 t -61.71 -44.48 98.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.005 -0.543 . . . . 72.41 111.533 -177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.509 ' NE2' ' HA ' ' A' ' 186' ' ' ASN . 33.5 p80 -89.53 12.86 15.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.512 -0.475 . . . . 74.4 111.238 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.36 4.13 38.64 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.53 -0.305 . . . . 64.13 110.785 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 12.8 m0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.063 -0.97 . . . . 72.42 111.027 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.66 0.267 . . . . 70.35 110.574 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.99 146.02 40.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 54.33 110.543 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -97.11 139.7 21.65 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.952 -0.567 . . . . 64.14 109.725 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.23 89.39 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.778 1.652 . . . . 51.21 110.64 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.97 118.15 4.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.669 -0.696 . . . . 62.1 111.475 -172.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.443 ' HA ' HG23 ' A' ' 61' ' ' VAL . 34.0 tp -91.86 105.13 17.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.743 -0.662 . . . . 65.22 109.542 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.652 ' HB ' HD23 ' A' ' 62' ' ' LEU . 40.5 t -114.89 112.9 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.199 0.523 . . . . 73.41 110.422 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.2 t -104.78 114.77 45.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.541 -0.754 . . . . 73.21 110.005 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.42 120.76 6.09 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.337 -1.105 . . . . 73.42 110.337 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.4 HD23 ' ND1' ' A' ' 94' ' ' HIS . 23.4 tp -94.66 81.4 3.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 41.43 110.477 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.49 107.36 0.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.636 -1.165 . . . . 35.12 110.75 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -87.49 144.38 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.859 0.361 . . . . 71.12 110.777 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.66 81.74 1.01 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.813 2.342 . . . . 75.51 111.685 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.564 ' H ' ' HB2' ' A' ' 18' ' ' ALA . . . -90.64 163.88 30.01 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.893 -0.67 . . . . 72.24 111.878 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.65 -14.85 33.63 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 122.715 2.277 . . . . 74.43 112.717 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -141.39 -45.39 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.2 0.445 . . . . 72.52 112.2 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.59 ' HA ' HG22 ' A' ' 20' ' ' THR . 54.4 p90 -76.25 -2.61 32.27 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.312 0.486 . . . . 74.43 112.312 -173.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.564 ' HB2' ' H ' ' A' ' 14' ' ' GLY . . . -88.85 -3.31 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.8 0.333 . . . . 74.2 110.851 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -122.95 19.61 10.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.496 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 17' ' ' TYR . 12.8 t -138.35 -169.11 2.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 71.44 110.104 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 70.8 mtt180 -48.12 -26.49 1.89 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.198 0.814 . . . . 74.2 113.198 -174.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -81.94 12.41 4.12 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.224 -0.298 . . . . 72.51 111.785 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 27' ' ' MET . 27.4 p-10 -95.8 -5.04 42.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.597 0.236 . . . . 75.24 110.745 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 21' ' ' ARG . 96.1 mt -52.73 -38.09 60.29 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.175 -0.466 . . . . 60.12 111.791 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -62.56 -30.06 75.45 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 121.131 -0.556 . . . . 75.23 112.657 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -91.5 -32.89 15.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.963 -0.139 . . . . 75.01 111.346 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.43 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 76.3 mtp -54.58 -40.15 68.52 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.145 0.794 . . . . 71.34 113.145 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.851 ' HB ' HD13 ' A' ' 93' ' ' ILE . 45.5 t -63.62 -46.3 95.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.801 -0.36 . . . . 54.31 110.41 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.08 79.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.268 -0.424 . . . . 74.12 110.324 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.87 -49.0 72.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.442 -0.799 . . . . 52.3 110.564 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.5 t -67.66 -43.38 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.836 -0.62 . . . . 65.42 110.934 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.7 mt -59.44 -40.79 87.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 73.51 111.221 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.3 -30.63 64.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 62.3 110.976 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.11 -33.39 40.78 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.99 -0.624 . . . . 43.11 113.311 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.63 ' HG3' HD12 ' A' ' 36' ' ' ILE . 14.7 ptm180 -69.78 -25.97 64.06 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.256 0.528 . . . . 71.02 111.196 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.63 HD12 ' HG3' ' A' ' 35' ' ' ARG . 2.0 mp -88.31 -42.21 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.542 . . . . 72.34 109.686 172.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.51 58.53 2.27 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.81 -0.709 . . . . 73.23 112.219 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.8 m -134.7 145.69 48.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.666 0.27 . . . . 54.34 110.562 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.52 150.82 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.17 -0.468 . . . . 65.2 110.513 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.696 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 1.1 p90 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.834 -0.621 . . . . 70.24 111.086 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -113.85 134.14 54.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 73.11 110.188 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 49' ' ' GLU . 43.6 t -74.68 129.59 36.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.224 0.535 . . . . 74.42 111.685 -172.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.96 149.64 32.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 65.15 110.378 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -70.64 -72.02 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.146 -0.479 . . . . 73.52 111.419 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -68.16 -27.38 66.37 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.213 -0.449 . . . . 73.53 111.374 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.5 m -83.51 -28.2 28.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.474 -0.33 . . . . 62.41 111.024 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.25 11.83 53.44 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.093 -0.575 . . . . 75.5 112.452 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -120.25 151.34 39.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.67 0.271 . . . . 43.22 110.947 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.696 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 45.7 mp0 -78.92 138.8 38.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.859 -0.61 . . . . 72.52 111.602 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.36 136.81 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 64.24 109.404 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 9.4 p -121.99 144.69 30.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.734 0.302 . . . . 61.05 110.442 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.824 HG22 HG12 ' A' ' 61' ' ' VAL . 7.2 p -118.14 144.52 45.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.335 -0.393 . . . . 73.22 111.319 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -169.53 -174.87 38.26 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.028 -0.606 . . . . 61.52 111.87 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 -109.92 126.05 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.808 -0.231 . . . . 74.53 110.524 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.152 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.3 pt? -105.48 108.8 20.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.838 -0.801 . . . . 72.21 108.838 174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.91 -51.93 0.63 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.618 -0.719 . . . . 60.22 111.526 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.37 -27.31 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.008 -0.837 . . . . 73.21 111.008 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.485 ' O ' HD23 ' A' ' 55' ' ' LEU . 27.1 m -78.07 153.12 32.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.403 -0.399 . . . . 75.43 110.385 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.6 m -80.8 129.13 34.36 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.953 -0.388 . . . . 71.41 109.953 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.152 ' HB ' HD22 ' A' ' 55' ' ' LEU . 13.9 p -118.0 135.56 58.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.926 0.393 . . . . 54.14 110.508 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.824 HG12 HG22 ' A' ' 52' ' ' THR . 17.4 m -116.14 112.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.251 0.548 . . . . 73.3 109.965 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 7' ' ' VAL . 84.3 mt -98.08 113.12 24.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 70.43 110.206 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.141 -0.481 . . . . 63.45 110.72 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 64' ' ' LYS . 3.1 ptmm? -123.81 119.3 26.89 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.182 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.45 160.9 40.55 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.703 2.268 . . . . 54.32 112.894 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 7.83 10.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.628 -0.715 . . . . 60.21 110.141 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.6 t -146.32 -179.36 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 61.42 109.613 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -70.7 170.72 11.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.077 0.465 . . . . 64.13 111.626 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.99 -23.41 66.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.352 -0.84 . . . . 72.4 111.455 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.05 -43.39 63.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.142 0.496 . . . . 73.23 110.21 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -75.67 -56.89 4.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.659 -0.7 . . . . 72.24 110.228 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 m -47.33 -44.62 23.87 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.745 0.653 . . . . 65.42 112.662 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.77 -41.75 94.1 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.902 -0.666 . . . . 71.03 113.053 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.37 3.07 40.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.79 0.293 . . . . 65.04 111.79 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.478 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 12.7 mm-40 -91.9 -43.78 9.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.571 -0.286 . . . . 71.51 111.274 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.43 -39.96 87.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.368 -0.378 . . . . 71.3 111.629 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 125' ' ' LEU . . . -55.24 -63.51 5.21 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 116.176 -0.465 . . . . 53.14 112.965 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -55.01 -26.02 47.58 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.131 2.554 . . . . 61.35 113.164 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 75' ' ' GLN . 28.8 mt -72.82 -40.44 65.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.529 0.204 . . . . 64.01 111.428 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.419 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.89 -39.24 88.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.422 0.63 . . . . 63.02 109.877 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -9.34 57.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.629 -0.714 . . . . 74.31 111.388 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -66.37 -43.98 84.44 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 72.31 109.204 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -93.81 3.81 54.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.434 -0.803 . . . . 71.33 109.707 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.7 p 45.41 54.47 7.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.923 -1.035 . . . . 74.34 112.553 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 80' ' ' ALA . 26.8 m -81.98 150.45 65.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.082 -0.508 . . . . 73.43 110.73 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.33 161.33 46.39 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.673 2.249 . . . . 44.12 111.72 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -48.1 111.85 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.269 2.646 . . . . 72.24 112.175 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -128.14 -173.97 3.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.347 -0.842 . . . . 71.15 111.44 -172.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -91.24 95.45 10.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.981 -0.554 . . . . 74.14 110.988 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.0 tt -76.02 110.85 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.462 0.648 . . . . 63.1 110.446 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 132.63 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.72 -0.673 . . . . 64.34 110.693 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.745 HG21 HG21 ' A' ' 121' ' ' VAL . 67.5 t -129.35 129.44 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.676 -0.49 . . . . 53.31 109.676 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.851 HD13 ' HB ' ' A' ' 28' ' ' VAL . 36.4 mt -106.17 126.59 61.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.46 . . . . 64.22 110.111 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' ND1' HD23 ' A' ' 10' ' ' LEU . 67.3 t60 -159.03 174.22 15.26 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.589 -0.445 . . . . 74.11 111.825 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -83.7 152.69 24.6 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.436 -0.802 . . . . 72.01 111.332 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.556 ' HG3' ' H ' ' A' ' 98' ' ' ASP . 9.0 tp10 -145.37 136.67 24.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.885 -0.598 . . . . 60.33 110.767 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.402 HD23 ' CG1' ' A' ' 137' ' ' VAL . 97.0 mt -83.89 -15.39 48.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.931 -0.577 . . . . 53.02 111.549 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.556 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 25.5 t70 -75.76 -22.61 56.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.971 -0.559 . . . . 75.32 112.267 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.694 HG13 ' HB2' ' A' ' 105' ' ' ARG . 46.6 mm -113.83 144.42 21.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.865 0.364 . . . . 74.32 111.876 -172.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.88 146.39 17.6 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.12 -0.945 . . . . 62.41 110.479 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 63.0 t80 -66.99 108.52 2.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.075 0.464 . . . . 74.43 110.272 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 -16.27 6.32 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.617 -0.801 . . . . 62.43 112.668 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -107.41 151.24 25.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.796 -0.446 . . . . 73.51 109.796 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.68 135.77 48.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.811 0.339 . . . . 72.24 110.776 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HB2' HG13 ' A' ' 99' ' ' ILE . 8.6 tpp180 -108.89 125.92 52.51 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.477 -0.564 . . . . 60.41 109.477 172.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 188' ' ' VAL . 67.8 mt -97.67 134.0 41.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.908 0.385 . . . . 70.11 110.183 177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.724 ' HE3' ' HA ' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -120.83 119.81 33.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.804 -0.634 . . . . 70.41 110.239 -177.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.777 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.5 pt? -103.5 -138.76 0.35 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.758 -0.46 . . . . 73.22 109.758 173.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 36.04 -145.82 0.07 OUTLIER Glycine 0 C--N 1.344 0.976 0 O-C-N 123.678 0.612 . . . . 72.34 113.411 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.86 127.99 8.35 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.486 -1.045 . . . . 52.4 110.486 162.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.04 107.93 3.29 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.862 -0.685 . . . . 71.23 113.756 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.91 101.51 12.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 72.22 110.108 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 152.88 -161.47 29.59 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.332 -1.107 . . . . 64.03 110.332 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.517 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . 64.47 15.62 59.56 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.823 -0.703 . . . . 75.25 112.157 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 m80 72.91 -76.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.442 0.697 . . . . 71.41 111.742 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -134.69 -59.48 0.8 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.381 0.511 . . . . 73.31 112.381 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 121' ' ' VAL . . . -57.11 -30.2 60.49 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.581 -0.343 . . . . 55.02 113.5 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.517 HD12 ' HA3' ' A' ' 114' ' ' GLY . 0.9 OUTLIER -63.87 -41.13 97.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.174 0.512 . . . . 72.24 110.101 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -76.73 -37.86 55.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.198 -0.91 . . . . 65.52 110.614 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.5 m -61.95 -49.37 76.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.928 -0.578 . . . . 74.1 111.327 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.745 HG21 HG21 ' A' ' 92' ' ' VAL . 27.3 m -72.64 -21.3 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.412 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.24 -59.74 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 72.3 111.057 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.4 m -63.27 -40.65 97.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.994 -0.548 . . . . 63.02 111.697 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.95 68.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 51.03 111.669 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.421 HD13 ' HA2' ' A' ' 77' ' ' GLY . 53.4 tp -85.02 -27.94 26.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 75.41 110.258 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.23 22.98 75.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.684 -0.77 . . . . 63.03 112.249 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.8 m -124.91 121.49 34.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.635 0.255 . . . . 61.02 110.369 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 44.9 mtmt -115.65 -173.6 2.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.047 -0.723 . . . . 73.53 109.047 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 t30 63.03 79.33 0.26 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.147 0.975 . . . . 74.32 109.629 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -145.88 -155.51 0.62 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.443 -1.253 . . . . 72.31 109.122 -176.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -149.0 110.04 4.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 75.33 110.409 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.523 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 2.3 mpt_? -104.55 146.85 28.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.774 -0.648 . . . . 53.31 109.88 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.18 102.44 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.986 -0.552 . . . . 74.34 110.292 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 64.4 mtp180 -96.64 97.26 9.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.786 -0.643 . . . . 65.11 109.386 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 135' ' ' ILE . 5.1 mp -80.08 128.53 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.86 -0.422 . . . . 71.42 109.86 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -64.11 123.31 27.75 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.627 -0.797 . . . . 73.05 111.816 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.466 HG21 HG12 ' A' ' 150' ' ' VAL . 9.8 p -96.84 0.75 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.216 0.532 . . . . 64.54 110.571 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 135.82 -87.32 0.24 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.5 -0.857 . . . . 54.14 112.84 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . 2.0 ptp180 -172.57 165.36 3.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 122.169 0.188 . . . . 75.43 110.536 -175.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 139' ' ' ARG . 27.9 Cg_endo -64.67 120.2 7.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.344 2.03 . . . . 64.25 111.198 171.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.15 167.09 20.12 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.727 2.285 . . . . 64.14 112.904 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -124.87 -59.13 0.17 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.702 -0.761 . . . . 55.11 112.59 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -79.6 -29.49 41.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.764 0.283 . . . . 71.33 111.764 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.45 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -107.92 134.22 51.15 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.588 -0.445 . . . . 73.11 110.402 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.5 141.55 78.42 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.389 -0.823 . . . . 75.05 110.427 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.95 -38.05 12.95 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.759 2.973 . . . . 75.12 113.984 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -25.83 61.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.943 0.402 . . . . 72.4 110.95 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.96 -21.89 25.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.111 0.481 . . . . 72.52 110.2 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -72.73 -38.34 67.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.801 -0.636 . . . . 62.33 110.367 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.466 HG12 HG21 ' A' ' 137' ' ' VAL . 34.2 m -82.9 2.12 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.266 -0.425 . . . . 74.34 110.486 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.95 -24.14 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.989 -0.551 . . . . 71.23 110.713 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -93.07 97.88 10.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.239 0.543 . . . . 61.44 110.92 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 20' ' ' THR . 32.9 p-10 -104.5 -7.43 19.79 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.009 -0.432 . . . . 54.42 110.897 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -84.1 52.87 2.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.222 -0.445 . . . . 72.03 110.092 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -75.16 -173.59 2.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.703 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.444 ' H ' HG22 ' A' ' 155' ' ' THR . . . -75.67 -71.32 0.38 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.807 0.336 . . . . 74.41 111.48 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.96 -37.49 11.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.355 0.597 . . . . 73.1 110.459 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 101' ' ' PHE . 3.6 mp0 -58.9 -34.6 71.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.962 -1.017 . . . . 72.13 111.712 -176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -65.93 -26.48 67.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.083 0.468 . . . . 74.45 111.123 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.89 -15.39 36.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.367 -0.379 . . . . 75.24 111.641 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -116.1 15.49 16.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.768 0.285 . . . . 75.41 111.768 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.711 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 57.9 t -56.33 -56.05 35.7 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.253 0.464 . . . . 64.04 112.253 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.711 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 17.1 Cg_exo -66.49 -31.38 42.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.738 1.625 . . . . 63.42 112.074 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.1 m -63.97 -45.56 88.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 52.11 111.794 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.3 pt -68.75 -32.05 53.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 72.53 111.156 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.58 -37.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.34 -0.391 . . . . 72.5 110.43 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.48 -51.29 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 74.24 110.887 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.04 -36.36 77.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 71.43 111.068 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.48 -43.46 97.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.443 -0.344 . . . . 75.43 111.172 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.58 95.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.952 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.25 -39.8 89.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 70.24 110.615 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.507 ' HB1' HG22 ' A' ' 188' ' ' VAL . . . -63.3 -35.76 81.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.73 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 60.8 m -65.85 -38.5 89.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 71.33 110.543 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -65.04 -39.03 92.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 73.4 110.045 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.65 -33.8 75.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.897 -0.592 . . . . 72.12 110.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 96.1 mt -61.41 -34.43 75.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.279 -0.419 . . . . 74.24 110.817 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.612 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 mm -80.7 -40.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.27 -0.423 . . . . 61.41 111.108 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -72.13 -43.87 64.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.333 0.494 . . . . 53.13 112.333 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -100.25 -49.86 4.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.946 0.403 . . . . 75.15 110.87 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 143.71 -168.63 26.31 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.503 -0.639 . . . . 52.34 111.503 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 182' ' ' GLU . 4.3 pp -104.13 -24.02 13.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.769 0.285 . . . . 73.23 110.83 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.717 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 34.4 tt0 -67.11 -57.23 11.43 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.199 -0.455 . . . . 75.32 111.845 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.717 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 83.4 Cg_endo -87.47 -29.63 0.35 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.833 1.688 . . . . 73.24 113.093 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -73.93 -31.43 63.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.508 -0.314 . . . . 75.01 111.823 -172.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -61.81 -29.57 70.25 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.123 0.487 . . . . 75.0 110.023 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -68.61 -48.38 64.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.635 -0.711 . . . . 53.02 109.846 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 36.0 m -56.26 -38.46 71.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.631 -0.713 . . . . 40.14 111.446 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 184' ' ' ALA . 82.7 t -57.24 -37.41 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.186 0.439 . . . . 71.51 112.186 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -104.14 -28.24 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.311 -0.555 . . . . 74.41 111.996 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -94.36 12.3 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.128 0.418 . . . . 43.13 112.128 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.488 ' HB2' ' O ' ' A' ' 187' ' ' THR . 3.8 t90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.479 -0.772 . . . . 75.13 110.17 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.115 -0.698 . . . . 75.33 109.115 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.04 60.96 6.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.848 0.356 . . . . 63.03 110.233 174.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.5 pm0 -86.29 142.81 35.93 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.452 -0.34 . . . . 75.32 110.219 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 5.7 Cg_exo -78.58 141.91 17.9 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.172 2.581 . . . . 35.14 113.577 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.713 HD12 HD21 ' A' ' 55' ' ' LEU . 97.0 mt -86.14 126.75 34.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.259 -0.882 . . . . 72.55 109.577 174.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.633 HD22 HG21 ' A' ' 85' ' ' VAL . 37.1 tp -93.28 114.77 27.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.737 0.303 . . . . 65.12 110.499 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' A' ' 62' ' ' LEU . 41.2 t -120.69 121.69 65.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.34 -0.391 . . . . 32.41 110.12 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 60.2 t -104.02 116.19 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.134 -0.485 . . . . 64.51 110.56 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.96 122.92 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.963 -0.562 . . . . 75.01 111.703 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.634 HD13 ' HG2' ' A' ' 65' ' ' PRO . 58.3 tp -107.74 105.07 14.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.931 0.396 . . . . 43.31 111.12 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.63 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -97.3 -142.94 13.93 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 61.42 112.098 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.777 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . 15.9 m120 -134.58 129.37 19.46 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.619 0.21 . . . . 75.34 111.155 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 68.6 Cg_endo -96.8 173.17 0.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.37 2.713 . . . . 74.15 111.716 170.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.78 -176.35 19.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.408 -0.901 . . . . 65.3 112.389 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.86 -67.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.054 2.502 . . . . 74.41 112.859 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.2 t -127.52 11.15 6.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 72.14 111.301 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 43.1 m-85 -65.55 -18.47 65.35 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.796 0.331 . . . . 62.45 111.102 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HA ' ' HB2' ' A' ' 12' ' ' ASN . . . -75.71 -1.4 24.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 44.54 111.386 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 153' ' ' ASN . 68.3 mmtt -107.16 26.75 9.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 62.21 109.878 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 151' ' ' LEU . 71.2 p -102.19 172.72 6.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.151 -0.477 . . . . 65.24 110.448 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -66.0 -19.38 65.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.716 0.294 . . . . 52.33 111.249 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -76.34 -9.08 58.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 70.13 110.986 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -8.08 12.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.715 0.293 . . . . 75.35 111.466 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 135' ' ' ILE . 94.9 mt -63.42 -31.81 73.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.375 -0.375 . . . . 74.55 110.513 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -63.83 -26.64 70.21 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.948 -0.569 . . . . 75.34 112.142 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.63 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 74.3 t80 -90.74 -36.38 14.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.789 0.328 . . . . 65.32 110.517 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 mmt -57.36 -42.33 81.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.547 0.573 . . . . 75.42 112.547 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.619 ' HB ' HD13 ' A' ' 93' ' ' ILE . 48.2 t -61.74 -38.83 81.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.034 0.445 . . . . 70.43 110.5 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.96 -38.64 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 53.42 110.851 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -57.36 -46.57 83.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.09 -0.505 . . . . 72.54 111.334 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG21 HG12 ' A' ' 166' ' ' VAL . 65.6 t -60.03 -45.56 95.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.402 -0.363 . . . . 71.13 110.745 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 36' ' ' ILE . 94.5 mt -61.6 -44.51 96.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.35 110.903 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.65 -35.5 72.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 71.23 111.167 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.53 -42.17 93.74 Favored Glycine 0 N--CA 1.454 -0.163 0 C-N-CA 121.288 -0.482 . . . . 53.52 112.916 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.27 -21.05 64.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.623 0.249 . . . . 72.41 111.015 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.883 HD13 ' HA3' ' A' ' 53' ' ' GLY . 70.5 mt -83.58 -45.71 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.177 0.513 . . . . 74.23 109.936 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.46 23.12 10.52 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.604 -0.725 . . . . 70.32 112.17 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -118.35 158.18 25.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.796 0.331 . . . . 35.44 110.757 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.77 146.56 43.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.252 -0.431 . . . . 71.41 110.726 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.603 ' CA ' ' HB ' ' A' ' 51' ' ' VAL . 38.9 p90 -80.79 151.03 28.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 62.4 110.682 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.55 164.14 32.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.855 0.359 . . . . 64.42 110.935 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 49' ' ' GLU . 46.6 t -75.2 126.1 35.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.694 -0.685 . . . . 74.42 112.063 -172.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -76.45 127.13 32.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.125 -0.694 . . . . 64.35 109.125 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 38.6 ttmt -67.45 -5.93 17.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.929 -0.578 . . . . 45.01 111.964 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -80.34 -76.96 0.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.817 0.341 . . . . 74.34 111.402 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -90.13 -16.88 28.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.391 -0.368 . . . . 74.11 111.906 -173.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.22 5.87 69.58 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.445 -0.883 . . . . 72.03 111.714 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.94 143.56 28.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.285 -0.265 . . . . 53.24 110.285 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' HG2' HG22 ' A' ' 42' ' ' VAL . 37.3 mt-10 -94.67 132.87 38.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 74.33 110.477 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 t -136.29 142.51 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.159 -0.473 . . . . 71.04 110.296 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.603 ' HB ' ' CA ' ' A' ' 40' ' ' PHE . 7.6 p -125.26 136.75 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.905 0.384 . . . . 75.13 110.641 175.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.481 HG22 HG12 ' A' ' 61' ' ' VAL . 2.0 p -97.58 149.79 21.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.901 -0.59 . . . . 74.22 111.094 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.883 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -179.07 -164.89 32.49 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.434 -0.889 . . . . 73.31 112.722 177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -122.35 143.04 49.89 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.058 -0.349 . . . . 73.12 110.058 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.141 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.6 pt? -127.84 109.04 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 74.25 109.361 174.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 69.05 -45.82 0.56 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 61.52 111.65 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.28 -27.93 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 110.72 -0.952 . . . . 74.44 110.72 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 59' ' ' SER . 2.0 m -71.79 169.38 15.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.974 -0.613 . . . . 73.4 110.436 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 58' ' ' THR . 14.7 m -97.35 130.56 44.49 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.468 -0.567 . . . . 74.05 109.468 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.141 ' HB ' HD22 ' A' ' 55' ' ' LEU . 15.0 p -120.05 137.98 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 44.34 110.688 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 HG22 ' A' ' 52' ' ' THR . 11.9 m -122.8 111.01 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.339 0.59 . . . . 72.41 109.847 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.66 HD23 ' HB ' ' A' ' 7' ' ' VAL . 77.9 mt -92.39 110.57 21.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.686 -0.688 . . . . 75.35 110.028 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 8' ' ' VAL . . . -109.64 132.23 54.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.855 -0.612 . . . . 65.54 110.674 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -120.88 127.92 26.01 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.937 -0.574 . . . . 74.43 110.369 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.634 ' HG2' HD13 ' A' ' 10' ' ' LEU . 48.4 Cg_endo -70.34 168.05 23.41 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.345 2.03 . . . . 75.05 111.262 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 66' ' ' ARG . 8.0 ttt180 -89.05 -60.54 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.837 -0.345 . . . . 75.33 110.726 -176.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 23.1 p -167.11 172.38 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 24.3 110.541 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.46 ' HD1' ' H ' ' A' ' 71' ' ' GLU . 10.1 t80 71.2 118.7 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.073 0.858 . . . . 73.11 111.336 175.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -53.29 -56.24 18.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.589 -0.732 . . . . 51.52 111.624 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 12.5 m120 -56.62 -46.57 80.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 74.41 111.114 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.628 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 5.6 mm-40 -64.18 -43.99 93.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 45.15 111.192 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 m -57.84 -39.01 76.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 73.15 110.908 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.656 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -64.61 -34.96 91.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.519 -0.848 . . . . 74.51 111.898 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' ASN . 44.8 mtp180 -86.98 -2.7 58.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.96 0.409 . . . . 62.55 110.486 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 27.5 mm-40 -79.43 -32.74 42.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 73.01 110.225 176.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.98 -32.18 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.681 -0.69 . . . . 72.41 110.751 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -47.17 -68.28 1.21 Allowed Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.626 -0.715 . . . . 52.43 113.871 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.61 -41.06 42.02 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.308 2.006 . . . . 75.24 112.844 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.57 -31.6 72.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.453 -0.339 . . . . 74.2 111.842 -176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.95 84.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 52.01 111.156 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -26.75 29.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.422 -0.354 . . . . 72.32 110.853 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -57.32 -46.04 83.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.042 0.449 . . . . 64.22 110.376 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.58 -3.88 45.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 75.1 110.649 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m 60.71 34.69 19.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.678 -0.692 . . . . 73.4 111.313 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.633 HG21 HD22 ' A' ' 6' ' ' LEU . 26.9 m -81.25 145.97 57.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.687 -0.688 . . . . 70.24 111.063 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 2.7 Cg_exo -76.49 131.06 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.95 2.434 . . . . 63.41 111.916 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 23.4 Cg_exo -66.43 47.0 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.782 2.988 . . . . 72.41 113.306 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -139.88 -37.67 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 72.34 109.926 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -84.59 -6.82 59.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 75.14 111.353 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.98 130.0 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.378 0.609 . . . . 72.35 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' HB ' HG13 ' A' ' 7' ' ' VAL . 45.8 t -106.16 127.23 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.514 -0.766 . . . . 62.02 110.111 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.705 ' HB ' ' HG3' ' A' ' 132' ' ' ARG . 40.0 t -114.7 110.18 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.072 -0.344 . . . . 73.44 110.072 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.619 HD13 ' HB ' ' A' ' 28' ' ' VAL . 39.5 mt -87.9 116.88 30.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.502 -0.317 . . . . 73.31 110.657 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -142.6 161.03 39.12 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.557 0.343 . . . . 65.43 110.197 -178.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 137' ' ' VAL . 10.8 p-10 -91.65 148.27 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.509 -0.314 . . . . 61.34 110.517 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 73.8 tt0 -124.96 128.23 48.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.222 0.534 . . . . 73.42 111.197 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.675 HD11 ' HD3' ' A' ' 141' ' ' PRO . 47.1 tp -81.95 -13.9 56.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.666 -0.697 . . . . 65.31 111.72 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.59 5.21 51.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.259 0.552 . . . . 73.34 111.433 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.75 146.58 28.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.323 -0.399 . . . . 72.23 110.559 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.15 154.29 23.6 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.061 -0.518 . . . . 75.41 111.041 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.515 ' N ' ' HA2' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -67.68 109.76 3.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 63.23 110.071 -176.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.453 ' HA2' ' CD1' ' A' ' 165' ' ' ILE . . . 114.87 -8.5 21.56 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.421 -0.895 . . . . 54.03 112.623 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -98.83 132.55 44.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.882 -0.414 . . . . 73.52 109.882 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.629 ' HB ' HG11 ' A' ' 188' ' ' VAL . 3.1 mp -101.04 129.54 51.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.236 -0.438 . . . . 54.41 110.061 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 105' ' ' ARG . 10.2 tpt180 -108.79 127.79 54.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.017 -0.538 . . . . 75.33 110.449 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 131' ' ' HIS . 48.1 tp -97.66 132.29 43.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.376 -0.601 . . . . 72.23 109.376 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -155.07 122.11 5.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.288 -0.415 . . . . 73.32 110.109 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.732 ' H ' HD23 ' A' ' 108' ' ' LEU . 1.4 pt? -102.3 -136.16 0.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.679 -0.408 . . . . 72.1 109.955 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.662 ' H ' ' HA ' ' A' ' 129' ' ' ASN . . . 40.3 -149.12 0.17 Allowed Glycine 0 C--N 1.334 0.472 0 O-C-N 123.625 0.578 . . . . 71.0 113.11 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.18 131.24 10.56 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.068 -1.213 . . . . 65.12 110.068 164.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.12 156.46 28.03 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.942 -1.123 . . . . 53.05 112.914 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -93.57 -178.63 4.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.792 0.33 . . . . 74.44 110.138 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' HA3' ' NH2' ' A' ' 134' ' ' ARG . . . 115.14 62.53 0.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.796 -0.716 . . . . 64.41 111.601 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.08 -102.34 0.18 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.801 -0.714 . . . . 75.31 111.593 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -154.22 168.38 26.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.254 -0.647 . . . . 74.1 109.254 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -41.86 -53.46 3.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.774 0.671 . . . . 73.32 111.617 174.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.499 ' HA2' ' OG ' ' A' ' 120' ' ' SER . . . -67.04 2.33 5.15 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.022 -0.535 . . . . 72.42 114.205 -173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 tt -83.83 -43.91 14.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.395 0.617 . . . . 72.34 109.366 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -79.68 -21.07 45.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.173 -0.921 . . . . 70.41 111.274 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.499 ' OG ' ' HA2' ' A' ' 117' ' ' GLY . 10.0 m -55.53 -43.8 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 65.12 111.726 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.656 HG12 ' HA2' ' A' ' 73' ' ' GLY . 33.9 m -68.11 -30.79 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.838 0.352 . . . . 73.41 111.343 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.416 ' HB1' ' HG3' ' A' ' 128' ' ' LYS . . . -78.16 -30.2 49.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 70.14 111.036 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.4 m -84.07 -39.71 19.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.093 -0.503 . . . . 51.1 110.967 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.51 77.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 73.31 111.861 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.654 HD23 ' HZ ' ' A' ' 130' ' ' PHE . 29.3 tp -85.45 -31.12 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.109 0.48 . . . . 73.23 109.806 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 96.33 -12.58 66.49 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.551 -0.75 . . . . 75.34 112.555 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.8 m -106.89 137.45 44.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.783 0.325 . . . . 61.1 110.858 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 8.0 mptt -110.58 -161.81 0.77 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.506 -0.553 . . . . 74.2 109.506 176.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.662 ' HA ' ' H ' ' A' ' 109' ' ' GLY . 86.3 m-20 76.6 12.97 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.199 0.6 . . . . 63.34 111.329 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.654 ' HZ ' HD23 ' A' ' 125' ' ' LEU . 16.7 m-30 -71.59 136.77 47.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.374 -0.602 . . . . 75.42 109.374 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.524 ' HB2' HD11 ' A' ' 106' ' ' LEU . 4.3 p-80 -89.88 107.77 19.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.303 0.573 . . . . 64.54 110.352 177.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.705 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 5.5 mpt_? -94.32 141.28 28.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.811 -0.631 . . . . 71.42 110.614 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 87.3 t -92.9 104.18 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.555 -0.905 . . . . 73.04 108.555 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 94' ' ' HIS . 9.1 mtp180 -106.45 114.75 29.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.749 -0.659 . . . . 71.14 110.529 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.1 mp -96.71 125.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.862 -0.422 . . . . 62.31 109.862 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -61.27 132.16 48.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.134 -0.555 . . . . 60.2 112.832 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 95' ' ' ASP . 23.9 t -86.44 -9.27 11.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.327 0.584 . . . . 71.41 111.035 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.515 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 117.37 -87.31 0.43 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.127 -1.035 . . . . 74.21 113.53 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -132.18 135.45 26.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.491 0.186 . . . . 74.15 111.229 -173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 29.2 Cg_endo -65.28 123.13 11.06 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.455 2.103 . . . . 73.31 111.113 171.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.948 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 14.3 Cg_exo -69.45 143.47 52.45 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.183 2.589 . . . . 20.33 112.58 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -128.66 -50.1 0.14 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.666 -0.778 . . . . 52.13 112.494 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -83.16 -32.67 26.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 72.5 111.405 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.542 ' HD3' ' HD1' ' A' ' 149' ' ' PHE . 4.7 ptmm? -114.81 158.84 21.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.868 -0.419 . . . . 70.22 109.868 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 20.3 t70 -52.87 131.91 48.37 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 123.549 0.531 . . . . 72.24 111.824 -175.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.948 ' HA ' ' HG2' ' A' ' 141' ' ' PRO . 53.7 Cg_exo -53.3 -41.04 75.59 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.473 2.782 . . . . 75.35 113.45 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -40.37 39.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.789 0.328 . . . . 71.43 110.423 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.34 -28.14 69.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 73.31 111.123 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.542 ' HD1' ' HD3' ' A' ' 144' ' ' LYS . 71.0 t80 -73.45 -23.17 60.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 71.02 110.528 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.41 -24.2 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.493 0.663 . . . . 70.33 109.924 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.488 ' HA ' ' CG2' ' A' ' 20' ' ' THR . 9.3 mp -87.16 12.1 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.674 -0.694 . . . . 52.41 112.043 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 149' ' ' PHE . 10.5 pt-20 -110.35 136.66 49.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.54 . . . . 63.13 111.083 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' A' ' 19' ' ' LYS . 28.9 p-10 -104.52 34.03 3.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.715 -0.675 . . . . 65.23 110.584 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -131.24 140.57 49.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.032 -0.531 . . . . 73.33 111.134 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.578 ' HB ' ' OE1' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -169.58 -177.71 2.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.312 -0.996 . . . . 75.42 108.312 173.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.3 -71.14 0.68 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.69 -0.404 . . . . 74.42 111.956 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.57 -42.58 8.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 71.33 111.294 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.578 ' OE1' ' HB ' ' A' ' 155' ' ' THR . 0.6 OUTLIER -72.26 -17.42 61.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.689 -0.687 . . . . 75.33 111.175 -174.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.431 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 11.8 tpp180 -70.02 -25.56 63.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.871 0.367 . . . . 74.43 110.149 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -87.53 -13.7 42.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 54.11 111.146 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -85.04 -16.83 39.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.248 -0.433 . . . . 64.32 111.098 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.766 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 47.3 t -52.23 -58.67 10.63 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 65.11 112.218 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.766 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.0 Cg_exo -59.68 -34.14 96.36 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.992 1.794 . . . . 55.14 112.5 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.2 m -71.97 -46.27 57.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.941 -0.572 . . . . 72.15 111.744 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.453 ' CD1' ' HA2' ' A' ' 102' ' ' GLY . 43.0 pt -69.2 -32.41 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 63.54 112.003 -174.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 162' ' ' VAL . 87.1 t -58.08 -42.3 82.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 42.45 111.32 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.8 -46.63 68.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.383 -0.371 . . . . 62.44 111.481 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -24.34 60.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.624 -0.262 . . . . 74.53 111.25 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.17 85.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 53.14 110.559 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.29 -43.48 94.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.556 . . . . 74.01 110.377 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -61.01 -43.73 98.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.67 -0.696 . . . . 73.44 110.969 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.13 95.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.418 -0.356 . . . . 63.34 110.944 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.423 ' HA ' HD12 ' A' ' 176' ' ' LEU . 90.8 m -61.65 -41.59 97.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 71.01 111.05 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.409 ' OE1' ' HB2' ' A' ' 55' ' ' LEU . 19.4 tt0 -71.56 -31.31 66.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.37 . . . . 74.15 110.372 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.43 -26.93 67.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.385 . . . . 73.34 110.418 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 173' ' ' THR . 90.8 mt -61.81 -46.47 89.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 64.54 110.911 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.564 HG13 ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -81.03 -32.88 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.017 0.437 . . . . 75.43 110.386 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.13 66.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.374 -0.376 . . . . 61.14 111.699 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.434 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.1 tp60 -117.44 -61.49 1.69 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.657 -0.247 . . . . 74.32 111.004 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.29 177.12 35.05 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.233 -0.984 . . . . 55.31 112.101 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 3.9 pp -75.76 -20.51 58.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.492 0.187 . . . . 74.55 111.397 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.659 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 54.1 mt-10 -60.87 -61.64 7.59 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.65 0.611 . . . . 61.05 112.65 -172.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 71.5 Cg_endo -78.23 -31.12 3.01 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.592 1.528 . . . . 74.22 112.51 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.77 -58.01 5.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.1 -0.5 . . . . 52.34 111.535 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 24.8 pt20 -70.36 -24.81 63.03 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.699 -0.401 . . . . 74.43 110.697 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 182' ' ' GLU . 9.9 t30 -52.25 -46.83 65.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.936 -0.574 . . . . 73.44 112.041 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -83.03 -32.62 26.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.869 -0.333 . . . . 74.34 111.232 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 104' ' ' ILE . 44.4 t -69.51 -28.82 39.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.568 -0.287 . . . . 71.15 111.724 -173.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -99.08 10.9 40.52 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.019 -0.672 . . . . 73.53 110.91 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -141.48 31.65 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.066 0.395 . . . . 62.34 112.066 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.6 p-90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.308 -0.853 . . . . 75.24 109.997 174.66 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.82 0.343 . . . . 71.21 110.431 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -157.42 48.68 0.42 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.258 -0.428 . . . . 35.32 110.037 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.9 pm0 -86.39 107.2 12.55 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.372 0.606 . . . . 62.13 110.501 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.546 ' HG2' HG23 ' A' ' 85' ' ' VAL . 83.8 Cg_endo -101.86 -167.92 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 123.944 3.096 . . . . 62.22 113.014 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 177' ' ' ILE . 55.9 tp -136.5 115.79 12.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.199 -0.91 . . . . 74.15 108.77 172.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.572 ' HA ' HG23 ' A' ' 61' ' ' VAL . 33.7 tp -90.82 104.4 16.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.47 -0.567 . . . . 72.03 109.47 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.666 ' HB ' HD23 ' A' ' 62' ' ' LEU . 43.3 t -111.63 122.06 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.258 -0.428 . . . . 64.11 110.54 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.57 114.77 47.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.938 -0.574 . . . . 71.1 109.753 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.1 121.16 6.19 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.681 -0.968 . . . . 70.33 110.681 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.4 tp -119.88 124.0 44.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.017 0.437 . . . . 64.02 111.431 -172.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.81 -147.14 4.72 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.435 -0.666 . . . . 74.24 111.435 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -116.66 98.47 51.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.674 0.273 . . . . 63.34 111.208 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.0 118.37 5.39 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.689 2.259 . . . . 62.34 111.351 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.69 171.96 43.23 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.891 -0.671 . . . . 74.1 111.661 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -56.91 -72.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.843 2.362 . . . . 70.41 112.522 -177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -87.05 -15.01 39.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.41 0.624 . . . . 51.12 110.068 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -71.67 -23.62 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 74.13 111.546 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.36 -1.61 50.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.032 0.444 . . . . 73.04 110.98 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -108.86 15.56 23.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 73.04 110.454 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 150' ' ' VAL . 65.6 p -101.85 -170.38 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.153 -0.476 . . . . 51.31 110.739 -175.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -73.18 -4.94 36.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.909 0.385 . . . . 73.45 110.74 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -99.11 21.98 11.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.193 0.442 . . . . 72.54 112.193 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' MET . 39.2 p30 -101.37 -1.05 34.33 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.855 -0.338 . . . . 52.45 110.458 174.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.82 -37.12 70.77 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.969 -0.56 . . . . 74.2 111.381 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 93' ' ' ILE . . . -62.54 -32.85 84.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.055 -0.593 . . . . 50.41 112.355 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -90.31 -24.61 20.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.793 -0.24 . . . . 75.34 111.239 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.503 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 17.2 mmt -55.91 -51.42 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.786 0.327 . . . . 74.43 111.175 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 22.0 t -66.46 -40.71 87.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.271 -0.422 . . . . 65.15 110.364 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.9 99.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.141 -0.481 . . . . 74.01 111.666 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -60.33 -45.08 94.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 75.53 110.553 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.36 -43.82 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 71.33 110.77 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 92.5 mt -60.97 -39.32 89.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.433 -0.349 . . . . 75.24 111.156 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.77 -46.32 58.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 60.11 110.793 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.55 -34.41 89.87 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.766 -0.652 . . . . 75.11 113.42 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -20.27 62.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 117.033 0.416 . . . . 74.21 111.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.473 HD13 ' HA3' ' A' ' 53' ' ' GLY . 75.4 mt -87.05 -41.97 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.934 0.397 . . . . 74.13 110.151 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.31 -4.23 60.22 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.821 -0.627 . . . . 74.12 111.914 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 m -100.45 140.65 34.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.801 0.334 . . . . 61.14 110.485 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.46 143.06 30.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.322 -0.399 . . . . 74.51 111.315 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 1.061 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 3.3 p90 -60.57 142.04 55.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 72.25 111.144 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -117.81 147.47 42.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.26 -0.427 . . . . 73.43 110.852 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG22 ' HG2' ' A' ' 49' ' ' GLU . 39.5 t -75.87 128.54 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.953 -0.567 . . . . 63.22 110.169 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.437 ' CD2' ' HB ' ' A' ' 50' ' ' VAL . 27.1 m-70 -85.4 117.03 24.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.423 -0.353 . . . . 72.41 110.331 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -71.47 81.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.588 0.709 . . . . 74.25 111.175 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -175.52 -70.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.266 -0.879 . . . . 74.43 109.484 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.538 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 13.0 m -86.81 -27.95 23.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.745 -0.661 . . . . 55.11 110.662 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . 94.55 10.71 57.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 33.41 112.405 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 79' ' ' LEU . . . -97.49 157.59 15.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.785 0.326 . . . . 33.03 110.788 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.655 ' HG2' HG22 ' A' ' 42' ' ' VAL . 32.9 mt-10 -103.28 127.91 50.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.866 -0.606 . . . . 73.1 111.039 -175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 58.5 t -140.53 137.97 36.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 72.13 109.817 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.061 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 7.2 p -116.87 135.23 57.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.886 0.374 . . . . 72.41 111.097 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.581 HG22 HG12 ' A' ' 61' ' ' VAL . 20.2 p -100.85 108.13 19.83 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 75.12 110.492 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' HA3' HD13 ' A' ' 36' ' ' ILE . . . -127.72 -161.7 10.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.819 -0.705 . . . . 73.54 112.178 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -129.94 143.22 50.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.652 0.226 . . . . 70.43 110.548 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.081 HD22 ' HB ' ' A' ' 60' ' ' VAL . 2.0 pt? -142.28 121.17 12.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.184 -0.673 . . . . 73.44 109.184 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.8 -57.24 0.46 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.41 0.684 . . . . 75.31 111.862 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -171.37 -12.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.343 -0.456 . . . . 75.32 112.447 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 34.4 p -104.05 168.82 8.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.94 0.4 . . . . 71.32 110.899 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 t -90.86 99.64 12.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 71.14 110.565 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.081 ' HB ' HD22 ' A' ' 55' ' ' LEU . 11.6 p -76.17 129.94 36.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.54 -0.464 . . . . 63.13 109.872 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 52' ' ' THR . 17.6 m -118.45 111.22 33.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.494 0.664 . . . . 70.44 110.12 177.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD23 ' HB ' ' A' ' 7' ' ' VAL . 87.5 mt -92.6 117.92 30.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.759 . . . . 71.2 110.28 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.43 125.33 51.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.933 -0.576 . . . . 65.3 109.802 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -117.92 136.19 23.68 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.093 -0.503 . . . . 73.43 111.102 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.45 137.82 62.14 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.986 2.457 . . . . 71.32 111.477 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 32.5 ttt-85 -85.56 -52.78 5.59 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.741 -0.384 . . . . 74.11 110.08 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.2 p -159.44 139.17 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.467 -0.333 . . . . 54.52 110.997 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.548 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 20.5 t80 71.06 133.38 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.096 0.873 . . . . 55.5 111.802 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.446 ' HB3' ' CA ' ' A' ' 117' ' ' GLY . 2.0 mpt? -62.07 -56.43 19.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.424 -0.807 . . . . 75.14 112.038 -174.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -61.28 -41.58 97.19 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.394 -0.366 . . . . 74.42 111.834 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 9.0 mm-40 -63.68 -30.11 71.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.386 -0.37 . . . . 71.11 110.89 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 m -63.52 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 74.23 110.697 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' HA2' HG12 ' A' ' 121' ' ' VAL . . . -63.08 -38.16 96.12 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.573 -0.822 . . . . 35.23 111.098 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -80.58 1.41 29.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.057 0.456 . . . . 74.53 110.594 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 13.0 mm-40 -97.37 -51.8 4.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.919 -0.582 . . . . 74.31 110.07 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.65 -41.03 91.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 44.35 111.531 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.64 -65.3 3.41 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 116.189 -0.459 . . . . 72.43 113.083 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.63 -39.94 87.89 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.792 2.328 . . . . 75.12 112.873 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 48' ' ' ALA . 55.1 mt -64.7 -36.99 86.05 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.816 0.302 . . . . 61.32 111.816 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.22 -41.4 83.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.403 0.62 . . . . 50.22 110.337 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.39 -0.82 56.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 61.11 111.666 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -80.22 -49.05 12.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.949 0.404 . . . . 71.22 110.564 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.551 ' CE2' ' HB ' ' A' ' 85' ' ' VAL . 40.0 p90 -108.45 9.42 27.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.303 -0.408 . . . . 74.02 110.86 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.9 m 60.67 77.95 0.3 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.397 -0.82 . . . . 52.44 112.177 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 83' ' ' TYR . 12.9 p -107.45 130.94 22.12 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.15 -0.477 . . . . 44.43 109.901 175.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 22.3 Cg_endo -62.64 118.64 5.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.7 2.267 . . . . 70.3 112.4 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 2.8 Cg_exo -76.18 67.6 6.85 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.295 2.664 . . . . 64.44 112.097 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -146.04 -53.66 0.26 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 74.55 109.972 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -80.71 74.16 7.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.886 -0.597 . . . . 74.31 109.991 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.1 tt -121.86 141.53 41.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.948 -0.569 . . . . 64.4 110.455 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG23 HD11 ' A' ' 5' ' ' LEU . 94.9 t -127.99 110.17 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.035 -0.53 . . . . 70.45 109.846 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.2 106.14 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.142 -0.318 . . . . 54.24 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.538 HG22 ' HA2' ' A' ' 25' ' ' GLY . 66.2 mt -94.97 117.34 38.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.349 -0.387 . . . . 75.35 110.259 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -154.78 161.21 41.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.923 0.392 . . . . 73.01 110.407 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.46 149.53 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 74.24 110.599 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.634 ' HB3' HG22 ' A' ' 99' ' ' ILE . 5.9 tp10 -123.41 109.09 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.399 -0.593 . . . . 62.21 109.399 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.765 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 6.1 mp -68.95 -34.19 74.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.07 -0.514 . . . . 75.23 111.793 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -69.96 -31.16 68.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.978 -0.555 . . . . 52.35 112.186 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.634 HG22 ' HB3' ' A' ' 96' ' ' GLU . 14.8 tt -97.74 160.39 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.944 0.402 . . . . 65.51 111.461 -172.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.662 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 22.2 t70 -58.5 148.83 27.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.607 -0.724 . . . . 74.2 112.158 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 69.8 t80 -69.68 138.95 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.75 -0.659 . . . . 72.15 111.948 -171.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.09 9.92 86.53 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.526 -0.761 . . . . 63.44 113.026 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -100.45 116.43 32.38 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.719 -0.474 . . . . 63.2 109.719 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 104' ' ' ILE . 3.7 mp -79.98 106.43 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.446 -0.575 . . . . 61.41 109.446 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -109.06 150.06 28.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.98 -0.554 . . . . 73.21 109.905 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 131' ' ' HIS . 15.1 tp -113.14 146.67 38.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.665 -0.494 . . . . 72.35 109.665 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 131' ' ' HIS . 38.0 tttm -147.34 153.92 40.28 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.569 -0.53 . . . . 61.34 109.569 175.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.738 ' HG ' ' H ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -125.05 -71.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.281 0.363 . . . . 74.43 111.446 -176.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.738 ' H ' ' HG ' ' A' ' 108' ' ' LEU . . . -63.69 161.04 36.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.273 -0.489 . . . . 62.12 112.828 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.52 143.59 31.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.935 -0.65 . . . . 61.53 112.329 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.42 -176.64 42.06 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.298 -0.721 . . . . 62.35 111.298 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -81.07 150.13 28.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.197 0.522 . . . . 73.22 110.723 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.79 -59.56 0.4 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.743 -1.343 . . . . 73.4 109.743 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.836 ' HA3' HD21 ' A' ' 118' ' ' LEU . . . -91.48 163.97 29.01 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.67 -0.972 . . . . 53.15 110.67 170.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.575 ' O ' ' HD3' ' A' ' 119' ' ' ARG . 4.7 t-80 -119.09 -63.33 1.41 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.268 -0.573 . . . . 51.43 111.631 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -107.82 -71.16 0.77 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.809 -0.357 . . . . 64.13 111.882 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 69' ' ' MET . . . -51.62 -48.24 50.15 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.812 -0.631 . . . . 72.24 114.659 -167.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.836 HD21 ' HA3' ' A' ' 114' ' ' GLY . 3.5 pp -78.28 -19.36 53.78 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.293 -0.563 . . . . 72.44 111.827 -174.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.575 ' HD3' ' O ' ' A' ' 115' ' ' HIS . 18.1 mtp180 -81.11 -26.45 36.18 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.0 -0.28 . . . . 43.32 110.29 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.0 m -67.57 -50.17 59.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.458 -0.337 . . . . 75.02 110.705 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.508 HG12 ' HA2' ' A' ' 73' ' ' GLY . 29.4 m -65.87 -33.8 66.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 70.12 111.089 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.92 -31.17 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.419 . . . . 73.12 111.118 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.1 m -82.07 -28.91 32.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 75.04 110.545 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.45 -43.46 81.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.711 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.89 -41.5 59.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 75.04 109.743 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.7 62.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.617 -0.72 . . . . 43.04 112.25 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.481 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 6.6 m -108.54 148.01 30.91 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.843 -0.429 . . . . 73.02 109.843 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 11.6 mptt -117.2 -155.83 0.6 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.35 109.11 176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 66.4 t30 73.88 9.96 4.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.797 0.808 . . . . 73.14 109.654 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -87.83 127.58 35.34 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.331 -0.849 . . . . 65.13 109.791 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.76 ' HB2' HD11 ' A' ' 106' ' ' LEU . 35.2 p-80 -73.05 120.41 18.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.359 0.599 . . . . 74.53 111.694 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 106' ' ' LEU . 43.0 mtm105 -95.21 139.77 31.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.635 -0.711 . . . . 72.41 110.451 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.85 104.16 15.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.449 -0.945 . . . . 64.53 108.449 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.485 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 53.5 mtp180 -100.92 107.86 19.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.456 -0.793 . . . . 73.13 110.377 -172.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 135' ' ' ILE . 4.3 mp -93.81 113.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.609 . . . . 75.35 109.357 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 100' ' ' ASP . . . -57.46 138.5 48.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.136 -0.554 . . . . 73.31 113.904 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.765 ' HB ' ' HA ' ' A' ' 97' ' ' LEU . 89.6 t -88.98 -20.35 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 62.25 110.588 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 101' ' ' PHE . . . 130.33 -78.43 0.38 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.282 -0.961 . . . . 75.31 113.312 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.587 ' HD3' ' O ' ' A' ' 140' ' ' PRO . 0.2 OUTLIER -163.7 158.78 17.17 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 110.048 -0.353 . . . . 75.23 110.048 -174.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.587 ' O ' ' HD3' ' A' ' 139' ' ' ARG . 51.4 Cg_exo -55.43 159.65 10.3 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.018 2.479 . . . . 73.11 112.616 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.495 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 49.2 Cg_endo -67.12 161.45 42.73 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.707 2.272 . . . . 74.52 112.877 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -103.87 -86.87 1.97 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.73 . . . . 72.23 112.345 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -103.21 8.28 38.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 72.33 111.412 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -131.48 161.86 31.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.407 -0.361 . . . . 64.54 110.605 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.67 150.64 25.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 123.454 0.471 . . . . 64.24 111.445 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.88 -43.07 59.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.776 2.317 . . . . 70.44 112.075 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.34 -26.25 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.453 . . . . 60.02 111.072 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 151' ' ' LEU . . . -83.54 -27.8 29.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.416 -0.356 . . . . 60.41 110.949 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 86.3 t80 -67.65 -35.36 78.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.15 110.223 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.752 ' O ' ' HB ' ' A' ' 20' ' ' THR . 35.5 m -84.86 -6.22 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 74.1 111.021 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.697 HD23 HG21 ' A' ' 20' ' ' THR . 11.1 mt -90.78 6.12 45.54 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.174 0.435 . . . . 64.32 112.174 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -93.27 167.44 11.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.487 -0.485 . . . . 71.02 110.054 175.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -149.5 148.9 29.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.544 -0.298 . . . . 71.11 111.301 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.789 ' HA ' ' HG2' ' A' ' 159' ' ' ARG . 84.4 m-85 66.89 96.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.331 0 O-C-N 124.477 1.11 . . . . 75.13 112.313 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 13.3 p -114.68 -166.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.275 -0.875 . . . . 75.21 109.572 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -83.2 -72.69 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.846 0.684 . . . . 64.12 112.846 -171.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.67 -56.46 2.78 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.157 0.429 . . . . 63.4 112.157 -171.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.474 ' HB2' ' CD2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -65.81 -23.73 66.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.756 -0.656 . . . . 75.55 111.878 -171.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.789 ' HG2' ' HA ' ' A' ' 154' ' ' PHE . 3.3 tpp180 -71.97 -28.05 63.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.011 0.434 . . . . 75.21 110.396 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.432 ' O ' ' HD2' ' A' ' 163' ' ' PRO . . . -87.6 -11.11 49.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.957 -0.565 . . . . 61.41 110.183 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -86.6 -3.6 59.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.731 . . . . 75.11 111.058 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.695 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 95.8 t -57.87 -52.91 70.97 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.616 -0.265 . . . . 71.34 110.731 176.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 51.1 Cg_exo -55.84 -35.92 94.59 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.968 1.779 . . . . 73.44 111.977 173.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -64.35 -48.92 73.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 45.54 111.198 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 36.0 pt -79.93 -26.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 74.13 111.944 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 163' ' ' PRO . 9.3 p -68.48 -31.91 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.882 -0.327 . . . . 43.21 110.698 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 163' ' ' PRO . 44.8 mt-10 -64.68 -43.32 93.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.181 0.515 . . . . 73.44 109.621 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.63 -47.23 82.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.345 -0.843 . . . . 61.25 110.851 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.38 99.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.077 -0.511 . . . . 73.44 111.547 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.08 -44.12 96.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.022 0.439 . . . . 73.41 110.783 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.42 -39.04 81.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.004 -0.544 . . . . 73.43 110.687 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 176' ' ' LEU . . . -61.88 -42.03 98.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 44.33 111.062 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.6 m -61.62 -38.13 86.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 62.21 110.516 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -73.11 -34.01 65.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 72.25 110.252 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 56.2 tp -66.55 -27.3 67.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 73.52 110.832 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 172' ' ' ALA . 92.0 mt -61.29 -33.73 74.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.5 176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.479 HD11 HD13 ' A' ' 5' ' ' LEU . 38.0 mm -81.28 -46.62 20.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.938 -0.574 . . . . 53.3 110.938 176.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.79 -61.27 2.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.786 -0.643 . . . . 33.02 111.773 -176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.432 ' OE1' ' HA ' ' A' ' 179' ' ' GLN . 6.5 tp60 -93.14 -44.62 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 72.44 110.576 -175.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 183' ' ' PRO . . . 130.26 156.64 8.75 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.064 -0.814 . . . . 54.31 111.064 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.68 -27.73 66.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.164 0.482 . . . . 63.21 110.959 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.714 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 35.1 tt0 -72.5 -52.46 6.58 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.812 -0.631 . . . . 73.04 111.664 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.714 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 9.9 Cg_exo -73.89 -32.23 7.43 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.891 1.727 . . . . 62.14 112.895 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -64.3 -40.03 95.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 111.76 0.281 . . . . 54.42 111.76 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 9.9 pt20 -58.22 -30.75 66.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.645 0.259 . . . . 74.41 110.904 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.41 -47.86 74.81 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.617 -0.512 . . . . 72.32 109.617 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 98.4 m -59.03 -38.84 80.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.671 -0.695 . . . . 61.4 111.237 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 184' ' ' ALA . 99.5 t -58.47 -35.91 56.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.992 -0.549 . . . . 61.31 112.237 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.458 ' HD2' ' O ' ' A' ' 185' ' ' GLN . 9.4 p80 -106.8 15.22 25.79 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.116 -0.634 . . . . 71.33 110.675 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -97.86 6.52 47.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.103 -0.499 . . . . 72.44 111.496 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.489 -0.767 . . . . 73.23 110.105 176.303 . . . . . . . . 0 0 . 1 stop_ save_